Clustering O 0 0.06904537975788116
of O 0 0.021181095391511917
missense O 0 0.03875858336687088
mutations O 0 0.013400236144661903
in O 0 0.007602548226714134
the O 0 0.015167231671512127
ataxia B-Disease 1 1.0
- I-Disease 1 1.0
telangiectasia I-Disease 1 1.0
gene O 0 0.010036640800535679
in O 0 0.00500192167237401
a O 0 0.007311687804758549
sporadic B-Disease 0 0.038973819464445114
T I-Disease 1 1.0
- I-Disease 1 1.0
cell I-Disease 1 0.9998993873596191
leukaemia I-Disease 1 1.0
. O 0 0.034480832517147064

Ataxia B-Disease 1 1.0
- I-Disease 1 1.0
telangiectasia I-Disease 1 1.0
( O 0 0.015348563902080059
A B-Disease 1 0.9999954700469971
- I-Disease 1 1.0
T I-Disease 1 1.0
) O 0 0.005740001797676086
is O 0 0.0035779487807303667
a O 0 0.0052197640761733055
recessive B-Disease 0 0.3471715450286865
multi I-Disease 1 0.9999998807907104
- I-Disease 1 1.0
system I-Disease 1 0.999992847442627
disorder I-Disease 1 1.0
caused O 1 0.9990319013595581
by O 0 0.005253048148006201
mutations O 0 0.007037132512778044
in O 0 0.004765237215906382
the O 0 0.0068837543949484825
ATM O 0 0.179661825299263
gene O 0 0.007994355633854866
at O 0 0.008462310768663883
11q22 O 1 0.9994483590126038
- O 1 0.9999992847442627
q23 O 1 0.9998977184295654
( O 0 0.01344980113208294
ref O 1 0.999163031578064
. O 0 0.012244435027241707
3 O 0 0.024161212146282196
) O 0 0.01604282669723034
. O 0 0.02315131202340126

The O 0 0.020384345203638077
risk O 0 0.02318354696035385
of O 0 0.1172337457537651
cancer B-Disease 1 1.0
, O 0 0.26674380898475647
especially O 0 0.17775973677635193
lymphoid B-Disease 1 1.0
neoplasias I-Disease 1 0.9999998807907104
, O 0 0.007135515566915274
is O 0 0.005108913406729698
substantially O 0 0.00922329444438219
elevated O 0 0.027695432305336
in O 0 0.00499667227268219
A B-Disease 1 0.9994031190872192
- I-Disease 1 1.0
T I-Disease 1 1.0
patients O 1 0.999993085861206
and O 0 0.004249463323503733
has O 0 0.004838904831558466
long O 0 0.005052703432738781
been O 0 0.003771611489355564
associated O 0 0.005968764424324036
with O 0 0.00841674953699112
chromosomal O 1 0.9999998807907104
instability O 1 1.0
. O 0 0.23382879793643951

By O 0 0.026555843651294708
analysing O 0 0.06924542039632797
tumour B-Disease 1 1.0
DNA O 0 0.018061624839901924
from O 0 0.007482701912522316
patients O 0 0.013274074532091618
with O 0 0.005359341856092215
sporadic B-Disease 0 0.03351029008626938
T I-Disease 1 1.0
- I-Disease 1 0.9999998807907104
cell I-Disease 1 0.5408689379692078
prolymphocytic I-Disease 1 0.9999964237213135
leukaemia I-Disease 1 1.0
( O 1 0.6574851870536804
T B-Disease 1 1.0
- I-Disease 1 1.0
PLL I-Disease 1 1.0
) O 0 0.008680539205670357
, O 0 0.005461385007947683
a O 0 0.0066047850996255875
rare O 0 0.012522982433438301
clonal B-Disease 1 0.9999561309814453
malignancy I-Disease 1 1.0
with O 0 0.005443876143544912
similarities O 0 0.006250300444662571
to O 0 0.0038696443662047386
a O 0 0.006784659810364246
mature B-Disease 0 0.03829608112573624
T I-Disease 1 1.0
- I-Disease 1 1.0
cell I-Disease 1 0.8607322573661804
leukaemia I-Disease 1 0.9999998807907104
seen O 0 0.00794040597975254
in O 0 0.00516560347750783
A B-Disease 1 0.9999433755874634
- I-Disease 1 1.0
T I-Disease 1 1.0
, O 0 0.006970482412725687
we O 0 0.004000426270067692
demonstrate O 0 0.0069453176110982895
a O 0 0.006050414405763149
high O 0 0.008760323747992516
frequency O 0 0.008073283359408379
of O 0 0.007868706248700619
ATM O 0 0.23884694278240204
mutations O 0 0.014413388445973396
in O 0 0.013944677077233791
T B-Disease 1 1.0
- I-Disease 1 0.9999998807907104
PLL I-Disease 1 0.9999936819076538
. O 0 0.04797874763607979

In O 0 0.017725661396980286
marked O 0 0.019494304433465004
contrast O 0 0.009469366632401943
to O 0 0.005798970814794302
the O 0 0.007497547194361687
ATM O 1 0.730187177658081
mutation O 0 0.009667056612670422
pattern O 0 0.0064798034727573395
in O 0 0.0046967267990112305
A B-Disease 1 0.9997294545173645
- I-Disease 1 1.0
T I-Disease 1 1.0
, O 0 0.006633976474404335
the O 0 0.004775720648467541
most O 0 0.0052429065108299255
frequent O 0 0.008676501922309399
nucleotide O 0 0.011228205636143684
changes O 0 0.004994501359760761
in O 0 0.006872666999697685
this O 0 0.008940295316278934
leukaemia B-Disease 1 1.0
were O 0 0.014475397765636444
missense O 0 0.06073174253106117
mutations O 0 0.03334278613328934
. O 0 0.030484477058053017

These O 0 0.014349257573485374
clustered O 0 0.02481514774262905
in O 0 0.00614133570343256
the O 0 0.006017857696861029
region O 0 0.007301177829504013
corresponding O 0 0.005594109185039997
to O 0 0.004562166053801775
the O 0 0.007215029094368219
kinase O 0 0.23248524963855743
domain O 0 0.011087710037827492
, O 0 0.005545876454561949
which O 0 0.0035885232500731945
is O 0 0.003992414567619562
highly O 0 0.008104141801595688
conserved O 0 0.010416579432785511
in O 0 0.00686004338786006
ATM O 1 0.9948683977127075
- O 1 0.9999594688415527
related O 0 0.011234385892748833
proteins O 0 0.00908304937183857
in O 0 0.007331984117627144
mouse O 0 0.027504252269864082
, O 0 0.011007159017026424
yeast O 0 0.037444453686475754
and O 0 0.016792118549346924
Drosophila O 0 0.054889656603336334
. O 0 0.026691889390349388

The O 0 0.023488499224185944
resulting O 0 0.024794839322566986
amino O 0 0.02957744337618351
- O 1 0.9999963045120239
acid O 0 0.03334953263401985
substitutions O 0 0.01763346791267395
are O 0 0.0036749194841831923
predicted O 0 0.00925028882920742
to O 0 0.00515920203179121
interfere O 0 0.011797905899584293
with O 0 0.009317100048065186
ATP O 1 0.9999990463256836
binding O 0 0.01938832737505436
or O 0 0.012035098858177662
substrate O 0 0.0357704721391201
recognition O 0 0.028226366266608238
. O 0 0.02895132638514042

Two O 0 0.014409627765417099
of O 0 0.014815974049270153
seventeen O 0 0.03721066564321518
mutated O 1 0.5154534578323364
T B-Disease 1 1.0
- I-Disease 1 1.0
PLL I-Disease 1 0.999984860420227
samples O 0 0.011774402111768723
had O 0 0.006416452117264271
a O 0 0.005719996988773346
previously O 0 0.007176680956035852
reported O 0 0.00867933314293623
A B-Disease 1 0.993757963180542
- I-Disease 1 1.0
T I-Disease 1 1.0
allele O 0 0.07250107079744339
. O 0 0.03606831282377243

In O 0 0.018960298970341682
contrast O 0 0.017409002408385277
, O 0 0.007851184345781803
no O 0 0.007154966238886118
mutations O 0 0.007542767096310854
were O 0 0.0034142727963626385
detected O 0 0.005490295123308897
in O 0 0.0039261807687580585
the O 0 0.007615366019308567
p53 O 0 0.13282053172588348
gene O 0 0.0075017353519797325
, O 0 0.004230992868542671
suggesting O 0 0.00409428495913744
that O 0 0.002393722767010331
this O 0 0.005566136445850134
tumour B-Disease 1 1.0
suppressor O 1 1.0
is O 0 0.006400566082447767
not O 0 0.003588528372347355
frequently O 0 0.006004702765494585
altered O 0 0.007827323861420155
in O 0 0.005804611835628748
this O 0 0.009682655334472656
leukaemia B-Disease 1 1.0
. O 0 0.02708761766552925

Occasional O 0 0.07434801757335663
missense O 0 0.06933312118053436
mutations O 0 0.021128183230757713
in O 0 0.008837342262268066
ATM O 0 0.04562146216630936
were O 0 0.004192471969872713
also O 0 0.004072496201843023
found O 0 0.003685642033815384
in O 0 0.006188530940562487
tumour B-Disease 1 1.0
DNA O 0 0.007584602106362581
from O 0 0.004053244832903147
patients O 0 0.012236259877681732
with O 0 0.0049310666508972645
B B-Disease 1 0.9999998807907104
- I-Disease 1 0.9999998807907104
cell I-Disease 0 0.021290650591254234
non I-Disease 0 0.07958538085222244
- I-Disease 1 1.0
Hodgkins I-Disease 1 1.0
lymphomas I-Disease 1 1.0
( O 0 0.06946957856416702
B B-Disease 1 1.0
- I-Disease 1 0.9999996423721313
NHL I-Disease 1 0.9224162101745605
) O 0 0.005499391350895166
and O 0 0.004286619368940592
a O 0 0.009002701379358768
B B-Disease 1 0.9999964237213135
- I-Disease 1 0.9999990463256836
NHL I-Disease 1 0.9998546838760376
cell O 0 0.09677128493785858
line O 0 0.029357563704252243
. O 0 0.021546242758631706

The O 0 0.01629416085779667
evidence O 0 0.00664878636598587
of O 0 0.0049548461101949215
a O 0 0.005407300312072039
significant O 0 0.0046215360052883625
proportion O 0 0.005314551293849945
of O 0 0.004650093149393797
loss O 1 0.9381732940673828
- O 1 0.9999990463256836
of O 0 0.018380234017968178
- O 1 0.9999998807907104
function O 0 0.008287043310701847
mutations O 0 0.0061199115589261055
and O 0 0.0030636615119874477
a O 0 0.004538446664810181
complete O 0 0.007270046044141054
absence O 0 0.008801581338047981
of O 0 0.005264387000352144
the O 0 0.00599321536719799
normal O 0 0.006652534939348698
copy O 0 0.012295608408749104
of O 0 0.008008288219571114
ATM O 0 0.028835460543632507
in O 0 0.005136847496032715
the O 0 0.005513988900929689
majority O 0 0.006266070995479822
of O 0 0.009808482602238655
mutated O 1 0.9285259246826172
tumours B-Disease 1 1.0
establishes O 1 0.9997569918632507
somatic O 1 0.9951751232147217
inactivation O 1 0.999996542930603
of O 0 0.009023076854646206
this O 0 0.00449963565915823
gene O 0 0.005347083788365126
in O 0 0.003427686169743538
the O 0 0.006079630460590124
pathogenesis O 1 0.9995019435882568
of O 0 0.008325205184519291
sporadic B-Disease 1 0.9855650067329407
T I-Disease 1 1.0
- I-Disease 1 1.0
PLL I-Disease 1 0.9999995231628418
and O 0 0.00816425308585167
suggests O 0 0.007941066287457943
that O 0 0.004198751412332058
ATM O 0 0.029645580798387527
acts O 0 0.007753294426947832
as O 0 0.008591786026954651
a O 0 0.04063721001148224
tumour B-Disease 1 1.0
suppressor O 1 0.9999998807907104
. O 0 0.038378432393074036

As O 0 0.017185969278216362
constitutional O 0 0.020713791251182556
DNA O 0 0.01545660849660635
was O 0 0.009372367523610592
not O 0 0.0031753110233694315
available O 0 0.004107109736651182
, O 0 0.0039886184968054295
a O 0 0.007012285757809877
putative O 0 0.16257232427597046
hereditary O 1 0.9999998807907104
predisposition O 1 0.9999998807907104
to O 1 0.9127720594406128
T B-Disease 1 1.0
- I-Disease 1 1.0
PLL I-Disease 1 0.9999990463256836
will O 0 0.009676867164671421
require O 0 0.0074620554223656654
further O 0 0.007751160766929388
investigation O 0 0.013255064375698566
. O 0 0.012922941707074642
. O 0 0.02151891589164734

Myotonic B-Disease 1 1.0
dystrophy I-Disease 1 1.0
protein O 1 0.9985418319702148
kinase O 1 0.9795498251914978
is O 0 0.007106316275894642
involved O 0 0.004702485166490078
in O 0 0.0038485899567604065
the O 0 0.005145934410393238
modulation O 0 0.013130436651408672
of O 0 0.0060435133054852486
the O 0 0.011298072524368763
Ca2 O 1 0.9999936819076538
+ O 1 0.9984719157218933
homeostasis O 1 0.9999579191207886
in O 0 0.03131149709224701
skeletal O 1 1.0
muscle O 1 1.0
cells O 0 0.23208150267601013
. O 0 0.031019829213619232

Myotonic B-Disease 1 1.0
dystrophy I-Disease 1 1.0
( O 1 0.9999996423721313
DM B-Disease 1 1.0
) O 0 0.01294614840298891
, O 0 0.006016477011144161
the O 0 0.005427422467619181
most O 0 0.006790240295231342
prevalent O 1 0.9999868869781494
muscular B-Disease 1 1.0
disorder I-Disease 1 1.0
in O 1 0.9942803382873535
adults O 0 0.4099781811237335
, O 0 0.005912587977945805
is O 0 0.00454931054264307
caused O 0 0.006802381481975317
by O 0 0.0042580910958349705
( O 0 0.009608916938304901
CTG O 1 0.9999994039535522
) O 0 0.012435082346200943
n O 0 0.025256672874093056
- O 1 0.9672673940658569
repeat O 0 0.022627145051956177
expansion O 0 0.014378841035068035
in O 0 0.006358914077281952
a O 0 0.008280963636934757
gene O 0 0.008948215283453465
encoding O 0 0.00858205184340477
a O 0 0.008690360002219677
protein O 0 0.01596551015973091
kinase O 0 0.03861206769943237
( O 0 0.01859341375529766
DM B-Disease 1 1.0
protein O 0 0.04374299198389053
kinase O 0 0.36070016026496887
; O 0 0.013886679895222187
DMPK O 1 0.9999994039535522
) O 0 0.008158734068274498
and O 0 0.0059860870242118835
involves O 0 0.007419462315738201
changes O 0 0.004985552281141281
in O 0 0.007872928865253925
cytoarchitecture O 1 0.9998506307601929
and O 0 0.016690438613295555
ion O 1 0.9999533891677856
homeostasis O 1 0.9999915361404419
. O 0 0.040805794298648834

To O 0 0.01682182215154171
obtain O 0 0.014606785029172897
clues O 0 0.0143740838393569
to O 0 0.005782934837043285
the O 0 0.006114160642027855
normal O 0 0.007105034310370684
biological O 0 0.008655479177832603
role O 0 0.00774541636928916
of O 0 0.00808099564164877
DMPK O 1 0.9999818801879883
in O 0 0.010077901184558868
cellular O 1 0.9998791217803955
ion O 1 0.9999529123306274
homeostasis O 1 0.9999834299087524
, O 0 0.007745613809674978
we O 0 0.0035695102997124195
have O 0 0.002865763148292899
compared O 0 0.0056872982531785965
the O 0 0.007370414678007364
resting O 1 0.9068793654441833
[ O 0 0.15631867945194244
Ca2 O 1 0.9999868869781494
+ O 1 0.9839832782745361
] O 0 0.02918556146323681
i O 0 0.011874636635184288
, O 0 0.006126943975687027
the O 0 0.006699466612190008
amplitude O 0 0.01444352138787508
and O 0 0.0061157201416790485
shape O 0 0.010964359156787395
of O 0 0.009126387536525726
depolarization O 1 1.0
- O 1 1.0
induced O 1 1.0
Ca2 O 1 0.9999998807907104
+ O 1 0.9978524446487427
transients O 0 0.06658708304166794
, O 0 0.007823140360414982
and O 0 0.0049120900221168995
the O 0 0.004565192386507988
content O 0 0.0061123003251850605
of O 0 0.008538544178009033
ATP O 1 0.9999998807907104
- O 1 0.9999984502792358
driven O 0 0.03483680635690689
ion O 0 0.0470685176551342
pumps O 0 0.03354768082499504
in O 0 0.009982269257307053
cultured O 1 0.6716485023498535
skeletal O 1 0.9999997615814209
muscle O 1 0.99997878074646
cells O 0 0.009249415248632431
of O 0 0.006725689861923456
wild O 0 0.009736526757478714
- O 1 0.9999959468841553
type O 0 0.010691234841942787
and O 0 0.006434370297938585
DMPK O 1 0.9999990463256836
[ O 0 0.48742493987083435
- O 1 1.0
/ O 1 0.9999997615814209
- O 1 1.0
] O 1 0.9723818302154541
knockout O 1 0.9997898936271667
mice O 0 0.05389392748475075
. O 0 0.03217081353068352

In O 0 0.023696256801486015
vitro O 0 0.048147041350603104
- O 1 0.9924759268760681
differentiated O 0 0.24261878430843353
DMPK O 1 0.9999954700469971
[ O 0 0.47810661792755127
- O 1 0.9999998807907104
/ O 1 0.9999977350234985
- O 1 0.9999991655349731
] O 0 0.034178368747234344
myotubes O 0 0.06498942524194717
exhibit O 0 0.015078285709023476
a O 0 0.008620713837444782
higher O 0 0.00959069188684225
resting O 1 0.9560320973396301
[ O 0 0.4042155146598816
Ca2 O 1 0.9999923706054688
+ O 1 0.994986891746521
] O 0 0.026500891894102097
i O 0 0.008700652047991753
than O 0 0.003866649465635419
do O 0 0.004589573945850134
wild O 0 0.010814662091434002
- O 1 0.9998925924301147
type O 0 0.03149203956127167
myotubes O 1 0.9849087595939636
because O 0 0.005185418296605349
of O 0 0.004446133505553007
an O 0 0.0042314687743783
altered O 0 0.009120618924498558
open O 0 0.008237741887569427
probability O 0 0.00528687285259366
of O 0 0.006675947457551956
voltage O 0 0.020943354815244675
- O 1 0.9999141693115234
dependent O 0 0.015442165546119213
l O 1 0.9919326901435852
- O 1 0.9999465942382812
type O 0 0.06992688775062561
Ca2 O 1 0.99886155128479
+ O 0 0.05899476259946823
and O 0 0.018623510375618935
Na O 1 0.9999996423721313
+ O 0 0.11984722316265106
channels O 0 0.027869926765561104
. O 0 0.023668065667152405

The O 0 0.039734337478876114
mutant O 0 0.07889292389154434
myotubes O 1 0.853204071521759
exhibit O 0 0.030681293457746506
smaller O 0 0.015086203813552856
and O 0 0.010237415321171284
slower O 0 0.03010791540145874
Ca2 O 1 0.9930239915847778
+ O 0 0.033186379820108414
responses O 0 0.015123552642762661
upon O 0 0.011967320926487446
triggering O 0 0.020986566320061684
by O 0 0.008043601177632809
acetylcholine O 0 0.03435949608683586
or O 0 0.007910487242043018
high O 0 0.032503463327884674
external O 0 0.08817854523658752
K O 1 0.9999653100967407
+ O 0 0.12500473856925964
. O 0 0.03223796188831329

In O 0 0.016013963147997856
addition O 0 0.011338894255459309
, O 0 0.006420587655156851
we O 0 0.003380631096661091
observed O 0 0.0036299300845712423
that O 0 0.0028367293998599052
these O 0 0.004561347886919975
Ca2 O 1 0.999549925327301
+ O 1 0.9973862767219543
transients O 1 0.9914344549179077
partially O 0 0.02075454778969288
result O 0 0.007135940715670586
from O 0 0.004591238684952259
an O 0 0.005511406809091568
influx O 0 0.016946468502283096
of O 0 0.011631464585661888
extracellular O 0 0.18007491528987885
Ca2 O 1 0.988013505935669
+ O 0 0.02153799682855606
through O 0 0.006538589019328356
the O 0 0.00813946221023798
l O 1 0.999112069606781
- O 1 0.9999991655349731
type O 1 0.8680001497268677
Ca2 O 1 0.9995130300521851
+ O 0 0.0713663399219513
channel O 0 0.04062442108988762
. O 0 0.030113890767097473

Neither O 0 0.02953430451452732
the O 0 0.012020017020404339
content O 0 0.008315163664519787
nor O 0 0.007364623248577118
the O 0 0.005412985570728779
activity O 0 0.005434077233076096
of O 0 0.008788250386714935
Na O 1 1.0
+ O 1 0.9977904558181763
/ O 1 0.9995136260986328
K O 1 0.9838316440582275
+ O 0 0.08885441720485687
ATPase O 1 0.9788549542427063
and O 0 0.01961948350071907
sarcoplasmic O 1 0.9999992847442627
reticulum O 1 0.9999996423721313
Ca2 O 1 0.9999996423721313
+ O 1 0.9999891519546509
- O 1 0.9999996423721313
ATPase O 1 0.9976825714111328
are O 0 0.00661933608353138
affected O 0 0.013455210253596306
by O 0 0.0110104288905859
DMPK O 1 0.999998927116394
absence O 1 0.5270779132843018
. O 0 0.03089487925171852

In O 0 0.017174243927001953
conclusion O 0 0.012448885478079319
, O 0 0.006607851479202509
our O 0 0.0059076957404613495
data O 0 0.005258759018033743
suggest O 0 0.00648012850433588
that O 0 0.005408769007772207
DMPK O 1 0.9998974800109863
is O 0 0.007249930873513222
involved O 0 0.005376629065722227
in O 0 0.006371405441313982
modulating O 0 0.027578234672546387
the O 0 0.006978113669902086
initial O 0 0.00878885667771101
events O 0 0.00603885855525732
of O 0 0.007732022553682327
excitation O 1 0.9239782094955444
- O 1 1.0
contraction O 1 0.9954013824462891
coupling O 0 0.03748878464102745
in O 0 0.020198343321681023
skeletal O 1 0.9999998807907104
muscle O 1 0.9999958276748657
. O 0 0.019529785960912704
. O 0 0.026394695043563843

Constitutional O 0 0.0704607367515564
RB1 O 1 1.0
- O 1 0.9999997615814209
gene O 0 0.022385146468877792
mutations O 0 0.011306620202958584
in O 0 0.007587560452520847
patients O 1 0.9718215465545654
with O 0 0.008378250524401665
isolated O 1 0.6582725048065186
unilateral B-Disease 1 0.8162108659744263
retinoblastoma I-Disease 1 1.0
. O 0 0.039111070334911346

In O 0 0.015138886868953705
most O 0 0.009468980133533478
patients O 0 0.030203912407159805
with O 0 0.006136518437415361
isolated O 0 0.018901193514466286
unilateral B-Disease 1 0.9343400001525879
retinoblastoma I-Disease 1 1.0
, O 1 0.9995476603507996
tumor B-Disease 1 1.0
development O 0 0.13326655328273773
is O 0 0.007069413084536791
initiated O 0 0.01774952933192253
by O 0 0.008334193378686905
somatic O 0 0.03448373079299927
inactivation O 1 0.9852584600448608
of O 0 0.008578425273299217
both O 0 0.007182663772255182
alleles O 0 0.01614765264093876
of O 0 0.010299592278897762
the O 0 0.022200806066393852
RB1 O 1 1.0
gene O 0 0.03769231587648392
. O 0 0.028397629037499428

However O 0 0.012639608234167099
, O 0 0.005643357988446951
some O 0 0.0028771136421710253
of O 0 0.003946568816900253
these O 0 0.0032587344758212566
patients O 1 0.8355518579483032
can O 0 0.005912290420383215
transmit O 1 0.9869263172149658
retinoblastoma B-Disease 1 1.0
predisposition O 1 0.9999992847442627
to O 0 0.014320758171379566
their O 0 0.012486282736063004
offspring O 0 0.03771393746137619
. O 0 0.02841445989906788

To O 0 0.015164089389145374
determine O 0 0.009962675161659718
the O 0 0.007862730883061886
frequency O 0 0.007145650219172239
and O 0 0.004493304993957281
nature O 0 0.005569692235440016
of O 0 0.006006988696753979
constitutional O 0 0.027583304792642593
RB1 O 1 1.0
- O 1 1.0
gene O 0 0.015355432406067848
mutations O 0 0.008650366216897964
in O 0 0.005637616850435734
patients O 1 0.5658553242683411
with O 0 0.005328197497874498
isolated O 0 0.1644369661808014
unilateral B-Disease 1 0.9331830143928528
retinoblastoma I-Disease 1 1.0
, O 0 0.005869677290320396
we O 0 0.0035106658469885588
analyzed O 0 0.00564712705090642
DNA O 0 0.006560002453625202
from O 0 0.005100187845528126
peripheral O 1 0.9999977350234985
blood O 1 0.9942611455917358
and O 0 0.03337056562304497
from O 1 0.977797269821167
tumor B-Disease 1 1.0
tissue O 1 0.9999997615814209
. O 0 0.03555464744567871

The O 0 0.01570373959839344
analysis O 0 0.010240198113024235
of O 0 0.009385453537106514
tumors B-Disease 1 0.9999957084655762
from O 0 0.005925229750573635
54 O 0 0.02220367267727852
( O 0 0.007905235514044762
71 O 0 0.021236907690763474
% O 0 0.0070686363615095615
) O 0 0.005540151614695787
of O 0 0.00695250416174531
76 O 0 0.042384982109069824
informative O 0 0.027821380645036697
patients O 0 0.055383872240781784
showed O 0 0.010324273258447647
loss O 0 0.012241627089679241
of O 0 0.007178457919508219
constitutional O 0 0.06435640901327133
heterozygosity O 1 1.0
( O 1 0.9441888332366943
LOH O 1 1.0
) O 0 0.022729044780135155
at O 0 0.029596038162708282
intragenic O 1 0.9965866804122925
loci O 0 0.06485474854707718
. O 0 0.03276962414383888

Three O 0 0.014748923480510712
of O 0 0.014629121869802475
13 O 0 0.02493572048842907
uninformative O 1 0.999991774559021
patients O 1 0.9998311996459961
had O 0 0.018179161474108696
constitutional O 0 0.03573836386203766
deletions O 0 0.08255402743816376
. O 0 0.03131323680281639

For O 0 0.019020570442080498
39 O 0 0.029844531789422035
randomly O 0 0.018155362457036972
selected O 0 0.024518141523003578
tumors B-Disease 1 0.9999898672103882
, O 0 0.013235246762633324
SSCP O 1 0.9999994039535522
, O 0 0.016610724851489067
hetero O 1 0.9999997615814209
- O 1 0.9999998807907104
duplex O 1 0.9790573120117188
analysis O 0 0.008573965169489384
, O 0 0.005820194259285927
sequencing O 0 0.011640556156635284
, O 0 0.005214577075093985
and O 0 0.004793680738657713
Southern O 0 0.010354891419410706
blot O 1 0.9895846247673035
analysis O 0 0.005560317076742649
were O 0 0.003417433239519596
used O 0 0.004011385142803192
to O 0 0.006185009144246578
identify O 0 0.014644154347479343
mutations O 0 0.019295448437333107
. O 0 0.021256931126117706

Mutations O 0 0.02745557762682438
were O 0 0.0061455583199858665
detected O 0 0.009463798254728317
in O 0 0.0051086037419736385
21 O 0 0.00866018608212471
( O 0 0.007112964056432247
91 O 0 0.02311379462480545
% O 0 0.006577926222234964
) O 0 0.005031396634876728
of O 0 0.008759399875998497
23 O 0 0.19331610202789307
tumors B-Disease 1 1.0
with O 0 0.3477848470211029
LOH O 1 1.0
. O 0 0.04734454303979874

In O 0 0.015939274802803993
6 O 0 0.02067861147224903
( O 0 0.009938829578459263
38 O 0 0.01730976067483425
% O 0 0.007414796389639378
) O 0 0.005577639676630497
of O 0 0.0075258733704686165
16 O 0 0.022282075136899948
tumors B-Disease 1 1.0
without O 0 0.01725662499666214
LOH O 1 1.0
, O 0 0.010017210617661476
one O 0 0.007654616143554449
mutation O 0 0.010295474901795387
was O 0 0.007403144147247076
detected O 0 0.007536287419497967
, O 0 0.003788539208471775
and O 0 0.0029644942842423916
in O 0 0.003665498225018382
9 O 0 0.008328096009790897
( O 0 0.0057684555649757385
56 O 0 0.013000343926250935
% O 0 0.0054974001832306385
) O 0 0.004060251638293266
of O 0 0.005497107282280922
the O 0 0.010776350274682045
tumors B-Disease 1 1.0
without O 0 0.04336472973227501
LOH O 1 1.0
, O 0 0.012639347463846207
both O 0 0.008222823031246662
mutations O 0 0.010711660608649254
were O 0 0.005646160803735256
found O 0 0.009962313808500767
. O 0 0.016237789765000343

Thus O 0 0.019266173243522644
, O 0 0.006747868377715349
a O 0 0.006048860959708691
total O 0 0.005313001107424498
of O 0 0.006325450260192156
45 O 0 0.012351348996162415
mutations O 0 0.006999621633440256
were O 0 0.003151939483359456
identified O 0 0.005389861762523651
in O 0 0.007248064037412405
tumors B-Disease 1 0.9999978542327881
of O 0 0.015698691830039024
36 O 1 0.9496661424636841
patients O 1 0.999977707862854
. O 0 0.024249263107776642

Thirty O 0 0.0559629462659359
- O 0 0.0698438361287117
nine O 0 0.010533374734222889
of O 0 0.005805338732898235
the O 0 0.0062297917902469635
mutations O 0 0.008656910620629787
- O 1 0.9738107323646545
including O 0 0.00480622285977006
34 O 0 0.010492111556231976
small O 0 0.005926915444433689
mutations O 0 0.006192650180310011
, O 0 0.00390425231307745
2 O 0 0.008076891303062439
large O 0 0.006346471142023802
structural O 1 0.9569475650787354
alterations O 0 0.03175150230526924
, O 0 0.005994417238980532
and O 0 0.005446079187095165
hypermethylation O 1 0.9996557235717773
in O 0 0.00667990418151021
3 O 1 0.6805397868156433
tumors O 1 1.0
- O 1 0.9999970197677612
were O 0 0.003982475958764553
not O 0 0.0029250415973365307
detected O 0 0.005265190731734037
in O 0 0.0038925993721932173
the O 0 0.007174449507147074
corresponding O 0 0.01590771973133087
peripheral O 1 0.9999997615814209
blood O 1 0.9976693987846375
DNA O 0 0.03550688177347183
. O 0 0.029651498422026634

In O 0 0.015030990354716778
6 O 0 0.017287615686655045
( O 0 0.008642861619591713
17 O 0 0.01061198115348816
% O 0 0.005771891679614782
) O 0 0.0038868205156177282
of O 0 0.0036165269557386637
the O 0 0.004927446600049734
36 O 0 0.013391992077231407
patients O 1 0.6087392568588257
, O 0 0.0046790773048996925
a O 0 0.006762498989701271
mutation O 0 0.008223977871239185
was O 0 0.00743924779817462
detected O 0 0.0065700034610927105
in O 0 0.003294522874057293
constitutional O 0 0.008234555833041668
DNA O 0 0.007111671380698681
, O 0 0.0036532869562506676
and O 0 0.0027289921417832375
1 O 0 0.005577174015343189
of O 0 0.004110540263354778
these O 0 0.0025438901502639055
mutations O 0 0.004712971858680248
is O 0 0.0030554889235645533
known O 0 0.004151610191911459
to O 0 0.0032207202166318893
be O 0 0.002914902986958623
associated O 0 0.0054154046811163425
with O 0 0.007034400478005409
reduced O 0 0.03050820901989937
expressivity O 1 0.9999977350234985
. O 0 0.030911458656191826

The O 0 0.01642952673137188
presence O 0 0.009630158543586731
of O 0 0.005654763430356979
a O 0 0.0062565915286540985
constitutional O 0 0.01160756591707468
mutation O 0 0.010834237560629845
was O 0 0.006589321885257959
not O 0 0.0027048217598348856
associated O 0 0.0033543522004038095
with O 0 0.002685446757823229
an O 0 0.0038354152347892523
early O 0 0.007477759383618832
age O 0 0.011971539817750454
at O 0 0.022116459906101227
treatment O 1 0.9985052347183228
. O 0 0.02504384145140648

In O 0 0.020209554582834244
1 O 0 0.029334189370274544
patient O 1 0.7865299582481384
, O 0 0.014536951668560505
somatic O 1 0.7611008286476135
mosaicism O 1 0.9999897480010986
was O 0 0.016953222453594208
demonstrated O 0 0.011542334221303463
by O 0 0.0044266232289373875
molecular O 0 0.009314658120274544
analysis O 0 0.004819030407816172
of O 0 0.004836432635784149
DNA O 0 0.009070946834981441
and O 0 0.006534428335726261
RNA O 0 0.020802373066544533
from O 0 0.012996827252209187
peripheral O 1 0.9999982118606567
blood O 1 0.9785308241844177
. O 0 0.02769000083208084

In O 0 0.020012274384498596
2 O 0 0.02389320358633995
patients O 0 0.02371901087462902
without O 0 0.004766267724335194
a O 0 0.008543676696717739
detectable O 0 0.42264947295188904
mutation O 0 0.012334642000496387
in O 0 0.0077691697515547276
peripheral O 1 1.0
blood O 1 0.9999200105667114
, O 0 0.03442211449146271
mosaicism O 1 0.9999997615814209
was O 0 0.012602980248630047
suggested O 0 0.005921324249356985
because O 0 0.003426510374993086
1 O 0 0.006616984028369188
of O 0 0.004280197434127331
the O 0 0.0064667826518416405
patients O 1 0.999812662601471
showed O 1 0.9960771203041077
multifocal O 1 1.0
tumors B-Disease 1 1.0
and O 0 0.008335486985743046
the O 0 0.0069992863573133945
other O 0 0.005101647228002548
later O 0 0.009942663833498955
developed O 0 0.019813809543848038
bilateral B-Disease 0 0.4717327952384949
retinoblastoma I-Disease 1 0.9999995231628418
. O 0 0.03861996904015541

In O 0 0.01890246756374836
conclusion O 0 0.015219821594655514
, O 0 0.007486754562705755
our O 0 0.006415983662009239
results O 0 0.005967825651168823
emphasize O 0 0.010953810065984726
that O 0 0.0031465417705476284
the O 0 0.006298431660979986
manifestation O 1 0.9826550483703613
and O 0 0.009112823754549026
transmissibility O 1 0.9999988079071045
of O 0 0.46980923414230347
retinoblastoma B-Disease 1 1.0
depend O 0 0.008264033123850822
on O 0 0.004491726867854595
the O 0 0.004926550202071667
nature O 0 0.003998532425612211
of O 0 0.004027084913104773
the O 0 0.004296392668038607
first O 0 0.006997775752097368
mutation O 0 0.006962123792618513
, O 0 0.003035865956917405
its O 0 0.003219330683350563
time O 0 0.003341715782880783
in O 0 0.0030211114790290594
development O 0 0.004165180027484894
, O 0 0.002917374949902296
and O 0 0.002391157438978553
the O 0 0.002765769837424159
number O 0 0.0021843642462044954
and O 0 0.0025320155546069145
types O 0 0.0035852729342877865
of O 0 0.004386120475828648
cells O 0 0.005276771262288094
that O 0 0.002911483170464635
are O 0 0.0027414567302912474
affected O 0 0.008442822843790054
. O 0 0.00923710037022829
. O 0 0.01757439784705639

Hereditary B-Disease 1 1.0
deficiency I-Disease 1 1.0
of I-Disease 0 0.036656565964221954
the I-Disease 0 0.019312750548124313
fifth I-Disease 1 0.9999442100524902
component I-Disease 1 0.8215818405151367
of I-Disease 0 0.013362362049520016
complement I-Disease 0 0.02916758507490158
in O 0 0.01330957654863596
man O 0 0.028444675728678703
. O 0 0.023276621475815773

I O 0 0.12772713601589203
. O 0 0.04970258101820946

Clinical O 1 0.9999269247055054
, O 0 0.021208614110946655
immunochemical O 1 0.9999840259552002
, O 0 0.01279608253389597
and O 0 0.010147740133106709
family O 0 0.018356721848249435
studies O 0 0.01812889240682125
. O 0 0.01967471092939377

The O 0 0.019606534391641617
first O 0 0.01345562282949686
recognized O 0 0.011556967161595821
human O 0 0.010114978067576885
kindred O 1 0.9999759197235107
with O 0 0.13159649074077606
hereditary B-Disease 1 1.0
deficiency I-Disease 1 1.0
of I-Disease 1 0.9997110962867737
the I-Disease 1 0.7733117938041687
fifth I-Disease 1 0.9997650980949402
component I-Disease 1 0.7355260252952576
of I-Disease 0 0.010568185709416866
complement I-Disease 1 0.8231895565986633
( O 0 0.02067619375884533
C5 O 1 0.9999998807907104
) O 0 0.014216963201761246
is O 0 0.012893068604171276
described O 0 0.019354723393917084
. O 0 0.020287124440073967

The O 0 0.027387429028749466
proband O 0 0.15785081684589386
, O 0 0.007001630030572414
a O 0 0.005823757499456406
20 O 0 0.008086043410003185
- O 1 0.9972463846206665
year O 0 0.006710607558488846
- O 1 0.9997896552085876
old O 0 0.014511187560856342
black O 0 0.010447998531162739
female O 0 0.008749308995902538
with O 0 0.06042361631989479
systemic B-Disease 1 1.0
lupus I-Disease 1 1.0
erythematosus I-Disease 1 1.0
since O 1 0.9999996423721313
age O 1 0.9969370365142822
11 O 0 0.014793661423027515
, O 0 0.009554962627589703
lacked O 1 0.9755575656890869
serum O 1 1.0
hemolytic O 1 1.0
complement O 1 0.9987648725509644
activity O 0 0.011441659182310104
, O 0 0.007449247408658266
even O 0 0.008184642530977726
during O 0 0.015329224988818169
remission O 1 0.9998231530189514
. O 0 0.03080742619931698

C5 O 1 0.9999991655349731
was O 0 0.08950261771678925
undetectable O 1 0.9991720914840698
in O 0 0.010921178385615349
her O 0 0.016143381595611572
serum O 1 0.9914809465408325
by O 0 0.005592454224824905
both O 0 0.008990601636469364
immunodiffusion O 1 0.9999748468399048
and O 0 0.2137436717748642
hemolytic O 1 1.0
assays O 1 0.9833695292472839
. O 0 0.031196564435958862

Other O 0 0.018797636032104492
complement O 0 0.031159546226263046
components O 0 0.015810109674930573
were O 0 0.004787934012711048
normal O 0 0.006475568749010563
during O 0 0.008832769468426704
remission O 1 0.9998772144317627
of O 1 0.9139474034309387
lupus O 1 1.0
, O 1 0.7595301270484924
but O 0 0.011186123825609684
C1 O 1 1.0
, O 0 0.017220022156834602
C4 O 1 1.0
, O 0 0.019474441185593605
C2 O 1 1.0
, O 0 0.009954900480806828
and O 0 0.010922260582447052
C3 O 1 1.0
levels O 0 0.0447995588183403
fell O 1 0.998665452003479
during O 0 0.031203847378492355
exacerbations O 1 0.9999998807907104
. O 0 0.03994651511311531

A O 0 0.030220316722989082
younger O 0 0.025489557534456253
half O 0 0.014790709130465984
- O 1 0.9999831914901733
sister O 0 0.01688099466264248
, O 0 0.004165769554674625
who O 0 0.003905782476067543
had O 0 0.0035930797457695007
no O 0 0.00526055321097374
underlying O 1 0.9999996423721313
disease O 1 1.0
, O 1 0.8834978342056274
was O 1 0.9604219794273376
also O 0 0.003855414455756545
found O 0 0.0038593984209001064
to O 0 0.005529338028281927
lack O 0 0.017749538645148277
immunochemically O 1 0.9999998807907104
detectable O 1 0.999998927116394
C5 O 1 0.9999997615814209
. O 0 0.04417983442544937

By O 0 0.029096588492393494
hemolytic O 1 1.0
assay O 1 0.9851247072219849
, O 0 0.0103445528075099
she O 0 0.00964609906077385
exhibited O 0 0.013881822116672993
1 O 0 0.016840333119034767
- O 1 0.9980295300483704
2 O 0 0.010451012291014194
% O 0 0.004566800314933062
of O 0 0.004580390173941851
the O 0 0.006160744931548834
normal O 0 0.011748907156288624
serum O 1 0.9999988079071045
C5 O 1 1.0
level O 0 0.01370050385594368
and O 0 0.007935861125588417
normal O 0 0.009534222073853016
concentrations O 0 0.014672034420073032
of O 0 0.007903281599283218
other O 0 0.00841263122856617
complement O 0 0.032334618270397186
components O 0 0.03756803646683693
. O 0 0.02718507871031761

C5 O 1 0.999974250793457
levels O 0 0.02083737775683403
of O 0 0.010274418629705906
other O 0 0.005404462106525898
family O 0 0.0072940378449857235
members O 0 0.003816616255789995
were O 0 0.002961245598271489
either O 0 0.0032290311064571142
normal O 0 0.003486701287329197
or O 0 0.0031588778365403414
approximately O 0 0.005127948243170977
half O 0 0.007164714392274618
- O 1 0.9999674558639526
normal O 0 0.006453664507716894
, O 0 0.004637534264475107
consistent O 0 0.006653517950326204
with O 0 0.0060813939198851585
autosomal O 1 0.9933358430862427
codominant O 1 0.9999887943267822
inheritance O 0 0.02796783670783043
of O 0 0.008493845351040363
the O 0 0.010968376882374287
gene O 0 0.02257874608039856
determining O 0 0.3008032739162445
C5 B-Disease 1 1.0
deficiency I-Disease 1 1.0
. O 0 0.13165844976902008

Normal O 1 0.5910943150520325
hemolytic O 1 1.0
titers O 1 0.9999796152114868
were O 0 0.010049616917967796
restored O 0 0.016810359433293343
to O 0 0.006138688884675503
both O 0 0.006129031535238028
homozygous O 0 0.03322463855147362
C5 B-Disease 1 1.0
- I-Disease 1 1.0
deficient I-Disease 1 1.0
( O 1 0.777056872844696
C5D B-Disease 1 1.0
) O 0 0.01486627571284771
sera O 1 0.7861250042915344
by O 0 0.005189757328480482
addition O 0 0.0071864016354084015
of O 0 0.008054422214627266
highly O 0 0.0243820920586586
purified O 1 0.9977649450302124
human O 0 0.030125722289085388
C5 O 1 0.9999983310699463
. O 0 0.039958782494068146

In O 0 0.020805316045880318
specific O 0 0.018240517005324364
C5 O 1 0.9999996423721313
titrations O 1 0.9998601675033569
, O 0 0.01082158274948597
however O 0 0.005130466539412737
, O 0 0.0046990918926894665
it O 0 0.0034905255306512117
was O 0 0.006714616436511278
noted O 0 0.005380414426326752
that O 0 0.002536821411922574
when O 0 0.0033449933398514986
limited O 0 0.004518395755439997
amounts O 0 0.005736194085329771
of O 0 0.00886678695678711
C5 O 1 0.9999949932098389
were O 0 0.007761688902974129
assayed O 0 0.026801109313964844
in O 0 0.005347403697669506
the O 0 0.004472845233976841
presence O 0 0.005603650584816933
of O 0 0.005903382785618305
low O 0 0.011853236705064774
dilutions O 0 0.393980473279953
of O 0 0.008716327138245106
either O 0 0.011779401451349258
C5D B-Disease 1 1.0
serum O 1 0.9999996423721313
, O 0 0.012309415265917778
curving O 0 0.02601330541074276
rather O 0 0.005622355733066797
than O 0 0.004997810814529657
linear O 0 0.013604034669697285
dose O 1 0.9994051456451416
- O 1 0.9999696016311646
response O 0 0.011423900723457336
plots O 0 0.011870061047375202
were O 0 0.004136534873396158
consistently O 0 0.009738105349242687
obtained O 0 0.0075747244991362095
, O 0 0.006491153035312891
suggesting O 0 0.009100130759179592
some O 0 0.006251656915992498
inhibitory O 0 0.03589845076203346
effect O 0 0.01637253351509571
. O 0 0.022194718942046165

Further O 0 0.018297413364052773
studies O 0 0.009354334324598312
suggested O 0 0.00782399158924818
that O 0 0.004192360211163759
low O 0 0.012620147317647934
dilutions O 0 0.14982804656028748
of O 0 0.012765947729349136
C5D B-Disease 1 1.0
serum O 1 0.9999959468841553
contain O 0 0.010639673098921776
a O 0 0.008231931366026402
factor O 0 0.026851875707507133
( O 0 0.006398420315235853
or O 0 0.005096971057355404
factors O 0 0.006001803558319807
) O 0 0.005479586310684681
interfering O 0 0.009452000260353088
at O 0 0.006560835521668196
some O 0 0.002971900161355734
step O 0 0.007000979967415333
in O 0 0.0052672987803816795
the O 0 0.010071961209177971
hemolytic O 1 1.0
assay O 1 0.877101480960846
of O 0 0.09682141989469528
C5 O 1 0.9999998807907104
, O 0 0.008145677857100964
rather O 0 0.005016474053263664
than O 0 0.003809745889157057
a O 0 0.009851562790572643
true O 0 0.02276672050356865
C5 O 1 1.0
inhibitor O 1 0.9999955892562866
or O 0 0.01975274458527565
inactivator O 1 0.9993730187416077
. O 0 0.03629693761467934

Of O 0 0.02486298978328705
clinical O 1 0.9794794917106628
interest O 0 0.010445304214954376
are O 0 0.003993706312030554
( O 0 0.005949754733592272
a O 0 0.005900173913687468
) O 0 0.004517029505223036
the O 0 0.005425723269581795
documentation O 0 0.013075976632535458
of O 0 0.012600339949131012
membranous O 1 1.0
glomerulonephritis B-Disease 1 1.0
, O 1 0.9999974966049194
vasculitis B-Disease 1 1.0
, O 1 0.9998962879180908
and O 1 0.999992847442627
arthritis B-Disease 1 1.0
in O 0 0.38890963792800903
an O 0 0.00868501327931881
individual O 0 0.008221193216741085
lacking O 1 0.9985803365707397
C5 O 1 1.0
( O 0 0.006922672502696514
and O 0 0.004548472352325916
its O 0 0.006629006005823612
biologic O 1 0.9999306201934814
functions O 0 0.007181170862168074
) O 0 0.00489948783069849
, O 0 0.004510649014264345
and O 0 0.004746285267174244
( O 0 0.00815508421510458
b O 1 0.5428940057754517
) O 0 0.004956101533025503
a O 0 0.007218968588858843
remarkable O 0 0.014003375545144081
propensity O 1 0.6001399755477905
to O 0 0.012734721414744854
bacterial B-Disease 1 1.0
infections I-Disease 1 1.0
in O 0 0.009391156025230885
the O 0 0.027094531804323196
proband O 1 0.9999958276748657
, O 0 0.004751933738589287
even O 0 0.0036347724962979555
during O 0 0.0034769452176988125
periods O 0 0.004994610324501991
of O 0 0.004847286269068718
low O 0 0.06500428169965744
- O 1 0.9999945163726807
dose O 1 0.850110650062561
or O 0 0.005632531829178333
alternate O 0 0.015946276485919952
- O 1 0.9999963045120239
day O 0 0.0361221507191658
corticosteroid O 1 0.9999998807907104
therapy O 1 0.9999865293502808
. O 0 0.02997279167175293

Other O 0 0.014516451396048069
observations O 0 0.014524339698255062
indicate O 0 0.006770703475922346
that O 0 0.0034983993973582983
the O 0 0.007505780551582575
C5D B-Disease 1 0.9999998807907104
state O 0 0.004483516793698072
is O 0 0.0042316303588449955
compatible O 0 0.009053398855030537
with O 0 0.004658025689423084
normal O 0 0.010420526377856731
coagulation O 1 0.9999960660934448
function O 0 0.0072120679542422295
and O 0 0.004464249592274427
the O 0 0.006017252802848816
capacity O 0 0.009991632774472237
to O 0 0.008474129252135754
mount O 0 0.1949252039194107
a O 0 0.01906854286789894
neutrophilic O 1 1.0
leukocytosis O 1 1.0
during O 1 0.9999161958694458
pyogenic B-Disease 1 1.0
infection I-Disease 1 1.0
. O 0 0.020929064601659775
. O 0 0.02661363035440445

Susceptibility O 1 0.9997840523719788
to O 0 0.08624527603387833
ankylosing B-Disease 1 1.0
spondylitis I-Disease 1 1.0
in O 1 0.9914324283599854
twins O 1 0.9997754693031311
: O 0 0.009050657041370869
the O 0 0.006242726463824511
role O 0 0.007369601633399725
of O 0 0.007200796157121658
genes O 0 0.009861988015472889
, O 0 0.010914530605077744
HLA O 1 1.0
, O 0 0.008945629000663757
and O 0 0.006307917181402445
the O 0 0.009843162260949612
environment O 0 0.019411077722907066
. O 0 0.01934780925512314

OBJECTIVE O 0 0.040409866720438004
To O 0 0.00983913242816925
determine O 0 0.007264475803822279
the O 0 0.006707086693495512
relative O 0 0.00838913582265377
effects O 0 0.007448943797498941
of O 0 0.005227395799010992
genetic O 0 0.007569886744022369
and O 0 0.00461806682869792
environmental O 0 0.010259606875479221
factors O 0 0.0055489069782197475
in O 0 0.006840163841843605
susceptibility O 1 0.9999936819076538
to O 1 0.9744486212730408
ankylosing B-Disease 1 1.0
spondylitis I-Disease 1 1.0
( O 1 0.9999994039535522
AS B-Disease 1 0.9999998807907104
) O 0 0.019829455763101578
. O 0 0.0253592561930418

METHODS O 0 0.03067944385111332
Twins O 0 0.039780594408512115
with O 0 0.00821954570710659
AS B-Disease 0 0.012610928155481815
were O 0 0.003292810171842575
identified O 0 0.00314556946977973
from O 0 0.002551499754190445
the O 0 0.004066606052219868
Royal O 1 0.7504341006278992
National O 1 0.9987136125564575
Hospital O 1 1.0
for O 1 0.9999324083328247
Rheumatic B-Disease 1 1.0
Diseases I-Disease 1 1.0
database O 1 0.9998950958251953
. O 0 0.031898967921733856

Clinical O 1 0.9998395442962646
and O 0 0.01615007594227791
radiographic O 1 0.9999969005584717
examinations O 1 0.7670824527740479
were O 0 0.004895850550383329
performed O 0 0.007019335404038429
to O 0 0.004634202923625708
establish O 0 0.011561124585568905
diagnoses O 1 0.9999985694885254
, O 0 0.013151486404240131
and O 1 0.9419936537742615
disease O 1 1.0
severity O 1 1.0
was O 1 0.9993532299995422
assessed O 0 0.013457958586513996
using O 0 0.0058385515585541725
a O 0 0.007253583054989576
combination O 0 0.011304422281682491
of O 0 0.007660787086933851
validated O 0 0.030245088040828705
scoring O 0 0.023445794358849525
systems O 0 0.03389962017536163
. O 0 0.023904576897621155

HLA O 1 0.9999985694885254
typing O 0 0.07304103672504425
for O 0 0.020102592185139656
HLA O 1 1.0
- O 1 0.9999998807907104
B27 O 1 0.9998488426208496
, O 0 0.017822466790676117
HLA O 1 1.0
- O 1 0.9999998807907104
B60 O 1 0.9912229776382446
, O 0 0.01002421136945486
and O 0 0.012558967806398869
HLA O 1 1.0
- O 1 1.0
DR1 O 1 1.0
was O 0 0.014145828783512115
performed O 0 0.009440596215426922
by O 0 0.006235961802303791
polymerase O 0 0.030966563150286674
chain O 0 0.016407079994678497
reaction O 0 0.007473567500710487
with O 0 0.005206035450100899
sequence O 0 0.007500266190618277
- O 1 0.7904709577560425
specific O 0 0.00784819945693016
primers O 0 0.027140095829963684
, O 0 0.00934571772813797
and O 0 0.010143396444618702
zygosity O 1 0.9924482107162476
was O 0 0.01853109337389469
assessed O 0 0.02381538785994053
using O 0 0.017370259389281273
microsatellite O 1 0.9009021520614624
markers O 0 0.059981293976306915
. O 0 0.033221784979104996

Genetic O 0 0.029490623623132706
and O 0 0.009318280033767223
environmental O 0 0.011610088869929314
variance O 0 0.011335194110870361
components O 0 0.013583696447312832
were O 0 0.003910816740244627
assessed O 0 0.007817864418029785
with O 0 0.004064817912876606
the O 0 0.0063409521244466305
program O 0 0.013148806989192963
Mx O 1 0.9999945163726807
, O 0 0.005876938812434673
using O 0 0.003350003156810999
data O 0 0.0029255731496959925
from O 0 0.0027726036496460438
this O 0 0.002388840541243553
and O 0 0.0037586656399071217
previous O 0 0.005913451313972473
studies O 0 0.006242300383746624
of O 0 0.007624921854585409
twins O 0 0.038602009415626526
with O 0 0.010549921542406082
AS B-Disease 1 0.9973196387290955
. O 0 0.024168835952878

RESULTS O 0 0.023172730579972267
Six O 0 0.011465040035545826
of O 0 0.009655850939452648
8 O 0 0.021638214588165283
monozygotic O 1 0.9968637228012085
( O 0 0.026795873418450356
MZ O 1 1.0
) O 0 0.015453733503818512
twin O 0 0.04727525636553764
pairs O 0 0.012687848880887032
were O 0 0.007968363352119923
disease O 1 0.999998927116394
concordant O 1 0.9969804883003235
, O 0 0.006157854571938515
compared O 0 0.00467078760266304
with O 0 0.0037567128892987967
4 O 0 0.00793310534209013
of O 0 0.006235660053789616
15 O 0 0.012426652014255524
B27 O 1 0.9857686161994934
- O 1 0.9912994503974915
positive O 0 0.014710883609950542
dizygotic O 1 0.9550598859786987
( O 0 0.017854122444987297
DZ O 1 0.9999998807907104
) O 0 0.012997517362236977
twin O 0 0.03768273442983627
pairs O 0 0.010356483049690723
( O 0 0.006812633015215397
27 O 0 0.012153076939284801
% O 0 0.006526557728648186
) O 0 0.004236042033880949
and O 0 0.0035457483027130365
4 O 0 0.006746094673871994
of O 0 0.006590424105525017
32 O 0 0.020880188792943954
DZ O 1 0.9999996423721313
twin O 0 0.1627999246120453
pairs O 0 0.011865639127790928
overall O 0 0.013087784871459007
( O 0 0.006691043730825186
12 O 0 0.008298804052174091
. O 0 0.0058679659850895405
5 O 0 0.013391727581620216
% O 0 0.012557579204440117
) O 0 0.014388170093297958
. O 0 0.020216600969433784

Nonsignificant O 1 0.9968301653862
increases O 0 0.02402712218463421
in O 0 0.007314703427255154
similarity O 0 0.008748848922550678
with O 0 0.003527540946379304
regard O 0 0.0046305968426167965
to O 0 0.0037423777393996716
age O 0 0.007964929565787315
at O 1 0.998073935508728
disease O 1 1.0
onset O 1 1.0
and O 0 0.004716271534562111
all O 0 0.0029361157212406397
of O 0 0.004486812278628349
the O 1 0.9023246169090271
disease O 1 1.0
severity O 1 1.0
scores O 0 0.027056662365794182
assessed O 0 0.009133419021964073
were O 0 0.003590772859752178
noted O 0 0.006287118885666132
in O 0 0.008326677605509758
disease O 1 1.0
- O 1 1.0
concordant O 1 0.9999940395355225
MZ O 1 1.0
twins O 0 0.37043535709381104
compared O 0 0.01848726160824299
with O 0 0.015598042868077755
concordant O 1 0.9985103011131287
DZ O 1 1.0
twins O 1 0.9930729269981384
. O 0 0.043943021446466446

HLA O 1 1.0
- O 1 0.9999998807907104
B27 O 1 0.9983175992965698
and O 0 0.012466730549931526
B60 O 0 0.07763120532035828
were O 0 0.005093408282846212
associated O 0 0.004705870524048805
with O 0 0.003744772868230939
the O 0 0.008258332498371601
disease O 1 1.0
in O 0 0.026908420026302338
probands O 1 0.9999997615814209
, O 0 0.004379869904369116
and O 0 0.0033429255709052086
the O 0 0.004424251150339842
rate O 0 0.005776266101747751
of O 0 0.006766676437109709
disease O 1 0.9999998807907104
concordance O 1 0.9991914629936218
was O 0 0.016322994604706764
significantly O 0 0.010577701963484287
increased O 0 0.010196106508374214
among O 0 0.013345574960112572
DZ O 1 0.9999998807907104
twin O 0 0.47058844566345215
pairs O 0 0.008720768615603447
in O 0 0.004129691049456596
which O 0 0.0026745672803372145
the O 0 0.006167425308376551
co O 1 0.9999265670776367
- O 1 1.0
twin O 1 0.9923197627067566
was O 0 0.008498355746269226
positive O 0 0.005794812459498644
for O 0 0.00513047818094492
both O 0 0.008526897057890892
B27 O 1 0.998769223690033
and O 0 0.021004030480980873
DR1 O 1 0.9999978542327881
. O 0 0.032027680426836014

Additive O 0 0.07932795584201813
genetic O 0 0.02729073353111744
effects O 0 0.013046442531049252
were O 0 0.004265720024704933
estimated O 0 0.006029660347849131
to O 0 0.005021230783313513
contribute O 0 0.011893102899193764
97 O 0 0.028011377900838852
% O 0 0.008793926797807217
of O 0 0.007387158460915089
the O 0 0.008867749944329262
population O 0 0.00967965554445982
variance O 0 0.021533465012907982
. O 0 0.024548042565584183

CONCLUSION O 0 0.05117303878068924
Susceptibility O 1 0.9290303587913513
to O 0 0.011913977563381195
AS B-Disease 0 0.02228519879281521
is O 0 0.0063843755051493645
largely O 0 0.007166655268520117
genetically O 0 0.00838483776897192
determined O 0 0.007078516762703657
, O 0 0.004685249645262957
and O 0 0.003592834109440446
the O 0 0.004577308427542448
environmental O 0 0.010057822801172733
trigger O 0 0.022671204060316086
for O 0 0.006511610466986895
the O 1 0.9013797044754028
disease O 1 1.0
is O 0 0.02052115835249424
probably O 0 0.021843640133738518
ubiquitous O 1 0.8451390266418457
. O 0 0.025314776226878166

HLA O 1 1.0
- O 1 0.9999996423721313
B27 O 1 0.7160801291465759
accounts O 0 0.009412740357220173
for O 0 0.004384180530905724
a O 0 0.005034847650676966
minority O 0 0.006167176645249128
of O 0 0.004089434631168842
the O 0 0.005662194918841124
overall O 0 0.028783701360225677
genetic O 0 0.06981612741947174
susceptibility O 1 0.9999827146530151
to O 0 0.011440671049058437
AS B-Disease 1 0.998768150806427
. O 0 0.022237706929445267

Cell O 0 0.1250889152288437
cycle O 0 0.0361119881272316
- O 1 0.9891863465309143
dependent O 0 0.01792856678366661
colocalization O 0 0.16611911356449127
of O 0 0.01480324286967516
BARD1 O 1 0.9999994039535522
and O 0 0.01769125461578369
BRCA1 O 1 0.9999986886978149
proteins O 0 0.013014143332839012
in O 0 0.009649215266108513
discrete O 0 0.023115409538149834
nuclear O 0 0.03044307976961136
domains O 0 0.04156022518873215
. O 0 0.026524638757109642

Germ O 1 0.9999998807907104
- O 1 0.9999834299087524
line O 0 0.020883766934275627
mutations O 0 0.008586224168539047
of O 0 0.005317665170878172
the O 0 0.00736234663054347
BRCA1 O 1 0.9999997615814209
gene O 0 0.011954359710216522
predispose O 0 0.34019938111305237
women O 0 0.004666931927204132
to O 0 0.003696163184940815
early O 0 0.007476543076336384
- O 1 1.0
onset O 1 1.0
breast B-Disease 1 1.0
and I-Disease 1 0.9999998807907104
ovarian I-Disease 1 1.0
cancer I-Disease 1 1.0
by O 0 0.01013877335935831
compromising O 1 0.9886477589607239
the O 0 0.010981912724673748
genes O 0 0.014173178002238274
presumptive O 1 0.9999945163726807
function O 0 0.010820835828781128
as O 0 0.009579143486917019
a O 0 0.027378572151064873
tumor B-Disease 1 1.0
suppressor O 1 0.9999940395355225
. O 0 0.037447649985551834

Although O 0 0.014241061173379421
the O 0 0.011170633137226105
biochemical O 0 0.029096994549036026
properties O 0 0.017591306939721107
of O 0 0.01397335808724165
BRCA1 O 1 0.9999996423721313
polypeptides O 0 0.031559254974126816
are O 0 0.0032683019526302814
not O 0 0.003010147251188755
understood O 0 0.006905620452016592
, O 0 0.003980055917054415
their O 0 0.003745223395526409
expression O 0 0.007205822505056858
pattern O 0 0.009616406634449959
and O 0 0.007107163779437542
subcellular O 0 0.039096247404813766
localization O 0 0.02140740305185318
suggest O 0 0.007317147683352232
a O 0 0.006177347153425217
role O 0 0.007775112520903349
in O 0 0.0065410989336669445
cell O 0 0.3441788852214813
- O 1 0.9999977350234985
cycle O 0 0.02505570650100708
regulation O 0 0.02355917915701866
. O 0 0.021050607785582542

When O 0 0.0367404967546463
resting O 1 0.9806914329528809
cells O 0 0.016588306054472923
are O 0 0.006331458687782288
induced O 0 0.3668898046016693
to O 0 0.008177384734153748
proliferate O 0 0.03445262089371681
, O 0 0.0051733083091676235
the O 0 0.004684804938733578
steady O 0 0.011002613231539726
- O 1 0.8727911710739136
state O 0 0.0033665404189378023
levels O 0 0.005128003191202879
of O 0 0.005725928582251072
BRCA1 O 1 0.9595348834991455
increase O 0 0.005416508764028549
in O 0 0.006031803786754608
late O 0 0.017438111826777458
G1 O 1 0.9999673366546631
and O 0 0.007148620672523975
reach O 0 0.008776686154305935
a O 0 0.007229511626064777
maximum O 0 0.012033699080348015
during O 0 0.017995240166783333
S O 1 0.9997206330299377
phase O 0 0.05668589100241661
. O 0 0.032832127064466476

Moreover O 0 0.033631742000579834
, O 0 0.01051025465130806
in O 0 0.010139482095837593
S O 1 0.9998433589935303
phase O 1 0.6327544450759888
cells O 0 0.01986156962811947
, O 0 0.014945737086236477
BRCA1 O 1 0.996967613697052
polypeptides O 0 0.030850950628519058
are O 0 0.005415566265583038
hyperphosphorylated O 0 0.18079107999801636
and O 0 0.008335951715707779
accumulate O 0 0.022921930998563766
into O 0 0.009409770369529724
discrete O 0 0.024047112092375755
subnuclear O 1 0.9999219179153442
foci O 1 0.9995930790901184
termed O 1 0.7337964773178101
" O 0 0.029287947341799736
BRCA1 O 1 0.9999971389770508
nuclear O 0 0.04745044931769371
dots O 0 0.07287223637104034
. O 0 0.0350223034620285

" O 0 0.03829731047153473
BRCA1 O 1 0.999983549118042
associates O 1 0.6411341428756714
in O 0 0.01096255425363779
vivo O 0 0.02838379144668579
with O 0 0.008114317432045937
a O 0 0.014215334318578243
structurally O 0 0.06182553246617317
related O 0 0.016636744141578674
protein O 0 0.025247624143958092
termed O 1 0.893381655216217
BARD1 O 1 0.9999984502792358
. O 0 0.03671155124902725

Here O 0 0.019792484119534492
we O 0 0.00706117320805788
show O 0 0.005850210320204496
that O 0 0.0031048038508743048
the O 0 0.005159246269613504
steady O 0 0.013631218113005161
- O 0 0.20122268795967102
state O 0 0.0038147075101733208
levels O 0 0.005290560889989138
of O 0 0.006558570545166731
BARD1 O 1 0.9999996423721313
, O 0 0.004993306938558817
unlike O 0 0.005009980406612158
those O 0 0.0026275981217622757
of O 0 0.005631231237202883
BRCA1 O 1 0.9999911785125732
, O 0 0.004997525364160538
remain O 0 0.005552728194743395
relatively O 0 0.005651051178574562
constant O 0 0.009880274534225464
during O 0 0.01213480532169342
cell O 1 0.7295710444450378
cycle O 0 0.03506554290652275
progression O 1 0.5871883034706116
. O 0 0.025927064940333366

However O 0 0.019911812618374825
, O 0 0.016265669837594032
immunostaining O 1 0.8769837021827698
revealed O 0 0.014921256341040134
that O 0 0.007258731871843338
BARD1 O 1 0.9999581575393677
resides O 0 0.03464512899518013
within O 0 0.011517873033881187
BRCA1 O 1 0.9999239444732666
nuclear O 0 0.015452565625309944
dots O 0 0.020520417019724846
during O 0 0.010367803275585175
S O 1 0.8682432174682617
phase O 0 0.012445544824004173
of O 0 0.005715166684240103
the O 0 0.007914102636277676
cell O 0 0.0225015077739954
cycle O 0 0.010447472333908081
, O 0 0.004811439663171768
but O 0 0.002887383569031954
not O 0 0.0028269952163100243
during O 0 0.006929831579327583
the O 0 0.013395999558269978
G1 O 1 0.9999998807907104
phase O 0 0.0922142043709755
. O 0 0.03138520568609238

Nevertheless O 0 0.05171702802181244
, O 0 0.027673212811350822
BARD1 O 1 0.9999816417694092
polypeptides O 0 0.03721850737929344
are O 0 0.004793349653482437
found O 0 0.004461559467017651
exclusively O 0 0.007180939428508282
in O 0 0.004412829410284758
the O 0 0.005538126453757286
nuclear O 0 0.010506080463528633
fractions O 0 0.011081667616963387
of O 0 0.00601126067340374
both O 0 0.00694240489974618
G1 O 1 0.9999998807907104
- O 1 0.9999767541885376
and O 0 0.01208016648888588
S O 1 0.9999997615814209
- O 1 0.9999998807907104
phase O 1 0.7221300601959229
cells O 0 0.029732780531048775
. O 0 0.023407410830259323

Therefore O 0 0.022434357553720474
, O 0 0.01357877068221569
progression O 0 0.02431880496442318
to O 0 0.01000717282295227
S O 1 0.9999991655349731
phase O 0 0.31983682513237
is O 0 0.006816647946834564
accompanied O 0 0.012197718024253845
by O 0 0.004049523267894983
the O 0 0.006601550150662661
aggregation O 0 0.014268084429204464
of O 0 0.010278313420712948
nuclear O 0 0.02746657282114029
BARD1 O 1 0.9999669790267944
polypeptides O 0 0.049019262194633484
into O 0 0.0218801386654377
BRCA1 O 1 0.9999350309371948
nuclear O 0 0.03995538130402565
dots O 0 0.05853516235947609
. O 0 0.029071727767586708

This O 0 0.015464453026652336
cell O 0 0.024854378774762154
cycle O 0 0.023429760709404945
- O 1 0.9994090795516968
dependent O 0 0.016737457364797592
colocalization O 0 0.08093919605016708
of O 0 0.013788490556180477
BARD1 O 1 0.9999998807907104
and O 0 0.014516828581690788
BRCA1 O 1 0.9999980926513672
indicates O 0 0.010828490369021893
a O 0 0.007564704865217209
role O 0 0.008183542639017105
for O 0 0.007110385689884424
BARD1 O 1 0.9999622106552124
in O 0 0.014213002286851406
BRCA1 O 1 0.9999998807907104
- O 1 1.0
mediated O 1 0.9999990463256836
tumor B-Disease 1 1.0
suppression O 1 0.9999954700469971
. O 0 0.04380851984024048

Ethnic O 0 0.02417411282658577
differences O 0 0.01511212158948183
in O 0 0.010021860711276531
the O 0 0.014758252538740635
HFE O 1 0.9999215602874756
codon O 0 0.051338691264390945
282 O 1 0.799506425857544
( O 0 0.03421226143836975
Cys O 1 1.0
/ O 1 0.9999997615814209
Tyr O 1 0.9999998807907104
) O 0 0.03154240921139717
polymorphism O 0 0.07401134818792343
. O 0 0.03176364302635193

Recent O 0 0.014848679304122925
studies O 0 0.006402037106454372
have O 0 0.002478873822838068
shown O 0 0.0035037463530898094
that O 0 0.00511160446330905
hereditary B-Disease 1 1.0
hemochromatosis I-Disease 1 1.0
( O 1 1.0
HH B-Disease 1 1.0
) O 0 0.015613541938364506
is O 0 0.006378107704222202
likely O 0 0.00549415173009038
to O 0 0.004330492578446865
be O 0 0.0039020369295030832
caused O 0 0.006990015972405672
by O 0 0.00422633858397603
homozygosity O 1 0.7077164053916931
for O 0 0.00565216364338994
a O 0 0.010126596316695213
Cys282Tyr O 1 0.9991675615310669
mutation O 0 0.011472786776721478
in O 0 0.00637147156521678
the O 0 0.011939533986151218
HFE O 1 0.9999995231628418
gene O 0 0.020795797929167747
located O 0 0.023072529584169388
4 O 0 0.02757028490304947
. O 0 0.025464212521910667

5 O 0 0.056096870452165604
Mb O 1 0.970057487487793
telomeric O 1 0.877871036529541
to O 0 0.032101962715387344
HLA O 1 1.0
- O 1 0.9999998807907104
A O 0 0.05235139653086662
. O 0 0.025741789489984512

Population O 0 0.01588440127670765
studies O 0 0.009907035157084465
of O 0 0.0072454363107681274
this O 0 0.005022112745791674
polymorphism O 0 0.01492776907980442
are O 0 0.0031471310649067163
facilitated O 0 0.009467129595577717
by O 0 0.0032439196947962046
the O 0 0.00430169515311718
fact O 0 0.003737772349268198
that O 0 0.002872155047953129
the O 0 0.006755316164344549
Cys282Tyr O 1 0.9999877214431763
mutation O 0 0.01733098365366459
creates O 0 0.017644330859184265
a O 0 0.014849482104182243
Rsal O 1 0.9998311996459961
restriction O 0 0.03392741084098816
site O 0 0.03869497776031494
. O 0 0.028936538845300674

We O 0 0.014173883944749832
have O 0 0.005863759201020002
studied O 0 0.010508013889193535
the O 0 0.00719645107164979
codon O 0 0.022939585149288177
282 O 0 0.05852637067437172
( O 0 0.02429688349366188
Cys O 1 1.0
/ O 1 1.0
Tyr O 1 1.0
) O 0 0.018897471949458122
polymorphism O 0 0.020313043147325516
in O 0 0.0063317506574094296
different O 0 0.004000622313469648
ethnic O 0 0.007696470245718956
groups O 0 0.008520813658833504
. O 0 0.017915833741426468

In O 0 0.015633584931492805
agreement O 0 0.01012865174561739
with O 0 0.005337895825505257
previous O 0 0.007468273863196373
observations O 0 0.01180312316864729
the O 0 0.01090622041374445
Tyr O 1 1.0
allele O 0 0.023956850171089172
appeared O 0 0.008527437224984169
to O 0 0.004736834205687046
be O 0 0.0037570034619420767
rare O 0 0.00643409276381135
or O 0 0.004362965933978558
absent O 0 0.01085857953876257
in O 0 0.007948621176183224
Asiatic O 1 0.9999997615814209
( O 0 0.007855691947042942
Indian O 0 0.013190197758376598
, O 0 0.008869821205735207
Chinese O 0 0.016685009002685547
) O 0 0.012132839299738407
populations O 0 0.014557638205587864
. O 0 0.01978405937552452

The O 0 0.021328439936041832
highest O 0 0.03173724189400673
allele O 0 0.028126828372478485
frequency O 0 0.011571275070309639
( O 0 0.007241623941808939
7 O 0 0.010660795494914055
. O 0 0.005658099893480539
5 O 0 0.010530258528888226
% O 0 0.007660903502255678
) O 0 0.00736036105081439
was O 0 0.009897198528051376
found O 0 0.006794444750994444
in O 0 0.010267618112266064
Swedes O 0 0.041868656873703
. O 0 0.02639896050095558

Saamis O 1 0.9985848665237427
( O 0 0.014015823602676392
2 O 0 0.01579168811440468
% O 0 0.00799836590886116
) O 0 0.005785156041383743
and O 0 0.005870205815881491
Mordvinians O 1 0.9999444484710693
( O 0 0.006261654198169708
1 O 0 0.008025611750781536
. O 0 0.0037575052119791508
8 O 0 0.007797813042998314
% O 0 0.005171196069568396
) O 0 0.004355602897703648
had O 0 0.005430413875728846
significantly O 0 0.007940773852169514
lower O 0 0.008803179487586021
frequencies O 0 0.007452752441167831
of O 0 0.00815068744122982
the O 0 0.017912721261382103
Tyr O 1 0.9999995231628418
allele O 0 0.08193544298410416
. O 0 0.03431195765733719

Comparisons O 0 0.031108424067497253
with O 0 0.011877993121743202
allele O 0 0.024725541472434998
frequencies O 0 0.007987330667674541
based O 0 0.006896747276186943
on O 0 0.0057158684358000755
prevalence O 0 0.022403230890631676
estimates O 0 0.009116646833717823
of O 0 0.01088065467774868
HH B-Disease 1 1.0
showed O 0 0.011325445957481861
some O 0 0.004680116195231676
disagreements O 0 0.011988291516900063
with O 0 0.005065395496785641
the O 0 0.007447247859090567
RFLP O 1 0.9846524596214294
data O 0 0.007259972859174013
, O 0 0.007446574978530407
particularly O 0 0.008241076953709126
in O 0 0.011945070698857307
Finns O 0 0.06918467581272125
. O 0 0.027862481772899628

The O 0 0.029374128207564354
newly O 0 0.045633163303136826
described O 0 0.02748909965157509
HFE O 1 0.9999997615814209
marker O 0 0.263251930475235
provides O 0 0.011956928297877312
a O 0 0.007212955970317125
new O 0 0.006789964158087969
approach O 0 0.006372613366693258
to O 0 0.003974902909249067
the O 0 0.004982976242899895
screening O 0 0.011691697873175144
of O 0 0.011111848056316376
HH B-Disease 1 1.0
as O 0 0.005882641300559044
well O 0 0.004011581186205149
as O 0 0.0034161112271249294
studies O 0 0.003617647336795926
of O 0 0.0033853785134851933
the O 0 0.004049988929182291
relationship O 0 0.005506050772964954
between O 0 0.005264257546514273
the O 0 0.013114147819578648
HFE O 1 1.0
Tyr O 1 1.0
allele O 0 0.04468140751123428
and O 0 0.011229027062654495
different O 0 0.010255326516926289
disorders O 1 1.0
including O 1 0.9852977395057678
cancer B-Disease 1 1.0

Autosomal B-Disease 1 0.9998524188995361
dominant I-Disease 1 0.9999815225601196
neurohypophyseal I-Disease 1 1.0
diabetes I-Disease 1 1.0
insipidus I-Disease 1 1.0
associated O 0 0.02389419823884964
with O 0 0.008347543887794018
a O 0 0.011248283088207245
missense O 0 0.028666965663433075
mutation O 0 0.012794324196875095
encoding O 0 0.015584766864776611
Gly23 O 1 0.9999359846115112
- O 1 1.0
- O 1 0.9999997615814209
> O 1 0.9997065663337708
Val O 1 0.9997090697288513
in O 0 0.021599631756544113
neurophysin O 1 0.9999828338623047
II O 1 1.0
. O 0 0.04446898400783539

Autosomal B-Disease 1 0.9988566637039185
dominant I-Disease 1 0.9998741149902344
neurohypophyseal I-Disease 1 1.0
diabetes I-Disease 1 1.0
insipidus I-Disease 1 1.0
( O 1 0.9993941783905029
ADNDI B-Disease 1 1.0
) O 0 0.006836990360170603
is O 0 0.004172436892986298
an O 0 0.012098663486540318
inherited B-Disease 1 1.0
disease I-Disease 1 1.0
caused O 1 1.0
by O 1 0.744468629360199
progressive O 1 1.0
degeneration O 1 1.0
of O 1 0.99928218126297
the O 1 0.9785701632499695
magnocellular O 1 0.9999997615814209
neurons O 0 0.020214179530739784
of O 0 0.009236503392457962
the O 0 0.009243285283446312
hypothalamus O 1 0.55142742395401
leading O 0 0.02056572213768959
to O 0 0.006926465313881636
decreased O 0 0.008955162018537521
ability O 0 0.005997298285365105
to O 0 0.004538401961326599
produce O 0 0.007024329621344805
the O 0 0.00961209274828434
hormone O 1 0.9567157626152039
arginine O 1 0.8187680840492249
vasopressin O 1 0.9975670576095581
( O 0 0.04166755825281143
AVP O 1 0.9999998807907104
) O 0 0.029248572885990143
. O 0 0.029132988303899765

Affected O 0 0.021605467423796654
individuals O 0 0.005032039247453213
are O 0 0.0024039195850491524
not O 0 0.003340816590934992
symptomatic O 1 0.9999998807907104
at O 1 0.9738057255744934
birth O 1 0.5345078110694885
, O 0 0.0037891415413469076
but O 0 0.002617418533191085
usually O 0 0.004013746045529842
develop O 1 0.8756380081176758
diabetes B-Disease 1 1.0
insipidus I-Disease 1 1.0
at O 1 0.9811267256736755
1 O 1 0.675399661064148
- O 1 0.9999982118606567
6 O 0 0.024164557456970215
yr O 1 0.9991346001625061
of O 0 0.01905387081205845
age O 0 0.02746051922440529
. O 0 0.02842615731060505

The O 0 0.017504144459962845
genetic O 0 0.01626557670533657
locus O 0 0.03284350782632828
of O 0 0.008215892128646374
the O 0 0.012654013000428677
disease O 1 1.0
is O 0 0.005288172047585249
the O 0 0.009586955420672894
AVP O 1 1.0
- O 1 1.0
neurophysin O 1 0.9999998807907104
II O 1 1.0
( O 0 0.02251802757382393
NPII O 1 1.0
) O 0 0.008686753921210766
gene O 0 0.007678089663386345
, O 0 0.005013746675103903
and O 0 0.004837621469050646
mutations O 0 0.00744118494912982
that O 0 0.003804483450949192
cause O 1 0.9621924161911011
ADNDI B-Disease 1 1.0
have O 0 0.0034102904610335827
been O 0 0.0031913830898702145
found O 0 0.00248419726267457
in O 0 0.0022366575431078672
both O 0 0.0025107802357524633
the O 0 0.004138120450079441
signal O 0 0.009748777374625206
peptide O 0 0.012885491363704205
of O 0 0.0048292954452335835
the O 0 0.00815767701715231
prepro O 1 0.9999841451644897
- O 1 1.0
AVP O 1 1.0
- O 1 1.0
NPII O 1 0.9999997615814209
precursor O 0 0.04290404170751572
and O 0 0.012124467641115189
within O 0 0.013918855227530003
NPII O 1 0.9999899864196777
itself O 0 0.03454720973968506
. O 0 0.026496654376387596

An O 0 0.019287878647446632
affected O 0 0.01709180511534214
girl O 0 0.018008440732955933
who O 0 0.0074981930665671825
presented O 0 0.00793421734124422
at O 0 0.005968241486698389
9 O 0 0.006745916325598955
months O 0 0.00508136535063386
of O 0 0.004118261858820915
age O 0 0.0057092406786978245
and O 0 0.004243072122335434
her O 0 0.007701577618718147
similarly O 0 0.010011509992182255
affected O 0 0.008960521779954433
younger O 0 0.22676551342010498
brother O 1 0.9124563336372375
and O 0 0.005893135443329811
father O 0 0.012544105760753155
were O 0 0.0029971248004585505
all O 0 0.0026644114404916763
found O 0 0.0027537932619452477
to O 0 0.0028033119160681963
have O 0 0.0021988372318446636
a O 0 0.0050107212737202644
novel O 0 0.010617670603096485
missense O 0 0.019632698968052864
mutation O 0 0.011693483218550682
( O 0 0.009194754995405674
G1758 O 1 0.9988177418708801
- O 1 0.9999998807907104
- O 1 0.9999998807907104
> O 1 0.9999979734420776
T O 1 0.9999977350234985
) O 0 0.00811764132231474
encoding O 0 0.010114043019711971
the O 0 0.008670119568705559
amino O 0 0.01610391028225422
acid O 0 0.02058054693043232
substitution O 0 0.030415896326303482
Gly23 O 1 0.9999446868896484
- O 1 0.9999997615814209
- O 1 0.9999997615814209
> O 1 0.9999372959136963
Val O 1 0.9998679161071777
within O 0 0.024553699418902397
NPII O 1 0.9999159574508667
. O 0 0.036971140652894974

The O 0 0.02632875181734562
mutation O 0 0.02083326317369938
was O 0 0.012255731970071793
confirmed O 0 0.01090125273913145
by O 0 0.006115678697824478
restriction O 0 0.018079454079270363
endonuclease O 0 0.2106887698173523
analysis O 0 0.022188572213053703
. O 0 0.023904211819171906

A O 0 0.06568398326635361
T1 O 1 0.9999996423721313
- O 1 0.9999384880065918
weighted O 0 0.026300450786948204
magnetic O 0 0.018580934032797813
resonance O 0 0.022017545998096466
imaging O 0 0.02848128229379654
of O 0 0.009582387283444405
the O 0 0.013400563970208168
fathers O 1 0.9236631393432617
pituitary O 1 1.0
gland O 1 0.9999998807907104
demonstrates O 1 0.7238261699676514
an O 0 0.028343047946691513
attenuated O 1 0.9999994039535522
posterior O 1 0.9999998807907104
pituitary O 1 1.0
bright O 1 0.9999889135360718
spot O 1 0.9005218744277954
. O 0 0.034320928156375885

This O 0 0.01754530891776085
mutation O 0 0.01974475011229515
may O 0 0.007385543081909418
be O 0 0.004440353251993656
valuable O 0 0.009927087463438511
for O 0 0.004991038236767054
developing O 0 0.00833965465426445
models O 0 0.012028495781123638
of O 0 0.012783694081008434
dominantly B-Disease 1 1.0
inherited I-Disease 1 1.0
neurodegeneration I-Disease 1 1.0
, O 0 0.010700884275138378
as O 0 0.004627915099263191
the O 0 0.004192995373159647
early O 0 0.004180262330919504
age O 0 0.005824844818562269
of O 0 0.0071092271246016026
onset O 1 1.0
of O 1 0.9980291724205017
symptoms O 1 1.0
suggests O 0 0.01487505529075861
that O 0 0.003274142974987626
this O 0 0.003690381534397602
mutation O 0 0.008465255610644817
may O 0 0.004628021735697985
be O 0 0.0038195108063519
particularly O 0 0.007438064552843571
deleterious O 0 0.01979716494679451
to O 0 0.008117679506540298
the O 0 0.015682857483625412
magnocellular O 1 0.9999997615814209
neuron O 1 0.9999905824661255
. O 0 0.019215118139982224
. O 0 0.02594941109418869

Frequent O 0 0.05286237224936485
inactivation O 1 0.9995703101158142
of O 0 0.02932700887322426
PTEN O 1 1.0
/ O 1 0.9999951124191284
MMAC1 O 1 0.9999997615814209
in O 0 0.026582909747958183
primary O 1 0.9999997615814209
prostate B-Disease 1 1.0
cancer I-Disease 1 1.0
. O 1 0.9283562898635864

Sporadic B-Disease 1 0.9999966621398926
prostate I-Disease 1 1.0
carcinoma I-Disease 1 1.0
is O 0 0.010158964432775974
the O 0 0.006360246334224939
most O 0 0.0042088874615728855
common O 0 0.0063078999519348145
male B-Disease 1 0.8211404085159302
cancer I-Disease 1 1.0
in O 0 0.004480636212974787
the O 0 0.004978739656507969
Western O 0 0.007968030869960785
world O 0 0.010829214937984943
, O 0 0.003559676930308342
yet O 0 0.0030545375775545835
many O 0 0.001732577569782734
of O 0 0.0027398536913096905
the O 0 0.0041917054913938046
major O 0 0.008863435126841068
genetic O 0 0.006040501408278942
events O 0 0.004110520705580711
involved O 0 0.003438351908698678
in O 0 0.0030631315894424915
the O 0 0.004497072659432888
progression O 0 0.03416014462709427
of O 0 0.004124956205487251
this O 0 0.0035107978619635105
often O 0 0.006395113654434681
fatal O 1 1.0
cancer B-Disease 1 1.0
remain O 0 0.016898263245821
to O 0 0.009703155606985092
be O 0 0.011729942634701729
elucidated O 0 0.3490334153175354
. O 0 0.03243555501103401

Numerous O 0 0.03712943568825722
cytogenetic O 1 0.8958292007446289
and O 0 0.01641777902841568
allelotype O 1 0.9994350075721741
studies O 0 0.008384773507714272
have O 0 0.003990469500422478
reported O 0 0.0057989079505205154
frequent O 0 0.006938105449080467
loss O 0 0.015219321474432945
of O 0 0.0099970493465662
heterozygosity O 1 0.9999990463256836
on O 0 0.01252079475671053
chromosomal O 1 0.9964648485183716
arm O 1 0.9999845027923584
10q O 1 0.9999761581420898
in O 0 0.020286746323108673
sporadic B-Disease 1 0.9999994039535522
prostate I-Disease 1 1.0
cancer I-Disease 1 1.0
. O 1 0.9550944566726685

Deletion O 0 0.0982641726732254
mapping O 0 0.03285405784845352
studies O 0 0.01317331288009882
have O 0 0.005420070607215166
unambiguously O 0 0.019223898649215698
identified O 0 0.0069526853039860725
a O 0 0.005021469201892614
region O 0 0.007578983902931213
of O 0 0.007060367614030838
chromosome O 0 0.12285446375608444
10q23 O 1 0.9959968328475952
to O 0 0.004809921607375145
be O 0 0.003471696749329567
the O 0 0.005308014340698719
minimal O 0 0.009881320409476757
area O 0 0.009028500877320766
of O 0 0.011021120473742485
loss O 1 0.9580891728401184
. O 0 0.02895120531320572

A O 0 0.03120570257306099
new O 0 0.025877460837364197
tumor B-Disease 1 0.9999992847442627
suppressor O 1 0.9999030828475952
gene O 0 0.01608392223715782
, O 0 0.012860307469964027
PTEN O 1 1.0
/ O 1 1.0
MMAC1 O 1 1.0
, O 0 0.008906146511435509
was O 0 0.010385936126112938
isolated O 0 0.009427681565284729
recently O 0 0.008114378899335861
at O 0 0.0052045295014977455
this O 0 0.0024399824906140566
region O 0 0.005397547967731953
of O 0 0.006010354962199926
chromosome O 0 0.08443541824817657
10q23 O 1 0.9999459981918335
and O 0 0.004468239843845367
found O 0 0.0032429287675768137
to O 0 0.003579829353839159
be O 0 0.0037502399645745754
inactivated O 0 0.2721066474914551
by O 0 0.00393292959779501
mutation O 0 0.0066244108602404594
in O 0 0.004699581302702427
three O 0 0.013087564148008823
prostate B-Disease 1 1.0
cancer I-Disease 1 1.0
cell O 1 0.9999997615814209
lines O 0 0.041680265218019485
. O 0 0.022498097270727158

We O 0 0.02075861766934395
screened O 0 0.043503548949956894
80 O 1 0.8424807786941528
prostate B-Disease 1 1.0
tumors I-Disease 1 1.0
by O 0 0.011740083806216717
microsatellite O 1 0.9983343482017517
analysis O 0 0.008188203908503056
and O 0 0.005768198519945145
found O 0 0.007569428533315659
chromosome O 0 0.01541134249418974
10q23 O 1 0.819416880607605
to O 0 0.0067559052258729935
be O 0 0.005740644410252571
deleted O 0 0.016422213986516
in O 0 0.007995427586138248
23 O 0 0.016781531274318695
cases O 0 0.013636411167681217
. O 0 0.02035750076174736

We O 0 0.016435930505394936
then O 0 0.012019235640764236
proceeded O 0 0.015247225761413574
with O 0 0.0045782169327139854
sequence O 0 0.004592790734022856
analysis O 0 0.004079577047377825
of O 0 0.004190678708255291
the O 0 0.00733628123998642
entire O 0 0.021371526643633842
PTEN O 1 0.9999998807907104
/ O 1 0.9999969005584717
MMAC1 O 1 0.9999998807907104
coding O 0 0.08812528103590012
region O 0 0.011072338558733463
and O 0 0.00666796462610364
tested O 0 0.010644850321114063
for O 0 0.006260179914534092
homozygous O 0 0.018506444990634918
deletion O 0 0.017467860132455826
with O 0 0.005508374888449907
new O 0 0.011305936612188816
intragenic O 1 0.9994332194328308
markers O 0 0.013731428422033787
in O 0 0.005083652678877115
these O 0 0.002906447509303689
23 O 0 0.008366887457668781
cases O 0 0.00499980291351676
with O 0 0.007030059117823839
10q23 O 1 0.9998453855514526
loss O 1 0.9704470038414001
of O 0 0.02724064700305462
heterozygosity O 1 0.9999985694885254
. O 0 0.04407734051346779

The O 0 0.017676942050457
identification O 0 0.010715157724916935
of O 0 0.0071117449551820755
the O 0 0.008646393194794655
second O 0 0.018515238538384438
mutational O 1 0.9977007508277893
event O 0 0.01221062894910574
in O 0 0.00569158187136054
10 O 0 0.0073386807925999165
( O 0 0.006344672758132219
43 O 0 0.016094913706183434
% O 0 0.010010555386543274
) O 0 0.014502202160656452
tumors B-Disease 1 0.9999988079071045
establishes O 1 0.9998377561569214
PTEN O 1 1.0
/ O 1 0.9999996423721313
MMAC1 O 1 0.9999974966049194
as O 0 0.008463655598461628
a O 0 0.009505662135779858
main O 0 0.016820263117551804
inactivation O 1 0.9232150316238403
target O 0 0.010227914899587631
of O 0 0.009935394860804081
10q O 1 0.9584603309631348
loss O 0 0.04970564320683479
in O 0 0.013451674021780491
sporadic B-Disease 1 0.9999978542327881
prostate I-Disease 1 1.0
cancer I-Disease 1 1.0
. O 0 0.3578197956085205
. O 0 0.029831940308213234

Risk O 1 0.7998875379562378
reversals O 0 0.057441700249910355
in O 0 0.01071980781853199
predictive O 0 0.030919374898076057
testing O 0 0.019373636692762375
for O 0 0.029567517340183258
Huntington B-Disease 1 1.0
disease I-Disease 1 1.0
. O 0 0.17359718680381775

The O 0 0.018127450719475746
first O 0 0.011575714685022831
predictive O 0 0.017137477174401283
testing O 0 0.011371724307537079
for O 0 0.010549254715442657
Huntington B-Disease 1 1.0
disease I-Disease 1 1.0
( O 1 0.9998960494995117
HD B-Disease 1 1.0
) O 0 0.0074966708198189735
was O 0 0.006433590315282345
based O 0 0.004306663293391466
on O 0 0.003457628656178713
analysis O 0 0.004175635986030102
of O 0 0.005606037098914385
linked O 0 0.013981956988573074
polymorphic O 0 0.0526350773870945
DNA O 0 0.01577642187476158
markers O 0 0.01618068292737007
to O 0 0.005761369131505489
estimate O 0 0.0077722580172121525
the O 0 0.006230025086551905
likelihood O 0 0.011496027000248432
of O 0 0.00906442105770111
inheriting O 0 0.25343066453933716
the O 0 0.01123125571757555
mutation O 0 0.017067302018404007
for O 0 0.012137355282902718
HD B-Disease 1 0.9993599057197571
. O 0 0.03232979774475098

Limits O 0 0.022357435896992683
to O 0 0.008975889533758163
accuracy O 0 0.01050158403813839
included O 0 0.007890177890658379
recombination O 0 0.012359418906271458
between O 0 0.0045462846755981445
the O 0 0.005884107667952776
DNA O 0 0.009180499240756035
markers O 0 0.00985399167984724
and O 0 0.003994036000221968
the O 0 0.00631180964410305
mutation O 0 0.009623167105019093
, O 0 0.006823641248047352
pedigree O 0 0.446348637342453
structure O 0 0.008465551771223545
, O 0 0.004595913924276829
and O 0 0.003849409054964781
whether O 0 0.004629394970834255
DNA O 0 0.007097889669239521
samples O 0 0.0045771305449306965
were O 0 0.0026113493368029594
available O 0 0.004937632009387016
from O 0 0.005442050751298666
family O 0 0.010464813560247421
members O 0 0.009423043578863144
. O 0 0.020334111526608467

With O 0 0.012567291036248207
direct O 0 0.008648727089166641
tests O 0 0.00635218620300293
for O 0 0.004123792517930269
the O 0 0.008705238811671734
HD B-Disease 1 0.9999959468841553
mutation O 0 0.013271307572722435
, O 0 0.00520694674924016
we O 0 0.003059990471228957
have O 0 0.002223702147603035
assessed O 0 0.005899345502257347
the O 0 0.003960144240409136
accuracy O 0 0.0055009773932397366
of O 0 0.004280494060367346
results O 0 0.004104891326278448
obtained O 0 0.003898254130035639
by O 0 0.0035082176327705383
linkage O 0 0.013002156279981136
approaches O 0 0.009620312601327896
when O 0 0.004787463694810867
requested O 0 0.0077402060851454735
to O 0 0.004989313893020153
do O 0 0.0035142689011991024
so O 0 0.0035113696940243244
by O 0 0.0035178125835955143
the O 0 0.006651526782661676
test O 0 0.01293142233043909
individuals O 0 0.009537125937640667
. O 0 0.020939435809850693

For O 0 0.013678215444087982
six O 0 0.008552219718694687
such O 0 0.004218884278088808
individuals O 0 0.0032941207755357027
, O 0 0.003666285425424576
there O 0 0.0027278957422822714
was O 0 0.007596413139253855
significant O 0 0.007055080961436033
disparity O 0 0.04753890261054039
between O 0 0.006695672869682312
the O 0 0.009877951815724373
tests O 0 0.018945837393403053
. O 0 0.021271569654345512

Three O 0 0.013746943324804306
went O 0 0.013014388270676136
from O 0 0.005581126548349857
a O 0 0.008217711932957172
decreased O 0 0.029882097616791725
risk O 0 0.006861379370093346
to O 0 0.00346095091663301
an O 0 0.0034361323341727257
increased O 0 0.007601141929626465
risk O 1 0.5965770483016968
, O 0 0.0042474460788071156
while O 0 0.003282374469563365
in O 0 0.0029475705232471228
another O 0 0.004122617654502392
three O 0 0.003250687848776579
the O 0 0.006075713317841291
risk O 1 0.9749312996864319
was O 1 0.9141714572906494
decreased O 1 0.7481694221496582
. O 0 0.02431267872452736

Knowledge O 0 0.024798043072223663
of O 0 0.010702003724873066
the O 0 0.00879144947975874
potential O 0 0.009746904484927654
reasons O 0 0.005919463932514191
for O 0 0.0033287114929407835
these O 0 0.002045990666374564
changes O 0 0.002724076621234417
in O 0 0.0028062460478395224
results O 0 0.003574788337573409
and O 0 0.0030960857402533293
impact O 0 0.0048919194377958775
of O 0 0.003977580461651087
these O 0 0.0025017214938998222
risk O 0 0.011692491360008717
reversals O 1 0.8564514517784119
on O 0 0.0037715681828558445
both O 0 0.004118954297155142
patients O 1 0.7996691465377808
and O 0 0.00386725552380085
the O 0 0.005465774331241846
counseling O 1 0.9998971223831177
team O 0 0.010101770050823689
can O 0 0.0036574217956513166
assist O 0 0.007754509802907705
in O 0 0.0036074521485716105
the O 0 0.003668923629447818
development O 0 0.004312107339501381
of O 0 0.0036582404281944036
strategies O 0 0.006486880127340555
for O 0 0.0029019322246313095
the O 0 0.006060181185603142
prevention O 1 0.9999997615814209
and O 0 0.004257973749190569
, O 0 0.003837217576801777
where O 0 0.003130898578092456
necessary O 0 0.003364256350323558
, O 0 0.003233807859942317
management O 0 0.006459439639002085
of O 0 0.0038559348322451115
a O 0 0.009103381074965
risk O 1 0.9932776093482971
reversal O 0 0.016102442517876625
in O 0 0.004750057123601437
any O 0 0.00475994823500514
predictive O 0 0.019219890236854553
testing O 0 0.013918089680373669
program O 0 0.013686052523553371
. O 0 0.009686852805316448
. O 0 0.01566464640200138

A O 0 0.04059821739792824
novel O 0 0.035090718418359756
common O 0 0.01473227608948946
missense O 0 0.038144223392009735
mutation O 0 0.01899094320833683
G301C O 0 0.05754411220550537
in O 0 0.006555113010108471
the O 0 0.008869712240993977
N O 0 0.039762984961271286
- O 1 0.9999812841415405
acetylgalactosamine O 1 0.9999587535858154
- O 1 0.9999955892562866
6 O 0 0.04413182660937309
- O 1 0.9999994039535522
sulfate O 1 0.9999978542327881
sulfatase O 1 0.9999958276748657
gene O 0 0.027107466012239456
in O 0 0.023322131484746933
mucopolysaccharidosis B-Disease 1 0.9999891519546509
IVA I-Disease 1 1.0
. O 0 0.0510886050760746

Mucopolysaccharidosis B-Disease 1 0.9999985694885254
IVA I-Disease 1 1.0
( O 0 0.03510649874806404
MPS B-Disease 1 0.999956488609314
IVA I-Disease 1 1.0
) O 0 0.011312628164887428
is O 0 0.005676882807165384
an O 0 0.007843634113669395
autosomal B-Disease 1 0.9997302889823914
recessive I-Disease 1 1.0
lysosomal I-Disease 1 1.0
storage I-Disease 1 1.0
disorder I-Disease 1 1.0
caused O 1 0.9999951124191284
by O 0 0.006532239727675915
a O 0 0.022738859057426453
genetic B-Disease 1 0.9898226261138916
defect I-Disease 1 0.9999991655349731
in O 0 0.010180555284023285
N O 1 0.6412956118583679
- O 1 0.9999706745147705
acetylgalactosamine O 1 0.9956411123275757
- O 1 0.9999724626541138
6 O 0 0.06351163238286972
- O 1 0.9999998807907104
sulfate O 1 1.0
sulfatase O 1 1.0
( O 0 0.042316701263189316
GALNS O 1 0.9999990463256836
) O 0 0.02754136547446251
. O 0 0.03100595995783806

In O 0 0.013898123055696487
previous O 0 0.01076685730367899
studies O 0 0.007199027109891176
, O 0 0.0045897639356553555
we O 0 0.0024586187209933996
have O 0 0.001639902708120644
found O 0 0.00205250084400177
two O 0 0.0021376549266278744
common O 0 0.003725196933373809
mutations O 0 0.006178379990160465
in O 0 0.006151956506073475
Caucasians O 1 0.9998592138290405
and O 0 0.008495948277413845
Japanese O 1 0.8984583020210266
, O 0 0.012985583394765854
respectively O 0 0.020755354315042496
. O 0 0.022548900917172432

To O 0 0.01920454390347004
characterize O 0 0.040927205234766006
the O 0 0.01694360189139843
mutational O 1 0.9888982176780701
spectrum O 0 0.02089744247496128
in O 0 0.006670072209089994
various O 0 0.004285779781639576
ethnic O 0 0.0059524825774133205
groups O 0 0.003755217418074608
, O 0 0.005627451930195093
mutations O 0 0.006598292384296656
in O 0 0.004114043898880482
the O 0 0.008138592354953289
GALNS O 1 0.9999983310699463
gene O 0 0.010680234991014004
in O 0 0.006281866226345301
Colombian O 0 0.0318368598818779
MPS B-Disease 1 0.999924898147583
IVA I-Disease 1 1.0
patients O 1 0.9999727010726929
were O 0 0.006182633340358734
investigated O 0 0.01243649236857891
, O 0 0.006340411491692066
and O 0 0.005553634371608496
genetic O 0 0.0083684790879488
backgrounds O 0 0.007933643646538258
were O 0 0.0033496972173452377
extensively O 0 0.007922463119029999
analyzed O 0 0.0071807014755904675
to O 0 0.00418877461925149
identify O 0 0.006382795982062817
racial O 0 0.008133024908602238
origin O 0 0.004063656087964773
, O 0 0.004343181848526001
based O 0 0.006756339222192764
on O 0 0.006933698430657387
mitochondrial O 0 0.016550615429878235
DNA O 0 0.015102061443030834
( O 0 0.013092342764139175
mtDNA O 0 0.02248910628259182
) O 0 0.016102412715554237
lineages O 0 0.035313211381435394
. O 0 0.025030558928847313

Three O 0 0.025578580796718597
novel O 0 0.035417940467596054
missense O 0 0.0407482348382473
mutations O 0 0.013137253932654858
never O 0 0.007923160679638386
identified O 0 0.005875000264495611
previously O 0 0.005265865474939346
in O 0 0.003101853420957923
other O 0 0.0024481776636093855
populations O 0 0.00308206700719893
and O 0 0.0034764462616294622
found O 0 0.0030164646450430155
in O 0 0.0037379125133156776
16 O 0 0.006188677158206701
out O 0 0.005558682139962912
of O 0 0.00642996933311224
19 O 0 0.0172116719186306
Colombian O 0 0.058346547186374664
MPS B-Disease 1 0.9975378513336182
IVA I-Disease 1 1.0
unrelated O 0 0.0419660359621048
alleles O 0 0.024726057425141335
account O 0 0.010970115661621094
for O 0 0.010693585500121117
84 O 0 0.0588671900331974
. O 0 0.03153282776474953

2 O 0 0.026162024587392807
% O 0 0.010431078262627125
of O 0 0.008509451523423195
the O 0 0.009577954187989235
alleles O 0 0.015466784127056599
in O 0 0.007187701296061277
this O 0 0.006252418737858534
study O 0 0.01349567249417305
. O 0 0.019009320065379143

The O 0 0.03840896114706993
G301C O 1 0.961548388004303
and O 0 0.021036570891737938
S162F O 1 0.991344690322876
mutations O 0 0.020493993535637856
account O 0 0.012388906441628933
for O 0 0.013045074418187141
68 O 0 0.05015119910240173
. O 0 0.031933046877384186

4 O 0 0.039216991513967514
% O 0 0.01780741661787033
and O 0 0.013933810405433178
10 O 0 0.021784022450447083
. O 0 0.022895097732543945

5 O 0 0.02494163252413273
% O 0 0.01136227697134018
of O 0 0.009335449896752834
mutations O 0 0.01118865143507719
, O 0 0.006341504864394665
respectively O 0 0.009175980463624
, O 0 0.006115226540714502
whereas O 0 0.006311725825071335
the O 0 0.006182034965604544
remaining O 0 0.013377193361520767
F69V O 1 0.9999960660934448
is O 0 0.007152758073061705
limited O 0 0.007561215665191412
to O 0 0.0067773316986858845
a O 0 0.011368213221430779
single O 0 0.02014586515724659
allele O 0 0.0415191613137722
. O 0 0.02391762100160122

The O 0 0.03265835717320442
skewed O 0 0.04189041256904602
prevalence O 0 0.1509208232164383
of O 0 0.011920608580112457
G301C O 1 0.9533229470252991
in O 0 0.006304561626166105
only O 0 0.005310199689120054
Colombian O 0 0.3070351481437683
patients O 1 0.9376660585403442
and O 0 0.006177332252264023
haplotype O 0 0.035856205970048904
analysis O 0 0.006086601410061121
by O 0 0.0048470329493284225
restriction O 0 0.013343026861548424
fragment O 0 0.019502034410834312
length O 0 0.009248190559446812
polymorphisms O 0 0.01440555788576603
in O 0 0.005833514034748077
the O 0 0.010140467435121536
GALNS O 1 0.9999991655349731
gene O 0 0.011129793711006641
suggest O 0 0.007475824560970068
that O 0 0.004713360220193863
G301C O 0 0.10529442131519318
originated O 0 0.012002859264612198
from O 0 0.006029540207237005
a O 0 0.009515760466456413
common O 0 0.012855298817157745
ancestor O 0 0.03263833746314049
. O 0 0.025253385305404663

Investigation O 0 0.02436613105237484
of O 0 0.012242035940289497
the O 0 0.010336226783692837
genetic O 0 0.009330551140010357
background O 0 0.007951050065457821
by O 0 0.0031215320341289043
means O 0 0.0046899220906198025
of O 0 0.005551530048251152
mtDNA O 0 0.010024315677583218
lineages O 0 0.009184233844280243
indicate O 0 0.004486276302486658
that O 0 0.002285236958414316
all O 0 0.0028708172030746937
our O 0 0.006615655496716499
patients O 1 0.8022180199623108
are O 0 0.002678138669580221
probably O 0 0.006247112061828375
of O 0 0.006749348249286413
native O 0 0.014244470745325089
American O 0 0.029406249523162842
descent O 0 0.05603611841797829

Low O 0 0.038419440388679504
frequency O 0 0.019287027418613434
of O 0 0.018355056643486023
BRCA1 O 1 0.9997535347938538
germline O 0 0.05290636047720909
mutations O 0 0.009978081099689007
in O 0 0.0049765571020543575
45 O 0 0.013407563790678978
German O 1 0.9999085664749146
breast B-Disease 1 1.0
/ I-Disease 1 1.0
ovarian I-Disease 1 1.0
cancer I-Disease 1 1.0
families O 1 0.9366557002067566
. O 0 0.0311554204672575

In O 0 0.01475896593183279
this O 0 0.006111547350883484
study O 0 0.005620366428047419
we O 0 0.003066091798245907
investigated O 0 0.007590660359710455
45 O 0 0.012780395336449146
German O 1 0.9974848031997681
breast B-Disease 1 1.0
/ I-Disease 1 1.0
ovarian I-Disease 1 1.0
cancer I-Disease 1 1.0
families O 0 0.12016750127077103
for O 0 0.011463931761682034
germline O 1 0.9824602603912354
mutations O 0 0.013350849971175194
in O 0 0.008312507532536983
the O 0 0.017223071306943893
BRCA1 O 1 0.9999903440475464
gene O 0 0.028666028752923012
. O 0 0.027895260602235794

We O 0 0.015888957306742668
identified O 0 0.012518604286015034
four O 0 0.00960247591137886
germline O 0 0.03216211870312691
mutations O 0 0.00831665936857462
in O 0 0.005761704873293638
three O 0 0.00931259524077177
breast B-Disease 1 1.0
cancer I-Disease 1 1.0
families O 0 0.006540805101394653
and O 0 0.0030271902214735746
in O 0 0.003137007588520646
one O 0 0.006381967570632696
breast B-Disease 1 1.0
- I-Disease 1 1.0
ovarian I-Disease 1 1.0
cancer I-Disease 1 1.0
family O 1 0.9999358654022217
. O 0 0.004104341380298138
among O 0 0.004036639351397753
these O 0 0.0018516619456931949
were O 0 0.0026773642748594284
one O 0 0.006001886446028948
frameshift O 1 0.9462977647781372
mutation O 0 0.011022013612091541
, O 0 0.0056450548581779
one O 0 0.00645214831456542
nonsense O 0 0.025487177073955536
mutation O 0 0.012371940538287163
, O 0 0.005530084948986769
one O 0 0.005641827825456858
novel O 0 0.014626002870500088
splice O 0 0.06123221665620804
site O 0 0.01671847701072693
mutation O 0 0.011525888927280903
, O 0 0.005906133446842432
and O 0 0.006673983298242092
one O 0 0.009811971336603165
missense O 0 0.04607260599732399
mutation O 0 0.028772832825779915
. O 0 0.02085755579173565

The O 0 0.02844155952334404
missense O 0 0.05147610604763031
mutation O 0 0.019013963639736176
was O 0 0.011946668848395348
also O 0 0.007664801087230444
found O 0 0.005554595030844212
in O 0 0.00798752624541521
2 O 0 0.021417180076241493
. O 0 0.018058447167277336

8 O 0 0.025572841987013817
% O 0 0.009183027781546116
of O 0 0.006204375997185707
the O 0 0.005654916167259216
general O 0 0.007541261147707701
population O 0 0.00429939990863204
, O 0 0.004163866862654686
suggesting O 0 0.004458569455891848
that O 0 0.0019521223148331046
it O 0 0.002460360759869218
is O 0 0.0041655912064015865
not O 0 0.006358953192830086
disease O 1 1.0
associated O 0 0.035580042749643326
. O 0 0.018728500232100487

The O 0 0.016691314056515694
average O 0 0.013257209211587906
age O 0 0.012312686070799828
of O 0 0.03685334324836731
disease O 1 1.0
onset O 1 1.0
in O 0 0.013357962481677532
those O 0 0.00686701200902462
families O 0 0.012200646102428436
harbouring O 1 0.9999977350234985
causative O 1 0.999985933303833
mutations O 0 0.0199966412037611
was O 0 0.015457636676728725
between O 0 0.010001467540860176
32 O 0 0.028374213725328445
. O 0 0.024235578253865242

3 O 0 0.0440378338098526
and O 0 0.022682329639792442
37 O 0 0.045626889914274216
. O 0 0.02846786566078663

4 O 0 0.03142084553837776
years O 0 0.011922175996005535
, O 0 0.00846873875707388
whereas O 0 0.008313979022204876
the O 0 0.007386941462755203
family O 0 0.013868655078113079
harbouring O 1 0.9414598941802979
the O 0 0.012012657709419727
missense O 0 0.04662622883915901
mutation O 0 0.010493021458387375
had O 0 0.005125733092427254
an O 0 0.004070269409567118
average O 0 0.007946635596454144
age O 0 0.007547979708760977
of O 0 0.009207699447870255
onset O 1 0.9999994039535522
of O 0 0.02249460108578205
51 O 1 0.8589550256729126
. O 0 0.029602807015180588

2 O 0 0.05767529457807541
years O 0 0.03594541177153587
. O 0 0.037044547498226166

These O 0 0.01029896829277277
findings O 0 0.010362375527620316
show O 0 0.007825168780982494
that O 0 0.005708699580281973
BRCA1 O 1 0.9999254941940308
is O 0 0.005905929487198591
implicated O 0 0.019512800499796867
in O 0 0.004041930194944143
a O 0 0.004756115842610598
small O 0 0.003892801236361265
fraction O 0 0.007901309058070183
of O 0 0.010112496092915535
breast B-Disease 1 1.0
/ I-Disease 1 1.0
ovarian I-Disease 1 1.0
cancer I-Disease 1 1.0
families O 0 0.03972114250063896
suggesting O 0 0.009320851415395737
the O 0 0.006828770972788334
involvement O 0 0.00886637531220913
of O 0 0.0070573496632277966
another O 0 0.01559698861092329
susceptibility O 1 0.9999974966049194
gene O 0 0.022428156808018684
( O 0 0.01675616391003132
s O 1 0.9789502620697021
) O 0 0.03302363306283951

Paternal O 1 0.9778661131858826
transmission O 1 0.9677578210830688
of O 1 0.9999037981033325
congenital B-Disease 1 1.0
myotonic I-Disease 1 1.0
dystrophy I-Disease 1 1.0
. O 1 0.9999977350234985

We O 0 0.012644489295780659
report O 0 0.009593944996595383
a O 0 0.0077057331800460815
rare O 0 0.009224405512213707
case O 0 0.0077731553465127945
of O 0 0.010703583247959614
paternally O 1 0.9999998807907104
transmitted O 1 1.0
congenital B-Disease 1 1.0
myotonic I-Disease 1 1.0
dystrophy I-Disease 1 1.0
( O 1 1.0
DM B-Disease 1 1.0
) O 1 0.9046399593353271
. O 0 0.035954251885414124

The O 0 0.02883220463991165
proband O 1 0.8058655858039856
is O 0 0.006912857294082642
a O 0 0.006927288603037596
23 O 0 0.009156864136457443
year O 0 0.00748547213152051
old O 0 0.027934666723012924
, O 0 0.01176748052239418
mentally B-Disease 1 0.9999998807907104
retarded I-Disease 1 0.9999958276748657
male O 1 0.8899961709976196
who O 1 0.9999812841415405
suffers O 1 1.0
severe O 1 1.0
muscular B-Disease 1 1.0
weakness I-Disease 1 1.0
. O 1 0.9995567202568054

He O 0 0.017429169267416
presented O 0 0.01852499134838581
with O 0 0.04335987567901611
respiratory O 1 1.0
and O 1 0.9755081534385681
feeding O 1 0.9983177185058594
difficulties O 1 0.9999970197677612
at O 1 0.9987326264381409
birth O 1 0.9660426378250122
. O 0 0.022931769490242004

His O 0 0.027889594435691833
two O 0 0.015149996615946293
sibs O 1 0.9999977350234985
suffer O 1 0.9998854398727417
from O 0 0.04867228493094444
childhood O 1 1.0
onset O 1 1.0
DM B-Disease 1 1.0
. O 1 0.9801178574562073

Their O 0 0.014660650864243507
late O 0 0.016108406707644463
father O 0 0.014416421763598919
had O 0 0.0062086815014481544
the O 0 0.004941817373037338
adult O 0 0.007841185666620731
type O 0 0.01041390560567379
of O 0 0.012387668713927269
DM B-Disease 1 1.0
, O 0 0.01056705228984356
with O 0 0.0074586449190974236
onset O 1 1.0
around O 0 0.010558945126831532
30 O 0 0.01644660159945488
years O 0 0.016705166548490524
. O 0 0.02342267334461212

Only O 0 0.011280550621449947
six O 0 0.00714528514072299
other O 0 0.0038502062670886517
cases O 0 0.004188669379800558
of O 0 0.005861727520823479
paternal O 1 0.9744267463684082
transmission O 1 0.999733030796051
of O 1 0.9999991655349731
congenital B-Disease 1 1.0
DM I-Disease 1 1.0
have O 0 0.41280311346054077
been O 0 0.010447472333908081
reported O 0 0.013215220533311367
recently O 0 0.02338043600320816
. O 0 0.021549591794610023

We O 0 0.012797554023563862
review O 0 0.011316293850541115
the O 0 0.006885540671646595
sex O 0 0.008034673519432545
related O 0 0.006987690459936857
effects O 0 0.00786122027784586
on O 0 0.007053268142044544
transmission O 1 0.8431487083435059
of O 1 0.9994199275970459
congenital B-Disease 1 1.0
DM I-Disease 1 1.0
. O 1 0.9994515776634216

Decreased O 0 0.05641629546880722
fertility O 0 0.037481214851140976
of O 0 0.009377344511449337
males O 0 0.007444833870977163
with O 0 0.005581126548349857
adult O 0 0.2982527017593384
onset O 1 1.0
DM B-Disease 1 1.0
and O 1 0.5441078543663025
contraction O 1 0.9625903367996216
of O 0 0.00789940170943737
the O 0 0.008316600695252419
repeat O 0 0.014487368054687977
upon O 0 0.008131966926157475
male O 0 0.01168904174119234
transmission O 0 0.013693972490727901
contribute O 0 0.00830343272536993
to O 0 0.005493076518177986
the O 0 0.0059089562855660915
almost O 0 0.007602605037391186
absent O 0 0.014012893661856651
occurrence O 0 0.012017525732517242
of O 0 0.008815308101475239
paternal O 1 0.9717393517494202
transmission O 1 0.9971760511398315
of O 1 0.9999860525131226
congenital B-Disease 1 1.0
DM I-Disease 1 1.0
. O 1 0.9998600482940674

Also O 0 0.015321820043027401
the O 0 0.009202676825225353
fathers O 0 0.011277700774371624
of O 0 0.005057782866060734
the O 0 0.006419091485440731
reported O 0 0.021382072940468788
congenitally O 1 0.9999997615814209
affected O 0 0.07788670808076859
children O 0 0.008415053598582745
showed O 0 0.005827850196510553
, O 0 0.004078519530594349
on O 0 0.004497419111430645
average O 0 0.007947304286062717
, O 0 0.006671995390206575
shorter O 0 0.018818113952875137
CTG O 1 0.999944806098938
repeat O 0 0.0262379702180624
lengths O 0 0.020598895847797394
and O 0 0.005303927231580019
hence O 0 0.00726693868637085
less O 0 0.007199831772595644
severe O 1 1.0
clinical O 1 1.0
symptoms O 1 1.0
than O 0 0.006205728277564049
the O 0 0.007748875766992569
mothers O 0 0.015593430958688259
of O 0 0.0060852584429085255
children O 0 0.06643585115671158
with O 1 0.9980878233909607
congenital B-Disease 1 1.0
DM I-Disease 1 1.0
. O 1 0.9999743700027466

We O 0 0.013368524610996246
conclude O 0 0.01575137861073017
that O 0 0.005850675981491804
paternal O 0 0.021704120561480522
transmission O 0 0.058989252895116806
of O 1 0.9991316199302673
congenital B-Disease 1 1.0
DM I-Disease 1 1.0
is O 1 0.9999692440032959
rare O 1 0.9544482827186584
and O 0 0.008306200616061687
preferentially O 0 0.01728605106472969
occurs O 0 0.005445303861051798
with O 0 0.00465021887794137
onset O 1 0.9999992847442627
of O 1 0.8653474450111389
DM B-Disease 1 1.0
past O 0 0.014077856205403805
30 O 0 0.01008637249469757
years O 0 0.006229473277926445
in O 0 0.0052008917555212975
the O 0 0.00807447824627161
father O 0 0.01818431168794632
. O 0 0.011635180562734604
. O 0 0.019751248881220818

The O 0 0.05073825269937515
RB1 O 1 0.9999992847442627
gene O 0 0.025779150426387787
mutation O 0 0.016645416617393494
in O 0 0.00584237277507782
a O 0 0.0092031080275774
child O 0 0.04305863380432129
with O 0 0.04336277022957802
ectopic B-Disease 1 1.0
intracranial I-Disease 1 1.0
retinoblastoma I-Disease 1 1.0
. O 0 0.2113916426897049

The O 0 0.04162226617336273
RB1 O 1 0.9999996423721313
gene O 0 0.02722114324569702
mutation O 0 0.016380999237298965
was O 0 0.010817633010447025
investigated O 0 0.011930672451853752
in O 0 0.006384883541613817
a O 0 0.008598312735557556
child O 0 0.01812794618308544
with O 0 0.013463955372571945
ectopic B-Disease 1 1.0
intracranial I-Disease 1 1.0
retinoblastoma I-Disease 1 1.0
using O 0 0.011501023545861244
DNA O 0 0.011931335553526878
obtained O 0 0.006199485156685114
from O 0 0.0037109407130628824
both O 0 0.00405676057562232
the O 0 0.008532681502401829
pineal B-Disease 1 0.9999953508377075
and I-Disease 0 0.0616510808467865
retinal I-Disease 1 1.0
tumours I-Disease 1 1.0
of O 1 0.9952424764633179
the O 1 0.988274097442627
patient O 1 0.9999992847442627
. O 0 0.029686180874705315

A O 0 0.04377241060137749
nonsense O 0 0.04997769743204117
mutation O 0 0.022474490106105804
in O 0 0.01173202134668827
exon O 0 0.05621592700481415
17 O 0 0.015415576286613941
( O 0 0.009782398119568825
codon O 0 0.023372234776616096
556 O 0 0.03413311764597893
) O 0 0.005706650670617819
of O 0 0.0051257857121527195
the O 0 0.009628312662243843
RB1 O 1 1.0
gene O 0 0.009363163262605667
was O 0 0.006383948493748903
found O 0 0.0028167148120701313
to O 0 0.002838631859049201
be O 0 0.003047881182283163
present O 0 0.005383109673857689
homozygously O 0 0.16273130476474762
in O 0 0.004276275169104338
both O 0 0.004283501300960779
the O 0 0.008791905827820301
retinal B-Disease 1 0.9999996423721313
and I-Disease 0 0.024280620738863945
the I-Disease 1 0.9719510078430176
pineal I-Disease 1 1.0
tumours I-Disease 1 1.0
. O 0 0.046205099672079086

The O 0 0.01906033232808113
same O 0 0.010937388986349106
mutation O 0 0.01612935960292816
was O 0 0.011126624420285225
present O 0 0.009643406607210636
heterozygously O 1 0.5437098741531372
in O 0 0.005759296473115683
the O 0 0.005790924187749624
DNA O 0 0.006167515646666288
from O 0 0.0030408864840865135
the O 0 0.00383609882555902
constitutional O 0 0.006984451320022345
cells O 0 0.005109892692416906
of O 0 0.0043081785552203655
the O 0 0.007137576583772898
patient O 1 0.9999492168426514
, O 0 0.006433412898331881
proving O 0 0.040281664580106735
it O 0 0.003292384557425976
to O 0 0.004263448063284159
be O 0 0.004341780208051205
of O 0 0.008184270933270454
germline O 0 0.04227716848254204
origin O 0 0.015599038451910019
. O 0 0.02367866039276123

The O 0 0.021236883476376534
initial O 0 0.02205467037856579
mutation O 0 0.0167732872068882
was O 0 0.008720019832253456
shown O 0 0.0054234289564192295
to O 0 0.004111090674996376
have O 0 0.003088840516284108
occurred O 0 0.006205105222761631
in O 0 0.004375322721898556
the O 0 0.01168617233633995
paternally O 1 0.9314698576927185
derived O 0 0.03370654955506325
RB1 O 1 0.9999974966049194
allele O 0 0.07610611617565155
. O 0 0.040530357509851456

The O 0 0.024510223418474197
mutation O 0 0.017314724624156952
is O 0 0.0052184793166816235
in O 0 0.0038343097548931837
an O 0 0.004199840594083071
area O 0 0.006268562749028206
of O 0 0.004443352110683918
the O 0 0.006430256180465221
gene O 0 0.005944616161286831
that O 0 0.0033100557047873735
encodes O 0 0.008306735195219517
the O 0 0.006343386601656675
protein O 0 0.010110089555382729
- O 1 0.9943901896476746
binding O 0 0.007609243039041758
region O 0 0.006428020540624857
known O 0 0.004273906350135803
as O 0 0.003888602601364255
the O 0 0.005319542251527309
pocket O 1 0.999998927116394
region O 0 0.00961499847471714
and O 0 0.0036832476034760475
has O 0 0.004197487607598305
been O 0 0.0038309856317937374
detected O 0 0.005375506356358528
in O 0 0.002743347780779004
other O 0 0.0025558830238878727
cases O 0 0.004854343365877867
of O 0 0.027201829478144646
retinoblastoma B-Disease 1 1.0
. O 0 0.015763284638524055
. O 0 0.02452448569238186

Low O 0 0.03250672668218613
levels O 0 0.0123041532933712
of O 0 0.009470806457102299
beta O 0 0.043358832597732544
hexosaminidase O 1 0.9919167160987854
A O 0 0.012383271008729935
in O 0 0.0064673153683543205
healthy O 0 0.00972601305693388
individuals O 0 0.00312423356808722
with O 0 0.005672663915902376
apparent O 1 0.9999991655349731
deficiency O 1 1.0
of O 1 0.9997425675392151
this O 0 0.03802332654595375
enzyme O 0 0.052880436182022095
. O 0 0.021951861679553986

Appreciable O 1 0.564410924911499
beta O 0 0.09384546428918839
hexosaminidase O 1 0.9430643320083618
A O 0 0.0205977875739336
( O 0 0.011681640520691872
hex O 0 0.038348451256752014
A O 0 0.015937533229589462
) O 0 0.006356208585202694
activity O 0 0.004832213744521141
has O 0 0.003488261019811034
been O 0 0.003068153280764818
detected O 0 0.00607801740989089
in O 0 0.005831509362906218
cultured O 1 0.9989098310470581
skin O 1 1.0
fibroblasts O 1 0.9999996423721313
and O 1 0.9999099969863892
melanoma B-Disease 1 1.0
tissue O 1 1.0
from O 0 0.021659543737769127
healthy O 0 0.4494405686855316
individuals O 0 0.004304193891584873
previously O 0 0.006486843340098858
reported O 0 0.005809335969388485
as O 0 0.005413139704614878
having O 0 0.013870245777070522
deficiency B-Disease 1 1.0
of I-Disease 1 0.5726610422134399
hex I-Disease 1 0.9982988238334656
A I-Disease 0 0.03315233811736107
activity O 0 0.00840930175036192
indistinguishable O 0 0.011429643258452415
from O 0 0.0031652268953621387
that O 0 0.0021703853271901608
of O 0 0.0035737762227654457
patients O 0 0.049635469913482666
with O 0 0.024275831878185272
Tay B-Disease 1 1.0
- I-Disease 1 1.0
Sachs I-Disease 1 1.0
disease I-Disease 1 1.0
( O 1 0.9998551607131958
TSD B-Disease 1 1.0
) O 0 0.02497677132487297
. O 0 0.027873195707798004

Identification O 0 0.03596777468919754
and O 0 0.01556423120200634
quantitation O 1 0.898114800453186
of O 0 0.015275660902261734
hex O 1 0.6297803521156311
A O 0 0.022030020132660866
, O 0 0.010485864244401455
amounting O 0 0.021879594773054123
to O 0 0.012545807287096977
3 O 0 0.02629709616303444
. O 0 0.0209982767701149

5 O 0 0.034558411687612534
% O 0 0.02269280143082142
- O 1 0.999701201915741
6 O 0 0.04135820269584656
. O 0 0.033205170184373856

9 O 0 0.030783761292696
% O 0 0.010688255541026592
of O 0 0.007228645496070385
total O 0 0.010794888250529766
beta O 1 0.7310189604759216
hexosaminidase O 1 0.9993636012077332
activity O 0 0.010680528357625008
, O 0 0.006348846480250359
has O 0 0.005936126224696636
been O 0 0.005210014991462231
obtained O 0 0.0075305551290512085
by O 0 0.008691411465406418
cellulose O 1 0.9999898672103882
acetate O 1 0.999997615814209
gel O 1 0.9999892711639404
electrophoresis O 0 0.23446723818778992
, O 0 0.01873069256544113
DEAE O 1 0.9999994039535522
- O 1 0.9999994039535522
cellulose O 1 0.9999169111251831
ion O 1 0.905097246170044
- O 1 0.9998106360435486
exchange O 0 0.022357698529958725
chromatography O 0 0.134779155254364
, O 0 0.017433783039450645
radial O 1 0.6122814416885376
immunodiffusion O 1 0.9995941519737244
, O 0 0.015852656215429306
and O 0 0.015757611021399498
radioimmunoassay O 1 0.9998714923858643
. O 0 0.03505510464310646

Previous O 0 0.030779339373111725
family O 0 0.017844540998339653
studies O 0 0.008111907169222832
suggested O 0 0.005334540270268917
that O 0 0.002623241860419512
these O 0 0.0022106708493083715
individuals O 0 0.0025702642742544413
may O 0 0.003595764981582761
be O 0 0.0036458380054682493
compound O 0 0.05239231139421463
heterozygotes O 0 0.07641785591840744
for O 0 0.004856375977396965
the O 0 0.0065938313491642475
common O 0 0.009004717692732811
mutant O 1 0.9378287196159363
TSD B-Disease 1 1.0
gene O 0 0.014614955522119999
and O 0 0.006182914134114981
a O 0 0.008242091163992882
rare O 0 0.013095731846988201
( O 0 0.012259385548532009
allelic O 1 0.9989715814590454
) O 0 0.016344666481018066
mutant O 0 0.05114181339740753
gene O 0 0.023738056421279907
. O 0 0.022063756361603737

Thus O 0 0.021118951961398125
, O 0 0.01025630347430706
the O 0 0.009491593576967716
postulated O 0 0.028860826045274734
rate O 0 0.011036275885999203
mutant O 0 0.026972109451889992
gene O 0 0.01009444985538721
appears O 0 0.0068730441853404045
to O 0 0.004072732757776976
code O 0 0.004527586977928877
for O 0 0.003265953855589032
the O 0 0.003972137812525034
expression O 0 0.005414217710494995
of O 0 0.005950623657554388
low O 0 0.010718696750700474
amounts O 0 0.00842307135462761
of O 0 0.011420012451708317
hex O 0 0.0644569918513298
A O 0 0.03436075896024704
. O 0 0.027777627110481262

Heterozygotes O 0 0.10833308845758438
for O 0 0.013541016727685928
the O 0 0.014509362168610096
rare O 0 0.021817302331328392
mutant O 0 0.0492931567132473
may O 0 0.009039385244250298
be O 0 0.005681772716343403
indistinguishable O 0 0.018472256138920784
from O 0 0.007985509000718594
heterozygotes O 0 0.02862565405666828
for O 0 0.007102545350790024
the O 0 0.012946258299052715
common O 0 0.021077098324894905
TSD B-Disease 1 1.0
mutant O 1 0.8289161920547485
. O 0 0.0435936413705349

However O 0 0.015475813299417496
, O 0 0.009391188621520996
direct O 0 0.011038722470402718
visualization O 0 0.030102519318461418
and O 0 0.00929236225783825
quantitation O 1 0.9975269436836243
of O 0 0.011701383627951145
hex O 0 0.3223998546600342
A O 0 0.011389480903744698
by O 0 0.004274184349924326
the O 0 0.005781854968518019
methods O 0 0.00563320005312562
described O 0 0.008314312435686588
may O 0 0.006043273024260998
prevent O 0 0.008328449912369251
false O 0 0.012006876058876514
- O 1 0.9999990463256836
positive O 0 0.012281028553843498
prenatal O 1 0.9999982118606567
diagnosis O 1 0.9999990463256836
of O 1 0.5830594301223755
TSD B-Disease 1 1.0
in O 0 0.012943675741553307
fetuses O 0 0.08522730320692062
having O 0 0.007209248375147581
the O 0 0.0055524553172290325
incomplete O 0 0.009978274814784527
hex B-Disease 0 0.2496900111436844
A I-Disease 1 0.9761129021644592
deficiency I-Disease 1 1.0
of O 0 0.07783803343772888
the O 0 0.045484330505132675
type O 0 0.32076960802078247
described O 0 0.009479008615016937
in O 0 0.00595176313072443
the O 0 0.00828075222671032
four O 0 0.012529401108622551
healthy O 0 0.030680788680911064
individuals O 0 0.020788904279470444

The O 0 0.03825617954134941
tumor B-Disease 1 0.9999992847442627
suppressor O 1 0.9999611377716064
gene O 0 0.03184112161397934
Smad4 O 1 0.9999997615814209
/ O 1 0.9999991655349731
Dpc4 O 1 0.9999213218688965
is O 0 0.006933481432497501
required O 0 0.006690638605505228
for O 0 0.005957616958767176
gastrulation O 1 0.9981164932250977
and O 0 0.006749859545379877
later O 0 0.008066805079579353
for O 0 0.007043312303721905
anterior O 1 0.9992212057113647
development O 0 0.010385490953922272
of O 0 0.010325072333216667
the O 0 0.023586509749293327
mouse O 1 0.9301935434341431
embryo O 0 0.042532194405794144
. O 0 0.028384847566485405

Mutations O 0 0.02977217547595501
in O 0 0.0086132837459445
the O 0 0.013360985554754734
SMAD4 O 1 1.0
/ O 1 1.0
DPC4 O 1 1.0
tumor B-Disease 1 1.0
suppressor O 1 0.9999990463256836
gene O 0 0.013389719650149345
, O 0 0.006858598906546831
a O 0 0.007658032700419426
key O 0 0.012513499706983566
signal O 0 0.014686918817460537
transducer O 0 0.027885261923074722
in O 0 0.006154010072350502
most O 0 0.007410201244056225
TGFbeta O 1 0.9999890327453613
- O 1 0.9999995231628418
related O 0 0.02690001204609871
pathways O 0 0.017342956736683846
, O 0 0.005542663857340813
are O 0 0.0021321193780750036
involved O 0 0.002648330759257078
in O 0 0.003433060599491
50 O 0 0.008006053976714611
% O 0 0.007149974815547466
of O 0 0.11934715509414673
pancreatic B-Disease 1 1.0
cancers I-Disease 1 1.0
. O 0 0.04226280003786087

Homozygous O 0 0.12960071861743927
Smad4 O 1 0.9999711513519287
mutant O 1 0.9979912042617798
mice O 1 0.9100097417831421
die O 1 0.6067990660667419
before O 0 0.01413748599588871
day O 0 0.01759258471429348
7 O 0 0.03045828826725483
. O 0 0.02729780413210392

5 O 0 0.04822691157460213
of O 0 0.03294868767261505
embryogenesis O 1 0.6456475257873535
. O 0 0.04050682857632637

Mutant O 0 0.07223302870988846
embryos O 0 0.01739402301609516
have O 0 0.005191535223275423
reduced O 0 0.009877636097371578
size O 0 0.009298360906541348
, O 0 0.006048083771020174
fail O 0 0.01100520696491003
to O 0 0.007291596382856369
gastrulate O 1 0.9705193042755127
or O 0 0.005628709215670824
express O 0 0.012654262594878674
a O 0 0.01076466403901577
mesodermal O 1 0.9999489784240723
marker O 1 0.9973190426826477
, O 0 0.008357160724699497
and O 0 0.006706381682306528
show O 0 0.014399021863937378
abnormal O 1 0.9638372659683228
visceral O 1 0.9999998807907104
endoderm O 1 1.0
development O 0 0.2833883762359619
. O 0 0.03816436603665352

Growth B-Disease 1 0.7341086268424988
retardation I-Disease 1 0.9999716281890869
of O 0 0.013582308776676655
the O 0 0.018822187557816505
Smad4 O 1 1.0
- O 1 1.0
deficient O 1 0.9982684850692749
embryos O 0 0.00936127919703722
results O 0 0.005725163035094738
from O 0 0.005433064419776201
reduced O 0 0.01279411930590868
cell O 0 0.022547181695699692
proliferation O 0 0.02209426648914814
rather O 0 0.008098325692117214
than O 0 0.00854642316699028
increased O 0 0.01630939356982708
apoptosis O 0 0.2942655682563782
. O 0 0.025911271572113037

Aggregation O 0 0.04904646798968315
of O 0 0.022304385900497437
mutant O 0 0.10369004309177399
Smad4 O 1 0.9999991655349731
ES O 1 0.9999986886978149
cells O 0 0.015039490535855293
with O 0 0.0074437703005969524
wild O 0 0.015731031075119972
- O 1 0.9999735355377197
type O 0 0.03197444602847099
tetraploid O 0 0.11833414435386658
morulae O 1 0.9988833069801331
rescues O 1 0.9763676524162292
the O 0 0.030023476108908653
gastrulation B-Disease 1 0.9999980926513672
defect I-Disease 1 0.9999929666519165
. O 0 0.047046829015016556

These O 0 0.010531623847782612
results O 0 0.009055033326148987
indicate O 0 0.0071175592020154
that O 0 0.005007936153560877
Smad4 O 1 0.9996957778930664
is O 0 0.006038588937371969
initially O 0 0.006475255824625492
required O 0 0.0036296145990490913
for O 0 0.0033300535287708044
the O 0 0.0056844791397452354
differentiation O 0 0.012809088453650475
of O 0 0.007828020490705967
the O 0 0.01234668493270874
visceral O 1 0.9999969005584717
endoderm O 1 0.9999985694885254
and O 0 0.007825705222785473
that O 0 0.004241093527525663
the O 0 0.009545044042170048
gastrulation B-Disease 1 0.9999978542327881
defect I-Disease 1 0.9998544454574585
in O 0 0.007594105787575245
the O 0 0.009830301627516747
epiblast O 1 0.9999995231628418
is O 0 0.006788054946810007
secondary O 0 0.010861867107450962
and O 0 0.006522155832499266
non O 1 0.8028795719146729
- O 1 1.0
cell O 0 0.3228254020214081
autonomous O 0 0.028653500601649284
. O 0 0.02304273098707199

Rescued O 0 0.08509758859872818
embryos O 0 0.02792603336274624
show O 0 0.024888262152671814
severe O 1 0.9999992847442627
anterior O 1 1.0
truncations O 1 1.0
, O 0 0.014393376186490059
indicating O 0 0.009727382101118565
a O 0 0.006514460314065218
second O 0 0.009406189434230328
important O 0 0.004891195334494114
role O 0 0.005673011299222708
for O 0 0.006060537416487932
Smad4 O 1 0.9999871253967285
in O 0 0.015831828117370605
anterior O 1 0.9999997615814209
patterning O 1 0.9999998807907104
during O 1 0.9366070032119751
embryogenesis O 1 0.9975689053535461
. O 0 0.039550911635160446

Prevalence O 1 0.9713129997253418
of O 0 0.02890958823263645
p16 O 1 0.9986953139305115
and O 0 0.02075933665037155
CDK4 O 1 0.9999996423721313
germline O 1 0.6842803955078125
mutations O 0 0.016208825632929802
in O 0 0.009149875491857529
48 O 1 0.6250253915786743
melanoma B-Disease 1 1.0
- O 1 1.0
prone O 1 0.9999934434890747
families O 0 0.015967443585395813
in O 0 0.012334182858467102
France O 0 0.04066598787903786
. O 0 0.024402862414717674

The O 0 0.034644488245248795
French O 1 0.9708163142204285
Familial B-Disease 1 1.0
Melanoma I-Disease 1 1.0
Study O 1 0.95235675573349
Group O 0 0.08213549107313156
. O 0 0.027551954612135887

Germline O 1 0.525730311870575
mutations O 0 0.02088126167654991
in O 0 0.007574272342026234
the O 0 0.010003016330301762
p16 O 1 0.9898855686187744
and O 0 0.012169825844466686
CDK4 O 1 1.0
genes O 0 0.00927455723285675
have O 0 0.0030344086699187756
been O 0 0.0035597747191786766
reported O 0 0.0043617296032607555
in O 0 0.0033677825704216957
a O 0 0.006335771642625332
subset O 0 0.016056939959526062
of O 0 0.017154231667518616
melanoma B-Disease 1 1.0
pedigrees O 1 0.9999204874038696
, O 0 0.006759729236364365
but O 0 0.003891033586114645
their O 0 0.004178076051175594
prevalence O 1 0.9998157620429993
is O 0 0.004915494937449694
not O 0 0.004285268951207399
well O 0 0.008602744899690151
known O 0 0.015621356666088104
. O 0 0.01849932037293911

We O 0 0.015261887572705746
searched O 0 0.022043680772185326
for O 0 0.006944423541426659
such O 0 0.006284020841121674
germline O 0 0.029608219861984253
mutations O 0 0.008863836526870728
in O 0 0.005191382020711899
48 O 0 0.017262786626815796
French O 1 0.9998518228530884
melanoma B-Disease 1 1.0
- O 1 1.0
prone O 1 0.9999960660934448
families O 0 0.007618386764079332
selected O 0 0.007436987943947315
according O 0 0.003279502270743251
to O 0 0.003270138520747423
two O 0 0.0026120496913790703
major O 0 0.005186776630580425
criteria O 0 0.005114631727337837
families O 0 0.0034492788836359978
with O 0 0.0026534656062722206
at O 0 0.004224059637635946
least O 0 0.0027702501974999905
three O 0 0.002768245991319418
affected O 0 0.004239678382873535
members O 0 0.0037595066241919994
( O 0 0.004902875982224941
n O 0 0.016224458813667297
= O 0 0.018377112224698067
20 O 0 0.009794127196073532
) O 0 0.005849780049175024
or O 0 0.004454263020306826
families O 0 0.004215504042804241
with O 0 0.003057171357795596
two O 0 0.003518785582855344
affected O 0 0.004633943550288677
members O 0 0.0031149950809776783
, O 0 0.0033979732543230057
one O 0 0.002816216554492712
of O 0 0.003105025039985776
them O 0 0.0025065443478524685
affected O 0 0.003904236014932394
before O 0 0.003176835598424077
the O 0 0.003623554715886712
age O 0 0.004915018565952778
of O 0 0.0041036359034478664
50 O 0 0.007800680585205555
( O 0 0.006208434700965881
n O 0 0.016458826139569283
= O 0 0.02001951076090336
28 O 0 0.013076911680400372
) O 0 0.0056578475050628185
, O 0 0.004845570307224989
and O 0 0.003970255143940449
one O 0 0.0053052837029099464
additional O 0 0.01050079707056284
minor O 0 0.043385326862335205
criterion O 1 0.9910785555839539
. O 0 0.03292241320014

Sixteen O 0 0.05401613190770149
different O 0 0.015283273532986641
p16 O 1 0.8872790932655334
germline O 1 0.5368282198905945
mutations O 0 0.01242114044725895
were O 0 0.0037861084565520287
found O 0 0.003360987175256014
in O 0 0.003943049814552069
21 O 0 0.007914031855762005
families O 0 0.005774719174951315
, O 0 0.004762833938002586
while O 0 0.005238029174506664
one O 0 0.007634861394762993
germline O 0 0.08467521518468857
mutation O 0 0.016874302178621292
, O 0 0.010577233508229256
Arg24His O 1 0.9999796152114868
, O 0 0.008318185806274414
was O 0 0.010541283525526524
detected O 0 0.00999311450868845
in O 0 0.007394357584416866
the O 0 0.01474003680050373
CDK4 O 1 0.9999996423721313
gene O 0 0.028781073167920113
. O 0 0.022412952035665512

The O 0 0.019694704562425613
frequency O 0 0.014536816626787186
of O 0 0.013808617368340492
p16 O 1 0.9817209243774414
gene O 0 0.01463830191642046
mutation O 0 0.01088733784854412
in O 0 0.004456020426005125
our O 0 0.0052165561355650425
sample O 0 0.006017395295202732
( O 0 0.005183709319680929
44 O 0 0.013278347440063953
% O 0 0.006692723836749792
) O 0 0.0047843498177826405
is O 0 0.0032426263205707073
among O 0 0.003252248512580991
the O 0 0.004133646842092276
highest O 0 0.01172719057649374
rates O 0 0.006046932190656662
yet O 0 0.004271151497960091
reported O 0 0.0038645120803266764
and O 0 0.0028576452750712633
the O 0 0.006198245566338301
CDK4 O 1 1.0
mutation O 0 0.009900550357997417
is O 0 0.004395805299282074
the O 0 0.005223914980888367
second O 0 0.011111879721283913
mutation O 0 0.010737725533545017
detected O 0 0.007739064283668995
in O 0 0.004793975036591291
this O 0 0.005178026854991913
gene O 0 0.011929744854569435
worldwide O 0 0.017926475033164024
. O 0 0.01858600787818432

In O 0 0.02179080620408058
summary O 0 0.022127285599708557
, O 0 0.008463071659207344
our O 0 0.006904904264956713
results O 0 0.006070790812373161
show O 0 0.005952823907136917
frequent O 0 0.006571694742888212
involvement O 0 0.007316731847822666
of O 0 0.004664849955588579
the O 0 0.007609155494719744
p16 O 1 0.9942420125007629
gene O 0 0.009355232119560242
in O 0 0.008863472379744053
familial B-Disease 1 1.0
melanoma I-Disease 1 1.0
and O 0 0.011098286136984825
confirm O 0 0.008001131936907768
the O 0 0.005293567199259996
role O 0 0.006308120675384998
of O 0 0.004961096681654453
the O 0 0.007899140939116478
CDK4 O 1 0.9999992847442627
gene O 0 0.007574308663606644
as O 0 0.005409061908721924
a O 0 0.013275636360049248
melanoma B-Disease 1 1.0
- O 1 1.0
predisposing O 1 1.0
gene O 0 0.020393529906868935
. O 0 0.011601068079471588
. O 0 0.017795434221625328

Progression O 0 0.44775402545928955
of O 0 0.02506275475025177
somatic O 1 0.8668997287750244
CTG O 1 0.9999988079071045
repeat O 0 0.038535721600055695
length O 0 0.016152523458003998
heterogeneity O 0 0.024652214720845222
in O 0 0.006719515658915043
the O 0 0.00985253881663084
blood O 0 0.29229268431663513
cells O 0 0.017776552587747574
of O 1 0.9877201914787292
myotonic B-Disease 1 1.0
dystrophy I-Disease 1 1.0
patients O 1 1.0
. O 1 0.8554883003234863

The O 0 0.018501847982406616
genetic O 0 0.011022555641829967
basis O 0 0.006947127170860767
of O 0 0.016001766547560692
myotonic B-Disease 1 1.0
dystrophy I-Disease 1 1.0
( O 1 1.0
DM B-Disease 1 1.0
) O 0 0.016246315091848373
is O 0 0.005370053928345442
the O 0 0.005337546579539776
expansion O 0 0.00951278954744339
of O 0 0.007105494849383831
an O 0 0.009510189294815063
unstable O 1 0.9999157190322876
CTG O 1 0.9999998807907104
repeat O 0 0.025403082370758057
in O 0 0.006649192422628403
the O 0 0.0074860816821455956
34 O 0 0.015675799921154976
UTR O 0 0.07472416758537292
of O 0 0.011607850901782513
the O 0 0.01866004802286625
DM B-Disease 1 1.0
protein O 0 0.04391881078481674
kinase O 0 0.06277262419462204
gene O 0 0.011610136367380619
on O 0 0.009908709675073624
chromosome O 0 0.02539924718439579
19 O 0 0.028387486934661865
. O 0 0.028036195784807205

One O 0 0.014727485366165638
of O 0 0.008002608083188534
the O 0 0.0068311323411762714
principal O 0 0.010540219023823738
features O 0 0.006978424731642008
of O 0 0.00607282854616642
the O 0 0.02193821594119072
DM B-Disease 1 1.0
mutation O 0 0.10975968837738037
is O 0 0.005245737265795469
an O 0 0.005005897954106331
extraordinarily O 0 0.014844034798443317
high O 0 0.00873811636120081
level O 0 0.007555881980806589
of O 0 0.008292542770504951
somatic O 1 0.9643897414207458
mosaicism O 1 0.9999986886978149
, O 0 0.006408859975636005
due O 0 0.004820352420210838
to O 0 0.003695904742926359
an O 0 0.003566556377336383
extremely O 0 0.00612129271030426
high O 0 0.006645618937909603
degree O 0 0.007831546477973461
of O 0 0.008055275306105614
somatic O 1 0.916440486907959
instability O 1 0.9448924660682678
both O 0 0.004363758023828268
within O 0 0.004254711791872978
and O 0 0.005198207683861256
between O 0 0.0057825050316751
different O 0 0.006716280244290829
tissues O 0 0.17650622129440308
. O 0 0.022430866956710815

This O 0 0.020479245111346245
instability O 0 0.25553393363952637
appears O 0 0.014301938004791737
to O 0 0.0061024934984743595
be O 0 0.004195937421172857
biased O 0 0.008265619166195393
towards O 0 0.0058050635270774364
further O 0 0.00516422837972641
expansion O 0 0.010184346698224545
and O 0 0.004609852097928524
continuous O 0 0.005863750819116831
throughout O 0 0.003756880294531584
the O 0 0.0038896461483091116
life O 0 0.003933457657694817
of O 0 0.002920344937592745
an O 0 0.0030978042632341385
individual O 0 0.0031473045237362385
, O 0 0.0035738444421440363
features O 0 0.004608999006450176
that O 0 0.001922902651131153
could O 0 0.0024675801396369934
be O 0 0.0019427041988819838
associated O 0 0.0027682448271661997
with O 0 0.003147328272461891
the O 0 0.005332425702363253
progressive O 0 0.1403261125087738
nature O 0 0.007906308397650719
of O 0 0.010104327462613583
the O 1 0.9876917004585266
disease O 1 1.0
. O 0 0.05083952844142914

Although O 0 0.015657076612114906
increasing O 0 0.011407379992306232
measured O 0 0.012228644452989101
allele O 0 0.01936931535601616
size O 0 0.01313773076981306
between O 0 0.008032294921576977
patients O 0 0.3933101296424866
clearly O 0 0.007735395338386297
correlates O 0 0.013608418405056
with O 0 0.0033662430942058563
an O 0 0.003435018938034773
increased O 0 0.007107705343514681
severity O 1 0.9999964237213135
of O 1 0.9978876709938049
symptoms O 1 1.0
and O 0 0.004883067682385445
an O 0 0.0037640330847352743
earlier O 0 0.006286856718361378
age O 0 0.007678769528865814
of O 0 0.009049489162862301
onset O 1 1.0
, O 0 0.006249551195651293
this O 0 0.004387272521853447
correlation O 0 0.006793283391743898
is O 0 0.0033293317537754774
not O 0 0.0023697286378592253
precise O 0 0.005897394381463528
and O 0 0.004616981837898493
measured O 0 0.009018021635711193
allele O 0 0.015008035115897655
length O 0 0.0067837475799024105
cannot O 0 0.004727648571133614
be O 0 0.003155618440359831
used O 0 0.0036547291092574596
as O 0 0.0037737188395112753
an O 0 0.004837641958147287
accurate O 0 0.008997521363198757
predictor O 0 0.024579431861639023
of O 0 0.007432680577039719
age O 0 0.012956621125340462
of O 0 0.022105634212493896
onset O 1 1.0
. O 0 0.03711589425802231

In O 0 0.016476549208164215
order O 0 0.010578989051282406
to O 0 0.006054227240383625
further O 0 0.006771210115402937
characterize O 0 0.015516864135861397
the O 0 0.008164913393557072
dynamics O 0 0.019895348697900772
of O 0 0.01820559613406658
DM B-Disease 1 1.0
CTG O 1 1.0
repeat O 1 0.9999768733978271
somatic O 1 0.9987905621528625
instability O 1 0.9934211373329163
, O 0 0.006307792384177446
we O 0 0.0038760092575103045
have O 0 0.003086612094193697
studied O 0 0.007285752333700657
repeat O 0 0.012731298804283142
length O 0 0.005647062789648771
changes O 0 0.0040773386135697365
over O 0 0.004331670235842466
time O 0 0.004529732279479504
in O 0 0.007966485805809498
111 O 1 0.9999665021896362
myotonic B-Disease 1 1.0
dystrophy I-Disease 1 1.0
patients O 1 0.9999997615814209
with O 0 0.0088810371235013
varying O 0 0.01258369255810976
clinical O 1 0.9999994039535522
severity O 1 0.9999994039535522
and O 0 0.24490374326705933
CTG O 1 1.0
repeat O 0 0.030869320034980774
size O 0 0.010988964699208736
over O 0 0.005091816186904907
time O 0 0.004099403973668814
intervals O 0 0.005052916705608368
of O 0 0.004979636985808611
1 O 0 0.01548840757459402
- O 1 0.9998794794082642
7 O 0 0.019154606387019157
years O 0 0.01688810996711254
. O 0 0.022565914317965508

We O 0 0.011758222244679928
have O 0 0.004343369510024786
found O 0 0.004569214303046465
a O 0 0.005911856424063444
direct O 0 0.006844756193459034
progression O 0 0.018489539623260498
of O 0 0.005530363414436579
the O 0 0.00568907568231225
size O 0 0.011725135147571564
heterogeneity O 0 0.0198493842035532
over O 0 0.006337038241326809
time O 0 0.0043490296229720116
related O 0 0.004982799757272005
to O 0 0.005011662840843201
initial O 0 0.014901561662554741
CTG O 1 0.9999934434890747
repeat O 0 0.02312798984348774
size O 0 0.009980803355574608
and O 0 0.004723150283098221
the O 0 0.00581208523362875
time O 0 0.007019495125859976
interval O 0 0.012605598196387291
and O 0 0.005959370639175177
always O 0 0.007616108749061823
biased O 0 0.011901679448783398
towards O 0 0.010857841931283474
further O 0 0.011884587816894054
expansion O 0 0.03434273973107338
. O 0 0.02714524418115616

Attempts O 0 0.026290135458111763
to O 0 0.010567097924649715
mathematically O 0 0.015480187721550465
model O 0 0.0111276526004076
the O 0 0.007566735148429871
dynamics O 0 0.013475270941853523
have O 0 0.004211874678730965
proved O 0 0.010317839682102203
only O 0 0.00485496548935771
partially O 0 0.011739078909158707
successful O 0 0.009068966843187809
suggesting O 0 0.006030840799212456
that O 0 0.0021101997699588537
individual O 0 0.002539806067943573
specific O 0 0.0026331183034926653
genetic O 0 0.005596282426267862
and O 0 0.0062058656476438046
/ O 1 0.9999998807907104
or O 0 0.006657320074737072
environmental O 0 0.01910405419766903
factors O 0 0.006867880932986736
also O 0 0.005594485905021429
play O 0 0.006129603832960129
a O 0 0.006130992900580168
role O 0 0.01014704629778862
in O 0 0.011058853007853031
somatic O 1 0.9573785066604614
mosaicism O 1 0.9999961853027344
. O 0 0.017124930396676064
. O 0 0.02468963898718357

Aspartylglucosaminuria B-Disease 1 0.9999321699142456
among O 0 0.030901148915290833
Palestinian O 0 0.03443599492311478
Arabs O 0 0.042563408613204956
. O 0 0.03655672445893288

Aspartylglucosaminuria B-Disease 1 1.0
( O 1 0.8050112128257751
AGU B-Disease 1 1.0
) O 0 0.010943100787699223
is O 0 0.005771579686552286
a O 0 0.006742495112121105
rare O 0 0.09430381655693054
disorder B-Disease 1 1.0
of I-Disease 1 0.9999946355819702
glycoprotein I-Disease 1 1.0
metabolism I-Disease 1 0.9999966621398926
caused O 0 0.2590438723564148
by O 0 0.005421672482043505
the O 0 0.016020096838474274
deficiency B-Disease 1 1.0
of I-Disease 0 0.03885667771100998
the I-Disease 0 0.4807455241680145
lysosomal I-Disease 1 1.0
enzyme I-Disease 1 0.9883290529251099
aspartylglucosaminidase I-Disease 1 0.9999998807907104
( O 0 0.06308057904243469
AGA O 1 1.0
) O 0 0.029807204380631447
. O 0 0.03321182727813721

AGU B-Disease 1 1.0
is O 0 0.019840536639094353
inherited O 1 0.9976255297660828
as O 0 0.007983997464179993
an O 0 0.010151433758437634
autosomal O 1 1.0
recessive O 1 1.0
trait O 1 0.9999997615814209
and O 0 0.054173510521650314
occurs O 0 0.004633767530322075
with O 0 0.003521340899169445
a O 0 0.006201236508786678
high O 0 0.011097103357315063
frequency O 0 0.005846378859132528
in O 0 0.004445010330528021
Finland O 0 0.016718950122594833
because O 0 0.004831376951187849
of O 0 0.007191414013504982
a O 0 0.012823700904846191
founder O 1 0.999808132648468
effect O 0 0.01832001470029354
. O 0 0.022169658914208412

While O 0 0.014456341974437237
very O 0 0.008203359320759773
few O 0 0.009569543413817883
patients O 1 0.9064872860908508
with O 0 0.009947902522981167
AGU B-Disease 1 1.0
have O 0 0.004514025058597326
been O 0 0.004712443333119154
reported O 0 0.005256496835500002
from O 0 0.0037305166479200125
non O 0 0.011018668301403522
- O 1 0.9999951124191284
Finnish O 1 0.9026686549186707
origin O 0 0.005055767949670553
, O 0 0.0045702229253947735
we O 0 0.005042277276515961
diagnosed O 1 0.9999998807907104
the O 0 0.08442612737417221
disorder O 1 1.0
in O 0 0.025922808796167374
8 O 1 0.6277039647102356
patients O 1 0.9911991953849792
originating O 0 0.009696632623672485
from O 0 0.006303316447883844
3 O 0 0.010148726403713226
unrelated O 0 0.00934565532952547
families O 0 0.005012399982661009
, O 0 0.0034131761640310287
all O 0 0.0025295685045421124
Palestinian O 0 0.006225716322660446
Arabs O 0 0.007849008776247501
from O 0 0.004550040699541569
the O 0 0.006263752933591604
region O 0 0.01054826844483614
of O 0 0.01119097787886858
Jerusalem O 0 0.16130569577217102
. O 0 0.026990193873643875

The O 0 0.026811840012669563
clinical O 1 0.9998631477355957
diagnosis O 1 0.9999994039535522
of O 1 0.999736487865448
AGU B-Disease 1 1.0
is O 0 0.011275052092969418
often O 0 0.004474608227610588
difficult O 0 0.005316318944096565
, O 0 0.003342614509165287
in O 0 0.0025770256761461496
particular O 0 0.0029681918676942587
early O 0 0.0037682373076677322
in O 0 0.002784792799502611
the O 0 0.0034418520517647266
course O 0 0.006311504635959864
of O 0 0.004772870801389217
the O 0 0.020678984001278877
disease O 1 1.0
, O 0 0.004243954084813595
and O 0 0.0027324229013174772
most O 0 0.0026509594172239304
of O 0 0.0034686413127928972
the O 0 0.008049470372498035
patients O 1 0.9999961853027344
are O 0 0.0031909674871712923
diagnosed O 1 1.0
after O 0 0.00821713637560606
the O 0 0.005727880634367466
age O 0 0.007732084020972252
of O 0 0.006599792744964361
5 O 0 0.013757296837866306
years O 0 0.013377849012613297
. O 0 0.018773028627038002

However O 0 0.013207057490944862
, O 0 0.008832189254462719
since O 0 0.007330758962780237
these O 0 0.005237174686044455
patients O 1 0.9140952229499817
excrete O 1 0.9921635389328003
early O 0 0.008371138013899326
large O 0 0.005231340415775776
amounts O 0 0.0048968056216835976
of O 0 0.0057374257594347
aspartylglucosamine O 1 0.9503600001335144
in O 0 0.007516760844737291
urine O 0 0.015745731070637703
, O 0 0.008208943530917168
biochemical O 0 0.026835914701223373
screening O 0 0.013699139468371868
is O 0 0.004820275120437145
easy O 0 0.008724654093384743
by O 0 0.0062578218057751656
urine O 0 0.03393855318427086
chromatography O 1 0.9863046407699585
. O 0 0.01790672540664673
. O 0 0.02383730188012123

Detection O 0 0.051197513937950134
of O 0 0.01673557423055172
heterozygous O 0 0.026071757078170776
carriers O 0 0.01882816106081009
of O 0 0.008880524896085262
the O 0 0.01359370443969965
ataxia B-Disease 1 1.0
- I-Disease 1 1.0
telangiectasia I-Disease 1 1.0
( O 0 0.17176255583763123
ATM O 1 0.9999241828918457
) O 0 0.009456934407353401
gene O 0 0.008693203330039978
by O 0 0.007178200408816338
G2 O 1 0.9999991655349731
phase O 0 0.051473598927259445
chromosomal O 0 0.14032188057899475
radiosensitivity O 1 0.99937903881073
of O 0 0.45087188482284546
peripheral O 1 1.0
blood O 1 0.9999998807907104
lymphocytes O 1 0.9999996423721313
. O 0 0.03496675193309784

In O 0 0.03199135884642601
ataxia B-Disease 1 1.0
- I-Disease 1 1.0
telangiectasia I-Disease 1 1.0
( O 0 0.012222458608448505
A B-Disease 1 0.9999934434890747
- I-Disease 1 1.0
T I-Disease 1 1.0
) O 0 0.012542521581053734
patients O 1 0.9901132583618164
, O 0 0.0066447751596570015
mutations O 0 0.006611702032387257
in O 0 0.0035370609257370234
a O 0 0.005136325489729643
single O 0 0.006714810151606798
gene O 0 0.006977410521358252
, O 0 0.005974544677883387
ATM O 1 0.5305355787277222
, O 0 0.004202565643936396
result O 0 0.0027791019529104233
in O 0 0.0030905704479664564
an O 0 0.009461774490773678
autosomal B-Disease 1 1.0
recessive I-Disease 1 1.0
syndrome I-Disease 1 1.0
that O 0 0.14107106626033783
embraces O 1 0.9988538026809692
a O 0 0.009119567461311817
variety O 0 0.007743056397885084
of O 0 0.008120851591229439
clinical O 1 0.9999537467956543
features O 0 0.01150529645383358
and O 0 0.007132178172469139
manifests O 1 0.9774227738380432
extreme O 1 0.9968805313110352
radiosensitivity O 1 0.9999986886978149
and O 0 0.0057520512491464615
a O 0 0.00716088991612196
strong O 0 0.010536461137235165
pre O 1 0.9999772310256958
- O 1 0.9999997615814209
disposition O 1 0.9752702713012695
to O 0 0.02164365164935589
malignancy B-Disease 1 0.9999996423721313
. O 0 0.03470347076654434

Heterozygotes O 0 0.0899796262383461
for O 0 0.011956669390201569
the O 0 0.012893730774521828
ATM O 1 0.9844621419906616
gene O 0 0.0084464643150568
have O 0 0.0026864763349294662
no O 0 0.0035374555736780167
clinical O 0 0.009612102061510086
expression O 0 0.004516283981502056
of O 0 0.004221455194056034
A B-Disease 1 0.9999997615814209
- I-Disease 1 1.0
T I-Disease 1 1.0
but O 0 0.004309262614697218
may O 0 0.004529695957899094
be O 0 0.004938263911753893
cancer B-Disease 1 1.0
prone O 1 0.9999922513961792
with O 0 0.004395316820591688
a O 0 0.009287957102060318
moderate O 0 0.4264652729034424
increase O 0 0.006669881287962198
in O 0 0.007334756664931774
in O 0 0.010790230706334114
vitro O 0 0.14606767892837524
radiosensitivity O 1 0.983379065990448
. O 0 0.033255357295274734

We O 0 0.015066733583807945
performed O 0 0.013889448717236519
a O 0 0.012915682047605515
blind O 0 0.02933374047279358
chromosomal O 0 0.020912885665893555
analysis O 0 0.007233263924717903
on O 0 0.00766332121565938
G2 O 1 1.0
- O 1 1.0
phase O 0 0.2326122671365738
lymphocytes O 0 0.04036741331219673
from O 0 0.005455664824694395
7 O 0 0.009970579296350479
unrelated O 0 0.010836660861968994
A B-Disease 1 0.998988926410675
- I-Disease 1 1.0
T I-Disease 1 1.0
patients O 1 0.9992855191230774
, O 0 0.006226707715541124
13 O 0 0.009333407506346703
obligate O 0 0.021397363394498825
A B-Disease 1 0.9966151118278503
- I-Disease 1 1.0
T I-Disease 1 1.0
heterozygotes O 1 0.9966369867324829
( O 0 0.0068816617131233215
parents O 0 0.005038714036345482
of O 0 0.004677340388298035
the O 0 0.006254024803638458
patients O 1 0.9999845027923584
) O 0 0.004977761767804623
, O 0 0.0036421518307179213
and O 0 0.0032829858828336
14 O 0 0.005840093828737736
normal O 0 0.005633337888866663
controls O 0 0.00892755389213562
following O 0 0.0076362662948668
X O 1 0.9982491731643677
- O 1 0.9999575614929199
irradiation O 0 0.027672074735164642
with O 0 0.008485615253448486
1 O 0 0.021489819511771202
Gy O 1 0.9999860525131226
in O 0 0.0075117540545761585
order O 0 0.0061753010377287865
to O 0 0.0064532882533967495
evaluate O 0 0.01447117980569601
this O 0 0.006916665937751532
cytogenetic O 0 0.03621531277894974
method O 0 0.0072642732411623
as O 0 0.0054025654681026936
a O 0 0.006932578515261412
tool O 0 0.01376449316740036
for O 0 0.005864582024514675
detection O 0 0.019846949726343155
of O 0 0.014303025789558887
ATM O 1 0.9998939037322998
carriers O 0 0.14190234243869781
. O 0 0.02676481567323208

Both O 0 0.01664637215435505
A B-Disease 1 0.993511974811554
- I-Disease 1 1.0
T I-Disease 1 1.0
homozygotes O 1 0.999974250793457
and O 0 0.011586620472371578
heterozygotes O 0 0.49538707733154297
showed O 0 0.010825257748365402
significantly O 0 0.007942884229123592
increased O 0 0.005873735062777996
levels O 0 0.005607913713902235
of O 0 0.006639476865530014
radiation O 1 0.9999978542327881
- O 1 1.0
induced O 1 1.0
chromatid O 1 1.0
damage O 1 0.9956814050674438
relative O 0 0.008697439916431904
to O 0 0.004112273920327425
that O 0 0.00338709051720798
of O 0 0.006967043969780207
normal O 0 0.0115535082295537
controls O 0 0.028537599369883537
. O 0 0.024790456518530846

These O 0 0.0106304120272398
results O 0 0.009964227676391602
show O 0 0.006381221115589142
that O 0 0.0031935072038322687
the O 0 0.008791940286755562
G2 O 1 1.0
- O 1 0.9999998807907104
phase O 1 0.5197444558143616
chromosomal O 1 0.9835817813873291
radiosensitivity O 1 0.9999936819076538
assay O 0 0.06211473420262337
can O 0 0.00450502336025238
be O 0 0.002473834902048111
used O 0 0.0026671546511352062
for O 0 0.0026967828162014484
the O 0 0.004143205471336842
detection O 0 0.009339230135083199
of O 0 0.007947748526930809
A B-Disease 1 0.9999983310699463
- I-Disease 1 1.0
T I-Disease 1 1.0
heterozygotes O 1 0.9982398748397827
. O 0 0.034845542162656784

In O 0 0.018550477921962738
combination O 0 0.019858652725815773
with O 0 0.008387398906052113
molecular O 0 0.016081063076853752
genetic O 0 0.009312375448644161
analyses O 0 0.008291731588542461
, O 0 0.0044440315105021
this O 0 0.0027539373841136694
test O 0 0.0067969197407364845
may O 0 0.003341670846566558
be O 0 0.0019396980060264468
of O 0 0.0026728406082838774
value O 0 0.0033487838227301836
in O 0 0.002808487042784691
studies O 0 0.003676889231428504
of O 0 0.0058931466192007065
familial B-Disease 1 0.9999678134918213
and I-Disease 0 0.010803313925862312
sporadic I-Disease 1 0.997684121131897
cancers I-Disease 1 1.0
aimed O 0 0.015512589365243912
at O 0 0.008797833696007729
determination O 0 0.009110283106565475
of O 0 0.004898688290268183
the O 0 0.004698796197772026
potential O 0 0.0074966074898839
involvement O 0 0.008808469399809837
of O 0 0.0070045022293925285
ATM O 1 0.9979215264320374
mutations O 0 0.009572166018188
in O 0 0.009607951156795025
tumor B-Disease 1 1.0
risk O 1 0.9999980926513672
or O 0 0.01040323730558157
development O 0 0.014225540682673454
. O 0 0.011270391754806042
. O 0 0.018094105646014214

Ataxia B-Disease 1 1.0
- I-Disease 1 1.0
telangiectasia I-Disease 1 1.0
: O 0 0.012793843634426594
identification O 0 0.008130612783133984
and O 0 0.0046395836398005486
detection O 0 0.011151689104735851
of O 0 0.008166755549609661
founder O 1 0.9999998807907104
- O 1 0.9999998807907104
effect O 0 0.009127974510192871
mutations O 0 0.007171234115958214
in O 0 0.004388303495943546
the O 0 0.008218593895435333
ATM O 1 0.9982625842094421
gene O 0 0.010071566328406334
in O 0 0.006590899080038071
ethnic O 0 0.011957379058003426
populations O 0 0.01505288202315569
. O 0 0.025321515277028084

To O 0 0.01658974029123783
facilitate O 0 0.014517653733491898
the O 0 0.007397165056318045
evaluation O 0 0.013246966525912285
of O 0 0.011207732371985912
ATM O 1 0.9985852241516113
heterozygotes O 1 0.560012698173523
for O 0 0.007158334832638502
susceptibility O 0 0.3303787410259247
to O 0 0.005699277855455875
other O 0 0.004934418015182018
diseases O 1 1.0
, O 0 0.003853478003293276
such O 0 0.0030051569920033216
as O 1 0.9984409213066101
breast B-Disease 1 1.0
cancer I-Disease 1 1.0
, O 0 0.23408247530460358
we O 0 0.0031050927937030792
have O 0 0.002358910860493779
attempted O 0 0.005596568342298269
to O 0 0.003115682164207101
define O 0 0.0056557985953986645
the O 0 0.004059813916683197
most O 0 0.003943169489502907
common O 0 0.004617227241396904
mutations O 0 0.0052275811322033405
and O 0 0.0030730068683624268
their O 0 0.0027689014095813036
frequencies O 0 0.0054033417254686356
in O 0 0.007261518854647875
ataxia B-Disease 1 1.0
- I-Disease 1 1.0
telangiectasia I-Disease 1 1.0
( O 0 0.012792542576789856
A B-Disease 1 0.9999958276748657
- I-Disease 1 1.0
T I-Disease 1 1.0
) O 0 0.014968760311603546
homozygotes O 0 0.13269494473934174
from O 0 0.007928470149636269
10 O 0 0.010702114552259445
ethnic O 0 0.012511673383414745
populations O 0 0.016028404235839844
. O 0 0.022551951929926872

Both O 0 0.021674949675798416
genomic O 0 0.041396185755729675
mutations O 0 0.013878505676984787
and O 0 0.006090677343308926
their O 0 0.00620160112157464
effects O 0 0.01200046855956316
on O 0 0.00970108900219202
cDNA O 0 0.03331208974123001
were O 0 0.010499450378119946
characterized O 0 0.02310076169669628
. O 0 0.019970688968896866

Protein O 0 0.0607173815369606
- O 1 0.9903404116630554
truncation O 0 0.044150400906801224
testing O 0 0.014938444830477238
of O 0 0.00834006816148758
the O 0 0.008286799304187298
entire O 0 0.018164627254009247
ATM O 0 0.04725224897265434
cDNA O 0 0.03078986331820488
detected O 0 0.01470075361430645
92 O 0 0.03161965683102608
( O 0 0.00997647549957037
66 O 0 0.025639448314905167
% O 0 0.010665347799658775
) O 0 0.011614750139415264
truncating O 0 0.05230507254600525
mutations O 0 0.01566668599843979
in O 0 0.009971917606890202
140 O 0 0.03670445829629898
mutant O 0 0.06665942817926407
alleles O 0 0.058457743376493454
screened O 0 0.07433931529521942
. O 0 0.039693400263786316

The O 0 0.028772931545972824
haplotyping O 1 0.6462148427963257
of O 0 0.013908113352954388
patients O 1 0.9309143424034119
with O 0 0.005878370255231857
identical O 0 0.01301993802189827
mutations O 0 0.008687402121722698
indicates O 0 0.006267179269343615
that O 0 0.002067587338387966
almost O 0 0.00251592556014657
all O 0 0.002065184060484171
of O 0 0.0024412188213318586
these O 0 0.0017551456112414598
represent O 0 0.0034494884312152863
common O 0 0.0038719719741493464
ancestry O 0 0.005862625781446695
and O 0 0.0036953238304704428
that O 0 0.0026825161185115576
very O 0 0.004626324400305748
few O 0 0.007567171938717365
spontaneously O 0 0.028778620064258575
recurring O 1 0.9997146725654602
ATM O 1 0.9999940395355225
mutations O 0 0.024287506937980652
exist O 0 0.012737234123051167
. O 0 0.021740645170211792

Assays O 0 0.06713946908712387
requiring O 0 0.019733896479010582
minimal O 0 0.01838054321706295
amounts O 0 0.008579585701227188
of O 0 0.008369626477360725
genomic O 0 0.018157046288251877
DNA O 0 0.008421191945672035
were O 0 0.0033805747516453266
designed O 0 0.008597666397690773
to O 0 0.0038952629547566175
allow O 0 0.006290927529335022
rapid O 0 0.01378912478685379
screening O 0 0.014317126013338566
for O 0 0.0072953663766384125
common O 0 0.009564589709043503
ethnic O 0 0.015172571875154972
mutations O 0 0.023877723142504692
. O 0 0.02140001207590103

These O 0 0.020743247121572495
rapid O 0 0.03950507566332817
assays O 0 0.04025597125291824
detected O 0 0.023904947564005852
mutations O 0 0.012177138589322567
in O 0 0.007674516644328833
76 O 0 0.024094106629490852
% O 0 0.007770070806145668
of O 0 0.007986144162714481
Costa O 0 0.03367846459150314
Rican O 1 0.8769444823265076
patients O 1 0.9993681311607361
( O 0 0.007755618076771498
3 O 0 0.010634083300828934
) O 0 0.005036070477217436
, O 0 0.0035425000824034214
50 O 0 0.005260562989860773
% O 0 0.0032088810112327337
of O 0 0.0041205743327736855
Norwegian O 0 0.09905555844306946
patients O 1 0.9998842477798462
( O 0 0.007062230259180069
1 O 0 0.01166070718318224
) O 0 0.0047415983863174915
, O 0 0.003369110869243741
25 O 0 0.005233658477663994
% O 0 0.003469250863417983
of O 0 0.004689761437475681
Polish O 1 0.9999982118606567
patients O 1 0.9999990463256836
( O 0 0.008593687787652016
4 O 0 0.015010424889624119
) O 0 0.005352381616830826
, O 0 0.004029897507280111
and O 0 0.0031412288080900908
14 O 0 0.005118185188621283
% O 0 0.003726570401340723
of O 0 0.004626328591257334
Italian O 1 0.9999128580093384
patients O 1 0.9999973773956299
( O 0 0.007340292911976576
1 O 0 0.04077688604593277
) O 0 0.005311273038387299
, O 0 0.003981551621109247
as O 0 0.0034592917654663324
well O 0 0.0036316479090601206
as O 0 0.003828962566331029
in O 0 0.005290449596941471
patients O 0 0.04926417022943497
of O 0 0.010017183609306812
Amish O 1 0.9996819496154785
/ O 1 0.9999606609344482
Mennonite O 1 0.7415140867233276
and O 0 0.011070395819842815
Irish O 0 0.022962892428040504
English O 0 0.017931485548615456
backgrounds O 0 0.02052859403192997
. O 0 0.021395809948444366

Additional O 0 0.03219304606318474
mutations O 0 0.019078098237514496
were O 0 0.005903368350118399
observed O 0 0.007203534711152315
in O 0 0.006309800315648317
Japanese O 0 0.01713094860315323
, O 0 0.008282773196697235
Utah O 0 0.02167440578341484
Mormon O 0 0.021280437707901
, O 0 0.006424622610211372
and O 0 0.006519901100546122
African O 0 0.017818128690123558
American O 1 0.6528588533401489
patients O 1 0.9999788999557495
. O 0 0.02444915659725666

These O 0 0.015518268570303917
assays O 0 0.02085861749947071
should O 0 0.006180372089147568
facilitate O 0 0.009054797701537609
screening O 0 0.008760704658925533
for O 0 0.005044090561568737
A B-Disease 1 0.9992094039916992
- I-Disease 1 1.0
T I-Disease 1 1.0
heterozygotes O 1 0.8145921230316162
in O 0 0.007841355167329311
the O 0 0.008834147825837135
populations O 0 0.008980767801404
studied O 0 0.018153797835111618
. O 0 0.012710626237094402
. O 0 0.019984731450676918

The O 0 0.03191320225596428
von B-Disease 1 0.8724016547203064
Hippel I-Disease 1 0.9999997615814209
- I-Disease 1 1.0
Lindau I-Disease 1 1.0
tumor I-Disease 1 1.0
suppressor O 1 0.9999996423721313
gene O 0 0.011975284665822983
is O 0 0.004574320279061794
required O 0 0.004471397493034601
for O 0 0.005152735393494368
cell O 0 0.01524411141872406
cycle O 0 0.01745200902223587
exit O 0 0.021915659308433533
upon O 0 0.01939997263252735
serum O 1 0.9997110962867737
withdrawal O 0 0.12362979352474213
. O 0 0.03679651767015457

The O 0 0.03157243877649307
inactivation O 1 0.6722768545150757
of O 0 0.012990144081413746
the O 0 0.013011448085308075
von B-Disease 1 0.9990599751472473
Hippel I-Disease 1 1.0
- I-Disease 1 1.0
Lindau I-Disease 1 0.9999998807907104
( I-Disease 0 0.022163255140185356
VHL I-Disease 1 1.0
) I-Disease 0 0.03839505463838577
tumor I-Disease 1 1.0
suppressor O 1 0.9999998807907104
gene O 0 0.02614651620388031
predisposes O 1 0.9997865557670593
affected O 0 0.007208883296698332
individuals O 0 0.0021475835237652063
to O 0 0.002869632327929139
the O 0 0.005073782056570053
human O 1 0.8188060522079468
VHL B-Disease 1 1.0
cancer I-Disease 1 1.0
syndrome I-Disease 1 1.0
and O 1 0.9991360306739807
is O 0 0.006465716287493706
associated O 0 0.005219224374741316
with O 0 0.00523895351216197
sporadic B-Disease 1 0.9974405765533447
renal I-Disease 1 1.0
cell I-Disease 1 1.0
carcinomas I-Disease 1 1.0
( O 1 0.9999905824661255
RCC B-Disease 1 1.0
) O 0 0.07458160072565079
and O 0 0.023878322914242744
brain B-Disease 1 0.9999512434005737
hemangioblastomas I-Disease 1 0.9999932050704956
. O 0 0.03793618828058243

VHL O 1 0.9999955892562866
- O 1 0.9978943467140198
negative O 0 0.030939139425754547
786 O 1 0.9998301267623901
- O 1 0.9999997615814209
0 O 0 0.48088228702545166
RCC B-Disease 1 1.0
cells O 0 0.016447436064481735
are O 0 0.005543457344174385
tumorigenic O 1 0.8976368308067322
in O 0 0.008834592998027802
nude O 1 0.99367356300354
mice O 0 0.030143793672323227
which O 0 0.004548084922134876
is O 0 0.005074723158031702
suppressed O 0 0.014129843562841415
by O 0 0.005190473981201649
the O 0 0.008488673716783524
reintroduction O 0 0.17161935567855835
of O 0 0.02657335251569748
VHL B-Disease 1 0.9999998807907104
. O 0 0.039421819150447845

Remarkably O 0 0.12596747279167175
, O 0 0.01175257284194231
this O 0 0.005265845451503992
occurs O 0 0.005658142734318972
without O 0 0.003913399763405323
affecting O 0 0.006529353559017181
the O 0 0.004641392268240452
growth O 0 0.00690032821148634
rate O 0 0.005455915350466967
and O 0 0.005059122107923031
cell O 0 0.01115269772708416
cycle O 0 0.009917953051626682
profile O 0 0.01165667362511158
of O 0 0.006491953041404486
these O 0 0.005087209399789572
cells O 0 0.01024922076612711
in O 0 0.009310456924140453
culture O 0 0.02561667375266552
. O 0 0.0246436707675457

The O 0 0.02712329290807247
786 O 1 0.9987612962722778
- O 1 0.9999592304229736
0 O 0 0.026067111641168594
cell O 0 0.01620207354426384
line O 0 0.009327339008450508
, O 0 0.004209487233310938
like O 0 0.004364376422017813
many O 0 0.004677073564380407
cancer B-Disease 1 1.0
cells O 0 0.023238549008965492
, O 0 0.005159530322998762
fails O 0 0.00986071303486824
to O 0 0.004432933870702982
exit O 0 0.01099737361073494
the O 0 0.007466138806194067
cell O 0 0.01654798537492752
cycle O 0 0.014954717829823494
upon O 0 0.016034351661801338
serum O 1 0.9997746348381042
withdrawal O 0 0.17608480155467987
. O 0 0.03377440571784973

Here O 0 0.018321426585316658
, O 0 0.008468402549624443
it O 0 0.004898213781416416
is O 0 0.00408950075507164
shown O 0 0.0031975903548300266
that O 0 0.0021886713802814484
reintroduction O 0 0.010592710226774216
of O 0 0.003937186673283577
the O 0 0.005442350637167692
wild O 0 0.01174080464988947
- O 1 0.9999996423721313
type O 1 0.6856926083564758
VHL B-Disease 1 0.9999995231628418
gene O 0 0.016558464616537094
restores O 0 0.0287379901856184
the O 0 0.006621358450502157
ability O 0 0.0069085280410945415
of O 0 0.008920860476791859
VHL O 1 1.0
- O 1 1.0
negative O 1 0.9350633025169373
RCC B-Disease 1 1.0
cancer I-Disease 1 1.0
cells O 0 0.011834291741251945
to O 0 0.007138873916119337
exit O 0 0.015747830271720886
the O 0 0.009774464182555676
cell O 0 0.014337286353111267
cycle O 0 0.011704795993864536
and O 0 0.007915855385363102
enter O 0 0.02364431880414486
G0 O 1 0.9999997615814209
/ O 1 0.9999407529830933
quiescence O 1 0.9946861267089844
in O 0 0.021642504259943962
low O 0 0.053731925785541534
serum O 1 0.9949253797531128
. O 0 0.0364777073264122

Both O 0 0.025685088708996773
VHL O 1 0.9999997615814209
- O 1 0.9997097849845886
positive O 0 0.010925241746008396
and O 0 0.011097030714154243
VHL O 1 1.0
- O 1 1.0
negative O 0 0.07219134271144867
RCC B-Disease 1 1.0
cells O 0 0.01709694042801857
exit O 0 0.01949123665690422
the O 0 0.012837180867791176
cell O 0 0.020248163491487503
cycle O 0 0.01586296409368515
by O 0 0.009297619573771954
contact O 0 0.029143238440155983
inhibition O 0 0.27765366435050964
. O 0 0.028688987717032433

The O 0 0.048879243433475494
cyclin O 1 0.9999523162841797
- O 1 0.9999511241912842
dependent O 0 0.03857065737247467
kinase O 1 0.8131069540977478
inhibitor O 1 0.9811481833457947
, O 0 0.014707964845001698
p27 O 1 0.9993376135826111
, O 0 0.012669106014072895
accumulates O 0 0.052867643535137177
upon O 0 0.013930653221905231
serum O 1 0.999988317489624
withdrawal O 0 0.19201697409152985
, O 0 0.005820268765091896
only O 0 0.002769333543255925
in O 0 0.002945581218227744
the O 0 0.004249931313097477
presence O 0 0.006621191743761301
of O 0 0.00883660651743412
VHL B-Disease 1 1.0
, O 0 0.0060853902250528336
as O 0 0.004225391428917646
a O 0 0.004711188841611147
result O 0 0.003361188108101487
of O 0 0.003624370787292719
the O 0 0.00556911900639534
stabilization O 1 0.6959824562072754
of O 0 0.009265153668820858
the O 0 0.014970215037465096
protein O 0 0.020177338272333145
. O 0 0.020668407902121544

We O 0 0.014808458276093006
propose O 0 0.01398041658103466
that O 0 0.003202180378139019
the O 0 0.004269835073500872
loss O 0 0.008404023945331573
of O 0 0.004878430627286434
wild O 0 0.009823286905884743
- O 1 1.0
type O 1 0.9931924939155579
VHL B-Disease 1 1.0
gene O 0 0.009904005564749241
results O 0 0.005198710598051548
in O 0 0.0033872374333441257
a O 0 0.005599807482212782
specific O 0 0.006564647424966097
cellular O 0 0.4731703996658325
defect O 1 0.9956358075141907
in O 0 0.01019060704857111
serum O 1 0.9999998807907104
- O 1 0.9999998807907104
dependent O 0 0.01051628589630127
growth O 0 0.007947920821607113
control O 0 0.007663837168365717
, O 0 0.005748596973717213
which O 0 0.00591213908046484
may O 0 0.00997250061482191
initiate O 1 0.9737610816955566
tumor B-Disease 1 1.0
formation O 0 0.4589288830757141
. O 0 0.030047426000237465

This O 0 0.015477889217436314
is O 0 0.010501728393137455
corrected O 0 0.01866244524717331
by O 0 0.0038851555436849594
the O 0 0.005469523835927248
reintroduction O 0 0.018126240000128746
of O 0 0.006679005920886993
wild O 0 0.014188437722623348
- O 1 0.9999995231628418
type O 1 0.9012292623519897
VHL B-Disease 1 0.9999998807907104
, O 0 0.013887906447052956
implicating O 1 0.9998182654380798
VHL B-Disease 1 0.9999996423721313
as O 0 0.0070024956949055195
the O 0 0.0072156330570578575
first O 0 0.06326403468847275
tumor B-Disease 1 1.0
suppressor O 1 0.9997408986091614
involved O 0 0.005182934924960136
in O 0 0.003191046416759491
the O 0 0.0040749418549239635
regulation O 0 0.005138196982443333
of O 0 0.0050088088028132915
cell O 0 0.014520328491926193
cycle O 0 0.011524857021868229
exit O 0 0.012278391979634762
, O 0 0.0047302814200520515
which O 0 0.0030408259481191635
is O 0 0.0026418461930006742
consistent O 0 0.0037369802594184875
with O 0 0.002649309579282999
its O 0 0.005736486986279488
gatekeeper O 1 0.9999994039535522
function O 0 0.006432188209146261
in O 0 0.005883616860955954
the O 0 0.10778500884771347
kidney O 1 1.0
. O 0 0.014095463789999485
. O 0 0.02135241962969303

Piebaldism B-Disease 1 0.9999980926513672
with O 0 0.3191084563732147
deafness B-Disease 1 1.0
: O 0 0.025056835263967514
molecular O 0 0.013221303932368755
evidence O 0 0.0048265280202031136
for O 0 0.004491918720304966
an O 0 0.0092154024168849
expanded O 1 0.99921715259552
syndrome O 1 1.0
. O 0 0.04239046946167946

In O 0 0.01720435731112957
a O 0 0.014997866936028004
South O 0 0.018800480291247368
African O 0 0.014923086389899254
girl O 0 0.019044145941734314
of O 0 0.009122111834585667
Xhosa O 1 0.9999977350234985
stock O 0 0.029265981167554855
with O 0 0.007839500904083252
severe O 1 0.9999998807907104
piebaldism B-Disease 1 1.0
and O 1 0.960981011390686
profound O 1 1.0
congenital O 1 1.0
sensorineural B-Disease 1 1.0
deafness I-Disease 1 1.0
we O 1 0.9862514138221741
identified O 0 0.01514821033924818
a O 0 0.01162559911608696
novel O 0 0.020572129637002945
missense O 0 0.029523849487304688
substitution O 0 0.017468055710196495
at O 0 0.009769657626748085
a O 0 0.008882188238203526
highly O 0 0.016995703801512718
conserved O 0 0.02055373042821884
residue O 0 0.02062470093369484
in O 0 0.00705236941576004
the O 0 0.011888821609318256
intracellular O 0 0.04283881559967995
kinase O 0 0.031429704278707504
domain O 0 0.012273559346795082
of O 0 0.007875334471464157
the O 0 0.01366085559129715
KIT O 1 1.0
proto O 1 1.0
- O 1 1.0
oncogene O 1 0.9999996423721313
, O 0 0.03371548280119896
R796G O 1 0.9775788187980652
. O 0 0.03877320513129234

Though O 0 0.03187977895140648
auditory B-Disease 1 0.9631229043006897
anomalies I-Disease 0 0.25374916195869446
have O 0 0.005000158678740263
been O 0 0.004911997355520725
observed O 0 0.004423086065798998
in O 0 0.004225738812237978
mice O 0 0.007071300409734249
with O 0 0.004336489364504814
dominant O 0 0.09366603940725327
white O 0 0.26956379413604736
spotting O 1 0.9999650716781616
( O 0 0.030508682131767273
W O 1 1.0
) O 0 0.00633006077259779
due O 0 0.005373222753405571
to O 0 0.00724796112626791
KIT O 1 1.0
mutations O 0 0.04735599830746651
, O 0 0.23108278214931488
deafness B-Disease 1 1.0
is O 0 0.008332286961376667
not O 0 0.004434443078935146
typical O 0 0.01016984973102808
in O 0 0.006674028467386961
human O 0 0.011251995339989662
piebaldism B-Disease 1 0.9999607801437378
. O 0 0.02567594312131405

Thus O 0 0.019555093720555305
, O 0 0.007366149686276913
the O 0 0.008043022826313972
occurrence O 0 0.014313692227005959
of O 0 0.08424469828605652
sensorineural B-Disease 1 1.0
deafness I-Disease 1 1.0
in O 1 0.7324859499931335
this O 0 0.00964025966823101
patient O 1 0.997923731803894
extends O 0 0.02107246220111847
considerably O 0 0.01327727735042572
the O 0 0.007071829866617918
phenotypic O 0 0.013707218691706657
range O 0 0.007417976390570402
of O 0 0.007061650976538658
piebaldism B-Disease 1 0.944796085357666
due O 0 0.007420259062200785
to O 0 0.008613662794232368
KIT O 1 0.9999998807907104
gene O 0 0.013575078919529915
mutation O 0 0.009628452360630035
in O 0 0.005477183498442173
humans O 0 0.005783297121524811
and O 0 0.005197581835091114
tightens O 1 0.9956088662147522
the O 0 0.007742221001535654
clinical O 1 0.9994086027145386
similarity O 0 0.012245957739651203
between O 0 0.007174585480242968
piebaldism B-Disease 1 0.9997232556343079
and O 0 0.004659844562411308
the O 0 0.0038557606749236584
various O 0 0.003402911825105548
forms O 0 0.0071456837467849255
of O 1 0.9974108338356018
Waardenburg B-Disease 1 1.0
syndrome I-Disease 1 1.0
. O 1 0.8798291683197021
. O 0 0.028612710535526276

Cycloheximide O 1 0.9906760454177856
facilitates O 0 0.04447140172123909
the O 0 0.01462316419929266
identification O 0 0.012904330156743526
of O 0 0.011959587223827839
aberrant O 0 0.04427196830511093
transcripts O 0 0.019199827685952187
resulting O 0 0.01024413388222456
from O 0 0.005248924717307091
a O 0 0.007734847255051136
novel O 0 0.015855224803090096
splice O 0 0.39495664834976196
- O 1 0.9976237416267395
site O 0 0.014475105330348015
mutation O 0 0.009645433165133
in O 0 0.0056313625536859035
COL17A1 O 1 0.9998103976249695
in O 0 0.006115470547229052
a O 0 0.009890766814351082
patient O 1 0.9850907325744629
with O 0 0.012912423349916935
generalized O 1 0.9999998807907104
atrophic B-Disease 1 1.0
benign I-Disease 1 1.0
epidermolysis I-Disease 1 1.0
bullosa I-Disease 1 1.0
. O 0 0.38373756408691406

Patients O 1 0.9887630939483643
with O 0 0.02055116556584835
generalized O 1 0.9999951124191284
atrophic B-Disease 1 1.0
benign I-Disease 1 1.0
epidermolysis I-Disease 1 1.0
bullosa I-Disease 1 1.0
often O 0 0.011446679942309856
show O 0 0.00939448457211256
decreased O 0 0.009212163276970387
expression O 0 0.007027650251984596
of O 0 0.009812995791435242
type O 1 0.9999855756759644
XVII O 1 1.0
collagen O 1 1.0
, O 0 0.014748173765838146
a O 0 0.019003091380000114
transmembrane O 1 0.9963529109954834
hemidesmosomal O 1 0.9997729659080505
protein O 0 0.022996896877884865
encoded O 0 0.017622197046875954
by O 0 0.014401023276150227
COL17A1 O 1 0.9996376037597656
. O 0 0.03210851550102234

This O 0 0.010882148519158363
report O 0 0.007709773723036051
documents O 0 0.007881000638008118
a O 0 0.00829305686056614
novel O 0 0.016150251030921936
splice O 0 0.3020736277103424
- O 1 0.9993239641189575
site O 0 0.01631021685898304
mutation O 0 0.012648366391658783
in O 0 0.0075843152590096
COL17A1 O 1 0.9996153116226196
in O 0 0.006432618014514446
a O 0 0.009283376857638359
patient O 1 0.8481940031051636
with O 0 0.009452760219573975
generalized O 1 0.9999997615814209
atrophic B-Disease 1 1.0
benign I-Disease 1 1.0
epidermolysis I-Disease 1 1.0
bullosa I-Disease 1 1.0
, O 0 0.03023160807788372
and O 0 0.010158483870327473
applies O 0 0.010861672461032867
a O 0 0.007208628114312887
new O 0 0.008156472817063332
methodology O 0 0.009782226756215096
to O 0 0.00536442780867219
define O 0 0.011422219686210155
and O 0 0.007135752122849226
characterize O 0 0.02010624296963215
the O 0 0.010024352930486202
resulting O 0 0.015345051884651184
mRNA O 0 0.037452373653650284
splice O 0 0.07973513752222061
variants O 0 0.035316985100507736
. O 0 0.030200069770216942

Mutational O 0 0.2099369913339615
analysis O 0 0.02055041864514351
of O 0 0.015318475663661957
COL17A1 O 1 0.9993745684623718
identified O 0 0.010241735726594925
a O 0 0.011332998052239418
maternally O 1 0.9526584148406982
inherited O 1 0.9999977350234985
G O 1 0.999998927116394
- O 1 0.9999792575836182
to O 0 0.0098524559289217
- O 1 0.9999997615814209
T O 1 0.9999990463256836
transversion O 1 0.6653025150299072
at O 0 0.008799323812127113
the O 0 0.007838224992156029
- O 1 0.9985337257385254
1 O 0 0.014732440002262592
position O 0 0.012543780729174614
of O 0 0.012510789558291435
exon O 0 0.07027393579483032
32 O 0 0.037145569920539856
. O 0 0.027021601796150208

This O 0 0.01622253842651844
acceptor O 0 0.04482705518603325
splice O 0 0.483659029006958
- O 1 0.9993539452552795
site O 0 0.0185212604701519
mutation O 0 0.013821831904351711
led O 0 0.008858933113515377
to O 0 0.004494251683354378
the O 0 0.005472367163747549
formation O 0 0.009494317695498466
of O 0 0.007497624959796667
aberrant O 0 0.02642299048602581
transcripts O 0 0.01485223788768053
present O 0 0.009935246780514717
at O 0 0.010600803419947624
extremely O 0 0.01485641673207283
low O 0 0.02280348166823387
levels O 0 0.017471127212047577
. O 0 0.021935386583209038

Based O 0 0.020151842385530472
on O 0 0.009577520191669464
our O 0 0.010057571344077587
recent O 0 0.00865150336176157
finding O 0 0.008618252351880074
that O 0 0.00655190646648407
cycloheximide O 1 0.9996739625930786
stabilized O 1 0.9999619722366333
mutant O 0 0.489022433757782
COL17A1 O 1 0.999995231628418
transcripts O 0 0.030297985300421715
in O 0 0.012860090471804142
keratinocytes O 0 0.06629841029644012
homozygous O 0 0.02220255322754383
for O 0 0.007596714422106743
a O 0 0.013458408415317535
frameshift O 1 0.9968896508216858
mutation O 0 0.012792217545211315
, O 0 0.0052882167510688305
the O 0 0.005707449745386839
effects O 0 0.008520763367414474
of O 0 0.00580357713624835
the O 0 0.008973496034741402
splice O 1 0.9914975762367249
- O 1 0.9998045563697815
site O 0 0.015407290309667587
mutation O 0 0.00988511461764574
on O 0 0.005777838174253702
splicing O 0 0.01520825456827879
of O 0 0.011259286664426327
COL17A1 O 1 0.9993909597396851
transcripts O 0 0.019380245357751846
were O 0 0.0049456036649644375
determined O 0 0.007904788479208946
using O 0 0.0072309901006519794
reverse O 0 0.019857577979564667
transcriptase O 0 0.1384112536907196
polymerase O 0 0.040707897394895554
chain O 0 0.019839514046907425
reaction O 0 0.008878426626324654
of O 0 0.006653675809502602
total O 0 0.009391999803483486
RNA O 0 0.02402820996940136
from O 0 0.011421263217926025
keratinocytes O 0 0.07258844375610352
incubated O 0 0.04420481249690056
for O 0 0.01246856339275837
2 O 0 0.026734931394457817
. O 0 0.023766962811350822

5 O 0 0.03436734527349472
h O 0 0.039730388671159744
in O 0 0.006374522112309933
the O 0 0.006196647882461548
presence O 0 0.008502189069986343
or O 0 0.005351483356207609
absence O 0 0.009875712916254997
of O 0 0.009579130448400974
10 O 0 0.020165178924798965
microg O 1 0.9985992312431335
cycloheximide O 1 0.9991610050201416
per O 0 0.031091099604964256
ml O 1 0.9951292276382446
. O 0 0.034390535205602646

Using O 0 0.013423139229416847
this O 0 0.006128459703177214
approach O 0 0.008628101088106632
, O 0 0.0058797807432711124
an O 0 0.006673202849924564
abnormally O 0 0.22387582063674927
spliced O 0 0.02654370665550232
transcript O 0 0.016314152628183365
was O 0 0.008799530565738678
identified O 0 0.006328921765089035
that O 0 0.0032591684721410275
contains O 0 0.00529178511351347
an O 0 0.004746109712868929
extra O 0 0.012441342696547508
264 O 0 0.02600742317736149
bases O 0 0.015406387858092785
upstream O 0 0.016921160742640495
from O 0 0.008786018937826157
exon O 0 0.03657392039895058
32 O 0 0.016942959278821945
, O 0 0.007995150052011013
resulting O 0 0.007689313963055611
in O 0 0.005032392218708992
a O 0 0.00908918958157301
premature O 1 0.9611098170280457
termination O 1 0.9178144335746765
codon O 0 0.037778496742248535
27 O 0 0.02751295641064644
bp O 0 0.0394652783870697
downstream O 0 0.02145177125930786
from O 0 0.008281002752482891
the O 0 0.012986584566533566
cryptic O 0 0.07948683947324753
splice O 0 0.3506185710430145
site O 0 0.043167635798454285
. O 0 0.027147362008690834

Three O 0 0.014682048000395298
other O 0 0.009592504240572453
splice O 0 0.037002675235271454
variants O 0 0.01263411808758974
, O 0 0.005751154851168394
including O 0 0.004456043243408203
one O 0 0.0042625777423381805
derived O 0 0.0053915358148515224
from O 0 0.004336083773523569
the O 0 0.006131337955594063
skipping O 0 0.021538836881518364
of O 0 0.01001457218080759
exon O 0 0.32707247138023376
32 O 0 0.016115473583340645
, O 0 0.007134316023439169
were O 0 0.005013713613152504
also O 0 0.008707243017852306
identified O 0 0.014550094492733479
. O 0 0.01922238990664482

These O 0 0.010445140302181244
results O 0 0.008265220560133457
indicate O 0 0.006619787309318781
the O 0 0.005940596107393503
usefulness O 0 0.02406025119125843
of O 0 0.012737348675727844
cycloheximide O 1 0.9999984502792358
treatment O 1 0.9992706179618835
in O 0 0.007650017272680998
evaluating O 0 0.015480469912290573
the O 0 0.009507153183221817
abnormal O 0 0.014004575088620186
processing O 0 0.008003786206245422
of O 0 0.006260188762098551
mRNA O 0 0.009679144248366356
due O 0 0.005144650116562843
to O 0 0.0069238352589309216
splice O 0 0.05987510830163956
- O 1 0.9935424327850342
site O 0 0.013188404031097889
mutations O 0 0.009111656807363033
, O 0 0.005518629215657711
because O 0 0.004920110106468201
( O 0 0.00621790299192071
i O 0 0.011992963962256908
) O 0 0.007885416969656944
aberrant O 0 0.02596043050289154
splicing O 0 0.017594043165445328
often O 0 0.005487553775310516
generates O 0 0.012682014144957066
a O 0 0.00815028790384531
premature O 0 0.05098896101117134
termination O 1 0.5991164445877075
codon O 0 0.024439843371510506
, O 0 0.008151628077030182
( O 0 0.008551083505153656
ii O 1 0.9999885559082031
) O 0 0.005490695592015982
transcripts O 0 0.010088847950100899
with O 0 0.005887288600206375
premature O 1 0.9841503500938416
termination O 1 0.9990631937980652
codons O 0 0.015634149312973022
can O 0 0.004447361920028925
occur O 0 0.003969795070588589
at O 0 0.007431794423609972
low O 0 0.010715289041399956
or O 0 0.007050830405205488
undetectable O 1 0.9988093376159668
levels O 0 0.007835549302399158
due O 0 0.004652401898056269
to O 0 0.005258491728454828
nonsense O 0 0.02716846577823162
- O 1 0.9999642372131348
mediated O 0 0.026555024087429047
mRNA O 0 0.016735613346099854
decay O 0 0.014919770881533623
, O 0 0.005132530350238085
and O 0 0.003981398418545723
( O 0 0.006062789354473352
iii O 1 0.9999988079071045
) O 0 0.005202051252126694
the O 0 0.004922253545373678
levels O 0 0.004729493521153927
of O 0 0.003944563679397106
these O 0 0.002260603243485093
transcripts O 0 0.007506956811994314
can O 0 0.0032812294084578753
be O 0 0.0037501100450754166
increased O 0 0.008350927382707596
by O 0 0.009183969348669052
cycloheximide O 1 0.9875087141990662
. O 0 0.029838867485523224

A O 0 0.03812944516539574
deletion O 0 0.16259333491325378
mutation O 0 0.01753217726945877
in O 0 0.008231546729803085
COL17A1 O 1 0.9999592304229736
in O 0 0.006112885661423206
five O 0 0.006969511974602938
Austrian O 0 0.028167136013507843
families O 0 0.007417140994220972
with O 0 0.009411877952516079
generalized O 1 0.9999959468841553
atrophic B-Disease 1 1.0
benign I-Disease 1 1.0
epidermolysis I-Disease 1 1.0
bullosa I-Disease 1 1.0
represents O 1 0.9920738935470581
propagation O 0 0.028549401089549065
of O 0 0.0126127814874053
an O 0 0.015019424259662628
ancestral O 1 0.957645833492279
allele O 0 0.06735574454069138
. O 0 0.02995716966688633

Patients O 1 0.9883242845535278
with O 0 0.024385353550314903
generalized O 1 0.9999985694885254
atrophic B-Disease 1 1.0
benign I-Disease 1 1.0
epidermolysis I-Disease 1 1.0
bullosa I-Disease 1 1.0
, O 0 0.029902538284659386
a O 0 0.014282725751399994
usually O 0 0.010438346303999424
nonlethal O 0 0.03801725059747696
form O 0 0.012881160713732243
of O 0 0.019290415570139885
junctional B-Disease 1 1.0
epidermolysis I-Disease 1 1.0
bullosa I-Disease 1 1.0
, O 0 0.012130371294915676
have O 0 0.006130632013082504
generalized O 1 0.5568023324012756
blistering B-Disease 1 0.9999979734420776
, O 1 0.9847678542137146
nail B-Disease 1 1.0
dystrophy I-Disease 1 1.0
, O 1 0.9995922446250916
patchy B-Disease 1 1.0
alopecia I-Disease 1 1.0
, O 1 0.9998028874397278
and O 1 0.9999536275863647
dental B-Disease 1 1.0
abnormalities I-Disease 1 1.0
. O 1 0.545499324798584

Skin B-Disease 1 1.0
fragility I-Disease 1 0.9999997615814209
in O 0 0.010148445144295692
most O 0 0.006387797184288502
cases O 0 0.005424367263913155
is O 0 0.003934684209525585
due O 0 0.004605757538229227
to O 0 0.005232818890362978
mutations O 0 0.005863415077328682
in O 0 0.003282068530097604
the O 0 0.005078812595456839
gene O 0 0.007285441737622023
encoding O 0 0.01245823223143816
type O 1 0.919700562953949
XVII O 1 1.0
collagen O 1 1.0
( O 1 0.9353940486907959
COL17A1 O 1 1.0
) O 0 0.025515180081129074
. O 0 0.0285099595785141

Recently O 0 0.03718837723135948
, O 0 0.008428358472883701
we O 0 0.004222695715725422
reported O 0 0.006137524731457233
five O 0 0.0061561972834169865
Austrian O 0 0.0668758973479271
families O 0 0.008638083003461361
with O 0 0.010482861660420895
generalized O 1 0.9999997615814209
atrophic B-Disease 1 1.0
benign I-Disease 1 1.0
epidermolysis I-Disease 1 1.0
bullosa I-Disease 1 1.0
who O 0 0.10097917914390564
share O 0 0.015819303691387177
the O 0 0.009783404879271984
same O 0 0.013264359906315804
COL17A1 O 1 0.9999997615814209
mutation O 0 0.03282144293189049
. O 0 0.02381308563053608

Affected O 0 0.025187896564602852
individuals O 0 0.007999935187399387
in O 0 0.0059980894438922405
three O 0 0.004877155181020498
families O 0 0.005651487503200769
are O 0 0.002914020325988531
homozygous O 0 0.012396878562867641
for O 0 0.0066844807006418705
4003delTC O 1 0.9999735355377197
, O 0 0.007390886545181274
whereas O 0 0.006501524709165096
those O 0 0.002764846431091428
in O 0 0.0032319468446075916
two O 0 0.0031176263000816107
others O 0 0.00435740826651454
are O 0 0.0035782174672931433
compound O 0 0.07240254431962967
heterozygotes O 1 0.9946438074111938
. O 0 0.030760858207941055

To O 0 0.014025211334228516
determine O 0 0.0089102853089571
if O 0 0.004491165746003389
the O 0 0.0057711913250386715
occurrence O 0 0.011106831021606922
of O 0 0.007642586249858141
4003delTC O 1 0.9996138215065002
in O 0 0.006190698128193617
these O 0 0.004018609412014484
unrelated O 0 0.012718169018626213
families O 0 0.009096132591366768
signifies O 0 0.032940223813056946
propagation O 0 0.01618769019842148
of O 0 0.007512781303375959
an O 0 0.007831331342458725
ancestral O 0 0.03648309037089348
allele O 0 0.02244042232632637
or O 0 0.007386200129985809
a O 0 0.011734873987734318
mutational O 1 0.9999898672103882
hot O 1 0.9975990653038025
spot O 0 0.02806980535387993
, O 0 0.011264140717685223
haplotypes O 0 0.021863948553800583
were O 0 0.00474539352580905
determined O 0 0.006870206445455551
for O 0 0.005259741563349962
polymorphisms O 0 0.01054978184401989
both O 0 0.00465985806658864
within O 0 0.006009989883750677
and O 0 0.012334009632468224
flanking O 1 0.9999814033508301
COL17A1 O 1 1.0
. O 0 0.03296826407313347

Five O 0 0.041931264102458954
intragenic O 1 0.9104671478271484
polymorphisms O 0 0.029251158237457275
were O 0 0.006085534580051899
chosen O 0 0.009301092475652695
based O 0 0.008589180186390877
on O 0 0.008448136039078236
their O 0 0.011483212932944298
informativeness O 1 0.9839969873428345
. O 0 0.034441228955984116

One O 0 0.012693453580141068
of O 0 0.007216811645776033
these O 0 0.002947758184745908
, O 0 0.003396068699657917
not O 0 0.002335562603548169
previously O 0 0.00442793034017086
reported O 0 0.0045478856191039085
, O 0 0.003968187607824802
was O 0 0.008712776936590672
2988 O 1 0.9951412677764893
A O 0 0.01501498743891716
or O 0 0.007187442854046822
C O 1 0.7265645861625671
that O 0 0.004593161400407553
introduces O 0 0.01565477065742016
a O 0 0.0058672791346907616
new O 0 0.006765581201761961
restriction O 0 0.009599066339433193
site O 0 0.011238767765462399
for O 0 0.009981751441955566
Eco0109 O 1 0.9994986057281494
I O 0 0.08461029827594757
. O 0 0.02514597401022911

All O 0 0.015196853317320347
the O 0 0.01871386356651783
4003delTC O 1 0.9714945554733276
alleles O 0 0.022122062742710114
showed O 0 0.011411531828343868
the O 0 0.006182451266795397
same O 0 0.005754159297794104
haplotype O 0 0.02012794092297554
for O 0 0.005821113009005785
these O 0 0.003979073371738195
five O 0 0.010585330426692963
polymorphic O 0 0.08689305931329727
markers O 0 0.042953040450811386
. O 0 0.027053458616137505

Fourteen O 0 0.09691730886697769
microsatellite O 1 0.9951176643371582
polymorphisms O 0 0.029923729598522186
were O 0 0.005636381916701794
selected O 0 0.008624398149549961
based O 0 0.004571194760501385
on O 0 0.0038894761819392443
their O 0 0.004316339269280434
high O 0 0.01480904221534729
heterozygosity O 1 0.9997640252113342
and O 0 0.006555423606187105
their O 0 0.004580038599669933
location O 0 0.00776132196187973
within O 0 0.008470237255096436
10q23 O 1 0.9995736479759216
- O 1 0.9999988079071045
q25 O 1 0.9996092915534973
near O 0 0.06954880058765411
COL17A1 O 1 0.9999176263809204
. O 0 0.04586910083889961

Three O 0 0.018206775188446045
families O 0 0.013827306218445301
shared O 0 0.018503136932849884
microsatellite O 1 0.9835679531097412
polymorphisms O 0 0.026693889871239662
covering O 0 0.01616322062909603
at O 0 0.00800835620611906
most O 0 0.005951632745563984
19 O 0 0.014204633422195911
cM O 0 0.027718927711248398
, O 0 0.005373579915612936
whereas O 0 0.006250380538403988
the O 0 0.004720075987279415
others O 0 0.004464669618755579
shared O 0 0.006633064243942499
smaller O 0 0.005272628739476204
regions O 0 0.0036679806653410196
consistent O 0 0.0043393089435994625
with O 0 0.003605000441893935
cross O 0 0.04875179007649422
- O 1 0.9999719858169556
over O 0 0.004888907074928284
events O 0 0.004533081315457821
during O 0 0.004468952305614948
passage O 0 0.005516070872545242
of O 0 0.004082445986568928
this O 0 0.0036945887841284275
mutation O 0 0.008346514776349068
through O 0 0.005424040835350752
several O 0 0.0062255216762423515
generations O 0 0.01930517889559269
. O 0 0.017246084287762642

These O 0 0.011841977946460247
results O 0 0.009477508254349232
indicate O 0 0.008059337735176086
that O 0 0.00537729449570179
4003delTC O 1 0.9959934949874878
occurs O 0 0.006265230476856232
on O 0 0.004919918719679117
a O 0 0.00865865871310234
single O 0 0.012456010095775127
ancestral O 0 0.07376866042613983
allele O 0 0.03387047350406647
. O 0 0.013032081536948681
. O 0 0.01983834244310856

The O 0 0.0462387353181839
haptoglobin O 1 0.9995707869529724
- O 1 0.9999712705612183
gene O 0 0.026893049478530884
deletion O 0 0.034330420196056366
responsible O 0 0.018236391246318817
for O 0 0.01615012064576149
anhaptoglobinemia B-Disease 1 0.9998916387557983
. O 0 0.03084614686667919

We O 0 0.013490773737430573
have O 0 0.005184944253414869
found O 0 0.0047861626371741295
an O 0 0.006502596195787191
allelic O 0 0.04060223326086998
deletion O 0 0.019042612984776497
of O 0 0.007933211512863636
the O 0 0.011559653095901012
haptoglobin O 1 0.9999978542327881
( O 0 0.014389374293386936
Hp O 1 0.9999535083770752
) O 0 0.008974887430667877
gene O 0 0.00659964932128787
from O 0 0.00397898256778717
an O 0 0.005384897347539663
individual O 0 0.007497504819184542
with O 0 0.012511271983385086
anhaptoglobinemia B-Disease 1 0.999821126461029
. O 0 0.03293563798069954

The O 0 0.03282427415251732
Hp O 1 0.9937471151351929
gene O 0 0.018899457529187202
cluster O 0 0.023138858377933502
consists O 0 0.008886621333658695
of O 0 0.006716413889080286
coding O 0 0.01434924453496933
regions O 0 0.006159532815217972
of O 0 0.0050847092643380165
the O 0 0.007848726585507393
alpha O 0 0.12645818293094635
chain O 0 0.019598213955760002
and O 0 0.006120428908616304
beta O 0 0.016828835010528564
chain O 0 0.014424743130803108
of O 0 0.005964833777397871
the O 0 0.008543341420590878
haptoglobin O 1 0.9999896287918091
gene O 0 0.01200920157134533
( O 0 0.00943612027913332
Hp O 1 0.9980193376541138
) O 0 0.005236809607595205
and O 0 0.0035391838755458593
of O 0 0.004289311356842518
the O 0 0.0071152751334011555
alpha O 0 0.04676100239157677
chain O 0 0.018931236118078232
and O 0 0.006935116834938526
beta O 0 0.019120655953884125
chain O 0 0.013952940702438354
of O 0 0.006270078010857105
the O 0 0.008331608958542347
haptoglobin O 1 0.9997546076774597
- O 1 0.999985933303833
related O 0 0.014363778755068779
gene O 0 0.013731500133872032
( O 0 0.011247285641729832
Hpr O 1 0.9999092817306519
) O 0 0.009280562400817871
, O 0 0.007277803495526314
in O 0 0.007349582854658365
tandem O 0 0.02610612101852894
from O 0 0.006972641684114933
the O 0 0.010590266436338425
5 O 0 0.02102435752749443
side O 0 0.027159489691257477
. O 0 0.026534605771303177

Southern O 0 0.05997927859425545
blot O 1 0.9961799383163452
and O 0 0.015842489898204803
PCR O 0 0.049096960574388504
analyses O 0 0.016589868813753128
have O 0 0.004079156555235386
indicated O 0 0.005752125289291143
that O 0 0.002655210206285119
the O 0 0.004745990503579378
individual O 0 0.0043364278972148895
with O 0 0.005918083246797323
anhaptoglobinemia B-Disease 1 0.9984667897224426
was O 0 0.010986036621034145
homozygous O 0 0.012060833163559437
for O 0 0.0038754683919250965
the O 0 0.006564199458807707
gene O 0 0.00836765207350254
deletion O 0 0.013862943276762962
and O 0 0.003520650090649724
that O 0 0.002638531383126974
the O 0 0.005267416592687368
gene O 0 0.00805094838142395
deletion O 0 0.01590648666024208
was O 0 0.007461494766175747
included O 0 0.005535668693482876
at O 0 0.005204575601965189
least O 0 0.003343424526974559
from O 0 0.003261395264416933
the O 0 0.0057031759060919285
promoter O 1 0.7114933133125305
region O 0 0.008655528537929058
of O 0 0.008410010486841202
Hp O 1 0.9986429810523987
to O 0 0.012546833604574203
Hpr O 1 0.9999690055847168
alpha O 0 0.02579406462609768
but O 0 0.004941071383655071
not O 0 0.003338055219501257
to O 0 0.008290484547615051
Hpr O 1 0.9999042749404907
beta O 1 0.8175418376922607
( O 0 0.02549690380692482
Hpdel O 1 0.9998327493667603
) O 0 0.02553628385066986
. O 0 0.024508126080036163

In O 0 0.01764748990535736
addition O 0 0.0126822954043746
, O 0 0.0068040695041418076
we O 0 0.003234287491068244
found O 0 0.003049543360248208
seven O 0 0.0036326453555375338
individuals O 0 0.0021658402401953936
with O 0 0.00430737528949976
hypohaptoglobinemia B-Disease 1 0.9996179342269897
in O 0 0.004676537122577429
three O 0 0.003985927440226078
families O 0 0.004617560189217329
, O 0 0.003453362500295043
and O 0 0.003668972523882985
the O 0 0.0053345877677202225
genotypes O 0 0.01773662306368351
of O 0 0.005033428780734539
six O 0 0.004596690181642771
of O 0 0.004679245408624411
the O 0 0.005016683135181665
seven O 0 0.005083180498331785
individuals O 0 0.002538407454267144
were O 0 0.002499842084944248
found O 0 0.0028604483231902122
to O 0 0.004575162660330534
be O 0 0.00765655841678381
Hp2 O 1 0.9999978542327881
/ O 1 0.9999959468841553
Hpdel O 1 0.9999518394470215
. O 0 0.03504122793674469

The O 0 0.02802388183772564
phenotypes O 0 0.10280013084411621
and O 0 0.009957841597497463
genotypes O 0 0.3864622414112091
in O 0 0.006146793253719807
one O 0 0.004150723572820425
of O 0 0.0034804409369826317
these O 0 0.001990141347050667
three O 0 0.0023491415195167065
families O 0 0.0037925797514617443
showed O 0 0.004201623611152172
the O 0 0.004458275623619556
father O 0 0.008158000186085701
to O 0 0.00490894028916955
be O 0 0.004991516005247831
hypohaptoglobinemic B-Disease 1 0.9954386353492737
( O 0 0.010823022574186325
Hp2 O 1 0.9998038411140442
) O 0 0.008444252423942089
and O 0 0.009115596301853657
Hp2 O 1 0.999998927116394
/ O 1 0.9999991655349731
Hpdel O 1 0.9999864101409912
, O 0 0.0065772938542068005
the O 0 0.006042780354619026
mother O 0 0.007849175482988358
to O 0 0.0035094248596578836
be O 0 0.004005475901067257
Hp2 O 1 0.9989598989486694
- O 1 0.99993896484375
1 O 0 0.013031321577727795
and O 0 0.009270399808883667
Hp1 O 1 0.9999926090240479
/ O 1 0.999990701675415
Hp2 O 1 0.9997947812080383
, O 0 0.005521221086382866
one O 0 0.003801553277298808
of O 0 0.003921255469322205
the O 0 0.004195180255919695
two O 0 0.0024942245800048113
children O 0 0.0034551618155092
to O 0 0.0033022307325154543
be O 0 0.0038248903583735228
hypohaptoglobinemic B-Disease 1 0.9998916387557983
( O 0 0.008852717466652393
Hp2 O 1 0.9998910427093506
) O 0 0.007375663612037897
and O 0 0.007937956601381302
Hp2 O 1 0.9999996423721313
/ O 1 0.9999996423721313
Hpdel O 1 0.9999963045120239
, O 0 0.0072284578345716
and O 0 0.0037224937696009874
the O 0 0.004135036375373602
other O 0 0.0026342961937189102
child O 0 0.004909284878522158
to O 0 0.003299478907138109
be O 0 0.003477813908830285
Hp1 O 1 0.9989728927612305
and O 0 0.007408236153423786
Hp1 O 1 1.0
/ O 1 0.9999998807907104
Hpdel O 1 0.9999983310699463
, O 0 0.008818624541163445
showing O 0 0.009178347885608673
an O 0 0.007106265984475613
anomalous O 0 0.030902517959475517
inheritance O 0 0.021372366696596146
of O 0 0.011796226724982262
Hp O 1 0.9999985694885254
phenotypes O 0 0.17112243175506592
in O 0 0.008239862509071827
the O 0 0.010778327472507954
child O 0 0.026790333911776543
with O 0 0.013572429306805134
Hp1 O 1 0.9999827146530151
. O 0 0.030176926404237747

The O 0 0.03909541666507721
Hp2 O 1 0.9999935626983643
/ O 1 0.999992847442627
Hpdel O 1 0.9994387030601501
individuals O 0 0.0060585238970816135
had O 0 0.005868255626410246
an O 0 0.0037671152967959642
extremely O 0 0.006712413392961025
low O 0 0.006989301647990942
level O 0 0.005895038601011038
of O 0 0.0059252046048641205
Hp O 1 0.9996212720870972
( O 0 0.006921553984284401
mean O 0 0.00888547021895647
+ O 0 0.049924418330192566
/ O 1 0.9945487380027771
- O 1 0.999997615814209
SD O 1 0.9999862909317017
= O 0 0.026550352573394775
0 O 0 0.01844841055572033
. O 0 0.009555977769196033
049 O 1 0.9873183369636536
+ O 0 0.3400118947029114
/ O 1 0.990467369556427
- O 1 0.9910064339637756
0 O 0 0.016146879643201828
. O 0 0.008553690277040005
043 O 1 0.9771339297294617
mg O 1 0.9999942779541016
/ O 1 0.9998575448989868
ml O 1 0.9999010562896729
; O 0 0.011029990389943123
n O 0 0.021159568801522255
= O 0 0.024949008598923683
6 O 0 0.013895979151129723
) O 0 0.005365746095776558
, O 0 0.0038125773426145315
compared O 0 0.0038207140751183033
with O 0 0.0025993476156145334
the O 0 0.0036229658871889114
level O 0 0.006621285807341337
( O 0 0.004965537693351507
1 O 0 0.007282883394509554
. O 0 0.003841974539682269
64 O 0 0.016757890582084656
+ O 0 0.0674755871295929
/ O 1 0.9923393726348877
- O 1 0.9948322772979736
1 O 0 0.012303815223276615
. O 0 0.007461003493517637
07 O 1 0.9993040561676025
mg O 1 0.9999998807907104
/ O 1 0.9999990463256836
ml O 1 0.9999808073043823
) O 0 0.006776021793484688
obtained O 0 0.006306841969490051
from O 0 0.005545876454561949
52 O 0 0.01886431872844696
healthy O 0 0.01780741661787033
volunteers O 0 0.021367479115724564
having O 0 0.012974575161933899
phenotype O 1 0.8980686664581299
Hp2 O 1 0.9999638795852661
, O 0 0.008786439895629883
whereas O 0 0.008177051320672035
the O 0 0.009667249396443367
serum O 1 0.9999634027481079
Hp O 1 0.9998724460601807
level O 0 0.007893776521086693
of O 0 0.004758206661790609
an O 0 0.003815197153016925
individual O 0 0.004704630933701992
with O 0 0.007345099467784166
Hp1 O 1 1.0
/ O 1 0.9999998807907104
Hpdel O 1 0.9999984502792358
was O 0 0.03459229692816734
0 O 0 0.037000443786382675
. O 0 0.028725162148475647

50 O 0 0.045998964458703995
mg O 1 0.9999998807907104
/ O 1 0.9999994039535522
ml O 1 0.9999988079071045
, O 0 0.008682955987751484
which O 0 0.004276890307664871
was O 0 0.006598048843443394
approximately O 0 0.0050901984795928
half O 0 0.003927967511117458
the O 0 0.003776369383558631
level O 0 0.005520378239452839
of O 0 0.0063802991062402725
Hp O 1 0.9743072390556335
in O 0 0.006949232891201973
control O 0 0.012644078582525253
sera O 1 0.9827083945274353
from O 0 0.0061851623468101025
the O 0 0.00866776704788208
Hp1 O 1 0.9999929666519165
phenotype O 0 0.37395066022872925
( O 0 0.007258006837219
1 O 0 0.009487967938184738
. O 0 0.00448631402105093
26 O 0 0.011854205280542374
+ O 0 0.05044982582330704
/ O 1 0.9710421562194824
- O 1 0.944882869720459
0 O 0 0.013736867345869541
. O 0 0.0058488487266004086
33 O 0 0.019087785854935646
mg O 1 0.9999681711196899
/ O 1 0.9995383024215698
ml O 1 0.9998906850814819
; O 0 0.01096787117421627
n O 0 0.02039153501391411
= O 0 0.02277955412864685
9 O 0 0.012885266914963722
) O 0 0.00591563805937767
, O 0 0.004388053435832262
showing O 0 0.006219750270247459
a O 0 0.008667344227433205
gene O 0 0.019733695313334465
- O 1 0.9999997615814209
dosage O 1 0.9999370574951172
effect O 0 0.02016177959740162
. O 0 0.02253701351583004

The O 0 0.02154291607439518
other O 0 0.010227448306977749
allele O 0 0.03196725994348526
( O 0 0.014425489120185375
Hp2 O 1 0.9992865920066833
) O 0 0.006624078378081322
of O 0 0.004503926262259483
individuals O 0 0.003641344141215086
with O 0 0.0070455074310302734
Hp2 O 1 1.0
/ O 1 1.0
Hpdel O 1 0.9999998807907104
was O 0 0.013046607375144958
found O 0 0.004118035081773996
to O 0 0.0035930427256971598
have O 0 0.002244682749733329
, O 0 0.0031371566001325846
in O 0 0.0027623597998172045
all O 0 0.0033772513270378113
exons O 0 0.011136607266962528
, O 0 0.005207405891269445
no O 0 0.00562705472111702
mutation O 0 0.010064085945487022
, O 0 0.005707168020308018
by O 0 0.006105213426053524
DNA O 0 0.017619159072637558
sequencing O 0 0.030116006731987
. O 0 0.01999298855662346

On O 0 0.012501002289354801
the O 0 0.006864834576845169
basis O 0 0.003813785267993808
of O 0 0.0040401131846010685
the O 0 0.004091538488864899
present O 0 0.004675254225730896
study O 0 0.004988774191588163
, O 0 0.003698467742651701
the O 0 0.004307031165808439
mechanism O 0 0.007609962020069361
of O 0 0.006908828858286142
anhaptoglobinemia B-Disease 1 0.999984860420227
and O 0 0.005456572864204645
the O 0 0.005952062085270882
mechanism O 0 0.009110954590141773
of O 0 0.007437001448124647
anomalous O 0 0.055924464017152786
inheritance O 0 0.04849633574485779
of O 0 0.01484407763928175
Hp O 1 0.9999998807907104
phenotypes O 1 0.5714611411094666
were O 0 0.008490732870995998
well O 0 0.009433909319341183
explained O 0 0.019521433860063553
. O 0 0.01926111802458763

However O 0 0.0162005927413702
, O 0 0.01024701539427042
the O 0 0.010664095170795918
mechanism O 0 0.014397477731108665
of O 0 0.0162933599203825
hypohaptoglobinemia B-Disease 1 0.9998985528945923
remains O 0 0.04663029685616493
unknown O 0 0.05137450248003006

ATM O 1 0.9245181679725647
mutations O 0 0.022332575172185898
and O 0 0.00956693384796381
phenotypes O 0 0.03105270303785801
in O 0 0.019776849076151848
ataxia B-Disease 1 1.0
- I-Disease 1 1.0
telangiectasia I-Disease 1 1.0
families O 0 0.009253330528736115
in O 0 0.005113398656249046
the O 0 0.006151245441287756
British O 0 0.012079153209924698
Isles O 0 0.026843508705496788
: O 0 0.006627627648413181
expression O 0 0.006105673033744097
of O 0 0.00622651306912303
mutant O 0 0.10572860389947891
ATM O 0 0.3695361912250519
and O 0 0.003750657197088003
the O 0 0.004513167776167393
risk O 0 0.008706971071660519
of O 0 0.21313492953777313
leukemia B-Disease 1 1.0
, O 1 0.9999998807907104
lymphoma B-Disease 1 1.0
, O 1 0.999997615814209
and O 1 0.9999992847442627
breast B-Disease 1 1.0
cancer I-Disease 1 1.0
. O 0 0.47565171122550964

We O 0 0.011354940943419933
report O 0 0.007895823568105698
the O 0 0.006346705835312605
spectrum O 0 0.013653341680765152
of O 0 0.009049613028764725
59 O 0 0.02894313633441925
ATM O 1 0.6659854650497437
mutations O 0 0.011385546065866947
observed O 0 0.006088546942919493
in O 0 0.009010651148855686
ataxia B-Disease 1 1.0
- I-Disease 1 1.0
telangiectasia I-Disease 1 1.0
( O 0 0.01193319633603096
A B-Disease 1 0.9999986886978149
- I-Disease 1 1.0
T I-Disease 1 1.0
) O 0 0.011197982355952263
patients O 0 0.12389646470546722
in O 0 0.006261449307203293
the O 0 0.009847591631114483
British O 0 0.024860724806785583
Isles O 0 0.12977643311023712
. O 0 0.025861479341983795

Of O 0 0.028940614312887192
51 O 0 0.05318041518330574
ATM O 1 0.9693326950073242
mutations O 0 0.016171524301171303
identified O 0 0.007838024757802486
in O 0 0.004503370728343725
families O 0 0.004698662087321281
native O 0 0.00456258887425065
to O 0 0.003857939038425684
the O 0 0.0054967375472188
British O 0 0.009386057034134865
Isles O 0 0.0204456839710474
, O 0 0.004739793483167887
11 O 0 0.006076059304177761
were O 0 0.0040099844336509705
founder O 1 0.9987078905105591
mutations O 0 0.007759941276162863
, O 0 0.0037648449651896954
and O 0 0.0033371129538863897
2 O 0 0.005573991220444441
of O 0 0.0034529753029346466
these O 0 0.002325365087017417
11 O 0 0.006413084454834461
conferred O 0 0.01717531681060791
a O 0 0.009300913661718369
milder O 1 0.9971531629562378
clinical O 1 0.9999984502792358
phenotype O 0 0.17577002942562103
with O 0 0.005282055586576462
respect O 0 0.005442314315587282
to O 0 0.0064100828021764755
both O 0 0.009142326191067696
cerebellar B-Disease 1 1.0
degeneration I-Disease 1 1.0
and O 1 0.9999837875366211
cellular O 1 0.9999995231628418
features O 0 0.036375172436237335
. O 0 0.025366831570863724

We O 0 0.012703591026365757
report O 0 0.007972430437803268
, O 0 0.0041807289235293865
in O 0 0.00286217057146132
two O 0 0.0032661869190633297
A B-Disease 1 0.9656468629837036
- I-Disease 1 1.0
T I-Disease 1 1.0
families O 0 0.006847080774605274
, O 0 0.004388528410345316
an O 0 0.0045752148143947124
ATM O 1 0.7576159834861755
mutation O 0 0.009966561570763588
( O 0 0.007661943323910236
7271T O 1 0.9993372559547424
- O 1 0.9999997615814209
- O 1 1.0
> O 1 0.9999994039535522
G O 1 0.9999978542327881
) O 0 0.005950422957539558
that O 0 0.0032522298861294985
may O 0 0.003949989564716816
be O 0 0.0023138578981161118
associated O 0 0.0028072725981473923
with O 0 0.0018850205233320594
an O 0 0.0027118935249745846
increased O 0 0.0053038266487419605
risk O 1 0.9322868585586548
of O 1 0.998757004737854
breast B-Disease 1 1.0
cancer I-Disease 1 1.0
in O 0 0.010492556728422642
both O 0 0.0075524034909904
homozygotes O 1 0.9997373223304749
and O 0 0.010030867531895638
heterozygotes O 1 0.9379211068153381
( O 0 0.009396561421453953
relative O 0 0.011404143646359444
risk O 0 0.00855528935790062
12 O 0 0.007796015590429306
. O 0 0.00427633011713624
7 O 0 0.008744967170059681
; O 0 0.008512715809047222
P O 1 0.9684547781944275
= O 0 0.024722369387745857
. O 0 0.010547671467065811
0025 O 1 0.9999988079071045
) O 0 0.007631837856024504
, O 0 0.004530963022261858
although O 0 0.002818693872541189
there O 0 0.0019964505918323994
is O 0 0.002278027357533574
a O 0 0.003727522911503911
less O 0 0.004352154675871134
severe O 1 0.999869704246521
A B-Disease 1 1.0
- I-Disease 1 1.0
T I-Disease 1 1.0
phenotype O 1 0.6465104818344116
in O 0 0.0042601535096764565
terms O 0 0.003792563686147332
of O 0 0.0040729958564043045
the O 0 0.006100631784647703
degree O 0 0.0161471888422966
of O 1 0.9605128169059753
cerebellar B-Disease 1 1.0
degeneration I-Disease 1 1.0
. O 1 0.9874858260154724

This O 0 0.01524922251701355
mutation O 0 0.021127773448824883
( O 0 0.011894184164702892
7271T O 1 0.9968693852424622
- O 1 0.9999998807907104
- O 1 1.0
> O 1 0.9999985694885254
G O 1 0.9999812841415405
) O 0 0.0066839298233389854
also O 0 0.004262638743966818
allows O 0 0.003627300960943103
expression O 0 0.004010032396763563
of O 0 0.004076370503753424
full O 0 0.009370622225105762
- O 1 0.9999809265136719
length O 0 0.01035606861114502
ATM O 0 0.16858981549739838
protein O 0 0.008942019194364548
at O 0 0.0065268296748399734
a O 0 0.00574254197999835
level O 0 0.006860310211777687
comparable O 0 0.009675437584519386
with O 0 0.003790877526625991
that O 0 0.004237367771565914
in O 0 0.007975888438522816
unaffected O 0 0.06872378289699554
individuals O 0 0.010857422836124897
. O 0 0.02201073057949543

In O 0 0.01730046048760414
addition O 0 0.009458784013986588
, O 0 0.005495731253176928
we O 0 0.002635175595059991
have O 0 0.0016910020494833589
studied O 0 0.0040470026433467865
18 O 0 0.005180133040994406
A B-Disease 1 0.9983929991722107
- I-Disease 1 1.0
T I-Disease 1 1.0
patients O 1 0.9999953508377075
, O 0 0.0042722225189208984
in O 0 0.0037069639656692743
15 O 0 0.005405209958553314
families O 0 0.0038039409555494785
, O 0 0.0033779286313802004
who O 0 0.00677496986463666
developed O 1 0.8769820928573608
leukemia B-Disease 1 1.0
, O 1 0.9999959468841553
lymphoma B-Disease 1 1.0
, O 1 0.9983071088790894
preleukemic O 1 1.0
T O 1 1.0
- O 1 1.0
cell O 1 0.7726698517799377
proliferation O 1 0.7067736983299255
, O 0 0.01125379465520382
or O 1 0.9818983674049377
Hodgkin B-Disease 1 1.0
lymphoma I-Disease 1 1.0
, O 1 0.9947155117988586
mostly O 0 0.012077992781996727
in O 0 0.013119448907673359
childhood O 1 0.9992838501930237
. O 0 0.025611046701669693

A O 0 0.026653705164790154
wide O 0 0.017488298937678337
variety O 0 0.010025423020124435
of O 0 0.011288084089756012
ATM O 1 0.9892351031303406
mutation O 0 0.01580163650214672
types O 0 0.006693560630083084
, O 0 0.005254034418612719
including O 0 0.004950326401740313
missense O 0 0.01994149014353752
mutations O 0 0.006659082602709532
and O 0 0.00380313559435308
in O 0 0.006998348981142044
- O 1 1.0
frame O 0 0.42086291313171387
deletions O 0 0.01804860308766365
, O 0 0.005322813056409359
were O 0 0.0038661756552755833
seen O 0 0.005641432013362646
in O 0 0.00627492880448699
these O 0 0.006901922635734081
patients O 1 0.80259108543396
. O 0 0.021491138264536858

We O 0 0.012083387933671474
also O 0 0.008010667748749256
show O 0 0.004862906876951456
that O 0 0.0022156969644129276
25 O 0 0.005121760535985231
% O 0 0.0025655131321400404
of O 0 0.002620403654873371
all O 0 0.002725027734413743
A B-Disease 1 0.9985170960426331
- I-Disease 1 1.0
T I-Disease 1 1.0
patients O 1 0.8234057426452637
carried O 0 0.007645400241017342
in O 0 0.0070405988954007626
- O 1 0.9999908208847046
frame O 0 0.02222611755132675
deletions O 0 0.021546533331274986
or O 0 0.007772522978484631
missense O 0 0.022784600034356117
mutations O 0 0.008064248599112034
, O 0 0.003928299527615309
many O 0 0.0018770296592265368
of O 0 0.002930797403678298
which O 0 0.0026936104986816645
were O 0 0.002242270391434431
also O 0 0.003112304490059614
associated O 0 0.003682072041556239
with O 0 0.0035823958460241556
expression O 0 0.006866609212011099
of O 0 0.00947914645075798
mutant O 1 0.9715343117713928
ATM O 1 0.9999204874038696
protein O 0 0.033608581870794296
. O 0 0.023853380233049393

The O 0 0.028405234217643738
DMPK O 1 0.9998134970664978
gene O 0 0.016787411645054817
of O 0 0.012549646198749542
severely O 1 0.9999980926513672
affected O 1 0.9999953508377075
myotonic B-Disease 1 1.0
dystrophy I-Disease 1 1.0
patients O 1 1.0
is O 1 0.9998927116394043
hypermethylated O 1 1.0
proximal O 1 0.9999977350234985
to O 0 0.01154477708041668
the O 0 0.013030163943767548
largely O 0 0.017593828961253166
expanded O 0 0.036092840135097504
CTG O 1 0.9999629259109497
repeat O 0 0.07553353160619736
. O 0 0.03497283533215523

Using O 0 0.02100541442632675
methylation O 0 0.03342302888631821
- O 1 0.9969027638435364
sensitive O 0 0.022278688848018646
restriction O 0 0.01828237809240818
enzymes O 0 0.013345688581466675
, O 0 0.005553425755351782
we O 0 0.004418661352247
characterized O 0 0.00733440974727273
the O 0 0.005788102280348539
methylation O 0 0.009947936981916428
pattern O 0 0.005039918702095747
on O 0 0.0039373645558953285
the O 0 0.005113920662552118
5 O 0 0.007027569692581892
side O 0 0.007131550926715136
of O 0 0.005148596130311489
the O 0 0.008956965059041977
CTG O 1 0.9999896287918091
repeat O 0 0.016361916437745094
in O 0 0.006509352941066027
the O 0 0.009805575013160706
DMPK O 1 0.9999849796295166
gene O 0 0.009313060902059078
of O 0 0.00577957509085536
normal O 0 0.004409110639244318
individuals O 0 0.002560955937951803
and O 0 0.0034950352273881435
of O 0 0.005583641584962606
patients O 1 0.9999850988388062
affected O 1 0.9478564262390137
with O 1 0.9978888630867004
myotonic B-Disease 1 1.0
dystrophy I-Disease 1 1.0
, O 1 0.9374162554740906
showing O 0 0.015356873162090778
expansions O 0 0.02356984280049801
of O 0 0.010060381144285202
the O 0 0.013651350513100624
repetitive O 0 0.051181547343730927
sequence O 0 0.018093548715114594
. O 0 0.02127189189195633

The O 0 0.03216630220413208
gene O 0 0.025262130424380302
segment O 0 0.02527027390897274
analyzed O 0 0.018432211130857468
corresponds O 0 0.014724953100085258
to O 0 0.007118054199963808
the O 0 0.01086348295211792
genomic O 0 0.03871997073292732
SacI O 1 0.9999518394470215
- O 1 0.9999786615371704
HindIII O 1 0.9723552465438843
fragment O 0 0.03327368199825287
carrying O 0 0.017325250431895256
exons O 0 0.02653217501938343
11 O 0 0.023820726200938225
- O 1 0.9987230896949768
15 O 0 0.03080027364194393
. O 0 0.02852838672697544

There O 0 0.016932373866438866
is O 0 0.013022555969655514
constitutive O 0 0.04088461026549339
methylation O 0 0.021632472053170204
in O 0 0.011529356241226196
intron O 1 0.9935592412948608
12 O 0 0.01520166452974081
at O 0 0.011471332050859928
restriction O 0 0.010687807574868202
sites O 0 0.007390201091766357
of O 0 0.00861833430826664
SacII O 1 0.9907953143119812
and O 0 0.012219708412885666
HhaI O 1 0.9936661124229431
, O 0 0.010903654620051384
localized O 0 0.01987016573548317
1 O 0 0.01170574501156807
, O 0 0.007874672301113605
159 O 0 0.032121412456035614
- O 1 0.9999425411224365
1 O 0 0.014478947967290878
, O 0 0.008035913109779358
232 O 0 0.026040444150567055
bp O 0 0.027495479211211205
upstream O 0 0.016536379233002663
of O 0 0.007790629286319017
the O 0 0.011979155242443085
CTG O 1 0.9999982118606567
repeat O 0 0.05356747657060623
, O 0 0.008050857111811638
whereas O 0 0.007922152057290077
most O 0 0.004642978310585022
, O 0 0.004083508159965277
if O 0 0.002888256451115012
not O 0 0.001726955408230424
all O 0 0.0021519195288419724
, O 0 0.0027845213189721107
of O 0 0.0029026044066995382
the O 0 0.0033569771330803633
other O 0 0.0024710665456950665
sites O 0 0.004919424187391996
of O 0 0.00674904091283679
SacII O 1 0.9999483823776245
, O 0 0.010031170211732388
HhaI O 1 0.9999887943267822
, O 0 0.007759581785649061
and O 0 0.006369739305227995
HpaII O 1 0.9989197254180908
in O 0 0.005604166071861982
this O 0 0.0042135510593652725
region O 0 0.007280922029167414
are O 0 0.003827933222055435
unmethylated O 0 0.16753338277339935
, O 0 0.005350051913410425
in O 0 0.004394753370434046
normal O 0 0.004172447137534618
individuals O 0 0.00229843333363533
and O 0 0.0024900578428059816
most O 0 0.0033258656039834023
of O 0 0.005730700213462114
the O 0 0.07087521255016327
patients O 1 0.9999866485595703
. O 0 0.022099532186985016

In O 0 0.0110219931229949
a O 0 0.007220810279250145
number O 0 0.003868038533255458
of O 0 0.00436665304005146
young O 0 0.008452770300209522
and O 0 0.007154654711484909
severely O 1 1.0
affected O 1 0.9999426603317261
patients O 1 0.9999998807907104
, O 0 0.009882309474050999
however O 0 0.003927924204617739
, O 0 0.0038187543395906687
complete O 0 0.006851679645478725
methylation O 0 0.008130444213747978
of O 0 0.004302565474063158
these O 0 0.0026098694652318954
restriction O 0 0.007652186788618565
sites O 0 0.006449141073971987
was O 0 0.006768933497369289
found O 0 0.0043573458679020405
in O 0 0.005174839869141579
the O 0 0.010930422693490982
mutated O 0 0.04113820195198059
allele O 0 0.04611806944012642
. O 0 0.027774382382631302

In O 0 0.011166220530867577
most O 0 0.005326394457370043
of O 0 0.005316659342497587
these O 0 0.0030436720699071884
patients O 0 0.05591127276420593
, O 0 0.0040522110648453236
the O 0 0.0047733234241604805
onset O 1 0.9999997615814209
of O 1 0.5403176546096802
the O 1 0.9999692440032959
disease O 1 1.0
was O 1 1.0
congenital O 1 1.0
. O 1 0.9977890253067017

Preliminary O 0 0.03280952572822571
in O 0 0.02121371403336525
vivo O 0 0.061827484518289566
footprinting O 1 0.7434583902359009
data O 0 0.008303149603307247
gave O 0 0.008799812756478786
evidence O 0 0.0042793238535523415
for O 0 0.004924529232084751
protein O 0 0.010248186066746712
- O 1 0.9932096600532532
DNA O 0 0.010234401561319828
contact O 0 0.007274772506207228
in O 0 0.00487966975197196
normal O 0 0.007266470696777105
genes O 0 0.007042666431516409
at O 0 0.007706814911216497
an O 0 0.008033320307731628
Sp1 O 1 0.9999570846557617
consensus O 0 0.015386724844574928
binding O 0 0.01067575253546238
site O 0 0.010330496355891228
upstream O 0 0.009830059483647346
of O 0 0.005693398416042328
the O 0 0.009068100713193417
CTG O 1 0.999994158744812
repeat O 0 0.020297935232520103
and O 0 0.00412549264729023
for O 0 0.00372882978990674
a O 0 0.004562381189316511
significant O 0 0.004950322210788727
reduction O 0 0.008033663034439087
of O 0 0.004834362305700779
this O 0 0.0033071564976125956
interaction O 0 0.0051034241914749146
in O 0 0.004893214907497168
cells O 0 0.005977065302431583
with O 0 0.005240768194198608
a O 0 0.01302400790154934
hypermethylated O 1 0.9999911785125732
DMPK O 1 0.9999998807907104
gene O 0 0.024998363107442856
. O 0 0.015348180197179317
. O 0 0.025044729933142662

The O 0 0.04728114977478981
hemochromatosis B-Disease 1 1.0
gene O 0 0.02618509903550148
product O 0 0.01844756305217743
complexes O 0 0.020118746906518936
with O 0 0.006633988115936518
the O 0 0.01186663843691349
transferrin O 1 0.9999741315841675
receptor O 0 0.031494058668613434
and O 0 0.011784038506448269
lowers O 1 0.9902529716491699
its O 0 0.012971192598342896
affinity O 0 0.021559065207839012
for O 0 0.012594658881425858
ligand O 0 0.1150018572807312
binding O 0 0.03168492019176483
. O 0 0.031685128808021545

We O 0 0.016094928607344627
recently O 0 0.018190206959843636
reported O 0 0.01065855287015438
the O 0 0.008458202704787254
positional O 0 0.03104143775999546
cloning O 0 0.015042593702673912
of O 0 0.007317618932574987
a O 0 0.008194023743271828
candidate O 0 0.013394134119153023
gene O 0 0.009806139394640923
for O 0 0.012569841928780079
hereditary B-Disease 1 1.0
hemochromatosis I-Disease 1 1.0
called O 1 0.9999996423721313
HFE O 1 1.0
. O 0 0.05021706968545914

The O 0 0.02302578277885914
gene O 0 0.014425748027861118
product O 0 0.011448180302977562
, O 0 0.005362987983971834
a O 0 0.004949960391968489
member O 0 0.004196335561573505
of O 0 0.0037631194572895765
the O 0 0.004991681780666113
major O 0 0.20157353579998016
histocompatibility O 1 1.0
complex O 0 0.3839952051639557
class O 1 0.982810378074646
I O 1 0.9991720914840698
- O 1 0.9999786615371704
like O 0 0.007540772203356028
family O 0 0.009110731072723866
, O 0 0.004674020688980818
was O 0 0.006730377208441496
found O 0 0.0035073242615908384
to O 0 0.0031211639288812876
have O 0 0.0021750284358859062
a O 0 0.005720474757254124
mutation O 0 0.01005557645112276
, O 0 0.008036741055548191
Cys O 1 0.9999998807907104
- O 1 0.9999967813491821
282 O 1 0.9998564720153809
- O 1 1.0
- O 1 0.9999998807907104
> O 1 0.9999879598617554
Tyr O 1 0.9999998807907104
( O 0 0.02098904363811016
C282Y O 1 0.9994387030601501
) O 0 0.007605382706969976
, O 0 0.004972386639565229
in O 0 0.004845062270760536
85 O 0 0.015731733292341232
% O 0 0.009050266817212105
of O 0 0.01106590311974287
patient O 1 0.9994010925292969
chromosomes O 0 0.0322427935898304
. O 0 0.022410176694393158

This O 0 0.018951943144202232
mutation O 0 0.027245838195085526
eliminates O 0 0.03159709274768829
the O 0 0.007992250844836235
ability O 0 0.008512398228049278
of O 0 0.008154173381626606
HFE O 1 0.9999871253967285
to O 0 0.007526164874434471
associate O 0 0.011808394454419613
with O 0 0.006436157040297985
beta2 O 1 0.9999992847442627
- O 1 1.0
microglobulin O 1 0.9999966621398926
( O 0 0.010341525077819824
beta2m O 1 0.9996271133422852
) O 0 0.00605470035225153
and O 0 0.005462695844471455
prevents O 0 0.10745521634817123
cell O 1 0.9953041076660156
- O 1 1.0
surface O 0 0.023235099390149117
expression O 0 0.021146180108189583
. O 0 0.021080676466226578

A O 0 0.02595171332359314
second O 0 0.0175081305205822
mutation O 0 0.010741443373262882
that O 0 0.003254037583246827
has O 0 0.004054746590554714
no O 0 0.0032743688207119703
effect O 0 0.004446357488632202
on O 0 0.005041906144469976
beta2m O 1 0.9997116923332214
association O 0 0.013940351083874702
, O 0 0.009653134271502495
H63D O 1 1.0
, O 0 0.006704913917928934
was O 0 0.00717145437374711
found O 0 0.003017253475263715
in O 0 0.0029414419550448656
eight O 0 0.004177028313279152
out O 0 0.004299195948988199
of O 0 0.004625317174941301
nine O 0 0.008624006994068623
patients O 0 0.31563234329223633
heterozygous O 0 0.014241136610507965
for O 0 0.007729863282293081
the O 0 0.01692992076277733
C282Y O 1 0.9998301267623901
mutant O 0 0.07579643279314041
. O 0 0.03333296254277229

In O 0 0.015151305124163628
this O 0 0.007127769757062197
report O 0 0.007769801653921604
, O 0 0.005545765161514282
we O 0 0.0040761204436421394
demonstrate O 0 0.009107803925871849
in O 0 0.008728505112230778
cultured O 0 0.034169912338256836
293 O 1 0.6969334483146667
cells O 0 0.02428809367120266
overexpressing O 1 0.8749536275863647
wild O 0 0.020853474736213684
- O 1 0.9999769926071167
type O 0 0.0174129419028759
or O 0 0.009365321137011051
mutant O 0 0.12504729628562927
HFE O 1 0.9999992847442627
proteins O 0 0.008520240895450115
that O 0 0.002865667687729001
both O 0 0.0027154411654919386
the O 0 0.004219845402985811
wild O 0 0.00865645706653595
- O 1 0.9999513626098633
type O 0 0.014710993506014347
and O 0 0.009190349839627743
H63D O 1 1.0
HFE O 1 1.0
proteins O 0 0.015520111657679081
form O 0 0.009519302286207676
stable O 0 0.01864812895655632
complexes O 0 0.017285265028476715
with O 0 0.007041205186396837
the O 0 0.012119701132178307
transferrin O 1 0.9999994039535522
receptor O 1 0.8465798497200012
( O 0 0.02515966072678566
TfR O 1 0.9999773502349854
) O 0 0.02593727968633175
. O 0 0.025908755138516426

The O 0 0.029984688386321068
C282Y O 1 0.9958821535110474
mutation O 0 0.0225618127733469
nearly O 0 0.012556674890220165
completely O 0 0.014549232088029385
prevents O 0 0.0156303271651268
the O 0 0.007493333891034126
association O 0 0.007986442185938358
of O 0 0.006268042605370283
the O 0 0.010742801241576672
mutant O 1 0.9753869771957397
HFE O 1 1.0
protein O 0 0.01716030389070511
with O 0 0.01050157006829977
the O 0 0.021565832197666168
TfR O 1 0.999903678894043
. O 0 0.0381610170006752

Studies O 0 0.016241461038589478
on O 0 0.010678463615477085
cell O 0 0.028271010145545006
- O 1 0.9998944997787476
associated O 0 0.01085658185184002
transferrin O 0 0.13750414550304413
at O 0 0.010757405310869217
37 O 0 0.016720766201615334
degrees O 0 0.015083860605955124
C O 0 0.03595810383558273
suggest O 0 0.007537884637713432
that O 0 0.00284000881947577
the O 0 0.005648672115057707
overexpressed O 0 0.037207964807748795
wild O 0 0.013489325530827045
- O 1 0.9999984502792358
type O 1 0.8781377077102661
HFE O 1 0.9999998807907104
protein O 0 0.023851390928030014
decreases O 0 0.01740209385752678
the O 0 0.00827120617032051
affinity O 0 0.015165664255619049
of O 0 0.009420213289558887
the O 0 0.01421192567795515
TfR O 1 0.9999823570251465
for O 0 0.025179648771882057
transferrin O 1 0.999943733215332
. O 0 0.04472486302256584

The O 0 0.03840860724449158
overexpressed O 1 0.999614953994751
H63D O 1 0.9999998807907104
protein O 0 0.02167230099439621
does O 0 0.006698540411889553
not O 0 0.002927904948592186
have O 0 0.0021933403331786394
this O 0 0.0025997331831604242
effect O 0 0.004357391968369484
, O 0 0.0036420756950974464
providing O 0 0.004865380935370922
the O 0 0.0043627237901091576
first O 0 0.005133821163326502
direct O 0 0.0049724881537258625
evidence O 0 0.003500944236293435
for O 0 0.0032327102962881327
a O 0 0.0069764722138643265
functional O 0 0.014284109696745872
consequence O 0 0.011463074013590813
of O 0 0.009273518808186054
the O 0 0.01743963174521923
H63D O 1 1.0
mutation O 0 0.04568643867969513
. O 0 0.026544000953435898

Addition O 0 0.02678900957107544
of O 0 0.015097842551767826
soluble O 1 0.6756055951118469
wild O 0 0.0205825287848711
- O 1 0.9999980926513672
type O 1 0.9772704243659973
HFE O 1 1.0
/ O 1 0.9999972581863403
beta2m O 1 0.9999703168869019
heterodimers O 1 0.9998946189880371
to O 0 0.013583063147962093
cultured O 0 0.06304576247930527
cells O 0 0.01139767188578844
also O 0 0.007347134407609701
decreased O 0 0.011567064560949802
the O 0 0.006907539442181587
apparent O 0 0.01234797015786171
affinity O 0 0.013232076540589333
of O 0 0.007169230841100216
the O 0 0.008453604765236378
TfR O 1 0.996573805809021
for O 0 0.005833044182509184
its O 0 0.007889177650213242
ligand O 0 0.02070980705320835
under O 0 0.010294973850250244
steady O 0 0.019722629338502884
- O 1 0.9955039620399475
state O 0 0.004870065022259951
conditions O 0 0.006325054448097944
, O 0 0.003930436447262764
both O 0 0.003025682410225272
in O 0 0.005654806271195412
293 O 1 0.9986762404441833
cells O 0 0.012423785403370857
and O 0 0.00889711081981659
in O 0 0.014658274129033089
HeLa O 1 0.9999998807907104
cells O 0 0.035073306411504745
. O 0 0.028922686353325844

Furthermore O 0 0.031171554699540138
, O 0 0.00993447657674551
at O 0 0.009851302020251751
4 O 0 0.011886156164109707
degrees O 0 0.015372160822153091
C O 1 0.8505160808563232
, O 0 0.006044167093932629
the O 0 0.006422504782676697
added O 0 0.010182514786720276
soluble O 0 0.21411006152629852
complex O 0 0.01436704769730568
of O 0 0.014994597993791103
HFE O 1 1.0
/ O 1 0.9999997615814209
beta2m O 1 0.9999750852584839
inhibited O 0 0.05592111125588417
binding O 0 0.01642548106610775
of O 0 0.012350877746939659
transferrin O 1 0.9684630632400513
to O 0 0.015621987171471119
HeLa O 1 0.9999940395355225
cell O 0 0.04273275285959244
TfR O 1 0.924635648727417
in O 0 0.008344840258359909
a O 0 0.011811093427240849
concentration O 1 0.992745041847229
- O 1 0.9999979734420776
dependent O 0 0.021191159263253212
manner O 0 0.0185796357691288
. O 0 0.01960781402885914

Scatchard O 0 0.09103156626224518
plots O 0 0.01871228590607643
of O 0 0.007157093845307827
these O 0 0.0027055186219513416
data O 0 0.003221736988052726
indicate O 0 0.003408492077142
that O 0 0.00244131195358932
the O 0 0.005026708822697401
added O 0 0.011511147953569889
heterodimer O 1 0.9982221722602844
substantially O 0 0.021814793348312378
reduced O 0 0.0111696757376194
the O 0 0.00859813392162323
affinity O 0 0.01790286786854267
of O 0 0.014362840913236141
TfR O 1 0.9999591112136841
for O 0 0.02466784417629242
transferrin O 1 0.9999366998672485
. O 0 0.03741753101348877

These O 0 0.011000402271747589
results O 0 0.009251538664102554
establish O 0 0.010536560788750648
a O 0 0.008348627015948296
molecular O 0 0.015148338861763477
link O 0 0.012247337028384209
between O 0 0.00812691543251276
HFE O 1 0.999997615814209
and O 0 0.006266400683671236
a O 0 0.007854821160435677
key O 0 0.01231500506401062
protein O 0 0.007430064491927624
involved O 0 0.005182323046028614
in O 0 0.006173890549689531
iron O 1 0.9999024868011475
transport O 0 0.011585540138185024
, O 0 0.005523881874978542
the O 0 0.007424169685691595
TfR O 1 0.9999990463256836
, O 0 0.006194721907377243
and O 0 0.003820312675088644
raise O 0 0.006827155128121376
the O 0 0.004618088714778423
possibility O 0 0.005474079865962267
that O 0 0.0027297798078507185
alterations O 0 0.008520313538610935
in O 0 0.0034769284538924694
this O 0 0.003133323509246111
regulatory O 0 0.014135544188320637
mechanism O 0 0.008821616880595684
may O 0 0.003916468005627394
play O 0 0.004729080479592085
a O 0 0.004890802316367626
role O 0 0.005354453809559345
in O 0 0.0037053790874779224
the O 0 0.006560754496604204
pathogenesis O 1 1.0
of O 1 0.9998986721038818
hereditary B-Disease 1 1.0
hemochromatosis I-Disease 1 1.0
. O 1 0.9992467164993286
. O 0 0.03752588480710983

Genomic O 0 0.06428790092468262
organization O 0 0.018954727798700333
of O 0 0.012384075671434402
the O 0 0.01645868644118309
UBE3A O 1 0.9999998807907104
/ O 1 0.9999977350234985
E6 O 1 0.9999995231628418
- O 1 1.0
AP O 1 0.9997493624687195
gene O 0 0.016649771481752396
and O 0 0.009961443953216076
related O 0 0.01884370669722557
pseudogenes O 0 0.18171370029449463
. O 0 0.029050704091787338

The O 0 0.0490666963160038
UBE3A O 1 0.9992499947547913
gene O 0 0.02257862314581871
encodes O 0 0.023585112765431404
the O 0 0.013112198561429977
E6 O 1 0.9978893399238586
- O 1 0.9999901056289673
AP O 1 0.9973811507225037
ubiquitin O 1 0.9977521300315857
- O 1 0.9999967813491821
protein O 0 0.01768793910741806
ligase O 0 0.023918265476822853
and O 0 0.005965201184153557
has O 0 0.005514579825103283
recently O 0 0.008321097120642662
been O 0 0.003815632313489914
shown O 0 0.0031990709248930216
to O 0 0.0031742455903440714
be O 0 0.003705294569954276
mutated O 0 0.0175365898758173
in O 0 0.1379343420267105
Angelman B-Disease 1 1.0
syndrome I-Disease 1 1.0
patients O 1 1.0
who O 1 0.999853253364563
lack O 1 0.9997640252113342
15q11 O 1 1.0
- O 1 1.0
q13 O 1 0.9998489618301392
deletions O 0 0.04476204887032509
or O 0 0.014712085016071796
chromosome O 0 0.0273840744048357
15 O 0 0.028433095663785934
paternal O 1 0.9699941277503967
uniparental B-Disease 1 1.0
disomy I-Disease 1 0.9999969005584717
. O 0 0.04599744454026222

Previous O 0 0.06633377820253372
UBE3A O 1 0.9990187883377075
cDNA O 0 0.05012081563472748
analysis O 0 0.011398923583328724
has O 0 0.006608946248888969
shown O 0 0.004842021968215704
a O 0 0.007439353037625551
coding O 0 0.016036948189139366
region O 0 0.00954714510589838
of O 0 0.008863694034516811
approximately O 0 0.014344538561999798
2 O 0 0.02357809990644455
. O 0 0.022610517218708992

6 O 0 0.047589316964149475
kb O 0 0.09814124554395676
and O 0 0.0076260045170784
a O 0 0.00832479540258646
3 O 0 0.01576671190559864
- O 1 0.999990701675415
untranslated O 1 0.9996498823165894
region O 0 0.016101324930787086
( O 0 0.011030828580260277
UTR O 1 0.9998205304145813
) O 0 0.009168959222733974
of O 0 0.010880530811846256
< O 1 0.9895721673965454
50 O 0 0.016269691288471222
bp O 0 0.02764759585261345
, O 0 0.008605733513832092
whereas O 0 0.008856533095240593
Northern O 0 0.00811890047043562
analysis O 0 0.0048625050112605095
has O 0 0.005349737126380205
indicated O 0 0.0065839956514537334
mRNA O 0 0.008971894159913063
sizes O 0 0.0082376254722476
of O 0 0.006538161542266607
5 O 0 0.01578696072101593
- O 1 0.9991737008094788
8 O 0 0.03452145680785179
kb O 1 0.6041983962059021
. O 0 0.035823408514261246

We O 0 0.01569385826587677
have O 0 0.0068455892615020275
analyzed O 0 0.01465634722262621
additional O 0 0.014714221470057964
cDNA O 0 0.037738289684057236
clones O 0 0.030939938500523567
and O 0 0.0067576514557003975
provide O 0 0.00657045841217041
evidence O 0 0.004620423540472984
for O 0 0.004101874772459269
an O 0 0.007035986520349979
additional O 0 0.014189871028065681
0 O 0 0.03162398189306259
. O 0 0.02517886646091938

5 O 0 0.039193540811538696
kb O 0 0.06840062886476517
of O 0 0.013920936733484268
5 O 0 0.0234314426779747
- O 1 0.9998840093612671
UTR O 1 0.9994988441467285
and O 0 0.012326889671385288
> O 1 0.5466295480728149
2 O 0 0.02311602048575878
kb O 0 0.05799455940723419
of O 0 0.01432584784924984
3 O 0 0.028897903859615326
- O 1 0.9999685287475586
UTR O 1 0.9996985197067261
. O 0 0.03917679935693741

We O 0 0.012103589251637459
have O 0 0.005474158097058535
established O 0 0.00969248078763485
the O 0 0.007469603791832924
genomic O 0 0.016619358211755753
organization O 0 0.0113760931417346
of O 0 0.011714133433997631
UBE3A O 1 0.9999983310699463
and O 0 0.007104227319359779
the O 0 0.006617868319153786
sequence O 0 0.00820987205952406
of O 0 0.012612995691597462
intron O 1 0.9999983310699463
- O 1 0.9999978542327881
exon O 1 0.7071231603622437
borders O 0 0.03289113566279411
. O 0 0.028933459892868996

We O 0 0.0157671757042408
have O 0 0.006754925474524498
also O 0 0.008503317832946777
mapped O 0 0.01851206086575985
two O 0 0.00607004901394248
highly O 0 0.011860288679599762
homologous O 0 0.019562585279345512
processed O 0 0.019007477909326553
pseudogenes O 0 0.03752978891134262
, O 0 0.013629678636789322
UBE3AP1 O 1 0.9999961853027344
and O 0 0.011155737563967705
UBE3AP2 O 1 0.9999953508377075
, O 0 0.007338826544582844
to O 0 0.00561832869425416
chromosomes O 0 0.008977686055004597
2 O 0 0.00780578562989831
and O 0 0.0045149121433496475
21 O 0 0.010066394694149494
, O 0 0.005850829184055328
respectively O 0 0.006898961495608091
, O 0 0.004946126602590084
and O 0 0.005479919258505106
determined O 0 0.00853841844946146
their O 0 0.008107895031571388
genomic O 0 0.0338948555290699
organization O 0 0.02339337207376957
. O 0 0.025882916525006294

These O 0 0.011251517571508884
results O 0 0.009318746626377106
will O 0 0.0053348843939602375
form O 0 0.004461631178855896
the O 0 0.003774830373004079
basis O 0 0.002737404080107808
for O 0 0.003230541478842497
studies O 0 0.004857684951275587
of O 0 0.007383048068732023
mutation O 0 0.011672517284750938
and O 0 0.009010354056954384
imprinting O 1 0.9926196932792664
of O 0 0.04466450959444046
UBE3A O 1 1.0
. O 0 0.046102337539196014

Mutation O 0 0.04625169560313225
spectrum O 0 0.031805332750082016
and O 0 0.014597777277231216
genotype O 1 0.9802609086036682
- O 1 0.999998927116394
phenotype O 0 0.0938800498843193
analyses O 0 0.014732038602232933
in O 0 0.01375169400125742
Cowden B-Disease 1 1.0
disease I-Disease 1 1.0
and O 1 0.6086915135383606
Bannayan B-Disease 1 1.0
- I-Disease 1 1.0
Zonana I-Disease 1 1.0
syndrome I-Disease 1 1.0
, O 0 0.018141377717256546
two O 0 0.014479526318609715
hamartoma B-Disease 1 1.0
syndromes I-Disease 1 1.0
with O 1 0.9925991296768188
germline O 1 1.0
PTEN O 1 1.0
mutation O 0 0.4979054033756256
. O 0 0.0330481193959713

The O 0 0.07421112060546875
tumour B-Disease 1 1.0
suppressor O 1 0.9999998807907104
gene O 1 0.680418848991394
PTEN O 1 0.9999933242797852
, O 0 0.014380895532667637
which O 0 0.0084946034476161
maps O 0 0.01741483435034752
to O 0 0.014062979258596897
10q23 O 0 0.3759654760360718
. O 0 0.03174712508916855

3 O 0 0.03433508053421974
and O 0 0.015461361967027187
encodes O 0 0.028838975355029106
a O 0 0.015384246595203876
403 O 0 0.05394664406776428
amino O 0 0.02476377598941326
acid O 0 0.027806852012872696
dual O 0 0.030927447602152824
specificity O 0 0.042860936373472214
phosphatase O 1 0.9988489151000977
( O 0 0.015649575740098953
protein O 0 0.023930395022034645
tyrosine O 0 0.04733475670218468
phosphatase O 1 0.9930102229118347
; O 0 0.017875229939818382
PTPase O 1 0.9999871253967285
) O 0 0.008820016868412495
, O 0 0.006621769163757563
was O 0 0.008728332817554474
shown O 0 0.00570825906470418
recently O 0 0.007793150842189789
to O 0 0.003913507331162691
play O 0 0.004475470632314682
a O 0 0.006396443583071232
broad O 0 0.009716621600091457
role O 0 0.008357868529856205
in O 0 0.008914263918995857
human O 0 0.0204547718167305
malignancy B-Disease 1 1.0
. O 0 0.040026355534791946

Somatic O 1 0.9982213377952576
PTEN O 1 0.9999957084655762
deletions O 0 0.07396925985813141
and O 0 0.01292774174362421
mutations O 0 0.009904145263135433
were O 0 0.0037500299513339996
observed O 0 0.004311200696974993
in O 0 0.004061896353960037
sporadic B-Disease 0 0.06964197009801865
breast I-Disease 1 1.0
, I-Disease 0 0.1866718828678131
brain I-Disease 1 0.9999817609786987
, I-Disease 1 0.8478586077690125
prostate I-Disease 1 1.0
and I-Disease 1 1.0
kidney I-Disease 1 1.0
cancer I-Disease 1 1.0
cell O 1 1.0
lines O 0 0.013649091124534607
and O 0 0.004066420719027519
in O 0 0.003664815565571189
several O 0 0.004420814104378223
primary O 0 0.014612016268074512
tumours B-Disease 1 0.9999977350234985
such O 0 0.00635536527261138
as O 0 0.015005555935204029
endometrial B-Disease 1 1.0
carcinomas I-Disease 1 1.0
, O 1 1.0
malignant B-Disease 1 1.0
melanoma I-Disease 1 1.0
and O 1 1.0
thyroid B-Disease 1 1.0
tumours I-Disease 1 1.0
. O 1 0.9991047978401184

In O 0 0.014886547811329365
addition O 0 0.015318813733756542
, O 0 0.013597670011222363
PTEN O 1 0.9999974966049194
was O 0 0.011204445734620094
identified O 0 0.006247884128242731
as O 0 0.004139618016779423
the O 0 0.0066356598399579525
susceptibility O 1 0.7233442664146423
gene O 0 0.006328382529318333
for O 0 0.004718460608273745
two O 0 0.008951942436397076
hamartoma B-Disease 1 1.0
syndromes I-Disease 1 1.0
Cowden B-Disease 1 1.0
disease I-Disease 1 1.0
( O 1 0.9990206956863403
CD B-Disease 1 0.9999935626983643
; O 0 0.020381374284625053
MIM O 1 1.0
158350 O 1 0.999961256980896
) O 0 0.009893354028463364
and O 0 0.009884688071906567
Bannayan B-Disease 1 0.9999819993972778
- I-Disease 1 1.0
Zonana I-Disease 1 1.0
( I-Disease 0 0.01903887465596199
BZS I-Disease 1 0.9999904632568359
) I-Disease 0 0.011682748794555664
or I-Disease 0 0.009746527299284935
Ruvalcaba I-Disease 1 0.9999874830245972
- I-Disease 1 0.9999984502792358
Riley I-Disease 1 0.9999740123748779
- I-Disease 1 1.0
Smith I-Disease 1 0.9999991655349731
syndrome I-Disease 1 1.0
( O 1 0.9977739453315735
MIM O 1 1.0
153480 O 1 1.0
) O 0 0.02896224521100521
. O 0 0.0307147316634655

Constitutive O 0 0.10672784596681595
DNA O 0 0.030108937993645668
from O 0 0.012290519662201405
37 O 0 0.02355186827480793
CD B-Disease 0 0.03537944704294205
families O 0 0.009556311182677746
and O 0 0.006847631651908159
seven O 0 0.012670084834098816
BZS B-Disease 1 0.999987006187439
families O 0 0.013537292368710041
was O 0 0.016229944303631783
screened O 0 0.030140522867441177
for O 0 0.018614256754517555
germline O 1 0.9989979863166809
PTEN O 1 0.9999991655349731
mutations O 0 0.049100611358881
. O 0 0.033254314213991165

PTEN O 1 0.9999979734420776
mutations O 0 0.023415924981236458
were O 0 0.005427895113825798
identified O 0 0.0064283921383321285
in O 0 0.0037976293824613094
30 O 0 0.006045909132808447
of O 0 0.005434064194560051
37 O 0 0.01311382558196783
( O 0 0.008736364543437958
81 O 0 0.028030643239617348
% O 0 0.009327990934252739
) O 0 0.008619180880486965
CD B-Disease 0 0.02915564924478531
families O 0 0.0074402340687811375
, O 0 0.004887065850198269
including O 0 0.005319476593285799
missense O 0 0.016144493594765663
and O 0 0.0062839738093316555
nonsense O 0 0.07534389197826385
point O 0 0.011796328239142895
mutations O 0 0.011341224424540997
, O 0 0.009399833157658577
deletions O 0 0.023842738941311836
, O 0 0.00972402561455965
insertions O 0 0.031138021498918533
, O 0 0.007477098144590855
a O 0 0.011598477140069008
deletion O 1 0.8867515921592712
/ O 1 0.9999878406524658
insertion O 0 0.05786547437310219
and O 0 0.01230146549642086
splice O 0 0.34997501969337463
site O 0 0.030162068083882332
mutations O 0 0.025545643642544746
. O 0 0.02312597446143627

These O 0 0.014469241723418236
mutations O 0 0.012919334694743156
were O 0 0.004841056652367115
scattered O 0 0.006720296107232571
over O 0 0.0038543930277228355
the O 0 0.004767021629959345
entire O 0 0.00871725007891655
length O 0 0.0061452435329556465
of O 0 0.007236473262310028
PTEN O 1 0.9999998807907104
, O 0 0.004639885388314724
with O 0 0.002689572051167488
the O 0 0.003483258653432131
exception O 0 0.005184102803468704
of O 0 0.004128388594835997
the O 0 0.0047075701877474785
first O 0 0.005792153999209404
, O 0 0.0057897488586604595
fourth O 0 0.013267268426716328
and O 0 0.007435471285134554
last O 0 0.01621297560632229
exons O 0 0.04026021435856819
. O 0 0.02530505321919918

A O 0 0.042070697993040085
hot O 0 0.06107879430055618
spot O 0 0.029303770512342453
for O 0 0.01335446909070015
PTEN O 1 0.9999815225601196
mutation O 0 0.019703924655914307
in O 0 0.009130476042628288
CD B-Disease 0 0.056731920689344406
was O 0 0.009115657769143581
identified O 0 0.007788661867380142
in O 0 0.00586295360699296
exon O 0 0.02576678991317749
5 O 0 0.007788616698235273
that O 0 0.003250765148550272
contains O 0 0.006070861127227545
the O 0 0.007129032630473375
PTPase O 1 0.9998127818107605
core O 0 0.14161747694015503
motif O 0 0.020453540608286858
, O 0 0.004790431819856167
with O 0 0.003107151249423623
13 O 0 0.00530226668342948
of O 0 0.0044913385063409805
30 O 0 0.0073900953866541386
( O 0 0.005646500736474991
43 O 0 0.01548527367413044
% O 0 0.009680477902293205
) O 0 0.010400321334600449
CD B-Disease 0 0.05265119671821594
mutations O 0 0.014720450155436993
identified O 0 0.009608590975403786
in O 0 0.006865922827273607
this O 0 0.011010688729584217
exon O 0 0.07565948367118835
. O 0 0.030034763738512993

Seven O 0 0.01679343916475773
of O 0 0.008703754283487797
30 O 0 0.01081256102770567
( O 0 0.007805106695741415
23 O 0 0.01181376539170742
% O 0 0.0065480307675898075
) O 0 0.004595180973410606
were O 0 0.002340512117370963
within O 0 0.0031474032439291477
the O 0 0.006129438057541847
core O 0 0.02183450758457184
motif O 0 0.023684337735176086
, O 0 0.005973117891699076
the O 0 0.006000016815960407
majority O 0 0.006431365851312876
( O 0 0.004233625251799822
five O 0 0.003491954179480672
of O 0 0.003914954140782356
seven O 0 0.00435872795060277
) O 0 0.003837060881778598
of O 0 0.003959241323173046
which O 0 0.0029500098899006844
were O 0 0.003877692623063922
missense O 0 0.019544538110494614
mutations O 0 0.008330323733389378
, O 0 0.005382226314395666
possibly O 0 0.006708452943712473
pointing O 0 0.007010474801063538
to O 0 0.004497956950217485
the O 0 0.006257997360080481
functional O 0 0.012633748352527618
significance O 0 0.01102298591285944
of O 0 0.008100749924778938
this O 0 0.006750774569809437
region O 0 0.0197192020714283
. O 0 0.02147204801440239

Germline O 1 0.9999586343765259
PTEN O 1 0.999998927116394
mutations O 0 0.023442121222615242
were O 0 0.005880070850253105
identified O 0 0.00525919534265995
in O 0 0.003295725677162409
four O 0 0.003633170621469617
of O 0 0.003998574335128069
seven O 0 0.0051950328052043915
( O 0 0.007132995408028364
57 O 0 0.021665645763278008
% O 0 0.012025987729430199
) O 0 0.01488201692700386
BZS B-Disease 1 0.999866247177124
families O 0 0.019889608025550842
studied O 0 0.02929653786122799
. O 0 0.024722926318645477

Interestingly O 0 0.04871712625026703
, O 0 0.009968603029847145
none O 0 0.008471241220831871
of O 0 0.005230615846812725
these O 0 0.003733346238732338
mutations O 0 0.008881406858563423
was O 0 0.007954924367368221
observed O 0 0.006239100359380245
in O 0 0.006600023712962866
the O 0 0.012816893868148327
PTPase O 1 0.999991774559021
core O 1 0.8040134310722351
motif O 0 0.16891032457351685
. O 0 0.035028934478759766

It O 0 0.013642634265124798
is O 0 0.007920620031654835
also O 0 0.00739438459277153
worthy O 0 0.01539267785847187
of O 0 0.006893808487802744
note O 0 0.00747284572571516
that O 0 0.003139940556138754
a O 0 0.005542933940887451
single O 0 0.0078507699072361
nonsense O 0 0.01697606034576893
point O 0 0.00826911348849535
mutation O 0 0.01004632469266653
, O 0 0.0076271663419902325
R233X O 1 0.9874168634414673
, O 0 0.005658977199345827
was O 0 0.007663995958864689
observed O 0 0.0040023778565227985
in O 0 0.0038116283249109983
the O 0 0.006350417155772448
germline O 0 0.022334497421979904
DNA O 0 0.009210865944623947
from O 0 0.004113928414881229
two O 0 0.004038759972900152
unrelated O 0 0.011691312305629253
CD B-Disease 0 0.09979431331157684
families O 0 0.009925223886966705
and O 0 0.007757859770208597
one O 0 0.013551958836615086
BZS B-Disease 1 0.9999970197677612
family O 0 0.03444434702396393
. O 0 0.029309827834367752

Genotype O 1 0.9998420476913452
- O 1 0.9999990463256836
phenotype O 1 0.5721761584281921
studies O 0 0.008829085156321526
were O 0 0.003946969285607338
not O 0 0.003256873693317175
performed O 0 0.005916767753660679
on O 0 0.004427742678672075
this O 0 0.003846981795504689
small O 0 0.006170807406306267
group O 0 0.010719288140535355
of O 0 0.014237670227885246
BZS B-Disease 1 0.9999988079071045
families O 0 0.03111017867922783
. O 0 0.027730876579880714

However O 0 0.01889713481068611
, O 0 0.016711238771677017
genotype O 0 0.4975932240486145
- O 1 0.9999666213989258
phenotype O 0 0.0381571426987648
analysis O 0 0.010913826525211334
inthe O 0 0.06929480284452438
group O 0 0.013547554612159729
of O 0 0.009476703591644764
CD B-Disease 1 0.7722453474998474
families O 0 0.008694308809936047
revealed O 0 0.008792825043201447
two O 0 0.003253500908613205
possible O 0 0.0043258583173155785
associations O 0 0.005507549736648798
worthy O 0 0.01188970822840929
of O 0 0.0061734458431601524
follow O 0 0.009226947091519833
- O 1 0.9998517036437988
up O 0 0.010564944706857204
in O 0 0.006834245752543211
independent O 0 0.012448216788470745
analyses O 0 0.024825526401400566
. O 0 0.020452069118618965

The O 0 0.013973490335047245
first O 0 0.010499677620828152
was O 0 0.009202481247484684
an O 0 0.005417675245553255
association O 0 0.008309303782880306
noted O 0 0.005431846249848604
in O 0 0.0035603444557636976
the O 0 0.004652922973036766
group O 0 0.0062347352504730225
of O 0 0.0056379991583526134
CD B-Disease 0 0.17268608510494232
families O 0 0.011558019556105137
with O 0 0.25639772415161133
breast B-Disease 1 1.0
disease I-Disease 1 1.0
. O 0 0.18220096826553345

A O 0 0.02833712287247181
correlation O 0 0.01661554165184498
was O 0 0.009867092594504356
observed O 0 0.004685781430453062
between O 0 0.004223538096994162
the O 0 0.006061619613319635
presence O 0 0.010779263451695442
/ O 1 0.8980170488357544
absence O 0 0.012208551168441772
of O 0 0.00824512355029583
a O 0 0.012348498217761517
PTEN O 1 0.9999998807907104
mutation O 0 0.009525557048618793
and O 0 0.0035526305437088013
the O 0 0.0049218423664569855
type O 0 0.009981629438698292
of O 0 0.01922348514199257
breast O 1 1.0
involvement O 1 0.9998699426651001
( O 0 0.031431227922439575
unaffected O 1 0.9998906850814819
versus O 1 0.9999868869781494
benign O 1 1.0
versus O 1 1.0
malignant O 1 1.0
) O 0 0.0337706096470356
. O 0 0.03116616979241371

Specifically O 0 0.020499540492892265
and O 0 0.006761842407286167
more O 0 0.004289676435291767
directly O 0 0.005682005081325769
, O 0 0.0035028508864343166
an O 0 0.004014649428427219
association O 0 0.010834421962499619
was O 0 0.010059650056064129
also O 0 0.0036291659343987703
observed O 0 0.0029069604352116585
between O 0 0.00231776456348598
the O 0 0.003293256275355816
presence O 0 0.004209607373923063
of O 0 0.004925533663481474
a O 0 0.008972487412393093
PTEN O 1 1.0
mutation O 1 0.6801506876945496
and O 1 0.9894415140151978
malignant B-Disease 1 1.0
breast I-Disease 1 1.0
disease I-Disease 1 1.0
. O 1 0.9987014532089233

Secondly O 1 0.6922697424888611
, O 0 0.011119616217911243
there O 0 0.004939074628055096
appeared O 0 0.006934210192412138
to O 0 0.004019752610474825
be O 0 0.002817426109686494
an O 0 0.005411496851593256
interdependent O 1 0.9581308364868164
association O 0 0.014861567877233028
between O 0 0.00778217101469636
mutations O 0 0.009660398587584496
upstream O 0 0.010224658064544201
and O 0 0.004174264147877693
within O 0 0.0044882395304739475
the O 0 0.008853395469486713
PTPase O 1 0.9999905824661255
core O 0 0.3791043758392334
motif O 0 0.02878919057548046
, O 0 0.007049148436635733
the O 0 0.007379428017884493
core O 0 0.023967597633600235
motif O 0 0.020788904279470444
containing O 0 0.008786696940660477
the O 0 0.005589246284216642
majority O 0 0.005475123878568411
of O 0 0.007532942574471235
missense O 0 0.03334357216954231
mutations O 0 0.008780411444604397
, O 0 0.00406898558139801
and O 0 0.002987850224599242
the O 0 0.003359985537827015
involvement O 0 0.005388457793742418
of O 0 0.002869161544367671
all O 0 0.0026362724602222443
major O 0 0.024171866476535797
organ O 1 0.9999853372573853
systems O 1 0.9983440637588501
( O 0 0.005549364723265171
central O 0 0.008726022206246853
nervous O 1 0.9453127384185791
system O 0 0.010303178802132607
, O 0 0.26124629378318787
thyroid O 1 1.0
, O 1 0.9999629259109497
breast O 1 1.0
, O 1 0.9999978542327881
skin O 1 1.0
and O 1 1.0
gastrointestinal O 1 1.0
tract O 1 1.0
) O 1 0.9991946816444397
. O 0 0.038823697715997696

However O 0 0.015321426093578339
, O 0 0.008492976427078247
these O 0 0.0034239988308399916
observations O 0 0.006562010385096073
would O 0 0.0038113207556307316
need O 0 0.004611685872077942
to O 0 0.0037681302055716515
be O 0 0.0031133517622947693
confirmed O 0 0.004474650602787733
by O 0 0.002566152485087514
studying O 0 0.006486634723842144
a O 0 0.006361987441778183
larger O 0 0.007768952287733555
number O 0 0.004951606970280409
of O 0 0.00965720135718584
CD B-Disease 0 0.2329169511795044
families O 0 0.018478741869330406
. O 0 0.020154094323515892

Molecular O 1 0.7757712006568909
defects O 1 0.9997848868370056
leading O 0 0.01802494190633297
to O 0 0.007155193015933037
human O 0 0.00883407611399889
complement B-Disease 1 0.9949055910110474
component I-Disease 1 1.0
C6 I-Disease 1 1.0
deficiency I-Disease 1 1.0
in O 0 0.010786470025777817
an O 0 0.009216882288455963
African O 1 0.9738789796829224
- O 1 0.9999991655349731
American O 0 0.028502225875854492
family O 0 0.02544908970594406
. O 0 0.023324696347117424

Complement B-Disease 1 0.5130055546760559
component I-Disease 1 0.9999951124191284
C6 I-Disease 1 1.0
deficiency I-Disease 1 1.0
( O 1 0.9991613626480103
C6D B-Disease 1 1.0
) O 0 0.015686051920056343
was O 0 0.38288724422454834
diagnosed O 1 0.999996542930603
in O 0 0.0045974585227668285
a O 0 0.005524533800780773
16 O 0 0.009075602516531944
- O 1 0.9991494417190552
year O 0 0.009012951515614986
- O 1 0.9961519837379456
old O 0 0.016991298645734787
African O 0 0.017094314098358154
- O 1 0.998239278793335
American O 0 0.014024749398231506
male O 0 0.018340280279517174
with O 0 0.023457195609807968
meningococcal B-Disease 1 1.0
meningitis I-Disease 1 1.0
. O 1 0.6546878218650818

The O 0 0.03227962553501129
patients O 1 0.9987444877624512
father O 0 0.027049412950873375
and O 0 0.00530063733458519
two O 0 0.004351623356342316
brothers O 0 0.015341279096901417
also O 0 0.0048851268365979195
had O 0 0.008944123052060604
C6D B-Disease 1 0.9999998807907104
, O 0 0.005660965573042631
but O 0 0.0031656960491091013
gave O 0 0.0056074620224535465
no O 0 0.0036168277729302645
history O 0 0.008078527636826038
of O 0 0.01828480139374733
meningitis B-Disease 1 1.0
or O 0 0.1426859349012375
other O 0 0.011446108110249043
neisserial B-Disease 1 1.0
infection I-Disease 1 1.0
. O 0 0.02657209523022175

By O 0 0.01386978942900896
using O 0 0.013423731550574303
exon O 0 0.054865118116140366
- O 0 0.38396331667900085
specific O 0 0.010733121074736118
polymerase O 0 0.03441963344812393
chain O 0 0.021808762103319168
reaction O 0 0.012046387419104576
( O 0 0.009373672306537628
PCR O 0 0.04837396368384361
) O 0 0.012060503475368023
/ O 0 0.43537062406539917
single O 0 0.017512526363134384
- O 1 0.9985330104827881
strand O 0 0.02910667471587658
conformation O 0 0.022370629012584686
polymorphism O 0 0.018205512315034866
as O 0 0.006705752573907375
a O 0 0.007887240499258041
screening O 0 0.015102828852832317
step O 0 0.010977444238960743
and O 0 0.005657858215272427
nucleotide O 0 0.011521597392857075
sequencing O 0 0.01010281965136528
of O 0 0.005710887257009745
target O 0 0.0109439417719841
exons O 0 0.018300222232937813
, O 0 0.005483464803546667
we O 0 0.003246433800086379
determined O 0 0.004384064115583897
that O 0 0.0030332058668136597
the O 0 0.00738515192642808
proband O 1 0.9868342280387878
was O 0 0.009821385145187378
a O 0 0.009045539423823357
compound O 0 0.025177447125315666
heterozygote O 0 0.04638288915157318
for O 0 0.008667176589369774
two O 0 0.013487874530255795
C6 O 1 0.9999998807907104
gene O 0 0.03919168561697006
mutations O 0 0.03348809853196144
. O 0 0.02871493622660637

The O 0 0.02225075103342533
first O 0 0.014339819550514221
, O 0 0.012501602061092854
1195delC O 0 0.21940232813358307
located O 0 0.014143827371299267
in O 0 0.008216149173676968
exon O 0 0.13215355575084686
7 O 0 0.013026666827499866
, O 0 0.006045948714017868
is O 0 0.004509638529270887
a O 0 0.005876281298696995
novel O 0 0.01190341729670763
mutation O 0 0.008526349440217018
, O 0 0.003774640616029501
while O 0 0.003502974286675453
the O 0 0.004691355861723423
second O 0 0.008054925128817558
, O 0 0.006210041232407093
1936delG O 0 0.23223252594470978
in O 0 0.007032426074147224
exon O 0 0.26781725883483887
12 O 0 0.008387524634599686
, O 0 0.004545073490589857
has O 0 0.003618603339418769
been O 0 0.0028862827457487583
described O 0 0.004729556385427713
before O 0 0.0045447261072695255
to O 0 0.005252656526863575
cause O 0 0.29087215662002563
C6D B-Disease 1 0.9999996423721313
in O 0 0.005597197916358709
an O 0 0.006681220605969429
unrelated O 0 0.01440784614533186
African O 0 0.1129944697022438
- O 1 0.9999977350234985
American O 0 0.020506562665104866
individual O 0 0.014731541275978088
. O 0 0.022217946127057076

Both O 0 0.01844746433198452
mutations O 0 0.017985720187425613
result O 0 0.008115668781101704
in O 0 0.009265858680009842
premature O 1 0.9955971837043762
termination O 1 0.9999535083770752
codons O 0 0.06382560729980469
and O 0 0.023210715502500534
C6 O 1 0.9999998807907104
null O 0 0.10988352447748184
alleles O 0 0.07042478024959564
. O 0 0.04182624816894531

Allele O 0 0.2511153519153595
- O 1 0.9729173183441162
specific O 0 0.012371101416647434
PCR O 0 0.03381716087460518
indicated O 0 0.009724810719490051
that O 0 0.003575800685212016
the O 0 0.007017361465841532
probands O 0 0.3181817829608917
two O 0 0.006745385471731424
brothers O 0 0.016182323917746544
also O 0 0.0073781185783445835
inherited O 1 0.9985179305076599
the O 0 0.01086117047816515
1195delC O 1 0.9999955892562866
mutation O 0 0.011353335343301296
from O 0 0.004500823561102152
their O 0 0.005962990690022707
heterozygous O 0 0.016595784574747086
mother O 0 0.011848223395645618
and O 0 0.005324868485331535
the O 0 0.008982423692941666
1936delG O 1 0.9997681975364685
mutation O 0 0.012268483638763428
from O 0 0.00522586377337575
their O 0 0.006191795691847801
homozygous O 0 0.0245110671967268
father O 0 0.13241125643253326
. O 0 0.012437459081411362
. O 0 0.018449334427714348

PAX6 O 1 0.9999903440475464
mutations O 0 0.07130375504493713
reviewed O 0 0.06062828749418259
. O 0 0.04199711233377457

Mutations O 0 0.038528893142938614
in O 0 0.015825295820832253
PAX6 O 1 0.9996598958969116
are O 0 0.003952946979552507
responsible O 0 0.005078056361526251
for O 0 0.003775171469897032
human O 0 0.006812817417085171
aniridia B-Disease 1 1.0
and O 0 0.005248681642115116
have O 0 0.002920155879110098
also O 0 0.0029120619874447584
been O 0 0.0021953273098915815
found O 0 0.0025407811626791954
in O 0 0.0036459797993302345
patients O 0 0.35300958156585693
with O 0 0.004846375901252031
Peters B-Disease 1 0.9999998807907104
anomaly I-Disease 1 0.9999998807907104
, O 0 0.04534101113677025
with O 1 0.9979850053787231
congenital B-Disease 1 1.0
cataracts I-Disease 1 1.0
, O 1 0.9999898672103882
with O 1 0.9661484360694885
autosomal B-Disease 1 1.0
dominant I-Disease 1 1.0
keratitis I-Disease 1 1.0
, O 0 0.22600989043712616
and O 0 0.0073959603905677795
with O 0 0.009763007052242756
isolated B-Disease 1 0.9991142153739929
foveal I-Disease 1 1.0
hypoplasia I-Disease 1 1.0
. O 0 0.0801466777920723

No O 0 0.02251349575817585
locus O 0 0.03926903381943703
other O 0 0.006451796740293503
than O 0 0.0071505033411085606
chromosome O 0 0.020236114040017128
11p13 O 1 0.9845359921455383
has O 0 0.006297581363469362
been O 0 0.00508542824536562
implicated O 0 0.015237863175570965
in O 0 0.006815919186919928
aniridia B-Disease 1 1.0
, O 0 0.007038728334009647
and O 0 0.0068688178434967995
PAX6 O 1 1.0
is O 0 0.005546967964619398
clearly O 0 0.004752587527036667
the O 0 0.004170404747128487
major O 0 0.010212162509560585
, O 0 0.0036503374576568604
if O 0 0.002760663628578186
not O 0 0.0023008324205875397
only O 0 0.003347590332850814
, O 0 0.007063035853207111
gene O 0 0.011992030777037144
responsible O 0 0.01892693154513836
. O 0 0.023277999833226204

Twenty O 0 0.05115975812077522
- O 0 0.21149864792823792
eight O 0 0.011347930878400803
percent O 0 0.009890827350318432
of O 0 0.007327934727072716
identified O 0 0.013023235835134983
PAX6 O 1 0.9999897480010986
mutations O 0 0.0113093052059412
are O 0 0.005078689660876989
C O 1 0.9999972581863403
- O 1 1.0
T O 1 0.9999940395355225
changes O 0 0.009398257359862328
at O 0 0.015802498906850815
CpG O 0 0.07716897875070572
dinucleotides O 1 0.8028478622436523
, O 0 0.00895821861922741
20 O 0 0.009791173040866852
% O 0 0.005737882573157549
are O 0 0.003334506880491972
splicing O 0 0.014342287555336952
errors O 0 0.011628849431872368
, O 0 0.005766509100794792
and O 0 0.003882130142301321
more O 0 0.0025724335573613644
than O 0 0.002775070257484913
30 O 0 0.006833747029304504
% O 0 0.005155984777957201
are O 0 0.003753057448193431
deletion O 0 0.022577274590730667
or O 0 0.010481160134077072
insertion O 0 0.042020030319690704
events O 0 0.0190130528062582
. O 0 0.02669607289135456

There O 0 0.010952720418572426
is O 0 0.007431667763739824
a O 0 0.0093391053378582
noticeably O 0 0.0472574420273304
elevated O 1 0.9996614456176758
level O 0 0.009187484160065651
of O 0 0.008074707351624966
mutation O 0 0.008857596665620804
in O 0 0.005292643792927265
the O 0 0.0067748380824923515
paired O 0 0.016646498814225197
domain O 0 0.010388961061835289
compared O 0 0.0052517494186758995
with O 0 0.0035375747829675674
the O 0 0.0055829426273703575
rest O 0 0.008746578358113766
of O 0 0.006730312947183847
the O 0 0.011043802835047245
gene O 0 0.017577428370714188
. O 0 0.01797831989824772

Increased O 0 0.0317077673971653
mutation O 0 0.021790672093629837
in O 0 0.007785124238580465
the O 0 0.011824865825474262
homeodomain O 1 0.9968639612197876
is O 0 0.009592567570507526
accounted O 0 0.014344511553645134
for O 0 0.006210200022906065
by O 0 0.005987777840346098
the O 0 0.015558073297142982
hypermutable O 1 0.9993433356285095
CpG O 1 0.9735541343688965
dinucleotide O 1 0.9710369110107422
in O 0 0.026287173852324486
codon O 0 0.06798151135444641
240 O 0 0.07318412512540817
. O 0 0.03180259093642235

Very O 0 0.015058541670441628
nearly O 0 0.011134075932204723
all O 0 0.006132771261036396
mutations O 0 0.008413303643465042
appear O 0 0.004394661635160446
to O 0 0.004858533386141062
cause O 0 0.011022149585187435
loss O 0 0.19102510809898376
of O 0 0.006029780488461256
function O 0 0.005466264672577381
of O 0 0.0045615993440151215
the O 0 0.0070543233305215836
mutant O 1 0.514036238193512
allele O 0 0.01723020151257515
, O 0 0.004687127191573381
and O 0 0.0030518248677253723
more O 0 0.0024532447569072247
than O 0 0.0031041367910802364
80 O 0 0.008608374744653702
% O 0 0.005404272116720676
of O 0 0.008233411237597466
exonic O 1 0.9991616010665894
substitutions O 0 0.024559957906603813
result O 0 0.009641389362514019
in O 0 0.012281336821615696
nonsense O 0 0.05554242432117462
codons O 0 0.055527690798044205
. O 0 0.0321345180273056

In O 0 0.01482829824090004
a O 0 0.010974244214594364
gene O 0 0.00966997817158699
with O 0 0.004050650633871555
such O 0 0.003806276712566614
extraordinarily O 0 0.06841297447681427
high O 0 0.00966589618474245
sequence O 0 0.0064382366836071014
conservation O 0 0.006900073029100895
throughout O 0 0.004564029164612293
evolution O 0 0.006196055095642805
, O 0 0.004183876793831587
there O 0 0.002726649632677436
are O 0 0.0027019765693694353
presumed O 0 0.01707042194902897
undiscovered O 1 0.9993863105773926
missense O 1 0.752640962600708
mutations O 0 0.014105911366641521
, O 0 0.005611039232462645
these O 0 0.0025433769915252924
are O 0 0.002165736397728324
hypothesized O 0 0.009029345586895943
to O 0 0.0039459820836782455
exist O 0 0.0031096511520445347
in O 0 0.0035939267836511135
as O 0 0.006293097510933876
- O 1 0.9998705387115479
yet O 0 0.013582922518253326
unidentified O 0 0.03237763047218323
phenotypes O 0 0.044128257781267166
. O 0 0.015275409445166588
. O 0 0.025666186586022377

Genetic O 0 0.04799164831638336
heterogeneity O 0 0.0497175008058548
and O 0 0.012132879346609116
penetrance O 0 0.07461497187614441
analysis O 0 0.008722848258912563
of O 0 0.0068164970725774765
the O 0 0.008383041247725487
BRCA1 O 1 0.9999904632568359
and O 0 0.00949783530086279
BRCA2 O 1 0.9999995231628418
genes O 0 0.01379464939236641
in O 1 0.5366880297660828
breast B-Disease 1 1.0
cancer I-Disease 1 1.0
families O 0 0.28900545835494995
. O 0 0.03134850040078163

The O 1 0.9959916472434998
Breast B-Disease 1 1.0
Cancer I-Disease 1 1.0
Linkage O 1 0.9999978542327881
Consortium O 1 0.9889658093452454
. O 0 0.034450799226760864

The O 0 0.01620517484843731
contribution O 0 0.017399126663804054
of O 0 0.011570772156119347
BRCA1 O 1 0.9998966455459595
and O 0 0.007218964863568544
BRCA2 O 1 0.9999959468841553
to O 0 0.10485626012086868
inherited B-Disease 1 1.0
breast I-Disease 1 1.0
cancer I-Disease 1 1.0
was O 1 0.9999979734420776
assessed O 0 0.034529149532318115
by O 0 0.0056717232801020145
linkage O 0 0.019488085061311722
and O 0 0.007442829664796591
mutation O 0 0.009155682288110256
analysis O 0 0.0050752670504152775
in O 0 0.005056559108197689
237 O 0 0.021099718287587166
families O 0 0.0055906036868691444
, O 0 0.003620652947574854
each O 0 0.0021642488427460194
with O 0 0.00249777571298182
at O 0 0.0034826381597667933
least O 0 0.00218973564915359
four O 0 0.0025733320508152246
cases O 0 0.0034864135086536407
of O 0 0.3992033302783966
breast B-Disease 1 1.0
cancer I-Disease 1 1.0
, O 0 0.0054747965186834335
collected O 0 0.005923451855778694
by O 0 0.004462787881493568
the O 0 0.14269424974918365
Breast B-Disease 1 1.0
Cancer I-Disease 1 1.0
Linkage O 1 0.999998927116394
Consortium O 1 0.9317331910133362
. O 0 0.030808938667178154

Families O 0 0.02356593869626522
were O 0 0.007061611860990524
included O 0 0.006202849559485912
without O 0 0.004231294617056847
regard O 0 0.00538247125223279
to O 0 0.004021047614514828
the O 0 0.00487729674205184
occurrence O 0 0.013209283351898193
of O 0 0.21987003087997437
ovarian B-Disease 1 1.0
or I-Disease 0 0.33661651611328125
other I-Disease 0 0.017913702875375748
cancers I-Disease 1 0.9999998807907104
. O 0 0.03207211196422577

Overall O 1 0.6967595815658569
, O 0 0.022001121193170547
disease O 1 1.0
was O 1 0.5347288250923157
linked O 0 0.11843513697385788
to O 0 0.007978390902280807
BRCA1 O 1 0.9999685287475586
in O 0 0.004064216278493404
an O 0 0.004016838502138853
estimated O 0 0.006942851934581995
52 O 0 0.01276628952473402
% O 0 0.004662787076085806
of O 0 0.00508314510807395
families O 0 0.005339836236089468
, O 0 0.004727868363261223
to O 0 0.006019693799316883
BRCA2 O 1 0.8636595010757446
in O 0 0.004813888110220432
32 O 0 0.008625531569123268
% O 0 0.004278287757188082
of O 0 0.005005517974495888
families O 0 0.005142840091139078
, O 0 0.0038053758908063173
and O 0 0.003020741045475006
to O 0 0.0038560964167118073
neither O 0 0.006883206311613321
gene O 0 0.004391429480165243
in O 0 0.0035137063823640347
16 O 0 0.007477646693587303
% O 0 0.005113396793603897
( O 0 0.004511792212724686
95 O 0 0.01479741558432579
% O 0 0.007556021213531494
confidence O 0 0.016197847202420235
interval O 0 0.021403437480330467
[ O 0 0.02516598254442215
CI O 1 0.999998927116394
] O 0 0.024565191939473152
6 O 0 0.015820113942027092
% O 0 0.010527477599680424
- O 1 0.9902462959289551
28 O 0 0.015295419842004776
% O 0 0.008036801591515541
) O 0 0.006676298100501299
, O 0 0.006596192717552185
suggesting O 0 0.011026703752577305
other O 0 0.008754529058933258
predisposition O 1 0.9999146461486816
genes O 0 0.02331441640853882
. O 0 0.024686403572559357

The O 0 0.0174917820841074
majority O 0 0.010819550603628159
( O 0 0.007882753387093544
81 O 0 0.023080574348568916
% O 0 0.006070636212825775
) O 0 0.003241104306653142
of O 0 0.0037281105760484934
the O 0 0.008022019639611244
breast B-Disease 1 1.0
- I-Disease 1 1.0
ovarian I-Disease 1 1.0
cancer I-Disease 1 1.0
families O 0 0.024322571232914925
were O 0 0.003261207602918148
due O 0 0.0046628364361822605
to O 0 0.0062292455695569515
BRCA1 O 1 0.9999899864196777
, O 0 0.004621169529855251
with O 0 0.003190943505614996
most O 0 0.0033278544433414936
others O 0 0.0035311568062752485
( O 0 0.0046263267286121845
14 O 0 0.008201233111321926
% O 0 0.007365895435214043
) O 0 0.00748580414801836
due O 0 0.00883928406983614
to O 0 0.01771438866853714
BRCA2 O 1 0.9997584223747253
. O 0 0.027537941932678223

Conversely O 0 0.045334696769714355
, O 0 0.009343228302896023
the O 0 0.006584338843822479
majority O 0 0.005668152589350939
of O 0 0.003957053646445274
families O 0 0.0033158245496451855
with O 0 0.0028457457665354013
male B-Disease 0 0.006177092436701059
and I-Disease 0 0.005586395971477032
female I-Disease 1 0.9999605417251587
breast I-Disease 1 1.0
cancer I-Disease 1 1.0
were O 0 0.004638534039258957
due O 0 0.005670736078172922
to O 0 0.008365281857550144
BRCA2 O 1 0.9999977350234985
( O 0 0.01059556845575571
76 O 1 0.9630268216133118
% O 0 0.013749546371400356
) O 0 0.014693647623062134
. O 0 0.021154092624783516

The O 0 0.020900651812553406
largest O 0 0.022283682599663734
proportion O 0 0.01242188923060894
( O 0 0.007681568618863821
67 O 0 0.021221887320280075
% O 0 0.00643939571455121
) O 0 0.0045454250648617744
of O 0 0.004899394698441029
families O 0 0.004565409384667873
due O 0 0.0037385534960776567
to O 0 0.00409805728122592
other O 0 0.0033407851587980986
genes O 0 0.004497183952480555
was O 0 0.005373065359890461
found O 0 0.002832753350958228
in O 0 0.002922907704487443
families O 0 0.0028945202939212322
with O 0 0.002292548306286335
four O 0 0.0025403304025530815
or O 0 0.0023244470357894897
five O 0 0.002658558776602149
cases O 0 0.0029816676396876574
of O 0 0.006522594951093197
female O 1 0.9999991655349731
breast B-Disease 1 1.0
cancer I-Disease 1 1.0
only O 0 0.016743039712309837
. O 0 0.0223383866250515

These O 0 0.010928618721663952
estimates O 0 0.010044229216873646
were O 0 0.003608484286814928
not O 0 0.003741869004443288
substantially O 0 0.012934266589581966
affected O 0 0.007339087314903736
either O 0 0.004115300253033638
by O 0 0.003149180905893445
changing O 0 0.0054514664225280285
the O 0 0.006911635864526033
assumed O 0 0.01755489595234394
penetrance O 1 0.5919615626335144
model O 0 0.015546479262411594
for O 0 0.010602603666484356
BRCA1 O 1 0.9999858140945435
or O 0 0.005869746673852205
by O 0 0.00404642429202795
including O 0 0.005426240619271994
or O 0 0.007988743484020233
excluding O 0 0.06780438125133514
BRCA1 O 1 0.9999957084655762
mutation O 0 0.022912919521331787
data O 0 0.014183522202074528
. O 0 0.020326927304267883

Among O 0 0.01402657013386488
those O 0 0.005319107789546251
families O 0 0.006943755783140659
with O 0 0.006884399335831404
disease O 1 1.0
due O 0 0.27147120237350464
to O 0 0.13380944728851318
BRCA1 O 1 1.0
that O 0 0.0037347974721342325
were O 0 0.003150269389152527
tested O 0 0.005772083066403866
by O 0 0.0022944894153624773
one O 0 0.002468087477609515
of O 0 0.0027027886826545
the O 0 0.004668407142162323
standard O 0 0.009192356839776039
screening O 0 0.010681365616619587
methods O 0 0.005408841650933027
, O 0 0.005626926198601723
mutations O 0 0.005376088432967663
were O 0 0.003161708125844598
detected O 0 0.005620020441710949
in O 0 0.0030428592581301928
the O 0 0.005087837111204863
coding O 0 0.01324843056499958
sequence O 0 0.006181707605719566
or O 0 0.005296963267028332
splice O 0 0.02220763824880123
sites O 0 0.0049578119069337845
in O 0 0.0031470395624637604
an O 0 0.0036538613494485617
estimated O 0 0.006999886129051447
63 O 0 0.016715241596102715
% O 0 0.007321354001760483
( O 0 0.006388003006577492
95 O 0 0.018706290051341057
% O 0 0.011974665336310863
CI O 1 0.9999008178710938
51 O 0 0.026897629722952843
% O 0 0.014879275113344193
- O 1 0.999800980091095
77 O 0 0.05269316956400871
% O 0 0.017136825248599052
) O 0 0.019400907680392265
. O 0 0.023345662280917168

The O 0 0.01923767849802971
estimated O 0 0.014361781068146229
sensitivity O 0 0.02022509276866913
was O 0 0.012065425515174866
identical O 0 0.008579757064580917
for O 0 0.004541284870356321
direct O 0 0.0072134570218622684
sequencing O 0 0.015360882505774498
and O 0 0.006707131862640381
other O 0 0.0061305128037929535
techniques O 0 0.015465645119547844
. O 0 0.019712042063474655

The O 0 0.032120611518621445
penetrance O 1 0.799406111240387
of O 0 0.023943759500980377
BRCA2 O 1 0.9999988079071045
was O 0 0.013621686957776546
estimated O 0 0.010323463939130306
by O 0 0.006232821382582188
maximizing O 0 0.026428623124957085
the O 0 0.011135919950902462
LOD O 1 0.9999210834503174
score O 0 0.013895262964069843
in O 0 0.011463770642876625
BRCA2 O 1 0.9999972581863403
- O 1 0.9999991655349731
mutation O 0 0.01489399652928114
families O 0 0.006790240295231342
, O 0 0.00467631034553051
over O 0 0.004977279808372259
all O 0 0.004656139761209488
possible O 0 0.010576779022812843
penetrance O 1 0.9765342473983765
functions O 0 0.019596178084611893
. O 0 0.024493061006069183

The O 0 0.018646007403731346
estimated O 0 0.016001921147108078
cumulative O 0 0.020410574972629547
risk O 0 0.013496093451976776
of O 0 0.09810851514339447
breast B-Disease 1 1.0
cancer I-Disease 1 1.0
reached O 1 0.9412757158279419
28 O 0 0.015746165066957474
% O 0 0.007161167450249195
( O 0 0.00714128790423274
95 O 0 0.0177389495074749
% O 0 0.011399407871067524
CI O 1 0.9999532699584961
9 O 0 0.016909917816519737
% O 0 0.010071185417473316
- O 1 0.8531522750854492
44 O 0 0.017922572791576385
% O 0 0.007438909728080034
) O 0 0.004277775529772043
by O 0 0.0031028620433062315
age O 0 0.006095307879149914
50 O 0 0.007288787513971329
years O 0 0.005386894568800926
and O 0 0.005025392398238182
84 O 0 0.017207147553563118
% O 0 0.006256911903619766
( O 0 0.005803981330245733
95 O 0 0.015990490093827248
% O 0 0.009629358537495136
CI O 1 0.9989705085754395
43 O 0 0.01898100972175598
% O 0 0.009558992460370064
- O 1 0.9478480815887451
95 O 0 0.017580077052116394
% O 0 0.0074234772473573685
) O 0 0.004361054860055447
by O 0 0.0037197712808847427
age O 0 0.010126974433660507
70 O 0 0.017914677038788795
years O 0 0.014373461715877056
. O 0 0.0203961580991745

The O 0 0.03370761126279831
corresponding O 1 0.9339749217033386
ovarian B-Disease 1 1.0
cancer I-Disease 1 1.0
risks O 1 0.9999991655349731
were O 0 0.014984960667788982
0 O 0 0.03180759772658348
. O 0 0.021482300013303757

4 O 0 0.03486982733011246
% O 0 0.013922172598540783
( O 0 0.009003985673189163
95 O 0 0.021710824221372604
% O 0 0.01325896754860878
CI O 1 0.9998401403427124
0 O 0 0.016925668343901634
% O 0 0.009622493758797646
- O 1 0.9991720914840698
1 O 0 0.012798938900232315
% O 0 0.006339468061923981
) O 0 0.004023290239274502
by O 0 0.002766275778412819
age O 0 0.006276213098317385
50 O 0 0.006333508528769016
years O 0 0.004673049319535494
and O 0 0.0038947206921875477
27 O 0 0.009102512151002884
% O 0 0.0057518198154866695
( O 0 0.0061444868333637714
95 O 0 0.017881041392683983
% O 0 0.010566030628979206
CI O 1 0.9999449253082275
0 O 0 0.016978001222014427
% O 0 0.009797236882150173
- O 1 0.9411259889602661
47 O 0 0.02066251076757908
% O 0 0.00746765173971653
) O 0 0.005272470880299807
by O 0 0.004612675402313471
age O 0 0.011196831241250038
70 O 0 0.018667146563529968
years O 0 0.016363803297281265
. O 0 0.022183306515216827

The O 0 0.01825866661965847
lifetime O 0 0.03541440889239311
risk O 1 0.500535249710083
of O 1 0.9933253526687622
breast B-Disease 1 1.0
cancer I-Disease 1 1.0
appears O 0 0.14246544241905212
similar O 0 0.004485990386456251
to O 0 0.0033887489698827267
the O 0 0.004629212897270918
risk O 0 0.008592266589403152
in O 0 0.008099788799881935
BRCA1 O 1 1.0
carriers O 1 0.9978914856910706
, O 0 0.0052251447923481464
but O 0 0.0031564796809107065
there O 0 0.0023330259136855602
was O 0 0.004864833317697048
some O 0 0.002430316060781479
suggestion O 0 0.00810497347265482
of O 0 0.004416837356984615
a O 0 0.007344476878643036
lower O 0 0.013546234928071499
risk O 0 0.010443706065416336
in O 0 0.009626799263060093
BRCA2 O 1 0.9999825954437256
carriers O 1 0.7225728631019592
< O 1 0.9951465725898743
50 O 0 0.01599346287548542
years O 0 0.010041223838925362
of O 0 0.011693792417645454
age O 0 0.020934689790010452
. O 0 0.02108406461775303

Eye B-Disease 1 0.9999998807907104
movement I-Disease 0 0.07400541752576828
abnormalities I-Disease 1 0.98944491147995
correlate O 0 0.024287154898047447
with O 0 0.008918790146708488
genotype O 0 0.07309360802173615
in O 0 0.011143330484628677
autosomal O 1 0.999997615814209
dominant O 1 0.9999998807907104
cerebellar B-Disease 1 1.0
ataxia I-Disease 1 1.0
type I-Disease 1 1.0
I I-Disease 1 0.9999995231628418
. O 0 0.03179185837507248

We O 0 0.017663342878222466
compared O 0 0.022416938096284866
horizontal O 0 0.04112118110060692
eye O 1 0.9999402761459351
movements O 0 0.01620119996368885
( O 0 0.0140204643830657
visually O 0 0.03368822857737541
guided O 0 0.05221765860915184
saccades O 1 0.9999858140945435
, O 0 0.013060971163213253
antisaccades O 1 0.9998342990875244
, O 0 0.006768792401999235
and O 0 0.0054264673963189125
smooth O 0 0.10964854061603546
pursuit O 1 0.9664884209632874
) O 0 0.005277074407786131
in O 0 0.004344600718468428
control O 0 0.008194084279239178
subjects O 0 0.010596213862299919
( O 0 0.007537004537880421
n O 0 0.018353693187236786
= O 0 0.020132893696427345
14 O 0 0.010178627446293831
) O 0 0.006010651122778654
and O 0 0.005091939587146044
patients O 0 0.009899802505970001
with O 0 0.0030495058745145798
three O 0 0.003218807280063629
forms O 0 0.004141725599765778
of O 0 0.006618282292038202
autosomal O 1 0.99994957447052
dominant O 1 0.9999942779541016
cerebellar B-Disease 1 1.0
ataxias I-Disease 1 1.0
type I-Disease 1 0.9999762773513794
I I-Disease 1 0.9999200105667114
spinocerebellar B-Disease 1 1.0
ataxias I-Disease 1 0.999984860420227
1 I-Disease 0 0.017428956925868988
and I-Disease 0 0.007158726919442415
2 I-Disease 0 0.012488976120948792
( O 0 0.010957162827253342
SCA1 B-Disease 1 0.9996298551559448
, O 0 0.00980294682085514
n O 0 0.019091764464974403
= O 0 0.01943308860063553
11 O 0 0.010884406045079231
; O 0 0.008989736437797546
SCA2 B-Disease 1 0.9993027448654175
, O 0 0.009057010523974895
n O 0 0.0175512433052063
= O 0 0.01680842787027359
10 O 0 0.008239616639912128
) O 0 0.0060101100243628025
and O 0 0.007999670691788197
SCA3 B-Disease 1 0.9999998807907104
/ O 1 0.9999672174453735
Machado B-Disease 1 0.9999947547912598
- I-Disease 1 1.0
Joseph I-Disease 1 0.999988317489624
disease I-Disease 1 1.0
( O 0 0.21038194000720978
MJD B-Disease 1 1.0
) O 0 0.01042336318641901
( O 0 0.009511572308838367
n O 0 0.022807644680142403
= O 0 0.031014395877718925
16 O 0 0.020957576110959053
) O 0 0.01724177598953247
. O 0 0.02480226568877697

In O 0 0.03244457766413689
SCA1 B-Disease 1 0.9999294281005859
, O 0 0.02237595058977604
saccade O 1 0.9958505630493164
amplitude O 0 0.03439243510365486
was O 0 0.016136109828948975
significantly O 0 0.015967706218361855
increased O 0 0.011856981553137302
, O 0 0.009652268141508102
resulting O 0 0.013502461835741997
in O 0 0.014790457673370838
hypermetria B-Disease 1 0.9993255138397217
. O 0 0.027484146878123283

The O 0 0.02869909442961216
smooth O 0 0.03135977312922478
pursuit O 0 0.057500071823596954
gain O 0 0.03150252252817154
was O 0 0.21046903729438782
decreased O 0 0.19255489110946655
. O 0 0.024108441546559334

In O 0 0.042180873453617096
SCA2 B-Disease 1 0.9999315738677979
, O 0 0.02498776838183403
saccade O 1 0.9971120357513428
velocity O 0 0.035713788121938705
was O 0 0.028538929298520088
markedly O 0 0.06214313209056854
decreased O 0 0.048299431800842285
. O 0 0.02833816222846508

The O 0 0.01974835805594921
percentage O 0 0.0139224948361516
of O 0 0.0079793157055974
errors O 0 0.012320782989263535
in O 0 0.008299601264297962
antisaccades O 1 0.9998621940612793
was O 0 0.014108782634139061
greatly O 0 0.011792202480137348
increased O 0 0.006971125490963459
and O 0 0.004913652315735817
was O 0 0.008046936243772507
significantly O 0 0.008829968050122261
correlated O 0 0.009886826388537884
with O 0 0.004246213939040899
age O 0 0.015765409916639328
at O 1 0.9999121427536011
disease O 1 1.0
onset O 1 1.0
. O 0 0.08827485889196396

In O 0 0.01703287474811077
addition O 0 0.010877632535994053
, O 0 0.006033468060195446
a O 0 0.007445820141583681
correlation O 0 0.009144800715148449
between O 0 0.005414551589637995
smooth O 0 0.013663825578987598
pursuit O 0 0.027993451803922653
gain O 0 0.009289312176406384
and O 0 0.0038869089912623167
the O 0 0.004407436121255159
number O 0 0.0037259296514093876
of O 0 0.00804869458079338
trinucleotide O 1 0.9999984502792358
repeats O 0 0.03183779492974281
was O 0 0.015816884115338326
found O 0 0.010201348923146725
. O 0 0.0170871764421463

In O 0 0.02985519729554653
SCA3 B-Disease 1 0.9999998807907104
, O 0 0.01704355888068676
gaze B-Disease 1 0.9988343119621277
- I-Disease 1 1.0
evoked I-Disease 1 0.9999955892562866
nystagmus I-Disease 1 0.9999998807907104
was O 0 0.0218140110373497
often O 0 0.00500962371006608
present O 0 0.004534030798822641
as O 0 0.005379273556172848
was O 0 0.014710978604853153
saccade O 1 0.9999954700469971
hypometria O 1 0.999976396560669
and O 0 0.0076760342344641685
smooth O 0 0.017957093194127083
pursuit O 0 0.23411375284194946
gain O 0 0.024585867300629616
was O 0 0.029701776802539825
markedly O 0 0.11878235638141632
decreased O 0 0.08496659994125366
. O 0 0.02747323177754879

Three O 0 0.017392588779330254
major O 0 0.016996117308735847
criteria O 0 0.014521189033985138
, O 0 0.011691608466207981
saccade O 1 0.9986280202865601
amplitude O 0 0.028569402173161507
, O 0 0.012987465597689152
saccade O 1 0.9942144751548767
velocity O 0 0.014866185374557972
, O 0 0.005519707687199116
and O 0 0.00466827442869544
presence O 0 0.007036313414573669
of O 0 0.0079038729891181
gaze B-Disease 1 0.9999767541885376
- I-Disease 1 1.0
evoked I-Disease 1 0.999985933303833
nystagmus I-Disease 1 0.9999905824661255
, O 0 0.0092390738427639
permitted O 0 0.009246260859072208
the O 0 0.007020256016403437
correct O 0 0.010348624549806118
assignment O 0 0.015060323290526867
of O 0 0.005911306478083134
90 O 0 0.008832423016428947
% O 0 0.0044790408574044704
of O 0 0.004606529604643583
the O 0 0.007383910473436117
SCA1 B-Disease 1 0.999996542930603
, O 0 0.006190988700836897
90 O 0 0.007908204570412636
% O 0 0.004593889694660902
of O 0 0.0046313791535794735
the O 0 0.007673764135688543
SCA2 B-Disease 1 0.9999812841415405
, O 0 0.006020453292876482
and O 0 0.0043261293321847916
93 O 0 0.01350037194788456
% O 0 0.0038420252967625856
of O 0 0.004481882322579622
the O 0 0.006006208714097738
patients O 1 0.9669805765151978
with O 0 0.006002127658575773
SCA3 B-Disease 1 1.0
to O 0 0.005245644599199295
their O 0 0.003929521888494492
genetically O 0 0.00752554927021265
confirmed O 0 0.007580189500004053
patient O 1 0.9729248881340027
group O 0 0.007502914406359196
and O 0 0.004328208975493908
, O 0 0.005075180437415838
therefore O 0 0.003929981496185064
, O 0 0.003772442927584052
may O 0 0.0045550218783319
help O 0 0.010080109350383282
orient O 1 0.8568212985992432
diagnoses O 1 0.9999336004257202
of O 0 0.019958412274718285
SCA1 B-Disease 1 1.0
, O 0 0.014337151311337948
SCA2 B-Disease 1 0.999998927116394
, O 0 0.00809098593890667
and O 0 0.007450082339346409
SCA3 B-Disease 1 1.0
at O 0 0.009930987842381
early O 0 0.007424558512866497
clinical O 0 0.30670517683029175
stages O 0 0.01145741157233715
of O 0 0.008473825640976429
the O 0 0.3396029770374298
diseases O 1 1.0
. O 0 0.0142131969332695
. O 0 0.020104866474866867

Genetic O 0 0.024381224066019058
basis O 0 0.006759488955140114
and O 0 0.007502843160182238
molecular O 0 0.014874306507408619
mechanism O 0 0.01741361804306507
for O 0 0.21137617528438568
idiopathic B-Disease 1 1.0
ventricular I-Disease 1 1.0
fibrillation I-Disease 1 1.0
. O 1 0.9997933506965637

Ventricular B-Disease 1 1.0
fibrillation I-Disease 1 1.0
causes O 1 0.9416502118110657
more O 0 0.005523850210011005
than O 0 0.004914736840873957
300 O 0 0.011074729263782501
, O 0 0.006881476379930973
000 O 0 0.022026747465133667
sudden O 1 0.6314391493797302
deaths O 0 0.00911126472055912
each O 0 0.003512464463710785
year O 0 0.005448370240628719
in O 0 0.005942375864833593
the O 0 0.010724766179919243
USA O 0 0.07295016199350357
alone O 0 0.028369950130581856
. O 0 0.0204812940210104

In O 0 0.013343434780836105
approximately O 0 0.011144834570586681
5 O 0 0.011985896155238152
- O 1 0.5531914234161377
12 O 0 0.00902883056551218
% O 0 0.005294345319271088
of O 0 0.004068367648869753
these O 0 0.002384503837674856
cases O 0 0.0038512088358402252
, O 0 0.0034064077772200108
there O 0 0.0021122603211551905
are O 0 0.0017928691813722253
no O 0 0.003978910390287638
demonstrable O 1 0.9999995231628418
cardiac O 1 1.0
or O 1 0.9535812139511108
non O 1 0.9999998807907104
- O 1 1.0
cardiac O 1 1.0
causes O 1 0.9951112866401672
to O 0 0.004990190267562866
account O 0 0.004516978748142719
for O 0 0.0036954712122678757
the O 0 0.004840151406824589
episode O 0 0.009259969927370548
, O 0 0.0038116828072816133
which O 0 0.0026815528981387615
is O 0 0.002877915510907769
therefore O 0 0.003609752980992198
classified O 0 0.009692134335637093
as O 0 0.04854960739612579
idiopathic B-Disease 1 1.0
ventricular I-Disease 1 1.0
fibrillation I-Disease 1 1.0
( O 1 1.0
IVF B-Disease 1 1.0
) O 0 0.027129296213388443
. O 0 0.029239272698760033

A O 0 0.022546175867319107
distinct O 0 0.011588902212679386
group O 0 0.011482985690236092
of O 0 0.011606241576373577
IVF B-Disease 1 1.0
patients O 1 0.9999997615814209
has O 0 0.007113207131624222
been O 0 0.003757158759981394
found O 0 0.0026578176766633987
to O 0 0.00262212916277349
present O 0 0.003738812869414687
with O 0 0.004064088687300682
a O 0 0.010485340841114521
characteristic O 1 0.6524362564086914
electrocardiographic O 1 0.9999995231628418
pattern O 0 0.03263871371746063
. O 0 0.02431653067469597

Because O 0 0.012665427289903164
of O 0 0.007197197526693344
the O 0 0.00626109354197979
small O 0 0.005644193384796381
size O 0 0.005935225170105696
of O 0 0.003922231495380402
most O 0 0.0039303358644247055
pedigrees O 0 0.011537249200046062
and O 0 0.0032806838862597942
the O 0 0.0041248067282140255
high O 0 0.01429049577564001
incidence O 1 0.999164342880249
of O 0 0.019294817000627518
sudden B-Disease 1 0.9999996423721313
death I-Disease 1 0.9989107847213745
, O 0 0.005167598836123943
however O 0 0.003809629939496517
, O 0 0.004332123324275017
molecular O 0 0.007658848073333502
genetic O 0 0.006186067592352629
studies O 0 0.005025696940720081
of O 0 0.006460761651396751
IVF B-Disease 1 1.0
have O 0 0.004501182120293379
not O 0 0.0038506598211824894
yet O 0 0.007117175497114658
been O 0 0.006913911551237106
done O 0 0.013514871709048748
. O 0 0.019051512703299522

Because O 0 0.03313248232007027
IVF B-Disease 1 1.0
causes O 1 1.0
cardiac O 1 1.0
rhythm O 1 1.0
disturbance O 1 1.0
, O 0 0.009744622744619846
we O 0 0.005309363827109337
investigated O 0 0.009757560677826405
whether O 0 0.006253425497561693
malfunction O 1 0.9824560880661011
of O 0 0.008038329891860485
ion O 0 0.027900056913495064
channels O 0 0.007862647995352745
could O 0 0.005203114822506905
cause O 0 0.010325949639081955
the O 0 0.009286543354392052
disorder O 1 1.0
by O 0 0.0045201461762189865
studying O 0 0.010453705675899982
mutations O 0 0.007834362797439098
in O 0 0.005534786731004715
the O 0 0.010732508264482021
cardiac O 1 1.0
sodium O 1 0.9999094009399414
channel O 0 0.038875922560691833
gene O 0 0.03520796820521355
SCN5A O 1 0.999386191368103
. O 0 0.03673504665493965

We O 0 0.012215068563818932
have O 0 0.005428161006420851
now O 0 0.0065610287711024284
identified O 0 0.0061836144886910915
a O 0 0.007346751168370247
missense O 0 0.021961236372590065
mutation O 0 0.009539447724819183
, O 0 0.0048163169994950294
a O 0 0.008320514112710953
splice O 1 0.9979255199432373
- O 1 0.9999983310699463
donor O 0 0.4821324944496155
mutation O 0 0.012284072116017342
, O 0 0.005284401122480631
and O 0 0.004579260479658842
a O 0 0.008540327660739422
frameshift O 1 0.9644705653190613
mutation O 0 0.008235451765358448
in O 0 0.004140003118664026
the O 0 0.006214910186827183
coding O 0 0.016069576144218445
region O 0 0.009612800553441048
of O 0 0.009496022947132587
SCN5A O 1 0.9999984502792358
in O 0 0.011169022880494595
three O 0 0.013134775683283806
IVF B-Disease 1 0.9999938011169434
families O 0 0.025660283863544464
. O 0 0.026214253157377243

We O 0 0.01363044697791338
show O 0 0.010219331830739975
that O 0 0.005910553969442844
sodium O 0 0.019669488072395325
channels O 0 0.006263116840273142
with O 0 0.004581288434565067
the O 0 0.008241151459515095
missense O 0 0.026452146470546722
mutation O 0 0.01320800930261612
recover O 0 0.19177483022212982
from O 0 0.0071009183302521706
inactivation O 1 0.99998939037323
more O 0 0.006321884226053953
rapidly O 0 0.011464077979326248
than O 0 0.004954208619892597
normal O 0 0.005212598480284214
and O 0 0.0037050871178507805
that O 0 0.002613488817587495
the O 0 0.006380818784236908
frameshift O 1 0.8916941285133362
mutation O 0 0.013705570250749588
causes O 0 0.010810032486915588
the O 0 0.008541051298379898
sodium O 0 0.09043285995721817
channel O 0 0.00961097702383995
to O 0 0.0051408689469099045
be O 0 0.004955257289111614
non O 0 0.02160687930881977
- O 1 0.9999904632568359
functional O 0 0.05308789387345314
. O 0 0.024833770468831062

Our O 0 0.020181825384497643
results O 0 0.01092457864433527
indicate O 0 0.006620884872972965
that O 0 0.0035449007991701365
mutations O 0 0.006959051825106144
in O 0 0.006628192961215973
cardiac O 1 1.0
ion O 1 0.9999991655349731
- O 1 1.0
channel O 0 0.013762951828539371
genes O 0 0.006869380362331867
contribute O 0 0.006568784359842539
to O 0 0.004459301941096783
the O 0 0.006038016639649868
risk O 0 0.00963872205466032
of O 0 0.009775730781257153
developing O 1 0.9968687891960144
IVF B-Disease 1 1.0
. O 0 0.019509170204401016
. O 0 0.021858271211385727

Molecular O 0 0.06359649449586868
heterogeneity O 0 0.05980204418301582
in O 0 0.01974540576338768
mucopolysaccharidosis B-Disease 1 0.9999982118606567
IVA I-Disease 1 1.0
in O 0 0.010782899335026741
Australia O 0 0.011286413297057152
and O 0 0.005588063970208168
Northern O 0 0.008231156505644321
Ireland O 0 0.009330031462013721
: O 0 0.006964484695345163
nine O 0 0.007709335535764694
novel O 0 0.013445562683045864
mutations O 0 0.007784373126924038
including O 0 0.005932629574090242
T312S O 1 0.9996514320373535
, O 0 0.0063051143661141396
a O 0 0.007163819391280413
common O 0 0.0062055932357907295
allele O 0 0.012867126613855362
that O 0 0.005301306024193764
confers O 1 0.9996943473815918
a O 0 0.29172849655151367
mild O 1 0.9999998807907104
phenotype O 1 0.999925971031189
. O 0 0.031146299093961716

Mucopolysaccharidosis B-Disease 1 0.9999953508377075
IVA I-Disease 1 1.0
( O 0 0.03590080887079239
MPS B-Disease 1 0.9999935626983643
IVA I-Disease 1 1.0
) O 0 0.009933453984558582
is O 0 0.00564532307907939
an O 0 0.007191475946456194
autosomal B-Disease 1 0.9999792575836182
recessive I-Disease 1 1.0
lysosomal I-Disease 1 1.0
storage I-Disease 1 1.0
disorder I-Disease 1 1.0
caused O 1 0.9999580383300781
by O 0 0.005754273850470781
a O 0 0.018617024645209312
genetic B-Disease 1 0.9962077140808105
defect I-Disease 1 0.9999992847442627
in O 0 0.00932532548904419
N O 1 0.9598512053489685
- O 1 0.9999922513961792
acetylgalactosamine O 1 0.9997792840003967
- O 1 0.9999816417694092
6 O 0 0.03992656245827675
- O 1 0.9999998807907104
sulfate O 1 0.9999998807907104
sulfatase O 1 1.0
( O 0 0.06688306480646133
GALNS O 1 0.9999997615814209
) O 0 0.027412552386522293
. O 0 0.028859565034508705

Previous O 0 0.015564274974167347
studies O 0 0.009028778411448002
of O 0 0.007428270764648914
patients O 0 0.05560293793678284
from O 0 0.00360790453851223
a O 0 0.005937459412962198
British O 0 0.41978079080581665
- O 1 0.9999979734420776
Irish O 0 0.009807927533984184
population O 0 0.0033316651824861765
showed O 0 0.004166699480265379
that O 0 0.002406473271548748
the O 0 0.0063403574749827385
I113F O 1 0.9998682737350464
mutation O 0 0.009915645234286785
is O 0 0.0034633607137948275
the O 0 0.003418123349547386
most O 0 0.00299264257773757
common O 0 0.003882956225425005
single O 0 0.005644803401082754
mutation O 0 0.007850708439946175
among O 0 0.007282193284481764
MPS B-Disease 1 0.9999978542327881
IVA I-Disease 1 1.0
patients O 1 1.0
and O 0 0.012224070727825165
produces O 0 0.12752065062522888
a O 0 0.26118648052215576
severe O 1 1.0
clinical O 1 1.0
phenotype O 1 0.9999997615814209
. O 0 0.03618534654378891

We O 0 0.018235549330711365
studied O 0 0.020807383581995964
mutations O 0 0.011124828830361366
in O 0 0.005609413608908653
the O 0 0.009027307853102684
GALNS O 1 0.9999963045120239
gene O 0 0.007904826663434505
from O 0 0.004204864613711834
23 O 0 0.00948314182460308
additional O 0 0.010211301036179066
MPS B-Disease 1 0.9992256164550781
IVA I-Disease 1 1.0
patients O 1 0.9999996423721313
( O 0 0.008474630303680897
15 O 0 0.00796122569590807
from O 0 0.004533358849585056
Australia O 0 0.00810142420232296
, O 0 0.004619085695594549
8 O 0 0.006170989014208317
from O 0 0.003625975688919425
Northern O 0 0.006747715640813112
Ireland O 0 0.008219626732170582
) O 0 0.004278616979718208
, O 0 0.0031690653413534164
with O 0 0.002292153425514698
various O 0 0.003795477794483304
clinical O 1 0.9999984502792358
phenotypes O 1 0.9999889135360718
( O 0 0.08373182266950607
severe O 1 0.9999998807907104
, O 0 0.007858825847506523
16 O 0 0.009414778091013432
cases O 0 0.005632433108985424
; O 0 0.005601849406957626
intermediate O 0 0.010752636939287186
, O 0 0.004878780338913202
4 O 0 0.008602311834692955
cases O 0 0.005328476428985596
; O 0 0.006533223669975996
mild O 1 0.999139666557312
, O 0 0.0075943851843476295
3 O 0 0.013203095644712448
cases O 0 0.009874203242361546
) O 0 0.01367584802210331
. O 0 0.021106908097863197

We O 0 0.01150733046233654
found O 0 0.006816370878368616
two O 0 0.004885109141469002
common O 0 0.0062448447570204735
mutations O 0 0.006527036894112825
that O 0 0.002960281679406762
together O 0 0.004187053069472313
accounted O 0 0.0065554361790418625
for O 0 0.0033528904896229506
32 O 0 0.008021621964871883
% O 0 0.0037579014897346497
of O 0 0.003951516468077898
the O 0 0.005662511568516493
44 O 0 0.01575218327343464
unrelated O 0 0.01564173214137554
alleles O 0 0.015354652889072895
in O 0 0.007992438971996307
these O 0 0.007906083017587662
patients O 1 0.9723871350288391
. O 0 0.02344832755625248

One O 0 0.01690523512661457
is O 0 0.008132497780025005
the O 0 0.011584076099097729
T312S O 1 0.9992414712905884
mutation O 0 0.014464292675256729
, O 0 0.006291148252785206
a O 0 0.00789031945168972
novel O 0 0.01594822108745575
mutation O 0 0.011210893280804157
found O 0 0.005769164301455021
exclusively O 0 0.008337781764566898
in O 0 0.009362482465803623
milder O 1 0.9977487921714783
patients O 1 0.9990110397338867
. O 0 0.029885295778512955

The O 0 0.017533615231513977
other O 0 0.005788832437247038
is O 0 0.004451096523553133
the O 0 0.0064272708259522915
previously O 0 0.009530868381261826
described O 0 0.01152974646538496
I113F O 0 0.4040706753730774
that O 0 0.006430021487176418
produces O 0 0.015671854838728905
a O 0 0.019497398287057877
severe O 1 1.0
phenotype O 1 0.9999722242355347
. O 0 0.03813428059220314

The O 0 0.033228799700737
I113F O 1 0.6968957781791687
and O 0 0.013256866484880447
T312S O 1 0.9785335659980774
mutations O 0 0.011953948996961117
accounted O 0 0.010800551623106003
for O 0 0.004910543095320463
8 O 0 0.008475860580801964
( O 0 0.005089587066322565
18 O 0 0.006538670044392347
% O 0 0.004470654297620058
) O 0 0.004097019787877798
and O 0 0.004588363692164421
6 O 0 0.009034925140440464
( O 0 0.0056444201618433
14 O 0 0.008324017748236656
% O 0 0.0055603692308068275
) O 0 0.00570416497066617
of O 0 0.007848131470382214
44 O 0 0.023837829008698463
unrelated O 0 0.022566067054867744
alleles O 0 0.027256343513727188
, O 0 0.013550090603530407
respectively O 0 0.02432439476251602
. O 0 0.02227603830397129

The O 0 0.021653784438967705
relatively O 0 0.017397502437233925
high O 0 0.025687772780656815
residual O 1 0.9998157620429993
GALNS O 1 1.0
activity O 0 0.01204453781247139
seen O 0 0.010424171574413776
when O 0 0.008167331106960773
the O 0 0.011299931444227695
T312S O 1 0.6118214726448059
mutant O 0 0.04567916318774223
cDNA O 0 0.04352521896362305
is O 0 0.011078113690018654
overexpressed O 0 0.044354088604450226
in O 0 0.010563408955931664
mutant O 0 0.029456088319420815
cells O 0 0.010945407673716545
provides O 0 0.00737693440169096
an O 0 0.003970540594309568
explanation O 0 0.006334130186587572
for O 0 0.004133948590606451
the O 0 0.007979173213243484
mild O 1 0.9999973773956299
phenotype O 1 0.9999070167541504
in O 0 0.011908970773220062
patients O 1 0.9999696016311646
with O 0 0.006426851265132427
this O 0 0.007419626694172621
mutation O 0 0.02174139767885208
. O 0 0.021660322323441505

The O 0 0.02166309580206871
distribution O 0 0.012859225273132324
and O 0 0.0072608282789587975
relative O 0 0.008542860858142376
frequencies O 0 0.00632467120885849
of O 0 0.005850129295140505
the O 0 0.008496394380927086
I113F O 1 0.9982998967170715
and O 0 0.01137169636785984
T312S O 1 0.9999380111694336
mutations O 0 0.011058082804083824
in O 0 0.006090656388550997
Australia O 0 0.010055324994027615
corresponded O 0 0.010290675796568394
to O 0 0.0038020587526261806
those O 0 0.0023870638106018305
observed O 0 0.003312012879177928
in O 0 0.003164706053212285
Northern O 0 0.0063104103319346905
Ireland O 0 0.006950370967388153
and O 0 0.0027886738535016775
are O 0 0.001310795545578003
unique O 0 0.002824712311848998
to O 0 0.0020823541563004255
these O 0 0.0014614722458645701
two O 0 0.0020691484678536654
populations O 0 0.002675264375284314
, O 0 0.00306818843819201
suggesting O 0 0.0034672010224312544
that O 0 0.002352110343053937
both O 0 0.003221015678718686
mutations O 0 0.005005945917218924
were O 0 0.0027949586510658264
probably O 0 0.004988163709640503
introduced O 0 0.005680533591657877
to O 0 0.003915327601134777
Australia O 0 0.006687171757221222
by O 0 0.0033878216054290533
Irish O 0 0.009527145884931087
migrants O 0 0.007547119632363319
during O 0 0.00734416488558054
the O 0 0.010105778463184834
19th O 0 0.03326999768614769
century O 0 0.03840775415301323
. O 0 0.025814957916736603

Haplotype O 0 0.09090138226747513
analysis O 0 0.015939924865961075
using O 0 0.01148571353405714
6 O 0 0.024990953505039215
RFLPs O 0 0.07512431591749191
provides O 0 0.01220776978880167
additional O 0 0.007100891321897507
data O 0 0.004240058828145266
that O 0 0.0031636713538318872
the O 0 0.00877153966575861
I113F O 1 0.9285359978675842
mutation O 0 0.014110435731709003
originated O 0 0.0101633220911026
from O 0 0.00532099325209856
a O 0 0.008815021254122257
common O 0 0.01006623450666666
ancestor O 0 0.03063693270087242
. O 0 0.02218589372932911

The O 0 0.01537390798330307
other O 0 0.006647173780947924
9 O 0 0.013705376535654068
novel O 0 0.014166777953505516
mutations O 0 0.007783209439367056
identified O 0 0.004784462973475456
in O 0 0.0027959116268903017
these O 0 0.003142350586131215
23 O 0 0.011972454376518726
patients O 0 0.18197911977767944
were O 0 0.0035711675882339478
each O 0 0.00259153894148767
limited O 0 0.0055435411632061005
to O 0 0.005047988146543503
a O 0 0.0075838202610611916
single O 0 0.0128383943811059
family O 0 0.020812951028347015
. O 0 0.018997948616743088

These O 0 0.009008836932480335
data O 0 0.007067993748933077
provide O 0 0.007345221005380154
further O 0 0.005272808484733105
evidence O 0 0.004736510571092367
for O 0 0.0050480240024626255
extensive O 0 0.012599439360201359
allelic O 0 0.4773443043231964
heterogeneity O 0 0.042977288365364075
in O 0 0.011335986666381359
MPS B-Disease 1 0.9925846457481384
IVA I-Disease 1 1.0
in O 0 0.010320601053535938
British O 0 0.39984503388404846
- O 1 0.9999998807907104
Irish O 1 0.7559140920639038
patients O 1 0.7930783033370972
and O 0 0.003874904941767454
provide O 0 0.003579639131203294
evidence O 0 0.002428499748930335
for O 0 0.0024178263265639544
their O 0 0.0030994564294815063
transmission O 0 0.006842633243650198
to O 0 0.003971449099481106
Australia O 0 0.007129501551389694
by O 0 0.004240203183144331
British O 0 0.01691039465367794
- O 1 0.9999986886978149
Irish O 0 0.017883051186800003
migrants O 0 0.012455944903194904
. O 0 0.011128575541079044
. O 0 0.01843860186636448

Identification O 0 0.02266167290508747
of O 0 0.012694217264652252
constitutional O 0 0.02736196480691433
WT1 O 1 1.0
mutations O 0 0.014255160465836525
, O 0 0.005149436183273792
in O 0 0.004955059848725796
patients O 0 0.2791481614112854
with O 0 0.005844461265951395
isolated O 1 0.9949799180030823
diffuse B-Disease 1 1.0
mesangial I-Disease 1 1.0
sclerosis I-Disease 1 1.0
, O 1 0.6410786509513855
and O 0 0.005495257209986448
analysis O 0 0.005830140318721533
of O 0 0.009823828004300594
genotype O 1 0.999984860420227
/ O 1 0.9999994039535522
phenotype O 1 0.7654660940170288
correlations O 0 0.017482416704297066
by O 0 0.003938642330467701
use O 0 0.00430765887722373
of O 0 0.0065110307186841965
a O 0 0.00984200555831194
computerized O 1 0.7806865572929382
mutation O 0 0.02376636303961277
database O 0 0.02793809585273266
. O 0 0.024041669443249702

Constitutional O 0 0.041923779994249344
mutations O 0 0.019780484959483147
of O 0 0.00937133189290762
the O 0 0.013917258940637112
WT1 O 1 0.9999992847442627
gene O 0 0.011973378248512745
, O 0 0.0061906492337584496
encoding O 0 0.008801036514341831
a O 0 0.011300032958388329
zinc O 1 1.0
- O 1 0.9999998807907104
finger O 1 0.9672935009002686
transcription O 0 0.016644945368170738
factor O 0 0.012224732898175716
involved O 0 0.005550191272050142
in O 0 0.009395869448781013
renal O 1 1.0
and O 1 0.9992546439170837
gonadal O 1 1.0
development O 1 0.5803223848342896
, O 0 0.005501444451510906
are O 0 0.001976887695491314
found O 0 0.0020771175622940063
in O 0 0.002510971389710903
most O 0 0.0030503005255013704
patients O 0 0.00833812914788723
with O 0 0.005559752695262432
Denys B-Disease 1 1.0
- I-Disease 1 1.0
Drash I-Disease 1 1.0
syndrome I-Disease 1 1.0
( O 1 0.9999778270721436
DDS B-Disease 1 1.0
) O 0 0.009877300821244717
, O 0 0.007319486699998379
or O 0 0.008899263106286526
diffuse B-Disease 1 1.0
mesangial I-Disease 1 1.0
sclerosis I-Disease 1 1.0
( O 1 0.9999998807907104
DMS B-Disease 1 1.0
) O 0 0.009966881014406681
associated O 0 0.007708598393946886
with O 0 0.006246667820960283
pseudohermaphroditism B-Disease 1 0.9999992847442627
and O 0 0.01192599069327116
/ O 1 0.9999996423721313
or O 1 0.9259101748466492
Wilms B-Disease 1 1.0
tumor I-Disease 1 1.0
( O 1 0.9996988773345947
WT B-Disease 1 1.0
) O 0 0.0287643913179636
. O 0 0.03335554525256157

Most O 0 0.022548789158463478
mutations O 0 0.020701665431261063
in O 0 0.014762531034648418
DDS B-Disease 1 1.0
patients O 1 0.9999587535858154
lie O 0 0.0235789492726326
in O 0 0.009428617544472218
exon O 1 0.6581379771232605
8 O 0 0.013898110948503017
or O 0 0.007634333800524473
exon O 0 0.02854953333735466
9 O 0 0.012002837844192982
, O 0 0.007752036675810814
encoding O 0 0.01643543690443039
zinc O 1 0.9999750852584839
finger O 0 0.39320895075798035
2 O 0 0.016811447218060493
or O 0 0.011342667043209076
zinc O 1 1.0
finger O 1 0.9990399479866028
3 O 0 0.013591639697551727
, O 0 0.006316513288766146
respectively O 0 0.00716792419552803
, O 0 0.004277783911675215
with O 0 0.003514113835990429
a O 0 0.007800314575433731
hot O 1 0.862648606300354
spot O 0 0.17353816330432892
( O 0 0.011980476789176464
R394W O 1 0.9912354946136475
) O 0 0.010865387506783009
in O 0 0.011922664940357208
exon O 0 0.06576033681631088
9 O 0 0.03457709401845932
. O 0 0.027742944657802582

We O 0 0.012741252779960632
analyzed O 0 0.012800012715160847
a O 0 0.006874880287796259
series O 0 0.006791559513658285
of O 0 0.005982155445963144
24 O 0 0.012400129809975624
patients O 0 0.0821264311671257
, O 0 0.004804298281669617
10 O 0 0.0050873588770627975
with O 0 0.005572807509452105
isolated B-Disease 1 0.7124714255332947
DMS I-Disease 1 1.0
( O 1 0.7994505763053894
IDMS B-Disease 1 1.0
) O 0 0.008050795644521713
, O 0 0.005497498903423548
10 O 0 0.006608208641409874
with O 0 0.0070749372243881226
DDS B-Disease 1 1.0
, O 0 0.006212713196873665
and O 0 0.005274178925901651
4 O 0 0.009944546967744827
with O 0 0.00924081914126873
urogenital B-Disease 1 1.0
abnormalities I-Disease 1 1.0
and O 1 0.998719334602356
/ O 1 1.0
or O 1 0.5821242332458496
WT B-Disease 1 1.0
. O 0 0.03836705535650253

We O 0 0.0204465389251709
report O 0 0.02267724834382534
WT1 O 1 0.998049259185791
heterozygous O 0 0.03522563725709915
mutations O 0 0.013255750760436058
in O 0 0.0061554452404379845
16 O 0 0.012940251268446445
patients O 1 0.6221029162406921
, O 0 0.005982167087495327
4 O 0 0.009237038902938366
of O 0 0.006357717793434858
whom O 0 0.009364713914692402
presented O 0 0.016304535791277885
with O 0 0.016358017921447754
IDMS B-Disease 1 1.0
. O 0 0.03562615439295769

One O 0 0.01965359039604664
male O 0 0.01582236960530281
and O 0 0.005794120486825705
two O 0 0.005790341645479202
female O 0 0.029442867264151573
IDMS B-Disease 1 1.0
patients O 1 0.9999986886978149
with O 0 0.08619599044322968
WT1 O 1 1.0
mutations O 1 0.9996034502983093
underwent O 1 1.0
normal O 0 0.25346454977989197
puberty O 1 0.9949294328689575
. O 0 0.035245899111032486

Two O 0 0.018997283652424812
mutations O 0 0.019229736179113388
associated O 0 0.01094881072640419
with O 0 0.009216995909810066
IDMS B-Disease 1 1.0
are O 0 0.0032249295618385077
different O 0 0.0023455724585801363
from O 0 0.0029120510444045067
those O 0 0.0035883134696632624
described O 0 0.008743288926780224
in O 0 0.016771040856838226
DDS B-Disease 1 1.0
patients O 1 0.9999994039535522
. O 0 0.028799716383218765

No O 0 0.036803487688302994
WT1 O 1 0.9999991655349731
mutations O 0 0.019991016015410423
were O 0 0.005726001691073179
detected O 0 0.008826264180243015
in O 0 0.004199680406600237
the O 0 0.004807582125067711
six O 0 0.007170564960688353
other O 0 0.007823480293154716
IDMS B-Disease 1 1.0
patients O 1 0.9999884366989136
, O 0 0.007368120364844799
suggesting O 0 0.010389363393187523
genetic O 0 0.0116427568718791
heterogeneity O 0 0.03765684738755226
of O 0 0.01246779877692461
this O 0 0.012895641848444939
disease O 1 1.0
. O 0 0.026967665180563927

We O 0 0.017274845391511917
analyzed O 0 0.032257333397865295
genotype O 0 0.36105042695999146
/ O 1 0.9993054866790771
phenotype O 0 0.40453818440437317
correlations O 0 0.020799806341528893
, O 0 0.005121157970279455
on O 0 0.0035559372045099735
the O 0 0.003503130516037345
basis O 0 0.0024735992774367332
of O 0 0.003370424034073949
the O 0 0.003849994158372283
constitution O 0 0.007039471995085478
of O 0 0.00612563407048583
a O 0 0.011625808663666248
WT1 O 1 0.9999926090240479
mutation O 0 0.01218324713408947
database O 0 0.009185731410980225
of O 0 0.007466598879545927
84 O 1 0.748725950717926
germ O 1 1.0
- O 1 1.0
line O 0 0.020639732480049133
mutations O 0 0.00873127207159996
, O 0 0.00371186644770205
to O 0 0.00300483126193285
compare O 0 0.006293384358286858
the O 0 0.003991375677287579
distribution O 0 0.004103143233805895
and O 0 0.0034036680590361357
type O 0 0.0072232517413794994
of O 0 0.006037020590156317
mutations O 0 0.006973304785788059
, O 0 0.0034880947787314653
according O 0 0.0027296512853354216
to O 0 0.0035090476740151644
the O 0 0.005801839288324118
different O 0 0.006359480321407318
symptoms O 1 0.9999959468841553
. O 0 0.02366158366203308

This O 0 0.010596003383398056
demonstrated O 0 0.015896154567599297
( O 0 0.008205779828131199
1 O 0 0.011003254912793636
) O 0 0.004776289686560631
the O 0 0.004927904810756445
association O 0 0.0064730108715593815
between O 0 0.00389251671731472
mutations O 0 0.0050981780514121056
in O 0 0.0033911815844476223
exons O 0 0.009638221003115177
8 O 0 0.006101271137595177
and O 0 0.0035329891834408045
9 O 0 0.0068069989793002605
and O 0 0.005728377960622311
DMS B-Disease 1 1.0
; O 0 0.006527435965836048
( O 0 0.004833644721657038
2 O 0 0.007284138817340136
) O 0 0.004447817802429199
among O 0 0.004991821479052305
patients O 0 0.21728280186653137
with O 0 0.006940518040210009
DMS B-Disease 1 1.0
, O 0 0.006658168509602547
a O 0 0.005694551393389702
higher O 0 0.007399528753012419
frequency O 0 0.006667392794042826
of O 0 0.007842727936804295
exon O 0 0.03773493692278862
8 O 0 0.014256821013987064
mutations O 0 0.010280117392539978
among O 0 0.007005735300481319
46 O 0 0.01734396442770958
, O 0 0.01272394135594368
XY O 1 1.0
patients O 1 0.9959442019462585
with O 0 0.0070078023709356785
female O 0 0.017183301970362663
phenotype O 0 0.020881827920675278
than O 0 0.00491669774055481
among O 0 0.0060769193805754185
46 O 0 0.014749220572412014
, O 0 0.011244804598391056
XY O 1 1.0
patients O 1 0.9940859079360962
with O 0 0.00698044104501605
sexual O 0 0.010969044640660286
ambiguity O 0 0.017691422253847122
or O 0 0.006593387573957443
male O 0 0.03084845468401909
phenotype O 1 0.9930863380432129
; O 0 0.006618971936404705
and O 0 0.005341405980288982
( O 0 0.0061994618736207485
3 O 0 0.010249878279864788
) O 0 0.0061093345284461975
statistically O 0 0.006314000114798546
significant O 0 0.0044844914227724075
evidence O 0 0.003510734299197793
that O 0 0.0027240882627665997
mutations O 0 0.005854713264852762
in O 0 0.0042002033442258835
exons O 0 0.014140077866613865
8 O 0 0.00984951201826334
and O 0 0.005919008981436491
9 O 0 0.014229372143745422
preferentially O 0 0.024347523227334023
affect O 0 0.014749650843441486
amino O 0 0.014093756675720215
acids O 0 0.009595920331776142
with O 0 0.004996601026505232
different O 0 0.004233705811202526
functions O 0 0.008252589963376522
. O 0 0.010149425826966763
. O 0 0.01842317171394825

The O 0 0.042719777673482895
185delAG O 1 0.9999783039093018
BRCA1 O 1 0.999992847442627
mutation O 0 0.020048638805747032
originated O 0 0.011990549974143505
before O 0 0.006015952210873365
the O 0 0.006139189004898071
dispersion O 0 0.011059616692364216
of O 0 0.0051795970648527145
Jews O 0 0.006145091727375984
in O 0 0.0036773087922483683
the O 0 0.004521835129708052
diaspora O 0 0.01055957656353712
and O 0 0.0046312324702739716
is O 0 0.0036173586267977953
not O 0 0.002894764766097069
limited O 0 0.007560069672763348
to O 0 0.011050639674067497
Ashkenazim O 1 0.6921387910842896
. O 0 0.025608070194721222

The O 0 0.03073321469128132
185delAG O 1 0.9961423277854919
mutation O 0 0.0268891379237175
in O 0 0.013910952024161816
BRCA1 O 1 0.9999879598617554
is O 0 0.008088824339210987
detected O 0 0.011331351473927498
in O 0 0.006495712324976921
Ashkenazi O 0 0.030452344566583633
Jews O 0 0.006472207605838776
both O 0 0.00354959350079298
in O 0 0.006311720237135887
familial B-Disease 1 0.9999998807907104
breast I-Disease 1 1.0
and I-Disease 1 1.0
ovarian I-Disease 1 1.0
cancer I-Disease 1 1.0
and O 1 0.999407172203064
in O 0 0.009939735755324364
the O 0 0.008632034063339233
general O 0 0.018306948244571686
population O 0 0.01219225488603115
. O 0 0.02135985903441906

All O 0 0.022628171369433403
tested O 0 0.03686698153614998
Ashkenazi O 1 0.5539454221725464
mutation O 0 0.023912470787763596
carriers O 0 0.018961718305945396
share O 0 0.009163692593574524
the O 0 0.005708548240363598
same O 0 0.006737441755831242
allelic O 0 0.0461592823266983
pattern O 0 0.01413718517869711
at O 0 0.013750569894909859
the O 0 0.019671723246574402
BRCA1 O 1 0.9999834299087524
locus O 1 0.9968851208686829
. O 0 0.03429481387138367

Our O 0 0.022601880133152008
previous O 0 0.012311873957514763
study O 0 0.008548731915652752
showed O 0 0.006577758118510246
that O 0 0.0026077500078827143
this O 0 0.0034651337191462517
Ashkenazi O 1 0.9731311202049255
mutation O 0 0.010640807449817657
also O 0 0.005374798085540533
occurs O 0 0.004477986134588718
in O 0 0.004322200082242489
Iraqi O 0 0.009150895290076733
Jews O 0 0.008048645220696926
with O 0 0.0050583784468472
a O 0 0.009527910500764847
similar O 0 0.0105665298178792
allelic O 1 0.9912859797477722
pattern O 0 0.02858559973537922
. O 0 0.028335662558674812

We O 0 0.017301766201853752
extended O 0 0.01581130176782608
our O 0 0.008604965172708035
analysis O 0 0.005796483252197504
to O 0 0.004421767313033342
other O 0 0.004392905626446009
non O 0 0.015827162191271782
- O 1 0.999964714050293
Ashkenazi O 1 0.6764666438102722
subsets O 0 0.03099682554602623
354 O 0 0.04460086673498154
of O 0 0.013148071244359016
Moroccan O 0 0.03424495831131935
origin O 0 0.01006145030260086
, O 0 0.010013490915298462
200 O 0 0.022818105295300484
Yemenites O 0 0.33380764722824097
and O 0 0.011045917868614197
150 O 0 0.01951834000647068
Iranian O 0 0.028987206518650055
Jews O 0 0.02925199642777443
. O 0 0.026165001094341278

Heteroduplex O 1 0.8899818062782288
analysis O 0 0.0215662382543087
complemented O 0 0.03413422405719757
by O 0 0.007054479792714119
direct O 0 0.010621408931910992
DNA O 0 0.015997882932424545
sequencing O 0 0.016886858269572258
of O 0 0.012179942801594734
abnormally O 0 0.11743178963661194
migrating O 0 0.024928446859121323
bands O 0 0.01931168884038925
were O 0 0.008365855552256107
employed O 0 0.02206210233271122
. O 0 0.020557519048452377

Four O 0 0.014243426732718945
of O 0 0.009561891667544842
Moroccan O 0 0.021524665877223015
origin O 0 0.005928596016019583
( O 0 0.006366323679685593
1 O 0 0.008760691620409489
. O 0 0.004893293604254723
1 O 0 0.009893299080431461
% O 0 0.0061997403390705585
) O 0 0.004213234875351191
and O 0 0.0038857313338667154
none O 0 0.005575905088335276
of O 0 0.005683977156877518
the O 0 0.010076522827148438
Yemenites O 1 0.9999771118164062
or O 0 0.007190880365669727
Iranians O 0 0.012867610901594162
was O 0 0.010172759182751179
a O 0 0.008280955255031586
carrier O 0 0.036847736686468124
of O 0 0.0092214560136199
the O 0 0.012182100676000118
185delAG O 1 0.9999914169311523
mutation O 0 0.03595317527651787
. O 0 0.025087567046284676

BRCA1 O 1 0.9999573230743408
allelic O 1 0.5184520483016968
patterns O 0 0.014948579482734203
were O 0 0.004812798462808132
determined O 0 0.005457586608827114
for O 0 0.0032651876099407673
four O 0 0.003725459100678563
of O 0 0.0035132623743265867
these O 0 0.001658781198784709
individuals O 0 0.0016050036065280437
and O 0 0.0022819004952907562
for O 0 0.0024016909301280975
12 O 0 0.005136863328516483
additional O 0 0.005916647147387266
non O 0 0.013798659667372704
- O 1 0.9999898672103882
Ashkenazi O 1 0.9937776327133179
185delAG O 1 0.9988046884536743
mutation O 0 0.0158656295388937
carriers O 0 0.013632948510348797
who O 0 0.008151308633387089
had O 1 0.9512119889259338
breast B-Disease 1 1.0
/ I-Disease 1 1.0
ovarian I-Disease 1 1.0
cancer I-Disease 1 1.0
. O 1 0.9933300614356995

Six O 0 0.02533644624054432
non O 0 0.0387151874601841
- O 1 0.9999798536300659
Ashkenazi O 0 0.31626224517822266
individuals O 0 0.005061493720859289
shared O 0 0.008706756867468357
the O 0 0.006141266785562038
common O 0 0.008349861949682236
Ashkenazi O 1 0.9998414516448975
haplotype O 1 0.8944284915924072
, O 0 0.006594487000256777
four O 0 0.005110013764351606
had O 0 0.004543897695839405
a O 0 0.004301221575587988
closely O 0 0.005310588050633669
related O 0 0.005048126447945833
pattern O 0 0.00490000331774354
, O 0 0.0032774144783616066
and O 0 0.0027782628312706947
the O 0 0.004430264234542847
rest O 0 0.007907628081738949
( O 0 0.00696859834715724
n O 0 0.015897929668426514
= O 0 0.02253120206296444
6 O 0 0.01585189253091812
) O 0 0.007576079107820988
displayed O 0 0.012491504661738873
a O 0 0.009876115247607231
distinct O 0 0.017421657219529152
BRCA1 O 1 0.9999921321868896
allelic O 1 0.9997346997261047
pattern O 0 0.039504606276750565
. O 0 0.028311220929026604

We O 0 0.012327870354056358
conclude O 0 0.014839754439890385
that O 0 0.00513041764497757
the O 0 0.011071743443608284
185delAG O 1 0.999997615814209
BRCA1 O 1 0.9999998807907104
mutation O 0 0.01988757774233818
occurs O 0 0.005558605305850506
in O 0 0.003286557737737894
some O 0 0.00296596041880548
non O 0 0.013557301834225655
- O 1 0.9999980926513672
Ashkenazi O 1 0.7149696946144104
populations O 0 0.006626344285905361
at O 0 0.008306266739964485
rates O 0 0.008475973270833492
comparable O 0 0.009772324934601784
with O 0 0.004272794350981712
that O 0 0.004760343115776777
of O 0 0.011934618465602398
Ashkenazim O 1 0.9958880543708801
. O 0 0.029795436188578606

The O 0 0.01952119544148445
majority O 0 0.012368141673505306
of O 0 0.01010592095553875
Jewish O 0 0.018795156851410866
185delAG O 1 0.9999904632568359
mutation O 0 0.019441969692707062
carriers O 0 0.0146590331569314
have O 0 0.0031971342395991087
a O 0 0.0059113879688084126
common O 0 0.007195825222879648
allelic O 1 0.9895110726356506
pattern O 0 0.01087486743927002
, O 0 0.004968040157109499
supporting O 0 0.008080643601715565
the O 0 0.008227775804698467
founder O 1 0.9969350099563599
effect O 0 0.007822014391422272
notion O 0 0.011452734470367432
, O 0 0.004842281341552734
but O 0 0.003284495323896408
dating O 0 0.00802583061158657
the O 0 0.006009067874401808
mutations O 0 0.006204716861248016
origin O 0 0.003053956665098667
to O 0 0.0035272808745503426
an O 0 0.0041191065683960915
earlier O 0 0.006464141421020031
date O 0 0.007260062266141176
than O 0 0.005449431948363781
currently O 0 0.01197870448231697
estimated O 0 0.017463319003582
. O 0 0.02022824063897133

However O 0 0.015162588097155094
, O 0 0.008317363448441029
the O 0 0.005448414012789726
different O 0 0.0028151790611445904
allelic O 0 0.02478114515542984
pattern O 0 0.009049836546182632
at O 0 0.008395612239837646
the O 0 0.009965036995708942
BRCA1 O 1 0.9999991655349731
locus O 1 0.9935581088066101
even O 0 0.005789084825664759
in O 0 0.00344177708029747
some O 0 0.0028476191218942404
Jewish O 0 0.008813474327325821
mutation O 0 0.012847191654145718
carriers O 0 0.024952491745352745
, O 0 0.005682020913809538
might O 0 0.00524200638756156
suggest O 0 0.004661309067159891
that O 0 0.0028778372798115015
the O 0 0.006574562750756741
mutation O 0 0.012049213983118534
arose O 0 0.011072603054344654
independently O 0 0.009692233987152576
. O 0 0.010737181641161442
. O 0 0.01893487758934498

Crystal O 0 0.06345776468515396
structure O 0 0.018068157136440277
of O 0 0.011225194670259953
the O 0 0.01900172047317028
hemochromatosis B-Disease 1 1.0
protein O 1 0.9902191758155823
HFE O 1 0.9999998807907104
and O 0 0.012374493293464184
characterization O 0 0.018589846789836884
of O 0 0.007499783765524626
its O 0 0.008877260610461235
interaction O 0 0.011063287034630775
with O 0 0.015187001787126064
transferrin O 1 0.9999905824661255
receptor O 0 0.06982496380805969
. O 0 0.03136556223034859

HFE O 1 0.9998862743377686
is O 0 0.014461072161793709
an O 0 0.015103097073733807
MHC O 1 0.9999998807907104
- O 1 0.9999990463256836
related O 0 0.015604517422616482
protein O 0 0.008620069362223148
that O 0 0.003111310303211212
is O 0 0.0035434914752840996
mutated O 0 0.008485492318868637
in O 0 0.0032714318949729204
the O 0 0.006371430121362209
iron B-Disease 1 1.0
- I-Disease 1 1.0
overload I-Disease 1 1.0
disease I-Disease 1 1.0
hereditary B-Disease 1 1.0
hemochromatosis I-Disease 1 1.0
. O 1 0.9999945163726807

HFE O 1 0.9999552965164185
binds O 0 0.06586512178182602
to O 0 0.024230457842350006
transferrin O 1 0.9998890161514282
receptor O 0 0.09892699122428894
( O 0 0.021343868225812912
TfR O 1 0.9999572038650513
) O 0 0.010676105506718159
and O 0 0.008256133645772934
reduces O 0 0.016379091888666153
its O 0 0.007578187622129917
affinity O 0 0.014117859303951263
for O 0 0.0081072011962533
iron O 1 0.9999998807907104
- O 1 0.9999992847442627
loaded O 0 0.0512627474963665
transferrin O 1 0.9949060678482056
, O 0 0.01981327496469021
implicating O 1 0.9982686042785645
HFE O 1 1.0
in O 0 0.17856861650943756
iron O 1 1.0
metabolism O 1 0.9994845390319824
. O 0 0.034031230956315994

The O 0 0.04357593134045601
2 O 0 0.05077214539051056
. O 0 0.033277906477451324

6 O 0 0.0408468171954155
A O 0 0.026799676939845085
crystal O 0 0.035937413573265076
structure O 0 0.018193019554018974
of O 0 0.01314423605799675
HFE O 1 0.9999994039535522
reveals O 0 0.016957402229309082
the O 0 0.007594892289489508
locations O 0 0.007376816123723984
of O 0 0.010184068232774734
hemochromatosis B-Disease 1 1.0
mutations O 0 0.014044743031263351
and O 0 0.005332693457603455
a O 0 0.009613491594791412
patch O 1 1.0
of O 0 0.3102911412715912
histidines O 1 0.9999959468841553
that O 0 0.00419259537011385
could O 0 0.0037320624105632305
be O 0 0.0026770897675305605
involved O 0 0.004525208380073309
in O 0 0.008473552763462067
pH O 1 0.9999996423721313
- O 1 0.9999997615814209
dependent O 0 0.026222320273518562
interactions O 0 0.02373233251273632
. O 0 0.024494081735610962

We O 0 0.016356714069843292
also O 0 0.010488586500287056
demonstrate O 0 0.014343959279358387
that O 0 0.009199620224535465
soluble O 1 0.999782383441925
TfR O 1 0.9999898672103882
and O 0 0.018729280680418015
HFE O 1 1.0
bind O 0 0.02827834151685238
tightly O 0 0.01905466802418232
at O 0 0.007267585955560207
the O 0 0.004965032916516066
basic O 0 0.008186880499124527
pH O 1 0.5682412981987
of O 0 0.004739294294267893
the O 0 0.0077324602752923965
cell O 1 0.5882971286773682
surface O 0 0.009601369500160217
, O 0 0.004181096330285072
but O 0 0.002464375691488385
not O 0 0.002413287293165922
at O 0 0.005734768696129322
the O 0 0.008520553819835186
acidic O 1 0.9997467398643494
pH O 1 0.9999632835388184
of O 0 0.03691454231739044
intracellular O 1 0.9996843338012695
vesicles O 1 0.9395301342010498
. O 0 0.043402429670095444

TfR O 1 0.9999817609786987
HFE O 1 0.9999971389770508
stoichiometry O 0 0.3215961456298828
( O 0 0.017586281523108482
2 O 0 0.02090422436594963
1 O 0 0.020021870732307434
) O 0 0.008998380042612553
differs O 0 0.01384145487099886
from O 0 0.009175833314657211
TfR O 1 0.9996191263198853
transferrin O 1 0.9991863369941711
stoichiometry O 0 0.05462253838777542
( O 0 0.011009431444108486
2 O 0 0.014892974868416786
2 O 0 0.013862292282283306
) O 0 0.0073289270512759686
, O 0 0.006031983997672796
implying O 0 0.008609741926193237
a O 0 0.00466495007276535
different O 0 0.0025101567152887583
mode O 0 0.008605225943028927
of O 0 0.005559198558330536
binding O 0 0.007297252770513296
for O 0 0.008041441440582275
HFE O 1 0.9999998807907104
and O 0 0.011046689003705978
transferrin O 1 0.9998044371604919
to O 0 0.013643692247569561
TfR O 1 0.9999973773956299
, O 0 0.007728956639766693
consistent O 0 0.007908967323601246
with O 0 0.004099460318684578
our O 0 0.007414284162223339
demonstration O 0 0.01441959384828806
that O 0 0.006903288420289755
HFE O 1 0.9999998807907104
, O 0 0.014878850430250168
transferrin O 1 0.9998918771743774
, O 0 0.011218739673495293
and O 0 0.009553992189466953
TfR O 1 0.999933123588562
form O 0 0.011170201003551483
a O 0 0.014832650311291218
ternary O 1 0.6884191036224365
complex O 0 0.03560518100857735
. O 0 0.02849854901432991

Identification O 0 0.022287258878350258
of O 0 0.008692528121173382
three O 0 0.006520321127027273
novel O 0 0.013154729269444942
mutations O 0 0.006704913917928934
and O 0 0.0033839470706880093
a O 0 0.00438330415636301
high O 0 0.006724705453962088
frequency O 0 0.005026987753808498
of O 0 0.004306396935135126
the O 0 0.0075595625676214695
Arg778Leu O 1 0.9999023675918579
mutation O 0 0.011811644770205021
in O 0 0.0071198646910488605
Korean O 1 0.9988070726394653
patients O 1 0.9994027614593506
with O 0 0.015908585861325264
Wilson B-Disease 1 0.9999997615814209
disease I-Disease 1 1.0
. O 0 0.03138122707605362

Four O 0 0.02573573775589466
mutations O 0 0.027467098087072372
- O 1 0.9999974966049194
- O 1 0.9999992847442627
R778L O 1 0.9995782971382141
, O 0 0.012666202150285244
A874V O 1 0.9895787835121155
, O 0 0.009350812993943691
L1083F O 0 0.3488505482673645
, O 0 0.006918191909790039
and O 0 0.007336173672229052
2304delC O 1 0.9999958276748657
- O 1 1.0
- O 1 0.9994439482688904
in O 0 0.006010747514665127
the O 0 0.00940177496522665
copper O 1 0.99272620677948
- O 1 0.9995477795600891
transporting O 0 0.018700789660215378
enzyme O 0 0.01340473722666502
, O 0 0.008285554125905037
P O 1 0.9958951473236084
- O 1 0.9999845027923584
type O 1 0.7314208149909973
ATPase O 1 0.9999966621398926
( O 0 0.015280674211680889
ATP7B O 1 0.9999984502792358
) O 0 0.008325984701514244
, O 0 0.004711396526545286
were O 0 0.003580069402232766
identified O 0 0.005461996421217918
in O 0 0.005353311076760292
Korean O 1 0.9991028308868408
Patients O 1 0.9999626874923706
with O 0 0.04173322394490242
Wilson B-Disease 1 0.9999998807907104
disease I-Disease 1 1.0
. O 0 0.03419584408402443

Arg778Leu O 1 0.9996483325958252
, O 0 0.011363283731043339
the O 0 0.007173104677349329
most O 0 0.004881888162344694
frequently O 0 0.004716841969639063
reported O 0 0.005316787865012884
mutation O 0 0.005964257288724184
of O 0 0.0043887365609407425
this O 0 0.0039002730045467615
enzyme O 0 0.009675305336713791
, O 0 0.004995290189981461
was O 0 0.005668692756444216
found O 0 0.0031468376982957125
in O 0 0.00273111741989851
six O 0 0.0041004568338394165
of O 0 0.004259203094989061
eight O 0 0.006826982833445072
unrelated O 0 0.014903688803315163
patients O 1 0.9754756689071655
studied O 0 0.009634784422814846
, O 0 0.00474131666123867
an O 0 0.0058337626978755
allele O 0 0.016513779759407043
frequency O 0 0.009606384672224522
of O 0 0.010505297221243382
37 O 0 0.02927286922931671
. O 0 0.021957991644740105

5 O 0 0.028423704206943512
% O 0 0.011575168929994106
, O 0 0.0069909729063510895
which O 0 0.003569289343431592
is O 0 0.004063910339027643
considerably O 0 0.007222402840852737
higher O 0 0.004800982307642698
than O 0 0.002770539838820696
those O 0 0.0024973333347588778
in O 0 0.003911117557436228
other O 0 0.004758875351399183
Asian O 0 0.02146659977734089
populations O 0 0.015153490006923676
. O 0 0.021099384874105453

The O 0 0.033947233110666275
novel O 0 0.030904121696949005
single O 0 0.015746284276247025
nucleotide O 0 0.025198424234986305
deletion O 0 0.02762594260275364
, O 0 0.011238347738981247
2304delC O 1 0.9998304843902588
, O 0 0.007402173243463039
was O 0 0.008407541550695896
found O 0 0.004628294613212347
in O 0 0.0053436001762747765
one O 0 0.009832650423049927
patient O 1 0.980391263961792
. O 0 0.02145925723016262

Since O 0 0.02197498269379139
a O 0 0.01773858442902565
mutation O 0 0.019028039649128914
at O 0 0.013814177364110947
cDNA O 0 0.041517455130815506
nucleotide O 0 0.037839483469724655
2302 O 1 0.9999606609344482
( O 0 0.01728695072233677
2302insC O 1 0.9987560510635376
) O 0 0.007746950723230839
had O 0 0.006680372636765242
been O 0 0.004361825063824654
previously O 0 0.005968951154500246
described O 0 0.005382757168263197
, O 0 0.0029089595191180706
this O 0 0.0018435603706166148
region O 0 0.0035019919741898775
of O 0 0.003528177971020341
the O 0 0.006522075738757849
ATP7B O 1 1.0
gene O 0 0.009793110191822052
may O 0 0.004935640376061201
be O 0 0.004191042855381966
susceptible O 0 0.012347737327218056
to O 0 0.007092078682035208
gene O 0 0.015719003975391388
rearrangements O 1 0.9933578372001648
causing O 1 0.9999561309814453
Wilson B-Disease 1 0.9999998807907104
disease I-Disease 1 1.0
. O 0 0.03772381693124771

Disruption O 0 0.06445101648569107
of O 0 0.018268311396241188
splicing O 0 0.027130816131830215
regulated O 0 0.011460717767477036
by O 0 0.004518972709774971
a O 0 0.010002619586884975
CUG O 1 0.9999995231628418
- O 1 0.9999943971633911
binding O 0 0.017412126064300537
protein O 0 0.015944954007864
in O 0 0.019614584743976593
myotonic B-Disease 1 1.0
dystrophy I-Disease 1 1.0
. O 1 0.5083596110343933

Myotonic B-Disease 1 1.0
dystrophy I-Disease 1 1.0
( O 1 0.9999998807907104
DM B-Disease 1 1.0
) O 0 0.21184180676937103
is O 0 0.009252116084098816
caused O 0 0.009709769859910011
by O 0 0.004953410010784864
a O 0 0.010767782106995583
CTG O 1 0.9999957084655762
expansion O 0 0.014173444360494614
in O 0 0.004964284598827362
the O 0 0.0056449538096785545
3 O 0 0.011557472869753838
untranslated O 0 0.09426272660493851
region O 0 0.010220152325928211
of O 0 0.009609048254787922
the O 0 0.049891259521245956
DM B-Disease 1 1.0
gene O 0 0.05098472908139229
. O 0 0.030660782009363174

One O 0 0.017704850062727928
model O 0 0.020763622596859932
of O 0 0.022007649764418602
DM B-Disease 1 1.0
pathogenesis O 1 1.0
suggests O 0 0.018800387158989906
that O 0 0.007356961257755756
RNAs O 0 0.03120175004005432
from O 0 0.005911555606871843
the O 0 0.007082793395966291
expanded O 0 0.01287608128041029
allele O 0 0.013559125363826752
create O 0 0.005286140367388725
a O 0 0.005493529606610537
gain O 0 0.009877495467662811
- O 1 0.9989424347877502
of O 0 0.00883503258228302
- O 1 0.9999984502792358
function O 0 0.009584009647369385
mutation O 0 0.008123326115310192
by O 0 0.003252315102145076
the O 0 0.00527094816789031
inappropriate O 0 0.009129691869020462
binding O 0 0.008406559936702251
of O 0 0.007110163569450378
proteins O 0 0.0074358051642775536
to O 0 0.006290154997259378
the O 0 0.016149666160345078
CUG O 1 0.9999963045120239
repeats O 0 0.05390946567058563
. O 0 0.029526926577091217

Data O 0 0.018712785094976425
presented O 0 0.01592906191945076
here O 0 0.0078390222042799
indicate O 0 0.0062332903034985065
that O 0 0.0032710523810237646
the O 0 0.008003070019185543
conserved O 0 0.020518140867352486
heterogeneous O 0 0.031690794974565506
nuclear O 0 0.03269354999065399
ribonucleoprotein O 1 0.9956973791122437
, O 0 0.015792163088917732
CUG O 1 0.9999990463256836
- O 1 0.9998979568481445
binding O 0 0.012926573865115643
protein O 0 0.009266884066164494
( O 0 0.007876207120716572
CUG O 1 0.9999992847442627
- O 1 0.9999998807907104
BP O 1 0.9997196793556213
) O 0 0.007520532701164484
, O 0 0.005070514511317015
may O 0 0.004485415760427713
mediate O 0 0.013212217018008232
the O 0 0.009068743325769901
trans O 1 0.9966362714767456
- O 1 0.9999996423721313
dominant O 0 0.028012478724122047
effect O 0 0.008526272140443325
of O 0 0.009273207746446133
the O 0 0.014439014717936516
RNA O 0 0.04383521527051926
. O 0 0.02257510833442211

CUG O 1 0.9999992847442627
- O 1 0.9999996423721313
BP O 1 0.9935861229896545
was O 0 0.014034049585461617
found O 0 0.005241896957159042
to O 0 0.004709277767688036
bind O 0 0.008496426977217197
to O 0 0.003924467135220766
the O 0 0.005940500646829605
human O 0 0.010660585016012192
cardiac O 1 1.0
troponin O 1 1.0
T O 1 1.0
( O 0 0.017991110682487488
cTNT O 1 0.9993316531181335
) O 0 0.010159933008253574
pre O 1 0.8983507752418518
- O 1 0.9999969005584717
messenger O 0 0.13412579894065857
RNA O 0 0.024940388277173042
and O 0 0.007433510851114988
regulate O 0 0.013957198709249496
its O 0 0.014050026424229145
alternative O 0 0.025378864258527756
splicing O 0 0.05127841234207153
. O 0 0.02710529789328575

Splicing O 0 0.06392165273427963
of O 0 0.022742271423339844
cTNT O 1 0.5992461442947388
was O 0 0.019270291551947594
disrupted O 0 0.026753824204206467
in O 0 0.021239647641777992
DM B-Disease 1 1.0
striated O 1 1.0
muscle O 1 0.9999997615814209
and O 0 0.010905150324106216
in O 0 0.008350896649062634
normal O 0 0.010453049093484879
cells O 0 0.01115487515926361
expressing O 0 0.01478961668908596
transcripts O 0 0.01648310199379921
that O 0 0.006951332092285156
contain O 0 0.021019313484430313
CUG O 1 0.9999836683273315
repeats O 0 0.0546119250357151
. O 0 0.03158583119511604

Altered O 0 0.03837016597390175
expression O 0 0.018600011244416237
of O 0 0.011260594241321087
genes O 0 0.012887571938335896
regulated O 0 0.015494821593165398
posttranscriptionally O 0 0.04365964233875275
by O 0 0.011529975570738316
CUG O 1 1.0
- O 1 0.9999997615814209
BP O 1 0.99788898229599
therefore O 0 0.009454813785851002
may O 0 0.006331843324005604
contribute O 0 0.011781306006014347
to O 0 0.01809011399745941
DM B-Disease 1 1.0
pathogenesis O 1 1.0
. O 0 0.026821818202733994
. O 0 0.031730327755212784

Identification O 0 0.02522221766412258
of O 0 0.012018635869026184
a O 0 0.01275574043393135
novel O 0 0.024012964218854904
nonsense O 0 0.15072113275527954
mutation O 0 0.013068963773548603
and O 0 0.005299677141010761
a O 0 0.008929945528507233
missense O 0 0.021543150767683983
substitution O 0 0.01382136344909668
in O 0 0.005935386288911104
the O 0 0.008007833734154701
vasopressin O 1 0.823837161064148
- O 1 0.9999992847442627
neurophysin O 1 0.9999978542327881
II O 1 1.0
gene O 0 0.011526894755661488
in O 0 0.0049645439721643925
two O 0 0.004435150418430567
Spanish O 0 0.014522668905556202
kindreds O 0 0.03959117829799652
with O 0 0.013541463762521744
familial B-Disease 1 1.0
neurohypophyseal I-Disease 1 1.0
diabetes I-Disease 1 1.0
insipidus I-Disease 1 1.0
. O 1 0.6435006856918335

Familial B-Disease 1 0.9999992847442627
neurohypophyseal I-Disease 1 1.0
diabetes I-Disease 1 1.0
insipidus I-Disease 1 1.0
( O 1 0.9999923706054688
FNDI B-Disease 1 1.0
) O 0 0.006856919266283512
is O 0 0.0039537884294986725
an O 0 0.004660004284232855
autosomal B-Disease 1 0.9999997615814209
dominant I-Disease 1 1.0
disease I-Disease 1 1.0
caused O 1 1.0
by O 1 0.9997884631156921
deficiency O 1 1.0
in O 1 0.9809184074401855
the O 1 0.9892274141311646
antidiuretic O 1 1.0
hormone O 1 0.9999679327011108
arginine O 1 0.9756504893302917
vasopressin O 1 0.9989640712738037
( O 0 0.023348834365606308
AVP O 1 0.9999971389770508
) O 0 0.010349736548960209
encoded O 0 0.006749694235622883
by O 0 0.0037116180174052715
the O 0 0.008951819501817226
AVP O 1 0.9999998807907104
- O 1 0.9999992847442627
neurophysin O 1 0.9999945163726807
II O 1 1.0
( O 0 0.02479211799800396
AVP O 1 1.0
- O 1 1.0
NPII O 1 0.9999994039535522
) O 0 0.018734093755483627
gene O 0 0.01842113584280014
on O 0 0.015103466808795929
chromosome O 0 0.04522428289055824
20p13 O 1 0.9052956700325012
. O 0 0.03546003997325897

In O 0 0.014296259731054306
this O 0 0.00681760348379612
study O 0 0.007003930862993002
, O 0 0.005347616970539093
we O 0 0.0034605725668370724
analyzed O 0 0.006131905131042004
two O 0 0.0030083907768130302
families O 0 0.0036643140483647585
with O 0 0.0048474883660674095
FNDI B-Disease 1 1.0
using O 0 0.005401028785854578
direct O 0 0.00873653870075941
automated O 0 0.01944666914641857
fluorescent O 0 0.028904467821121216
, O 0 0.007555435411632061
solid O 0 0.013920948840677738
phase O 0 0.016482850536704063
, O 0 0.0078853415325284
single O 0 0.009938904084265232
- O 1 0.9568652510643005
stranded O 0 0.022610770538449287
DNA O 0 0.012120340950787067
sequencing O 0 0.01321096159517765
of O 0 0.010815545916557312
PCR O 0 0.06689562648534775
- O 1 0.9996383190155029
amplified O 0 0.0985909029841423
AVP O 1 0.9999997615814209
- O 1 0.9999992847442627
NPII O 1 0.9999822378158569
DNA O 0 0.050873130559921265
. O 0 0.030007081106305122

In O 0 0.011930626817047596
one O 0 0.006898863706737757
of O 0 0.00582165876403451
the O 0 0.006204934325069189
families O 0 0.005816319026052952
, O 0 0.005103845149278641
affected O 0 0.005242724437266588
individuals O 0 0.0028063184581696987
presented O 0 0.008305718190968037
a O 0 0.008427676744759083
novel O 0 0.016667861491441727
nonsense O 0 0.027317875996232033
mutation O 0 0.010513060726225376
in O 0 0.005852401256561279
exon O 0 0.02591298706829548
3 O 0 0.007628834340721369
of O 0 0.005823370534926653
the O 0 0.005938917864114046
gene O 0 0.007439659908413887
, O 0 0.004746600985527039
consisting O 0 0.004833477549254894
in O 0 0.0040049185045063496
a O 0 0.007520479615777731
G O 1 0.9322774410247803
to O 0 0.009518749080598354
T O 1 0.9998973608016968
transition O 0 0.01584024727344513
at O 0 0.013786233961582184
nucleotide O 0 0.024477209895849228
2101 O 1 0.996905505657196
, O 0 0.008906567469239235
which O 0 0.005331046879291534
produces O 0 0.008569654077291489
a O 0 0.005187315866351128
stop O 0 0.0072661335580050945
signal O 0 0.007978847250342369
in O 0 0.00538294343277812
codon O 0 0.019859207794070244
82 O 0 0.03600873053073883
( O 0 0.018120164051651955
Glu O 1 1.0
) O 0 0.01859845221042633
of O 0 0.02557196095585823
NPII O 1 0.9999854564666748
. O 0 0.036555979400873184

The O 0 0.03209303691983223
premature O 1 0.8823933005332947
termination O 1 0.8936021327972412
eliminates O 0 0.06985268741846085
part O 0 0.009567058645188808
of O 0 0.006219765171408653
the O 0 0.008372515439987183
C O 1 0.9999984502792358
- O 1 0.9999983310699463
terminal O 1 0.5638564229011536
domain O 0 0.013186882250010967
of O 0 0.009949796833097935
NPII O 1 0.9999939203262329
, O 0 0.006409655325114727
including O 0 0.004785296507179737
a O 0 0.006870437413454056
cysteine O 0 0.013909120112657547
residue O 0 0.012327353470027447
in O 0 0.00454747537150979
position O 0 0.008530639111995697
85 O 0 0.016587547957897186
, O 0 0.004770882427692413
which O 0 0.002790321595966816
could O 0 0.002743431134149432
be O 0 0.002227005548775196
involved O 0 0.002867954783141613
in O 0 0.00341208977624774
the O 0 0.006300169043242931
correct O 0 0.013038039207458496
folding O 1 0.956811249256134
of O 0 0.011742065660655499
the O 0 0.020972786471247673
prohormone O 1 0.9999997615814209
. O 0 0.03169984370470047

In O 0 0.013348979875445366
the O 0 0.010041289031505585
second O 0 0.013644276186823845
family O 0 0.010222109965980053
, O 0 0.005350254941731691
a O 0 0.00816478580236435
G279A O 0 0.4268524944782257
substitution O 0 0.011615697294473648
at O 0 0.00736843328922987
position O 0 0.009535410441458225
- O 1 0.9836549162864685
1 O 0 0.008575384505093098
of O 0 0.004667636007070541
the O 0 0.006163991987705231
signal O 0 0.014067276380956173
peptide O 0 0.021929621696472168
was O 0 0.010640868917107582
observed O 0 0.0059302086010575294
in O 0 0.00499564316123724
all O 0 0.005196575541049242
affected O 0 0.010121272876858711
individuals O 0 0.010098900645971298
. O 0 0.02089318260550499

This O 0 0.020186860114336014
missense O 0 0.05013962462544441
mutation O 0 0.020477265119552612
, O 0 0.008709078654646873
which O 0 0.00721778953447938
replaces O 1 0.9999852180480957
Ala O 1 1.0
with O 0 0.02074391208589077
Thr O 1 1.0
, O 0 0.007832854054868221
is O 0 0.005475749261677265
frequent O 0 0.008172983303666115
among O 0 0.009184992872178555
FNDI B-Disease 1 1.0
patients O 1 0.9999997615814209
and O 0 0.005673328414559364
is O 0 0.0035573095083236694
thought O 0 0.003963527735322714
to O 0 0.003715305123478174
reduce O 0 0.006670630536973476
the O 0 0.005735498387366533
efficiency O 0 0.013324195519089699
of O 0 0.010382125154137611
cleavage O 1 0.8839406967163086
by O 0 0.008603923954069614
signal O 0 0.026785552501678467
peptidases O 0 0.3396605849266052
. O 0 0.017513694241642952
. O 0 0.025092294439673424

Genetic O 0 0.034343138337135315
heterogeneity O 0 0.042543765157461166
of O 0 0.01704435795545578
Saethre B-Disease 1 1.0
- I-Disease 1 1.0
Chotzen I-Disease 1 1.0
syndrome I-Disease 1 1.0
, O 0 0.02362184040248394
due O 0 0.009724617004394531
to O 0 0.010457681491971016
TWIST O 1 0.9991115927696228
and O 0 0.02072708122432232
FGFR O 1 0.9999998807907104
mutations O 0 0.03824065998196602
. O 0 0.02858162298798561

Thirty O 0 0.06493526697158813
- O 1 0.9783160090446472
two O 0 0.009669531136751175
unrelated O 0 0.014753530733287334
patients O 0 0.011646218597888947
with O 0 0.003916515968739986
features O 0 0.006728455424308777
of O 0 0.007463730406016111
Saethre B-Disease 1 1.0
- I-Disease 1 1.0
Chotzen I-Disease 1 1.0
syndrome I-Disease 1 1.0
, O 0 0.006621053908020258
a O 0 0.0062335096299648285
common O 0 0.008586163632571697
autosomal B-Disease 1 0.9998955726623535
dominant I-Disease 1 0.999799907207489
condition I-Disease 1 0.9996874332427979
of O 1 0.9999431371688843
craniosynostosis B-Disease 1 1.0
and O 1 0.9999998807907104
limb B-Disease 1 1.0
anomalies I-Disease 1 0.9999998807907104
, O 0 0.008579651825129986
were O 0 0.004783255513757467
screened O 0 0.011502605862915516
for O 0 0.005060721188783646
mutations O 0 0.007588214706629515
in O 0 0.005445275921374559
TWIST O 1 0.9941384792327881
, O 0 0.013064777478575706
FGFR2 O 1 0.9999985694885254
, O 0 0.013612470589578152
and O 0 0.017827650532126427
FGFR3 O 1 0.9999969005584717
. O 0 0.03526683896780014

Nine O 0 0.03259407356381416
novel O 0 0.02325071580708027
and O 0 0.008245216682553291
three O 0 0.009838622063398361
recurrent O 1 1.0
TWIST O 1 0.999998927116394
mutations O 0 0.012169172056019306
were O 0 0.004886731971055269
found O 0 0.004431596025824547
in O 0 0.005682284943759441
12 O 0 0.012326713651418686
families O 0 0.014041164889931679
. O 0 0.01960103213787079

Seven O 0 0.02324102073907852
families O 0 0.01067456416785717
were O 0 0.004301233682781458
found O 0 0.003029415849596262
to O 0 0.0031270806211978197
have O 0 0.002465365454554558
the O 0 0.006429658737033606
FGFR3 O 1 0.9999998807907104
P250R O 1 0.9999985694885254
mutation O 0 0.01427109632641077
, O 0 0.005188762675970793
and O 0 0.004020100459456444
one O 0 0.0042177061550319195
individual O 0 0.00406431220471859
was O 0 0.006112297531217337
found O 0 0.0031227075960487127
to O 0 0.0035873448941856623
have O 0 0.0031670297030359507
an O 0 0.008188420906662941
FGFR2 O 1 0.9999988079071045
VV269 O 1 0.9999866485595703
- O 1 0.9999901056289673
270 O 0 0.08988291025161743
deletion O 0 0.07870595902204514
. O 0 0.03810807317495346

To O 0 0.016593871638178825
date O 0 0.01297649834305048
, O 0 0.0073456414975225925
our O 0 0.008151520043611526
detection O 0 0.014863187447190285
rate O 0 0.006943601183593273
for O 0 0.007370017468929291
TWIST O 0 0.11662309616804123
or O 0 0.011032512411475182
FGFR O 1 0.9999985694885254
mutations O 0 0.012532935477793217
is O 0 0.005440619308501482
68 O 0 0.014013043604791164
% O 0 0.004907594062387943
in O 0 0.00405655475333333
our O 0 0.007995094172656536
Saethre B-Disease 1 0.9999996423721313
- I-Disease 1 1.0
Chotzen I-Disease 1 1.0
syndrome I-Disease 1 1.0
patients O 1 1.0
, O 0 0.005734730511903763
including O 0 0.003469049697741866
our O 0 0.004974928684532642
five O 0 0.005453692749142647
patients O 1 0.9727802276611328
elsewhere O 0 0.00603725528344512
reported O 0 0.006731604691594839
with O 0 0.007555427961051464
TWIST O 1 0.999968409538269
mutations O 0 0.022457661107182503
. O 0 0.021595550701022148

More O 0 0.011437209323048592
than O 0 0.007309400476515293
35 O 0 0.012873922474682331
different O 0 0.005063636228442192
TWIST O 0 0.033371854573488235
mutations O 0 0.010159941390156746
are O 0 0.002609974006190896
now O 0 0.005691220052540302
known O 0 0.005884135607630014
in O 0 0.004899308551102877
the O 0 0.008207123726606369
literature O 0 0.016264356672763824
. O 0 0.01778402179479599

The O 0 0.018697701394557953
most O 0 0.009254870004951954
common O 0 0.009722892194986343
phenotypic O 0 0.018008070066571236
features O 0 0.010853192768990993
, O 0 0.005335642956197262
present O 0 0.004211514722555876
in O 0 0.0032475776970386505
more O 0 0.002443844685330987
than O 0 0.002147695980966091
a O 0 0.004353778902441263
third O 0 0.006407289765775204
of O 0 0.004667371045798063
our O 0 0.00739970663562417
patients O 1 0.6359586119651794
with O 0 0.006846931762993336
TWIST O 1 0.999911904335022
mutations O 0 0.012215857394039631
, O 0 0.006515813060104847
are O 0 0.004400704056024551
coronal B-Disease 1 0.8577512502670288
synostosis I-Disease 1 0.999640703201294
, O 0 0.00934230163693428
brachycephaly B-Disease 1 0.9994019269943237
, O 0 0.010486398823559284
low B-Disease 1 0.9332049489021301
frontal I-Disease 1 1.0
hairline I-Disease 1 1.0
, O 1 0.9994675517082214
facial B-Disease 1 1.0
asymmetry I-Disease 1 1.0
, O 1 0.9998421669006348
ptosis B-Disease 1 1.0
, O 1 0.8806885480880737
hypertelorism B-Disease 1 1.0
, O 0 0.011982842348515987
broad B-Disease 1 0.9758127927780151
great I-Disease 1 0.9999374151229858
toes I-Disease 1 0.9999934434890747
, O 0 0.013106663711369038
and O 0 0.01413312554359436
clinodactyly B-Disease 1 0.999992847442627
. O 0 0.0287772323936224

Significant O 0 0.02559923194348812
intra O 1 0.9998170733451843
- O 1 0.9999951124191284
and O 0 0.012287469580769539
interfamilial O 1 0.9998599290847778
phenotypic O 0 0.03725814074277878
variability O 0 0.019279800355434418
is O 0 0.005913266446441412
present O 0 0.005368373356759548
for O 0 0.00510071124881506
either O 0 0.008367465808987617
TWIST O 1 0.9802015423774719
mutations O 0 0.016767604276537895
or O 0 0.014430508017539978
FGFR O 1 1.0
mutations O 0 0.03877941891551018
. O 0 0.026998775079846382

The O 0 0.019825810566544533
overlap O 0 0.015998348593711853
in O 0 0.008858803659677505
clinical O 1 0.9688845276832581
features O 0 0.0077031878754496574
and O 0 0.0035477166529744864
the O 0 0.0035165254957973957
presence O 0 0.004397335462272167
, O 0 0.002953905612230301
in O 0 0.0027645679656416178
the O 0 0.003362619783729315
same O 0 0.0028728407341986895
genes O 0 0.004482826683670282
, O 0 0.0034957905299961567
of O 0 0.004194985143840313
mutations O 0 0.004153301939368248
for O 0 0.0025494724977761507
more O 0 0.002175684552639723
than O 0 0.0027523597236722708
one O 0 0.0045795016922056675
craniosynostotic B-Disease 1 0.9998518228530884
condition I-Disease 1 0.7411940693855286
- O 1 0.9989948868751526
such O 0 0.004278125241398811
as O 0 0.006742054596543312
Saethre B-Disease 1 0.9999985694885254
- I-Disease 1 0.9999998807907104
Chotzen I-Disease 1 0.9999849796295166
, I-Disease 0 0.00925793033093214
Crouzon I-Disease 1 0.9991536140441895
, I-Disease 0 0.006406889762729406
and I-Disease 0 0.008218569681048393
Pfeiffer I-Disease 1 1.0
syndromes I-Disease 1 1.0
- O 1 1.0
support O 0 0.01076844334602356
the O 0 0.0073773120529949665
hypothesis O 0 0.009684392251074314
that O 0 0.004184593912214041
TWIST O 0 0.02762693352997303
and O 0 0.006494367495179176
FGFRs O 1 0.996006429195404
are O 0 0.002795163542032242
components O 0 0.007525642402470112
of O 0 0.0038806258235126734
the O 0 0.004511848092079163
same O 0 0.0053342413157224655
molecular O 0 0.01229230035096407
pathway O 0 0.00876658596098423
involved O 0 0.004265128634870052
in O 0 0.003831069217994809
the O 0 0.005640373099595308
modulation O 0 0.018094060942530632
of O 0 0.08025150001049042
craniofacial O 1 1.0
and O 1 0.9999890327453613
limb O 1 1.0
development O 1 0.9968512654304504
in O 0 0.01829485408961773
humans O 0 0.012711499817669392
. O 0 0.010430547408759594
. O 0 0.02050872892141342

Mutation O 0 0.033548686653375626
analysis O 0 0.013487347401678562
of O 0 0.01427278108894825
UBE3A O 1 1.0
in O 1 0.9998277425765991
Angelman B-Disease 1 1.0
syndrome I-Disease 1 1.0
patients O 1 1.0
. O 1 0.9944725632667542

Angelman B-Disease 1 1.0
syndrome I-Disease 1 1.0
( O 1 0.9999802112579346
AS B-Disease 1 1.0
) O 0 0.008764316327869892
is O 0 0.006146548315882683
caused O 0 0.008621121756732464
by O 0 0.0058721317909657955
chromosome O 0 0.02640099637210369
15q11 O 1 0.9999984502792358
- O 1 0.9999997615814209
q13 O 1 0.9988842606544495
deletions O 0 0.031161963939666748
of O 0 0.011054928414523602
maternal O 0 0.2030956894159317
origin O 0 0.00641716318204999
, O 0 0.005804958287626505
by O 0 0.007052031811326742
paternal O 1 0.9633899331092834
uniparental B-Disease 1 1.0
disomy I-Disease 1 1.0
( O 1 0.8898629546165466
UPD B-Disease 1 1.0
) O 0 0.010776136070489883
15 O 0 0.01052489411085844
, O 0 0.006434461567550898
by O 0 0.006396070588380098
imprinting O 1 0.999998927116394
defects O 1 1.0
, O 0 0.0072014168836176395
and O 0 0.004982524551451206
by O 0 0.004995326045900583
mutations O 0 0.00908154807984829
in O 0 0.007941870018839836
the O 0 0.017239786684513092
UBE3A O 1 0.9999997615814209
gene O 0 0.04032239690423012
. O 0 0.027940019965171814

UBE3A O 1 0.9909413456916809
encodes O 0 0.05640627443790436
a O 0 0.023268461227416992
ubiquitin O 1 0.8930664658546448
- O 1 0.9999806880950928
protein O 0 0.018706699833273888
ligase O 0 0.0288037471473217
and O 0 0.009428025223314762
shows O 0 0.01400971133261919
brain O 1 0.9976786971092224
- O 1 0.9999935626983643
specific O 0 0.01788974367082119
imprinting O 1 0.9554197192192078
. O 0 0.030566660687327385

Here O 0 0.01832665130496025
we O 0 0.007580045610666275
describe O 0 0.019149448722600937
UBE3A O 1 0.9999679327011108
coding O 1 0.9484823942184448
- O 1 0.9999829530715942
region O 0 0.01711130514740944
mutations O 0 0.012634153477847576
detected O 0 0.008814874105155468
by O 0 0.004964380990713835
SSCP O 1 0.999279797077179
analysis O 0 0.004781889729201794
in O 0 0.005330359097570181
13 O 0 0.009389559738337994
AS B-Disease 0 0.014555647037923336
individuals O 0 0.005287055391818285
or O 0 0.007567848544567823
families O 0 0.012920009903609753
. O 0 0.02020193822681904

Two O 0 0.019106028601527214
identical O 0 0.027734778821468353
de O 0 0.04655008018016815
novo O 0 0.12556688487529755
5 O 0 0.025368046015501022
- O 1 0.9921701550483704
bp O 0 0.04472045600414276
duplications O 0 0.03761903941631317
in O 0 0.010455727577209473
exon O 0 0.052507951855659485
16 O 0 0.017670417204499245
were O 0 0.008474738337099552
found O 0 0.013147655874490738
. O 0 0.0200852882117033

Among O 0 0.01965816505253315
the O 0 0.008894444443285465
other O 0 0.004230462945997715
11 O 0 0.008782709948718548
unique O 0 0.008999843150377274
mutations O 0 0.008368471637368202
, O 0 0.00526032317429781
8 O 0 0.007284952327609062
were O 0 0.0036472929641604424
small O 0 0.0056100869551301
deletions O 0 0.015450106002390385
or O 0 0.005662087816745043
insertions O 0 0.025894859805703163
predicted O 0 0.011211473494768143
to O 0 0.0064101628959178925
cause O 0 0.028837889432907104
frameshifts O 1 0.9998860359191895
, O 0 0.007414649240672588
1 O 0 0.010136457160115242
was O 0 0.008073507808148861
a O 0 0.0061942581087350845
mutation O 0 0.006670147180557251
to O 0 0.003566441358998418
a O 0 0.00566085334867239
stop O 0 0.007418682333081961
codon O 0 0.013208245858550072
, O 0 0.00517903920263052
1 O 0 0.007436034269630909
was O 0 0.006262167822569609
a O 0 0.006290456745773554
missense O 0 0.019039945676922798
mutation O 0 0.007217372301965952
, O 0 0.003711552359163761
and O 0 0.0034630149602890015
1 O 0 0.007576043251901865
was O 0 0.006453040987253189
predicted O 0 0.0073850397020578384
to O 0 0.0049427952617406845
cause O 0 0.008539012633264065
insertion O 0 0.01577715575695038
of O 0 0.0065776025876402855
an O 0 0.007391299586743116
isoleucine O 1 0.9996163845062256
in O 0 0.0069211930967867374
the O 0 0.008247580379247665
hect O 0 0.25636768341064453
domain O 0 0.011593738570809364
of O 0 0.007314065936952829
the O 0 0.010205132886767387
UBE3A O 1 1.0
protein O 0 0.013263723812997341
, O 0 0.005788662005215883
which O 0 0.0036171216052025557
functions O 0 0.005310255568474531
in O 0 0.008390098810195923
E2 O 1 0.9996926784515381
binding O 0 0.019866321235895157
and O 0 0.013446124270558357
ubiquitin O 0 0.07867075502872467
transfer O 0 0.03280065581202507
. O 0 0.028467804193496704

Eight O 0 0.018542321398854256
of O 0 0.008444620296359062
the O 0 0.007021749392151833
cases O 0 0.005285854451358318
were O 0 0.004392275586724281
familial O 1 0.9999896287918091
, O 0 0.005916120018810034
and O 0 0.005077343434095383
five O 0 0.007090094033628702
were O 0 0.0068440851755440235
sporadic O 0 0.024096248671412468
. O 0 0.021967822685837746

In O 0 0.015120151452720165
two O 0 0.008882800117135048
familial O 1 0.9860050082206726
cases O 0 0.008031511679291725
and O 0 0.005612388253211975
one O 0 0.0057972501963377
sporadic O 0 0.010202436707913876
case O 0 0.0077932546846568584
, O 0 0.007338531780987978
mosaicism O 1 0.9998297691345215
for O 0 0.010134926997125149
UBE3A O 1 1.0
mutations O 0 0.016598500311374664
was O 0 0.0107435816898942
detected O 0 0.008001798763871193
in O 0 0.003975387662649155
the O 0 0.004591156262904406
mother O 0 0.006425219122320414
of O 0 0.003734426572918892
three O 0 0.0038114257622510195
AS B-Disease 1 0.9221774339675903
sons O 0 0.36058714985847473
, O 0 0.003885797690600157
in O 0 0.003633819054812193
the O 0 0.006087963934987783
maternal O 1 0.9936423301696777
grandfather O 1 0.9271818995475769
of O 0 0.0044213575311005116
two O 0 0.0033068291377276182
AS B-Disease 0 0.31256046891212463
first O 0 0.006211730185896158
cousins O 0 0.012696740217506886
, O 0 0.003395345527678728
and O 0 0.002686647232621908
in O 0 0.002810414880514145
the O 0 0.003956660628318787
mother O 0 0.009955876506865025
of O 0 0.005641737021505833
an O 0 0.007934698835015297
AS B-Disease 1 0.9998985528945923
daughter O 1 0.9977845549583435
. O 0 0.023831864818930626

The O 0 0.017159458249807358
frequencies O 0 0.010535864159464836
with O 0 0.0048707579262554646
which O 0 0.0034620543010532856
we O 0 0.0034592521842569113
detected O 0 0.006890466902405024
mutations O 0 0.004652331117540598
were O 0 0.0022319741547107697
5 O 0 0.00565314432606101
( O 0 0.0043528759852051735
14 O 0 0.006897022016346455
% O 0 0.004820569418370724
) O 0 0.0037536784075200558
of O 0 0.004604892339557409
35 O 0 0.008582043461501598
in O 0 0.0043084160424768925
sporadic O 0 0.008212683722376823
cases O 0 0.0040717776864767075
and O 0 0.004532067570835352
8 O 0 0.008673918433487415
( O 0 0.006631788797676563
80 O 0 0.011825299821794033
% O 0 0.005835236981511116
) O 0 0.004144060891121626
of O 0 0.0050505222752690315
10 O 0 0.008652035146951675
in O 0 0.0077239228412508965
familial O 1 0.9999479055404663
cases O 0 0.012834510765969753
. O 0 0.011797810904681683
. O 0 0.01956998184323311

The O 0 0.04691089689731598
hemochromatosis B-Disease 1 1.0
845 O 1 0.9999998807907104
G O 1 1.0
- O 1 1.0
- O 1 0.9999995231628418
> O 0 0.3126062750816345
A O 0 0.011980284005403519
and O 0 0.006406958680599928
187 O 0 0.022312570363283157
C O 1 0.9964134097099304
- O 1 0.9999974966049194
- O 1 0.9999988079071045
> O 1 0.9998797178268433
G O 1 0.9999470710754395
mutations O 0 0.015757640823721886
: O 0 0.012317825108766556
prevalence O 0 0.0714101791381836
in O 0 0.009519148617982864
non O 1 0.5347285866737366
- O 1 0.9999998807907104
Caucasian O 1 0.9994416832923889
populations O 0 0.022641262039542198
. O 0 0.025391291826963425

Hemochromatosis B-Disease 1 0.9999996423721313
, O 0 0.015754323452711105
the O 0 0.017821840941905975
inherited B-Disease 1 1.0
disorder I-Disease 1 1.0
of I-Disease 1 1.0
iron I-Disease 1 1.0
metabolism I-Disease 1 1.0
, O 0 0.012535419315099716
leads O 1 0.5086702704429626
, O 0 0.005617878865450621
if O 0 0.005156319588422775
untreated O 1 0.9999916553497314
, O 0 0.005038130097091198
to O 0 0.006692889146506786
progressive O 1 0.9999973773956299
iron B-Disease 1 1.0
overload I-Disease 1 1.0
and O 1 0.9966235160827637
premature B-Disease 1 0.9999996423721313
death I-Disease 1 0.9971005320549011
. O 0 0.030712813138961792

The O 0 0.04543444886803627
hemochromatosis B-Disease 1 1.0
gene O 0 0.028674891218543053
, O 0 0.016079645603895187
HFE O 1 1.0
, O 0 0.00988827459514141
recently O 0 0.011703423224389553
has O 0 0.005058656446635723
been O 0 0.004140919540077448
identified O 0 0.005058968439698219
, O 0 0.0032870545983314514
and O 0 0.0031250061001628637
characterization O 0 0.006828991696238518
of O 0 0.004093374591320753
this O 0 0.0037592099979519844
gene O 0 0.0052735391072928905
has O 0 0.0036528892815113068
shown O 0 0.003076238092035055
that O 0 0.0018102989997714758
it O 0 0.0023146129678934813
contains O 0 0.003700366010889411
two O 0 0.002578637795522809
mutations O 0 0.004009116441011429
that O 0 0.002078175311908126
result O 0 0.0037280982360243797
in O 0 0.006328042596578598
amino O 0 0.013874095864593983
acid O 0 0.021858133375644684
substitutions O 0 0.029094215482473373
- O 0 0.09920885413885117
cDNA O 0 0.04491821303963661
nucleotides O 0 0.02878066897392273
845 O 0 0.3211768567562103
G O 1 0.9996106028556824
- O 1 0.999998927116394
- O 1 0.9999980926513672
> O 1 0.9753348231315613
A O 0 0.018042152747511864
( O 0 0.010921910405158997
C282Y O 0 0.3350355923175812
) O 0 0.006027734372764826
and O 0 0.004968940746039152
187 O 0 0.01967870444059372
C O 1 0.9996511936187744
- O 1 0.9999997615814209
- O 1 0.9999998807907104
> O 1 0.9999960660934448
G O 1 0.9999970197677612
( O 0 0.024623574689030647
H63D O 1 0.9999936819076538
) O 0 0.024204721674323082
. O 0 0.028449727222323418

Although O 0 0.03967050835490227
hemochromatosis B-Disease 1 1.0
is O 0 0.011873853392899036
common O 0 0.008623840287327766
in O 0 0.00848427228629589
Caucasians O 1 0.9006956219673157
, O 0 0.00863663014024496
affecting O 0 0.01685870811343193
> O 1 0.9999192953109741
= O 0 0.125933438539505
1 O 0 0.019752541556954384
/ O 0 0.02866975963115692
300 O 0 0.011214609257876873
individuals O 0 0.0029042745009064674
of O 0 0.0036003529094159603
northern O 0 0.00522904796525836
European O 0 0.0055108442902565
origin O 0 0.0038861557841300964
, O 0 0.003851763205602765
it O 0 0.0029097949154675007
has O 0 0.002991265617311001
not O 0 0.0017552132485434413
been O 0 0.00279875542037189
recognized O 0 0.0054824817925691605
in O 0 0.004848003853112459
other O 0 0.004487805534154177
populations O 0 0.010125258006155491
. O 0 0.01734779216349125

The O 0 0.01895909197628498
present O 0 0.011570745147764683
study O 0 0.008692044764757156
used O 0 0.007074113469570875
PCR O 0 0.0253347959369421
and O 0 0.007205226458609104
restriction O 0 0.019467240199446678
- O 1 0.9999997615814209
enzyme O 0 0.023425107821822166
digestion O 0 0.02495327964425087
to O 0 0.006675489246845245
analyze O 0 0.010868518613278866
the O 0 0.005586249753832817
frequency O 0 0.004958510398864746
of O 0 0.003979700151830912
the O 0 0.007594296243041754
845 O 1 0.9999692440032959
G O 1 0.9999994039535522
- O 1 1.0
- O 1 0.9999988079071045
> O 0 0.19334720075130463
A O 0 0.01140432059764862
and O 0 0.005817946046590805
187 O 0 0.023367326706647873
C O 1 0.9941917061805725
- O 1 0.999996542930603
- O 1 0.9999966621398926
> O 1 0.9994059801101685
G O 1 0.9910135865211487
mutations O 0 0.014326953329145908
in O 0 0.01179615966975689
HLA O 1 1.0
- O 1 0.9999901056289673
typed O 0 0.027488429099321365
samples O 0 0.008591563440859318
from O 0 0.007108513731509447
non O 0 0.017722349613904953
- O 1 0.9999599456787109
Caucasian O 1 0.8856898546218872
populations O 0 0.008303573355078697
, O 0 0.007249999325722456
comprising O 0 0.013719023205339909
Australian O 0 0.017702952027320862
Aboriginal O 0 0.018353058025240898
, O 0 0.007572230417281389
Chinese O 0 0.012805581092834473
, O 0 0.007742513902485371
and O 0 0.008812516927719116
Pacific O 0 0.15831618010997772
Islanders O 0 0.06537662446498871
. O 0 0.029720226302742958

Results O 0 0.020077228546142578
showed O 0 0.009689799509942532
that O 0 0.003048960817977786
the O 0 0.006679036654531956
845 O 1 0.9995540976524353
G O 1 0.9999992847442627
- O 1 1.0
- O 1 0.9999998807907104
> O 1 0.9933894872665405
A O 0 0.018527572974562645
mutation O 0 0.013498225249350071
was O 0 0.00904698483645916
present O 0 0.005458873230963945
in O 0 0.004226716235280037
these O 0 0.002579220337793231
populations O 0 0.00419960729777813
( O 0 0.006301613990217447
allele O 0 0.015584150329232216
frequency O 0 0.008256841450929642
0 O 0 0.009184977039694786
. O 0 0.003861943492665887
32 O 0 0.009330769069492817
% O 0 0.005549398250877857
) O 0 0.0043809674680233
, O 0 0.004049826879054308
and O 0 0.0031051135156303644
, O 0 0.003971113823354244
furthermore O 0 0.005093652755022049
, O 0 0.003604642581194639
it O 0 0.003047306090593338
was O 0 0.005695833824574947
always O 0 0.004933341406285763
seen O 0 0.004289975855499506
in O 0 0.003869560081511736
conjunction O 0 0.012044752947986126
with O 0 0.009373713284730911
HLA O 1 1.0
haplotypes O 1 0.9650911688804626
common O 0 0.010282213799655437
in O 0 0.009624280035495758
Caucasians O 1 0.7596202492713928
, O 0 0.0072226556949317455
suggesting O 0 0.008187382481992245
that O 0 0.004688662011176348
845 O 1 0.9949662089347839
G O 1 0.999996542930603
- O 1 1.0
- O 1 1.0
> O 1 0.999782145023346
A O 0 0.01653117500245571
may O 0 0.0046151019632816315
have O 0 0.0025036297738552094
been O 0 0.0029399737250059843
introduced O 0 0.005506653804332018
into O 0 0.0040412661619484425
these O 0 0.0025920416228473186
populations O 0 0.005524830427020788
by O 0 0.007741556968539953
Caucasian O 1 0.9983493089675903
admixture O 1 0.973965585231781
. O 0 0.031144212931394577

187 O 0 0.07299407571554184
C O 1 0.9984007477760315
- O 1 0.9999986886978149
- O 1 0.9999995231628418
> O 1 0.9999759197235107
G O 1 0.9987163543701172
was O 0 0.011159251444041729
present O 0 0.0068818312138319016
at O 0 0.007870209403336048
an O 0 0.006837145891040564
allele O 0 0.01710265316069126
frequency O 0 0.011845343746244907
of O 0 0.012086143717169762
2 O 0 0.027625730261206627
. O 0 0.027122626081109047

68 O 0 0.055913299322128296
% O 0 0.013230451382696629
in O 0 0.006905057467520237
the O 0 0.005751235876232386
two O 0 0.004084254615008831
populations O 0 0.006168153136968613
analyzed O 0 0.010474401526153088
( O 0 0.005981903523206711
Australian O 0 0.01617041602730751
Aboriginal O 0 0.021511467173695564
and O 0 0.008917366154491901
Chinese O 0 0.019042905420064926
) O 0 0.015790127217769623
. O 0 0.021634753793478012

In O 0 0.017230847850441933
the O 0 0.013512366451323032
Australian O 0 0.019648930057883263
Aboriginal O 0 0.018448159098625183
samples O 0 0.008489890024065971
, O 0 0.005741374101489782
187 O 0 0.020224744454026222
C O 1 0.9978854060173035
- O 1 0.9999994039535522
- O 1 0.9999998807907104
> O 1 0.9999948740005493
G O 1 0.9999014139175415
was O 0 0.00991203635931015
found O 0 0.0035707789938896894
to O 0 0.0030410601757466793
be O 0 0.002926015527918935
associated O 0 0.006344711873680353
with O 0 0.007393362931907177
HLA O 1 1.0
haplotypes O 1 0.9936269521713257
common O 0 0.009104766882956028
in O 0 0.009389188140630722
Caucasians O 1 0.9953030347824097
, O 0 0.006815689150243998
suggesting O 0 0.0073353261686861515
that O 0 0.00261777825653553
it O 0 0.0033726387191563845
was O 0 0.007098548114299774
introduced O 0 0.008535068482160568
by O 0 0.004545144736766815
recent O 0 0.012681351974606514
admixture O 0 0.051798515021800995
. O 0 0.02329469472169876

In O 0 0.017807358875870705
the O 0 0.011897996999323368
Chinese O 0 0.014512729831039906
samples O 0 0.009708283469080925
analyzed O 0 0.008887696079909801
, O 0 0.00588056119158864
187 O 0 0.01873236708343029
C O 1 0.981767475605011
- O 1 0.9999990463256836
- O 1 0.9999996423721313
> O 1 0.999954104423523
G O 1 0.9992375373840332
was O 0 0.00968881044536829
present O 0 0.005814461037516594
in O 0 0.0038927181158214808
association O 0 0.005875662434846163
with O 0 0.0031899726018309593
a O 0 0.004733299370855093
wide O 0 0.005603948142379522
variety O 0 0.00610589561983943
of O 0 0.010044447146356106
HLA O 1 1.0
haplotypes O 1 0.992404043674469
, O 0 0.007967337034642696
showing O 0 0.0074080899357795715
this O 0 0.0038329109083861113
mutation O 0 0.0059708356857299805
to O 0 0.002882307395339012
be O 0 0.002880541142076254
widespread O 0 0.004949504975229502
and O 0 0.0037759027909487486
likely O 0 0.004885637667030096
to O 0 0.0050216857343912125
predate O 0 0.017037488520145416
the O 0 0.005046225618571043
more O 0 0.004217241890728474
genetically O 0 0.008765533566474915
restricted O 0 0.009150546044111252
845 O 1 0.9994282126426697
G O 1 0.9999994039535522
- O 1 1.0
- O 1 0.9999997615814209
> O 1 0.9980352520942688
A O 0 0.03922073170542717
mutation O 0 0.03552820160984993
. O 0 0.023081477731466293

Genotype O 1 0.9963531494140625
- O 1 0.999929666519165
phenotype O 0 0.11732712388038635
correlations O 0 0.03978621959686279
in O 0 0.022690318524837494
attenuated B-Disease 1 0.999998927116394
adenomatous I-Disease 1 1.0
polyposis I-Disease 1 1.0
coli I-Disease 1 1.0
. O 0 0.3338942527770996

Germ O 1 0.9999992847442627
- O 1 0.9999496936798096
line O 0 0.022394530475139618
mutations O 0 0.01203683577477932
of O 0 0.008137091994285583
the O 0 0.01664038747549057
tumor B-Disease 1 1.0
suppressor O 1 1.0
APC O 1 0.9999994039535522
are O 0 0.0065245418809354305
implicated O 0 0.02151835337281227
in O 0 0.012807214632630348
attenuated B-Disease 1 0.9999980926513672
adenomatous I-Disease 1 1.0
polyposis I-Disease 1 1.0
coli I-Disease 1 1.0
( O 1 0.9999980926513672
AAPC B-Disease 1 1.0
) O 0 0.01122722215950489
, O 0 0.006602025590837002
a O 0 0.006903072819113731
variant O 0 0.015699617564678192
of O 0 0.014551528729498386
familial B-Disease 1 1.0
adenomatous I-Disease 1 1.0
polyposis I-Disease 1 1.0
( O 1 1.0
FAP B-Disease 1 1.0
) O 0 0.05741031467914581
. O 0 0.03992880508303642

AAPC B-Disease 1 0.9999998807907104
is O 0 0.01673666574060917
recognized O 0 0.01219366118311882
by O 0 0.005729507189244032
the O 0 0.007611360400915146
occurrence O 0 0.012778638862073421
of O 0 0.010741828940808773
< O 1 0.999883770942688
100 O 0 0.04401654377579689
colonic B-Disease 1 1.0
adenomas I-Disease 1 0.9999911785125732
and O 0 0.006272187456488609
a O 0 0.006030941382050514
later O 0 0.009709040634334087
onset O 1 0.9999991655349731
of O 1 0.9999884366989136
colorectal B-Disease 1 1.0
cancer I-Disease 1 1.0
( O 1 0.9886654615402222
age O 1 0.797177255153656
> O 1 0.9999375343322754
40 O 0 0.019042113795876503
years O 0 0.014573665335774422
) O 0 0.014878806658089161
. O 0 0.020659269765019417

The O 0 0.019932275637984276
aim O 0 0.017288602888584137
of O 0 0.0069024390541017056
this O 0 0.003896580543369055
study O 0 0.004817059263586998
was O 0 0.006691633723676205
to O 0 0.00507104117423296
assess O 0 0.02292848378419876
genotype O 1 0.9908434152603149
- O 1 0.9999995231628418
phenotype O 1 0.8866197466850281
correlations O 0 0.03364700824022293
in O 0 0.024681534618139267
AAPC B-Disease 1 1.0
families O 0 0.033291637897491455
. O 0 0.03162581846117973

By O 0 0.01887301541864872
protein O 0 0.024077439680695534
- O 1 0.9959486722946167
truncation O 0 0.3679336905479431
test O 0 0.02678615041077137
( O 0 0.018205346539616585
PTT O 1 0.9997496008872986
) O 0 0.012499137781560421
assay O 0 0.024793686345219612
, O 0 0.005413971375674009
the O 0 0.005777446553111076
entire O 0 0.0095859095454216
coding O 0 0.012537962757050991
region O 0 0.00632577994838357
of O 0 0.0052895015105605125
the O 0 0.008669172413647175
APC B-Disease 1 1.0
gene O 0 0.012810186482965946
was O 0 0.010684419423341751
screened O 0 0.01508472952991724
in O 0 0.005968218203634024
affected O 0 0.006541049107909203
individuals O 0 0.003138717031106353
from O 0 0.005698526278138161
11 O 0 0.056331656873226166
AAPC B-Disease 1 1.0
kindreds O 1 0.9999829530715942
, O 0 0.009437010623514652
and O 0 0.007201447617262602
their O 0 0.007072556298226118
phenotypic O 0 0.021121535450220108
differences O 0 0.013388427905738354
were O 0 0.008437427692115307
examined O 0 0.02927139773964882
. O 0 0.02225561998784542

Five O 0 0.027119820937514305
novel O 0 0.039175618439912796
germ O 1 0.9999996423721313
- O 1 0.9999998807907104
line O 0 0.10740595310926437
APC B-Disease 1 0.9999978542327881
mutations O 0 0.015386405400931835
were O 0 0.005444970913231373
identified O 0 0.006962974555790424
in O 0 0.007796034216880798
seven O 0 0.017067722976207733
kindreds O 1 0.8359631896018982
. O 0 0.027909906581044197

Mutations O 0 0.02982601709663868
were O 0 0.006958557292819023
located O 0 0.01060322392731905
in O 0 0.004285154864192009
three O 0 0.0026136725209653378
different O 0 0.001593012479133904
regions O 0 0.003117889631539583
of O 0 0.00352450180798769
the O 0 0.007033331785351038
APC B-Disease 1 1.0
gene O 0 0.010200664401054382
( O 0 0.0055648223496973515
1 O 0 0.008829046972095966
) O 0 0.0038535618223249912
at O 0 0.004784667398780584
the O 0 0.0038457100745290518
5 O 0 0.0061354138888418674
end O 0 0.006946679204702377
spanning O 0 0.011865095235407352
exons O 0 0.012180067598819733
4 O 0 0.008820363320410252
and O 0 0.004841621965169907
5 O 0 0.007304575759917498
, O 0 0.004834162537008524
( O 0 0.004899519961327314
2 O 0 0.008720366284251213
) O 0 0.004486309830099344
within O 0 0.004143437370657921
exon O 0 0.025756705552339554
9 O 0 0.00976369995623827
, O 0 0.005106771364808083
and O 0 0.0043181185610592365
( O 0 0.0053571416065096855
3 O 0 0.007470737677067518
) O 0 0.004948896821588278
at O 0 0.006981902290135622
the O 0 0.006938618142157793
3 O 0 0.01421684492379427
distal O 0 0.3635517954826355
end O 0 0.010234028100967407
of O 0 0.008981446735560894
the O 0 0.011470921337604523
gene O 0 0.019954057410359383
. O 0 0.020577020943164825

Variability O 0 0.03773367032408714
in O 0 0.008156033232808113
the O 0 0.0062445783987641335
number O 0 0.0061222040094435215
of O 0 0.043621890246868134
colorectal B-Disease 1 1.0
adenomas I-Disease 1 1.0
was O 1 0.9996652603149414
most O 0 0.008083619177341461
apparent O 0 0.010543025098741055
in O 0 0.004438623320311308
individuals O 0 0.0028272063937038183
with O 0 0.0034959036856889725
mutations O 0 0.0044792406260967255
in O 0 0.0031161473598331213
region O 0 0.005051109008491039
1 O 0 0.00607844116166234
, O 0 0.003980260342359543
and O 0 0.005091249011456966
upper O 1 0.9999994039535522
- O 1 1.0
gastrointestinal O 1 1.0
manifestations O 1 0.9999996423721313
were O 0 0.006247096695005894
more O 0 0.006407869979739189
severe O 1 0.9999991655349731
in O 0 0.009963437914848328
them O 0 0.01024093758314848
. O 0 0.02111157961189747

In O 0 0.011351878754794598
individuals O 0 0.004998190328478813
with O 0 0.004932152107357979
mutations O 0 0.005904683843255043
in O 0 0.0033002037089318037
either O 0 0.0031783096492290497
region O 0 0.005538533441722393
2 O 0 0.007343465927988291
or O 0 0.003978286869823933
region O 0 0.007207402493804693
3 O 0 0.006771261338144541
, O 0 0.003461236832663417
the O 0 0.003908911719918251
average O 0 0.005316613707691431
number O 0 0.0034442993346601725
of O 0 0.00622129812836647
adenomas B-Disease 1 0.9999994039535522
tended O 0 0.012481562793254852
to O 0 0.004661662969738245
be O 0 0.0034814646933227777
lower O 0 0.0052370307967066765
than O 0 0.002479572081938386
those O 0 0.001872097491286695
in O 0 0.0022433078847825527
individuals O 0 0.0019215141655877233
with O 0 0.0029436969198286533
mutations O 0 0.004506400786340237
in O 0 0.0032065652776509523
region O 0 0.005745354574173689
1 O 0 0.007268610876053572
, O 0 0.0035897239577025175
although O 0 0.0035499443765729666
age O 0 0.007403844501823187
at O 0 0.025625871494412422
diagnosis O 1 1.0
was O 0 0.3587925136089325
similar O 0 0.013692270964384079
. O 0 0.01888330467045307

In O 0 0.02057179994881153
all O 0 0.02081969752907753
AAPC B-Disease 1 1.0
kindreds O 1 0.958072304725647
, O 0 0.00977274402976036
a O 0 0.008164709433913231
predominance O 0 0.03332749381661415
of O 0 0.009186425246298313
right O 0 0.4367014169692993
- O 1 1.0
sided O 1 1.0
colorectal B-Disease 1 1.0
adenomas I-Disease 1 1.0
and O 1 0.9999996423721313
rectal B-Disease 1 1.0
polyp I-Disease 1 1.0
sparing O 1 1.0
was O 1 0.9495431780815125
observed O 0 0.02878027968108654
. O 0 0.027008574455976486

No O 0 0.03743933513760567
desmoid B-Disease 1 0.9999992847442627
tumors I-Disease 1 0.9999998807907104
were O 0 0.009033720009028912
found O 0 0.006604245863854885
in O 0 0.0072705927304923534
these O 0 0.007881313562393188
kindreds O 0 0.2842158377170563
. O 0 0.024667151272296906

Our O 0 0.021221278235316277
data O 0 0.008842848241329193
suggest O 0 0.007822566665709019
that O 0 0.0033071874640882015
, O 0 0.006139538250863552
in O 0 0.009248165413737297
AAPC B-Disease 1 1.0
families O 0 0.008887973614037037
, O 0 0.004960750229656696
the O 0 0.004591435194015503
location O 0 0.005032598040997982
of O 0 0.0052552781999111176
the O 0 0.009589587338268757
APC B-Disease 1 1.0
mutation O 0 0.4669772684574127
may O 0 0.010750994086265564
partially O 0 0.0195515938103199
predict O 0 0.01635606959462166
specific O 0 0.009917222894728184
phenotypic O 0 0.031070630997419357
expression O 0 0.024343131110072136
. O 0 0.024974161759018898

This O 0 0.011391130276024342
should O 0 0.00680899154394865
help O 0 0.00746279489248991
in O 0 0.004121910780668259
the O 0 0.004328940063714981
design O 0 0.008363448083400726
of O 0 0.006092559080570936
tailored O 1 0.9169289469718933
clinical O 1 1.0
- O 1 1.0
management O 1 0.9823079109191895
protocols O 0 0.01778852939605713
in O 0 0.005553894676268101
this O 0 0.0043917023576796055
subset O 0 0.018267100676894188
of O 0 0.017908569425344467
FAP B-Disease 1 1.0
patients O 1 0.9999998807907104
. O 0 0.0181113351136446
. O 0 0.02467428520321846

Wilms B-Disease 1 1.0
' I-Disease 1 0.9996942281723022
tumor I-Disease 1 0.9999986886978149
1 O 0 0.02113320864737034
and O 0 0.013205300085246563
Dax O 1 1.0
- O 1 0.9999983310699463
1 O 0 0.021426480263471603
modulate O 0 0.03412262350320816
the O 0 0.011015009135007858
orphan O 1 0.9063706398010254
nuclear O 0 0.02781827002763748
receptor O 0 0.06028721109032631
SF O 1 1.0
- O 1 0.9999674558639526
1 O 0 0.01355609018355608
in O 0 0.0063002766110002995
sex O 0 0.013247620314359665
- O 1 0.9876711368560791
specific O 0 0.010025612078607082
gene O 0 0.015752501785755157
expression O 0 0.018126972019672394
. O 0 0.02172841690480709

Products O 0 0.03302428498864174
of O 0 0.017024358734488487
steroidogenic O 1 0.9999721050262451
factor O 0 0.02354787103831768
1 O 0 0.017361292615532875
( O 0 0.012405450455844402
SF O 1 1.0
- O 1 0.9999997615814209
1 O 0 0.015406936407089233
) O 0 0.006293909158557653
and O 0 0.009576933458447456
Wilms B-Disease 1 1.0
tumor I-Disease 1 1.0
1 O 1 0.9902116656303406
( O 0 0.02087588608264923
WT1 O 1 0.9999996423721313
) O 0 0.012006484903395176
genes O 0 0.008151743561029434
are O 0 0.002490655053406954
essential O 0 0.007387077901512384
for O 0 0.006243223324418068
mammalian O 0 0.020483970642089844
gonadogenesis O 1 0.9846758246421814
prior O 0 0.011278615333139896
to O 0 0.010148606263101101
sexual O 0 0.021152375265955925
differentiation O 0 0.0700068548321724
. O 0 0.026738962158560753

In O 0 0.015025901608169079
males O 0 0.01454008836299181
, O 0 0.013841734267771244
SF O 1 1.0
- O 1 1.0
1 O 0 0.022753071039915085
participates O 0 0.01836574450135231
in O 0 0.0071046375669538975
sexual O 0 0.008488793857395649
development O 0 0.00658884784206748
by O 0 0.004398124758154154
regulating O 0 0.010696442797780037
expression O 0 0.006762525532394648
of O 0 0.008025002665817738
the O 0 0.015516362152993679
polypeptide O 1 0.9998339414596558
hormone O 1 0.9986612796783447
Mullerian O 1 1.0
inhibiting O 1 0.9999542236328125
substance O 1 0.9998817443847656
( O 0 0.08865656703710556
MIS O 1 0.9999998807907104
) O 0 0.029004884883761406
. O 0 0.02962351217865944

Here O 0 0.026117172092199326
, O 0 0.011149690486490726
we O 0 0.006568497978150845
show O 0 0.00973375141620636
that O 0 0.008765057660639286
WT1 O 1 0.9999948740005493
- O 1 0.9999984502792358
KTS O 1 0.9999983310699463
isoforms O 0 0.03197041153907776
associate O 0 0.020982882007956505
and O 0 0.008553828112781048
synergize O 1 0.8911368250846863
with O 0 0.012396643869578838
SF O 1 1.0
- O 1 1.0
1 O 0 0.01895914040505886
to O 0 0.01141639519482851
promote O 0 0.032114334404468536
MIS O 1 0.999998927116394
expression O 0 0.034455958753824234
. O 0 0.03341894596815109

In O 0 0.025540797039866447
contrast O 0 0.02907603792846203
, O 0 0.020757459104061127
WT1 O 1 0.9999949932098389
missense O 0 0.16980290412902832
mutations O 0 0.014840919524431229
, O 0 0.007129220757633448
associated O 0 0.0065820347517728806
with O 0 0.005105390679091215
male B-Disease 0 0.013905772008001804
pseudohermaphroditism I-Disease 1 0.9999960660934448
in O 0 0.014527441002428532
Denys B-Disease 1 1.0
- I-Disease 1 1.0
Drash I-Disease 1 1.0
syndrome I-Disease 1 1.0
, O 0 0.01562938280403614
fail O 0 0.017497224733233452
to O 0 0.00887913629412651
synergize O 1 0.9994296431541443
with O 0 0.01803034357726574
SF O 1 1.0
- O 1 1.0
1 O 0 0.04852135479450226
. O 0 0.031246809288859367

Additionally O 0 0.02675565704703331
, O 0 0.009354683570563793
the O 0 0.009631677530705929
X O 1 0.9998258948326111
- O 1 0.9999953508377075
linked O 0 0.015951821580529213
, O 0 0.007193086203187704
candidate O 0 0.014790049754083157
dosage O 1 0.9999834299087524
- O 1 0.9999947547912598
sensitive O 0 0.019009899348020554
sex O 0 0.014685649424791336
- O 1 0.9992483258247375
reversal O 0 0.01976231299340725
gene O 0 0.010747079737484455
, O 0 0.009676537476480007
Dax O 1 1.0
- O 1 0.9999977350234985
1 O 0 0.015048332512378693
, O 0 0.009149832651019096
antagonizes O 0 0.4699394106864929
synergy O 0 0.055686548352241516
between O 0 0.01215155329555273
SF O 1 1.0
- O 1 0.9999998807907104
1 O 0 0.020023049786686897
and O 0 0.011471493169665337
WT1 O 1 0.9999984502792358
, O 0 0.008221721276640892
most O 0 0.004379791207611561
likely O 0 0.004878673702478409
through O 0 0.002876737853512168
a O 0 0.0038771142717450857
direct O 0 0.00518499780446291
interaction O 0 0.006881264969706535
with O 0 0.008941369131207466
SF O 1 1.0
- O 1 1.0
1 O 0 0.04412947595119476
. O 0 0.027486613020300865

We O 0 0.016436917707324028
propose O 0 0.023186583071947098
that O 0 0.008311339654028416
WT1 O 1 0.9998977184295654
and O 0 0.01637660525739193
Dax O 1 1.0
- O 1 1.0
1 O 0 0.02480502240359783
functionally O 0 0.025346772745251656
oppose O 0 0.01262478344142437
each O 0 0.004471053835004568
other O 0 0.004132586065679789
in O 0 0.005737286992371082
testis O 1 0.8021650314331055
development O 0 0.008690113201737404
by O 0 0.007372885011136532
modulating O 1 0.9998412132263184
SF O 1 1.0
- O 1 1.0
1 O 1 0.8708901405334473
- O 1 0.999998927116394
mediated O 1 0.671455442905426
transactivation O 1 0.9990021586418152
. O 0 0.019333627074956894
. O 0 0.0282706618309021

A O 0 0.04069129750132561
mouse O 0 0.040078695863485336
model O 0 0.019597075879573822
for O 0 0.016580522060394287
Prader B-Disease 1 1.0
- I-Disease 1 1.0
Willi I-Disease 1 1.0
syndrome I-Disease 1 1.0
imprinting O 1 1.0
- O 1 1.0
centre O 1 0.9999926090240479
mutations O 0 0.04557507485151291
. O 0 0.028924565762281418

Imprinting O 0 0.08778823912143707
in O 0 0.013203417882323265
the O 0 0.014856724068522453
15q11 O 1 0.9999417066574097
- O 1 0.9999918937683105
q13 O 1 0.8491464853286743
region O 0 0.013516015373170376
involves O 0 0.01069771870970726
an O 0 0.008402015082538128
imprinting O 1 0.9504385590553284
centre O 1 0.9840301275253296
( O 0 0.022263066843152046
IC O 1 1.0
) O 0 0.007992371916770935
, O 0 0.005357649642974138
mapping O 0 0.008094553835690022
in O 0 0.0034376527182757854
part O 0 0.005054731387645006
to O 0 0.004379145801067352
the O 0 0.007634778041392565
promoter O 1 0.663675844669342
and O 0 0.0074306754395365715
first O 0 0.014600307680666447
exon O 0 0.12564146518707275
of O 0 0.022707341238856316
SNRPN O 1 0.9999959468841553
. O 0 0.0350833535194397

Deletion O 0 0.06355118006467819
of O 0 0.016525983810424805
this O 0 0.01051739789545536
IC O 1 0.9999961853027344
abolishes O 1 0.99643874168396
local O 0 0.013491058722138405
paternally O 0 0.15712158381938934
derived O 0 0.011723443865776062
gene O 0 0.007623384706676006
expression O 0 0.004803067073225975
and O 0 0.003841642290353775
results O 0 0.005775625351816416
in O 0 0.009876255877315998
Prader B-Disease 1 1.0
- I-Disease 1 1.0
Willi I-Disease 1 1.0
syndrome I-Disease 1 1.0
( O 1 0.9999998807907104
PWS B-Disease 1 1.0
) O 0 0.04336164891719818
. O 0 0.04281565919518471

We O 0 0.013178670778870583
have O 0 0.005723925773054361
created O 0 0.010068381205201149
two O 0 0.005804777145385742
deletion O 0 0.02130189910531044
mutations O 0 0.010511286556720734
in O 0 0.0064947460778057575
mice O 0 0.011843523941934109
to O 0 0.0066811381839215755
understand O 0 0.015000276267528534
PWS B-Disease 1 1.0
and O 0 0.007202484644949436
the O 0 0.006750639993697405
mechanism O 0 0.01005429495126009
of O 0 0.00861450470983982
this O 0 0.01056883204728365
IC O 1 0.9999991655349731
. O 0 0.030548999086022377

Mice O 0 0.09394622594118118
harbouring O 1 0.5752403736114502
an O 0 0.021450677886605263
intragenic O 1 0.9995662569999695
deletion O 0 0.04929867759346962
in O 0 0.015971362590789795
Snrpn O 1 0.9995947480201721
are O 0 0.007422426249831915
phenotypically O 0 0.07039500772953033
normal O 0 0.009455532766878605
, O 0 0.005433510057628155
suggesting O 0 0.006607587914913893
that O 0 0.003329775296151638
mutations O 0 0.007365470286458731
of O 0 0.007385983131825924
SNRPN O 1 0.9999996423721313
are O 0 0.0031208579894155264
not O 0 0.0038444718811661005
sufficient O 0 0.010534551925957203
to O 0 0.014001150615513325
induce O 1 0.9888309836387634
PWS B-Disease 1 1.0
. O 0 0.05143508315086365

Mice O 0 0.04428645595908165
with O 0 0.00914161279797554
a O 0 0.010594428516924381
larger O 0 0.012145315296947956
deletion O 0 0.01855175569653511
involving O 0 0.008935226127505302
both O 0 0.006363151594996452
Snrpn O 1 0.9917511343955994
and O 0 0.006205410696566105
the O 0 0.01139796245843172
putative O 1 0.999980092048645
PWS O 1 1.0
- O 1 1.0
IC O 1 0.9999998807907104
lack O 0 0.012709620408713818
expression O 0 0.00853028055280447
of O 0 0.0070737251080572605
the O 0 0.009440185502171516
imprinted O 1 0.9996254444122314
genes O 0 0.016779927536845207
Zfp127 O 1 0.999971866607666
( O 0 0.012084822170436382
mouse O 0 0.03097747452557087
homologue O 0 0.06852935999631882
of O 0 0.01441399659961462
ZNF127 O 1 1.0
) O 0 0.012629253789782524
, O 0 0.014007728546857834
Ndn O 1 0.9999918937683105
and O 0 0.015413781628012657
Ipw O 1 0.9998243451118469
, O 0 0.011172630824148655
and O 0 0.006776352412998676
manifest O 0 0.01611478440463543
several O 0 0.005914067383855581
phenotypes O 0 0.046143751591444016
common O 0 0.01144369039684534
to O 0 0.1263662427663803
PWS B-Disease 1 1.0
infants O 1 0.9999998807907104
. O 0 0.04254724085330963

These O 0 0.010357406921684742
data O 0 0.006946646608412266
demonstrate O 0 0.009458517655730247
that O 0 0.0031129582785069942
both O 0 0.002736914437264204
the O 0 0.003915028180927038
position O 0 0.0055746412836015224
of O 0 0.005086283199489117
the O 0 0.008785180747509003
IC O 1 0.9999997615814209
and O 0 0.006298622582107782
its O 0 0.006205216981470585
role O 0 0.006793508771806955
in O 0 0.004398899152874947
the O 0 0.005459168925881386
coordinate O 0 0.010379905812442303
expression O 0 0.0063239336013793945
of O 0 0.006379903294146061
genes O 0 0.006008913274854422
is O 0 0.003908699844032526
conserved O 0 0.008395365439355373
between O 0 0.005237680859863758
mouse O 0 0.01646401360630989
and O 0 0.004283364862203598
human O 0 0.004493556451052427
, O 0 0.004285923670977354
and O 0 0.00327616510912776
indicate O 0 0.003730332711711526
that O 0 0.0025432677939534187
the O 0 0.004737405572086573
mouse O 0 0.013860559090971947
is O 0 0.0038002044893801212
a O 0 0.004383035935461521
suitable O 0 0.00826096162199974
model O 0 0.007607751991599798
system O 0 0.004921753890812397
in O 0 0.003283816622570157
which O 0 0.00203071441501379
to O 0 0.0022736391983926296
investigate O 0 0.005756304133683443
the O 0 0.0046746195293962955
molecular O 0 0.00843864120543003
mechanisms O 0 0.006918584927916527
of O 0 0.007402123883366585
imprinting O 1 0.8939395546913147
in O 0 0.0047887773253023624
this O 0 0.0034202649258077145
region O 0 0.0061716437339782715
of O 0 0.005838216748088598
the O 0 0.009430261328816414
genome O 0 0.020301327109336853
. O 0 0.01266445405781269
. O 0 0.020161213353276253

Mutations O 0 0.024006923660635948
of O 0 0.010438734665513039
the O 0 0.010963547974824905
ATM O 1 0.9101565480232239
gene O 0 0.012160101905465126
detected O 0 0.00936218909919262
in O 0 0.0068812184035778046
Japanese O 1 0.8378987312316895
ataxia B-Disease 1 1.0
- I-Disease 1 1.0
telangiectasia I-Disease 1 1.0
patients O 1 0.9999990463256836
: O 0 0.01157460082322359
possible O 0 0.008729455061256886
preponderance O 0 0.03938056901097298
of O 0 0.006552188657224178
the O 0 0.006588298361748457
two O 0 0.00707901269197464
founder O 1 0.9748221635818481
mutations O 0 0.024669090285897255
4612del165 O 1 0.999093770980835
and O 0 0.019401786848902702
7883del5 O 1 0.9997541308403015
. O 0 0.034497231245040894

The O 0 0.02450881153345108
ATM O 0 0.23522420227527618
( O 0 0.010536023415625095
A O 1 0.9970628619194031
- O 1 1.0
T O 1 1.0
, O 0 0.01025098655372858
mutated O 0 0.021870819851756096
) O 0 0.007019508630037308
gene O 0 0.006373425479978323
on O 0 0.006066442467272282
human O 0 0.01116732694208622
chromosome O 0 0.03896840661764145
11q22 O 1 0.9994266033172607
. O 0 0.031669747084379196

3 O 0 0.02654316835105419
has O 0 0.009389533661305904
recently O 0 0.010516340844333172
been O 0 0.004212294239550829
identified O 0 0.004168043378740549
as O 0 0.0031004175543785095
the O 0 0.004556684289127588
gene O 0 0.004411769565194845
responsible O 0 0.0033928065095096827
for O 0 0.0023718667216598988
the O 0 0.0037258341908454895
human O 0 0.0069392104633152485
recessive B-Disease 1 1.0
disease I-Disease 1 1.0
ataxia B-Disease 1 1.0
- I-Disease 1 1.0
telangiectasia I-Disease 1 1.0
( O 1 0.9816909432411194
A B-Disease 1 1.0
- I-Disease 1 1.0
T I-Disease 1 1.0
) O 0 0.024328049272298813
. O 0 0.02677788957953453

In O 0 0.013855330646038055
order O 0 0.009214252233505249
to O 0 0.0053391470573842525
define O 0 0.007685043383389711
the O 0 0.004722457844763994
types O 0 0.006051218137145042
of O 0 0.008913573808968067
disease O 1 1.0
- O 1 1.0
causing O 1 0.9999698400497437
ATM O 1 0.9999830722808838
mutations O 0 0.007453341037034988
in O 0 0.004133493173867464
Japanese O 0 0.012527849525213242
A B-Disease 1 0.9993460774421692
- I-Disease 1 1.0
T I-Disease 1 1.0
patients O 1 0.9999575614929199
as O 0 0.005003803875297308
well O 0 0.0040873512625694275
as O 0 0.003765867790207267
to O 0 0.004084948915988207
look O 0 0.006600868422538042
for O 0 0.004032386001199484
possible O 0 0.0076335035264492035
mutational O 1 0.9906630516052246
hotspots O 1 0.9689993262290955
, O 0 0.010024619288742542
reverse O 0 0.026950392872095108
- O 1 0.9998981952667236
transcribed O 0 0.020274408161640167
RNA O 0 0.01787218451499939
derived O 0 0.00611891457810998
from O 0 0.004368533380329609
ten O 0 0.009479970671236515
patients O 0 0.011801758781075478
belonging O 0 0.006535684689879417
to O 0 0.003428881522268057
eight O 0 0.004944523796439171
unrelated O 0 0.007613431196659803
Japanese O 0 0.012096014805138111
A B-Disease 1 0.9998576641082764
- I-Disease 1 1.0
T I-Disease 1 1.0
families O 0 0.00821793731302023
was O 0 0.00952569767832756
analyzed O 0 0.010044381022453308
for O 0 0.006041617598384619
mutations O 0 0.007547073066234589
by O 0 0.003965297248214483
the O 0 0.007739814464002848
restriction O 0 0.023922443389892578
endonuclease O 1 0.773727297782898
fingerprinting O 0 0.04530971124768257
method O 0 0.02255045808851719
. O 0 0.022955873981118202

As O 0 0.016066795215010643
has O 0 0.008439678698778152
been O 0 0.00496149156242609
reported O 0 0.0061933244578540325
by O 0 0.0031612662132829428
others O 0 0.00442572170868516
, O 0 0.004889477975666523
mutations O 0 0.0053026750683784485
that O 0 0.0026938142254948616
lead O 0 0.007599994074553251
to O 0 0.007291838061064482
exon O 0 0.11578454077243805
skipping O 0 0.027308033779263496
or O 0 0.008478891104459763
premature O 1 0.9460470676422119
protein O 0 0.013451876118779182
truncation O 0 0.024911466985940933
were O 0 0.004611452110111713
also O 0 0.006413166411221027
predominant O 0 0.015361987985670567
in O 0 0.007854870520532131
our O 0 0.014618760906159878
mutants O 0 0.048784397542476654
. O 0 0.023535875603556633

Six O 0 0.019323866814374924
different O 0 0.006008130498230457
mutations O 0 0.00853946153074503
were O 0 0.0034526570234447718
identified O 0 0.004023001063615084
on O 0 0.0033305459655821323
12 O 0 0.0047162603586912155
of O 0 0.004722989164292812
the O 0 0.00636476743966341
16 O 0 0.014632422477006912
alleles O 0 0.02585548721253872
examined O 0 0.032051656395196915
. O 0 0.025407634675502777

Four O 0 0.019741909578442574
were O 0 0.00999696459621191
deletions O 0 0.02454625442624092
involving O 0 0.010646757669746876
a O 0 0.00949125736951828
loss O 0 0.01873803697526455
of O 0 0.008137946017086506
a O 0 0.009512380696833134
single O 0 0.016882259398698807
exon O 0 0.07238002121448517
exon O 0 0.05550386384129524
7 O 0 0.019341565668582916
, O 0 0.011270318180322647
exon O 0 0.0401732437312603
16 O 0 0.01723325252532959
, O 0 0.011439948342740536
exon O 0 0.045751266181468964
33 O 0 0.02527233213186264
or O 0 0.013435648754239082
exon O 0 0.06478375941514969
35 O 0 0.03599386662244797
. O 0 0.024825770407915115

The O 0 0.024615703150629997
others O 0 0.01085992157459259
were O 0 0.00706088962033391
minute O 0 0.018787190318107605
deletions O 0 0.02537550963461399
, O 0 0.01132984645664692
4649delA O 1 0.5690324902534485
in O 0 0.011275764554738998
exon O 0 0.08053284138441086
33 O 0 0.02597680129110813
and O 0 0.012824423611164093
7883del5 O 0 0.06856570392847061
in O 0 0.018918508663773537
exon O 0 0.15887005627155304
55 O 0 0.052830617874860764
. O 0 0.031329285353422165

The O 0 0.030185284093022346
mutations O 0 0.033199917525053024
4612del165 O 1 0.9847464561462402
and O 0 0.01154341734945774
7883del5 O 1 0.998382568359375
were O 0 0.005600266624242067
found O 0 0.004495111759752035
in O 0 0.003026899415999651
more O 0 0.0022199705708771944
than O 0 0.002779584378004074
two O 0 0.002871263539418578
unrelated O 0 0.0064661200158298016
families O 0 0.00400213897228241
; O 0 0.004500885494053364
44 O 0 0.008846594020724297
% O 0 0.004499669652432203
( O 0 0.004171299748122692
7 O 0 0.0067568616941571236
of O 0 0.0046478379517793655
16 O 0 0.006689118221402168
) O 0 0.004034905228763819
of O 0 0.00436479551717639
the O 0 0.006942009553313255
mutant O 0 0.022075863555073738
alleles O 0 0.012140299193561077
had O 0 0.005555449053645134
one O 0 0.003947976976633072
of O 0 0.004015858750790358
the O 0 0.005972737912088633
two O 0 0.008379582315683365
mutations O 0 0.0173936877399683
. O 0 0.015508954413235188

The O 0 0.036329109221696854
4612del165 O 1 0.9995588660240173
mutations O 0 0.015208669006824493
in O 0 0.005765298381447792
three O 0 0.003984970040619373
different O 0 0.0021264217793941498
families O 0 0.003664290299639106
were O 0 0.0021991345565766096
all O 0 0.0029135076329112053
ascribed O 0 0.008249394595623016
to O 0 0.0030225743539631367
the O 0 0.003799650352448225
same O 0 0.005567435175180435
T O 1 1.0
- O 1 1.0
- O 1 0.9999998807907104
> O 1 0.9438027739524841
A O 0 0.012142501771450043
substitution O 0 0.012578994035720825
at O 0 0.008634609170258045
the O 0 0.009198594838380814
splice O 0 0.03819173946976662
donor O 0 0.021943168714642525
site O 0 0.02050745114684105
in O 0 0.01502147689461708
intron O 1 0.999330997467041
33 O 0 0.047670308500528336
. O 0 0.029921744018793106

Microsatellite O 1 0.9614958167076111
genotyping O 0 0.08659124374389648
around O 0 0.013918423093855381
the O 0 0.013489783741533756
ATM O 1 0.9992731213569641
locus O 1 0.9636946320533752
also O 0 0.006982394959777594
indicated O 0 0.005326898768544197
that O 0 0.002293811645358801
a O 0 0.00442312378436327
common O 0 0.004799808841198683
haplotype O 0 0.03401030972599983
was O 0 0.008195863105356693
shared O 0 0.007874240167438984
by O 0 0.003555899951606989
the O 0 0.006972779985517263
mutant O 0 0.041713353246450424
alleles O 0 0.01512084063142538
in O 0 0.007450995966792107
both O 0 0.009993944317102432
mutations O 0 0.020619269460439682
. O 0 0.01846715621650219

This O 0 0.012669475749135017
suggests O 0 0.0101731913164258
that O 0 0.0028855635318905115
these O 0 0.0023576298262923956
two O 0 0.0042945039458572865
founder O 1 0.9982123374938965
mutations O 0 0.010221309959888458
may O 0 0.004696608521044254
be O 0 0.004422938916832209
predominant O 0 0.015039563179016113
among O 0 0.01012298371642828
Japanese O 0 0.04016062989830971
ATM O 1 0.996953010559082
mutant O 0 0.07794947922229767
alleles O 0 0.05083121731877327
. O 0 0.029033593833446503

W474C O 1 0.9981628060340881
amino O 0 0.052664030343294144
acid O 0 0.05453905090689659
substitution O 0 0.029020655900239944
affects O 0 0.019051603972911835
early O 0 0.008282811380922794
processing O 0 0.008561491034924984
of O 0 0.006340363062918186
the O 0 0.008563312701880932
alpha O 0 0.028400195762515068
- O 0 0.06053055077791214
subunit O 0 0.02020327001810074
of O 0 0.00822994951158762
beta O 0 0.03361828625202179
- O 1 0.9999892711639404
hexosaminidase O 1 0.9723328351974487
A O 0 0.01149070169776678
and O 0 0.004428333602845669
is O 0 0.0038500726222991943
associated O 0 0.005631372798234224
with O 0 0.008186105638742447
subacute O 1 1.0
G B-Disease 1 1.0
( I-Disease 1 0.9816664457321167
M2 I-Disease 1 0.9999998807907104
) I-Disease 0 0.02751181647181511
gangliosidosis I-Disease 1 0.528170645236969
. O 0 0.03849947452545166

Mutations O 0 0.03725822642445564
in O 0 0.013176660984754562
the O 0 0.018060974776744843
HEXA O 1 0.9999991655349731
gene O 0 0.014254597947001457
, O 0 0.005734201055020094
encoding O 0 0.007779071573168039
the O 0 0.007211579941213131
alpha O 0 0.02449905499815941
- O 0 0.3190162777900696
subunit O 0 0.019613763317465782
of O 0 0.008531445637345314
beta O 0 0.03271620348095894
- O 1 0.9997467398643494
hexosaminidase O 1 0.6957160830497742
A O 0 0.016712147742509842
( O 0 0.010447653010487556
Hex O 0 0.047673311084508896
A O 0 0.015855513513088226
) O 0 0.006605484988540411
, O 0 0.00534754479303956
that O 0 0.0038499434012919664
abolish O 0 0.024958061054348946
Hex O 0 0.040558841079473495
A O 0 0.015297459438443184
enzyme O 0 0.01450223010033369
activity O 0 0.007991472259163857
cause O 0 0.35238465666770935
Tay B-Disease 1 1.0
- I-Disease 1 1.0
Sachs I-Disease 1 1.0
disease I-Disease 1 1.0
( O 1 0.9995962977409363
TSD B-Disease 1 1.0
) O 0 0.009141539223492146
, O 0 0.005591722205281258
the O 0 0.007964138872921467
fatal O 1 0.9998593330383301
infantile B-Disease 1 0.9999998807907104
form I-Disease 0 0.009841855615377426
of I-Disease 0 0.4789930284023285
G I-Disease 1 1.0
( I-Disease 0 0.23458896577358246
M2 I-Disease 1 0.9999998807907104
) I-Disease 0 0.011318502016365528
gangliosidosis I-Disease 1 0.7844611406326294
, I-Disease 0 0.012746850028634071
Type I-Disease 0 0.02876562997698784
1 I-Disease 0 0.029219945892691612
. O 0 0.0230406504124403

Less O 0 0.025243256241083145
severe O 1 0.9996240139007568
, O 0 0.01882341131567955
subacute O 1 1.0
( O 1 0.6159656643867493
juvenile O 1 1.0
- O 1 1.0
onset O 1 1.0
) O 0 0.010669504292309284
and O 0 0.047303471714258194
chronic O 1 1.0
( O 1 0.7424213886260986
adult O 1 0.9991793036460876
- O 1 1.0
onset O 1 1.0
) O 0 0.008580714464187622
variants O 0 0.00926904659718275
are O 0 0.0022631697356700897
characterized O 0 0.004523956682533026
by O 0 0.0023577329702675343
a O 0 0.004496667999774218
broad O 0 0.00888363178819418
spectrum O 0 0.01499194372445345
of O 0 0.016858352348208427
clinical O 1 1.0
manifestations O 1 0.999998927116394
and O 0 0.00649917172268033
are O 0 0.002792075974866748
associated O 0 0.004424824379384518
with O 0 0.004349053837358952
residual O 1 0.9991376399993896
levels O 0 0.009506389498710632
of O 0 0.011586270295083523
Hex O 1 0.8874296545982361
A O 0 0.07624509930610657
enzyme O 0 0.02928060293197632
activity O 0 0.018870214000344276
. O 0 0.022587811574339867

We O 0 0.012921536341309547
identified O 0 0.01221791747957468
a O 0 0.014369958080351353
1422 O 1 0.9999959468841553
G O 1 0.9999991655349731
- O 1 0.9999998807907104
- O 1 0.9999997615814209
> O 1 0.9999583959579468
C O 1 0.9988566637039185
( O 0 0.014776700176298618
amino O 0 0.019443251192569733
acid O 0 0.03382866457104683
W474C O 1 0.9316755533218384
) O 0 0.010339466854929924
substitution O 0 0.012461642734706402
in O 0 0.004568669479340315
the O 0 0.005170594900846481
first O 0 0.006074320059269667
position O 0 0.007567913271486759
of O 0 0.006864852737635374
exon O 0 0.03021419420838356
13 O 0 0.0105621088296175
of O 0 0.00896777305752039
HEXA O 1 0.9999810457229614
of O 0 0.008288411423563957
a O 0 0.010540020652115345
non O 0 0.022437911480665207
- O 1 0.999983549118042
Jewish O 0 0.02192908339202404
proband O 1 0.984468400478363
who O 0 0.014652014710009098
manifested O 0 0.03300417587161064
a O 0 0.0181142408400774
subacute O 1 1.0
variant O 1 0.8822643160820007
of O 0 0.3014194369316101
G B-Disease 1 1.0
( I-Disease 0 0.4311535656452179
M2 I-Disease 1 0.9999997615814209
) I-Disease 0 0.02468997612595558
gangliosidosis I-Disease 1 0.7141357660293579
. O 0 0.032872274518013

On O 0 0.017212536185979843
the O 0 0.015407108701765537
second O 0 0.03013439103960991
maternally O 1 0.9999366998672485
inherited O 1 0.9999997615814209
allele O 0 0.03234280273318291
, O 0 0.005519806873053312
we O 0 0.003053487977012992
identified O 0 0.004000181332230568
the O 0 0.004276293329894543
common O 0 0.013775099068880081
infantile O 1 1.0
disease O 1 1.0
- O 1 1.0
causing O 1 0.9999997615814209
4 O 1 0.9959719777107239
- O 1 0.9999969005584717
bp O 0 0.04578046128153801
insertion O 0 0.03463921323418617
, O 0 0.01596219837665558
+ O 1 0.5546731352806091
TATC O 1 0.9999982118606567
1278 O 1 0.9999971389770508
, O 0 0.01742240972816944
in O 0 0.016415661200881004
exon O 0 0.077634796500206
11 O 0 0.03290925174951553
. O 0 0.029429912567138672

Pulse O 1 0.9979459643363953
- O 1 0.9970666766166687
chase O 0 0.035777393728494644
analysis O 0 0.009891421534121037
using O 0 0.012327782809734344
proband O 1 0.9908509850502014
fibroblasts O 0 0.04113146290183067
revealed O 0 0.010142884217202663
that O 0 0.0032475267071276903
the O 0 0.006918297149240971
W474C O 1 0.9980559349060059
- O 1 0.9991809725761414
containing O 0 0.014276498928666115
alpha O 0 0.04092421010136604
- O 1 0.9963305592536926
subunit O 0 0.03141862899065018
precursor O 0 0.024356668815016747
was O 0 0.013448003679513931
normally O 0 0.012337698601186275
synthesized O 0 0.018188009038567543
, O 0 0.0065419417805969715
but O 0 0.003913726657629013
not O 0 0.003982502967119217
phosphorylated O 0 0.030692989006638527
or O 0 0.00773177295923233
secreted O 0 0.01683860458433628
, O 0 0.005528808571398258
and O 0 0.004872108343988657
the O 0 0.007274180185049772
mature O 0 0.023599447682499886
lysosomal O 1 0.999997615814209
alpha O 1 0.9883272051811218
- O 1 0.9999954700469971
subunit O 0 0.03688444197177887
was O 0 0.015231954865157604
not O 0 0.008728564716875553
detected O 0 0.023562047630548477
. O 0 0.020826030522584915

When O 0 0.021604524925351143
the O 0 0.016036257147789
W474C O 1 0.7293142676353455
- O 1 0.9937937259674072
containing O 0 0.019146159291267395
alpha O 0 0.03938087075948715
- O 1 0.9923415184020996
subunit O 0 0.029964473098516464
was O 0 0.01600220985710621
transiently O 0 0.07225579023361206
co O 0 0.27905237674713135
- O 1 0.880269467830658
expressed O 0 0.006420934107154608
with O 0 0.0042333174496889114
the O 0 0.0071053775027394295
beta O 0 0.16708946228027344
- O 1 0.9971501231193542
subunit O 0 0.018744030967354774
to O 0 0.006082057487219572
produce O 0 0.008380881510674953
Hex O 0 0.032223813235759735
A O 0 0.013196529820561409
( O 0 0.009027384221553802
alphabeta O 0 0.24520128965377808
) O 0 0.0061673810705542564
in O 0 0.007308265659958124
COS O 1 1.0
- O 1 1.0
7 O 0 0.018775468692183495
cells O 0 0.00932228658348322
, O 0 0.005028082057833672
the O 0 0.006096252705901861
mature O 0 0.013963927514851093
alpha O 0 0.035826630890369415
- O 1 0.9999072551727295
subunit O 0 0.01917661353945732
was O 0 0.007292687892913818
present O 0 0.004671754315495491
, O 0 0.0031956087332218885
but O 0 0.0021556797437369823
its O 0 0.0034995521418750286
level O 0 0.00457204133272171
was O 0 0.004835440777242184
much O 0 0.004319172352552414
lower O 0 0.0049092709086835384
than O 0 0.0019640051759779453
that O 0 0.0017192978411912918
from O 0 0.002701961202546954
normal O 0 0.005829292815178633
alpha O 0 0.0256282277405262
- O 1 0.9991777539253235
subunit O 0 0.02947346679866314
transfections O 0 0.48027604818344116
, O 0 0.0053169140592217445
although O 0 0.003523570951074362
higher O 0 0.00469471188262105
than O 0 0.0028940909542143345
in O 0 0.0037996647879481316
those O 0 0.0038736904971301556
cells O 0 0.008778768591582775
transfected O 0 0.04041256755590439
with O 0 0.004348783288151026
an O 0 0.006600919179618359
alpha O 0 0.35711029171943665
- O 1 0.9998339414596558
subunit O 0 0.03355085477232933
associated O 0 0.014464237727224827
with O 0 0.019755443558096886
infantile O 1 1.0
TSD B-Disease 1 1.0
. O 0 0.05230940878391266

Furthermore O 0 0.02896084263920784
, O 0 0.010606510564684868
the O 0 0.00908360444009304
precursor O 0 0.017527742311358452
level O 0 0.008688930422067642
of O 0 0.00585911376401782
the O 0 0.010106383822858334
W474C O 1 0.9773377180099487
alpha O 0 0.057769548147916794
- O 1 0.9990482926368713
subunit O 0 0.021826373413205147
was O 0 0.008188552223145962
found O 0 0.004222673363983631
to O 0 0.004520663525909185
accumulate O 0 0.01353734452277422
in O 0 0.0033575294073671103
comparison O 0 0.005223504267632961
to O 0 0.003414230654016137
the O 0 0.005224269349128008
normal O 0 0.008939551189541817
alpha O 0 0.04126809164881706
- O 1 0.9998869895935059
subunit O 0 0.051170364022254944
precursor O 0 0.04922720417380333
levels O 0 0.026995431631803513
. O 0 0.026167545467615128

We O 0 0.017364684492349625
conclude O 0 0.019283641129732132
that O 0 0.005551553796976805
the O 0 0.011262833140790462
1422 O 1 0.9999885559082031
G O 1 0.9999916553497314
- O 1 0.9999998807907104
- O 1 0.9999996423721313
> O 1 0.9999773502349854
C O 1 0.9998177886009216
mutation O 0 0.01335810124874115
is O 0 0.004591391421854496
the O 0 0.005250514019280672
cause O 0 0.00779741769656539
of O 0 0.008097050711512566
Hex B-Disease 1 0.9995170831680298
A I-Disease 1 0.9999822378158569
enzyme I-Disease 1 0.9999994039535522
deficiency I-Disease 1 1.0
in O 0 0.015611556358635426
the O 0 0.028477976098656654
proband O 1 0.9999669790267944
. O 0 0.03467192500829697

The O 0 0.030338779091835022
resulting O 0 0.026590736582875252
W474C O 1 0.9927506446838379
substitution O 0 0.02932979352772236
clearly O 0 0.014188097789883614
interferes O 0 0.025622548535466194
with O 0 0.008358241058886051
alpha O 0 0.11866571009159088
- O 1 0.9999717473983765
subunit O 0 0.02665892243385315
processing O 0 0.01059463806450367
, O 0 0.005734464153647423
but O 0 0.003030810272321105
because O 0 0.0027268154080957174
the O 0 0.00441168574616313
base O 0 0.015184042043983936
substitution O 0 0.015889963135123253
falls O 0 0.04025886580348015
at O 0 0.006916141603142023
the O 0 0.004849517717957497
first O 0 0.006588291842490435
position O 0 0.008653424680233002
of O 0 0.007640206720679998
exon O 0 0.041245315223932266
13 O 0 0.011760539375245571
, O 0 0.009057308547198772
aberrant O 0 0.06119353696703911
splicing O 0 0.019935788586735725
may O 0 0.006323433481156826
also O 0 0.004856417421251535
contribute O 0 0.007072743494063616
to O 0 0.006750620435923338
Hex B-Disease 1 0.9499921202659607
A I-Disease 1 0.9992846846580505
deficiency I-Disease 1 1.0
in O 0 0.01107216626405716
this O 0 0.009624524973332882
proband O 1 0.9999876022338867
. O 0 0.01428444404155016
. O 0 0.021187739446759224

Two O 0 0.017265871167182922
frequent O 0 0.024527467787265778
missense O 0 0.04459306597709656
mutations O 0 0.02057747170329094
in O 0 0.022652626037597656
Pendred B-Disease 1 1.0
syndrome I-Disease 1 1.0
. O 1 0.9909300208091736

Pendred B-Disease 1 1.0
syndrome I-Disease 1 1.0
is O 0 0.013454622589051723
an O 1 0.9192861318588257
autosomal B-Disease 1 1.0
recessive I-Disease 1 1.0
disorder I-Disease 1 1.0
characterized O 1 1.0
by O 1 0.78773033618927
early O 1 0.9999982118606567
childhood O 1 1.0
deafness B-Disease 1 1.0
and O 1 1.0
goiter B-Disease 1 1.0
. O 1 0.9998032450675964

A O 0 0.024899955838918686
century O 0 0.018747864291071892
after O 0 0.007529364433139563
its O 0 0.0052615804597735405
recognition O 0 0.00626083230599761
as O 0 0.005481221247464418
a O 0 0.014995197765529156
syndrome O 1 1.0
by O 0 0.0066232504323124886
Vaughan O 1 0.9999971389770508
Pendred O 1 0.9999974966049194
, O 0 0.007021442987024784
the O 0 0.01092613860964775
disease O 1 1.0
gene O 1 0.8355320692062378
( O 0 0.18524864315986633
PDS O 1 1.0
) O 0 0.009593953378498554
was O 0 0.013420278206467628
mapped O 0 0.024939123541116714
to O 0 0.012948648072779179
chromosome O 0 0.038060400635004044
7q22 O 1 0.9999642372131348
- O 1 0.9999985694885254
q31 O 1 0.9936124682426453
. O 0 0.04355771839618683

1 O 0 0.0326990969479084
and O 0 0.012197677046060562
, O 0 0.00889397319406271
recently O 0 0.011300916783511639
, O 0 0.005133022554218769
found O 0 0.0037864611949771643
to O 0 0.00541711738333106
encode O 0 0.01605869270861149
a O 0 0.01578633300960064
putative O 1 0.9909199476242065
sulfate O 1 0.9999998807907104
transporter O 1 0.9995602965354919
. O 0 0.04482727870345116

We O 0 0.01598222553730011
performed O 0 0.013707747682929039
mutation O 0 0.011078918352723122
analysis O 0 0.004284015856683254
of O 0 0.005100350361317396
the O 0 0.008900407701730728
PDS B-Disease 1 1.0
gene O 0 0.012537065893411636
in O 0 0.0069802794605493546
patients O 0 0.17556630074977875
from O 0 0.00549240130931139
14 O 0 0.011632275767624378
Pendred B-Disease 1 0.9939029812812805
families O 0 0.008644872345030308
originating O 0 0.008366492576897144
from O 0 0.0039827520959079266
seven O 0 0.004490611609071493
countries O 0 0.0027679430786520243
and O 0 0.004243470728397369
identified O 0 0.006372555624693632
all O 0 0.0064575825817883015
mutations O 0 0.015971265733242035
. O 0 0.017709853127598763

The O 0 0.024361077696084976
mutations O 0 0.016798511147499084
include O 0 0.007520860061049461
three O 0 0.005167010705918074
single O 0 0.008672147057950497
base O 0 0.018977629020810127
deletions O 0 0.02050807699561119
, O 0 0.006601328030228615
one O 0 0.007031603716313839
splice O 0 0.03910023346543312
site O 0 0.01484741736203432
mutation O 0 0.012125788256525993
and O 0 0.0075686718337237835
10 O 0 0.017086144536733627
missense O 0 0.053999874740839005
mutations O 0 0.027863379567861557
. O 0 0.027817994356155396

One O 0 0.027465803548693657
missense O 0 0.05318104103207588
mutation O 0 0.022370152175426483
( O 0 0.0129341259598732
L236P O 1 0.9999617338180542
) O 0 0.008114692755043507
was O 0 0.008756191469728947
found O 0 0.004001358989626169
in O 0 0.004077388439327478
a O 0 0.0057557146064937115
homozygous O 0 0.010525509715080261
state O 0 0.0036334218457341194
in O 0 0.004659530706703663
two O 0 0.005362922325730324
consanguineous O 0 0.041318099945783615
families O 0 0.0055351234041154385
and O 0 0.0039333682507276535
in O 0 0.004032822325825691
a O 0 0.005997309926897287
heterozygous O 0 0.01066034846007824
state O 0 0.0037015369161963463
in O 0 0.00358163146302104
five O 0 0.004400720354169607
additional O 0 0.008088069967925549
non O 0 0.022676628082990646
- O 1 0.9999938011169434
consanguineous O 1 0.928597092628479
families O 0 0.025450125336647034
. O 0 0.024443550035357475

Another O 0 0.03014766052365303
missense O 0 0.053453173488378525
mutation O 0 0.024377277120947838
( O 0 0.012403757311403751
T416P O 1 0.999967098236084
) O 0 0.00790863111615181
was O 0 0.008077969774603844
found O 0 0.003892625914886594
in O 0 0.003427836112678051
a O 0 0.005129371769726276
homozygous O 0 0.009572410956025124
state O 0 0.0029371546115726233
in O 0 0.00367731018923223
one O 0 0.004232764709740877
family O 0 0.006119331810623407
and O 0 0.0032349147368222475
in O 0 0.003376766573637724
a O 0 0.005852417554706335
heterozygous O 0 0.010014860890805721
state O 0 0.004001501947641373
in O 0 0.005528504494577646
four O 0 0.007765648420900106
families O 0 0.011283326894044876
. O 0 0.015144860371947289

Pendred B-Disease 1 0.9998478889465332
patients O 0 0.07918549329042435
in O 0 0.008436303585767746
three O 0 0.00840003602206707
non O 0 0.021984601393342018
- O 1 0.999995231628418
consanguineous O 1 0.949533998966217
families O 0 0.006307756062597036
were O 0 0.002882719738408923
shown O 0 0.003225453896448016
to O 0 0.0031020091846585274
be O 0 0.004237486515194178
compound O 0 0.021396776661276817
heterozygotes O 0 0.24960680305957794
for O 0 0.01098950207233429
L236P O 1 0.9995194673538208
and O 0 0.018154717981815338
T416P O 1 0.9988226294517517
. O 0 0.030739493668079376

In O 0 0.012722816318273544
total O 0 0.008095396682620049
, O 0 0.005457006860524416
one O 0 0.004206234589219093
or O 0 0.002940639154985547
both O 0 0.0024326988495886326
of O 0 0.0034257045481354
these O 0 0.00265480880625546
mutations O 0 0.004458151292055845
were O 0 0.0022646302822977304
found O 0 0.0023521047551184893
in O 0 0.002386805135756731
nine O 0 0.004819423891603947
of O 0 0.004157991148531437
the O 0 0.0060295118018984795
14 O 0 0.012027494609355927
families O 0 0.009803760796785355
analyzed O 0 0.024599706754088402
. O 0 0.022607926279306412

The O 0 0.016946867108345032
identification O 0 0.011566649191081524
of O 0 0.007033667992800474
two O 0 0.00640592398121953
frequent O 0 0.02149796299636364
PDS B-Disease 1 1.0
mutations O 0 0.013320370577275753
will O 0 0.006562227848917246
facilitate O 0 0.009174047037959099
the O 0 0.009065435267984867
molecular O 0 0.021044280380010605
diagnosis O 1 0.9999996423721313
of O 1 0.9999305009841919
Pendred B-Disease 1 1.0
syndrome I-Disease 1 1.0
. O 1 0.9870290756225586

Insertional O 1 0.9940225481987
mutation O 0 0.037737347185611725
by O 0 0.012011820450425148
transposable O 1 0.7312502861022949
element O 0 0.024999361485242844
, O 0 0.013538260012865067
L1 O 1 0.9999897480010986
, O 0 0.006144189275801182
in O 0 0.005751909222453833
the O 0 0.011764020659029484
DMD B-Disease 1 1.0
gene O 0 0.012167936190962791
results O 0 0.006566663272678852
in O 0 0.007644228637218475
X B-Disease 1 0.9999837875366211
- I-Disease 1 1.0
linked I-Disease 1 0.9999251365661621
dilated I-Disease 1 1.0
cardiomyopathy I-Disease 1 1.0
. O 0 0.31371617317199707

X B-Disease 1 0.9998476505279541
- I-Disease 1 0.9999998807907104
linked I-Disease 1 0.999902606010437
dilated I-Disease 1 1.0
cardiomyopathy I-Disease 1 1.0
( O 1 0.9999834299087524
XLDCM B-Disease 1 1.0
) O 0 0.008344382978975773
is O 0 0.005289004649966955
a O 0 0.006933222524821758
clinical O 1 0.995934009552002
phenotype O 1 0.8688300251960754
of O 0 0.05010160431265831
dystrophinopathy B-Disease 1 0.9999998807907104
which O 0 0.006008298601955175
is O 0 0.0055784014984965324
characterized O 0 0.00919762160629034
by O 0 0.006158257368952036
preferential O 1 0.9991556406021118
myocardial B-Disease 1 1.0
involvement I-Disease 1 0.8971545696258545
without O 0 0.007275185082107782
any O 0 0.006749003194272518
overt O 0 0.477938175201416
clinical O 1 0.9999990463256836
signs O 1 0.9952349066734314
of O 1 0.9998917579650879
skeletal B-Disease 1 1.0
myopathy I-Disease 1 1.0
. O 1 0.9940981864929199

To O 0 0.016746219247579575
date O 0 0.010881034657359123
, O 0 0.005902915261685848
several O 0 0.0037913857959210873
mutations O 0 0.006416810676455498
in O 0 0.005661255680024624
the O 0 0.018564417958259583
Duchenne B-Disease 1 1.0
muscular I-Disease 1 1.0
dystrophy I-Disease 1 1.0
gene O 1 0.9999992847442627
, O 1 0.9994694590568542
DMD O 1 1.0
, O 0 0.008394493721425533
have O 0 0.003017064183950424
been O 0 0.003365078242495656
identified O 0 0.0050431001000106335
in O 0 0.005513826385140419
patients O 1 0.9650374054908752
with O 0 0.006886133924126625
XLDCM B-Disease 1 1.0
, O 0 0.005953001789748669
but O 0 0.003758322913199663
a O 0 0.006511699873954058
pathogenic O 0 0.01367396954447031
correlation O 0 0.00834242720156908
of O 0 0.005138487555086613
these O 0 0.004511616658419371
cardiospecific O 1 0.9813318252563477
mutations O 0 0.01380031555891037
in O 0 0.00942097045481205
DMD O 1 1.0
with O 0 0.008940531872212887
the O 0 0.016385486349463463
XLDCM B-Disease 1 1.0
phenotype O 1 0.9931930899620056
has O 0 0.009565451182425022
remained O 0 0.01417528372257948
to O 0 0.00944824144244194
be O 0 0.01170432660728693
elucidated O 0 0.11580406129360199
. O 0 0.025204921141266823

We O 0 0.012760051526129246
report O 0 0.008287285454571247
here O 0 0.005231290124356747
the O 0 0.004527729470282793
identification O 0 0.006074985023587942
of O 0 0.005279209930449724
a O 0 0.007576867938041687
unique O 0 0.014108678326010704
de O 0 0.07233420759439468
novo O 1 0.9965278506278992
L1 O 1 0.999964714050293
insertion O 0 0.023168256506323814
in O 0 0.007041858974844217
the O 0 0.009755229577422142
muscle O 1 0.9554167985916138
exon O 1 0.8657927513122559
1 O 0 0.014583866111934185
in O 0 0.009663551114499569
DMD O 1 1.0
in O 0 0.008866783231496811
three O 0 0.00884976889938116
XLDCM B-Disease 1 1.0
patients O 1 0.9382769465446472
from O 0 0.006693942006677389
two O 0 0.00703290943056345
unrelated O 0 0.01662851683795452
Japanese O 0 0.03138219565153122
families O 0 0.019361412152647972
. O 0 0.024179117754101753

The O 0 0.022165151312947273
insertion O 0 0.03377194702625275
was O 0 0.011644902639091015
a O 0 0.010082663968205452
5 O 0 0.014211365021765232
- O 1 0.9899393916130066
truncated O 0 0.024444816634058952
form O 0 0.006693281698971987
of O 0 0.006858127657324076
human O 0 0.010024714283645153
L1 O 1 0.999992847442627
inversely O 0 0.03505273163318634
integrated O 0 0.017945993691682816
in O 0 0.005598403047770262
the O 0 0.006926950998604298
5 O 0 0.013793930411338806
- O 1 0.9998738765716553
untranslated O 1 0.9777520298957825
region O 0 0.00965125486254692
in O 0 0.005370171740651131
the O 0 0.008992357179522514
muscle O 1 0.9522231817245483
exon O 1 0.9905363917350769
1 O 0 0.013781268149614334
, O 0 0.004928142763674259
which O 0 0.0030774318147450686
affected O 0 0.004499512258917093
the O 0 0.00428997166454792
transcription O 0 0.008791117928922176
or O 0 0.0034856062848120928
the O 0 0.0040944479405879974
stability O 0 0.00756217073649168
of O 0 0.005377358756959438
the O 0 0.008360236883163452
muscle O 1 0.9969865679740906
form O 0 0.006643333472311497
of O 0 0.007478248327970505
dystrophin O 1 0.9999969005584717
transcripts O 0 0.012928344309329987
but O 0 0.0026394727174192667
not O 0 0.0014860972296446562
that O 0 0.0014640152221545577
of O 0 0.003298231167718768
the O 0 0.005332425702363253
brain O 1 0.9984723925590515
or O 0 0.009498925879597664
Purkinje O 1 1.0
cell O 1 0.9955363273620605
form O 0 0.007029453292489052
, O 0 0.004986034240573645
probably O 0 0.006080454681068659
due O 0 0.003662222297862172
to O 0 0.0033971338998526335
its O 0 0.005014850292354822
unique O 0 0.007095813751220703
site O 0 0.011976920999586582
of O 0 0.00897867139428854
integration O 0 0.028357157483696938
. O 0 0.02254839800298214

We O 0 0.017021188512444496
speculate O 0 0.01893756538629532
that O 0 0.004472794476896524
this O 0 0.003981551621109247
insertion O 0 0.014219657517969608
of O 0 0.006886471062898636
an O 0 0.008080643601715565
L1 O 1 0.9999099969863892
sequence O 0 0.011040913872420788
in O 0 0.011856025084853172
DMD O 1 1.0
is O 0 0.007609066087752581
responsible O 0 0.005121459253132343
for O 0 0.0026470033917576075
some O 0 0.0016613398911431432
of O 0 0.00244709849357605
the O 0 0.002729919971898198
population O 0 0.0020477264188230038
of O 0 0.0045693181455135345
Japanese O 1 0.8875663876533508
patients O 1 0.9996987581253052
with O 0 0.01222570613026619
XLDCM B-Disease 1 1.0
. O 0 0.012979485094547272
. O 0 0.02040509320795536

Severe O 1 0.9999055862426758
early O 0 0.17071491479873657
- O 1 1.0
onset O 1 1.0
obesity B-Disease 1 1.0
, O 1 0.9999994039535522
adrenal B-Disease 1 1.0
insufficiency I-Disease 1 1.0
and O 1 0.9999997615814209
red O 1 1.0
hair O 1 1.0
pigmentation O 1 1.0
caused O 1 0.999977707862854
by O 0 0.027773132547736168
POMC O 1 1.0
mutations O 0 0.04009871557354927
in O 0 0.012053812853991985
humans O 0 0.01577722281217575
. O 0 0.021245630457997322

Sequential O 0 0.0716230720281601
cleavage O 0 0.05355725437402725
of O 0 0.010692941024899483
the O 0 0.009019683115184307
precursor O 0 0.019272003322839737
protein O 0 0.010735648684203625
pre O 0 0.3476760983467102
- O 1 0.9999889135360718
pro O 1 0.9347719550132751
- O 1 0.9999996423721313
opiomelanocortin O 1 0.9999867677688599
( O 0 0.020373312756419182
POMC O 1 0.9999983310699463
) O 0 0.011223569512367249
generates O 0 0.019492559134960175
the O 0 0.012200487777590752
melanocortin O 1 0.9999716281890869
peptides O 0 0.071804940700531
adrenocorticotrophin O 1 0.9999972581863403
( O 0 0.02598658576607704
ACTH O 1 0.9999994039535522
) O 0 0.012965521775186062
, O 0 0.015788894146680832
melanocyte O 1 0.9999998807907104
- O 1 1.0
stimulating O 1 0.9999858140945435
hormones O 1 0.9515367150306702
( O 0 0.01739474944770336
MSH O 1 1.0
) O 0 0.011160114780068398
alpha O 0 0.023222902789711952
, O 0 0.008045945316553116
beta O 0 0.01910228468477726
and O 0 0.006211176980286837
gamma O 0 0.015721458941698074
as O 0 0.004088207613676786
well O 0 0.0029590532649308443
as O 0 0.003399268724024296
the O 0 0.006761083845049143
opioid O 1 0.9999643564224243
- O 1 0.9999997615814209
receptor O 0 0.05196695029735565
ligand O 1 0.7788797616958618
beta O 1 0.9372318983078003
- O 1 0.999992847442627
endorphin O 1 0.9997088313102722
. O 0 0.04124486446380615

While O 0 0.01405422855168581
a O 0 0.00940707791596651
few O 0 0.005258641671389341
cases O 0 0.005004356615245342
of O 0 0.008034049533307552
isolated O 1 0.9999849796295166
ACTH B-Disease 1 1.0
deficiency I-Disease 1 1.0
have O 0 0.005801871884614229
been O 0 0.005709587596356869
reported O 0 0.009451455436646938
( O 0 0.012658446095883846
OMIM O 1 1.0
201400 O 1 0.9999916553497314
) O 0 0.007745115086436272
, O 0 0.005904750898480415
an O 0 0.008183852769434452
inherited O 1 1.0
POMC O 1 1.0
defect O 1 1.0
has O 0 0.01711220294237137
not O 0 0.005388908553868532
been O 0 0.005908782593905926
described O 0 0.008612613193690777
so O 0 0.008497664704918861
far O 0 0.012239383533596992
. O 0 0.01722305826842785

Recent O 0 0.0237936619669199
studies O 0 0.01271547470241785
in O 0 0.008570708334445953
animal O 0 0.01178835704922676
models O 0 0.015089605934917927
elucidated O 0 0.03183559700846672
a O 0 0.008278544060885906
central O 0 0.007617045659571886
role O 0 0.007139725610613823
of O 0 0.0071810586377978325
alpha O 1 0.9560400247573853
- O 1 0.9999997615814209
MSH O 1 0.9999995231628418
in O 0 0.007049011066555977
the O 0 0.006472163833677769
regulation O 0 0.007821963168680668
of O 0 0.006372390314936638
food O 0 0.01334622222930193
intake O 0 0.017882993444800377
by O 0 0.0048602670431137085
activation O 0 0.01144482847303152
of O 0 0.005569135304540396
the O 0 0.008454141207039356
brain O 1 0.9906750321388245
melanocortin O 1 1.0
- O 1 0.9999995231628418
4 O 0 0.027083033695816994
- O 1 0.9999169111251831
receptor O 0 0.03232576325535774
( O 0 0.018026202917099
MC4 O 1 0.9999991655349731
- O 1 0.9999933242797852
R O 1 0.9328290820121765
; O 0 0.010768179781734943
refs O 0 0.03914617374539375
3 O 0 0.018680443987250328
- O 1 0.9994874000549316
5 O 0 0.012214764021337032
) O 0 0.005069463048130274
and O 0 0.003783900523558259
the O 0 0.004928283393383026
linkage O 0 0.013468815013766289
of O 0 0.006999306380748749
human O 0 0.012195741757750511
obesity B-Disease 1 1.0
to O 0 0.011083208955824375
chromosome O 0 0.016442153602838516
2 O 0 0.008789305575191975
in O 0 0.005395746789872646
close O 0 0.008340233936905861
proximity O 0 0.010171621106564999
to O 0 0.005361996591091156
the O 0 0.01168294157832861
POMC O 1 0.9999998807907104
locus O 1 0.9876185655593872
, O 0 0.008243602700531483
led O 0 0.00858552660793066
to O 0 0.005103017669171095
the O 0 0.004243824630975723
proposal O 0 0.006245057564228773
of O 0 0.004531805403530598
an O 0 0.00450564781203866
association O 0 0.01004872564226389
of O 0 0.011870787478983402
POMC O 1 1.0
with O 0 0.01659725420176983
human O 1 0.8287404775619507
obesity B-Disease 1 1.0
. O 0 0.04503558576107025

The O 0 0.022830449044704437
dual O 0 0.026639612391591072
role O 0 0.013008288107812405
of O 0 0.011731689795851707
alpha O 1 0.9546416401863098
- O 1 0.9999985694885254
MSH O 1 0.9999995231628418
in O 0 0.011657541617751122
regulating O 0 0.017788659781217575
food O 0 0.017452817410230637
intake O 0 0.026432862505316734
and O 0 0.00926830992102623
influencing O 0 0.04653025045990944
hair O 1 0.999915361404419
pigmentation O 1 0.9999998807907104
predicts O 0 0.2915984094142914
that O 0 0.004825442563742399
the O 0 0.006674002390354872
phenotype O 0 0.048071783035993576
associated O 0 0.005381570663303137
with O 0 0.0045539517886936665
a O 0 0.010018573142588139
defect O 1 0.9999964237213135
in O 0 0.014745674096047878
POMC O 1 1.0
function O 0 0.008928731083869934
would O 0 0.0063190702348947525
include O 0 0.01182242576032877
obesity B-Disease 1 1.0
, O 0 0.009123481810092926
alteration O 1 0.9946545362472534
in O 0 0.3961755037307739
pigmentation O 1 1.0
and O 1 0.9999967813491821
ACTH B-Disease 1 1.0
deficiency I-Disease 1 1.0
. O 1 0.6835394501686096

The O 0 0.024068044498562813
observation O 0 0.030184520408511162
of O 0 0.010930107906460762
these O 0 0.0075164553709328175
symptoms O 1 0.9999061822891235
in O 0 0.006680651102215052
two O 0 0.007536537013947964
probands O 1 0.9999468326568604
prompted O 0 0.013525241985917091
us O 0 0.008495602756738663
to O 0 0.0046349819749593735
search O 0 0.007225504610687494
for O 0 0.0055379560217261314
mutations O 0 0.008174248039722443
within O 0 0.006335195153951645
their O 0 0.012859673239290714
POMC O 1 0.9999991655349731
genes O 0 0.04172387719154358
. O 0 0.032756201922893524

Patient O 1 0.9999474287033081
1 O 0 0.024343494325876236
was O 0 0.011774557642638683
found O 0 0.0047834510914981365
to O 0 0.004106421954929829
be O 0 0.003344076219946146
a O 0 0.007039905060082674
compound O 0 0.020541194826364517
heterozygote O 0 0.035762470215559006
for O 0 0.004751324653625488
two O 0 0.004643487278372049
mutations O 0 0.007491695694625378
in O 0 0.005466121714562178
exon O 0 0.06322097778320312
3 O 0 0.012967370450496674
( O 0 0.009812716394662857
G7013T O 1 0.9781143665313721
, O 0 0.011656833812594414
C7133delta O 1 0.9999958276748657
) O 0 0.007890775799751282
which O 0 0.005202648229897022
interfere O 0 0.00839364342391491
with O 0 0.004575622733682394
appropriate O 0 0.008792617358267307
synthesis O 0 0.014086985029280186
of O 0 0.012537290342152119
ACTH O 1 0.9999992847442627
and O 0 0.02175719290971756
alpha O 1 0.9973575472831726
- O 1 0.9999983310699463
MSH O 1 0.9999974966049194
. O 0 0.05350560322403908

Patient O 1 0.9989240765571594
2 O 0 0.022946015000343323
was O 0 0.01357683539390564
homozygous O 0 0.013978155329823494
for O 0 0.00465887226164341
a O 0 0.006732972804456949
mutation O 0 0.00665923161432147
in O 0 0.005135054234415293
exon O 1 0.7909731268882751
2 O 0 0.01347574032843113
( O 0 0.010814076289534569
C3804A O 1 0.9770046472549438
) O 0 0.012629693374037743
which O 0 0.012914173305034637
abolishes O 1 0.9996117949485779
POMC O 1 0.9999971389770508
translation O 0 0.057880181819200516
. O 0 0.03779343515634537

These O 0 0.011568842455744743
findings O 0 0.009697508066892624
represent O 0 0.00693484116345644
the O 0 0.0051274592988193035
first O 0 0.006133189424872398
examples O 0 0.005175983998924494
of O 0 0.004737639334052801
a O 0 0.0085389269515872
genetic B-Disease 1 0.9674848318099976
defect I-Disease 1 0.9999990463256836
within O 0 0.008612867444753647
the O 0 0.01641329936683178
POMC O 1 1.0
gene O 0 0.012256008572876453
and O 0 0.005386996548622847
define O 0 0.010760684497654438
a O 0 0.007332098204642534
new O 0 0.014744903892278671
monogenic B-Disease 1 1.0
endocrine I-Disease 1 1.0
disorder I-Disease 1 1.0
resulting O 0 0.1148291751742363
in O 0 0.006167896091938019
early O 0 0.3642370402812958
- O 1 1.0
onset O 1 1.0
obesity B-Disease 1 1.0
, O 1 0.999996542930603
adrenal B-Disease 1 1.0
insufficiency I-Disease 1 1.0
and O 1 0.999998927116394
red O 1 1.0
hair O 1 1.0
pigmentation O 1 1.0
. O 0 0.022454092279076576
. O 0 0.02624020166695118

A O 0 0.030115576460957527
European O 0 0.023551827296614647
multicenter O 0 0.07393171638250351
study O 0 0.013461660593748093
of O 0 0.01622147485613823
phenylalanine B-Disease 1 1.0
hydroxylase I-Disease 1 1.0
deficiency I-Disease 1 1.0
: O 0 0.016137534752488136
classification O 0 0.017116183415055275
of O 0 0.008566997945308685
105 O 1 0.764915406703949
mutations O 0 0.009024811908602715
and O 0 0.00403248518705368
a O 0 0.005446461495012045
general O 0 0.008001244626939297
system O 0 0.006737173069268465
for O 0 0.006288829259574413
genotype O 0 0.11084704101085663
- O 1 0.9967495203018188
based O 0 0.01246740110218525
prediction O 0 0.031746577471494675
of O 0 0.019904395565390587
metabolic O 1 0.9999992847442627
phenotype O 1 0.9988946318626404
. O 0 0.03699629753828049

Phenylketonuria B-Disease 1 0.9999998807907104
( O 0 0.3537004590034485
PKU B-Disease 1 1.0
) O 0 0.013334304094314575
and O 0 0.011817695572972298
mild B-Disease 1 1.0
hyperphenylalaninemia I-Disease 1 1.0
( O 1 0.9998151659965515
MHP B-Disease 1 1.0
) O 0 0.011381221003830433
are O 0 0.007128225639462471
allelic B-Disease 1 0.9999997615814209
disorders I-Disease 1 1.0
caused O 1 0.9996215105056763
by O 0 0.007824353873729706
mutations O 0 0.008690450340509415
in O 0 0.004808299243450165
the O 0 0.006356124300509691
gene O 0 0.009374802000820637
encoding O 0 0.016834089532494545
phenylalanine O 1 0.9601679444313049
hydroxylase O 1 0.9999715089797974
( O 1 0.5564815998077393
PAH O 1 1.0
) O 0 0.0396176241338253
. O 0 0.03513700142502785

Previous O 0 0.022076239809393883
studies O 0 0.009276336058974266
have O 0 0.003332513617351651
suggested O 0 0.004712664522230625
that O 0 0.002037842059507966
the O 0 0.003897205926477909
highly O 0 0.009462239220738411
variable O 0 0.013547216542065144
metabolic O 1 0.9993640780448914
phenotypes O 1 0.9713886380195618
of O 1 0.9999850988388062
PAH B-Disease 1 1.0
deficiency I-Disease 1 1.0
correlate O 1 0.9999988079071045
with O 1 0.998703122138977
PAH O 1 1.0
genotypes O 1 0.9999823570251465
. O 0 0.059828344732522964

We O 0 0.016003528609871864
identified O 0 0.012349703349173069
both O 0 0.008403713814914227
causative O 0 0.09175419807434082
mutations O 0 0.013969313353300095
in O 0 0.010871775448322296
686 O 1 0.9999998807907104
patients O 1 0.9988242983818054
from O 0 0.009356610476970673
seven O 0 0.013426732271909714
European O 0 0.018404072150588036
centers O 0 0.02390112914144993
. O 0 0.02180701680481434

On O 0 0.014172778464853764
the O 0 0.00796100776642561
basis O 0 0.0048884316347539425
of O 0 0.005314816255122423
the O 0 0.007688302081078291
phenotypic O 0 0.02189541980624199
characteristics O 0 0.014346440322697163
of O 0 0.011694476008415222
297 O 1 0.9955173134803772
functionally O 1 0.9997419714927673
hemizygous O 1 0.9999986886978149
patients O 1 0.9643529057502747
, O 0 0.0065070344135165215
105 O 0 0.017472311854362488
of O 0 0.005820809863507748
the O 0 0.006068714894354343
mutations O 0 0.006833228748291731
were O 0 0.003122612601146102
assigned O 0 0.0085984505712986
to O 0 0.003667139448225498
one O 0 0.003520288737490773
of O 0 0.005160169210284948
four O 0 0.006933888420462608
arbitrary O 0 0.011493117548525333
phenotype O 0 0.3693755865097046
categories O 0 0.02724635601043701
. O 0 0.024448255077004433

We O 0 0.013795954175293446
proposed O 0 0.013471748679876328
and O 0 0.007309206295758486
tested O 0 0.014275812543928623
a O 0 0.007913938723504543
simple O 0 0.008147619664669037
model O 0 0.008896395564079285
for O 0 0.004953548312187195
correlation O 0 0.010347388684749603
between O 0 0.009106555953621864
genotype O 0 0.03502645716071129
and O 0 0.011013213545084
phenotypic O 0 0.031035346910357475
outcome O 0 0.02459847927093506
. O 0 0.027608342468738556

The O 0 0.02334502898156643
observed O 0 0.018378350883722305
phenotype O 0 0.028798025101423264
matched O 0 0.01611247844994068
the O 0 0.00689861923456192
predicted O 0 0.013050451874732971
phenotype O 0 0.016832008957862854
in O 0 0.006314493250101805
79 O 0 0.020993266254663467
% O 0 0.005412719212472439
of O 0 0.004082763567566872
the O 0 0.005399222485721111
cases O 0 0.005468361545354128
, O 0 0.004472930449992418
and O 0 0.0027779564261436462
in O 0 0.0026372841093689203
only O 0 0.002102938713505864
5 O 0 0.0047154612839221954
of O 0 0.0049977293238043785
184 O 1 0.9648157358169556
patients O 1 0.9995108842849731
was O 0 0.008801490068435669
the O 0 0.00543219642713666
observed O 0 0.006524479947984219
phenotype O 0 0.011826414614915848
more O 0 0.0026581843849271536
than O 0 0.002933256793767214
one O 0 0.0037395127583295107
category O 0 0.00759414816275239
away O 0 0.005610560532659292
from O 0 0.003838508389890194
that O 0 0.003600154770538211
expected O 0 0.0128182927146554
. O 0 0.01600569859147072

Among O 0 0.017763491719961166
the O 0 0.00998848769813776
seven O 0 0.009710998274385929
contributing O 0 0.01129266619682312
centers O 0 0.008238459937274456
, O 0 0.004020067863166332
the O 0 0.004092729650437832
proportion O 0 0.006333925295621157
of O 0 0.0053837355226278305
patients O 1 0.912290632724762
for O 0 0.00468329805880785
whom O 0 0.006789565552026033
the O 0 0.005847099237143993
observed O 0 0.007069921586662531
phenotype O 0 0.023400576785206795
did O 0 0.004218363203108311
not O 0 0.0028149608988314867
match O 0 0.006308054551482201
the O 0 0.004617851693183184
predicted O 0 0.010031994432210922
phenotype O 0 0.013689902611076832
was O 0 0.007152886595577002
4 O 0 0.008857103064656258
% O 0 0.0056273965165019035
- O 1 0.8235813975334167
23 O 0 0.009501119144260883
% O 0 0.006317231338471174
( O 0 0.008145177736878395
P O 1 0.9994833469390869
< O 1 0.9952675104141235
. O 0 0.009574525989592075
0001 O 1 0.9879429936408997
) O 0 0.008259398862719536
, O 0 0.0053946333937346935
suggesting O 0 0.006450015120208263
that O 0 0.0024219583719968796
differences O 0 0.0035040429793298244
in O 0 0.0031480405014008284
methods O 0 0.0032235842663794756
used O 0 0.0036641890183091164
for O 0 0.004400691483169794
mutation O 0 0.010957376100122929
detection O 0 0.09633586555719376
or O 0 0.007883204147219658
phenotype O 1 0.995223343372345
classification O 0 0.10238321125507355
may O 0 0.0063138436526060104
account O 0 0.00566028943285346
for O 0 0.003405119525268674
a O 0 0.004895471967756748
considerable O 0 0.007545872125774622
proportion O 0 0.010036665014922619
of O 0 0.010589594952762127
genotype O 1 0.9999676942825317
- O 1 1.0
phenotype O 1 0.9594119787216187
inconsistencies O 0 0.044188741594552994
. O 0 0.026930270716547966

Our O 0 0.01770944520831108
data O 0 0.0064356690272688866
indicate O 0 0.005208477843552828
that O 0 0.003514164127409458
the O 0 0.01116041000932455
PAH O 1 1.0
- O 1 1.0
mutation O 0 0.028780000284314156
genotype O 0 0.026554420590400696
is O 0 0.005657876841723919
the O 0 0.006438321899622679
main O 0 0.0107641676440835
determinant O 1 0.9466795325279236
of O 0 0.020739950239658356
metabolic O 1 0.9999992847442627
phenotype O 1 0.8790762424468994
in O 0 0.006608865223824978
most O 0 0.00878069456666708
patients O 1 0.9999966621398926
with O 1 0.9999299049377441
PAH B-Disease 1 1.0
deficiency I-Disease 1 1.0
. O 1 0.9761242866516113

In O 0 0.015148778446018696
the O 0 0.009230853989720345
present O 0 0.007752286270260811
study O 0 0.006404103245586157
, O 0 0.0037571536377072334
the O 0 0.00428456487134099
classification O 0 0.010574164800345898
of O 0 0.008828562684357166
105 O 1 0.999996542930603
PAH O 1 1.0
mutations O 0 0.0244711022824049
may O 0 0.0061566936783492565
allow O 0 0.0044386256486177444
the O 0 0.005338392220437527
prediction O 0 0.012845570221543312
of O 0 0.005024446174502373
the O 0 0.006577751599252224
biochemical O 0 0.26716482639312744
phenotype O 0 0.41675007343292236
in O 0 0.007585769519209862
> O 1 0.9976022839546204
10 O 0 0.00961286574602127
, O 0 0.008133409544825554
000 O 0 0.022764813154935837
genotypes O 0 0.10525643080472946
, O 0 0.00730007141828537
which O 0 0.003946503158658743
may O 0 0.003916728310286999
be O 0 0.002321646548807621
useful O 0 0.0040746089071035385
for O 0 0.002860053675249219
the O 0 0.004935116041451693
management O 0 0.01305007841438055
of O 0 0.011612577363848686
hyperphenylalaninemia B-Disease 1 1.0
in O 0 0.04537641257047653
newborns O 1 0.9998929500579834
. O 0 0.02638801746070385

Somatic O 0 0.16132797300815582
instability O 0 0.03615882992744446
of O 0 0.01390927005559206
the O 0 0.014983806759119034
CTG O 1 1.0
repeat O 0 0.1452884078025818
in O 0 0.011532312259078026
mice O 0 0.016287552192807198
transgenic O 0 0.021004706621170044
for O 0 0.007027629762887955
the O 0 0.01637181080877781
myotonic B-Disease 1 1.0
dystrophy I-Disease 1 1.0
region O 1 0.9999829530715942
is O 0 0.012748355977237225
age O 0 0.01597159542143345
dependent O 0 0.007632567547261715
but O 0 0.0036960295401513577
not O 0 0.003051150357350707
correlated O 0 0.009178034961223602
to O 0 0.003975306637585163
the O 0 0.005757352337241173
relative O 0 0.013236192055046558
intertissue O 1 0.999824583530426
transcription O 0 0.03475220128893852
levels O 0 0.016044460237026215
and O 0 0.018288565799593925
proliferative O 1 1.0
capacities O 1 0.9980849027633667
. O 0 0.04361575096845627

A O 0 0.04845926910638809
( O 0 0.03129112347960472
CTG O 1 0.9999498128890991
) O 0 0.017667407169938087
nexpansion O 0 0.03709956631064415
in O 0 0.0053644641302526
the O 0 0.006572762504220009
3 O 0 0.01194728258997202
- O 1 0.9999847412109375
untranslated O 1 0.9998372793197632
region O 0 0.013270214200019836
( O 0 0.009179388172924519
UTR O 1 0.9995911717414856
) O 0 0.005189328920096159
of O 0 0.0057928296737372875
the O 0 0.010097291320562363
DM O 1 1.0
protein O 0 0.03867175802588463
kinase O 0 0.2677488327026367
gene O 0 0.013642184436321259
( O 0 0.01096451934427023
DMPK O 1 0.9999980926513672
) O 0 0.006378724239766598
is O 0 0.004227187484502792
responsible O 0 0.005860651843249798
for O 0 0.007290564943104982
causing O 1 0.9999986886978149
myotonic B-Disease 1 1.0
dystrophy I-Disease 1 1.0
( O 1 1.0
DM B-Disease 1 1.0
) O 0 0.3035202920436859
. O 0 0.039325520396232605

Major O 1 0.9306789040565491
instability O 1 0.9985820055007935
, O 0 0.00886946078389883
with O 0 0.005202717147767544
very O 0 0.004366328939795494
large O 0 0.0054270001128315926
expansions O 0 0.01388147659599781
between O 0 0.004992885049432516
generations O 0 0.007884744554758072
and O 0 0.004016025923192501
high O 0 0.008134516887366772
levels O 0 0.006329371128231287
of O 0 0.00740669434890151
somatic O 1 0.922978401184082
mosaicism O 1 0.9999977350234985
, O 0 0.009387937374413013
is O 0 0.0059636314399540424
observed O 0 0.0076610371470451355
in O 0 0.011129971593618393
patients O 1 0.9971700310707092
. O 0 0.021915780380368233

There O 0 0.01122961938381195
is O 0 0.0064145163632929325
a O 0 0.006663099396973848
good O 0 0.007346963044255972
correlation O 0 0.0070000323466956615
between O 0 0.004032688681036234
repeat O 0 0.01127440482378006
size O 0 0.00732260150834918
( O 0 0.00417883787304163
at O 0 0.004867329262197018
least O 0 0.003344843629747629
in O 0 0.004853622522205114
leucocytes O 1 0.999405026435852
) O 0 0.005972828716039658
, O 0 0.006966449785977602
clinical O 1 0.9995989203453064
severity O 1 0.9999315738677979
and O 0 0.007877667434513569
age O 0 0.020234279334545135
of O 1 0.5959042906761169
onset O 1 1.0
. O 0 0.032200951129198074

The O 0 0.03582475334405899
trinucleotide O 1 0.9999833106994629
repeat O 0 0.29788967967033386
instability O 1 0.8438223004341125
mechanisms O 0 0.010408624075353146
involved O 0 0.0067844935692846775
in O 0 0.009512614458799362
DM B-Disease 1 1.0
and O 0 0.007443791255354881
other O 0 0.003794495016336441
human O 0 0.07285858690738678
genetic B-Disease 1 1.0
diseases I-Disease 1 1.0
are O 0 0.007619503885507584
unknown O 0 0.021811233833432198
. O 0 0.02026883140206337

We O 0 0.016890453174710274
studied O 0 0.02608262374997139
somatic O 0 0.0384538434445858
instability O 0 0.025966405868530273
by O 0 0.007531581446528435
measuring O 0 0.019345249980688095
the O 0 0.016028057783842087
CTG O 1 0.9999982118606567
repeat O 0 0.027048775926232338
length O 0 0.010127815417945385
at O 0 0.006847547832876444
several O 0 0.0036327114794403315
ages O 0 0.006238739937543869
in O 0 0.004420740529894829
various O 0 0.00500716594979167
tissues O 0 0.0253209937363863
of O 0 0.00871964916586876
transgenic O 1 0.8479697108268738
mice O 0 0.019856128841638565
carrying O 0 0.014350236393511295
a O 0 0.011152887716889381
( O 0 0.015494806692004204
CTG O 1 0.999993085861206
) O 0 0.016662094742059708
55expansion O 0 0.07071244716644287
surrounded O 0 0.020181676372885704
by O 0 0.005868931300938129
45 O 0 0.015179742127656937
kb O 0 0.041295070201158524
of O 0 0.0074111479334533215
the O 0 0.007460671477019787
human O 0 0.01347027812153101
DM B-Disease 1 1.0
region O 0 0.08060925453901291
, O 0 0.007764910347759724
using O 0 0.005790776573121548
small O 0 0.010567745193839073
- O 1 0.9999414682388306
pool O 0 0.15298044681549072
PCR O 0 0.07865248620510101
. O 0 0.03375065699219704

These O 0 0.017140379175543785
mice O 0 0.019292596727609634
have O 0 0.004740361124277115
been O 0 0.0045237308368086815
shown O 0 0.00410003075376153
to O 0 0.004574697930365801
reproduce O 0 0.012306217104196548
the O 0 0.007714167702943087
intergenerational O 1 0.9770375490188599
and O 0 0.008216467685997486
somatic O 0 0.039225008338689804
instability O 0 0.3777332603931427
of O 0 0.00784590095281601
the O 0 0.010978722013533115
55 O 0 0.07930255681276321
CTG O 1 0.9999992847442627
repeat O 0 0.020759528502821922
suggesting O 0 0.008280156180262566
that O 0 0.0034696266520768404
surrounding O 0 0.006860316731035709
sequences O 0 0.004124505445361137
and O 0 0.0034434515982866287
the O 0 0.005549906753003597
chromatin O 0 0.014880388975143433
environment O 0 0.0074708727188408375
are O 0 0.0024575989227741957
involved O 0 0.005194035358726978
in O 0 0.007803875952959061
instability O 1 0.9996843338012695
mechanisms O 0 0.10838191956281662
. O 0 0.024922583252191544

As O 0 0.015542239882051945
observed O 0 0.007591579109430313
in O 0 0.004082131665199995
some O 0 0.0023934016935527325
of O 0 0.0037623883690685034
the O 0 0.005712820682674646
tissues O 1 0.7620640993118286
of O 1 0.9996294975280762
DM B-Disease 1 1.0
patients O 1 1.0
, O 0 0.0075727603398263454
there O 0 0.003825795603916049
is O 0 0.0033770122099667788
a O 0 0.004822965245693922
tendency O 0 0.007778438273817301
for O 0 0.004609653260558844
repeat O 0 0.01285489834845066
length O 0 0.008241813629865646
and O 0 0.007583848666399717
somatic O 0 0.14497116208076477
mosaicism O 1 0.9997568726539612
to O 0 0.006353612989187241
increase O 0 0.004709076602011919
with O 0 0.0036053552757948637
the O 0 0.005559773184359074
age O 0 0.008690992370247841
of O 0 0.007952268235385418
the O 0 0.012736226432025433
mouse O 0 0.13527187705039978
. O 0 0.03136587515473366

Furthermore O 0 0.03794915974140167
, O 0 0.010981048457324505
we O 0 0.0046313670463860035
observed O 0 0.0043421098962426186
no O 0 0.0037014454137533903
correlation O 0 0.005768307950347662
between O 0 0.0041168672032654285
the O 0 0.0060476395301520824
somatic O 0 0.02525482140481472
mutation O 0 0.014367762953042984
rate O 0 0.011037388816475868
and O 0 0.012062139809131622
tissue O 1 0.9999967813491821
proliferation O 1 0.9999754428863525
capacity O 0 0.15485534071922302
. O 0 0.03407153859734535

The O 0 0.025379616767168045
somatic O 0 0.04619039222598076
mutation O 0 0.019862636923789978
rates O 0 0.009896120987832546
in O 0 0.0044522034004330635
different O 0 0.0036943722516298294
tissues O 0 0.013273212127387524
were O 0 0.0035057731438428164
also O 0 0.0037739432882517576
not O 0 0.002532782731577754
correlated O 0 0.007299739867448807
to O 0 0.003968455363065004
the O 0 0.0052062878385186195
relative O 0 0.012191375717520714
inter O 1 0.9992750287055969
- O 1 1.0
tissue O 1 0.9459363222122192
difference O 0 0.008518113754689693
in O 0 0.005215809214860201
transcriptional O 0 0.012697875499725342
levels O 0 0.00481630302965641
of O 0 0.003689443925395608
the O 0 0.004205323755741119
three O 0 0.004505481105297804
genes O 0 0.006851258222013712
( O 0 0.006910399533808231
DMAHP O 1 0.9999734163284302
, O 0 0.009215855039656162
DMPK O 1 0.9999819993972778
and O 0 0.007772949058562517
59 O 0 0.02482771873474121
) O 0 0.007443396840244532
surrounding O 0 0.010728206485509872
the O 0 0.011075080372393131
repeat O 0 0.05181676894426346
. O 0 0.013936052098870277
. O 0 0.01984306611120701

A O 0 0.03961620479822159
novel O 0 0.03778082877397537
missense O 0 0.041922152042388916
mutation O 0 0.01572914980351925
in O 0 0.007351071573793888
patients O 0 0.1001623272895813
from O 0 0.0069382768124341965
a O 0 0.013241625390946865
retinoblastoma B-Disease 1 1.0
pedigree O 1 0.9779611825942993
showing O 0 0.011157631874084473
only O 0 0.0055880118161439896
mild O 0 0.27332085371017456
expression O 0 0.008790789172053337
of O 0 0.009193120524287224
the O 1 0.7604838609695435
tumor B-Disease 1 1.0
phenotype O 1 0.99980229139328
. O 0 0.03425639867782593

We O 0 0.013599376194179058
have O 0 0.005947820842266083
used O 0 0.00677452702075243
single O 0 0.012953023426234722
strand O 0 0.025165071710944176
conformation O 0 0.024208752438426018
polymorphism O 0 0.01943921484053135
analysis O 0 0.005836435128003359
to O 0 0.00489327497780323
study O 0 0.006107771303504705
the O 0 0.006641471292823553
27 O 0 0.014109015464782715
exons O 0 0.018929164856672287
of O 0 0.008338451385498047
the O 0 0.012739608995616436
RB1 O 1 0.9999998807907104
gene O 0 0.009708990342915058
in O 0 0.00436773058027029
individuals O 0 0.002801763592287898
from O 0 0.003403480863198638
a O 0 0.006002901587635279
family O 0 0.009431932121515274
showing O 0 0.0119332792237401
mild O 1 0.994668185710907
expression O 0 0.009072300046682358
of O 0 0.01013211440294981
the O 1 0.5664055347442627
retinoblastoma B-Disease 1 1.0
phenotype O 1 0.9999096393585205
. O 0 0.02997690625488758

In O 0 0.011105939745903015
this O 0 0.005484879482537508
family O 0 0.008763935416936874
affected O 0 0.0064174709841609
individuals O 0 0.003968089818954468
developed O 0 0.3809179663658142
unilateral B-Disease 1 0.9998891353607178
tumors I-Disease 1 1.0
and O 0 0.03858398273587227
, O 0 0.0055081709288060665
as O 0 0.004394042305648327
a O 0 0.005363278556615114
result O 0 0.00469365855678916
of O 0 0.0060577597469091415
linkage O 0 0.01696101948618889
analysis O 0 0.007596024312078953
, O 0 0.007994024083018303
unaffected O 0 0.31737563014030457
mutation O 0 0.0146043561398983
carriers O 0 0.013917180709540844
were O 0 0.003694640938192606
also O 0 0.004581297282129526
identified O 0 0.0057168984785676
within O 0 0.00523754209280014
the O 0 0.011185716837644577
pedigree O 0 0.23567530512809753
. O 0 0.025642571970820427

A O 0 0.03421666845679283
single O 0 0.02217802405357361
band O 0 0.023547889664769173
shift O 0 0.017662813887000084
using O 0 0.01077475305646658
SSCP O 1 0.9980731010437012
was O 0 0.013361256569623947
identified O 0 0.009865758940577507
in O 0 0.008088414557278156
exon O 0 0.04099111631512642
21 O 0 0.013705247081816196
which O 0 0.005956606008112431
resulted O 0 0.008402260020375252
in O 0 0.005210017319768667
a O 0 0.009580153040587902
missense O 0 0.023566503077745438
mutation O 0 0.010477768257260323
converting O 0 0.012670966796576977
a O 0 0.01387269888073206
cys O 1 0.9999998807907104
- O 1 0.9999998807907104
- O 1 0.9999998807907104
> O 1 0.999786913394928
arg O 1 0.9990437626838684
at O 0 0.020890867337584496
nucleotide O 0 0.022088801488280296
position O 0 0.015599273145198822
28 O 0 0.015864573419094086
in O 0 0.010201020166277885
the O 0 0.01785295084118843
exon O 0 0.09433701634407043
. O 0 0.03041195124387741

The O 0 0.02890915423631668
mutation O 0 0.027393382042646408
destroyed O 0 0.02449086867272854
an O 0 0.012784690596163273
NdeI O 1 0.999915361404419
restriction O 0 0.034673456102609634
enzyme O 0 0.035432420670986176
site O 0 0.03564891591668129
. O 0 0.026045342907309532

Analysis O 0 0.019373221322894096
of O 0 0.009088587947189808
all O 0 0.006352018099278212
family O 0 0.009257043711841106
members O 0 0.005454596132040024
demonstrated O 0 0.007871956564486027
that O 0 0.0028150801081210375
the O 0 0.005816483870148659
missense O 0 0.022174213081598282
mutation O 0 0.015451441518962383
co O 1 0.9952461123466492
- O 1 0.9999966621398926
segregated O 0 0.06963784247636795
with O 0 0.005567086394876242
patients O 1 0.999786913394928
with O 1 0.5083892941474915
tumors B-Disease 1 1.0
or O 0 0.03452775254845619
who O 0 0.00798581913113594
, O 0 0.003827400505542755
as O 0 0.0031897404696792364
a O 0 0.004359077662229538
result O 0 0.0033138978760689497
of O 0 0.004277560394257307
linkage O 0 0.014682200737297535
analysis O 0 0.004584810696542263
had O 0 0.004694986157119274
been O 0 0.0035942818503826857
predicted O 0 0.007515274453908205
to O 0 0.004398114047944546
carry O 0 0.008882926777005196
the O 0 0.012113398872315884
predisposing O 1 0.9981877207756042
mutation O 0 0.02915189042687416
. O 0 0.024526167660951614

These O 0 0.011844037100672722
observations O 0 0.014523984864354134
point O 0 0.007927359081804752
to O 0 0.004610950592905283
another O 0 0.006527714431285858
region O 0 0.005980692338198423
of O 0 0.006322064436972141
the O 0 0.010443680919706821
RB1 O 1 1.0
gene O 0 0.01163942739367485
where O 0 0.0073903086595237255
mutations O 0 0.007045514415949583
only O 0 0.003229985712096095
modify O 0 0.008726807311177254
the O 0 0.005235743708908558
function O 0 0.004436935763806105
of O 0 0.0042512970976531506
the O 0 0.005306093487888575
gene O 0 0.005690172780305147
and O 0 0.0035550252068787813
raise O 0 0.00629947055131197
important O 0 0.0035069813020527363
questions O 0 0.0036965301260352135
for O 0 0.004150762688368559
genetic O 0 0.0077761197462677956
counseling O 1 0.9121281504631042
in O 0 0.005112806800752878
families O 0 0.005069279577583075
with O 0 0.004623766988515854
these O 0 0.004896422382444143
distinctive O 0 0.050780583173036575
phenotypes O 1 0.8122183084487915
. O 0 0.014568456448614597
. O 0 0.024906475096940994

Maternal B-Disease 1 0.9950426816940308
disomy I-Disease 1 0.9972475171089172
and O 0 0.03203822299838066
Prader B-Disease 1 1.0
- I-Disease 1 1.0
Willi I-Disease 1 1.0
syndrome I-Disease 1 1.0
consistent O 1 0.9875450730323792
with O 0 0.04681730642914772
gamete O 1 0.9999995231628418
complementation O 1 0.9999998807907104
in O 0 0.00898591335862875
a O 0 0.007554687559604645
case O 0 0.007944797165691853
of O 0 0.009533501230180264
familial O 1 0.9999951124191284
translocation O 1 0.9982068538665771
( O 0 0.007874255068600178
3 O 0 0.010613732971251011
; O 0 0.006969202309846878
15 O 0 0.00925692543387413
) O 0 0.007536494173109531
( O 0 0.008749543689191341
p25 O 1 0.9882735013961792
; O 0 0.013916289433836937
q11 O 1 0.9943365454673767
. O 0 0.010180934332311153
2 O 0 0.022008365020155907
) O 0 0.01521668303757906
. O 0 0.020777851343154907

Maternal B-Disease 1 0.9999858140945435
uniparental I-Disease 1 1.0
disomy I-Disease 1 0.9999996423721313
( I-Disease 0 0.3281629979610443
UPD I-Disease 1 1.0
) I-Disease 0 0.01263606920838356
for I-Disease 0 0.008970778435468674
chromosome I-Disease 0 0.013735459186136723
15 I-Disease 0 0.00807708315551281
is O 0 0.004182859789580107
responsible O 0 0.004522989969700575
for O 0 0.0032020434737205505
an O 0 0.0035112928599119186
estimated O 0 0.005424545146524906
30 O 0 0.005157028790563345
% O 0 0.003047665348276496
of O 0 0.0030341953970491886
cases O 0 0.0035976343788206577
of O 0 0.011360852047801018
Prader B-Disease 1 1.0
- I-Disease 1 1.0
Willi I-Disease 1 1.0
syndrome I-Disease 1 1.0
( O 1 1.0
PWS B-Disease 1 1.0
) O 0 0.053140729665756226
. O 0 0.030073782429099083

We O 0 0.014055397361516953
report O 0 0.008078675717115402
on O 0 0.004955859389156103
an O 0 0.004812535364180803
unusual O 0 0.0068282475695014
case O 0 0.006513930391520262
of O 0 0.0065656425431370735
maternal B-Disease 1 0.9999032020568848
disomy I-Disease 1 0.9999957084655762
15 I-Disease 0 0.0142214959487319
in O 0 0.010483509860932827
PWS B-Disease 1 1.0
that O 0 0.004460890311747789
is O 0 0.0038538766093552113
most O 0 0.003030792810022831
consistent O 0 0.0046538240276277065
with O 0 0.003724517533555627
adjacent O 0 0.011516907252371311
- O 1 0.9999828338623047
1 O 0 0.012621673755347729
segregation O 0 0.014735299162566662
of O 0 0.0062404898926615715
a O 0 0.008916261605918407
paternal O 1 0.9976499676704407
t O 1 0.9999923706054688
( O 0 0.006805539596825838
3 O 0 0.010282078757882118
; O 0 0.00626469636335969
15 O 0 0.010033576749265194
) O 0 0.006930815987288952
( O 0 0.010241049341857433
p25 O 1 0.985913097858429
; O 0 0.012118056416511536
q11 O 1 0.8789469599723816
. O 0 0.007779292296618223
2 O 0 0.01117017399519682
) O 0 0.0054262434132397175
with O 0 0.005599167197942734
simultaneous O 0 0.017620114609599113
maternal O 1 0.9969544410705566
meiotic O 1 0.9999994039535522
nondisjunction O 1 0.9999332427978516
for O 0 0.018595747649669647
chromosome O 0 0.03434889391064644
15 O 0 0.028287317603826523
. O 0 0.030109457671642303

The O 0 0.024010609835386276
patient O 1 0.9926182627677917
( O 0 0.015078313648700714
J O 1 1.0
. O 0 0.010165098123252392
B O 1 0.9999754428863525
. O 0 0.0047102272510528564
) O 0 0.003998095635324717
, O 0 0.0032322555780410767
a O 0 0.003944345749914646
17 O 0 0.008200209587812424
- O 1 0.9980145692825317
year O 0 0.008131382055580616
- O 1 0.9999527931213379
old O 0 0.014423557557165623
white O 0 0.011332500725984573
male O 0 0.011227132752537727
with O 0 0.009000424295663834
PWS B-Disease 1 1.0
, O 0 0.00993968453258276
was O 0 0.00838729552924633
found O 0 0.0036777786444872618
to O 0 0.003348354250192642
have O 0 0.0025930663105100393
47 O 0 0.01149293314665556
chromosomes O 0 0.006824620999395847
with O 0 0.0036583130713552237
a O 0 0.007005735300481319
supernumerary O 1 0.9987068176269531
, O 0 0.010123958811163902
paternal O 1 0.9995773434638977
der O 1 0.999997615814209
( O 0 0.007549923844635487
15 O 0 0.00853522215038538
) O 0 0.005047628656029701
consisting O 0 0.005104204174131155
of O 0 0.0040125069208443165
the O 0 0.005389138590544462
short O 0 0.009066901169717312
arm O 1 0.8418969511985779
and O 0 0.0053668152540922165
the O 0 0.00837485957890749
proximal O 1 0.999998927116394
long O 0 0.03276366367936134
arm O 1 0.9944394826889038
of O 0 0.009214941412210464
chromosome O 0 0.017193490639328957
15 O 0 0.011139909736812115
, O 0 0.008024449460208416
and O 0 0.01214271318167448
distal O 1 0.9999991655349731
chromosome O 1 0.9991419315338135
arm O 1 0.9999996423721313
3p O 1 0.9999997615814209
. O 0 0.04734606295824051

The O 0 0.0247271116822958
t O 1 0.9989544153213501
( O 0 0.008066468872129917
3 O 0 0.01013916451483965
; O 0 0.005522046238183975
15 O 0 0.007336986251175404
) O 0 0.004471274092793465
was O 0 0.006133913062512875
present O 0 0.0041263350285589695
in O 0 0.0033718307968229055
the O 0 0.003997919149696827
balanced O 0 0.007304143626242876
state O 0 0.0030780318193137646
in O 0 0.004156053997576237
the O 0 0.007374277804046869
patients O 1 0.9986656904220581
father O 1 0.6030625104904175
and O 0 0.00890022236853838
a O 0 0.017198802903294563
sister O 0 0.1829095482826233
. O 0 0.022213030606508255

Fluorescent O 0 0.36965471506118774
in O 0 0.01868101954460144
situ O 0 0.06639447063207626
hybridization O 0 0.021520603448152542
analysis O 0 0.008640443906188011
demonstrated O 0 0.011398070491850376
that O 0 0.0047304993495345116
the O 0 0.012017536908388138
PWS B-Disease 1 1.0
critical O 0 0.038862694054841995
region O 0 0.012042722664773464
resided O 0 0.016972016543149948
on O 0 0.00491493521258235
the O 0 0.006313365418463945
derivative O 0 0.025438599288463593
chromosome O 0 0.01261086855083704
3 O 0 0.008096161298453808
and O 0 0.003918410278856754
that O 0 0.0023953996133059263
there O 0 0.0026602635625749826
was O 0 0.005650019738823175
no O 0 0.004229799844324589
deletion O 0 0.011642388999462128
of O 0 0.0066275871358811855
the O 0 0.0136013338342309
PWS B-Disease 1 1.0
region O 0 0.012730988673865795
on O 0 0.005751988850533962
the O 0 0.006325908470898867
normal O 0 0.007263107690960169
pair O 0 0.012487047351896763
of O 0 0.008596877567470074
15s O 1 0.9999830722808838
present O 0 0.014777297154068947
in O 0 0.018448133021593094
J O 1 0.9999996423721313
. O 0 0.032794781029224396

B O 1 0.9980670809745789
. O 0 0.06932219862937927

Methylation O 0 0.05130213871598244
analysis O 0 0.01821397989988327
at O 0 0.020364822819828987
exon O 0 0.047025494277477264
alpha O 0 0.022995322942733765
of O 0 0.007896383292973042
the O 0 0.006433120463043451
small O 0 0.006789250299334526
nuclear O 0 0.017642877995967865
ribonucleoprotein O 1 0.9998268485069275
- O 1 0.9998329877853394
associated O 0 0.014064130373299122
polypeptide O 1 0.9165213108062744
N O 0 0.04400105029344559
( O 0 0.013123653829097748
SNRPN O 1 0.9999991655349731
) O 0 0.00849379226565361
gene O 0 0.008318617939949036
showed O 0 0.007143701892346144
a O 0 0.007379847578704357
pattern O 0 0.009874596260488033
characteristic O 0 0.008775516413152218
of O 0 0.00518468813970685
only O 0 0.00479446817189455
the O 0 0.009113891050219536
maternal O 1 0.9814922213554382
chromosome O 0 0.015948409214615822
15 O 0 0.01456756703555584
in O 0 0.015425088815391064
J O 1 0.9999994039535522
. O 0 0.02893752232193947

B O 1 0.9994217157363892
. O 0 0.05148201808333397

Maternal B-Disease 1 0.9999572038650513
disomy I-Disease 1 0.9998205304145813
was O 0 0.01482246071100235
confirmed O 0 0.010454286821186543
by O 0 0.006158070173114538
polymerase O 0 0.037334077060222626
chain O 0 0.01796100288629532
reaction O 0 0.009457019157707691
analysis O 0 0.0070076859556138515
of O 0 0.00863705389201641
microsatellite O 0 0.19978679716587067
repeats O 0 0.0182261411100626
at O 0 0.009073004126548767
the O 0 0.009822984226047993
gamma O 0 0.17120037972927094
- O 1 0.9999754428863525
aminobutyric O 1 0.9995310306549072
acid O 0 0.05765750631690025
receptor O 0 0.040174439549446106
beta3 O 1 0.5468326807022095
subunit O 0 0.05500240996479988
( O 0 0.02315274067223072
GABRB3 O 1 0.9999879598617554
) O 0 0.029789598658680916
locus O 0 0.11697130650281906
. O 0 0.032708145678043365

A O 0 0.04311782494187355
niece O 1 0.998940646648407
( O 0 0.01725350134074688
B O 1 0.999902606010437
. O 0 0.009350460022687912
B O 1 0.999915361404419
. O 0 0.004487941972911358
) O 0 0.0039052481297403574
with O 0 0.0035095096100121737
45 O 0 0.007896375842392445
chromosomes O 0 0.0077082375064492226
and O 0 0.0034299721010029316
the O 0 0.005296722054481506
derivative O 0 0.013221303932368755
3 O 0 0.007398961111903191
but O 0 0.0029394677840173244
without O 0 0.0035115431528538465
the O 0 0.006700107827782631
der O 1 0.9999152421951294
( O 0 0.00563845643773675
15 O 0 0.008616900071501732
) O 0 0.004860087297856808
demonstrated O 0 0.008082158863544464
a O 0 0.008524375036358833
phenotype O 0 0.025148088112473488
consistent O 0 0.0070810033939778805
with O 0 0.003734839614480734
that O 0 0.0029272062238305807
reported O 0 0.004591238684952259
for O 0 0.005061611998826265
haploinsufficiency O 1 0.9865033626556396
of O 0 0.01653274893760681
distal O 1 0.9999986886978149
3 O 0 0.4353797733783722
p O 1 0.5591515302658081
. O 0 0.02988261543214321

Uniparental B-Disease 1 1.0
disomy I-Disease 1 0.9999959468841553
associated O 0 0.020121829584240913
with O 0 0.011219574138522148
unbalanced O 0 0.04983387887477875
segregation O 0 0.024303829297423363
of O 0 0.011446209624409676
non O 1 0.9676854610443115
- O 1 1.0
Robertsonian O 1 0.9999998807907104
translocations O 0 0.08638161420822144
has O 0 0.0055098459124565125
been O 0 0.004357995931059122
reported O 0 0.004492724314332008
previously O 0 0.004352231044322252
but O 0 0.0025287093594670296
has O 0 0.002809420693665743
not O 0 0.0019469358958303928
, O 0 0.0025071403943002224
to O 0 0.002892968477681279
our O 0 0.004503379575908184
knowledge O 0 0.005857433658093214
, O 0 0.004144391510635614
been O 0 0.0032517139334231615
observed O 0 0.003556459443643689
in O 0 0.003534811083227396
a O 0 0.0069608911871910095
case O 0 0.010933006182312965
of O 0 0.022003786638379097
PWS B-Disease 1 1.0
. O 0 0.03311292827129364

Furthermore O 0 0.03725434094667435
, O 0 0.011987613514065742
our O 0 0.009270036593079567
findings O 0 0.00777393626049161
are O 0 0.0030267152469605207
best O 0 0.007087993435561657
interpreted O 0 0.006708186585456133
as O 0 0.006720222067087889
true O 0 0.013949188403785229
gamete O 1 0.9917758703231812
complementation O 1 0.9999978542327881
resulting O 0 0.021526366472244263
in O 0 0.01939520798623562
maternal B-Disease 1 0.9999984502792358
UPD I-Disease 1 1.0
15 I-Disease 0 0.09610506892204285
and O 0 0.05033622682094574
PWS B-Disease 1 1.0

Schwartz B-Disease 1 0.9999516010284424
- I-Disease 1 1.0
Jampel I-Disease 1 1.0
syndrome I-Disease 1 1.0
type I-Disease 1 0.8053652048110962
2 I-Disease 0 0.015287005342543125
and O 0 0.009790456853806973
Stuve B-Disease 1 1.0
- I-Disease 1 1.0
Wiedemann I-Disease 1 1.0
syndrome I-Disease 1 1.0
: O 0 0.01771119423210621
a O 0 0.009362340904772282
case O 0 0.00875632930546999
for O 0 0.006974417716264725
" O 0 0.0122676445171237
lumping O 1 0.5641301870346069
" O 0 0.02158190682530403
. O 0 0.027990801259875298

Recent O 0 0.023901574313640594
studies O 0 0.013846904039382935
demonstrated O 0 0.01468978263437748
the O 0 0.0067071253433823586
existence O 0 0.0064869471825659275
of O 0 0.005156573839485645
a O 0 0.006444153841584921
genetically O 0 0.009332532063126564
distinct O 0 0.005819937214255333
, O 0 0.004977813456207514
usually O 0 0.0037466450594365597
lethal O 0 0.006453811656683683
form O 0 0.003442030167207122
of O 0 0.0032309868838638067
the O 0 0.005516551434993744
Schwartz B-Disease 1 0.9999990463256836
- I-Disease 1 1.0
Jampel I-Disease 1 1.0
syndrome I-Disease 1 1.0
( O 1 0.9997814297676086
SJS B-Disease 1 1.0
) O 0 0.010359031148254871
of O 0 0.012998264282941818
myotonia B-Disease 1 1.0
and O 1 0.993689775466919
skeletal B-Disease 1 1.0
dysplasia I-Disease 1 1.0
, O 0 0.13124758005142212
which O 0 0.004983778577297926
we O 0 0.005596730392426252
called O 0 0.01664702221751213
SJS B-Disease 1 1.0
type I-Disease 0 0.4730634093284607
2 I-Disease 0 0.029758833348751068
. O 0 0.02680053748190403

This O 0 0.020672479644417763
disorder O 1 0.9999996423721313
is O 0 0.007774633821099997
reminiscent O 0 0.027754230424761772
of O 0 0.006388968788087368
another O 0 0.009497134946286678
rare O 0 0.08621653914451599
condition O 0 0.049632199108600616
, O 0 0.004654583986848593
the O 0 0.008486639708280563
Stuve B-Disease 1 1.0
- I-Disease 1 1.0
Wiedemann I-Disease 1 1.0
syndrome I-Disease 1 1.0
( O 1 0.999974250793457
SWS B-Disease 1 1.0
) O 0 0.008293567225337029
, O 0 0.005948841106146574
which O 0 0.004028978757560253
comprises O 0 0.01251248735934496
campomelia B-Disease 1 0.9927434921264648
at O 0 0.00803693849593401
birth O 0 0.012753411196172237
with O 0 0.008985564112663269
skeletal B-Disease 1 1.0
dysplasia I-Disease 1 1.0
, O 1 0.9999867677688599
contractures B-Disease 1 1.0
, O 0 0.14346358180046082
and O 0 0.007841343991458416
early B-Disease 0 0.014548481442034245
death I-Disease 0 0.25654974579811096
. O 0 0.022229237481951714

To O 0 0.016359230503439903
test O 0 0.013939695432782173
for O 0 0.005361266899853945
possible O 0 0.006376276724040508
nosologic O 0 0.15697775781154633
identity O 0 0.0062507507391273975
between O 0 0.005132988560944796
these O 0 0.005072060972452164
disorders O 1 1.0
, O 0 0.006937817204743624
we O 0 0.003245241241529584
reviewed O 0 0.005706616211682558
the O 0 0.004010758362710476
literature O 0 0.0047109671868383884
and O 0 0.0024279358331114054
obtained O 0 0.0032140237744897604
a O 0 0.004003864713013172
follow O 0 0.0047841500490903854
- O 1 0.8058114051818848
up O 0 0.0052218991331756115
of O 0 0.0031471936963498592
the O 0 0.0030812991317361593
only O 0 0.0025015324354171753
two O 0 0.003261513076722622
surviving O 0 0.16741278767585754
patients O 1 0.6203829050064087
, O 0 0.003024423960596323
one O 0 0.0031354378443211317
with O 0 0.004786097910255194
SJS B-Disease 1 1.0
type I-Disease 1 0.5118841528892517
2 I-Disease 0 0.0087186424061656
at O 0 0.0065915449522435665
age O 0 0.006136803422123194
10 O 0 0.005386327393352985
years O 0 0.004470255225896835
and O 0 0.0031550275161862373
another O 0 0.005796689540147781
with O 0 0.006531481631100178
SWS B-Disease 1 0.9999998807907104
at O 0 0.01911471039056778
age O 0 0.015712756663560867
7 O 0 0.019271474331617355
years O 0 0.01974761299788952
. O 0 0.022855767980217934

Patients O 1 0.9953786134719849
reported O 0 0.010837375186383724
as O 0 0.00620685238391161
having O 0 0.007329627871513367
either O 0 0.013065619394183159
neonatal O 1 1.0
SJS B-Disease 1 1.0
or O 1 0.9097784161567688
SWS B-Disease 1 0.9999997615814209
presented O 0 0.01483018696308136
a O 0 0.00850662775337696
combination O 0 0.010348676703870296
of O 0 0.005706567782908678
a O 0 0.006820885464549065
severe O 1 0.9999775886535645
, O 0 0.06146987900137901
prenatal O 1 1.0
- O 1 1.0
onset O 1 1.0
neuromuscular B-Disease 1 1.0
disorder I-Disease 1 1.0
( O 1 0.9998459815979004
with O 1 0.9991379976272583
congenital B-Disease 1 1.0
joint I-Disease 1 1.0
contractures I-Disease 1 1.0
, O 1 1.0
respiratory O 1 1.0
and O 1 0.9999533891677856
feeding O 1 0.9992008805274963
difficulties O 1 0.9999581575393677
, O 0 0.008016053587198257
tendency O 0 0.030911987647414207
to O 0 0.010060030035674572
hyperthermia B-Disease 1 1.0
, O 0 0.00737424660474062
and O 0 0.005554966628551483
frequent O 0 0.010480359196662903
death O 0 0.17569062113761902
in O 0 0.009301690384745598
infancy O 1 0.9999765157699585
) O 0 0.0053276726976037025
with O 0 0.004304187837988138
a O 0 0.007523387670516968
distinct O 0 0.014936423860490322
campomelic B-Disease 1 0.9999997615814209
- I-Disease 1 1.0
metaphyseal I-Disease 1 1.0
skeletal I-Disease 1 1.0
dysplasia I-Disease 1 1.0
. O 0 0.05754019320011139

The O 0 0.023193707689642906
similarity O 0 0.015769420191645622
of O 0 0.008076136000454426
the O 0 0.009739810600876808
clinical O 1 0.9995946288108826
and O 0 0.010489139705896378
radiographic O 1 0.9999991655349731
findings O 0 0.011183724738657475
is O 0 0.0049447305500507355
so O 0 0.0037295778747648
extensive O 0 0.005567640997469425
that O 0 0.003278682241216302
these O 0 0.004704054910689592
disorders O 1 1.0
appear O 0 0.005749044474214315
to O 0 0.005469217896461487
be O 0 0.004716766066849232
a O 0 0.009533370845019817
single O 0 0.015560979954898357
entity O 0 0.0325341671705246
. O 0 0.022452211007475853

The O 0 0.016589287668466568
follow O 0 0.016146449372172356
- O 1 0.6850321888923645
up O 0 0.009774530306458473
observation O 0 0.012633457779884338
of O 0 0.005008445121347904
an O 0 0.004249136429280043
identical O 0 0.0056441184133291245
and O 0 0.0027543301694095135
unique O 0 0.004934900440275669
pattern O 0 0.0057053398340940475
of O 0 0.17419902980327606
progressive O 1 1.0
bone B-Disease 1 1.0
dysplasia I-Disease 1 1.0
in O 0 0.022171203047037125
the O 0 0.00799383781850338
two O 0 0.004977728705853224
patients O 1 0.7615531086921692
( O 0 0.004575277678668499
one O 0 0.0047290874645113945
with O 0 0.007248091511428356
SJS B-Disease 1 1.0
type I-Disease 1 0.5520395040512085
2 I-Disease 0 0.011445536278188229
, O 0 0.004955468699336052
one O 0 0.0041230209171772
with O 0 0.0062690675258636475
SWS B-Disease 1 0.9999996423721313
) O 0 0.008980700746178627
surviving O 0 0.02419634722173214
beyond O 0 0.01453081239014864
infancy O 1 0.8734258413314819
adds O 0 0.013571172021329403
to O 0 0.005100899841636419
the O 0 0.004734397865831852
evidence O 0 0.003939931746572256
in O 0 0.0041266013868153095
favor O 0 0.007983137853443623
of O 0 0.008574032224714756
identity O 0 0.016029169782996178
. O 0 0.020365014672279358

The O 0 0.01968471147119999
hypothesis O 0 0.020273547619581223
that O 0 0.007347203325480223
SWS B-Disease 1 0.9999629259109497
and O 0 0.017700381577014923
SJS B-Disease 1 1.0
type I-Disease 1 0.8169222474098206
2 I-Disease 0 0.00897485762834549
are O 0 0.0021633736323565245
the O 0 0.004870934411883354
same O 0 0.006646065507084131
disorder O 1 1.0
should O 0 0.004785944242030382
be O 0 0.005183198489248753
testable O 0 0.019493907690048218
by O 0 0.005577163305133581
molecular O 0 0.015400270000100136
methods O 0 0.01005061250180006
. O 0 0.011279843747615814
. O 0 0.023227326571941376

A O 0 0.030092507600784302
mouse O 0 0.02625444158911705
model O 0 0.013045663945376873
of O 0 0.010066015645861626
severe O 1 1.0
von B-Disease 1 1.0
Willebrand I-Disease 1 1.0
disease I-Disease 1 1.0
: O 1 0.9999995231628418
defects O 1 1.0
in O 1 0.9994441866874695
hemostasis O 1 1.0
and O 1 0.9999315738677979
thrombosis B-Disease 1 1.0
. O 1 0.8268232345581055

von B-Disease 1 0.9996650218963623
Willebrand I-Disease 1 1.0
factor I-Disease 1 0.9258179664611816
( I-Disease 0 0.02390477806329727
vWf I-Disease 1 0.9999990463256836
) I-Disease 1 0.8843827247619629
deficiency I-Disease 1 1.0
causes O 1 1.0
severe O 1 1.0
von B-Disease 1 1.0
Willebrand I-Disease 1 1.0
disease I-Disease 1 1.0
in O 1 0.9999401569366455
humans O 0 0.030378343537449837
. O 0 0.026065830141305923

We O 0 0.01663103513419628
generated O 0 0.015303265303373337
a O 0 0.011212664656341076
mouse O 0 0.020944744348526
model O 0 0.01033715344965458
for O 0 0.005888717249035835
this O 0 0.005859516095370054
disease O 1 0.9995249509811401
by O 0 0.004864519461989403
using O 0 0.00830842088907957
gene O 0 0.014023866504430771
targeting O 0 0.02227969653904438
. O 0 0.017895232886075974

vWf B-Disease 1 0.9999974966049194
- I-Disease 1 1.0
deficient I-Disease 1 0.9999681711196899
mice O 0 0.02463964931666851
appeared O 0 0.011428936384618282
normal O 0 0.008174206130206585
at O 0 0.011193959042429924
birth O 0 0.012780106626451015
; O 0 0.004668017383664846
they O 0 0.0030742879025638103
were O 0 0.004358374513685703
viable O 0 0.01937372051179409
and O 0 0.012166880071163177
fertile O 0 0.05230152606964111
. O 0 0.02493985928595066

Neither O 0 0.07497145980596542
vWf O 1 0.839059591293335
nor O 0 0.0548199899494648
vWf O 1 0.9848551154136658
propolypeptide O 1 0.96897292137146
( O 0 0.02241133153438568
von B-Disease 1 0.999626636505127
Willebrand I-Disease 1 1.0
antigen O 1 1.0
II O 1 1.0
) O 0 0.009306270629167557
were O 0 0.006272279191762209
detectable O 0 0.01923411525785923
in O 0 0.0073391953483223915
plasma O 0 0.06281492114067078
, O 0 0.011229000985622406
platelets O 1 0.9973888993263245
, O 0 0.009164230898022652
or O 0 0.008885873481631279
endothelial O 1 0.9999607801437378
cells O 0 0.010149305686354637
of O 0 0.008724265731871128
the O 0 0.014110992662608624
homozygous O 0 0.05109194666147232
mutant O 0 0.4631282389163971
mice O 0 0.04457535222172737
. O 0 0.028823094442486763

The O 0 0.03369177132844925
mutant O 0 0.3829300105571747
mice O 0 0.3856266736984253
exhibited O 1 0.9683687686920166
defects O 1 0.9999970197677612
in O 0 0.013143419288098812
hemostasis O 1 0.9999997615814209
with O 0 0.007237215526401997
a O 0 0.011316059157252312
highly O 1 0.9859074354171753
prolonged O 1 1.0
bleeding O 1 1.0
time O 0 0.009970000945031643
and O 0 0.010879073292016983
spontaneous O 1 0.6556509137153625
bleeding O 1 1.0
events O 0 0.008414819836616516
in O 0 0.00538257323205471
approximately O 0 0.00843003299087286
10 O 0 0.007886654697358608
% O 0 0.009570873342454433
of O 0 0.014852342195808887
neonates O 1 0.9948616623878479
. O 0 0.032186705619096756

As O 0 0.012567208148539066
in O 0 0.007272376213222742
the O 0 0.006954980082809925
human O 0 0.00838332250714302
disease O 1 0.9999997615814209
, O 0 0.005753564648330212
the O 0 0.0068630073219537735
factor O 1 0.9384505748748779
VIII O 1 1.0
level O 0 0.010256793349981308
in O 0 0.00491041736677289
these O 0 0.0033950742799788713
mice O 0 0.009179973974823952
was O 0 0.007458990439772606
reduced O 0 0.006909057963639498
strongly O 0 0.005699879955500364
as O 0 0.0034517808817327023
a O 0 0.004680764861404896
result O 0 0.0038165904115885496
of O 0 0.0036435071378946304
the O 0 0.004770868457853794
lack O 0 0.00706408591940999
of O 0 0.007378785405308008
protection O 1 0.8884352445602417
provided O 0 0.015179271809756756
by O 0 0.01410271693021059
vWf O 1 0.9985092282295227
. O 0 0.027051594108343124

Defective O 1 0.9999998807907104
thrombosis B-Disease 1 1.0
in O 0 0.024821557104587555
mutant O 1 0.9992581009864807
mice O 1 0.5366153717041016
was O 0 0.014695602469146252
also O 0 0.006256940774619579
evident O 0 0.009284217841923237
in O 0 0.004526203498244286
an O 0 0.004258729983121157
in O 0 0.005990843754261732
vivo O 0 0.022356800734996796
model O 0 0.017696568742394447
of O 0 0.38661718368530273
vascular B-Disease 1 1.0
injury I-Disease 1 1.0
. O 0 0.38262420892715454

In O 0 0.0178081002086401
this O 0 0.007245538756251335
model O 0 0.014865212142467499
, O 0 0.008295480161905289
the O 0 0.011075794696807861
exteriorized O 1 0.998822033405304
mesentery O 1 0.9998866319656372
was O 0 0.022833889350295067
superfused O 1 0.9990172386169434
with O 0 0.014874327927827835
ferric O 1 1.0
chloride O 1 0.9999752044677734
and O 0 0.008661503903567791
the O 0 0.00941051822155714
accumulation O 0 0.027112459763884544
of O 0 0.015921736136078835
fluorescently O 1 1.0
labeled O 1 0.9999972581863403
platelets O 1 0.9999966621398926
was O 0 0.01716248132288456
observed O 0 0.010942677967250347
by O 0 0.0115268025547266
intravital O 1 0.9953625202178955
microscopy O 0 0.0671205073595047
. O 0 0.03798508644104004

We O 0 0.014100052416324615
conclude O 0 0.017192550003528595
that O 0 0.004214082844555378
these O 0 0.003820772049948573
mice O 0 0.00900071021169424
very O 0 0.00391739048063755
closely O 0 0.007133434060961008
mimic O 1 0.586040198802948
severe O 1 0.9999960660934448
human O 1 0.991356372833252
von B-Disease 1 1.0
Willebrand I-Disease 1 1.0
disease I-Disease 1 1.0
and O 1 0.9998447895050049
will O 0 0.008151899091899395
be O 0 0.003374482039362192
very O 0 0.00346929719671607
useful O 0 0.004403186496347189
for O 0 0.003370936494320631
investigating O 0 0.006443674676120281
the O 0 0.004652070347219706
role O 0 0.007765972055494785
of O 0 0.00753957312554121
vWf O 1 0.9952213168144226
in O 0 0.006978430785238743
normal O 0 0.009545521810650826
physiology O 1 0.971193253993988
and O 0 0.0077643743716180325
in O 0 0.04298196732997894
disease O 1 1.0
models O 0 0.2258627712726593
. O 0 0.012725899927318096
. O 0 0.02201801910996437

Oral O 1 0.9472472071647644
contraceptives O 1 0.9976267218589783
and O 0 0.007013864349573851
the O 0 0.007400302216410637
risk O 1 0.6527648568153381
of O 1 0.9999653100967407
hereditary B-Disease 1 1.0
ovarian I-Disease 1 1.0
cancer I-Disease 1 1.0
. O 1 0.9999934434890747

Hereditary B-Disease 1 1.0
Ovarian I-Disease 1 1.0
Cancer I-Disease 1 1.0
Clinical O 1 1.0
Study O 1 0.9641486406326294
Group O 0 0.0430748388171196
. O 0 0.02844255603849888

BACKGROUND O 0 0.04140789806842804
Women O 0 0.015831980854272842
with O 0 0.007012114394456148
mutations O 0 0.007777819409966469
in O 0 0.003514606272801757
either O 0 0.004005900118499994
the O 0 0.0058280653320252895
BRCA1 O 1 0.9999899864196777
or O 0 0.00528833270072937
the O 0 0.00918080285191536
BRCA2 O 1 0.9999994039535522
gene O 0 0.005994942970573902
have O 0 0.002431301400065422
a O 0 0.003923554439097643
high O 0 0.007602817844599485
lifetime O 0 0.07334260642528534
risk O 1 0.9917451739311218
of O 1 0.9999961853027344
ovarian B-Disease 1 1.0
cancer I-Disease 1 1.0
. O 1 0.9975511431694031

Oral O 1 0.8456903696060181
contraceptives O 1 0.9997901320457458
protect O 1 0.7938674092292786
against O 1 0.9999819993972778
ovarian B-Disease 1 1.0
cancer I-Disease 1 1.0
in O 1 0.9943840503692627
general O 1 0.9993793964385986
, O 0 0.006470849271863699
but O 0 0.0032333589624613523
it O 0 0.002846695715561509
is O 0 0.0028404383920133114
not O 0 0.0021528361830860376
known O 0 0.003494498785585165
whether O 0 0.0025509123224765062
they O 0 0.0015709588769823313
also O 0 0.002813935512676835
protect O 0 0.005584377329796553
against O 0 0.0070525966584682465
hereditary B-Disease 1 0.9999998807907104
forms I-Disease 1 0.9832903146743774
of I-Disease 1 1.0
ovarian I-Disease 1 1.0
cancer I-Disease 1 1.0
. O 1 0.9995294809341431

METHODS O 0 0.026284195482730865
We O 0 0.010632609017193317
enrolled O 0 0.02705203928053379
207 O 0 0.0384826622903347
women O 0 0.011090041138231754
with O 0 0.011424267664551735
hereditary B-Disease 1 1.0
ovarian I-Disease 1 1.0
cancer I-Disease 1 1.0
and O 1 0.9991328120231628
161 O 1 0.9998310804367065
of O 0 0.008159574121236801
their O 0 0.00556627893820405
sisters O 0 0.014710797928273678
as O 0 0.005487460643053055
controls O 0 0.007794846780598164
in O 0 0.0042527043260633945
a O 0 0.00591480266302824
case O 0 0.011545374989509583
- O 1 0.9999977350234985
control O 0 0.01690635085105896
study O 0 0.014976812526583672
. O 0 0.01834520883858204

All O 0 0.012517153285443783
the O 0 0.012717138975858688
patients O 0 0.03850305452942848
carried O 0 0.008704115636646748
a O 0 0.008615609258413315
pathogenic O 0 0.01891358569264412
mutation O 0 0.009120170958340168
in O 0 0.004988059867173433
either O 0 0.007031756918877363
BRCA1 O 1 0.9999097585678101
( O 0 0.008193944580852985
179 O 0 0.040367454290390015
women O 0 0.012176476418972015
) O 0 0.007854706607758999
or O 0 0.008764837868511677
BRCA2 O 1 0.9999982118606567
( O 0 0.009358184412121773
28 O 0 0.020961450412869453
women O 0 0.020718805491924286
) O 0 0.014081847853958607
. O 0 0.01974763162434101

The O 0 0.0242584478110075
control O 0 0.017529936507344246
women O 0 0.010574658401310444
were O 0 0.004524164367467165
enrolled O 0 0.013869659043848515
regardless O 0 0.006719239521771669
of O 0 0.004856016021221876
whether O 0 0.004760881420224905
or O 0 0.0036974679678678513
not O 0 0.0024910529609769583
they O 0 0.0027176332660019398
had O 0 0.006108779460191727
either O 0 0.008387275971472263
mutation O 0 0.02153901755809784
. O 0 0.018913673236966133

Lifetime O 0 0.04456493631005287
histories O 0 0.024548089131712914
of O 0 0.011605481617152691
oral O 1 0.9999603033065796
- O 1 1.0
contraceptive O 1 1.0
use O 0 0.005624135956168175
were O 0 0.003413228318095207
obtained O 0 0.004363005515187979
by O 0 0.0029444752726703882
interview O 0 0.006414026487618685
or O 0 0.0031289118342101574
by O 0 0.0028170642908662558
written O 0 0.003711305558681488
questionnaire O 0 0.008690687827765942
and O 0 0.003054726403206587
were O 0 0.0021384309511631727
compared O 0 0.0041017658077180386
between O 0 0.004161388147622347
patients O 1 0.9941587448120117
and O 0 0.004510640632361174
control O 1 0.8346081376075745
women O 0 0.09029466658830643
, O 0 0.004927682224661112
after O 0 0.006281097419559956
adjustment O 0 0.010961158201098442
for O 0 0.004837134387344122
year O 0 0.006827775854617357
of O 0 0.009306086227297783
birth O 0 0.021131908521056175
and O 0 0.012127639725804329
parity O 0 0.16136614978313446
. O 0 0.027684852480888367

RESULTS O 0 0.028495434671640396
The O 0 0.014269358478486538
adjusted O 0 0.020742002874612808
odds O 0 0.021634867414832115
ratio O 0 0.017691951245069504
for O 0 0.014914194121956825
ovarian B-Disease 1 1.0
cancer I-Disease 1 1.0
associated O 1 0.5538666844367981
with O 0 0.004311679396778345
any O 0 0.003476751735433936
past O 0 0.004864844493567944
use O 0 0.0038522405084222555
of O 0 0.006819835398346186
oral O 1 0.993020236492157
contraceptives O 1 0.9999990463256836
was O 0 0.31359636783599854
0 O 0 0.037888504564762115
. O 0 0.028495844453573227

5 O 0 0.02590288408100605
( O 0 0.011133262887597084
95 O 0 0.020205533131957054
percent O 0 0.011400934308767319
confidence O 0 0.016782483085989952
interval O 0 0.01321999728679657
, O 0 0.006265485659241676
0 O 0 0.01018883753567934
. O 0 0.003911521285772324
3 O 0 0.006060839165002108
to O 0 0.0049596321769058704
0 O 0 0.011866544373333454
. O 0 0.006924750283360481
8 O 0 0.015988975763320923
) O 0 0.01463038008660078
. O 0 0.021294955164194107

The O 0 0.024866759777069092
risk O 0 0.06968256831169128
decreased O 0 0.012953792698681355
with O 0 0.0055000330321490765
increasing O 0 0.006131661590188742
duration O 0 0.010468478314578533
of O 0 0.004872307181358337
use O 0 0.004851957317441702
( O 0 0.006538690999150276
P O 0 0.21604588627815247
for O 0 0.005450403783470392
trend O 0 0.010822398588061333
, O 0 0.007283476646989584
< O 0 0.4211578965187073
0 O 0 0.015608340501785278
. O 0 0.007964511401951313
001 O 1 0.9971725940704346
) O 0 0.006853971164673567
; O 0 0.004123146180063486
use O 0 0.002614513272419572
for O 0 0.0026310684625059366
six O 0 0.003593899542465806
or O 0 0.0021640551276504993
more O 0 0.0021051254589110613
years O 0 0.0038226600736379623
was O 0 0.005352471023797989
associated O 0 0.003799133701249957
with O 0 0.002744989236816764
a O 0 0.0047434973530471325
60 O 0 0.009000370278954506
percent O 0 0.009079269133508205
reduction O 0 0.014064518734812737
in O 0 0.012117543257772923
risk O 0 0.04370735213160515
. O 0 0.023979121819138527

Oral O 1 0.9976152181625366
- O 1 0.9999896287918091
contraceptive O 1 0.9998453855514526
use O 0 0.010108014568686485
protected O 0 0.029864581301808357
against O 1 0.997515082359314
ovarian B-Disease 1 1.0
cancer I-Disease 1 1.0
both O 0 0.005993059370666742
for O 0 0.0056390040554106236
carriers O 0 0.012565498240292072
of O 0 0.005491484887897968
the O 0 0.010639994405210018
BRCA1 O 1 0.9999986886978149
mutation O 0 0.012865697033703327
( O 0 0.007369696628302336
odds O 0 0.017909342423081398
ratio O 0 0.011659233830869198
, O 0 0.006415181327611208
0 O 0 0.009648694656789303
. O 0 0.003939751535654068
5 O 0 0.006613167934119701
; O 0 0.005100034177303314
95 O 0 0.012178611941635609
percent O 0 0.008288226090371609
confidence O 0 0.012370244599878788
interval O 0 0.013685113750398159
, O 0 0.006797808688133955
0 O 0 0.009547009132802486
. O 0 0.004019628744572401
3 O 0 0.0065323724411427975
to O 0 0.004425068385899067
0 O 0 0.010499687865376472
. O 0 0.005240131635218859
9 O 0 0.009446613490581512
) O 0 0.004118426237255335
and O 0 0.0031486782245337963
for O 0 0.0037447819486260414
carriers O 0 0.011052723042666912
of O 0 0.005554461386054754
the O 0 0.010118984617292881
BRCA2 O 1 0.9999994039535522
mutation O 0 0.011532898992300034
( O 0 0.0076387678273022175
odds O 0 0.0200661513954401
ratio O 0 0.011440002359449863
, O 0 0.0056560346856713295
0 O 0 0.008911848068237305
. O 0 0.0035358844324946404
4 O 0 0.0067511009983718395
; O 0 0.004127138294279575
95 O 0 0.011938543990254402
percent O 0 0.0072244140319526196
confidence O 0 0.011420496739447117
interval O 0 0.011836483143270016
, O 0 0.005418502259999514
0 O 0 0.00939960777759552
. O 0 0.0036903871223330498
2 O 0 0.005899482872337103
to O 0 0.0043493579141795635
1 O 0 0.009944613091647625
. O 0 0.006308760028332472
1 O 0 0.018210044130682945
) O 0 0.015355583280324936
. O 0 0.01955641247332096

CONCLUSIONS O 0 0.042200926691293716
Oral O 1 0.9976271986961365
- O 1 0.9999998807907104
contraceptive O 1 0.9999997615814209
use O 0 0.006145505700260401
may O 0 0.0040020206943154335
reduce O 0 0.00644321646541357
the O 0 0.0046814847737550735
risk O 0 0.4157080054283142
of O 1 0.999913215637207
ovarian B-Disease 1 1.0
cancer I-Disease 1 1.0
in O 1 0.8467702269554138
women O 0 0.021210409700870514
with O 0 0.007421568967401981
pathogenic O 0 0.03840654715895653
mutations O 0 0.009042790159583092
in O 0 0.006658801808953285
the O 0 0.014717171899974346
BRCA1 O 1 0.9999990463256836
or O 0 0.024273419752717018
BRCA2 O 1 0.9999938011169434
gene O 0 0.06137757748365402

A O 0 0.03569823503494263
Japanese O 0 0.040008001029491425
family O 0 0.022433126345276833
with O 0 0.013673237524926662
adrenoleukodystrophy B-Disease 1 1.0
with O 0 0.009366815909743309
a O 0 0.012984110042452812
codon O 0 0.031513333320617676
291 O 0 0.0519908107817173
deletion O 0 0.02405952662229538
: O 0 0.008644651621580124
a O 0 0.008491038344800472
clinical O 1 0.9965983033180237
, O 0 0.008300071582198143
biochemical O 1 0.9136029481887817
, O 0 0.008492743596434593
pathological O 1 0.9983634352684021
, O 0 0.00915550533682108
and O 0 0.00840211845934391
genetic O 0 0.014837105758488178
report O 0 0.013399568386375904
. O 0 0.020630674436688423

We O 0 0.011992978863418102
report O 0 0.009263137355446815
a O 0 0.007588992826640606
Japanese O 0 0.015272941440343857
family O 0 0.012697834521532059
with O 0 0.010472267866134644
adrenoleukodystrophy B-Disease 1 1.0
( O 1 0.9999957084655762
ALD B-Disease 1 1.0
) O 0 0.009303668513894081
with O 0 0.004872371442615986
a O 0 0.005785233341157436
three O 0 0.004452537279576063
base O 0 0.015935108065605164
pair O 0 0.013297103345394135
deletion O 0 0.025066988542675972
( O 0 0.010843603871762753
delGAG O 1 0.9975554347038269
291 O 0 0.1740364283323288
) O 0 0.007626040372997522
in O 0 0.00832119956612587
the O 0 0.01862996816635132
ALD B-Disease 1 1.0
gene O 0 0.04547036066651344
. O 0 0.034084003418684006

A O 0 0.026481997221708298
variety O 0 0.014013399370014668
of O 0 0.010331526398658752
phenotypes O 0 0.024998636916279793
were O 0 0.005019173491746187
observed O 0 0.006642169319093227
within O 0 0.005658422131091356
this O 0 0.0069265770725905895
family O 0 0.019116856157779694
. O 0 0.021931815892457962

While O 0 0.015462792478501797
the O 0 0.012295776978135109
proband O 1 0.9990978240966797
( O 0 0.01078975759446621
patient O 1 0.9985418319702148
1 O 0 0.12202539294958115
) O 0 0.006138799246400595
was O 0 0.007473549339920282
classified O 0 0.007886950857937336
as O 0 0.0036707192193716764
having O 0 0.004011623561382294
a O 0 0.004895051475614309
rare O 0 0.007320016156882048
intermediate O 0 0.023770399391651154
type O 0 0.008932997472584248
of O 0 0.006755734793841839
adult O 0 0.012900365516543388
cerebral O 1 0.999995231628418
and O 0 0.05430897697806358
cerebello O 1 1.0
- O 1 1.0
brain O 1 0.9999979734420776
stem O 0 0.015926998108625412
forms O 0 0.005274339113384485
, O 0 0.0049679698422551155
his O 0 0.008428613655269146
younger O 0 0.3721480667591095
brother O 1 0.9091691374778748
( O 0 0.007172629237174988
patient O 1 0.9924536347389221
2 O 0 0.01255690585821867
) O 0 0.006027697119861841
and O 0 0.00580096710473299
nephew O 1 0.9999954700469971
( O 0 0.008581670932471752
patient O 1 0.9997840523719788
3 O 0 0.0112110935151577
) O 0 0.005799449048936367
had O 0 0.007159689906984568
a O 0 0.016401132568717003
childhood O 1 1.0
ALD B-Disease 1 1.0
type O 1 0.9999750852584839
. O 0 0.03788972273468971

Another O 0 0.03791103512048721
nephew O 1 0.9999740123748779
( O 0 0.011761469766497612
patient O 1 0.9905633926391602
4 O 0 0.012366521172225475
) O 0 0.004847171250730753
of O 0 0.006151455454528332
patient O 1 0.9998339414596558
1 O 0 0.04455729201436043
was O 0 0.009086590260267258
classified O 0 0.008811183273792267
as O 0 0.004736834205687046
having O 0 0.006681011524051428
an O 0 0.00901514757424593
adolescent O 1 0.9999990463256836
form O 0 0.019698934629559517
. O 0 0.025460466742515564

The O 0 0.028741123154759407
tau O 0 0.08253771811723709
level O 0 0.012316931039094925
in O 0 0.007186367176473141
the O 0 0.011713829822838306
cerebrospinal O 1 0.9999998807907104
fluid O 1 0.999992847442627
( O 0 0.25408175587654114
CSF O 1 1.0
) O 0 0.007089309394359589
in O 0 0.005568759981542826
patient O 1 0.989679217338562
1 O 0 0.010863671079277992
was O 0 0.0062608239240944386
as O 0 0.0037002847529947758
high O 0 0.005478325765579939
as O 0 0.002965749939903617
that O 0 0.002079882426187396
of O 0 0.0045988247729837894
patients O 1 0.9621058702468872
with O 1 0.9647530913352966
Alzheimers B-Disease 1 1.0
disease I-Disease 1 1.0
( O 1 0.9999892711639404
AD B-Disease 1 1.0
) O 0 0.018852170556783676
. O 0 0.02365455962717533

His O 0 0.2903375029563904
brain O 1 0.9649812579154968
magnetic O 0 0.02549862489104271
resonance O 0 0.026150992140173912
image O 1 0.7190194129943848
( O 0 0.014998374506831169
MRI O 1 0.9999997615814209
) O 0 0.00886853039264679
showed O 0 0.010492903180420399
abnormalities B-Disease 0 0.037546731531620026
in I-Disease 0 0.0049225809052586555
the I-Disease 0 0.007758942898362875
bilateral I-Disease 1 0.9964498281478882
cerebellar I-Disease 1 1.0
hemispheres I-Disease 1 0.9999775886535645
and O 1 0.9973529577255249
brain O 1 1.0
stem O 1 0.9916883111000061
, O 0 0.004201994277536869
but O 0 0.002021869644522667
not O 0 0.0015146407531574368
in O 0 0.0028266876470297575
the O 0 0.006744714919477701
cerebral O 1 1.0
white O 1 0.9961690306663513
matter O 0 0.004864062648266554
, O 0 0.004336273297667503
where O 0 0.003895214991644025
marked O 0 0.006152691785246134
reductions O 0 0.00815407745540142
of O 0 0.005067700520157814
the O 0 0.010173470713198185
cerebral O 1 1.0
blood O 1 0.9993218183517456
flow O 0 0.010600432753562927
and O 0 0.011057686060667038
oxygen O 1 0.9998517036437988
metabolism O 1 0.6911571621894836
were O 0 0.004827930126339197
clearly O 0 0.0076486715115606785
demonstrated O 0 0.010400026105344296
by O 0 0.007392922416329384
positron O 0 0.04515087977051735
emission O 0 0.02893717773258686
tomography O 0 0.0380551852285862
( O 0 0.023538153618574142
PET O 1 0.9982971549034119
) O 0 0.022576892748475075
. O 0 0.024606242775917053

In O 0 0.019550524652004242
patients O 1 0.5994735360145569
2 O 0 0.012981586158275604
and O 0 0.00621783547103405
3 O 0 0.00980871357023716
, O 0 0.005680862348526716
the O 0 0.006196771748363972
autopsy O 0 0.014981919899582863
findings O 0 0.009160836227238178
showed O 0 0.0101541168987751
massive O 0 0.055340446531772614
demyelination B-Disease 1 1.0
of I-Disease 0 0.030400903895497322
the I-Disease 1 0.680770993232727
cerebral I-Disease 1 1.0
white I-Disease 1 0.7750493884086609
matter I-Disease 0 0.005817708559334278
with O 0 0.004450588952749968
sparing O 0 0.016495198011398315
of O 0 0.006859540473669767
the O 0 0.013958519324660301
U O 1 1.0
- O 1 1.0
fibers O 1 0.9991044402122498
, O 0 0.0080034788697958
compatible O 0 0.01159337256103754
with O 0 0.0037137046456336975
the O 0 0.00584146985784173
findings O 0 0.00885086040943861
of O 0 0.016466043889522552
childhood O 1 1.0
ALD B-Disease 1 1.0
. O 0 0.15667374432086945

Oleic O 1 0.9981409311294556
and O 0 0.03194708377122879
erucic O 1 0.9999990463256836
acids O 0 0.026036247611045837
( O 0 0.01641976647078991
Lorenzos O 1 0.9999147653579712
Oil O 0 0.017975734546780586
) O 0 0.005733015481382608
were O 0 0.003084450261667371
administered O 0 0.007059404626488686
to O 0 0.005368862301111221
patients O 1 0.9522643685340881
1 O 0 0.010392982512712479
and O 0 0.005116709042340517
4 O 0 0.009599437937140465
, O 0 0.00441078981384635
but O 0 0.0037805172614753246
sufficient O 0 0.008738206699490547
effectiveness O 0 0.07885917276144028
was O 0 0.010889515280723572
not O 0 0.006550286430865526
obtained O 0 0.01479122880846262
. O 0 0.019199233502149582

The O 0 0.01838187873363495
findings O 0 0.01106676273047924
in O 0 0.006003567483276129
this O 0 0.003672737628221512
family O 0 0.0074767544865608215
suggest O 0 0.004661851096898317
that O 0 0.0033517612610012293
delGAG291 O 1 0.9149470925331116
is O 0 0.0041916100308299065
part O 0 0.0051142312586307526
of O 0 0.003645262448117137
the O 0 0.005037256050854921
cause O 0 0.010835270397365093
of O 0 0.01476506981998682
Japanese O 1 0.9999982118606567
ALD B-Disease 1 1.0
with O 0 0.01903826743364334
phenotypic O 0 0.05407543480396271
variations O 0 0.027933182194828987
. O 0 0.028091492131352425

Moreover O 0 0.03418031707406044
, O 0 0.010241920128464699
although O 0 0.005177536979317665
the O 0 0.0046828207559883595
scale O 0 0.006938171572983265
of O 0 0.004492494277656078
the O 0 0.004331633914262056
study O 0 0.004856122191995382
is O 0 0.003410555887967348
limited O 0 0.004647154361009598
, O 0 0.003383889328688383
there O 0 0.0020043442491441965
is O 0 0.0028398223221302032
a O 0 0.0035455990582704544
possibility O 0 0.005385030061006546
that O 0 0.003358004614710808
PET O 1 0.7949497699737549
can O 0 0.004628132097423077
detect O 0 0.011654774658381939
an O 0 0.009532790631055832
insidious B-Disease 1 1.0
lesion I-Disease 1 1.0
which O 0 0.006661531049758196
is O 0 0.007537036668509245
undetectable O 0 0.21622928977012634
by O 0 0.005192327778786421
computed O 0 0.017419757321476936
tomogram O 1 0.9989559650421143
( O 0 0.015018281526863575
CT O 1 1.0
) O 0 0.009889738634228706
or O 0 0.008734378963708878
MRI O 1 0.9982370138168335
analysis O 0 0.007240691222250462
, O 0 0.004630803596228361
and O 0 0.002613212913274765
that O 0 0.0016658223466947675
the O 0 0.0029866474214941263
higher O 0 0.004654712043702602
level O 0 0.005778840743005276
of O 0 0.00617551151663065
tau O 1 0.9601179361343384
reflects O 0 0.008220883086323738
the O 0 0.005126602482050657
process O 0 0.004834686405956745
of O 0 0.010101228021085262
neuronal B-Disease 1 0.9997695088386536
degeneration I-Disease 1 1.0
in O 1 0.9999665021896362
ALD B-Disease 1 1.0
. O 0 0.2925901412963867

Lorenzos O 1 0.9997866749763489
Oil O 0 0.025909211486577988
should O 0 0.006876287050545216
be O 0 0.0037328905891627073
given O 0 0.003598507959395647
in O 0 0.0035033768508583307
the O 0 0.005253077019006014
early O 0 0.009008709341287613
stage O 0 0.022401463240385056
. O 0 0.009784726426005363
. O 0 0.01786062866449356

Nonsense O 0 0.09782447665929794
mutation O 0 0.0322878472507
in O 0 0.012456109747290611
exon O 0 0.040782034397125244
4 O 0 0.012247792445123196
of O 0 0.007103631738573313
human O 0 0.008569195866584778
complement O 1 0.5145793557167053
C9 O 1 1.0
gene O 0 0.011393708176910877
is O 0 0.004528988618403673
the O 0 0.005945326294749975
major O 0 0.008584585040807724
cause O 0 0.011012413538992405
of O 0 0.010744178667664528
Japanese O 1 0.9996631145477295
complement B-Disease 1 0.9999963045120239
C9 I-Disease 1 1.0
deficiency I-Disease 1 1.0
. O 0 0.04717622324824333

Deficiency B-Disease 1 1.0
of I-Disease 0 0.018256284296512604
the I-Disease 0 0.014186362735927105
ninth I-Disease 1 0.9959465861320496
component I-Disease 0 0.026752116158604622
of I-Disease 0 0.008400746621191502
human I-Disease 0 0.006827633362263441
complement I-Disease 0 0.33094385266304016
( O 0 0.015624466352164745
C9 O 1 1.0
) O 0 0.005583863705396652
is O 0 0.0029963466804474592
the O 0 0.0037033448461443186
most O 0 0.0033001815900206566
common O 0 0.006107855588197708
complement B-Disease 1 0.9999998807907104
deficiency I-Disease 1 1.0
in O 1 0.8560582995414734
Japan O 1 0.9982380867004395
but O 0 0.004616411868482828
is O 0 0.004275653976947069
rare O 0 0.006090307142585516
in O 0 0.004482933320105076
other O 0 0.004519659094512463
countries O 0 0.006909878458827734
. O 0 0.014450250193476677

We O 0 0.013717563822865486
studied O 0 0.013625972904264927
the O 0 0.007962244562804699
molecular O 0 0.011486764065921307
basis O 0 0.005912167485803366
of O 0 0.014275987632572651
C9 B-Disease 1 1.0
deficiency I-Disease 1 1.0
in O 0 0.00949313584715128
four O 0 0.00990874320268631
Japanese O 1 0.9259623885154724
C9 B-Disease 1 1.0
- I-Disease 1 1.0
deficient I-Disease 1 0.9999995231628418
patients O 1 0.9997580647468567
who O 0 0.01349225826561451
had O 1 0.6408353447914124
suffered O 1 1.0
from O 1 0.9999556541442871
meningococcal B-Disease 1 1.0
meningitis I-Disease 1 1.0
. O 1 0.9980237483978271

Direct O 0 0.02871975302696228
sequencing O 0 0.03557103872299194
of O 0 0.02188378944993019
amplified O 0 0.06931746006011963
C9 O 1 0.9999457597732544
cDNA O 0 0.05628411844372749
and O 0 0.013391300104558468
DNA O 0 0.01378669310361147
revealed O 0 0.011981024406850338
a O 0 0.008332153782248497
nonsense O 0 0.021411344408988953
substitution O 0 0.01798561029136181
( O 0 0.010682182386517525
CGA O 0 0.2207980751991272
- O 1 0.9999985694885254
- O 1 0.9999994039535522
> O 1 0.9999722242355347
TGA O 1 0.9999986886978149
) O 0 0.011210581287741661
at O 0 0.01225696038454771
codon O 0 0.021842917427420616
95 O 0 0.016970060765743256
in O 0 0.008795280940830708
exon O 0 0.0344383530318737
4 O 0 0.011853025294840336
in O 0 0.005963456816971302
the O 0 0.008002120070159435
four O 0 0.015142841264605522
C9 B-Disease 1 1.0
- I-Disease 1 1.0
deficient I-Disease 1 0.9999386072158813
individuals O 0 0.018838565796613693
. O 0 0.026047900319099426

An O 0 0.02033599093556404
allele O 0 0.04019248113036156
- O 1 0.9679829478263855
specific O 0 0.010805974714457989
polymerase O 0 0.13840501010417938
chain O 0 0.020762974396348
reaction O 0 0.010645558126270771
system O 0 0.009020065888762474
designed O 0 0.013079424388706684
to O 0 0.007104584015905857
detect O 0 0.013235369697213173
exclusively O 0 0.006089155562222004
only O 0 0.002784660318866372
one O 0 0.003034391440451145
of O 0 0.003862034762278199
the O 0 0.004649183712899685
normal O 0 0.005930554587393999
and O 0 0.005376496352255344
mutant O 0 0.021877644583582878
alleles O 0 0.012107637710869312
indicated O 0 0.0054222713224589825
that O 0 0.002020952757447958
all O 0 0.002419515047222376
the O 0 0.004206220619380474
four O 0 0.005555367097258568
patients O 0 0.04431623965501785
were O 0 0.0034704976715147495
homozygous O 0 0.01000905316323042
for O 0 0.004647701047360897
the O 0 0.006186782848089933
mutation O 0 0.00847586803138256
in O 0 0.006009973585605621
exon O 0 0.22524148225784302
4 O 0 0.009356538765132427
and O 0 0.003842598758637905
that O 0 0.0029080493841320276
the O 0 0.004765537101775408
parents O 0 0.0062214103527367115
of O 0 0.007053986191749573
patient O 1 0.9995653033256531
2 O 0 0.019236372783780098
were O 0 0.01144635584205389
heterozygous O 0 0.03528034687042236
. O 0 0.025494800880551338

The O 0 0.019758300855755806
common O 0 0.013658582232892513
mutation O 0 0.012670275755226612
at O 0 0.009625694714486599
codon O 0 0.016824092715978622
95 O 0 0.014469882473349571
in O 0 0.007628429681062698
exon O 0 0.03780867159366608
4 O 0 0.011990838684141636
might O 0 0.005089063197374344
be O 0 0.0027911390643566847
responsible O 0 0.004757328424602747
for O 0 0.0038672927767038345
most O 0 0.00781361572444439
Japanese O 1 0.9999457597732544
C9 B-Disease 1 1.0
deficiency I-Disease 1 1.0
. O 0 0.029691727831959724
. O 0 0.0327470637857914

BRCA1 O 1 0.559549868106842
required O 0 0.011696171946823597
for O 0 0.01002954225987196
transcription O 0 0.026710497215390205
- O 1 0.9999843835830688
coupled O 0 0.46193331480026245
repair O 1 0.9999027252197266
of O 0 0.024124078452587128
oxidative O 1 0.99997878074646
DNA O 0 0.2804364860057831
damage O 1 0.9892051219940186
. O 0 0.026560112833976746

The O 0 0.0349794365465641
breast B-Disease 1 1.0
and I-Disease 1 0.9994743466377258
ovarian I-Disease 1 1.0
cancer I-Disease 1 1.0
susceptibility O 1 1.0
gene O 1 0.9922796487808228
BRCA1 O 1 0.9999940395355225
encodes O 0 0.030284659937024117
a O 0 0.01833164319396019
zinc O 1 1.0
finger O 1 0.9760937094688416
protein O 0 0.015668831765651703
of O 0 0.011099448427557945
unknown O 0 0.016516709700226784
function O 0 0.01826784946024418
. O 0 0.023513097316026688

Association O 0 0.026280350983142853
of O 0 0.01345914788544178
the O 0 0.013636911287903786
BRCA1 O 1 0.999945878982544
protein O 0 0.01049416046589613
with O 0 0.004274267703294754
the O 0 0.006802735850214958
DNA O 0 0.014025990851223469
repair O 1 0.9999946355819702
protein O 0 0.02311304397881031
Rad51 O 1 0.9998958110809326
and O 0 0.006464546546339989
changes O 0 0.0043970076367259026
in O 0 0.004012644290924072
the O 0 0.005466914735734463
phosphorylation O 0 0.011229137890040874
and O 0 0.005935422610491514
cellular O 0 0.0190769974142313
localization O 0 0.01810767687857151
of O 0 0.006673958618193865
the O 0 0.00717914430424571
protein O 0 0.009127375669777393
after O 0 0.007700863294303417
exposure O 0 0.010549120604991913
to O 0 0.005508615169674158
DNA O 0 0.011694320477545261
- O 1 0.9999884366989136
damaging O 0 0.10276314616203308
agents O 0 0.006468201521784067
are O 0 0.002113793510943651
consistent O 0 0.00503901019692421
with O 0 0.0037334687076509
a O 0 0.0056855021975934505
role O 0 0.007802894338965416
for O 0 0.008051032200455666
BRCA1 O 1 0.9999594688415527
in O 0 0.011952027678489685
DNA O 0 0.031240230426192284
repair O 1 0.999921441078186
. O 0 0.025058187544345856

Here O 0 0.02330879680812359
, O 0 0.008871249854564667
it O 0 0.004227402154356241
is O 0 0.003873193636536598
shown O 0 0.003513098694384098
that O 0 0.00312042236328125
mouse O 0 0.01836266554892063
embryonic O 0 0.021349847316741943
stem O 0 0.053262025117874146
cells O 0 0.02045011706650257
deficient B-Disease 1 0.9978929162025452
in I-Disease 0 0.012044413015246391
BRCA1 I-Disease 1 0.9999891519546509
are O 0 0.005601138342171907
defective O 1 0.7843784093856812
in O 0 0.0053855557925999165
the O 0 0.00505372928455472
ability O 0 0.005137146916240454
to O 0 0.0031508489046245813
carry O 0 0.004059304483234882
out O 0 0.005250758025795221
transcription O 0 0.015568451955914497
- O 1 0.9999756813049316
coupled O 0 0.02285422757267952
repair O 1 0.9980173110961914
of O 0 0.012297072447836399
oxidative O 1 0.9999933242797852
DNA O 0 0.42145460844039917
damage O 1 0.998242974281311
, O 0 0.005985372234135866
and O 0 0.0053242165595293045
are O 0 0.004289666656404734
hypersensitive O 1 0.9983997941017151
to O 0 0.013770461082458496
ionizing O 1 0.9999966621398926
radiation O 1 0.9998791217803955
and O 0 0.022870175540447235
hydrogen O 0 0.2648591995239258
peroxide O 1 0.9943788647651672
. O 0 0.036440927535295486

These O 0 0.010736074298620224
results O 0 0.010090519674122334
suggest O 0 0.007670152932405472
that O 0 0.005713037680834532
BRCA1 O 1 0.9999558925628662
participates O 0 0.019201751798391342
, O 0 0.006545279640704393
directly O 0 0.005861674901098013
or O 0 0.003723632777109742
indirectly O 0 0.00635222252458334
, O 0 0.0037572267465293407
in O 0 0.004250701982527971
transcription O 0 0.029881399124860764
- O 1 0.9999973773956299
coupled O 0 0.10851483792066574
repair O 1 0.9998456239700317
of O 0 0.017064526677131653
oxidative O 1 0.999974250793457
DNA O 0 0.07047466188669205
damage O 1 0.9797088503837585
. O 0 0.014169381000101566
. O 0 0.022716909646987915

Truncation O 1 0.906173050403595
mutations O 0 0.02324475161731243
in O 0 0.008425465784966946
the O 0 0.00971055869013071
transactivation O 1 0.938701868057251
region O 0 0.01228997390717268
of O 0 0.011975396424531937
PAX6 O 1 1.0
result O 0 0.007985834032297134
in O 0 0.008322406560182571
dominant O 1 0.9995730519294739
- O 1 0.9999998807907104
negative O 0 0.026909543201327324
mutants O 0 0.06378193944692612
. O 0 0.028910212218761444

PAX6 O 1 0.9998935461044312
is O 0 0.016223210841417313
a O 0 0.01438418123871088
transcription O 0 0.01993461512029171
factor O 0 0.010969670489430428
with O 0 0.003931582439690828
two O 0 0.004079786129295826
DNA O 0 0.01054553221911192
- O 1 0.9966555833816528
binding O 0 0.011128513142466545
domains O 0 0.014891219325363636
( O 0 0.009040851145982742
paired O 0 0.02197416126728058
box O 0 0.08573555201292038
and O 0 0.01146208867430687
homeobox O 1 0.9999837875366211
) O 0 0.007205710280686617
and O 0 0.0058085317723453045
a O 0 0.010759253054857254
proline O 1 0.6325618028640747
- O 1 0.999993085861206
serine O 1 0.8324975371360779
- O 1 0.9999957084655762
threonine O 1 0.9417879581451416
( O 0 0.016076507046818733
PST O 1 0.9999951124191284
) O 0 0.019560309126973152
- O 1 0.9991858601570129
rich O 0 0.03634152561426163
transactivation O 1 0.9652515053749084
domain O 0 0.046059366315603256
. O 0 0.0320124477148056

PAX6 O 1 0.9999997615814209
regulates O 1 0.9892071485519409
eye O 1 0.9998396635055542
development O 0 0.015346741303801537
in O 0 0.008103904314339161
animals O 0 0.006409056950360537
ranging O 0 0.010925635695457458
from O 0 0.00761985732242465
jellyfish O 0 0.026677871122956276
to O 0 0.012010020203888416
Drosophila O 0 0.0314195416867733
to O 0 0.014437820762395859
humans O 0 0.01984965242445469
. O 0 0.023959219455718994

Heterozygous O 0 0.06510888040065765
mutations O 0 0.017134305089712143
in O 0 0.006998633034527302
the O 0 0.008108492940664291
human O 0 0.012428008951246738
PAX6 O 1 1.0
gene O 0 0.012922351248562336
result O 0 0.005311701446771622
in O 0 0.0047485786490142345
various O 0 0.004586438648402691
phenotypes O 0 0.014760567806661129
, O 0 0.005656528286635876
including O 0 0.007611618842929602
aniridia B-Disease 1 1.0
, O 0 0.014261393807828426
Peters B-Disease 1 0.9999988079071045
anomaly I-Disease 1 0.999980092048645
, O 0 0.013745785690844059
autosomal B-Disease 1 0.9999892711639404
dominant I-Disease 1 0.9999994039535522
keratitis I-Disease 1 1.0
, O 1 0.7887957096099854
and O 1 0.9719241261482239
familial B-Disease 1 1.0
foveal I-Disease 1 1.0
dysplasia I-Disease 1 1.0
. O 1 0.9756693243980408

It O 0 0.014345604926347733
is O 0 0.007898236624896526
believed O 0 0.008188723586499691
that O 0 0.003399820998311043
the O 0 0.006606179755181074
mutated O 0 0.024112451821565628
allele O 0 0.018304290249943733
of O 0 0.011416923254728317
PAX6 O 1 0.9999996423721313
produces O 0 0.018354741856455803
an O 0 0.008450619876384735
inactive O 0 0.16444669663906097
protein O 0 0.012471452355384827
and O 0 0.008766801096498966
aniridia B-Disease 1 1.0
is O 0 0.007764833513647318
caused O 0 0.016038130968809128
due O 0 0.0087464964017272
to O 0 0.012439239770174026
genetic O 0 0.03513646870851517
haploinsufficiency O 1 0.9999529123306274
. O 0 0.029328351840376854

However O 0 0.015901576727628708
, O 0 0.0074135963805019855
several O 0 0.0053276014514267445
truncation O 1 0.5661271810531616
mutations O 0 0.008530430495738983
have O 0 0.0029894812032580376
been O 0 0.003315380308777094
found O 0 0.002619272330775857
to O 0 0.0027171175461262465
occur O 0 0.0022678349632769823
in O 0 0.002858550287783146
the O 0 0.006359853781759739
C O 1 0.9999978542327881
- O 1 0.9999996423721313
terminal O 0 0.03753098100423813
half O 0 0.009310676716268063
of O 0 0.009107246063649654
PAX6 O 1 0.9999920129776001
in O 0 0.008902233093976974
patients O 1 0.6202471256256104
with O 0 0.010087552480399609
Aniridia B-Disease 1 1.0
resulting O 0 0.014947900548577309
in O 0 0.007436889223754406
mutant O 0 0.023061145097017288
proteins O 0 0.006663831416517496
that O 0 0.0029705294873565435
retain O 0 0.009989180602133274
the O 0 0.0062371050007641315
DNA O 0 0.011162872426211834
- O 1 0.9998310804367065
binding O 0 0.009315494447946548
domains O 0 0.009050536900758743
but O 0 0.00290436833165586
have O 0 0.0025161528028547764
lost O 0 0.007375233806669712
most O 0 0.003358490066602826
of O 0 0.005689164623618126
the O 0 0.010805545374751091
transactivation O 1 0.9999935626983643
domain O 0 0.040538884699344635
. O 0 0.02357747033238411

It O 0 0.014594381675124168
is O 0 0.007757782470434904
not O 0 0.003896266222000122
clear O 0 0.006285566370934248
whether O 0 0.0053925770334899426
such O 0 0.0054351394064724445
mutants O 0 0.025095980614423752
really O 0 0.009314190596342087
behave O 0 0.008029384538531303
as O 0 0.005227569490671158
loss O 0 0.36039385199546814
- O 1 0.9999980926513672
of O 0 0.013887893408536911
- O 1 0.9999998807907104
function O 0 0.012318880297243595
mutants O 0 0.024002712219953537
as O 0 0.010167047381401062
predicted O 0 0.021653281524777412
by O 0 0.012373297475278378
haploinsufficiency O 1 0.9716323018074036
. O 0 0.02827395685017109

Contrary O 0 0.022683123126626015
to O 0 0.007860345765948296
this O 0 0.004549729637801647
theory O 0 0.007153401616960764
, O 0 0.004441962577402592
our O 0 0.004994306713342667
data O 0 0.0038732197135686874
showed O 0 0.004822704941034317
that O 0 0.0021469930652529
these O 0 0.0021215099841356277
mutants O 0 0.011684414930641651
are O 0 0.0025671315379440784
dominant O 0 0.1383543610572815
- O 1 0.9999924898147583
negative O 0 0.008502893149852753
in O 0 0.008191303350031376
transient O 1 0.9692895412445068
transfection O 1 0.9999618530273438
assays O 0 0.021158691495656967
when O 0 0.0058013214729726315
they O 0 0.00248858705163002
are O 0 0.002227177144959569
coexpressed O 0 0.026256592944264412
with O 0 0.00624876981601119
wild O 0 0.0171714685857296
- O 1 1.0
type O 1 0.9932326078414917
PAX6 O 1 0.9999996423721313
. O 0 0.04055484011769295

We O 0 0.009162317030131817
found O 0 0.004099638666957617
that O 0 0.0021353543270379305
the O 0 0.00525115430355072
dominant O 1 0.7616344094276428
- O 1 0.9999998807907104
negative O 0 0.01160302571952343
effects O 0 0.008946300484240055
result O 0 0.0042405580170452595
from O 0 0.004280515015125275
the O 0 0.005615609232336283
enhanced O 0 0.018213970586657524
DNA O 0 0.013340805657207966
binding O 0 0.010850434191524982
ability O 0 0.008893919177353382
of O 0 0.008608056232333183
these O 0 0.008324351161718369
mutants O 0 0.04486120119690895
. O 0 0.02880101278424263

Kinetic O 0 0.07060927897691727
studies O 0 0.015171512961387634
of O 0 0.01271948590874672
binding O 0 0.015245298855006695
and O 0 0.009627912193536758
dissociation O 0 0.02654385007917881
revealed O 0 0.010004915297031403
that O 0 0.0030521713197231293
various O 0 0.004208412487059832
truncation O 0 0.022368382662534714
mutants O 0 0.01573149673640728
have O 0 0.003648634534329176
3 O 0 0.010117437690496445
- O 1 0.9997833371162415
5 O 0 0.014677689410746098
- O 1 0.9986690282821655
fold O 0 0.022808607667684555
higher O 0 0.008649994619190693
affinity O 0 0.00954520609229803
to O 0 0.003919333219528198
various O 0 0.004393202252686024
DNA O 0 0.011892251670360565
- O 1 0.9387819170951843
binding O 0 0.008431483060121536
sites O 0 0.006191356107592583
when O 0 0.004023559857159853
compared O 0 0.004100451245903969
with O 0 0.003596161026507616
the O 0 0.005883661564439535
wild O 0 0.01462646946310997
- O 1 0.9999994039535522
type O 1 0.8892523050308228
PAX6 O 1 0.9999982118606567
. O 0 0.04256110638380051

These O 0 0.009587141685187817
results O 0 0.008781785145401955
provide O 0 0.005497089121490717
a O 0 0.0053287893533706665
new O 0 0.006963231600821018
insight O 0 0.014183576218783855
into O 0 0.005153324455022812
the O 0 0.005162832792848349
role O 0 0.008833074010908604
of O 0 0.009571375325322151
mutant O 1 0.8466159701347351
PAX6 O 1 1.0
in O 0 0.02065974473953247
causing O 1 0.9990649819374084
aniridia B-Disease 1 1.0
. O 0 0.017588093876838684
. O 0 0.025035282596945763

Reversal O 0 0.06161923334002495
of O 0 0.08193567395210266
severe O 1 1.0
hypertrophic B-Disease 1 1.0
cardiomyopathy I-Disease 1 1.0
and O 1 0.9999874830245972
excellent O 1 0.9999842643737793
neuropsychologic O 1 0.9999992847442627
outcome O 0 0.008314943872392178
in O 0 0.004385150503367186
very B-Disease 0 0.004943117033690214
- I-Disease 1 0.9998804330825806
long I-Disease 0 0.011310948058962822
- I-Disease 1 0.999983549118042
chain I-Disease 0 0.23812909424304962
acyl I-Disease 1 0.9999734163284302
- I-Disease 1 0.9999997615814209
coenzyme I-Disease 1 0.9995939135551453
A I-Disease 1 0.9998025298118591
dehydrogenase I-Disease 1 0.9999995231628418
deficiency I-Disease 1 1.0
. O 0 0.039004191756248474

Very B-Disease 0 0.021600937470793724
- I-Disease 1 0.9995517134666443
long I-Disease 0 0.021428072825074196
- I-Disease 1 0.9999270439147949
chain I-Disease 0 0.3463785946369171
acyl I-Disease 1 0.9998517036437988
- I-Disease 1 0.9999909400939941
coenzyme I-Disease 1 0.8290594220161438
A I-Disease 0 0.19473636150360107
dehydrogenase I-Disease 1 0.9705877900123596
( I-Disease 0 0.014405125752091408
VLCAD I-Disease 1 1.0
) I-Disease 0 0.10428804904222488
deficiency I-Disease 1 1.0
is O 0 0.006525847129523754
a O 0 0.012224663980305195
disorder O 1 1.0
of O 1 0.9999980926513672
fatty O 1 1.0
acid O 1 0.9999991655349731
beta O 1 0.9969666600227356
oxidation O 0 0.014786935411393642
that O 0 0.003757340833544731
reportedly O 0 0.010199258103966713
has O 0 0.005128592252731323
high O 0 0.008546940982341766
rates O 0 0.008130966685712337
of O 0 0.010061739012598991
morbidity O 1 1.0
and O 0 0.15182055532932281
mortality O 1 0.9999655485153198
. O 0 0.02922520786523819

We O 0 0.015392945148050785
describe O 0 0.01281697303056717
the O 0 0.00579106155782938
outcome O 0 0.0052600339986383915
of O 0 0.0038154141511768103
a O 0 0.005201444029808044
5 O 0 0.009166914969682693
- O 1 0.9948626160621643
year O 0 0.009044907055795193
- O 1 0.9968833327293396
old O 0 0.014778560027480125
girl O 0 0.01704511046409607
with O 0 0.01037217490375042
VLCAD B-Disease 1 1.0
deficiency I-Disease 1 1.0
who O 1 0.9989213943481445
was O 0 0.1866617053747177
first O 0 0.006663862615823746
seen O 0 0.006131262984126806
at O 0 0.005806511268019676
5 O 0 0.0060126082971692085
months O 0 0.004137028008699417
of O 0 0.003993467427790165
age O 0 0.007169129326939583
with O 0 0.0076044476591050625
severe O 1 1.0
hypertrophic B-Disease 1 1.0
cardiomyopathy I-Disease 1 1.0
, O 1 1.0
hepatomegaly B-Disease 1 1.0
, O 1 1.0
encephalopathy B-Disease 1 1.0
, O 1 0.9998739957809448
and O 1 0.9828574657440186
hypotonia B-Disease 1 1.0
. O 0 0.0334591269493103

Biochemical O 0 0.06504601240158081
studies O 0 0.020242922008037567
indicated O 0 0.3023679256439209
VLCAD B-Disease 1 1.0
deficiency I-Disease 1 1.0
caused O 1 0.9999699592590332
by O 0 0.00798788946121931
a O 0 0.01587824709713459
stable O 1 0.746141791343689
yet O 0 0.02072610706090927
inactive O 1 0.9784001111984253
enzyme O 0 0.044789619743824005
. O 0 0.030630558729171753

Molecular O 0 0.0424158051609993
genetic O 0 0.01422750111669302
analysis O 0 0.007738097105175257
of O 0 0.007967058569192886
her O 0 0.01591862179338932
VLCAD O 1 1.0
gene O 0 0.01302095502614975
revealed O 0 0.012255950830876827
a O 0 0.011396274901926517
T1372C O 1 0.9991402626037598
( O 0 0.016703544184565544
F458L O 1 0.9947403073310852
) O 0 0.015319131314754486
missense O 0 0.03765751048922539
mutation O 0 0.01599888876080513
and O 0 0.007568124681711197
a O 0 0.017316292971372604
1668 O 1 0.9999998807907104
ACAG O 1 1.0
1669 O 1 0.9999996423721313
splice O 1 0.9899398684501648
site O 0 0.05293159931898117
mutation O 0 0.044467855244874954
. O 0 0.029532259330153465

After O 0 0.026403192430734634
initial O 0 0.02227914147078991
treatment O 0 0.057878319174051285
with O 0 0.011183545924723148
intravenous O 1 1.0
glucose O 1 0.9999969005584717
and O 0 0.015895705670118332
carnitine O 1 1.0
, O 0 0.008543531410396099
the O 0 0.008437659591436386
patient O 1 0.999816358089447
has O 0 0.006878948304802179
thrived O 0 0.021376686170697212
on O 0 0.004678050987422466
a O 0 0.007513261400163174
low O 0 0.021264653652906418
- O 1 0.9999982118606567
fat O 0 0.31622961163520813
diet O 0 0.027640322223305702
supplemented O 0 0.014680246822535992
with O 0 0.006285801995545626
medium O 0 0.060802068561315536
- O 1 0.9999985694885254
chain O 1 0.7567798495292664
triglyceride O 0 0.04870463162660599
oil O 0 0.016189925372600555
and O 0 0.01194387674331665
carnitine O 1 0.9999833106994629
and O 0 0.01631162501871586
avoidance O 1 0.9999831914901733
of O 0 0.1606147736310959
fasting O 1 0.9478439092636108
. O 0 0.03182404860854149

Her O 1 0.9995198249816895
ventricular O 1 1.0
hypertrophy O 1 1.0
resolved O 0 0.03213195875287056
significantly O 0 0.011224618181586266
over O 0 0.007121266797184944
1 O 0 0.00951186753809452
year O 0 0.007081000600010157
, O 0 0.005878866650164127
and O 0 0.00688967015594244
cognitively O 1 0.9998449087142944
, O 0 0.007953006774187088
she O 0 0.00788716971874237
is O 0 0.003911751788109541
in O 0 0.003908967133611441
the O 0 0.0059012421406805515
superior O 0 0.014388589188456535
range O 0 0.009347443468868732
for O 0 0.008845916949212551
age O 0 0.01755606196820736
. O 0 0.02055833674967289

Clinical O 0 0.3251536786556244
recognition O 0 0.01913309097290039
of O 1 0.9945622086524963
VLCAD B-Disease 1 1.0
deficiency I-Disease 1 1.0
is O 1 0.8515810370445251
important O 0 0.007829167880117893
because O 0 0.0036201956681907177
it O 0 0.0024925912730395794
is O 0 0.0022999003995209932
one O 0 0.002393130911514163
of O 0 0.002517129760235548
the O 0 0.0033976647537201643
few O 0 0.004803892690688372
directly O 0 0.008575867861509323
treatable O 1 1.0
causes O 1 0.9999862909317017
of O 1 0.9999992847442627
cardiomyopathy B-Disease 1 1.0
in O 1 0.9999878406524658
children O 1 0.9913460612297058
. O 0 0.012854788452386856
. O 0 0.01929810643196106

Cloning O 0 0.037094131112098694
of O 0 0.012229150161147118
a O 0 0.011120078153908253
novel O 0 0.012160968035459518
member O 0 0.007405152078717947
of O 0 0.00451654801145196
the O 0 0.006371194496750832
low O 0 0.08311817795038223
- O 1 0.9999996423721313
density O 0 0.043775785714387894
lipoprotein O 1 0.9999992847442627
receptor O 0 0.0480344332754612
family O 0 0.026668135076761246
. O 0 0.02411014772951603

A O 0 0.03250356391072273
gene O 0 0.016383180394768715
encoding O 0 0.01344980113208294
a O 0 0.010209988802671432
novel O 0 0.020662588998675346
transmembrane O 1 0.9006460309028625
protein O 0 0.011392478831112385
was O 0 0.009336186572909355
identified O 0 0.004853896796703339
by O 0 0.0028902406338602304
DNA O 0 0.005137297790497541
sequence O 0 0.002957880264148116
analysis O 0 0.0026412131264805794
within O 0 0.0021162957418709993
the O 0 0.004730139393359423
insulin B-Disease 1 0.999998927116394
- I-Disease 1 1.0
dependent I-Disease 1 0.9998847246170044
diabetes I-Disease 1 1.0
mellitus I-Disease 1 1.0
( O 1 0.9995216131210327
IDDM B-Disease 1 1.0
) O 0 0.02220759727060795
locus O 1 0.9938911199569702
IDDM4 O 1 0.9999964237213135
on O 0 0.023732023313641548
chromosome O 0 0.05252635106444359
11q13 O 1 0.9495567083358765
. O 0 0.032773781567811966

Based O 0 0.018103092908859253
on O 0 0.008588920347392559
its O 0 0.010228277184069157
chromosomal O 0 0.034483715891838074
position O 0 0.01035536453127861
, O 0 0.0050288052298128605
this O 0 0.003669957397505641
gene O 0 0.005480371415615082
is O 0 0.0032230482902377844
a O 0 0.0047068106941878796
candidate O 0 0.007815208286046982
for O 0 0.005665842443704605
conferring O 1 0.9148790836334229
susceptibility O 1 0.9999983310699463
to O 1 0.5865790843963623
diabetes B-Disease 1 1.0
. O 0 0.03951730579137802

The O 0 0.02120683714747429
gene O 0 0.013767890632152557
, O 0 0.007120861671864986
termed O 0 0.017374148592352867
low O 0 0.025407699868083
- O 1 0.9999464750289917
density O 0 0.020217640325427055
lipoprotein O 1 0.997253954410553
receptor O 0 0.027639510110020638
related O 0 0.011083397082984447
protein O 0 0.010745522566139698
5 O 0 0.012104921974241734
( O 0 0.010624585673213005
LRP5 O 1 0.9999984502792358
) O 0 0.008259914815425873
, O 0 0.006653517950326204
encodes O 0 0.013545294292271137
a O 0 0.007473613601177931
protein O 0 0.010482722893357277
of O 0 0.00984466727823019
1615 O 1 0.9969733953475952
amino O 0 0.016221648082137108
acids O 0 0.008261075243353844
that O 0 0.0033990328665822744
contains O 0 0.007811353076249361
conserved O 0 0.011931582354009151
modules O 0 0.014860941097140312
which O 0 0.0032746114302426577
are O 0 0.0017255863640457392
characteristic O 0 0.003724415088072419
of O 0 0.0026630533393472433
the O 0 0.004615084268152714
low O 0 0.12964139878749847
- O 1 0.9999996423721313
density O 0 0.027340661734342575
lipoprotein O 1 0.9999998807907104
( O 0 0.10402126610279083
LDL O 1 1.0
) O 0 0.0175726767629385
receptor O 0 0.035257142037153244
family O 0 0.02605457417666912
. O 0 0.022204656153917313

These O 0 0.016637925058603287
modules O 0 0.03370596840977669
include O 0 0.012387039139866829
a O 0 0.014452796429395676
putative O 0 0.05357332527637482
signal O 0 0.022736413404345512
peptide O 0 0.02362346090376377
for O 0 0.007335485890507698
protein O 0 0.00932381022721529
export O 0 0.009197334758937359
, O 0 0.006941957399249077
four O 0 0.00882655568420887
epidermal O 1 0.9979352951049805
growth O 0 0.019903015345335007
factor O 0 0.03356459364295006
( O 0 0.014429287053644657
EGF O 1 0.9999954700469971
) O 0 0.012265613302588463
repeats O 0 0.017020320519804955
with O 0 0.0064582740887999535
associated O 0 0.01085125282406807
spacer O 0 0.04029681906104088
domains O 0 0.013837217353284359
, O 0 0.006231560371816158
three O 0 0.008287740871310234
LDL O 1 1.0
- O 1 1.0
receptor O 0 0.3350948691368103
( O 0 0.01178849209100008
LDLR O 1 0.999997615814209
) O 0 0.009168899618089199
repeats O 0 0.013616403564810753
, O 0 0.0048737917095422745
a O 0 0.006208169739693403
single O 0 0.011285945773124695
transmembrane O 0 0.046592578291893005
spanning O 0 0.02116772159934044
domain O 0 0.014730951748788357
, O 0 0.006968713365495205
and O 0 0.006623393855988979
a O 0 0.01268328633159399
cytoplasmic O 0 0.06150301173329353
domain O 0 0.030654115602374077
. O 0 0.02197413705289364

The O 0 0.02397466078400612
encoded O 0 0.02057485841214657
protein O 0 0.013453780673444271
has O 0 0.006276390980929136
a O 0 0.005587550811469555
unique O 0 0.006103911437094212
organization O 0 0.007853216491639614
of O 0 0.009562022984027863
EGF O 1 1.0
and O 0 0.013401130214333534
LDLR O 1 1.0
repeats O 0 0.04557737708091736
; O 0 0.008078229613602161
therefore O 0 0.00677016144618392
, O 0 0.00818590447306633
LRP5 O 1 0.9999804496765137
likely O 0 0.00825152825564146
represents O 0 0.008598743006587029
a O 0 0.006240820977836847
new O 0 0.00749707967042923
category O 0 0.011935495771467686
of O 0 0.007891700603067875
the O 0 0.013541597872972488
LDLR O 1 0.9999996423721313
family O 0 0.03399809077382088
. O 0 0.02892974391579628

Both O 0 0.014022811315953732
human O 0 0.009234129451215267
and O 0 0.01004676055163145
mouse O 1 0.9945496916770935
LRP5 O 1 1.0
cDNAs O 1 0.9999902248382568
have O 0 0.004204125609248877
been O 0 0.004160510841757059
isolated O 0 0.006396249867975712
and O 0 0.003344667609781027
the O 0 0.005534353666007519
encoded O 0 0.0080410186201334
mature O 0 0.010291694663465023
proteins O 0 0.005126909352838993
are O 0 0.0022262362763285637
95 O 0 0.012044548988342285
% O 0 0.006828616373240948
identical O 0 0.00821958389133215
, O 0 0.004691751673817635
indicating O 0 0.005492542404681444
a O 0 0.004695057403296232
high O 0 0.007250810042023659
degree O 0 0.008011864498257637
of O 0 0.0069485874846577644
evolutionary O 0 0.014053533785045147
conservation O 0 0.021767200902104378
. O 0 0.012692377902567387
. O 0 0.02090197615325451

The O 0 0.04301167279481888
APC B-Disease 1 0.999909520149231
variants O 0 0.03600906953215599
I1307K O 1 0.9233464598655701
and O 0 0.011411973275244236
E1317Q O 0 0.056634265929460526
are O 0 0.0032862485386431217
associated O 0 0.0077329291962087154
with O 1 0.9577242136001587
colorectal B-Disease 1 1.0
tumors I-Disease 1 1.0
, O 1 0.9961901903152466
but O 0 0.004625448491424322
not O 0 0.0035850144922733307
always O 0 0.005373987834900618
with O 0 0.004071537405252457
a O 0 0.007687276229262352
family O 0 0.013573967851698399
history O 0 0.01892346329987049
. O 0 0.019218595698475838

Classical O 0 0.07483036816120148
familial B-Disease 1 1.0
adenomatous I-Disease 1 1.0
polyposis I-Disease 1 1.0
( O 1 0.9999979734420776
FAP B-Disease 1 1.0
) O 0 0.011492006480693817
is O 0 0.004528158809989691
a O 0 0.005715654231607914
high O 0 0.01645977608859539
- O 1 0.9999992847442627
penetrance O 1 0.9999996423721313
autosomal B-Disease 1 0.9999998807907104
dominant I-Disease 1 0.9999998807907104
disease I-Disease 1 1.0
that O 0 0.007227122783660889
predisposes O 1 0.9999855756759644
to O 0 0.005852617789059877
hundreds O 0 0.005514460150152445
or O 0 0.003540864447131753
thousands O 0 0.006611695513129234
of O 1 0.9476106762886047
colorectal B-Disease 1 1.0
adenomas I-Disease 1 1.0
and I-Disease 1 1.0
carcinoma I-Disease 1 1.0
and O 0 0.4284950792789459
that O 0 0.005114622414112091
results O 0 0.006485509220510721
from O 0 0.007747248280793428
truncating O 0 0.19248071312904358
mutations O 0 0.010824758559465408
in O 0 0.0074152871966362
the O 0 0.01714973710477352
APC B-Disease 1 0.9999996423721313
gene O 0 0.0349748432636261
. O 0 0.027287030592560768

A O 0 0.03369344770908356
variant O 0 0.037202734500169754
of O 0 0.020732050761580467
FAP B-Disease 1 1.0
is O 0 0.02515917457640171
attenuated B-Disease 1 0.9999994039535522
adenomatous I-Disease 1 1.0
polyposis I-Disease 1 1.0
coli I-Disease 1 1.0
, O 0 0.009925466030836105
which O 0 0.0037223307881504297
results O 0 0.004804307594895363
from O 0 0.004737719893455505
germ O 1 1.0
- O 1 1.0
line O 0 0.01614288054406643
mutations O 0 0.00642990879714489
in O 0 0.0036721969954669476
the O 0 0.004384557716548443
5 O 0 0.007158130407333374
and O 0 0.0048021902330219746
3 O 0 0.007604675367474556
regions O 0 0.005317952949553728
of O 0 0.0070591578260064125
the O 0 0.014242931269109249
APC B-Disease 1 1.0
gene O 0 0.03147883340716362
. O 0 0.027662893757224083

Attenuated B-Disease 1 0.9999953508377075
adenomatous I-Disease 1 1.0
polyposis I-Disease 1 1.0
coli I-Disease 1 1.0
patients O 1 1.0
have O 0 0.004998744931071997
" O 0 0.007107645273208618
multiple O 0 0.010041270405054092
" O 1 0.9871413707733154
colorectal B-Disease 1 1.0
adenomas I-Disease 1 1.0
( O 0 0.07344705611467361
typically O 0 0.007789306808263063
fewer O 0 0.007669161539524794
than O 0 0.004382030572742224
100 O 0 0.008291488513350487
) O 0 0.005247446708381176
without O 0 0.0051263016648590565
the O 0 0.009538562968373299
florid O 1 0.9995071887969971
phenotype O 0 0.44857269525527954
of O 0 0.016823839396238327
classical O 0 0.0601750873029232
FAP B-Disease 1 1.0
. O 0 0.04171097278594971

Another O 0 0.020318709313869476
group O 0 0.012834340333938599
of O 0 0.008100543171167374
patients O 1 0.9753705263137817
with O 0 0.0064239827916026115
multiple O 0 0.423554003238678
adenomas B-Disease 1 1.0
has O 0 0.008165419101715088
no O 0 0.005739937536418438
mutations O 0 0.00624849135056138
in O 0 0.0043478733859956264
the O 0 0.008117998018860817
APC B-Disease 1 1.0
gene O 0 0.010048060677945614
, O 0 0.004550424870103598
and O 0 0.003417868632823229
their O 0 0.004046497400850058
phenotype O 0 0.1988133043050766
probably O 0 0.006210946943610907
results O 0 0.003942240960896015
from O 0 0.0028826650232076645
variation O 0 0.004846170078963041
at O 0 0.005989572033286095
a O 0 0.007268005516380072
locus O 1 0.9410790205001831
, O 0 0.007275742944329977
or O 0 0.007347697392106056
loci O 0 0.013968116603791714
, O 0 0.006607052404433489
elsewhere O 0 0.008920978754758835
in O 0 0.007271900773048401
the O 0 0.012247647158801556
genome O 0 0.031043585389852524
. O 0 0.023990368470549583

Recently O 0 0.03586241602897644
, O 0 0.010527247563004494
however O 0 0.0051927268505096436
, O 0 0.00478887464851141
a O 0 0.007202647160738707
missense O 0 0.019603606313467026
variant O 0 0.014381660148501396
of O 0 0.011533573269844055
APC B-Disease 1 1.0
( O 0 0.028124652802944183
I1307K O 1 0.9999977350234985
) O 0 0.008463967591524124
was O 0 0.008484301157295704
described O 0 0.006703519728034735
that O 0 0.0031087498646229506
confers O 0 0.016215715557336807
an O 0 0.004725809674710035
increased O 0 0.0065385024063289165
risk O 1 0.822644829750061
of O 1 0.9999899864196777
colorectal B-Disease 1 1.0
tumors I-Disease 1 1.0
, O 1 0.9089044332504272
including O 0 0.010547248646616936
multiple O 0 0.22564098238945007
adenomas B-Disease 1 1.0
, O 0 0.014991246163845062
in O 0 0.017803439870476723
Ashkenazim O 1 0.9944144487380981
. O 0 0.030913930386304855

We O 0 0.011586838401854038
have O 0 0.0039960299618542194
studied O 0 0.007302981801331043
a O 0 0.004229558631777763
set O 0 0.004137122072279453
of O 0 0.004326972179114819
164 O 0 0.01902521774172783
patients O 0 0.14838485419750214
with O 0 0.005694410763680935
multiple O 1 0.980448305606842
colorectal B-Disease 1 1.0
adenomas I-Disease 1 1.0
and I-Disease 1 0.9999990463256836
/ I-Disease 1 1.0
or I-Disease 1 0.9965614676475525
carcinoma I-Disease 1 1.0
and O 0 0.015210775658488274
analyzed O 0 0.02615273930132389
codons O 0 0.0418991819024086
1263 O 1 0.9999514818191528
- O 1 0.9999985694885254
1377 O 1 0.9999802112579346
( O 0 0.029185054823756218
exon O 0 0.47626587748527527
15G O 1 0.8848586082458496
) O 0 0.00903801154345274
of O 0 0.0069217081181705
the O 0 0.00956067256629467
APC B-Disease 1 0.9999395608901978
gene O 0 0.013240939937531948
for O 0 0.010988700203597546
germ O 1 1.0
- O 1 0.9999998807907104
line O 0 0.038450729101896286
variants O 0 0.038469959050416946
. O 0 0.02649041824042797

Three O 0 0.019778834655880928
patients O 0 0.020494544878602028
with O 0 0.007694976404309273
the O 0 0.011672670021653175
I1307K O 1 0.9999896287918091
allele O 0 0.026504527777433395
were O 0 0.006164272781461477
detected O 0 0.009527218528091908
, O 0 0.005595061462372541
each O 0 0.0037428701762109995
of O 0 0.009345204569399357
Ashkenazi O 1 0.9955580830574036
descent O 0 0.037435248494148254
. O 0 0.02792048454284668

Four O 0 0.021775376051664352
patients O 0 0.04268200695514679
had O 0 0.00790006760507822
a O 0 0.012172991409897804
germ O 1 1.0
- O 1 1.0
line O 0 0.022944049909710884
E1317Q O 1 0.8129509091377258
missense O 0 0.029967274516820908
variant O 0 0.020816858857870102
of O 0 0.011636223644018173
APC O 1 0.9999980926513672
that O 0 0.0048287296667695045
was O 0 0.006592949386686087
not O 0 0.002466899575665593
present O 0 0.003804913256317377
in O 0 0.0038540009409189224
controls O 0 0.008877729997038841
; O 0 0.004169747233390808
one O 0 0.0032647186890244484
of O 0 0.003339522983878851
these O 0 0.0019235279178246856
individuals O 0 0.0020004010293632746
had O 0 0.003608960658311844
an O 0 0.0038008594419807196
unusually O 0 0.008077595382928848
large O 0 0.004704282619059086
number O 0 0.003688572673127055
of O 0 0.007438719738274813
metaplastic B-Disease 1 0.9999924898147583
polyps I-Disease 1 0.9999274015426636
of I-Disease 0 0.014900902286171913
the I-Disease 0 0.0215692650526762
colorectum I-Disease 1 0.9999079704284668
. O 0 0.03211652487516403

There O 0 0.015111986547708511
is O 0 0.0069525111466646194
increasing O 0 0.006775533780455589
evidence O 0 0.0037787631154060364
that O 0 0.0021580401808023453
there O 0 0.0025696223601698875
exist O 0 0.004880922380834818
germ O 1 0.9999984502792358
- O 1 0.999997615814209
line O 0 0.011428715661168098
variants O 0 0.008655349723994732
of O 0 0.005514527205377817
the O 0 0.008524865843355656
APC B-Disease 1 0.9999996423721313
gene O 0 0.009001076221466064
that O 0 0.004547302611172199
predispose O 0 0.01515262946486473
to O 0 0.0039140949957072735
the O 0 0.00418507307767868
development O 0 0.006542152259498835
of O 0 0.007893350906670094
multiple O 1 0.9832125306129456
colorectal B-Disease 1 1.0
adenomas I-Disease 1 1.0
and I-Disease 1 1.0
carcinoma I-Disease 1 1.0
, O 1 0.9699984788894653
but O 0 0.004367666319012642
without O 0 0.003950176760554314
the O 0 0.007073604967445135
florid O 1 0.9985160231590271
phenotype O 0 0.035941530019044876
of O 0 0.010437656193971634
classical O 0 0.059098418802022934
FAP B-Disease 1 1.0
, O 0 0.00868529174476862
and O 0 0.004937601275742054
possibly O 0 0.005192633718252182
with O 0 0.0030936291441321373
importance O 0 0.007282866630703211
for O 1 0.964607298374176
colorectal B-Disease 1 1.0
cancer I-Disease 1 1.0
risk O 1 1.0
in O 0 0.008657820522785187
the O 0 0.008664898574352264
general O 0 0.01533286739140749
population O 0 0.008957160636782646
. O 0 0.01126945111900568
. O 0 0.01968713290989399

Genomic O 0 0.05033442750573158
structure O 0 0.013876326382160187
of O 0 0.0073222205974161625
the O 0 0.00908188708126545
human O 1 0.9844987988471985
congenital B-Disease 1 1.0
chloride I-Disease 1 1.0
diarrhea I-Disease 1 1.0
( O 1 1.0
CLD B-Disease 1 1.0
) O 1 0.5073866248130798
gene O 0 0.030094658955931664
. O 0 0.02756391651928425

Congenital B-Disease 1 1.0
chloride I-Disease 1 1.0
diarrhea I-Disease 1 1.0
( O 1 1.0
CLD B-Disease 1 1.0
) O 0 0.11202611029148102
is O 0 0.007964376360177994
caused O 0 0.008385821245610714
by O 0 0.003907400649040937
mutations O 0 0.005112761631608009
in O 0 0.0031554100569337606
a O 0 0.005187060218304396
gene O 0 0.006934403907507658
which O 0 0.00431102653965354
encodes O 0 0.016436191275715828
an O 0 0.015711259096860886
intestinal O 1 1.0
anion O 1 1.0
transporter O 1 0.99998939037323
. O 0 0.045560602098703384

We O 0 0.013667643070220947
report O 0 0.008853703737258911
here O 0 0.005639282055199146
the O 0 0.005845231004059315
complete O 0 0.009859259240329266
genomic O 0 0.01672765053808689
organization O 0 0.008152784779667854
of O 0 0.006256090942770243
the O 0 0.007276446092873812
human O 0 0.010774062015116215
CLD B-Disease 1 1.0
gene O 0 0.016688138246536255
which O 0 0.007855397649109364
spans O 0 0.020789438858628273
approximately O 0 0.013644635677337646
39kb O 1 0.8628438711166382
, O 0 0.011319761164486408
and O 0 0.01085751410573721
comprises O 0 0.029144028201699257
21 O 0 0.030957650393247604
exons O 0 0.05475557968020439
. O 0 0.028124937787652016

All O 0 0.03283866122364998
exon O 1 0.8266377449035645
/ O 1 0.9971747398376465
intron O 1 0.9380434155464172
boundaries O 0 0.01153767853975296
conform O 0 0.014094297774136066
to O 0 0.0069620381109416485
the O 0 0.012413942255079746
GT O 1 1.0
/ O 1 0.9999998807907104
AG O 1 1.0
rule O 0 0.04224231466650963
. O 0 0.032416559755802155

An O 0 0.01623235084116459
analysis O 0 0.011356042698025703
of O 0 0.009707723744213581
the O 0 0.013649463653564453
putative O 1 0.6413673758506775
promoter O 1 0.9890215992927551
region O 0 0.013420209288597107
sequence O 0 0.008862672373652458
shows O 0 0.008316329680383205
a O 0 0.011748452670872211
putative O 1 0.9377268552780151
TATA O 1 1.0
box O 1 0.8385989665985107
and O 0 0.0087082264944911
predicts O 0 0.021982166916131973
multiple O 0 0.01112276315689087
transcription O 0 0.02551013045012951
factor O 0 0.01778937689960003
binding O 0 0.016335900872945786
sites O 0 0.019541369751095772
. O 0 0.021402738988399506

The O 0 0.02154257893562317
genomic O 0 0.033001773059368134
structure O 0 0.01489762868732214
was O 0 0.011144960299134254
determined O 0 0.008252028375864029
using O 0 0.004435154143720865
DNA O 0 0.0061302632093429565
from O 0 0.002903343876823783
several O 0 0.0023367763496935368
sources O 0 0.00258712493814528
including O 0 0.0029516236390918493
multiple O 0 0.005371622741222382
large O 0 0.007978704757988453
- O 1 0.9999992847442627
insert O 1 0.9974583983421326
libaries O 1 0.9098287224769592
and O 0 0.009043804369866848
genomic O 0 0.020248599350452423
DNA O 0 0.01177164539694786
from O 0 0.008955699391663074
Finnish O 1 0.9999895095825195
CLD B-Disease 1 1.0
patients O 1 0.9999897480010986
and O 0 0.01756320334970951
controls O 0 0.040540240705013275
. O 0 0.028835687786340714

Exon O 1 0.9720062017440796
- O 1 0.9965547323226929
specific O 0 0.01573537476360798
primers O 0 0.04312960430979729
developed O 0 0.011830872856080532
in O 0 0.005109368823468685
this O 0 0.003375043161213398
study O 0 0.004806382115930319
will O 0 0.004552153404802084
facilitate O 0 0.008357995189726353
mutation O 0 0.009122489020228386
screening O 0 0.009611866436898708
studies O 0 0.005515665281563997
of O 0 0.006032044067978859
patients O 1 0.9938905239105225
with O 0 0.00765264593064785
the O 1 0.9660137295722961
disease O 1 1.0
. O 0 0.031758006662130356

Genomic O 0 0.059899114072322845
sequencing O 0 0.023121429607272148
of O 0 0.010897699743509293
a O 0 0.015205619856715202
BAC O 1 0.9999998807907104
clone O 1 0.9999958276748657
H O 1 1.0
_ O 0 0.020729532465338707
RG364P16 O 1 0.8830097913742065
revealed O 0 0.010381091386079788
the O 0 0.004711110144853592
presence O 0 0.005094739608466625
of O 0 0.00429935147985816
another O 0 0.006514720153063536
, O 0 0.005359149072319269
highly O 0 0.009065186604857445
homologous O 0 0.010737866163253784
gene O 0 0.006197723094373941
3 O 0 0.005894151981920004
of O 0 0.0051540653221309185
the O 0 0.010200096294283867
CLD B-Disease 1 1.0
gene O 0 0.01085403747856617
, O 0 0.004985490348190069
with O 0 0.003213276853784919
a O 0 0.0049485331401228905
similar O 0 0.0047683739103376865
genomic O 0 0.013720816001296043
structure O 0 0.007183537352830172
, O 0 0.003914344124495983
recently O 0 0.005093384068459272
identified O 0 0.0028432379476726055
as O 0 0.0027884487062692642
the O 0 0.007530989591032267
Pendred B-Disease 1 1.0
syndrome I-Disease 1 1.0
gene O 1 0.9999924898147583
( O 1 0.9942076206207275
PDS B-Disease 1 1.0
) O 0 0.017331518232822418
. O 0 0.013384056277573109
. O 0 0.020285284146666527

The O 0 0.033320531249046326
APCI1307K O 1 0.999992847442627
allele O 0 0.06319539248943329
and O 0 0.01948109269142151
cancer B-Disease 1 1.0
risk O 1 0.9959039092063904
in O 0 0.004706390667706728
a O 0 0.006122035905718803
community O 0 0.007702806498855352
- O 1 0.9976835250854492
based O 0 0.008452306501567364
study O 0 0.007167411502450705
of O 0 0.01059042476117611
Ashkenazi O 1 0.5923798680305481
Jews O 0 0.0292817335575819
. O 0 0.027618231251835823

Mutations O 0 0.04452668875455856
in O 0 0.01709621213376522
APC O 1 0.9998986721038818
are O 0 0.007364968303591013
classically O 0 0.3693718910217285
associated O 0 0.008152831345796585
with O 0 0.009973465465009212
familial B-Disease 1 1.0
adenomatous I-Disease 1 1.0
polyposis I-Disease 1 1.0
( O 1 1.0
FAP B-Disease 1 1.0
) O 0 0.01044873334467411
, O 0 0.0049987067468464375
a O 0 0.0061365216970443726
highly O 0 0.027419231832027435
penetrant O 1 1.0
autosomal B-Disease 1 1.0
dominant I-Disease 1 1.0
disorder I-Disease 1 1.0
characterized O 1 0.9999992847442627
by O 0 0.21250015497207642
multiple O 1 0.9999994039535522
intestinal O 1 1.0
polyps B-Disease 1 1.0
and O 1 0.9967327117919922
, O 0 0.010755183175206184
without O 0 0.0067798420786857605
surgical O 1 1.0
intervention O 1 0.9856948256492615
, O 0 0.004728988278657198
the O 0 0.0044951182790100574
development O 0 0.008753734640777111
of O 1 0.9995930790901184
colorectal B-Disease 1 1.0
cancer I-Disease 1 1.0
( O 1 0.9999998807907104
CRC B-Disease 1 1.0
) O 0 0.029334543272852898
. O 0 0.03249957039952278

APC B-Disease 1 0.9993675351142883
is O 0 0.014003047719597816
a O 0 0.02007533423602581
tumour O 1 1.0
- O 1 1.0
suppressor O 1 0.9999997615814209
gene O 0 0.010926567018032074
, O 0 0.0053224521689116955
and O 0 0.005862375255674124
somatic O 1 0.5296297669410706
loss O 1 0.9999853372573853
occurs O 0 0.017373114824295044
in O 0 0.02303851954638958
tumours B-Disease 1 1.0
. O 0 0.03308481723070145

The O 0 0.03287748992443085
germline O 1 0.9795361161231995
T O 1 0.9999996423721313
- O 1 0.999671459197998
to O 0 0.01186707429587841
- O 1 0.9998052716255188
A O 0 0.020763041451573372
transversion O 1 0.8294214010238647
responsible O 0 0.0089386822655797
for O 0 0.005701469257473946
the O 0 0.011712521314620972
APC O 1 0.9999982118606567
I1307K O 1 0.9968992471694946
allele O 0 0.03207432106137276
converts O 0 0.018424464389681816
the O 0 0.008174445480108261
wild O 0 0.014003337360918522
- O 1 0.9938870072364807
type O 0 0.010684791021049023
sequence O 0 0.004053483251482248
to O 0 0.004080859944224358
a O 0 0.008384663611650467
homopolymer O 1 0.9999983310699463
tract O 1 1.0
( O 1 0.9986442923545837
A8 O 1 1.0
) O 0 0.0074332645162940025
that O 0 0.003786180866882205
is O 0 0.005652721039950848
genetically O 0 0.013941164128482342
unstable O 1 0.9963663816452026
and O 0 0.009730570018291473
prone O 1 0.9999970197677612
to O 0 0.0181682538241148
somatic O 1 0.9751876592636108
mutation O 0 0.041213784366846085
. O 0 0.0314338393509388

The O 0 0.038170281797647476
I1307K O 1 0.9881674647331238
allele O 0 0.0380188524723053
was O 0 0.015644684433937073
found O 0 0.008283290080726147
in O 0 0.008799904957413673
6 O 0 0.02378123067319393
. O 0 0.025391658768057823

1 O 0 0.032270099967718124
% O 0 0.012637133710086346
of O 0 0.012226800434291363
unselected O 1 0.9947524070739746
Ashkenazi O 1 0.8871181607246399
Jews O 0 0.015340710990130901
and O 0 0.0075432308949530125
higher O 0 0.009905759245157242
proportions O 0 0.01657891273498535
of O 0 0.0075513459742069244
Ashkenazim O 1 0.9929957985877991
with O 0 0.005512033589184284
family O 0 0.009086492471396923
or O 0 0.004039675462990999
personal O 0 0.009507511742413044
histories O 0 0.011972792446613312
of O 0 0.0784333273768425
CRC B-Disease 1 1.0
( O 0 0.2382928729057312
ref O 1 0.9999994039535522
. O 0 0.01086779311299324
2 O 0 0.02278519980609417
) O 0 0.014073798432946205
. O 0 0.02053496055305004

To O 0 0.014922700822353363
evaluate O 0 0.021473972126841545
the O 0 0.0081026004627347
role O 0 0.009830561466515064
of O 0 0.009100954979658127
I1307K O 1 0.9998841285705566
in O 0 0.012771626934409142
cancer B-Disease 1 1.0
, O 0 0.007654130458831787
we O 0 0.007065477780997753
genotyped O 1 0.7410876154899597
5 O 0 0.014118071645498276
, O 0 0.012609836645424366
081 O 1 0.999756395816803
Ashkenazi O 1 0.9399979114532471
volunteers O 0 0.0228855200111866
in O 0 0.007967058569192886
a O 0 0.00989426951855421
community O 0 0.011829802766442299
survey O 0 0.02218567579984665
. O 0 0.019514387473464012

Risk O 0 0.0243803970515728
of O 0 0.011538956314325333
developing O 1 0.9994687438011169
colorectal B-Disease 1 1.0
, I-Disease 1 0.9999947547912598
breast I-Disease 1 1.0
and I-Disease 0 0.3969234824180603
other I-Disease 0 0.00868053175508976
cancers I-Disease 1 0.9999994039535522
were O 0 0.004118481185287237
compared O 0 0.006228259764611721
between O 0 0.007002008613198996
genotyped O 1 0.9996397495269775
I1307K O 1 0.9998156428337097
carriers O 0 0.01860492117702961
and O 0 0.005884361453354359
non O 0 0.02301652356982231
- O 1 0.9999974966049194
carriers O 0 0.019635220989584923
and O 0 0.00433707470074296
their O 0 0.0037940663751214743
first O 0 0.010001150891184807
- O 1 0.9999539852142334
degree O 0 0.01995084434747696
relatives O 0 0.029240455478429794
. O 0 0.026639830321073532

Sperm O 0 0.038503147661685944
DNA O 0 0.017678944393992424
analysis O 0 0.008113116025924683
in O 0 0.006785936187952757
a O 0 0.016537820920348167
Friedreich B-Disease 1 1.0
ataxia I-Disease 1 1.0
premutation O 1 1.0
carrier O 1 0.9999954700469971
suggests O 0 0.019360030069947243
both O 0 0.010002014227211475
meiotic O 1 0.9997519850730896
and O 0 0.011830872856080532
mitotic O 1 0.9790027737617493
expansion O 0 0.017315423116087914
in O 0 0.01056055910885334
the O 0 0.016527967527508736
FRDA B-Disease 1 0.9999998807907104
gene O 0 0.030414702370762825
. O 0 0.028744928538799286

Friedreich B-Disease 1 1.0
ataxia I-Disease 1 1.0
is O 0 0.018238075077533722
usually O 0 0.008880171924829483
caused O 0 0.009243736043572426
by O 0 0.00325659173540771
an O 0 0.0039747911505401134
expansion O 0 0.009808812290430069
of O 0 0.006951526273041964
a O 0 0.014002684503793716
GAA O 1 0.9995529055595398
trinucleotide O 1 0.9998648166656494
repeat O 0 0.025979096069931984
in O 0 0.012009942904114723
intron O 1 0.9904289245605469
1 O 0 0.015702396631240845
of O 0 0.011289255693554878
the O 0 0.018361669033765793
FRDA B-Disease 1 0.9999914169311523
gene O 0 0.03713526949286461
. O 0 0.030990805476903915

Occasionally O 0 0.02620895393192768
, O 0 0.009174567647278309
a O 0 0.00823190063238144
fully O 0 0.012166892178356647
expanded O 0 0.013984492979943752
allele O 0 0.01567825675010681
has O 0 0.0056015970185399055
been O 0 0.003818226745352149
found O 0 0.003412326332181692
to O 0 0.0037312577478587627
arise O 0 0.00587810855358839
from O 0 0.003630958031862974
a O 0 0.006229582242667675
premutation O 1 0.8758305907249451
of O 0 0.007378400303423405
100 O 0 0.012014660984277725
or O 0 0.007452375255525112
less O 0 0.01267421804368496
triplet O 1 0.988672137260437
repeats O 0 0.04417792335152626
. O 0 0.026990791782736778

We O 0 0.013568912632763386
have O 0 0.005854729562997818
examined O 0 0.013368838466703892
the O 0 0.007333319168537855
sperm O 0 0.010569421574473381
DNA O 0 0.009359316900372505
of O 0 0.007446419447660446
a O 0 0.01544566173106432
premutation O 1 0.9997949004173279
carrier O 1 0.9986845850944519
. O 0 0.030031254515051842

This O 0 0.024640057235956192
mans O 0 0.10577350109815598
leucocyte O 1 0.6583550572395325
DNA O 0 0.022603463381528854
showed O 0 0.011374753899872303
one O 0 0.007578661199659109
normal O 0 0.010453951545059681
allele O 0 0.019892875105142593
and O 0 0.006085886619985104
one O 0 0.00662617152556777
allele O 0 0.017325032502412796
of O 0 0.008348220027983189
approximately O 0 0.013455774635076523
100 O 0 0.023837067186832428
repeats O 0 0.03792855143547058
. O 0 0.02608017809689045

His O 0 0.036175280809402466
sperm O 0 0.021987510845065117
showed O 0 0.01124088279902935
an O 0 0.006738016381859779
expanded O 0 0.016334986314177513
allele O 0 0.018457340076565742
in O 0 0.006435028277337551
a O 0 0.009453099220991135
tight O 0 0.017809608951210976
range O 0 0.012541991658508778
centering O 0 0.0216752327978611
on O 0 0.005605550482869148
a O 0 0.006919358856976032
size O 0 0.0101650794968009
of O 0 0.00796182919293642
approximately O 0 0.01573631353676319
320 O 0 0.08328668028116226
trinucleotide O 1 0.9995496869087219
repeats O 0 0.06585434079170227
. O 0 0.03355330228805542

His O 0 0.04162033274769783
affected O 0 0.031096097081899643
son O 1 0.9601463675498962
has O 0 0.011010534130036831
repeat O 0 0.02435581013560295
sizes O 0 0.019281448796391487
of O 0 0.015508269891142845
1040 O 1 0.9964274764060974
and O 0 0.020305193960666656
540 O 1 0.6392207145690918
. O 0 0.03282046690583229

These O 0 0.009930443949997425
data O 0 0.007513162214308977
suggest O 0 0.006243478041142225
that O 0 0.0032471639569848776
expansion O 0 0.010335417464375496
occurs O 0 0.004710041452199221
in O 0 0.003221206832677126
two O 0 0.0033883322030305862
stages O 0 0.00697722565382719
, O 0 0.003968873526901007
the O 0 0.004128997214138508
first O 0 0.0064985258504748344
during O 0 0.008807011879980564
meiosis O 0 0.031398992985486984
followed O 0 0.008719714358448982
by O 0 0.004410848021507263
a O 0 0.010157828219234943
second O 0 0.023494504392147064
mitotic O 1 0.5576330423355103
expansion O 0 0.03982195258140564
. O 0 0.03132118657231331

We O 0 0.015004610642790794
also O 0 0.00844353437423706
show O 0 0.00649956613779068
that O 0 0.0028958129696547985
in O 0 0.003173018805682659
all O 0 0.0035885146353393793
informative O 0 0.016389397904276848
carrier O 1 0.9122482538223267
father O 0 0.011577383615076542
to O 0 0.005354768596589565
affected O 0 0.007490270305424929
child O 0 0.02935159020125866
transmissions O 0 0.012259808368980885
, O 0 0.004421055782586336
with O 0 0.0034937644377350807
the O 0 0.004546495154500008
notable O 0 0.006600062362849712
exception O 0 0.006700958125293255
of O 0 0.005388984922319651
the O 0 0.007992574945092201
premutation O 1 0.9999914169311523
carrier O 1 0.9983677268028259
, O 0 0.0068936776369810104
the O 0 0.007904494181275368
expansion O 0 0.01976851001381874
size O 0 0.022853458300232887
decreases O 0 0.025459304451942444
. O 0 0.015934428200125694
. O 0 0.023602791130542755

The O 0 0.03582040220499039
R496H O 0 0.404757559299469
mutation O 0 0.022526947781443596
of O 0 0.01113672275096178
arylsulfatase O 1 0.9996688365936279
A O 0 0.050580788403749466
does O 0 0.008511407300829887
not O 0 0.007621133700013161
cause O 1 0.9598284363746643
metachromatic B-Disease 1 1.0
leukodystrophy I-Disease 1 1.0
. O 0 0.05846445634961128

Deficiency B-Disease 1 1.0
of I-Disease 0 0.031521108001470566
arylsulfatase I-Disease 1 0.9999986886978149
A I-Disease 1 0.9933338761329651
( O 0 0.05033867806196213
ARSA O 1 1.0
) O 0 0.015306060202419758
enzyme O 0 0.021767856553196907
activity O 0 0.013821681961417198
causes O 1 0.9406164288520813
metachromatic B-Disease 1 1.0
leukodystrophy I-Disease 1 1.0
( O 1 0.9999477863311768
MLD B-Disease 1 1.0
) O 0 0.041672054678201675
. O 0 0.03669383004307747

A O 0 0.024941563606262207
number O 0 0.009382412768900394
of O 0 0.013433245010674
ARSA O 1 0.9999998807907104
gene O 0 0.018313556909561157
mutations O 0 0.010606035590171814
responsible O 0 0.00893674697726965
for O 0 0.010574390180408955
MLD B-Disease 1 1.0
have O 0 0.007798285223543644
been O 0 0.008956660516560078
identified O 0 0.013874669559299946
. O 0 0.019099274650216103

Recently O 0 0.03619695454835892
, O 0 0.011483656242489815
the O 0 0.012077639810740948
R496H O 1 0.5075600147247314
mutation O 0 0.019247621297836304
of O 0 0.012750876136124134
ARSA O 1 1.0
was O 0 0.011982536874711514
proposed O 0 0.0069172619841992855
to O 0 0.004255184903740883
be O 0 0.0031095745507627726
a O 0 0.005212027113884687
cause O 0 0.008919388987123966
of O 0 0.014684544876217842
MLD B-Disease 1 1.0
( O 0 0.034962110221385956
Draghia O 1 0.9999983310699463
et O 0 0.041157856583595276
al O 0 0.13737791776657104
. O 0 0.009639904834330082
, O 0 0.010643480345606804
1997 O 0 0.02437986060976982
) O 0 0.016322318464517593
. O 0 0.021258659660816193

We O 0 0.009213888086378574
have O 0 0.003927193116396666
investigated O 0 0.00974160898476839
the O 0 0.008104152977466583
R496H O 1 0.9999823570251465
mutation O 0 0.010700161568820477
and O 0 0.0038305704947561026
found O 0 0.00339607335627079
this O 0 0.0027832137420773506
mutation O 0 0.005790282040834427
at O 0 0.004937378689646721
a O 0 0.0043765404261648655
relatively O 0 0.005623810924589634
high O 0 0.0065000527538359165
frequency O 0 0.004524398595094681
in O 0 0.0028813453391194344
an O 0 0.0031244922429323196
African O 0 0.006593703292310238
American O 0 0.006240928545594215
population O 0 0.0037737153470516205
( O 0 0.006829644553363323
f O 0 0.04665447771549225
= O 0 0.021676698699593544
0 O 0 0.013215153478085995
. O 0 0.007444602437317371
09 O 0 0.054505735635757446
, O 0 0.009730753488838673
n O 0 0.023064550012350082
= O 0 0.03181241452693939
61 O 0 0.04137515649199486
subjects O 0 0.025528889149427414
) O 0 0.02005503512918949
. O 0 0.0258933175355196

The O 0 0.04137466475367546
ARSA O 1 0.9999998807907104
enzyme O 0 0.02608155831694603
activity O 0 0.008406393229961395
in O 0 0.005131223239004612
subjects O 0 0.006542223505675793
with O 0 0.003214841242879629
and O 0 0.0030601287726312876
without O 0 0.003409451339393854
the O 0 0.006174188572913408
R496H O 1 0.9999990463256836
mutation O 0 0.011730373837053776
was O 0 0.007737115956842899
determined O 0 0.006260369438678026
and O 0 0.0038044287357479334
found O 0 0.0032870795112103224
to O 0 0.00431611854583025
be O 0 0.005616066977381706
normal O 0 0.01257497351616621
. O 0 0.018086589872837067

It O 0 0.014281738549470901
is O 0 0.007901730947196484
therefore O 0 0.005864190403372049
concluded O 0 0.00662182318046689
that O 0 0.003033202840015292
the O 0 0.0064884331077337265
R496H O 1 0.8994069695472717
mutation O 0 0.015931161120533943
of O 0 0.014387426897883415
ARSA O 1 1.0
does O 0 0.007640825118869543
not O 0 0.003450152464210987
negatively O 0 0.007933241315186024
influence O 0 0.005366845987737179
the O 0 0.005237183999270201
activity O 0 0.006217552348971367
of O 0 0.00949918944388628
ARSA O 1 1.0
and O 0 0.006539772264659405
is O 0 0.004754051566123962
not O 0 0.0036944779567420483
a O 0 0.00926477462053299
cause O 0 0.029597504064440727
of O 0 0.09853895753622055
MLD B-Disease 1 1.0

Down O 0 0.04815927892923355
- O 1 0.8637368679046631
regulation O 0 0.0163271501660347
of O 0 0.013800827786326408
transmembrane O 1 0.9419746398925781
carbonic O 1 0.9978383183479309
anhydrases O 1 0.9997770190238953
in O 0 0.0618465319275856
renal B-Disease 1 1.0
cell I-Disease 1 1.0
carcinoma I-Disease 1 1.0
cell O 1 0.9995588660240173
lines O 0 0.012989714741706848
by O 0 0.006588073913007975
wild O 0 0.013540362007915974
- O 1 0.9997143149375916
type O 0 0.03627408668398857
von B-Disease 1 0.9997636675834656
Hippel I-Disease 1 1.0
- I-Disease 1 1.0
Lindau I-Disease 1 0.9999984502792358
transgenes O 1 0.8072009086608887
. O 0 0.042436446994543076

To O 0 0.023438092321157455
discover O 0 0.02919253334403038
genes O 0 0.01014681626111269
involved O 0 0.007286739069968462
in O 0 0.00794126559048891
von B-Disease 1 0.9843683838844299
Hippel I-Disease 1 1.0
- I-Disease 1 1.0
Lindau I-Disease 1 1.0
( O 0 0.022396644577383995
VHL B-Disease 1 1.0
) O 0 0.01793212629854679
- O 1 0.9999983310699463
mediated O 1 0.9909949898719788
carcinogenesis O 1 0.9999991655349731
, O 0 0.007896861992776394
we O 0 0.005861036013811827
used O 0 0.010532274842262268
renal B-Disease 1 1.0
cell I-Disease 1 1.0
carcinoma I-Disease 1 1.0
cell O 1 0.999996542930603
lines O 0 0.03170815855264664
stably O 1 0.8321730494499207
transfected O 0 0.16777071356773376
with O 0 0.008640512824058533
wild O 0 0.018670760095119476
- O 1 0.9999997615814209
type O 1 0.9989503026008606
VHL O 1 1.0
- O 1 0.9999994039535522
expressing O 0 0.0768231526017189
transgenes O 1 0.6105283498764038
. O 0 0.04047170281410217

Large O 0 0.028188392519950867
- O 1 0.8448598384857178
scale O 0 0.020604265853762627
RNA O 0 0.024345185607671738
differential O 0 0.0188481155782938
display O 0 0.012367116287350655
technology O 0 0.012305770069360733
applied O 0 0.00792762916535139
to O 0 0.004469266626983881
these O 0 0.003653314197435975
cell O 0 0.010452126152813435
lines O 0 0.007483821362257004
identified O 0 0.005472979974001646
several O 0 0.0054455907084047794
differentially O 0 0.027862900868058205
expressed O 0 0.011582700535655022
genes O 0 0.009158083237707615
, O 0 0.005117097869515419
including O 0 0.004826249089092016
an O 0 0.00705672474578023
alpha O 0 0.46732717752456665
carbonic O 1 0.9993690848350525
anhydrase O 1 0.999983549118042
gene O 0 0.025978587567806244
, O 0 0.019630908966064453
termed O 0 0.20169663429260254
CA12 O 1 0.9999932050704956
. O 0 0.04201408475637436

The O 0 0.02361086569726467
deduced O 0 0.033773161470890045
protein O 0 0.013470410369336605
sequence O 0 0.007118633482605219
was O 0 0.007654406130313873
classified O 0 0.006398583296686411
as O 0 0.003132153069600463
a O 0 0.004512816667556763
one O 0 0.005402229726314545
- O 1 0.9999842643737793
pass O 0 0.013307317160069942
transmembrane O 1 0.9477624893188477
CA O 0 0.028344999998807907
possessing O 0 0.01075834035873413
an O 0 0.005991707555949688
apparently O 0 0.010255569592118263
intact O 0 0.019670803099870682
catalytic O 0 0.01868932694196701
domain O 0 0.011427563615143299
in O 0 0.006246455013751984
the O 0 0.012073817662894726
extracellular O 1 0.920596182346344
CA O 1 0.993133544921875
module O 1 0.8983034491539001
. O 0 0.032019782811403275

Reintroduced O 0 0.06264698505401611
wild O 0 0.031156621873378754
- O 1 0.9999752044677734
type O 1 0.5265788435935974
VHL B-Disease 1 0.9999995231628418
strongly O 0 0.017752332612872124
inhibited O 0 0.026814699172973633
the O 0 0.008806995116174221
overexpression O 0 0.025653012096881866
of O 0 0.007968558929860592
the O 0 0.01040589902549982
CA12 O 1 0.9999992847442627
gene O 0 0.007487069815397263
in O 0 0.004326470661908388
the O 0 0.008131966926157475
parental O 1 0.9998490810394287
renal B-Disease 1 1.0
cell I-Disease 1 1.0
carcinoma I-Disease 1 1.0
cell O 1 0.9999998807907104
lines O 0 0.24501891434192657
. O 0 0.029150251299142838

Similar O 0 0.021260946989059448
results O 0 0.012365171685814857
were O 0 0.005870306398719549
obtained O 0 0.008882606402039528
with O 0 0.008526104502379894
CA9 O 1 0.999983549118042
, O 0 0.00927483756095171
encoding O 0 0.013251771219074726
another O 0 0.014685194008052349
transmembrane O 1 0.929353654384613
CA O 0 0.022893572226166725
with O 0 0.008186020888388157
an O 0 0.01191636361181736
intact O 0 0.12274517863988876
catalytic O 0 0.0576225183904171
domain O 0 0.03954232856631279
. O 0 0.02509251795709133

Although O 0 0.016730263829231262
both O 0 0.009618605487048626
domains O 0 0.017150139436125755
of O 0 0.00899741891771555
the O 0 0.013590413145720959
VHL B-Disease 1 1.0
protein O 0 0.01431921124458313
contribute O 0 0.008529380895197392
to O 0 0.005468190182000399
regulation O 0 0.008365433663129807
of O 0 0.008022475987672806
CA12 O 1 0.9999997615814209
expression O 0 0.009664126671850681
, O 0 0.006483463570475578
the O 0 0.009423109702765942
elongin O 1 0.9718076586723328
binding O 0 0.014230470173060894
domain O 0 0.016385255381464958
alone O 0 0.011196080595254898
could O 0 0.008683905005455017
effectively O 0 0.01857273280620575
regulate O 0 0.038526501506567
CA9 O 1 0.9999960660934448
expression O 0 0.04107104241847992
. O 0 0.030047107487916946

We O 0 0.021745720878243446
mapped O 0 0.05140116065740585
CA12 O 1 0.9999759197235107
and O 0 0.023495744913816452
CA9 O 1 0.9999942779541016
loci O 0 0.043166790157556534
to O 0 0.016606871038675308
chromosome O 0 0.03031129576265812
bands O 0 0.03052152507007122
15q22 O 1 0.9890374541282654
and O 0 0.02296573668718338
17q21 O 1 0.999161958694458
. O 0 0.030890967696905136

2 O 0 0.03461623564362526
respectively O 0 0.019403429701924324
, O 0 0.010292764753103256
regions O 0 0.01087547279894352
prone O 1 0.7126230001449585
to O 0 0.0068310098722577095
amplification O 0 0.01968269608914852
in O 0 0.005940472241491079
some O 0 0.00681524770334363
human O 0 0.015590546652674675
cancers B-Disease 1 0.9999998807907104
. O 0 0.024340353906154633

Additional O 0 0.023467805236577988
experiments O 0 0.017849115654826164
are O 0 0.004393887706100941
needed O 0 0.00795490201562643
to O 0 0.004836800042539835
define O 0 0.0077239773236215115
the O 0 0.004599807318300009
role O 0 0.007015302311629057
of O 0 0.007425855845212936
CA O 1 0.9992000460624695
IX O 1 1.0
and O 0 0.017462462186813354
CA O 1 0.9999336004257202
XII O 1 1.0
enzymes O 0 0.013303635641932487
in O 0 0.004936310462653637
the O 0 0.004714576993137598
regulation O 0 0.0074437884613871574
of O 0 0.00782081950455904
pH O 1 0.8878875374794006
in O 0 0.0071806516498327255
the O 0 0.010236226953566074
extracellular O 0 0.03633309155702591
microenvironment O 1 0.9640628695487976
and O 0 0.004969884175807238
its O 0 0.004650207702070475
potential O 0 0.007113017141819
impact O 0 0.008882857859134674
on O 0 0.011758178472518921
cancer B-Disease 1 1.0
cell O 1 0.9971580505371094
growth O 0 0.03827648237347603
. O 0 0.025170691311359406

A O 0 0.03034854494035244
gene O 0 0.01696070283651352
encoding O 0 0.014419701881706715
a O 0 0.013800516724586487
transmembrane O 0 0.3064935505390167
protein O 0 0.01275583729147911
is O 0 0.005493510980159044
mutated O 0 0.014318558387458324
in O 0 0.005510893650352955
patients O 1 0.9160915017127991
with O 1 0.8974217772483826
diabetes B-Disease 1 1.0
mellitus I-Disease 1 1.0
and O 1 1.0
optic B-Disease 1 1.0
atrophy I-Disease 1 1.0
( O 1 1.0
Wolfram B-Disease 1 1.0
syndrome I-Disease 1 1.0
) O 1 0.9520350098609924
. O 0 0.03329378738999367

Wolfram B-Disease 1 1.0
syndrome I-Disease 1 1.0
( O 1 0.998855710029602
WFS B-Disease 1 1.0
; O 1 0.7688029408454895
OMIM O 1 1.0
222300 O 1 0.9999973773956299
) O 0 0.007571370340883732
is O 0 0.00398752186447382
an O 0 0.0063577876426279545
autosomal B-Disease 1 0.9999998807907104
recessive I-Disease 1 1.0
neurodegenerative I-Disease 1 1.0
disorder I-Disease 1 1.0
defined O 1 0.9948825836181641
by O 0 0.005022022407501936
young O 1 0.9995404481887817
- O 1 1.0
onset O 1 1.0
non O 1 0.999933123588562
- O 1 1.0
immune O 1 1.0
insulin B-Disease 1 1.0
- I-Disease 1 1.0
dependent I-Disease 1 0.9999918937683105
diabetes I-Disease 1 1.0
mellitus I-Disease 1 1.0
and O 1 0.9999997615814209
progressive O 1 1.0
optic B-Disease 1 1.0
atrophy I-Disease 1 1.0
. O 1 0.9872810244560242

Linkage O 0 0.04824889078736305
to O 0 0.01424323208630085
markers O 0 0.022547278553247452
on O 0 0.011733747087419033
chromosome O 0 0.07887890189886093
4p O 1 1.0
was O 0 0.021361617371439934
confirmed O 0 0.009957249276340008
in O 0 0.007664271630346775
five O 0 0.011142353527247906
families O 0 0.014303397387266159
. O 0 0.019683700054883957

On O 0 0.01654076762497425
the O 0 0.009643524885177612
basis O 0 0.0066832080483436584
of O 0 0.010988741181790829
meiotic O 1 0.9999649524688721
recombinants O 1 0.999997615814209
and O 0 0.4776855409145355
disease O 1 1.0
- O 1 1.0
associated O 0 0.01604646071791649
haplotypes O 0 0.03182385489344597
, O 0 0.009114476852118969
the O 0 0.013825289905071259
WFS B-Disease 1 1.0
gene O 0 0.017893850803375244
was O 0 0.013396996073424816
localized O 0 0.01872221939265728
to O 0 0.00770207354798913
a O 0 0.015903770923614502
BAC O 1 1.0
/ O 1 0.9999977350234985
P1 O 1 0.9999892711639404
contig O 1 0.6397354006767273
of O 0 0.010552957653999329
less O 0 0.008929848670959473
than O 0 0.00985186081379652
250 O 0 0.03843877464532852
kb O 1 0.5820661187171936
. O 0 0.03371540457010269

Mutations O 0 0.027973175048828125
in O 0 0.00905053224414587
a O 0 0.011099101975560188
novel O 0 0.019955722615122795
gene O 0 0.01289340853691101
( O 0 0.010069788433611393
WFS1 O 1 0.9999827146530151
) O 0 0.008989785797894001
encoding O 0 0.011375006288290024
a O 0 0.012035644613206387
putative O 0 0.37155118584632874
transmembrane O 1 0.9676197171211243
protein O 0 0.011822536587715149
were O 0 0.004681227263063192
found O 0 0.0037693800404667854
in O 0 0.003326271427795291
all O 0 0.0032248757779598236
affected O 0 0.004527009557932615
individuals O 0 0.0023557126987725496
in O 0 0.0042633917182683945
six O 0 0.009767324663698673
WFS B-Disease 1 1.0
families O 0 0.008971266448497772
, O 0 0.005540808197110891
and O 0 0.003335273824632168
these O 0 0.002531722653657198
mutations O 0 0.004234039690345526
were O 0 0.002312691416591406
associated O 0 0.004025991074740887
with O 0 0.0046483054757118225
the O 1 0.9547672271728516
disease O 1 1.0
phenotype O 1 0.9999996423721313
. O 0 0.02818559668958187

WFS1 O 1 0.9999778270721436
appears O 0 0.021111631765961647
to O 0 0.008114010095596313
function O 0 0.005778906401246786
in O 0 0.005391080863773823
survival O 0 0.01803872175514698
of O 0 0.0071182469837367535
islet O 1 0.9999629259109497
beta O 1 0.9999852180480957
- O 1 1.0
cells O 0 0.019951513037085533
and O 0 0.011202534660696983
neurons O 0 0.019429203122854233
. O 0 0.011835891753435135
. O 0 0.019656557589769363

Stable O 0 0.0451514795422554
interaction O 0 0.012273482978343964
between O 0 0.005093565210700035
the O 0 0.0054316394962370396
products O 0 0.007714955601841211
of O 0 0.00575662637129426
the O 0 0.009672500193119049
BRCA1 O 1 0.9999992847442627
and O 0 0.1223524957895279
BRCA2 O 1 1.0
tumor B-Disease 1 1.0
suppressor O 1 0.9999991655349731
genes O 0 0.014763966202735901
in O 0 0.011094559915363789
mitotic O 1 0.9981270432472229
and O 0 0.021508440375328064
meiotic O 1 0.9999990463256836
cells O 0 0.04557843878865242
. O 0 0.033328182995319366

BRCA1 O 1 0.9999954700469971
and O 0 0.02274114452302456
BRCA2 O 1 0.9993853569030762
account O 0 0.008082346059381962
for O 0 0.0034914661664515734
most O 0 0.0030028964392840862
cases O 0 0.0030030577909201384
of O 0 0.004832465201616287
familial O 1 0.9999685287475586
, O 0 0.0058012777008116245
early O 0 0.14671963453292847
onset O 1 1.0
breast B-Disease 1 1.0
and I-Disease 1 0.9958215951919556
/ I-Disease 1 1.0
or I-Disease 1 0.9999986886978149
ovarian I-Disease 1 1.0
cancer I-Disease 1 1.0
and O 1 0.9193668365478516
encode O 0 0.019735246896743774
products O 0 0.011324266903102398
that O 0 0.005328157916665077
each O 0 0.005172813311219215
interact O 0 0.01488853245973587
with O 0 0.013450035825371742
hRAD51 O 1 0.9886267781257629
. O 0 0.03205138072371483

Results O 0 0.02351341024041176
presented O 0 0.015922604128718376
here O 0 0.0068517387844622135
show O 0 0.0062393248081207275
that O 0 0.005368764977902174
BRCA1 O 1 0.9994742274284363
and O 0 0.011136249639093876
BRCA2 O 1 0.9999963045120239
coexist O 0 0.018986055627465248
in O 0 0.006210482679307461
a O 0 0.009058130905032158
biochemical O 0 0.03658759593963623
complex O 0 0.012699824757874012
and O 0 0.007484851870685816
colocalize O 1 0.9600078463554382
in O 0 0.00910145416855812
subnuclear O 1 0.9999030828475952
foci O 1 0.9975817203521729
in O 0 0.010456106625497341
somatic O 1 0.7815970182418823
cells O 0 0.010676780715584755
and O 0 0.00518408790230751
on O 0 0.005701499059796333
the O 0 0.007409618701785803
axial O 0 0.020327456295490265
elements O 0 0.012653905898332596
of O 0 0.014286613091826439
developing O 0 0.04133531451225281
synaptonemal O 1 0.9999686479568481
complexes O 0 0.472488135099411
. O 0 0.038405295461416245

Like O 0 0.04463675990700722
BRCA1 O 1 0.9999208450317383
and O 0 0.02516057714819908
RAD51 O 1 0.9999998807907104
, O 0 0.02572346292436123
BRCA2 O 1 0.9999474287033081
relocates O 1 0.939551591873169
to O 0 0.01681000553071499
PCNA O 1 0.9999983310699463
+ O 0 0.04284580424427986
replication O 0 0.019000142812728882
sites O 0 0.007011224050074816
following O 0 0.006086434703320265
exposure O 0 0.0157622117549181
of O 0 0.00835056509822607
S O 1 0.9999997615814209
phase O 1 0.5480882525444031
cells O 0 0.014215187169611454
to O 0 0.013529494404792786
hydroxyurea O 1 0.9999533891677856
or O 0 0.027176562696695328
UV O 1 1.0
irradiation O 1 0.9968407154083252
. O 0 0.045369286090135574

Thus O 0 0.025960823521018028
, O 0 0.01877526566386223
BRCA1 O 1 0.9998012185096741
and O 0 0.01271091215312481
BRCA2 O 1 0.9999796152114868
participate O 0 0.01003379374742508
, O 0 0.005091982893645763
together O 0 0.0047385296784341335
, O 0 0.003215137403458357
in O 0 0.0031093263532966375
a O 0 0.005916791036725044
pathway O 0 0.014895807020366192
( O 0 0.0074358368292450905
s O 1 0.9935182929039001
) O 0 0.005230178590863943
associated O 0 0.003952265251427889
with O 0 0.002966896630823612
the O 0 0.0046050152741372585
activation O 0 0.010266450233757496
of O 0 0.006449990440160036
double O 0 0.04097996652126312
- O 1 0.999998927116394
strand O 0 0.019055025652050972
break O 0 0.015546215698122978
repair O 1 0.99920254945755
and O 0 0.011555883102118969
/ O 1 0.9999369382858276
or O 0 0.015133671462535858
homologous O 0 0.036922525614500046
recombination O 0 0.042747437953948975
. O 0 0.02633814699947834

Dysfunction O 1 0.9999997615814209
of O 0 0.018587566912174225
this O 0 0.010310766287147999
pathway O 0 0.030839120969176292
may O 0 0.005449132528156042
be O 0 0.0035868713166564703
a O 0 0.005487502086907625
general O 0 0.00953762698918581
phenomenon O 0 0.00808565691113472
in O 0 0.003147271228954196
the O 0 0.003759731538593769
majority O 0 0.0037710953038185835
of O 0 0.0030255704186856747
cases O 0 0.0036811328027397394
of O 0 0.0075813401490449905
hereditary B-Disease 1 1.0
breast I-Disease 1 1.0
and I-Disease 1 0.9999995231628418
/ I-Disease 1 1.0
or I-Disease 1 0.9999998807907104
ovarian I-Disease 1 1.0
cancer I-Disease 1 1.0
. O 1 0.5582697987556458
. O 0 0.02504698373377323

A O 0 0.037547312676906586
novel O 0 0.04077344387769699
Arg362Ser O 1 0.9765059351921082
mutation O 0 0.014798777177929878
in O 0 0.006450076587498188
the O 0 0.008568585850298405
sterol O 0 0.20924335718154907
27 O 0 0.028366846963763237
- O 1 0.9999992847442627
hydroxylase O 1 0.9995642304420471
gene O 0 0.014600088819861412
( O 0 0.011487478390336037
CYP27 O 1 0.9999991655349731
) O 0 0.00855548307299614
: O 0 0.006840064190328121
its O 0 0.00547818373888731
effects O 0 0.008397454395890236
on O 0 0.006456475239247084
pre O 0 0.43522128462791443
- O 1 0.9988721013069153
mRNA O 0 0.028957746922969818
splicing O 0 0.030606994405388832
and O 0 0.014311890117824078
enzyme O 0 0.02608063630759716
activity O 0 0.016043968498706818
. O 0 0.02045888639986515

A O 0 0.03497641161084175
novel O 0 0.03217235207557678
C O 0 0.48464828729629517
to O 0 0.0078115640208125114
A O 0 0.012609116733074188
mutation O 0 0.01075070071965456
in O 0 0.004895662888884544
the O 0 0.00700306287035346
sterol O 0 0.06968800723552704
27 O 0 0.024024629965424538
- O 1 0.9999995231628418
hydroxylase O 1 0.9990298748016357
gene O 0 0.01489704754203558
( O 0 0.012337484396994114
CYP27 O 1 0.9999991655349731
) O 0 0.008314252831041813
was O 0 0.009282740764319897
identified O 0 0.006491565611213446
by O 0 0.0046998863108456135
sequencing O 0 0.016127385199069977
amplified O 0 0.03221803531050682
CYP27 O 1 0.9999884366989136
gene O 0 0.014505228027701378
products O 0 0.00947154313325882
from O 0 0.004835468251258135
a O 0 0.007880762219429016
patient O 0 0.4561299979686737
with O 0 0.009744714014232159
cerebrotendinous B-Disease 1 1.0
xanthomatosis I-Disease 1 1.0
( O 1 0.9939461350440979
CTX B-Disease 1 1.0
) O 0 0.024660741910338402
. O 0 0.027529466897249222

The O 0 0.033062685281038284
mutation O 0 0.02659647911787033
changed O 0 0.015929847955703735
the O 0 0.015237749554216862
adrenodoxin O 1 0.9994971752166748
cofactor O 1 0.9997642636299133
binding O 0 0.028006363660097122
residue O 0 0.042252786457538605
362Arg O 0 0.20539602637290955
to O 0 0.015180650167167187
362Ser O 1 0.9980410933494568
( O 0 0.015764091163873672
CGT O 1 0.9996671676635742
362Arg O 1 0.9868764877319336
to O 0 0.022460440173745155
AGT O 1 1.0
362Ser O 1 0.9999997615814209
) O 0 0.011181573383510113
, O 0 0.006998639553785324
and O 0 0.004917365498840809
was O 0 0.0076657989993691444
responsible O 0 0.007047692313790321
for O 0 0.009155405685305595
deficiency O 1 1.0
in O 0 0.007325576152652502
the O 0 0.010303577408194542
sterol O 1 0.9982345104217529
27 O 1 0.7552908658981323
- O 1 0.9999998807907104
hydroxylase O 1 0.990066647529602
activity O 0 0.007724130526185036
, O 0 0.005353153683245182
as O 0 0.004092582501471043
confirmed O 0 0.0053584701381623745
by O 0 0.0032229102216660976
expression O 0 0.005402291659265757
of O 0 0.006331299897283316
mutant O 0 0.025103753432631493
cDNA O 0 0.0326610766351223
into O 0 0.01752125658094883
COS O 1 1.0
- O 1 0.9999998807907104
1 O 0 0.061082273721694946
cells O 0 0.029040522873401642
. O 0 0.024868251755833626

Quantitative O 0 0.03337789326906204
analysis O 0 0.01247640885412693
showed O 0 0.008390961214900017
that O 0 0.0031744902953505516
the O 0 0.0051263547502458096
expression O 0 0.006281381007283926
of O 0 0.008307650685310364
CYP27 O 1 1.0
gene O 0 0.011809341609477997
mRNA O 0 0.012779600918293
in O 0 0.006290021352469921
the O 0 0.009758159518241882
patient O 0 0.028135092929005623
represented O 0 0.01912127248942852
52 O 0 0.04224507510662079
. O 0 0.027144955471158028

5 O 0 0.02314770594239235
% O 0 0.009193780831992626
of O 0 0.007187142968177795
the O 0 0.009572293609380722
normal O 0 0.012861205264925957
level O 0 0.017731288447976112
. O 0 0.025590283796191216

As O 0 0.01836242340505123
the O 0 0.014828632585704327
mutation O 0 0.016863645985722542
occurred O 0 0.011155916377902031
at O 0 0.009058927185833454
the O 0 0.009167591109871864
penultimate O 0 0.348347544670105
nucleotide O 0 0.015337425284087658
of O 0 0.008616892620921135
exon O 0 0.042098358273506165
6 O 0 0.016287626698613167
( O 0 0.009260915219783783
- O 1 0.8938843011856079
2 O 0 0.0107730096206069
position O 0 0.008627660572528839
of O 0 0.008238155394792557
exon O 0 0.0340733639895916
6 O 0 0.018535908311605453
- O 1 0.9990203380584717
intron O 1 0.9992011189460754
6 O 0 0.02086353674530983
splice O 0 0.03642153739929199
site O 0 0.013362552039325237
) O 0 0.004795142449438572
of O 0 0.005208396818488836
the O 0 0.006866004317998886
gene O 0 0.007429898716509342
, O 0 0.004636187572032213
we O 0 0.003918214701116085
hypothesized O 0 0.008669422008097172
that O 0 0.003091693390160799
the O 0 0.00608559837564826
mutation O 0 0.009718484245240688
may O 0 0.006185604725033045
partially O 0 0.012304429896175861
affect O 0 0.0068418062292039394
the O 0 0.00658288924023509
normal O 0 0.008361098356544971
splicing O 0 0.018502771854400635
efficiency O 0 0.016241345554590225
in O 0 0.008541559800505638
exon O 0 0.043650563806295395
6 O 0 0.015583353117108345
and O 0 0.007597555872052908
cause O 0 0.010651928372681141
alternative O 0 0.0120174465700984
splicing O 0 0.015986138954758644
elsewhere O 0 0.00854819267988205
, O 0 0.004953912924975157
which O 0 0.0038470840081572533
resulted O 0 0.007433194201439619
in O 0 0.006052462849766016
decreased O 0 0.01443248987197876
transcript O 0 0.018577629700303078
in O 0 0.010869821533560753
the O 0 0.01682666689157486
patient O 1 0.9811331629753113
. O 0 0.028668850660324097

Transfection O 1 0.719393789768219
of O 0 0.01922774687409401
constructed O 0 0.03097863681614399
minigenes O 1 0.9724435210227966
, O 0 0.007830360904335976
with O 0 0.005273524206131697
or O 0 0.0034882191102951765
without O 0 0.0030109197832643986
the O 0 0.004110504873096943
mutation O 0 0.0063635194674134254
, O 0 0.003809246700257063
into O 0 0.0072339484468102455
COS O 1 1.0
- O 1 1.0
1 O 0 0.02093418501317501
cells O 0 0.007360012270510197
confirmed O 0 0.005012237001210451
that O 0 0.002856210805475712
the O 0 0.005969550926238298
mutant O 0 0.02684907615184784
minigene O 1 0.9982150793075562
was O 0 0.00893934816122055
responsible O 0 0.006894252263009548
for O 0 0.004629841074347496
a O 0 0.006336194463074207
mRNA O 0 0.01055015530437231
species O 0 0.004735364578664303
alternatively O 0 0.013284796848893166
spliced O 0 0.01736443303525448
at O 0 0.008840525522828102
an O 0 0.007546308916062117
activated O 0 0.2682153880596161
cryptic O 0 0.04589124768972397
5 O 0 0.02069864608347416
splice O 0 0.04350854828953743
site O 0 0.02225891873240471
88 O 0 0.03623821958899498
bp O 0 0.03297467902302742
upstream O 0 0.01558611262589693
from O 0 0.004233147483319044
the O 0 0.005336250644177198
3 O 0 0.008706863969564438
end O 0 0.00986598338931799
of O 0 0.011323626153171062
exon O 1 0.7038684487342834
6 O 0 0.03339298814535141
. O 0 0.02345270849764347

Our O 0 0.020343944430351257
data O 0 0.007865669205784798
suggest O 0 0.006239940412342548
that O 0 0.0025785276666283607
the O 0 0.005797873716801405
C O 0 0.04894913733005524
to O 0 0.0058032856322824955
A O 0 0.012369527481496334
mutation O 0 0.012851322069764137
at O 0 0.009101820178329945
the O 0 0.008579001761972904
penultimate O 1 0.7310954928398132
nucleotide O 0 0.01620875671505928
of O 0 0.008969129994511604
exon O 0 0.03063562884926796
6 O 0 0.010434077121317387
of O 0 0.005763606633991003
the O 0 0.009054090827703476
CYP27 O 1 0.9999994039535522
gene O 0 0.008096862584352493
not O 0 0.0028522724751383066
only O 0 0.0037166306283324957
causes O 0 0.011149111203849316
the O 0 0.01717834360897541
deficiency B-Disease 1 1.0
in I-Disease 0 0.00691720936447382
the I-Disease 0 0.008219783194363117
sterol I-Disease 1 0.9943437576293945
27 I-Disease 0 0.35451745986938477
- I-Disease 1 0.9999998807907104
hydroxylase I-Disease 1 0.9893723130226135
activity I-Disease 0 0.009540446102619171
, O 0 0.0055956426076591015
but O 0 0.004368054214864969
also O 0 0.005464095156639814
partially O 0 0.012654977850615978
leads O 0 0.009797907434403896
to O 0 0.005393561441451311
alternative O 0 0.009983288124203682
pre O 0 0.1600896716117859
- O 1 0.9968421459197998
mRNA O 0 0.019876472651958466
splicing O 0 0.01943197287619114
of O 0 0.01004587858915329
the O 0 0.015476959757506847
gene O 0 0.021670036017894745
. O 0 0.022328106686472893

To O 0 0.012646496295928955
our O 0 0.009820669889450073
knowledge O 0 0.007696426007896662
, O 0 0.005177251063287258
this O 0 0.003074695821851492
is O 0 0.003034633817151189
the O 0 0.004135507624596357
first O 0 0.005208529997617006
report O 0 0.005017939954996109
regarding O 0 0.005226374603807926
effects O 0 0.007103725802153349
on O 0 0.0068710846826434135
pre O 1 0.9148414134979248
- O 1 0.996945321559906
mRNA O 0 0.018807075917720795
splicing O 0 0.014647389762103558
of O 0 0.00549218850210309
a O 0 0.00691103795543313
mutation O 0 0.008206060156226158
at O 0 0.006385092157870531
the O 0 0.0064256759360432625
- O 1 0.9996145963668823
2 O 0 0.010026000440120697
position O 0 0.009755516424775124
of O 0 0.0061308820731937885
a O 0 0.010252593085169792
5 O 0 0.020987847819924355
splice O 0 0.06085788086056709
site O 0 0.0341927707195282
. O 0 0.023180102929472923

ATM O 1 0.8976172208786011
germline O 0 0.08513998985290527
mutations O 0 0.020047660917043686
in O 0 0.01099378988146782
classical O 0 0.02765076607465744
ataxia B-Disease 1 1.0
- I-Disease 1 1.0
telangiectasia I-Disease 1 1.0
patients O 1 0.9999998807907104
in O 0 0.0090601472184062
the O 0 0.012331963516771793
Dutch O 0 0.1628894954919815
population O 0 0.011494997888803482
. O 0 0.020467426627874374

Germline O 1 0.7597681283950806
mutations O 0 0.01763005368411541
in O 0 0.006886512506753206
the O 0 0.008550994098186493
ATM O 1 0.98808354139328
gene O 0 0.006682695355266333
are O 0 0.001648145611397922
responsible O 0 0.0032531393226236105
for O 0 0.003498808480799198
the O 0 0.008939784951508045
autosomal B-Disease 1 1.0
recessive I-Disease 1 1.0
disorder I-Disease 1 1.0
ataxia B-Disease 1 1.0
- I-Disease 1 1.0
telangiectasia I-Disease 1 1.0
( O 1 0.9855629205703735
A B-Disease 1 1.0
- I-Disease 1 1.0
T I-Disease 1 1.0
) O 0 0.020099135115742683
. O 0 0.023374957963824272

In O 0 0.018266312777996063
our O 0 0.01274444442242384
study O 0 0.00926479883491993
, O 0 0.005399611778557301
we O 0 0.00283468933776021
have O 0 0.002125697210431099
determined O 0 0.0047897472977638245
the O 0 0.006822196301072836
ATM O 0 0.22080180048942566
mutation O 0 0.0109912334010005
spectrum O 0 0.010311068035662174
in O 0 0.004059574566781521
19 O 0 0.007850516587495804
classical O 0 0.009465689770877361
A B-Disease 1 0.9983626008033752
- I-Disease 1 1.0
T I-Disease 1 1.0
patients O 1 0.9999306201934814
, O 0 0.004963996820151806
including O 0 0.003220331622287631
some O 0 0.0030318708159029484
immigrant O 0 0.008599450811743736
populations O 0 0.004843239206820726
, O 0 0.004106191918253899
as O 0 0.003641831688582897
well O 0 0.003604269353672862
as O 0 0.003638919210061431
12 O 0 0.006420243997126818
of O 0 0.006760619580745697
Dutch O 0 0.02510996349155903
ethnic O 0 0.009315763600170612
origin O 0 0.012653392739593983
. O 0 0.018477946519851685

Both O 0 0.013587216846644878
the O 0 0.0141494395211339
protein O 0 0.02003142237663269
truncation O 0 0.046130966395139694
test O 0 0.02559194155037403
( O 0 0.01504860632121563
PTT O 1 0.9999332427978516
) O 0 0.00711672380566597
and O 0 0.004842765629291534
the O 0 0.006143758539110422
restriction O 0 0.014266422018408775
endonuclease O 0 0.3789524734020233
fingerprinting O 0 0.04064261540770531
( O 0 0.014294794760644436
REF O 1 0.9999998807907104
) O 0 0.007424657698720694
method O 0 0.00553382933139801
were O 0 0.0028750309720635414
used O 0 0.0034393700771033764
and O 0 0.0033394990023225546
compared O 0 0.004117417149245739
for O 0 0.0035463618114590645
their O 0 0.00480618653818965
detection O 0 0.015009317547082901
efficiency O 0 0.012485502287745476
, O 0 0.005732355173677206
identifying O 0 0.010128031484782696
76 O 0 0.019566847011446953
% O 0 0.0050680008716881275
and O 0 0.003816890064626932
60 O 0 0.006349827162921429
% O 0 0.004395606927573681
of O 0 0.00480162026360631
the O 0 0.008418237790465355
mutations O 0 0.013237349689006805
, O 0 0.009974326938390732
respectively O 0 0.01570490375161171
. O 0 0.018970731645822525

Most O 0 0.019327150657773018
patients O 0 0.2682736814022064
were O 0 0.005402034614235163
found O 0 0.004826871678233147
to O 0 0.005685607902705669
be O 0 0.007911557331681252
compound O 0 0.05656810849905014
heterozygote O 1 0.926956832408905
. O 0 0.03221255913376808

Seventeen O 0 0.06160106509923935
mutations O 0 0.01623758301138878
were O 0 0.004667401313781738
distinct O 0 0.0047271461226046085
, O 0 0.003626161953434348
of O 0 0.004204059951007366
which O 0 0.003473852062597871
10 O 0 0.005301660858094692
were O 0 0.003276218194514513
not O 0 0.003906676545739174
reported O 0 0.009261018596589565
previously O 0 0.014539589174091816
. O 0 0.01967167854309082

Mutations O 0 0.03316730633378029
are O 0 0.0055194515734910965
small O 0 0.008624332956969738
deletions O 0 0.020652025938034058
or O 0 0.007096939254552126
point O 0 0.010756004601716995
mutations O 0 0.012505187653005123
frequently O 0 0.012869658879935741
affecting O 0 0.024467866867780685
splice O 0 0.08485139161348343
sites O 0 0.02154824323952198
. O 0 0.025567732751369476

Moreover O 0 0.04656166583299637
, O 0 0.015352563001215458
a O 0 0.017742548137903214
16 O 0 0.02928854525089264
. O 0 0.025661353021860123

7 O 0 0.04652655869722366
- O 1 0.9991976618766785
kb O 1 0.8925845623016357
genomic O 0 0.028210997581481934
deletion O 0 0.018303263932466507
of O 0 0.005524578969925642
the O 0 0.005334848538041115
3 O 0 0.00661431485787034
end O 0 0.005120888352394104
of O 0 0.003624970093369484
the O 0 0.0041922274976968765
gene O 0 0.005687173921614885
, O 0 0.003422134555876255
most O 0 0.0028926311060786247
likely O 0 0.0033619441092014313
a O 0 0.00414913147687912
result O 0 0.003503989428281784
of O 0 0.004650252405554056
recombination O 0 0.011202618479728699
between O 0 0.004292636644095182
two O 0 0.0037568858824670315
LINE O 0 0.015039097517728806
elements O 0 0.0077750119380652905
, O 0 0.006888404954224825
was O 0 0.014606889337301254
identified O 0 0.017251329496502876
. O 0 0.020847009494900703

The O 0 0.01883639767765999
most O 0 0.008688166737556458
frequently O 0 0.00785015244036913
found O 0 0.00601457804441452
mutation O 0 0.007927224971354008
, O 0 0.00435712281614542
identified O 0 0.004713234957307577
in O 0 0.003014589427039027
three O 0 0.002924251602962613
unrelated O 0 0.006634952500462532
Turkish O 0 0.012695963494479656
A B-Disease 1 0.999927282333374
- I-Disease 1 1.0
T I-Disease 1 1.0
individuals O 0 0.0051893386989831924
, O 0 0.005413493607193232
was O 0 0.007028388325124979
previously O 0 0.006432586815208197
described O 0 0.005422878544777632
to O 0 0.003413919359445572
be O 0 0.0023084746208041906
a O 0 0.004752578679472208
Turkish O 0 0.013860916718840599
A B-Disease 1 0.9973102807998657
- I-Disease 1 1.0
T I-Disease 1 1.0
founder O 1 0.9999439716339111
mutation O 0 0.039342205971479416
. O 0 0.02657230570912361

The O 0 0.016668220981955528
presence O 0 0.01176398154348135
of O 0 0.007302124984562397
a O 0 0.009591435082256794
founder O 1 0.999016284942627
mutation O 0 0.013970849104225636
among O 0 0.0055633229203522205
relatively O 0 0.004658904392272234
small O 0 0.0034621101804077625
ethnic O 0 0.0032293444965034723
population O 0 0.0022826523054391146
groups O 0 0.0019869154784828424
in O 0 0.003265159437432885
Western O 0 0.007361011579632759
Europe O 0 0.006623783614486456
could O 0 0.0035312320105731487
indicate O 0 0.0038330531679093838
a O 0 0.005248188506811857
high O 0 0.013635319657623768
carrier O 1 0.9692849516868591
frequency O 0 0.009769228287041187
in O 0 0.006268289405852556
such O 0 0.0066065615974366665
communities O 0 0.011105844751000404
. O 0 0.019171541556715965

In O 0 0.02186901494860649
patients O 0 0.030825071036815643
of O 0 0.01044104527682066
Dutch O 0 0.02391389198601246
ethnic O 0 0.006646959576755762
origin O 0 0.004485287703573704
, O 0 0.004182887729257345
however O 0 0.0026450520381331444
, O 0 0.0032315703574568033
no O 0 0.0031853090040385723
significant O 0 0.005337996874004602
founder O 1 0.9998358488082886
effect O 0 0.008399448357522488
could O 0 0.005441731307655573
be O 0 0.005372107028961182
identified O 0 0.012736814096570015
. O 0 0.015445276163518429

The O 0 0.025148389860987663
observed O 0 0.0172622948884964
genetic O 0 0.015683136880397797
heterogeneity O 0 0.025518665090203285
including O 0 0.005832576658576727
the O 0 0.0057898638769984245
relative O 0 0.008106070570647717
high O 0 0.006874395068734884
percentage O 0 0.007053832523524761
of O 0 0.0062400526367127895
splice O 1 0.8614819645881653
- O 1 0.9999616146087646
site O 0 0.015257366001605988
mutations O 0 0.008670230396091938
had O 0 0.0052603487856686115
no O 0 0.004785898607224226
reflection O 0 0.010955065488815308
on O 0 0.008090212941169739
the O 0 0.014502429403364658
phenotype O 0 0.3923916220664978
. O 0 0.03270983323454857

All O 0 0.019480951130390167
patients O 0 0.034841541200876236
manifested O 0 0.025668811053037643
classical O 0 0.01585843786597252
A B-Disease 1 0.9999657869338989
- I-Disease 1 1.0
T I-Disease 1 1.0
and O 0 0.009520326741039753
increased O 0 0.013473129831254482
cellular O 1 0.8638333678245544
radioresistant O 1 0.999677300453186
DNA O 0 0.029905028641223907
synthesis O 0 0.034865763038396835
. O 0 0.027784792706370354

Determination O 0 0.03544927015900612
of O 0 0.011497457511723042
the O 0 0.01067372877150774
genomic O 0 0.0178234800696373
structure O 0 0.007287587504833937
of O 0 0.004979769699275494
the O 0 0.008793128654360771
COL4A4 O 1 1.0
gene O 0 0.008603216148912907
and O 0 0.005236344877630472
of O 0 0.006781993433833122
novel O 0 0.017235280945897102
mutations O 0 0.015681788325309753
causing O 1 0.9673327207565308
autosomal B-Disease 1 1.0
recessive I-Disease 1 1.0
Alport I-Disease 1 1.0
syndrome I-Disease 1 1.0
. O 1 0.9999688863754272

Autosomal B-Disease 1 1.0
recessive I-Disease 1 1.0
Alport I-Disease 1 1.0
syndrome I-Disease 1 1.0
is O 1 0.8624467253684998
a O 1 0.9063732028007507
progressive O 1 0.9999996423721313
hematuric B-Disease 1 1.0
glomerulonephritis I-Disease 1 1.0
characterized O 1 0.9997857213020325
by O 0 0.01625290885567665
glomerular B-Disease 1 1.0
basement I-Disease 1 1.0
membrane I-Disease 1 0.9999920129776001
abnormalities I-Disease 1 0.9999469518661499
and O 0 0.006065939553081989
associated O 0 0.00599760003387928
with O 0 0.004824915435165167
mutations O 0 0.005627764388918877
in O 0 0.0032354481518268585
either O 0 0.003677121363580227
the O 0 0.006212908308953047
COL4A3 O 1 0.9999967813491821
or O 0 0.006179042160511017
the O 0 0.009362459182739258
COL4A4 O 1 0.9999998807907104
gene O 0 0.011094801127910614
, O 0 0.006102230399847031
which O 0 0.003292339388281107
encode O 0 0.009380064904689789
the O 0 0.0071924058720469475
alpha3 O 0 0.3232371509075165
and O 0 0.008614863269031048
alpha4 O 1 0.9999823570251465
type O 1 0.9999697208404541
IV O 1 1.0
collagen O 1 1.0
chains O 1 0.9998297691345215
, O 0 0.017328757792711258
respectively O 0 0.024098223075270653
. O 0 0.02200922928750515

To O 0 0.01852131448686123
date O 0 0.015536105260252953
, O 0 0.009464499540627003
mutation O 0 0.011848961003124714
screening O 0 0.011332469992339611
in O 0 0.004428375978022814
the O 0 0.005252335220575333
two O 0 0.0040630195289850235
genes O 0 0.004773042630404234
has O 0 0.004661527927964926
been O 0 0.004764483775943518
hampered O 0 0.01860414631664753
by O 0 0.0035626208409667015
the O 0 0.0050907195545732975
lack O 0 0.0071992045268416405
of O 0 0.008555453270673752
genomic O 0 0.11380960792303085
structure O 0 0.01918354630470276
information O 0 0.012807617895305157
. O 0 0.01998230256140232

We O 0 0.012573979794979095
report O 0 0.009794535115361214
here O 0 0.006525302305817604
the O 0 0.005734649021178484
complete O 0 0.008624749258160591
characterization O 0 0.013887207955121994
of O 0 0.0065020425245165825
the O 0 0.006547240540385246
48 O 0 0.011652193032205105
exons O 0 0.011692854575812817
of O 0 0.00545133464038372
the O 0 0.00824604369699955
COL4A4 O 1 1.0
gene O 0 0.008120033890008926
, O 0 0.0039167157374322414
a O 0 0.005313510075211525
comprehensive O 0 0.011048158630728722
gene O 0 0.008429381996393204
screen O 0 0.010696254670619965
, O 0 0.003965059760957956
and O 0 0.0029254353139549494
the O 0 0.003962360788136721
subsequent O 0 0.007291617337614298
detection O 0 0.011868081986904144
of O 0 0.005737739149481058
10 O 0 0.007783740293234587
novel O 0 0.008914606645703316
mutations O 0 0.005201991181820631
in O 0 0.003683629212900996
eight O 0 0.008639716543257236
patients O 1 0.9999880790710449
diagnosed O 1 1.0
with O 1 0.9748748540878296
autosomal B-Disease 1 1.0
recessive I-Disease 1 1.0
Alport I-Disease 1 1.0
syndrome I-Disease 1 1.0
. O 1 0.9999945163726807

Furthermore O 0 0.035552121698856354
, O 0 0.010508023202419281
we O 0 0.006263372953981161
identified O 0 0.007580469362437725
a O 0 0.009022807702422142
glycine O 0 0.02168361097574234
to O 0 0.009174367412924767
alanine O 0 0.032455138862133026
substitution O 0 0.01532834768295288
in O 0 0.006744408514350653
the O 0 0.010840168222784996
collagenous O 1 0.9999972581863403
domain O 0 0.012498060241341591
that O 0 0.004657616373151541
is O 0 0.005870278924703598
apparently O 0 0.008065813221037388
silent O 0 0.014189683832228184
in O 0 0.0057740784250199795
the O 0 0.009137433022260666
heterozygous O 0 0.021585967391729355
carriers O 0 0.020165838301181793
, O 0 0.008572960272431374
in O 0 0.009926244616508484
11 O 0 0.020979493856430054
. O 0 0.02287052571773529

5 O 0 0.021449627354741096
% O 0 0.007739906199276447
of O 0 0.005303841549903154
all O 0 0.0038863755762577057
control O 0 0.007206604350358248
individuals O 0 0.0027377645019441843
, O 0 0.003389370860531926
and O 0 0.0030355427879840136
in O 0 0.0031029561068862677
one O 0 0.004082368221133947
control O 0 0.0069564818404614925
individual O 0 0.005530318710952997
homozygous O 0 0.011705259792506695
for O 0 0.005578608252108097
this O 0 0.007677309215068817
glycine O 0 0.0395381860435009
substitution O 0 0.039042431861162186
. O 0 0.024610335007309914

There O 0 0.014085542410612106
has O 0 0.007838692516088486
been O 0 0.004477331414818764
no O 0 0.0037381555885076523
previous O 0 0.005437142215669155
finding O 0 0.00507585471495986
of O 0 0.004196546971797943
a O 0 0.007111061830073595
glycine O 0 0.022465471178293228
substitution O 0 0.010380983352661133
that O 0 0.003086236771196127
is O 0 0.002883703913539648
not O 0 0.002187952632084489
associated O 0 0.0031343367882072926
with O 0 0.002579889027401805
any O 0 0.0037125260569155216
obvious O 0 0.03385040909051895
phenotype O 1 0.5318929553031921
in O 0 0.010285471566021442
homozygous O 0 0.02800956927239895
individuals O 0 0.012274599634110928
. O 0 0.01929868943989277

Founder O 1 0.9999678134918213
BRCA1 O 1 0.999995231628418
and O 0 0.01893298327922821
BRCA2 O 1 0.9999558925628662
mutations O 0 0.01052428875118494
in O 0 0.005663787014782429
French O 0 0.04621252045035362
Canadian O 1 0.9997804760932922
breast B-Disease 1 1.0
and I-Disease 1 1.0
ovarian I-Disease 1 1.0
cancer I-Disease 1 1.0
families O 1 0.9988988637924194
. O 0 0.03351936489343643

We O 0 0.011578453704714775
have O 0 0.004942361731082201
identified O 0 0.006082945503294468
four O 0 0.004913060460239649
mutations O 0 0.004722872283309698
in O 0 0.0020739687606692314
each O 0 0.0017736742738634348
of O 0 0.0034468797966837883
the O 0 0.008191162720322609
breast B-Disease 1 1.0
cancer I-Disease 1 1.0
- O 1 1.0
susceptibility O 1 0.9999998807907104
genes O 0 0.013370790518820286
, O 0 0.009648185223340988
BRCA1 O 1 0.9999954700469971
and O 0 0.008826284669339657
BRCA2 O 1 0.9998680353164673
, O 0 0.004439515061676502
in O 0 0.004362951964139938
French O 0 0.01392565481364727
Canadian O 1 0.637822687625885
breast B-Disease 1 1.0
cancer I-Disease 1 1.0
and O 1 0.9999996423721313
breast B-Disease 1 1.0
/ I-Disease 1 1.0
ovarian I-Disease 1 1.0
cancer I-Disease 1 1.0
families O 1 0.66228848695755
from O 0 0.016553029417991638
Quebec O 1 0.8740347623825073
. O 0 0.0250344667583704

To O 0 0.021397056058049202
identify O 0 0.02227579429745674
founder O 1 0.9986304044723511
effects O 0 0.07636365294456482
, O 0 0.007929639890789986
we O 0 0.005430166143923998
examined O 0 0.010759208351373672
independently O 0 0.005985768511891365
ascertained O 0 0.016551213338971138
French O 0 0.02093970961868763
Canadian O 1 0.7429651021957397
cancer B-Disease 1 1.0
families O 0 0.005670743994414806
for O 0 0.00373476161621511
the O 0 0.004728025756776333
distribution O 0 0.004328907933086157
of O 0 0.0045023104175925255
these O 0 0.0036783500108867884
eight O 0 0.011756916530430317
mutations O 0 0.017694853246212006
. O 0 0.019510870799422264

Mutations O 0 0.03660016506910324
were O 0 0.0070891305804252625
found O 0 0.005990444216877222
in O 0 0.006197367329150438
41 O 0 0.01576416566967964
of O 0 0.010097065940499306
97 O 0 0.0655418187379837
families O 0 0.022386524826288223
. O 0 0.02278021164238453

Six O 0 0.01766248047351837
of O 0 0.010751997120678425
eight O 0 0.010868602432310581
mutations O 0 0.008338806219398975
were O 0 0.003284943290054798
observed O 0 0.004719856195151806
at O 0 0.007194890640676022
least O 0 0.0066469283774495125
twice O 0 0.017472803592681885
. O 0 0.01839577965438366

The O 0 0.03475772216916084
BRCA1 O 1 0.9999966621398926
C4446T O 1 0.9999892711639404
mutation O 0 0.018021633848547935
was O 0 0.008425739593803883
the O 0 0.005652326624840498
most O 0 0.004842777270823717
common O 0 0.005821353290230036
mutation O 0 0.009238672442734241
found O 0 0.0038841150235384703
, O 0 0.004033166915178299
followed O 0 0.0055749244056642056
by O 0 0.0045339916832745075
the O 0 0.012789266183972359
BRCA2 O 1 0.9999995231628418
8765delAG O 1 0.9999994039535522
mutation O 0 0.04519340768456459
. O 0 0.026671821251511574

Together O 0 0.020024657249450684
, O 0 0.010470869950950146
these O 0 0.004931057337671518
mutations O 0 0.006787456106394529
were O 0 0.0028846310451626778
found O 0 0.0029431344009935856
in O 0 0.003067031968384981
28 O 0 0.007245661690831184
of O 0 0.004712255671620369
41 O 0 0.010223639197647572
families O 0 0.004428439307957888
identified O 0 0.00413808086887002
to O 0 0.0032872017472982407
have O 0 0.0030166166834533215
a O 0 0.009617106057703495
mutation O 0 0.019485609605908394
. O 0 0.01633133925497532

The O 0 0.023111732676625252
odds O 0 0.024587580934166908
of O 0 0.008966558612883091
detection O 0 0.011890290305018425
of O 0 0.0044196476228535175
any O 0 0.003270825371146202
of O 0 0.0039979517459869385
the O 0 0.005531284026801586
four O 0 0.010723845101892948
BRCA1 O 1 0.9999957084655762
mutations O 0 0.01540318876504898
was O 0 0.015870751813054085
18 O 0 0.0233180932700634
. O 0 0.023583753034472466

7x O 1 0.9999611377716064
greater O 0 0.019764695316553116
if O 0 0.0067489901557564735
one O 0 0.004641577135771513
or O 0 0.0026566258165985346
more O 0 0.002397664822638035
cases O 0 0.004155152942985296
of O 1 0.9973243474960327
ovarian B-Disease 1 1.0
cancer I-Disease 1 1.0
were O 0 0.010072820819914341
also O 0 0.004702108912169933
present O 0 0.0047235265374183655
in O 0 0.005362500436604023
the O 0 0.008609791286289692
family O 0 0.018923453986644745
. O 0 0.019593216478824615

The O 0 0.028130628168582916
odds O 0 0.03064604289829731
of O 0 0.01125788688659668
detection O 0 0.015031032264232635
of O 0 0.006240407470613718
any O 0 0.003867910010740161
of O 0 0.005460196640342474
the O 0 0.007125927601009607
four O 0 0.012814855203032494
BRCA2 O 1 0.9999946355819702
mutations O 0 0.0182346124202013
was O 0 0.01939394883811474
5 O 0 0.02085547149181366
. O 0 0.020987721160054207

3x O 1 0.9923315048217773
greater O 0 0.016296261921525
if O 0 0.005695231258869171
there O 0 0.0026269794907420874
were O 0 0.0019488604739308357
at O 0 0.0030741216614842415
least O 0 0.001976840430870652
five O 0 0.0022990601137280464
cases O 0 0.0031929246615618467
of O 0 0.11035672575235367
breast B-Disease 1 1.0
cancer I-Disease 1 1.0
in O 0 0.3928385376930237
the O 0 0.03865811601281166
family O 0 0.023747462779283524
. O 0 0.02050650678575039

Interestingly O 0 0.04535558074712753
, O 0 0.009539851918816566
the O 0 0.00568810710683465
presence O 0 0.007110795471817255
of O 0 0.0070388722233474255
a O 0 0.05555545166134834
breast B-Disease 1 1.0
cancer I-Disease 1 1.0
case O 0 0.47169870138168335
< O 1 0.9997623562812805
36 O 0 0.01483679935336113
years O 0 0.0074018510058522224
of O 0 0.006477691698819399
age O 0 0.008129105903208256
was O 0 0.007100763265043497
strongly O 0 0.007580332458019257
predictive O 0 0.011398768983781338
of O 0 0.0044571515172719955
the O 0 0.004406034480780363
presence O 0 0.00534885935485363
of O 0 0.0042418548837304115
any O 0 0.004057940561324358
of O 0 0.006273673847317696
the O 0 0.010228201746940613
eight O 0 0.018740730360150337
mutations O 0 0.02302451618015766
screened O 0 0.04685788229107857
. O 0 0.031877659261226654

Carriers O 0 0.04183126240968704
of O 0 0.008924271911382675
the O 0 0.007310584187507629
same O 0 0.00648806057870388
mutation O 0 0.008671844378113747
, O 0 0.004152142442762852
from O 0 0.0030529783107340336
different O 0 0.0017471553292125463
families O 0 0.0037620454095304012
, O 0 0.003944271244108677
shared O 0 0.0073128859512507915
similar O 0 0.006467364262789488
haplotypes O 0 0.02536064200103283
, O 0 0.005407484248280525
indicating O 0 0.005903172772377729
that O 0 0.0026736364234238863
the O 0 0.0051147486083209515
mutant O 0 0.01878635585308075
alleles O 0 0.010786529630422592
were O 0 0.003354275831952691
likely O 0 0.004360901657491922
to O 0 0.0030725288670510054
be O 0 0.002472157357260585
identical O 0 0.004575458355247974
by O 0 0.002570727374404669
descent O 0 0.006279389839619398
for O 0 0.003620739094913006
a O 0 0.006995188072323799
mutation O 0 0.008017027750611305
in O 0 0.005333978217095137
the O 0 0.010571605525910854
founder O 1 0.9657090902328491
population O 0 0.013490919023752213
. O 0 0.023453034460544586

The O 0 0.02055111527442932
identification O 0 0.014304074458777905
of O 0 0.01079430803656578
common O 0 0.014733348973095417
BRCA1 O 1 0.9999998807907104
and O 0 0.08270273357629776
BRCA2 O 1 0.9999998807907104
mutations O 0 0.014318996109068394
will O 0 0.007461996283382177
facilitate O 0 0.014528047293424606
carrier O 0 0.23453709483146667
detection O 0 0.015399140305817127
in O 0 0.006052325014024973
French O 0 0.015110041946172714
Canadian O 0 0.23106053471565247
breast B-Disease 1 1.0
cancer I-Disease 1 1.0
and O 1 0.9999994039535522
breast B-Disease 1 1.0
/ I-Disease 1 1.0
ovarian I-Disease 1 1.0
cancer I-Disease 1 1.0
families O 1 0.9977185726165771
. O 0 0.03369279205799103

Are O 0 0.017422456294298172
Dp71 O 1 0.9948828220367432
and O 0 0.017670169472694397
Dp140 O 1 0.9999990463256836
brain O 1 0.9999175071716309
dystrophin O 1 0.999931812286377
isoforms O 0 0.02642182819545269
related O 0 0.011686806567013264
to O 0 0.011189335957169533
cognitive B-Disease 1 0.9987391829490662
impairment I-Disease 1 1.0
in O 1 0.9999983310699463
Duchenne B-Disease 1 1.0
muscular I-Disease 1 1.0
dystrophy I-Disease 1 1.0
? O 1 0.9999992847442627

Molecular O 0 0.04666841775178909
study O 0 0.0160489771515131
and O 0 0.01127563789486885
neuropsychological O 0 0.49146923422813416
analysis O 0 0.00815632939338684
were O 0 0.004141595680266619
performed O 0 0.006502014584839344
concurrently O 0 0.00996751245111227
on O 0 0.004651103634387255
49 O 0 0.015273436903953552
patients O 1 0.6690362691879272
with O 0 0.036989349871873856
Duchenne B-Disease 1 1.0
muscular I-Disease 1 1.0
dystrophy I-Disease 1 1.0
( O 1 1.0
DMD B-Disease 1 1.0
) O 0 0.010191885754466057
in O 0 0.00538058765232563
order O 0 0.005037879571318626
to O 0 0.003999296110123396
find O 0 0.005890895612537861
a O 0 0.005287383683025837
molecular O 0 0.007666679564863443
explanation O 0 0.0056639136746525764
for O 0 0.003518379060551524
the O 0 0.006843825802206993
cognitive B-Disease 1 0.9960289001464844
impairment I-Disease 1 0.9999998807907104
observed O 0 0.009383734315633774
in O 0 0.010366805829107761
most O 0 0.02746497094631195
DMD B-Disease 1 1.0
patients O 1 0.9999998807907104
. O 0 0.03647001087665558

Complete O 0 0.023104047402739525
analysis O 0 0.009363383986055851
of O 0 0.008958464488387108
the O 0 0.012101217173039913
dystrophin O 1 0.9999992847442627
gene O 0 0.012178678996860981
was O 0 0.009512784890830517
performed O 0 0.008167311549186707
to O 0 0.0049820998683571815
define O 0 0.009742183610796928
the O 0 0.00780055858194828
localization O 0 0.02118826098740101
of O 0 0.00980636291205883
deletions O 0 0.0231835525482893
and O 0 0.008871480822563171
duplications O 0 0.026237767189741135
in O 0 0.006831352133303881
relation O 0 0.008707021363079548
to O 0 0.006052536889910698
the O 0 0.008378647267818451
different O 0 0.009768827818334103
DMD B-Disease 1 1.0
promoters O 1 0.9987521171569824
. O 0 0.03485827520489693

Qualitative O 0 0.03786684200167656
analysis O 0 0.01068211067467928
of O 0 0.009187988005578518
the O 0 0.01260810811072588
Dp71 O 1 0.999332845211029
transcript O 0 0.022022392600774765
and O 0 0.006586326751857996
testing O 0 0.00824140477925539
for O 0 0.0047881947830319405
the O 0 0.005092888604849577
specific O 0 0.004550696816295385
first O 0 0.010143033228814602
exon O 0 0.03589499741792679
of O 0 0.010670999996364117
Dp140 O 1 0.9165022969245911
were O 0 0.007067759055644274
also O 0 0.008615255355834961
carried O 0 0.012904956005513668
out O 0 0.014637758955359459
. O 0 0.020524155348539352

Neuropsychological O 0 0.47133317589759827
analysis O 0 0.017194515094161034
assessed O 0 0.02090972103178501
verbal O 0 0.023500707000494003
and O 0 0.01178963202983141
visuospatial O 1 0.9999268054962158
intelligence O 0 0.014323693700134754
, O 0 0.010256594978272915
verbal O 1 0.8343276381492615
memory O 1 0.9998811483383179
, O 0 0.0106598399579525
and O 0 0.00897145364433527
reading O 0 0.025113463401794434
skills O 0 0.03605520725250244
. O 0 0.02613685466349125

Comparison O 0 0.02620139718055725
of O 0 0.014771146699786186
molecular O 0 0.02406967617571354
and O 0 0.012391163967549801
psychometric O 0 0.32430770993232727
findings O 0 0.014752963557839394
demonstrated O 0 0.01355786807835102
that O 0 0.006771345157176256
deletions O 0 0.021008282899856567
and O 0 0.008009613491594791
duplications O 0 0.022868724539875984
that O 0 0.0044683120213449
were O 0 0.0043917130678892136
localized O 0 0.011936220340430737
in O 0 0.004664872772991657
the O 0 0.0074638002552092075
distal O 1 0.9800434112548828
part O 0 0.00649094395339489
of O 0 0.0054067024029791355
the O 0 0.0067747896537184715
gene O 0 0.006171357352286577
seemed O 0 0.006596443243324757
to O 0 0.003955286927521229
be O 0 0.004136395175009966
preferentially O 0 0.0147638488560915
associated O 0 0.00704435957595706
with O 0 0.009942344389855862
cognitive B-Disease 1 0.9999798536300659
impairment I-Disease 1 1.0
. O 0 0.04168180376291275

Two O 0 0.018914902582764626
altered O 0 0.029807759448885918
Dp71 O 1 0.7089701890945435
transcripts O 0 0.01911194808781147
and O 0 0.006805977784097195
two O 0 0.006000554654747248
deleted O 0 0.022738885134458542
Dp140 O 0 0.05281650274991989
DNA O 0 0.013430788181722164
sequences O 0 0.005613218527287245
were O 0 0.002136555500328541
found O 0 0.002079649129882455
in O 0 0.0024321572855114937
four O 0 0.004325428977608681
patients O 1 0.996333122253418
with O 1 0.8074858784675598
severe O 1 1.0
cerebral B-Disease 1 1.0
dysfunction I-Disease 1 1.0
. O 1 0.9999752044677734

These O 0 0.012532427906990051
findings O 0 0.009987764991819859
suggest O 0 0.0051971375942230225
that O 0 0.0020595493260771036
some O 0 0.0024269025307148695
sequences O 0 0.003652226645499468
located O 0 0.005530111957341433
in O 0 0.003563951002433896
the O 0 0.005978935398161411
distal O 0 0.25319522619247437
part O 0 0.005595737602561712
of O 0 0.0050489939749240875
the O 0 0.006448542699217796
gene O 0 0.005635673645883799
and O 0 0.00373731623403728
, O 0 0.003990428056567907
in O 0 0.003871508641168475
particular O 0 0.004027011804282665
, O 0 0.004585106857120991
some O 0 0.005133484955877066
DMD B-Disease 1 1.0
isoforms O 0 0.013498479500412941
expressed O 0 0.006166550796478987
in O 0 0.004903432447463274
the O 0 0.019111527130007744
brain O 1 0.9999173879623413
may O 0 0.0038611837662756443
be O 0 0.0028057016897946596
related O 0 0.00367051362991333
to O 0 0.003375845495611429
the O 0 0.006881700828671455
cognitive B-Disease 1 0.9992982149124146
impairment I-Disease 1 1.0
associated O 1 0.9816474318504333
with O 1 0.9857686161994934
DMD B-Disease 1 1.0
. O 0 0.025957325473427773
. O 0 0.026363423094153404

I1307K O 1 0.999819815158844
APC O 1 0.999993085861206
and O 0 0.024174915626645088
hMLH1 O 1 0.999853253364563
mutations O 0 0.013204491697251797
in O 0 0.005212890449911356
a O 0 0.006966911721974611
non O 0 0.014256943017244339
- O 1 0.9938846230506897
Jewish O 0 0.009227313101291656
family O 0 0.006853523664176464
with O 0 0.004890789277851582
hereditary B-Disease 1 0.9999998807907104
non I-Disease 1 1.0
- I-Disease 1 1.0
polyposis I-Disease 1 1.0
colorectal I-Disease 1 1.0
cancer I-Disease 1 1.0
. O 1 0.9999059438705444

We O 0 0.015710219740867615
describe O 0 0.013342030346393585
a O 0 0.009525940753519535
French O 0 0.01647067815065384
Canadian O 0 0.01903322897851467
hereditary B-Disease 1 0.9999935626983643
non I-Disease 1 0.999985933303833
- I-Disease 1 1.0
polyposis I-Disease 1 1.0
colorectal I-Disease 1 1.0
cancer I-Disease 1 1.0
( O 1 1.0
HNPCC B-Disease 1 1.0
) O 0 0.32053327560424805
kindred O 1 0.9999725818634033
which O 0 0.008562559261918068
carries O 0 0.015240403823554516
a O 0 0.012245139107108116
novel O 0 0.027246762067079544
truncating O 1 0.7549920082092285
mutation O 0 0.02201605588197708
in O 0 0.016290660947561264
hMLH1 O 1 0.9992706179618835
. O 0 0.034076470881700516

Interestingly O 0 0.0693046972155571
, O 0 0.016445724293589592
the O 0 0.015652118250727654
I1307K O 1 0.9998624324798584
APC O 1 0.9999997615814209
polymorphism O 0 0.03588879480957985
, O 0 0.008015419356524944
associated O 0 0.004860205110162497
with O 0 0.0026727798394858837
an O 0 0.0027957188431173563
increased O 0 0.0051961420103907585
risk O 1 0.763408362865448
of O 1 0.9999959468841553
colorectal B-Disease 1 1.0
cancer I-Disease 1 1.0
, O 1 0.9999797344207764
is O 0 0.006387835834175348
also O 0 0.004711186978965998
present O 0 0.004807445220649242
in O 0 0.005938613787293434
this O 0 0.006617761682718992
family O 0 0.019330227747559547
. O 0 0.018045106902718544

The O 0 0.039435215294361115
I1307K O 1 0.9214190244674683
polymorphism O 0 0.02864825539290905
has O 0 0.008940431289374828
previously O 0 0.007393728010356426
only O 0 0.003180486150085926
been O 0 0.0031805329490453005
identified O 0 0.004002013243734837
in O 0 0.0027818770613521338
individuals O 0 0.0023368606343865395
of O 0 0.005292638670653105
self O 1 0.9985498785972595
- O 1 1.0
reported O 0 0.02229831926524639
Ashkenazi O 1 0.943224310874939
Jewish O 0 0.022083045914769173
origins O 0 0.02877548336982727
. O 0 0.024122709408402443

In O 0 0.01486129593104124
addition O 0 0.009378309361636639
, O 0 0.004996468313038349
in O 0 0.00375754083506763
this O 0 0.00284748082049191
family O 0 0.005546002648770809
, O 0 0.003350174752995372
there O 0 0.0027057076804339886
appears O 0 0.004385420586913824
to O 0 0.0029610011260956526
be O 0 0.0023555310908704996
no O 0 0.003348191734403372
relationship O 0 0.004765370395034552
between O 0 0.004366373177617788
the O 0 0.007648352067917585
I1307K O 1 0.9981145858764648
polymorphism O 0 0.016177775338292122
and O 0 0.004660344682633877
the O 0 0.004515632055699825
presence O 0 0.006401749327778816
or O 0 0.0045922440476715565
absence O 0 0.11641716212034225
of O 1 0.9905946254730225
cancer B-Disease 1 1.0
. O 0 0.019272832199931145
. O 0 0.02315695770084858

Identification O 0 0.02793160267174244
of O 0 0.011674915440380573
a O 0 0.011755624786019325
novel O 0 0.015425117686390877
mutation O 0 0.010579339228570461
of O 0 0.007340368814766407
the O 0 0.010398486629128456
CPO O 1 0.9999501705169678
gene O 0 0.010994375683367252
in O 0 0.0055240727961063385
a O 0 0.009948602877557278
Japanese O 0 0.29899829626083374
hereditary B-Disease 1 0.9999998807907104
coproporphyria I-Disease 1 0.9999995231628418
family O 0 0.05143909901380539
. O 0 0.02904508262872696

Hereditary B-Disease 1 1.0
coproporphyria I-Disease 1 1.0
( O 1 0.7971992492675781
HCP B-Disease 1 1.0
) O 0 0.008746098726987839
is O 0 0.005484910681843758
an O 0 0.006346206180751324
autosomal B-Disease 1 0.9999985694885254
dominant I-Disease 1 1.0
disease I-Disease 1 1.0
characterized O 1 0.9999804496765137
by O 0 0.005174987018108368
a O 1 0.9636861085891724
deficiency B-Disease 1 1.0
of I-Disease 1 0.9999980926513672
coproporphyrinogen I-Disease 1 1.0
oxidase I-Disease 1 1.0
( O 0 0.414044588804245
CPO O 1 0.9999994039535522
) O 0 0.010397877544164658
caused O 0 0.008316419087350368
by O 0 0.004072840791195631
a O 0 0.007183884270489216
mutation O 0 0.00945428665727377
in O 0 0.006191939581185579
the O 0 0.01188983116298914
CPO O 1 0.999993085861206
gene O 0 0.028260767459869385
. O 0 0.02178444340825081

Only O 0 0.013045012019574642
11 O 0 0.014211044646799564
mutations O 0 0.009327986277639866
of O 0 0.005436186213046312
the O 0 0.00700821727514267
gene O 0 0.006598892621695995
have O 0 0.0028974914457648993
been O 0 0.005027266219258308
reported O 0 0.009368108585476875
in O 0 0.012432347051799297
HCP B-Disease 1 1.0
patients O 1 0.9999949932098389
. O 0 0.03182467818260193

We O 0 0.014989902265369892
report O 0 0.010164023377001286
another O 0 0.011876080185174942
mutation O 0 0.0123122688382864
in O 0 0.006773718167096376
a O 0 0.012855611741542816
Japanese O 0 0.035528842359781265
family O 0 0.029868094250559807
. O 0 0.02889684960246086

Polymerase O 0 0.29939591884613037
chain O 0 0.05230823531746864
reaction O 0 0.026166964322328568
- O 1 0.9918843507766724
single O 0 0.017790868878364563
strand O 0 0.03262331709265709
conformational O 0 0.03181903436779976
polymorphism O 0 0.02061973512172699
and O 0 0.006834595929831266
direct O 0 0.009757551364600658
sequence O 0 0.007704927586019039
analyses O 0 0.011141587048768997
demonstrated O 0 0.011936001479625702
a O 0 0.010548906400799751
C O 1 0.831882119178772
to O 0 0.012668484821915627
T O 1 0.9987624883651733
substitution O 0 0.020204966887831688
in O 0 0.009487268514931202
exon O 0 0.035409994423389435
1 O 0 0.013609283603727818
of O 0 0.00809871219098568
the O 0 0.010897202417254448
CPO O 1 0.9917574524879456
gene O 0 0.014193586073815823
at O 0 0.012798589654266834
nucleotide O 0 0.014033963903784752
position O 0 0.012837446294724941
85 O 0 0.022089410573244095
, O 0 0.0071154432371258736
which O 0 0.0051159909926354885
lies O 0 0.008676707744598389
in O 0 0.004719632677733898
the O 0 0.008200535550713539
putative O 1 0.6564805507659912
presequence O 1 0.9350622296333313
for O 0 0.008601279929280281
targeting O 0 0.015368659980595112
to O 0 0.013771952129900455
mitochondria O 0 0.039755191653966904
. O 0 0.025340178981423378

This O 0 0.01647157222032547
mutation O 0 0.017456840723752975
changes O 0 0.007091491017490625
the O 0 0.007019714917987585
codon O 0 0.015439093112945557
for O 0 0.006451201159507036
glutamine O 0 0.02245999500155449
to O 0 0.006511733867228031
a O 0 0.010127179324626923
termination O 0 0.03132146596908569
codon O 0 0.027710262686014175
at O 0 0.018943222239613533
amino O 0 0.019469069316983223
acid O 0 0.02491755783557892
position O 0 0.021055227145552635
29 O 0 0.03359151631593704
. O 0 0.025024758651852608

MaeI O 1 0.9958802461624146
restriction O 0 0.024133363738656044
analysis O 0 0.009493964724242687
showed O 0 0.00725753977894783
two O 0 0.003524122992530465
other O 0 0.003556464333087206
carriers O 0 0.012080587446689606
in O 0 0.006122017744928598
the O 0 0.009881529957056046
family O 0 0.01945207081735134
. O 0 0.021029850468039513

The O 0 0.027341783046722412
C O 1 0.9999942779541016
- O 1 1.0
T O 1 1.0
mutation O 0 0.016862444579601288
is O 0 0.006554352585226297
located O 0 0.00829901173710823
within O 0 0.0044519370421767235
a O 0 0.007088282145559788
recently O 0 0.012109576724469662
proposed O 0 0.01298012025654316
putative O 0 0.0290918480604887
alternative O 0 0.011366209015250206
translation O 0 0.011313263326883316
initiation O 0 0.020016247406601906
codon O 0 0.023927051573991776
( O 0 0.012207845225930214
TIC O 1 1.0
- O 1 0.9999995231628418
1 O 0 0.01744202710688114
) O 0 0.006072881165891886
, O 0 0.0049121021293103695
supporting O 0 0.006628912407904863
that O 0 0.00520048663020134
TIC O 1 1.0
- O 1 0.9999997615814209
1 O 0 0.011835088953375816
is O 0 0.004695601295679808
the O 0 0.006901367101818323
real O 0 0.011953897774219513
TIC O 1 0.9995664954185486
rather O 0 0.005947696510702372
than O 0 0.00661831721663475
TIC O 1 1.0
- O 1 0.9999998807907104
2 O 0 0.02204618602991104
. O 0 0.011698740534484386
. O 0 0.01770961284637451

Human B-Disease 0 0.021697545424103737
complement I-Disease 0 0.04660700261592865
factor I-Disease 1 0.9954838752746582
H I-Disease 1 1.0
deficiency I-Disease 1 1.0
associated O 1 0.9990873336791992
with O 1 0.999992847442627
hemolytic B-Disease 1 1.0
uremic I-Disease 1 1.0
syndrome I-Disease 1 1.0
. O 1 0.9999958276748657

This O 0 0.010237637907266617
study O 0 0.007717291824519634
reports O 0 0.0047384221106767654
on O 0 0.003243831917643547
six O 0 0.004786234814673662
cases O 0 0.005415091756731272
of O 0 0.022928515449166298
deficiency B-Disease 1 1.0
in I-Disease 0 0.007111253682523966
the I-Disease 0 0.0060916924849152565
human I-Disease 0 0.00517901498824358
complement I-Disease 0 0.01413954608142376
regulatory I-Disease 0 0.01305096223950386
protein I-Disease 0 0.012535071931779385
Factor I-Disease 1 0.8770745992660522
H I-Disease 1 1.0
( O 0 0.017020629718899727
FH O 1 1.0
) O 0 0.005880667828023434
in O 0 0.0034257336519658566
the O 0 0.003403089474886656
context O 0 0.004449440166354179
of O 0 0.00582644110545516
an O 1 0.9990887641906738
acute B-Disease 1 1.0
renal I-Disease 1 1.0
disease I-Disease 1 1.0
. O 1 0.9999996423721313

Five O 0 0.016944460570812225
of O 0 0.009761685505509377
the O 0 0.00826230552047491
cases O 0 0.005965257529169321
were O 0 0.0030939027201384306
observed O 0 0.003642357885837555
in O 0 0.003619325580075383
children O 0 0.004648230504244566
presenting O 0 0.011454560793936253
with O 0 0.10932217538356781
idiopathic O 1 1.0
hemolytic B-Disease 1 1.0
uremic I-Disease 1 1.0
syndrome I-Disease 1 1.0
( O 1 1.0
HUS B-Disease 1 1.0
) O 1 0.983364462852478
. O 0 0.03793298825621605

Two O 0 0.010607927106320858
of O 0 0.009819780476391315
the O 0 0.009121128357946873
children O 0 0.00877063162624836
exhibited O 0 0.016134506091475487
a O 0 0.020925631746649742
homozygous O 1 0.999998927116394
deficiency O 1 1.0
characterized O 1 0.9955345392227173
by O 0 0.004756901878863573
the O 0 0.006097229663282633
absence O 0 0.007492503616958857
of O 0 0.004387313965708017
the O 0 0.005245239939540625
150 O 0 0.016451478004455566
- O 1 0.9998903274536133
kD O 1 0.9915989637374878
form O 0 0.006653467658907175
of O 0 0.008516554720699787
Factor O 1 0.9118548035621643
H O 1 1.0
and O 0 0.005325413774698973
the O 0 0.0062313443049788475
presence O 0 0.007011536508798599
, O 0 0.005452748853713274
upon O 0 0.0075747244991362095
immunoblotting O 1 0.6892658472061157
, O 0 0.0046988604590296745
of O 0 0.004962588660418987
the O 0 0.006871305871754885
42 O 0 0.02487041987478733
- O 1 0.9999879598617554
kD O 1 0.9999879598617554
Factor O 1 0.6478530764579773
H O 1 0.9999998807907104
- O 1 0.9955050349235535
like O 0 0.010886569507420063
protein O 0 0.01014851126819849
1 O 0 0.013468490913510323
( O 0 0.010647185146808624
FHL O 1 0.9999996423721313
- O 1 0.999996542930603
1 O 0 0.01533093024045229
) O 0 0.0058883740566670895
and O 0 0.004655202850699425
other O 0 0.005473010707646608
FH O 1 1.0
- O 1 0.9999994039535522
related O 0 0.016397450119256973
protein O 0 0.016159845516085625
( O 0 0.01446449663490057
FHR O 1 0.999997615814209
) O 0 0.02008182555437088
bands O 0 0.04025466740131378
. O 0 0.02834632620215416

Southern O 0 0.05218607187271118
blot O 1 0.9667527079582214
and O 0 0.013482755050063133
PCR O 0 0.028410591185092926
analysis O 0 0.007135664578527212
of O 0 0.005219843238592148
DNA O 0 0.006457686424255371
of O 0 0.004182901233434677
one O 0 0.0051584974862635136
patient O 1 0.8241717219352722
with O 0 0.00814051739871502
homozygous O 1 0.999944806098938
deficiency O 1 1.0
ruled O 1 0.5070381760597229
out O 0 0.007899506948888302
the O 0 0.0065132975578308105
presence O 0 0.005961710587143898
of O 0 0.004538560751825571
a O 0 0.005349331069737673
large O 0 0.005979881621897221
deletion O 0 0.011851160787045956
of O 0 0.006241906434297562
the O 0 0.008847856894135475
FH O 1 1.0
gene O 0 0.009689479134976864
as O 0 0.005559890065342188
the O 0 0.008440556935966015
underlying O 1 0.8007438778877258
defect O 1 0.99998939037323
for O 0 0.017997751012444496
the O 1 0.9995507597923279
deficiency O 1 1.0
. O 0 0.31919190287590027

The O 0 0.015321374870836735
other O 0 0.005878252908587456
four O 0 0.006541972979903221
children O 0 0.005760508589446545
presented O 0 0.00840702187269926
with O 0 0.006688997149467468
heterozygous O 1 0.9956508278846741
deficiency O 1 1.0
and O 0 0.09111611545085907
exhibited O 1 0.9935426712036133
a O 0 0.010335797443985939
normal O 0 0.009909518994390965
immunoblotting O 1 0.9937018156051636
pattern O 0 0.009137661196291447
of O 0 0.006869073957204819
proteins O 0 0.006553867366164923
of O 0 0.007776999846100807
the O 0 0.014224558137357235
FH O 1 1.0
family O 0 0.04746698960661888
. O 0 0.02752133086323738

Factor B-Disease 1 0.9999791383743286
H I-Disease 1 1.0
deficiency I-Disease 1 1.0
is O 0 0.007901421748101711
the O 0 0.007781673688441515
only O 0 0.008796345442533493
complement B-Disease 1 0.9999927282333374
deficiency I-Disease 1 1.0
associated O 1 0.9982374906539917
with O 1 0.9939192533493042
HUS B-Disease 1 1.0
. O 0 0.06918764114379883

These O 0 0.012373506091535091
observations O 0 0.012480628676712513
suggest O 0 0.006645228248089552
a O 0 0.0054543293081223965
role O 0 0.006632094271481037
for O 0 0.006934854667633772
FH O 1 1.0
and O 0 0.029428046196699142
/ O 1 0.9999994039535522
or O 0 0.015369036234915257
FH O 1 1.0
receptors O 0 0.015018853358924389
in O 0 0.005969763267785311
the O 0 0.008713755756616592
pathogenesis O 1 1.0
of O 1 0.9999475479125977
idiopathic O 1 1.0
HUS B-Disease 1 1.0
. O 1 0.9833155870437622
. O 0 0.034759994596242905

Further O 0 0.014228669926524162
evidence O 0 0.007197016850113869
for O 0 0.004509458784013987
a O 0 0.005745848175138235
major O 0 0.007868192158639431
ancient O 0 0.013086504302918911
mutation O 0 0.04494475945830345
underlying O 1 0.9999991655349731
myotonic B-Disease 1 1.0
dystrophy I-Disease 1 1.0
from O 1 0.9999289512634277
linkage O 1 0.999998927116394
disequilibrium O 1 0.9999997615814209
studies O 0 0.011249672621488571
in O 0 0.007374560460448265
the O 0 0.00940016657114029
Japanese O 0 0.02535727061331272
population O 0 0.010494097135961056
. O 0 0.021807175129652023

The O 0 0.12825968861579895
myotonic B-Disease 1 1.0
dystrophy I-Disease 1 1.0
( O 1 0.9999998807907104
DM B-Disease 1 1.0
) O 0 0.07637659460306168
mutation O 0 0.015558012761175632
is O 0 0.005948812700808048
an O 0 0.007125907577574253
unstable O 1 0.9991523027420044
( O 0 0.016385279595851898
CTG O 1 1.0
) O 0 0.01302229892462492
n O 0 0.019100865349173546
repeat O 0 0.0176117904484272
, O 0 0.006156786810606718
present O 0 0.00538270128890872
at O 0 0.006451536901295185
a O 0 0.00516483886167407
copy O 0 0.008361042477190495
number O 0 0.0024044355377554893
of O 0 0.0038487582933157682
5 O 0 0.008753352798521519
- O 1 0.9940589666366577
37 O 0 0.016118595376610756
repeats O 0 0.012307524681091309
on O 0 0.005760530009865761
normal O 0 0.00795651413500309
chromosomes O 0 0.010414863005280495
but O 0 0.004548995289951563
amplified O 0 0.013758938759565353
to O 0 0.005878916475921869
50 O 0 0.01471845805644989
- O 1 0.9682039618492126
3000 O 0 0.039667680859565735
copies O 0 0.015311981551349163
on O 0 0.01837102323770523
DM B-Disease 1 1.0
chromosomes O 0 0.06259216368198395
. O 0 0.03611932322382927

Previous O 0 0.02822934277355671
findings O 0 0.019469186663627625
in O 0 0.010507955215871334
Caucasian O 0 0.03214823827147484
populations O 0 0.007729256059974432
of O 0 0.008517309091985226
a O 0 0.020802626386284828
DM B-Disease 1 1.0
founder O 1 0.9999998807907104
chromosome O 0 0.03157835081219673
raise O 0 0.01244133710861206
a O 0 0.006467713974416256
question O 0 0.005597810726612806
about O 0 0.004100616555660963
the O 0 0.005420147906988859
molecular O 0 0.010196274146437645
events O 0 0.005578476004302502
involved O 0 0.004425249062478542
in O 0 0.004893042612820864
the O 0 0.007821260020136833
expansion O 0 0.02710680663585663
mutation O 0 0.028293268755078316
. O 0 0.024114150553941727

To O 0 0.015326546505093575
investigate O 0 0.01658616214990616
whether O 0 0.007340891286730766
a O 0 0.010353254154324532
founder O 0 0.1123637929558754
chromosome O 0 0.015584913082420826
for O 0 0.006299429107457399
the O 0 0.015509777702391148
DM B-Disease 1 1.0
mutation O 0 0.08104020357131958
exists O 0 0.007340379524976015
in O 0 0.004335768986493349
the O 0 0.005105477757751942
Japanese O 0 0.012565742246806622
population O 0 0.004591818433254957
, O 0 0.005383523181080818
we O 0 0.005473036784678698
genotyped O 0 0.03367931395769119
families O 0 0.00683446554467082
using O 0 0.005998043809086084
polymorphic O 0 0.029567919671535492
markers O 0 0.018440553918480873
near O 0 0.013112228363752365
the O 0 0.010413619689643383
( O 0 0.014389523304998875
CTG O 1 0.9999990463256836
) O 0 0.013147595338523388
n O 0 0.026257624849677086
repeat O 0 0.02812398597598076
region O 0 0.01916060782968998
and O 0 0.01464761607348919
constructed O 0 0.039840396493673325
haplotypes O 0 0.07454631477594376
. O 0 0.033567748963832855

Six O 0 0.01790892891585827
different O 0 0.006477599963545799
haplotypes O 0 0.020911015570163727
were O 0 0.005164280533790588
found O 0 0.0069663249887526035
and O 0 0.011702236719429493
DM B-Disease 1 1.0
alleles O 0 0.03556723892688751
were O 0 0.00948606338351965
always O 0 0.016857292503118515
haplotype O 0 0.050477534532547
A O 0 0.03165001422166824
. O 0 0.0267945546656847

To O 0 0.013918318785727024
find O 0 0.008572191931307316
an O 0 0.004364741966128349
origin O 0 0.0036243810318410397
of O 0 0.004523410927504301
the O 0 0.007010802626609802
( O 0 0.010494868271052837
CTG O 1 1.0
) O 0 0.010005807504057884
n O 0 0.02090999111533165
repeat O 0 0.021845480427145958
mutation O 0 0.01124526560306549
and O 0 0.004107145592570305
to O 0 0.0037954042199999094
investigate O 0 0.00753551023080945
the O 0 0.005252200644463301
mechanism O 0 0.006104941014200449
of O 0 0.004564531613141298
the O 0 0.004981433507055044
expansion O 0 0.011577898636460304
mutation O 0 0.007547108922153711
in O 0 0.003792799776419997
the O 0 0.005282300990074873
Japanese O 0 0.011760284192860126
population O 0 0.003018032293766737
we O 0 0.0026198404375463724
have O 0 0.0024323214311152697
studied O 0 0.008493062108755112
90 O 0 0.01283024437725544
Japanese O 0 0.03682522103190422
DM B-Disease 1 1.0
families O 0 0.018452461808919907
comprising O 0 0.022660158574581146
190 O 0 0.03323568403720856
affected O 0 0.013487651012837887
and O 0 0.0111544756218791
130 O 0 0.035468939691782
unaffected O 0 0.056945379823446274
members O 0 0.017178906127810478
. O 0 0.023339951410889626

The O 0 0.02200244925916195
results O 0 0.013588257133960724
suggest O 0 0.006632599048316479
that O 0 0.0028247637674212456
a O 0 0.004560159053653479
few O 0 0.005173519719392061
common O 0 0.005298611242324114
ancestral O 0 0.021139906719326973
mutations O 0 0.00818787980824709
in O 0 0.004574889782816172
both O 0 0.005222102161496878
Caucasian O 1 0.9997656941413879
and O 0 0.005809732712805271
Japanese O 0 0.016884326934814453
populations O 0 0.006055945996195078
have O 0 0.0028633468318730593
originated O 0 0.005424290895462036
by O 0 0.003074659500271082
expansion O 0 0.0076533155515789986
of O 0 0.004981277044862509
an O 0 0.00656543392688036
ancestral O 0 0.026171740144491196
n O 0 0.020986145362257957
= O 0 0.020236970856785774
5 O 0 0.00963214598596096
repeat O 0 0.014708111062645912
to O 0 0.0069393315352499485
n O 0 0.021763725206255913
= O 0 0.027254141867160797
19 O 0 0.024622052907943726
- O 1 0.9574103951454163
37 O 0 0.031008567661046982
copies O 0 0.02462705783545971
. O 0 0.02246636152267456

These O 0 0.011456952430307865
data O 0 0.00973413698375225
support O 0 0.012519946321845055
multistep O 0 0.032328251749277115
models O 0 0.01798625849187374
of O 0 0.012606625445187092
triplet O 1 0.978756844997406
repeat O 0 0.02871619164943695
expansion O 0 0.013621245510876179
that O 0 0.004234956577420235
have O 0 0.001978853950276971
been O 0 0.002198136644437909
proposed O 0 0.0035628844052553177
for O 0 0.004071421455591917
both O 0 0.007160541135817766
DM B-Disease 1 1.0
and O 1 0.9980459213256836
Friedreichs B-Disease 1 1.0
ataxia I-Disease 1 1.0
. O 0 0.020649489015340805
. O 0 0.027092257514595985

The O 0 0.01922224462032318
molecular O 0 0.018540093675255775
basis O 0 0.009098963811993599
of O 0 0.02708277478814125
C6 B-Disease 1 1.0
deficiency I-Disease 1 1.0
in O 0 0.01597437635064125
the O 0 0.011715215630829334
western O 0 0.016232261434197426
Cape O 1 0.973816454410553
, O 0 0.010323621332645416
South O 0 0.021999865770339966
Africa O 0 0.026654614135622978
. O 0 0.023070691153407097

Deficiency B-Disease 1 1.0
of I-Disease 0 0.012989849783480167
the I-Disease 0 0.012936136685311794
sixth I-Disease 1 0.9766932129859924
component I-Disease 0 0.02066965214908123
of I-Disease 0 0.006619329564273357
human I-Disease 0 0.0058518461883068085
complement I-Disease 0 0.18103235960006714
( O 0 0.04556380957365036
C6 O 1 1.0
) O 0 0.007074977736920118
has O 0 0.005245284177362919
been O 0 0.0035915167536586523
reported O 0 0.004379757679998875
in O 0 0.0026669518556445837
a O 0 0.0037148301489651203
number O 0 0.003011493943631649
of O 0 0.004185363184660673
families O 0 0.004113463219255209
from O 0 0.003456981386989355
the O 0 0.0056625897996127605
western O 0 0.010938880033791065
Cape O 1 0.7749264240264893
, O 0 0.011505448259413242
South O 0 0.02411479316651821
Africa O 0 0.03129854053258896
. O 0 0.0222593042999506

Meningococcal B-Disease 1 1.0
disease I-Disease 1 1.0
is O 0 0.019632523879408836
endemic O 1 0.9844598770141602
in O 0 0.006669806316494942
the O 0 0.007763026747852564
Cape O 1 0.9768244624137878
and O 0 0.003699555294588208
almost O 0 0.0031071689445525408
all O 0 0.0024495194666087627
pedigrees O 0 0.012152676470577717
of O 0 0.005314433015882969
total O 0 0.31178805232048035
C6 B-Disease 1 1.0
deficiency I-Disease 1 1.0
( O 1 0.9999935626983643
C6Q0 O 1 1.0
) O 0 0.007569385226815939
have O 0 0.003527333028614521
been O 0 0.004895913880318403
ascertained O 0 0.01541666965931654
because O 0 0.007742939051240683
of O 0 0.053678687661886215
recurrent O 1 1.0
disease O 1 1.0
. O 1 0.9576560258865356

We O 0 0.015987783670425415
have O 0 0.006864671129733324
sequenced O 0 0.016623489558696747
the O 0 0.0064821308478713036
expressed O 0 0.007513851393014193
exons O 0 0.016255652531981468
of O 0 0.007849319837987423
the O 0 0.012135663069784641
C6 O 1 1.0
gene O 0 0.011172402650117874
from O 0 0.004631414543837309
selected O 0 0.008593623526394367
cases O 0 0.004172417335212231
and O 0 0.0031868689693510532
have O 0 0.0018234988674521446
found O 0 0.002110443077981472
three O 0 0.003297447459772229
molecular O 0 0.014087052084505558
defects O 1 0.9999018907546997
leading O 0 0.09040512144565582
to O 0 0.005922191776335239
total O 0 0.4348168671131134
deficiency O 1 1.0
879delG O 1 1.0
, O 0 0.006778153590857983
which O 0 0.0038990427274256945
is O 0 0.003360702656209469
the O 0 0.005027958191931248
common O 0 0.006410760805010796
defect O 1 0.9992321729660034
in O 0 0.007034677546471357
the O 0 0.00903219636529684
Cape O 1 0.9776380658149719
and O 0 0.008075807243585587
hitherto O 0 0.027133047580718994
unreported O 0 0.017675168812274933
, O 0 0.00550325820222497
and O 0 0.006012964528053999
1195delC O 1 0.9999929666519165
and O 0 0.008332766592502594
1936delG O 1 0.9999974966049194
, O 0 0.005979366600513458
which O 0 0.003139607608318329
have O 0 0.0024133825208991766
been O 0 0.002921037608757615
previously O 0 0.004811987746506929
reported O 0 0.005097812507301569
in O 0 0.005386751610785723
African O 1 0.63571697473526
- O 1 0.9999996423721313
Americans O 0 0.02288830652832985
. O 0 0.022344298660755157

We O 0 0.015129818581044674
also O 0 0.0075735487043857574
show O 0 0.005112336948513985
that O 0 0.0028043624479323626
the O 0 0.006292638368904591
879delG O 1 0.9952173233032227
and O 0 0.011666616424918175
1195delC O 1 1.0
defects O 1 0.9999915361404419
are O 0 0.003199901431798935
associated O 0 0.005247932393103838
with O 0 0.0063184830360114574
characteristic O 1 0.9999781847000122
C6 O 1 1.0
/ O 1 1.0
C7 O 1 1.0
region O 0 0.027586663141846657
DNA O 0 0.02208460122346878
marker O 1 0.6082030534744263
haplotypes O 0 0.03563591092824936
, O 0 0.009348641149699688
although O 0 0.006849396508187056
small O 0 0.007872005924582481
variations O 0 0.009103802032768726
were O 0 0.006718681659549475
observed O 0 0.01387419831007719
. O 0 0.018336022272706032

The O 0 0.03640219569206238
1936delG O 1 0.9999997615814209
defect O 1 0.9999969005584717
was O 0 0.017893163487315178
observed O 0 0.007564719300717115
only O 0 0.00435185432434082
once O 0 0.006650612689554691
in O 0 0.004943214822560549
the O 0 0.006379217375069857
Cape O 0 0.03537502884864807
, O 0 0.004562510177493095
but O 0 0.003924472723156214
its O 0 0.0066345068626105785
associated O 0 0.009549237787723541
haplotype O 0 0.11690078675746918
could O 0 0.009310167282819748
be O 0 0.011091704480350018
deduced O 0 0.036957886070013046
. O 0 0.024067802354693413

The O 0 0.015329239889979362
data O 0 0.007106783799827099
from O 0 0.005277952644973993
the O 0 0.007531471084803343
haplotypes O 0 0.021156491711735725
indicate O 0 0.005265910178422928
that O 0 0.002331090159714222
these O 0 0.0020369766280055046
three O 0 0.003957883920520544
molecular O 0 0.014240105636417866
defects O 1 0.9982617497444153
account O 0 0.005793729797005653
for O 0 0.004568304866552353
the O 0 0.008847405202686787
defects O 1 0.9998974800109863
in O 0 0.004200601950287819
all O 0 0.004062355495989323
the O 0 0.006719598546624184
38 O 0 0.01863791234791279
unrelated O 0 0.01968720555305481
C6Q0 O 1 0.9999924898147583
individuals O 0 0.004826935473829508
we O 0 0.003704474540427327
have O 0 0.0027610519900918007
studied O 0 0.008490867912769318
from O 0 0.005924353841692209
the O 0 0.01199759729206562
Cape O 1 0.5027205944061279
. O 0 0.02404693141579628

We O 0 0.012504205107688904
have O 0 0.004827714525163174
also O 0 0.005046290345489979
observed O 0 0.005927412770688534
the O 0 0.008689185604453087
879delG O 1 0.9998961687088013
defect O 1 0.9201808571815491
in O 0 0.0076178740710020065
two O 0 0.007906939834356308
Dutch O 1 0.9998879432678223
C6 B-Disease 1 1.0
- I-Disease 1 1.0
deficient I-Disease 1 1.0
kindreds O 1 0.9957081079483032
, O 0 0.008378463797271252
but O 0 0.0046991994604468346
the O 0 0.009134731255471706
879delG O 1 0.9999960660934448
defect O 1 0.9998420476913452
in O 0 0.009653453715145588
the O 0 0.011781971901655197
Cape O 1 0.992883563041687
probably O 0 0.009525318630039692
did O 0 0.003909427672624588
not O 0 0.002435579663142562
come O 0 0.003540606936439872
from O 0 0.003932314924895763
The O 0 0.009231002070009708
Netherlands O 0 0.026470785960555077
. O 0 0.012507060542702675
. O 0 0.02008919231593609

Complement B-Disease 1 0.9999949932098389
C7 I-Disease 1 1.0
deficiency I-Disease 1 1.0
: O 0 0.01482311636209488
seven O 0 0.01103950198739767
further O 0 0.008813991211354733
molecular O 1 0.793118953704834
defects O 1 0.9999914169311523
and O 0 0.006557033397257328
their O 0 0.007570488378405571
associated O 0 0.0238639023154974
marker O 1 0.9997574687004089
haplotypes O 0 0.48092538118362427
. O 0 0.033468566834926605

Seven O 0 0.021250931546092033
further O 0 0.010460800491273403
molecular O 0 0.014403413981199265
bases O 0 0.01882392354309559
of O 1 0.8007587790489197
C7 B-Disease 1 1.0
deficiency I-Disease 1 1.0
are O 0 0.012916531413793564
described O 0 0.028479604050517082
. O 0 0.022703003138303757

All O 0 0.010518927127122879
these O 0 0.004608104005455971
new O 0 0.010037044994533062
molecular O 0 0.019570650532841682
defects O 1 0.9741414785385132
involve O 0 0.00791233591735363
single O 0 0.011899605393409729
- O 1 0.999998927116394
nucleotide O 0 0.017010828480124474
events O 0 0.007734406739473343
, O 0 0.007899499498307705
deletions O 0 0.015922587364912033
and O 0 0.005485168192535639
substitutions O 0 0.012080268934369087
, O 0 0.003816453507170081
some O 0 0.0027695256285369396
of O 0 0.004195202142000198
which O 0 0.0042447280138731
alter O 0 0.012422960251569748
splice O 0 0.027021773159503937
sites O 0 0.008546561002731323
, O 0 0.0060487352311611176
and O 0 0.007184710819274187
others O 0 0.010210513137280941
codons O 0 0.030368225648999214
. O 0 0.02023986726999283

They O 0 0.009792842902243137
are O 0 0.003637320827692747
distributed O 0 0.006360390689224005
along O 0 0.005930726416409016
the O 0 0.009134454652667046
C7 O 1 1.0
gene O 0 0.011646253056824207
, O 0 0.005590709857642651
but O 0 0.0034513152204453945
predominantly O 0 0.00515159172937274
towards O 0 0.005746049340814352
the O 0 0.0067129372619092464
3 O 0 0.01426330953836441
end O 0 0.0215844064950943
. O 0 0.024343056604266167

All O 0 0.01372435875236988
were O 0 0.007012087386101484
found O 0 0.005612390581518412
in O 0 0.009223642759025097
compound O 0 0.03760373592376709
heterozygous O 0 0.031176462769508362
individuals O 0 0.012980512343347073
. O 0 0.025951752439141273

The O 0 0.05170252546668053
C6 O 1 1.0
/ O 1 0.9999997615814209
C7 O 1 1.0
marker O 1 0.9922167062759399
haplotypes O 0 0.042431604117155075
associated O 0 0.011436281725764275
with O 0 0.007852987386286259
most O 0 0.01643501967191696
C7 B-Disease 1 1.0
defects I-Disease 1 0.9999996423721313
are O 0 0.009182607755064964
tabulated O 0 0.028369765728712082
. O 0 0.015426820144057274
. O 0 0.02004091814160347

A O 0 0.03457190841436386
genome O 0 0.03288593143224716
- O 1 0.8766056895256042
wide O 0 0.011189463548362255
search O 0 0.010662619955837727
for O 0 0.006735418923199177
chromosomal O 0 0.06418593972921371
loci O 0 0.019421283155679703
linked O 0 0.011137562803924084
to O 0 0.00756273977458477
mental O 1 1.0
health O 1 1.0
wellness O 1 1.0
in O 0 0.007902901619672775
relatives O 0 0.010381286963820457
at O 0 0.00794186256825924
high O 0 0.013885424472391605
risk O 0 0.443500816822052
for O 1 0.8745076656341553
bipolar B-Disease 1 1.0
affective I-Disease 1 1.0
disorder I-Disease 1 1.0
among O 1 0.9898166656494141
the O 0 0.4433320462703705
Old O 1 0.9824175238609314
Order O 0 0.025819526985287666
Amish O 0 0.07157173752784729
. O 0 0.030214907601475716

Bipolar B-Disease 1 1.0
affective I-Disease 1 1.0
disorder I-Disease 1 1.0
( O 1 0.9999916553497314
BPAD B-Disease 1 1.0
; O 1 0.9999860525131226
manic B-Disease 1 1.0
- I-Disease 1 1.0
depressive I-Disease 1 1.0
illness I-Disease 1 1.0
) O 1 0.7981559634208679
is O 0 0.006394068710505962
characterized O 0 0.006895068567246199
by O 0 0.003376198234036565
episodes O 0 0.007716423366218805
of O 0 0.008787594735622406
mania B-Disease 1 1.0
and O 1 0.8262200355529785
/ O 1 1.0
or O 0 0.08726265281438828
hypomania B-Disease 1 1.0
interspersed O 0 0.024524718523025513
with O 0 0.008771161548793316
periods O 0 0.01849834993481636
of O 0 0.025514254346489906
depression B-Disease 1 1.0
. O 0 0.0368780754506588

Compelling O 0 0.04722503200173378
evidence O 0 0.011971494182944298
supports O 0 0.013777049258351326
a O 0 0.007151715457439423
significant O 0 0.0076980507001280785
genetic O 0 0.010564764030277729
component O 0 0.016378523781895638
in O 0 0.0066006057895720005
the O 0 0.01031916867941618
susceptibility O 1 0.9947699904441833
to O 0 0.01510903611779213
develop O 1 0.8915804624557495
BPAD B-Disease 1 1.0
. O 0 0.04686232656240463

To O 0 0.016702715307474136
date O 0 0.013194362632930279
, O 0 0.006491621024906635
however O 0 0.0047256662510335445
, O 0 0.005803561303764582
linkage O 0 0.01408118475228548
studies O 0 0.00491102272644639
have O 0 0.0027547127101570368
attempted O 0 0.006663231644779444
only O 0 0.00265569263137877
to O 0 0.0038254717364907265
identify O 0 0.008180880919098854
chromosomal O 0 0.388458788394928
loci O 0 0.014419239945709705
that O 0 0.004043251276016235
cause O 0 0.009938825853168964
or O 0 0.0034766842145472765
increase O 0 0.004404583014547825
the O 0 0.005893872119486332
risk O 0 0.20688818395137787
of O 0 0.012320597656071186
developing O 1 0.9975117444992065
BPAD B-Disease 1 1.0
. O 0 0.034381479024887085

To O 0 0.014193139038980007
determine O 0 0.00862207543104887
whether O 0 0.0045692832209169865
there O 0 0.0035657892003655434
could O 0 0.0040060351602733135
be O 0 0.004303435795009136
protective O 1 0.9866303205490112
alleles O 0 0.012249614112079144
that O 0 0.003968798089772463
prevent O 0 0.006545947398990393
or O 0 0.004429662600159645
reduce O 0 0.007064109202474356
the O 0 0.004817944020032883
risk O 0 0.008775565773248672
of O 0 0.006089659873396158
developing O 1 0.999631404876709
BPAD B-Disease 1 1.0
, O 0 0.005179191939532757
similar O 0 0.0034934559371322393
to O 0 0.0033815037459135056
what O 0 0.002848060103133321
is O 0 0.0021137483417987823
observed O 0 0.0023922030813992023
in O 0 0.0026451097801327705
other O 0 0.0036733727902173996
genetic B-Disease 1 0.9999743700027466
disorders I-Disease 1 1.0
, O 0 0.043651092797517776
we O 0 0.004164175596088171
used O 0 0.006822661496698856
mental O 1 1.0
health O 1 1.0
wellness O 1 1.0
( O 0 0.008558658882975578
absence O 0 0.009400326758623123
of O 0 0.005322717595845461
any O 0 0.007901645265519619
psychiatric B-Disease 1 1.0
disorder I-Disease 1 1.0
) O 0 0.10581367462873459
as O 0 0.005734396632760763
the O 0 0.006839211564511061
phenotype O 0 0.027586648240685463
in O 0 0.00432044779881835
our O 0 0.006904040463268757
genome O 0 0.015087076462805271
- O 1 0.9998689889907837
wide O 0 0.014742777682840824
linkage O 0 0.024958301335573196
scan O 0 0.02374858781695366
of O 0 0.005996025167405605
several O 0 0.0049122655764222145
large O 0 0.009427160955965519
multigeneration O 1 0.9733841419219971
Old O 0 0.022872034460306168
Order O 0 0.013284058310091496
Amish O 0 0.04149823635816574
pedigrees O 0 0.03304094821214676
exhibiting O 0 0.015011962503194809
an O 0 0.0056792087852954865
extremely O 0 0.010360727086663246
high O 0 0.15748253464698792
incidence O 1 0.9999434947967529
of O 1 0.7967745065689087
BPAD B-Disease 1 1.0
. O 0 0.03569314628839493

We O 0 0.011947417631745338
have O 0 0.004502404481172562
found O 0 0.0044369990937411785
strong O 0 0.005145741626620293
evidence O 0 0.003650557715445757
for O 0 0.003747851587831974
a O 0 0.008228926919400692
locus O 0 0.045749515295028687
on O 0 0.009920665062963963
chromosome O 0 0.030923301354050636
4p O 1 0.9999998807907104
at O 0 0.022612476721405983
D4S2949 O 1 0.9422293901443481
( O 0 0.012969494797289371
maximum O 0 0.02154558151960373
GENEHUNTER O 1 0.9999880790710449
- O 1 0.999788224697113
PLUS O 0 0.03745080903172493
nonparametric O 0 0.05143963545560837
linkage O 0 0.026462078094482422
score O 0 0.01390800904482603
= O 0 0.02149519883096218
4 O 0 0.01250354666262865
. O 0 0.006498611532151699
05 O 0 0.379292368888855
, O 0 0.00941617414355278
P O 1 0.9863408803939819
= O 0 0.015710031613707542
5 O 0 0.006955698598176241
. O 0 0.0035012299194931984
22 O 0 0.0076295845210552216
x O 0 0.012603869661688805
10 O 0 0.008008386008441448
( O 0 0.00848864484578371
- O 1 0.9997838139533997
4 O 0 0.013644861057400703
) O 0 0.008508832193911076
; O 0 0.010040655732154846
SIBPAL O 1 0.9967976212501526
Pempirical O 0 0.302118718624115
value O 0 0.011356963776051998
< O 0 0.03346453979611397
3 O 0 0.011793158948421478
x O 0 0.015417232178151608
10 O 0 0.008984367363154888
( O 0 0.009334132075309753
- O 1 0.9999607801437378
5 O 0 0.013287996873259544
) O 0 0.00669190613552928
) O 0 0.0054892925545573235
and O 0 0.004528677091002464
suggestive O 0 0.011997171677649021
evidence O 0 0.003064529737457633
for O 0 0.003366732271388173
a O 0 0.006497552618384361
locus O 0 0.21983757615089417
on O 0 0.008750738576054573
chromosome O 0 0.02293623983860016
4q O 1 0.9999978542327881
at O 0 0.018705448135733604
D4S397 O 1 0.9965102076530457
( O 0 0.00868493877351284
maximum O 0 0.016929959878325462
GENEHUNTER O 1 0.9999972581863403
- O 1 0.9993368983268738
PLUS O 0 0.03363883122801781
nonparametric O 0 0.046090252697467804
linkage O 0 0.02326563373208046
score O 0 0.014997027814388275
= O 0 0.01820416748523712
3 O 0 0.010175448842346668
. O 0 0.004601296037435532
29 O 0 0.010257331654429436
, O 0 0.00769383367151022
P O 1 0.9347802996635437
= O 0 0.01614391803741455
2 O 0 0.00800645537674427
. O 0 0.003704756498336792
57 O 0 0.01226634718477726
x O 0 0.012853560969233513
10 O 0 0.007315936032682657
( O 0 0.0073421411216259
- O 1 0.9994655251502991
3 O 0 0.01311315968632698
) O 0 0.007046215236186981
; O 0 0.009300838224589825
SIBPAL O 1 0.9946664571762085
Pempirical O 0 0.38521653413772583
value O 0 0.011485491879284382
< O 0 0.03959677368402481
1 O 0 0.014180134981870651
x O 0 0.015011101961135864
10 O 0 0.008254357613623142
( O 0 0.008350660093128681
- O 1 0.9999836683273315
3 O 0 0.01385550294071436
) O 0 0.0059805624186992645
) O 0 0.003687485121190548
that O 0 0.0022287818137556314
are O 0 0.0020132812205702066
linked O 0 0.00794006697833538
to O 0 0.008605395443737507
mental O 1 1.0
health O 1 1.0
wellness O 1 1.0
. O 1 0.6764523386955261

These O 0 0.009617561474442482
findings O 0 0.009946237318217754
are O 0 0.002375692594796419
consistent O 0 0.005271068308502436
with O 0 0.0034320394042879343
the O 0 0.005343650933355093
hypothesis O 0 0.007472920697182417
that O 0 0.002446468686684966
certain O 0 0.0033818187657743692
alleles O 0 0.00823589600622654
could O 0 0.0036793199833482504
prevent O 0 0.005608150735497475
or O 0 0.00339727895334363
modify O 0 0.009615898132324219
the O 0 0.006082432344555855
clinical O 1 0.999870777130127
manifestations O 1 0.999932050704956
of O 1 0.9970857501029968
BPAD B-Disease 1 1.0
and O 0 0.009021639823913574
perhaps O 0 0.01007738709449768
other O 0 0.006972489878535271
related O 1 0.9720170497894287
affective B-Disease 1 1.0
disorders I-Disease 1 1.0
. O 1 0.9840563535690308

Segregation O 1 0.9977483153343201
distortion O 1 0.9994205236434937
in O 1 0.8960061073303223
myotonic B-Disease 1 1.0
dystrophy I-Disease 1 1.0
. O 1 0.9774232506752014

Myotonic B-Disease 1 1.0
dystrophy I-Disease 1 1.0
( O 1 0.9999992847442627
DM B-Disease 1 1.0
) O 0 0.012235475704073906
is O 0 0.0052092247642576694
an O 0 0.005476356949657202
autosomal B-Disease 1 0.9999985694885254
dominant I-Disease 1 1.0
disease I-Disease 1 1.0
which O 0 0.006642580963671207
, O 0 0.00446378393098712
in O 0 0.004194646142423153
the O 0 0.006614865735173225
typical O 0 0.014426209032535553
pedigree O 0 0.038400039076805115
, O 0 0.005315521731972694
shows O 0 0.0050234184600412846
a O 0 0.006798992399126291
three O 0 0.007562275044620037
generation O 0 0.05164814740419388
anticipation O 0 0.2938436269760132
cascade O 1 0.9330391883850098
. O 0 0.036482129245996475

This O 0 0.009444366209208965
results O 0 0.010539453476667404
in O 0 0.009000834077596664
infertility B-Disease 1 1.0
and O 1 0.9999890327453613
congenital B-Disease 1 1.0
myotonic I-Disease 1 1.0
dystrophy I-Disease 1 1.0
( O 1 1.0
CDM B-Disease 1 1.0
) O 0 0.008513950742781162
with O 0 0.004684976767748594
the O 0 0.00566904479637742
disappearance O 0 0.013941314071416855
of O 0 0.01438130158931017
DM B-Disease 1 1.0
in O 0 0.014694261364638805
that O 0 0.011771843768656254
pedigree O 0 0.06077311560511589
. O 0 0.02680688537657261

The O 0 0.017579443752765656
concept O 0 0.01614474318921566
of O 0 0.013369619846343994
segregation O 1 0.999250590801239
distortion O 1 0.9996473789215088
, O 0 0.008436838164925575
where O 0 0.0058709909208118916
there O 0 0.0035930222366005182
is O 0 0.0048951655626297
preferential O 0 0.013268486596643925
transmission O 0 0.009497260674834251
of O 0 0.005163486581295729
the O 0 0.005254353396594524
larger O 0 0.007593042217195034
allele O 0 0.011417224071919918
at O 0 0.00782187469303608
the O 0 0.011639447882771492
DM B-Disease 1 1.0
locus O 1 0.9999984502792358
, O 0 0.008784886449575424
has O 0 0.005729341879487038
been O 0 0.004621730651706457
put O 0 0.007449267897754908
forward O 0 0.006805635988712311
to O 0 0.005334729794412851
explain O 0 0.009385676123201847
partially O 0 0.012346946634352207
the O 0 0.0075654322281479836
maintenance O 1 0.6940092444419861
of O 0 0.25025516748428345
DM B-Disease 1 1.0
in O 0 0.013965200632810593
the O 0 0.011814294382929802
population O 0 0.011477464810013771
. O 0 0.02009507827460766

In O 0 0.01569342240691185
a O 0 0.012589073739945889
survey O 0 0.014948250725865364
of O 0 0.01188662089407444
DM B-Disease 1 1.0
in O 0 0.013542922213673592
Northern O 0 0.015941167250275612
Ireland O 0 0.01677071489393711
, O 0 0.011364429257810116
59 O 0 0.032347194850444794
pedigrees O 0 0.03909428417682648
were O 0 0.01326641347259283
ascertained O 0 0.051300279796123505
. O 0 0.02928330935537815

Sibships O 1 0.9489636421203613
where O 0 0.01302376203238964
the O 0 0.0077885729260742664
status O 0 0.006888450589030981
of O 0 0.004259959328919649
all O 0 0.0033350042067468166
the O 0 0.003935939632356167
members O 0 0.0032402663491666317
had O 0 0.004467986058443785
been O 0 0.0036162089090794325
identified O 0 0.003894012188538909
were O 0 0.0025208010338246822
examined O 0 0.005874119233340025
to O 0 0.0028471045661717653
determine O 0 0.0034412515815347433
the O 0 0.003907155245542526
transmission O 0 0.0073838867247104645
of O 0 0.0053330776281654835
the O 0 0.013824289664626122
DM B-Disease 1 1.0
expansion O 1 0.6445522308349609
from O 0 0.008355233818292618
affected O 0 0.00977682787925005
parents O 0 0.007879707030951977
to O 0 0.0064462702721357346
their O 0 0.00884958729147911
offspring O 0 0.02881690301001072
. O 0 0.022665243595838547

Where O 0 0.020178627222776413
the O 0 0.016163401305675507
transmitting O 0 0.04325559362769127
parent O 0 0.03910689800977707
was O 0 0.018472887575626373
male O 0 0.01972651295363903
, O 0 0.01351910550147295
58 O 0 0.039723951369524
. O 0 0.02613891288638115

3 O 0 0.02791181392967701
% O 0 0.009519863873720169
of O 0 0.00623681815341115
the O 0 0.006465618964284658
offspring O 0 0.01239125058054924
were O 0 0.004293761681765318
affected O 0 0.005771443247795105
, O 0 0.003276214934885502
and O 0 0.0027614536229521036
in O 0 0.0026674845721572638
the O 0 0.003856832394376397
case O 0 0.004838199820369482
of O 0 0.004117389675229788
a O 0 0.007951012812554836
female O 0 0.015938295051455498
transmitting O 1 0.5354409217834473
parent O 0 0.053631823509931564
, O 0 0.01525940839201212
68 O 0 0.044446639716625214
. O 0 0.024467237293720245

7 O 0 0.04710734263062477
% O 0 0.021451137959957123
were O 0 0.014196422882378101
affected O 0 0.03005632571876049
. O 0 0.028175409883260727

Studies O 0 0.021082932129502296
on O 0 0.01538299024105072
meiotic O 1 0.9918811917304993
drive O 0 0.025709591805934906
in O 0 0.014253571629524231
DM B-Disease 1 1.0
have O 0 0.006764942780137062
shown O 0 0.00687262462452054
increased O 0 0.00617940491065383
transmission O 0 0.00894908793270588
of O 0 0.004353359807282686
the O 0 0.006142803467810154
larger O 0 0.008073749020695686
allele O 0 0.013302934356033802
at O 0 0.008787186816334724
the O 0 0.01111548487097025
DM B-Disease 1 1.0
locus O 1 0.9977309107780457
in O 0 0.012763718143105507
non O 1 0.9393638968467712
- O 1 1.0
DM O 1 1.0
heterozygotes O 1 0.9995741248130798
for O 0 0.0325978547334671
CTGn O 1 0.999565064907074
. O 0 0.03748637065291405

This O 0 0.012047762051224709
study O 0 0.009515372104942799
provides O 0 0.008329017087817192
further O 0 0.005094493273645639
evidence O 0 0.0041786194778978825
that O 0 0.003318962175399065
the O 0 0.008990899659693241
DM B-Disease 1 1.0
expansion O 1 0.707254946231842
tends O 0 0.024069800972938538
to O 0 0.012363586574792862
be O 0 0.011288441717624664
transmitted O 0 0.031517453491687775
preferentially O 0 0.04863763600587845
. O 0 0.025769751518964767

Diagnosis O 1 0.9999997615814209
of O 1 0.9671364426612854
hemochromatosis B-Disease 1 1.0
. O 0 0.08264579623937607

If O 0 0.028027230873703957
untreated O 1 0.9999982118606567
, O 0 0.3548210561275482
hemochromatosis B-Disease 1 1.0
can O 0 0.10711356997489929
cause O 1 0.9999982118606567
serious O 1 1.0
illness O 1 1.0
and O 1 0.9878445267677307
early B-Disease 1 0.905389130115509
death I-Disease 1 0.9173458814620972
, O 0 0.003624019445851445
but O 0 0.003135275561362505
the O 0 0.007227102294564247
disease O 1 1.0
is O 0 0.004617494996637106
still O 0 0.005205471999943256
substantially O 0 0.01337351929396391
under O 1 0.9519223570823669
- O 1 1.0
diagnosed O 1 1.0
. O 0 0.03166389837861061

The O 0 0.030789220705628395
cornerstone O 1 0.9906676411628723
of O 0 0.014776714146137238
screening O 0 0.02361666038632393
and O 0 0.008555196225643158
case O 0 0.01108324434608221
detection O 0 0.013079890981316566
is O 0 0.004529336933046579
the O 0 0.005790984723716974
measurement O 0 0.013116455636918545
of O 0 0.010999738238751888
serum O 1 0.9999964237213135
transferrin O 1 0.9999986886978149
saturation O 1 0.980320930480957
and O 0 0.014107199385762215
the O 0 0.02399042807519436
serum O 1 0.9999912977218628
ferritin O 1 0.9999932050704956
level O 0 0.04035620391368866
. O 0 0.030285339802503586

Once O 0 0.026293005794286728
the O 0 0.0159783773124218
diagnosis O 1 0.9999709129333496
is O 0 0.007322719320654869
suspected O 0 0.011072170920670033
, O 0 0.006699333433061838
physicians O 0 0.07164366543292999
must O 0 0.006573590449988842
use O 0 0.009624894708395004
serum O 1 0.9999936819076538
ferritin O 1 0.9999972581863403
levels O 0 0.01563240960240364
and O 0 0.01406091544777155
hepatic O 1 1.0
iron O 1 0.9999997615814209
stores O 0 0.029852446168661118
on O 0 0.013025766238570213
liver O 1 1.0
biopsy O 1 0.9999657869338989
specimens O 0 0.012271935120224953
to O 0 0.007379414048045874
assess O 0 0.01628868095576763
patients O 0 0.011089774779975414
for O 0 0.00398534070700407
the O 0 0.0059976535849273205
presence O 0 0.010200615972280502
of O 0 0.05910792946815491
iron B-Disease 1 1.0
overload I-Disease 1 1.0
. O 0 0.035294800996780396

Liver O 1 1.0
biopsy O 1 0.9999998807907104
is O 0 0.010494931600987911
also O 0 0.00602865731343627
used O 0 0.003520405851304531
to O 0 0.0036257589235901833
establish O 0 0.0065549211576581
the O 0 0.004655763972550631
presence O 0 0.00583291333168745
or O 0 0.003653047140687704
absence O 0 0.007779557723551989
of O 0 0.2400301992893219
cirrhosis B-Disease 1 1.0
, O 1 0.5023291110992432
which O 0 0.004436738323420286
can O 0 0.004305307287722826
affect O 0 0.011410865001380444
prognosis O 1 1.0
and O 0 0.020340751856565475
management O 1 0.9897956252098083
. O 0 0.027886144816875458

A O 0 0.03200483322143555
DNA O 0 0.023418428376317024
- O 0 0.35541725158691406
based O 0 0.008099391125142574
test O 0 0.008846674114465714
for O 0 0.005444162525236607
the O 0 0.010489486157894135
HFE O 1 1.0
gene O 0 0.0111538702622056
is O 0 0.0053914389573037624
commercially O 0 0.010686364956200123
available O 0 0.005180000327527523
, O 0 0.003509636502712965
but O 0 0.0023837978951632977
its O 0 0.003315900219604373
place O 0 0.0037065381184220314
in O 0 0.0028142286464571953
the O 0 0.005360772833228111
diagnosis O 1 0.9999995231628418
of O 1 0.9987006187438965
hemochromatosis B-Disease 1 1.0
is O 1 0.752170741558075
still O 0 0.011936540715396404
being O 0 0.011570772156119347
evaluated O 0 0.03301795572042465
. O 0 0.025516513735055923

Currently O 0 0.027772603556513786
, O 0 0.008921092376112938
the O 0 0.006607269402593374
most O 0 0.004316449631005526
useful O 0 0.006401961203664541
role O 0 0.004895388148725033
for O 0 0.0029196173418313265
this O 0 0.002649700501933694
test O 0 0.0056916167959570885
is O 0 0.0026519165839999914
in O 0 0.0025319852866232395
the O 0 0.004245792515575886
detection O 0 0.011687085963785648
of O 0 0.010683920234441757
hemochromatosis B-Disease 1 1.0
in O 0 0.006501807831227779
the O 0 0.006245051976293325
family O 0 0.006645461078733206
members O 0 0.003408560063689947
of O 0 0.004924199543893337
patients O 1 0.907811164855957
with O 0 0.0036069827619940042
a O 0 0.00675297761335969
proven O 0 0.013066872954368591
case O 0 0.006604746449738741
of O 0 0.008126736618578434
the O 0 0.31326764822006226
disease O 1 1.0
. O 0 0.02952101081609726

It O 0 0.013289798982441425
is O 0 0.007025154307484627
crucial O 0 0.013097071088850498
to O 0 0.011419657617807388
diagnose O 1 1.0
hemochromatosis B-Disease 1 1.0
before O 1 0.9999984502792358
hepatic B-Disease 1 1.0
cirrhosis I-Disease 1 1.0
develops O 1 1.0
because O 1 0.9741916060447693
phlebotomy O 1 1.0
therapy O 1 0.9999996423721313
can O 0 0.0064638592302799225
avert O 1 1.0
serious O 1 1.0
chronic O 1 1.0
disease O 1 1.0
and O 1 0.9999982118606567
can O 0 0.005490547511726618
even O 0 0.0044435421004891396
lead O 0 0.005603794474154711
to O 0 0.0056014107540249825
normal O 0 0.009549287147819996
life O 0 0.01588333025574684
expectancy O 0 0.27795934677124023
. O 0 0.013790084049105644
. O 0 0.020712658762931824

Prevalence O 0 0.20672369003295898
of O 0 0.014472533948719501
the O 0 0.0179717019200325
I1307K O 1 0.9999942779541016
APC B-Disease 1 0.9999997615814209
gene O 0 0.016856571659445763
variant O 0 0.014179815538227558
in O 0 0.00534300971776247
Israeli O 0 0.00858900137245655
Jews O 0 0.006679654121398926
of O 0 0.00422443263232708
differing O 0 0.004363967105746269
ethnic O 0 0.004004811868071556
origin O 0 0.0038387710228562355
and O 0 0.00453585758805275
risk O 1 0.9989650249481201
for O 1 0.9999719858169556
colorectal B-Disease 1 1.0
cancer I-Disease 1 1.0
. O 1 0.9996205568313599

BACKGROUND O 0 0.06236125901341438
& O 1 0.5095541477203369
AIMS O 0 0.03436886519193649
Israeli O 0 0.012833229266107082
Jews O 0 0.008410844951868057
of O 0 0.0054780589416623116
European O 0 0.008508292958140373
birth O 0 0.13771934807300568
, O 0 0.006318189203739166
i O 0 0.009040385484695435
. O 0 0.005699093919247389
e O 0 0.01278388500213623
. O 0 0.004826023709028959
, O 0 0.0067869992926716805
Ashkenazim O 0 0.024489033967256546
, O 0 0.0033015685621649027
have O 0 0.002112586982548237
the O 0 0.006004392169415951
highest O 1 0.999998927116394
colorectal B-Disease 1 1.0
cancer I-Disease 1 1.0
incidence O 1 1.0
of O 0 0.29336220026016235
any O 0 0.006293443497270346
Israeli O 0 0.011156989261507988
ethnic O 0 0.01325578149408102
group O 0 0.021613284945487976
. O 0 0.018717734143137932

The O 0 0.03641363978385925
I1307K O 1 0.9995529055595398
APC B-Disease 1 0.9999988079071045
gene O 0 0.025254124775528908
variant O 0 0.025739485397934914
was O 0 0.012983554042875767
found O 0 0.00689661642536521
in O 0 0.009199976921081543
6 O 0 0.025542771443724632
. O 0 0.021668964996933937

1 O 0 0.025501864030957222
% O 0 0.009603699669241905
of O 0 0.006815957371145487
American O 0 0.009816224686801434
Jews O 0 0.008393286727368832
, O 0 0.0049498435109853745
28 O 0 0.008183558471500874
% O 0 0.003801802173256874
of O 0 0.004472397267818451
their O 0 0.006540218368172646
familial O 1 1.0
colorectal B-Disease 1 1.0
cancer I-Disease 1 1.0
cases O 1 0.9999997615814209
, O 0 0.07134737819433212
but O 0 0.0030288109555840492
not O 0 0.002586020389571786
in O 0 0.004808025434613228
non O 0 0.016792189329862595
- O 1 0.9999897480010986
Jews O 0 0.026957670226693153
. O 0 0.023867253214120865

We O 0 0.017168644815683365
assessed O 0 0.020371587947010994
the O 0 0.016447866335511208
I1307K O 1 0.9989327788352966
prevalence O 1 0.8449210524559021
in O 0 0.007227752823382616
Israeli O 0 0.010639919899404049
Jews O 0 0.008887991309165955
of O 0 0.004951445385813713
differing O 0 0.00550925312563777
ethnic O 0 0.004600038751959801
origin O 0 0.004947251174598932
and O 0 0.005013430491089821
risk O 1 0.9885590076446533
for O 1 0.999969482421875
colorectal B-Disease 1 1.0
cancer I-Disease 1 1.0
. O 1 0.9998807907104492

METHODS O 0 0.026868171989917755
DNA O 0 0.01602356880903244
samples O 0 0.010347549803555012
from O 0 0.006020270753651857
500 O 0 0.013596126809716225
unrelated O 0 0.009479103609919548
Jews O 0 0.0061783683486282825
of O 0 0.004496213514357805
European O 0 0.006514393258839846
or O 0 0.004734235815703869
non O 0 0.016346031799912453
- O 1 0.9998689889907837
European O 0 0.007968731224536896
origin O 0 0.004327448550611734
, O 0 0.004023300018161535
with O 0 0.0029245505575090647
or O 0 0.00270293396897614
without O 0 0.0027126146014779806
a O 0 0.0043367124162614346
personal O 0 0.016974588856101036
and O 0 0.006148587446659803
/ O 1 0.9999550580978394
or O 0 0.004560427740216255
family O 0 0.006281550507992506
history O 0 0.008447582833468914
of O 0 0.010611440986394882
neoplasia B-Disease 1 1.0
, O 0 0.00707694748416543
were O 0 0.0041466159746050835
examined O 0 0.008981956169009209
for O 0 0.0043617133051157
the O 0 0.007935905829071999
I1307K O 1 0.9754226207733154
variant O 0 0.01558873150497675
by O 0 0.004381870850920677
the O 0 0.0062166801653802395
allele O 0 0.01946146972477436
- O 1 0.9645763635635376
specific O 0 0.009188292548060417
oligonucleotide O 1 0.8312261700630188
( O 0 0.018560491502285004
ASO O 1 1.0
) O 0 0.019708549603819847
method O 0 0.022032037377357483
. O 0 0.025063524022698402

RESULTS O 0 0.02283104695379734
In O 0 0.007802496198564768
persons O 0 0.005091968923807144
at O 0 0.006913810037076473
average O 0 0.007548833731561899
risk O 0 0.012807497754693031
for O 1 0.7900911569595337
colorectal B-Disease 1 1.0
cancer I-Disease 1 1.0
, O 1 0.9999948740005493
I1307K O 1 1.0
was O 0 0.11814970523118973
found O 0 0.006219256203621626
in O 0 0.008375744335353374
5 O 0 0.019767150282859802
. O 0 0.01946306601166725

0 O 0 0.036225575953722
% O 0 0.010120346210896969
of O 0 0.00787376333028078
120 O 0 0.01665889285504818
European O 0 0.013288771733641624
and O 0 0.00983466487377882
1 O 0 0.022285310551524162
. O 0 0.020484894514083862

6 O 0 0.03505124896764755
% O 0 0.011079513467848301
of O 0 0.00891569722443819
188 O 0 0.027343647554516792
non O 0 0.018612192943692207
- O 1 0.9103516340255737
European O 0 0.010254339314997196
Jews O 0 0.01230885274708271
( O 0 0.011656878516077995
P O 1 0.9882794618606567
= O 0 0.033633872866630554
0 O 0 0.026139674708247185
. O 0 0.014005521312355995
08 O 1 0.7214788794517517
) O 0 0.01893141306936741
. O 0 0.026466095820069313

It O 0 0.019975516945123672
occurred O 0 0.01856846734881401
in O 0 0.011943011544644833
15 O 0 0.02601044438779354
. O 0 0.024706175550818443

4 O 0 0.028389841318130493
% O 0 0.010425183922052383
of O 0 0.008476468734443188
52 O 0 0.019187211990356445
Ashkenazi O 0 0.0292909387499094
Israelis O 0 0.010057627223432064
with O 0 0.007630357518792152
familial O 1 1.0
cancer B-Disease 1 1.0
( O 1 0.925621747970581
P O 1 0.9999992847442627
= O 0 0.04127931594848633
0 O 0 0.013880412094295025
. O 0 0.007182510104030371
02 O 1 0.9999995231628418
) O 0 0.006610099226236343
and O 0 0.004316497594118118
was O 0 0.005339856259524822
not O 0 0.0026412406004965305
detected O 0 0.0056218490935862064
in O 0 0.0037454189732670784
51 O 0 0.013970429077744484
non O 0 0.00922077614814043
- O 1 0.7964069247245789
European O 0 0.00602387310937047
Jews O 0 0.007596218958497047
at O 0 0.009924360550940037
increased O 0 0.48673269152641296
cancer B-Disease 1 1.0
risk O 1 0.9999988079071045
. O 0 0.026265254244208336

Colorectal B-Disease 1 1.0
neoplasia I-Disease 1 1.0
occurred O 0 0.1626410335302353
personally O 1 0.9484535455703735
or O 0 0.005857185926288366
in O 0 0.004964971914887428
the O 0 0.004753737710416317
families O 0 0.0035298175644129515
of O 0 0.0037944158539175987
13 O 0 0.006037896499037743
of O 0 0.005163819529116154
20 O 0 0.010370456613600254
Ashkenazi O 1 0.97747403383255
I1307K O 1 0.9996234178543091
carriers O 0 0.02579253539443016
, O 0 0.005453129298985004
8 O 0 0.006971149239689112
of O 0 0.004709737841039896
whom O 0 0.0060298084281384945
also O 0 0.0045876516960561275
had O 0 0.004910492338240147
a O 0 0.0059697916731238365
personal O 0 0.01113569363951683
or O 0 0.005703127011656761
family O 0 0.010497285053133965
history O 0 0.014112398959696293
of O 0 0.019581250846385956
noncolonic O 1 0.9999998807907104
neoplasia B-Disease 1 1.0
. O 0 0.046863339841365814

CONCLUSIONS O 0 0.03474121540784836
The O 0 0.024232592433691025
I1307K O 1 0.9999972581863403
APC O 1 0.9999998807907104
variant O 0 0.10670188814401627
may O 0 0.006504088640213013
represent O 0 0.006297217216342688
a O 0 0.007583956699818373
susceptibility O 1 0.7406609654426575
gene O 0 0.008291017264127731
for O 0 0.00858362577855587
colorectal B-Disease 1 1.0
, I-Disease 0 0.007157724350690842
or I-Disease 0 0.004518033470958471
other I-Disease 0 0.0033197037409991026
, I-Disease 0 0.007333354093134403
cancers I-Disease 1 0.9999912977218628
in O 0 0.007136730942875147
Ashkenazi O 1 0.9999731779098511
Jews O 0 0.01076439954340458
, O 0 0.006703603081405163
and O 0 0.005878448020666838
partially O 0 0.012235846370458603
explains O 0 0.007283072918653488
the O 0 0.004078314173966646
higher O 0 0.006822248455137014
incidence O 1 0.9999833106994629
of O 1 0.9999972581863403
colorectal B-Disease 1 1.0
cancer I-Disease 1 1.0
in O 1 0.9737744331359863
European O 0 0.027911994606256485
Israelis O 0 0.02302296832203865
. O 0 0.02314753830432892

Systematic O 0 0.03217535465955734
analysis O 0 0.013439946807920933
of O 0 0.015973782166838646
coproporphyrinogen O 1 0.9999967813491821
oxidase O 1 0.9998980760574341
gene O 0 0.02551885135471821
defects O 1 0.9999278783798218
in O 0 0.013364141806960106
hereditary B-Disease 1 1.0
coproporphyria I-Disease 1 1.0
and O 0 0.32894909381866455
mutation O 0 0.04989496245980263
update O 0 0.4639001488685608
. O 0 0.02699252963066101

Hereditary B-Disease 1 1.0
coproporphyria I-Disease 1 0.9999998807907104
( O 1 0.6118693947792053
HC B-Disease 1 1.0
) O 0 0.0113592017441988
is O 0 0.007705915253609419
an O 0 0.012184074148535728
acute O 1 1.0
hepatic B-Disease 1 1.0
porphyria I-Disease 1 1.0
with O 1 0.999954104423523
autosomal O 1 1.0
dominant O 1 1.0
inheritance O 1 0.9999998807907104
caused O 1 0.9999450445175171
by O 0 0.007364361546933651
deficient B-Disease 1 0.9999865293502808
activity I-Disease 0 0.00838432926684618
of I-Disease 0 0.011534378863871098
coproporphyrinogen I-Disease 1 0.9999998807907104
III I-Disease 1 1.0
oxidase I-Disease 1 0.9999880790710449
( O 0 0.03296934440732002
CPO O 1 0.9998725652694702
) O 0 0.028976954519748688
. O 0 0.029238810762763023

Clinical O 1 0.9959316849708557
manifestations O 1 0.9342476725578308
of O 0 0.03144776448607445
the O 1 0.9875023365020752
disease O 1 1.0
are O 0 0.003437196835875511
characterized O 0 0.13601380586624146
by O 0 0.005566416308283806
acute O 1 1.0
attacks O 1 0.9997674822807312
of O 1 1.0
neurological B-Disease 1 1.0
dysfunction I-Disease 1 1.0
often O 1 0.99946528673172
precipitated O 1 1.0
by O 0 0.007329829037189484
drugs O 1 0.96190345287323
, O 0 0.007037112955003977
fasting O 0 0.019268659874796867
, O 0 0.010539697483181953
cyclical O 1 0.9999938011169434
hormonal O 1 0.999992847442627
changes O 0 0.008432707749307156
, O 0 0.012133055366575718
or O 1 0.9742634296417236
infectious B-Disease 1 1.0
diseases I-Disease 1 1.0
. O 1 0.9994363188743591

Skin O 1 1.0
photosensitivity O 1 1.0
may O 0 0.1693074107170105
also O 0 0.010229803621768951
be O 0 0.0071036419831216335
present O 0 0.013702372089028358
. O 0 0.021143915131688118

The O 0 0.02333708293735981
seven O 0 0.018809674307703972
exons O 0 0.02837011218070984
, O 0 0.009514329954981804
the O 0 0.012353274039924145
exon O 1 0.9816966652870178
/ O 1 0.9996613264083862
intron O 1 0.9983830451965332
boundaries O 0 0.012437435798346996
and O 0 0.005920075345784426
part O 0 0.007812303025275469
of O 0 0.008070530369877815
3 O 0 0.013339003548026085
noncoding O 0 0.03013746440410614
sequence O 0 0.00803530402481556
of O 0 0.008019034750759602
the O 0 0.011984405107796192
CPO O 1 0.9994514584541321
gene O 0 0.013017842546105385
were O 0 0.005029227584600449
systematically O 0 0.012149745598435402
analyzed O 0 0.009161467663943768
by O 0 0.0038877511397004128
an O 0 0.007092384155839682
exon O 0 0.12079199403524399
- O 1 0.9892882108688354
by O 0 0.010183028876781464
- O 1 0.9992625117301941
exon O 0 0.26534339785575867
denaturing O 1 0.9980140924453735
gradient O 0 0.3680087625980377
gel O 1 0.9999819993972778
electrophoresis O 1 0.9979380965232849
( O 0 0.020576683804392815
DGGE O 1 0.9999996423721313
) O 0 0.011056548915803432
strategy O 0 0.01556179765611887
followed O 0 0.008462706580758095
by O 0 0.004223513882607222
direct O 0 0.006662493571639061
sequencing O 0 0.011617877520620823
in O 0 0.0054951938800513744
seven O 0 0.009038582444190979
unrelated O 0 0.019335603341460228
heterozygous O 0 0.0336705707013607
HC B-Disease 1 1.0
patients O 1 0.9996134638786316
from O 0 0.008694678544998169
France O 0 0.1099170669913292
, O 0 0.00851765088737011
Holland O 0 0.3296893835067749
, O 0 0.006924904882907867
and O 0 0.007796967402100563
Czech O 1 0.859168529510498
Republic O 0 0.036938976496458054
. O 0 0.020765280351042747

Seven O 0 0.03041771799325943
novel O 0 0.030131248757243156
mutations O 0 0.013653400354087353
and O 0 0.005369350779801607
two O 0 0.0050105927512049675
new O 0 0.011267874389886856
polymorphisms O 0 0.021754425019025803
were O 0 0.008570404723286629
detected O 0 0.02228929102420807
. O 0 0.020520569756627083

Among O 0 0.021410807967185974
these O 0 0.007032809313386679
mutations O 0 0.008186782710254192
two O 0 0.0036375848576426506
are O 0 0.003229571506381035
missense O 0 0.018460173159837723
( O 0 0.010456669144332409
G197W O 1 0.9993996620178223
, O 0 0.011012661270797253
W427R O 1 0.9999709129333496
) O 0 0.0073633440770208836
, O 0 0.004339945502579212
two O 0 0.002699407748878002
are O 0 0.0020045293495059013
nonsense O 0 0.013569729402661324
( O 0 0.008082868531346321
Q306X O 1 0.9988521337509155
, O 0 0.00983743742108345
Q385X O 1 0.9999822378158569
) O 0 0.0059337373822927475
, O 0 0.004315546713769436
two O 0 0.002634471282362938
are O 0 0.0023318410385400057
small O 0 0.006466739811003208
deletions O 0 0.019179852679371834
( O 0 0.010872673243284225
662de14bp O 1 0.9923960566520691
; O 0 0.01228609774261713
1168del3bp O 1 0.9555765390396118
removing O 0 0.015346911735832691
a O 0 0.008828717283904552
glycine O 0 0.018709629774093628
at O 0 0.0076428744941949844
position O 0 0.01120423898100853
390 O 0 0.33446893095970154
) O 0 0.007194387260824442
, O 0 0.004944843705743551
and O 0 0.0033678205218166113
one O 0 0.0033984060864895582
is O 0 0.0034259746316820383
a O 0 0.006158993113785982
splicing O 0 0.017394766211509705
mutation O 0 0.010728470049798489
( O 0 0.009326391853392124
IVS1 O 1 0.9999868869781494
- O 1 0.999996542930603
15c O 1 0.9999940395355225
- O 1 0.999998927116394
- O 1 0.9999998807907104
> O 1 0.9999903440475464
g O 1 0.9871671795845032
) O 0 0.007298372220247984
which O 0 0.00550716882571578
creates O 0 0.013283384032547474
a O 0 0.007732548750936985
new O 0 0.012854618020355701
acceptor O 0 0.03879993408918381
splice O 0 0.08319345861673355
site O 0 0.0346020869910717
. O 0 0.022635912522673607

The O 0 0.02810318022966385
pathological O 0 0.03358343988656998
significance O 0 0.014700207859277725
of O 0 0.007410979364067316
the O 0 0.007451969664543867
point O 0 0.009481270797550678
mutations O 0 0.012395290657877922
G197W O 1 0.97989821434021
, O 0 0.009658022783696651
W427R O 1 0.9979470372200012
, O 0 0.005181929562240839
and O 0 0.003436207538470626
the O 0 0.004467489197850227
in O 0 0.005948142148554325
- O 1 0.9999992847442627
frame O 0 0.15895392000675201
deletion O 0 0.07744205743074417
390delGly O 1 0.9159812927246094
were O 0 0.0051864986307919025
assessed O 0 0.007692610379308462
by O 0 0.003129771910607815
their O 0 0.003580458927899599
respective O 0 0.007316199131309986
expression O 0 0.006658921483904123
in O 0 0.004415788687765598
a O 0 0.007371279876679182
prokaryotic O 0 0.01840771548449993
system O 0 0.007881216704845428
using O 0 0.006768436636775732
site O 0 0.019643619656562805
- O 1 0.9845044612884521
directed O 0 0.025138501077890396
mutagenesis O 0 0.06389660388231277
. O 0 0.026519127190113068

These O 0 0.014777595177292824
mutations O 0 0.01504384446889162
resulted O 0 0.009350283071398735
in O 0 0.005143675021827221
the O 0 0.0058384910225868225
absence O 0 0.010620958171784878
or O 0 0.0053987056016922
a O 0 0.008016569539904594
dramatic O 0 0.018083481118083
decrease O 0 0.015587501227855682
of O 0 0.016406919807195663
CPO O 1 0.9999954700469971
activity O 0 0.032050538808107376
. O 0 0.026158969849348068

The O 0 0.025525685399770737
two O 0 0.012231984175741673
polymorphisms O 0 0.022937040776014328
were O 0 0.006759758107364178
localized O 0 0.017619866877794266
in O 0 0.007044349797070026
noncoding O 0 0.025707464665174484
part O 0 0.007741060107946396
of O 0 0.004996132105588913
the O 0 0.006279818248003721
gene O 0 0.0069314660504460335
1 O 0 0.00957120768725872
) O 0 0.00531978951767087
a O 0 0.009768237359821796
C O 1 0.9992954730987549
/ O 1 0.9999159574508667
G O 1 0.998096764087677
polymorphism O 0 0.02197500504553318
in O 0 0.008180397562682629
the O 0 0.013287121430039406
promotor O 1 0.9998817443847656
region O 0 0.01551053300499916
, O 0 0.010633080266416073
142 O 0 0.03745963051915169
bp O 0 0.03530663996934891
upstream O 0 0.015399609692394733
from O 0 0.0044594863429665565
the O 0 0.006352794356644154
transcriptional O 0 0.017689241096377373
initiation O 0 0.017349647358059883
site O 0 0.011747246608138084
( O 0 0.008102755062282085
- O 1 0.999909520149231
142C O 1 0.9999933242797852
/ O 1 0.9999991655349731
G O 1 0.9999852180480957
) O 0 0.007286703679710627
, O 0 0.005291993264108896
and O 0 0.00437368405982852
2 O 0 0.008117522113025188
) O 0 0.0047209723852574825
a O 0 0.007276845630258322
6 O 0 0.015192622318863869
bp O 0 0.034050390124320984
deletion O 0 0.029090143740177155
polymorphism O 0 0.01939529925584793
in O 0 0.006137006916105747
the O 0 0.007894239388406277
3 O 0 0.015054948627948761
noncoding O 0 0.03229120746254921
part O 0 0.009587416425347328
of O 0 0.008855403400957584
the O 0 0.01353390421718359
CPO O 1 0.9994600415229797
gene O 0 0.01731746830046177
, O 0 0.011861858889460564
574 O 0 0.05889527499675751
bp O 0 0.0356193408370018
downstream O 0 0.01499152835458517
of O 0 0.005752637516707182
the O 0 0.005078673362731934
last O 0 0.006692330352962017
base O 0 0.010345293208956718
of O 0 0.005137795116752386
the O 0 0.006768760271370411
normal O 0 0.010035366751253605
termination O 1 0.6822558641433716
codon O 0 0.03548753261566162
( O 0 0.01808145083487034
+ O 0 0.13505317270755768
574 O 1 0.9966956377029419
delATTCTT O 1 0.9996962547302246
) O 0 0.028277454897761345
. O 0 0.03407285362482071

Five O 0 0.039130259305238724
intragenic O 1 0.9888132214546204
dimorphisms O 1 0.8979312777519226
are O 0 0.00549524137750268
now O 0 0.008529873564839363
well O 0 0.0058846380561590195
characterized O 0 0.008189044892787933
and O 0 0.003968831617385149
the O 0 0.004980308003723621
high O 0 0.008098605088889599
degree O 0 0.007241506595164537
of O 0 0.008370482362806797
allelic O 1 0.9989577531814575
heterogeneity O 1 0.8678101897239685
in O 0 0.013025221414864063
HC B-Disease 1 1.0
is O 0 0.008812974207103252
demonstrated O 0 0.009539266116917133
with O 0 0.003734417725354433
seven O 0 0.00491290632635355
new O 0 0.005317044910043478
different O 0 0.0027551462408155203
mutations O 0 0.005511249415576458
making O 0 0.0037846018094569445
a O 0 0.0050617000088095665
total O 0 0.005921501666307449
of O 0 0.007713590748608112
nineteen O 0 0.17695841193199158
CPO O 1 0.9999998807907104
gene B-Disease 1 0.8025319576263428
defects I-Disease 1 0.9999972581863403
reported O 0 0.012463185004889965
so O 0 0.007352645043283701
far O 0 0.010315561667084694
. O 0 0.010321447625756264
. O 0 0.019665755331516266

Coincidence O 0 0.04629451036453247
of O 0 0.01310998946428299
two O 0 0.008225340396165848
novel O 0 0.020932886749505997
arylsulfatase O 1 0.5787989497184753
A O 0 0.02080940455198288
alleles O 0 0.020179856568574905
and O 0 0.010038341395556927
mutation O 0 0.023151103407144547
459 O 1 0.9998270869255066
+ O 1 0.9990081191062927
1G O 1 0.9999972581863403
> O 0 0.388249009847641
A O 0 0.015606097877025604
within O 0 0.00553232803940773
a O 0 0.007603281177580357
family O 0 0.010549294762313366
with O 0 0.01026184856891632
metachromatic B-Disease 1 1.0
leukodystrophy I-Disease 1 1.0
: O 0 0.01764943264424801
molecular O 0 0.01536860316991806
basis O 0 0.007199490442872047
of O 0 0.011241845786571503
phenotypic O 0 0.03854520246386528
heterogeneity O 0 0.16578543186187744
. O 0 0.033111508935689926

In O 0 0.014666052535176277
a O 0 0.011872555129230022
family O 0 0.010369604453444481
with O 0 0.0046350168995559216
three O 0 0.0058520021848380566
siblings O 0 0.01397490780800581
, O 0 0.004525167867541313
one O 0 0.0042473371140658855
developed O 0 0.006972099654376507
classical O 0 0.010312909260392189
late O 0 0.02115931548178196
infantile O 1 1.0
metachromatic B-Disease 1 1.0
leukodystrophy I-Disease 1 1.0
( O 1 0.9998573064804077
MLD B-Disease 1 1.0
) O 0 0.014002487994730473
, O 0 0.009935207664966583
fatal O 0 0.2566837668418884
at O 0 0.007957657799124718
age O 0 0.007342447526752949
5 O 0 0.006861232686787844
years O 0 0.004504409618675709
, O 0 0.0038281003944575787
with O 0 0.004444217309355736
deficient O 1 0.9999774694442749
arylsulfatase O 1 0.9999964237213135
A O 1 0.9776791334152222
( O 0 0.026205265894532204
ARSA O 1 1.0
) O 0 0.007970880717039108
activity O 0 0.006297584157437086
and O 0 0.005685445852577686
increased O 0 0.010418407618999481
galactosylsulfatide O 1 0.9999926090240479
( O 1 0.6231231689453125
GS O 1 1.0
) O 0 0.03190656378865242
excretion O 0 0.32308486104011536
. O 0 0.030760161578655243

The O 0 0.014988888055086136
two O 0 0.0064605046063661575
other O 0 0.005605005659162998
siblings O 0 0.01521869096904993
, O 0 0.004752975422888994
apparently O 0 0.006565256975591183
healthy O 0 0.008225087076425552
at O 0 0.005192271433770657
12 O 0 0.00541389174759388
( O 0 0.004783437587320805
1 O 0 0.011611377820372581
/ O 1 0.9883233308792114
2 O 0 0.008309009484946728
) O 0 0.0038051391020417213
and O 0 0.0029909529257565737
15 O 0 0.004793995525687933
years O 0 0.004092282149940729
, O 0 0.0038316333666443825
respectively O 0 0.004458047449588776
, O 0 0.0032514294143766165
and O 0 0.0029561789706349373
their O 0 0.0032161157578229904
father O 0 0.3034738004207611
, O 0 0.006137469783425331
apparently O 0 0.009012933820486069
healthy O 0 0.011186330579221249
as O 0 0.004292628727853298
well O 0 0.0047004083171486855
, O 0 0.005647871643304825
presented O 0 0.016772205010056496
ARSA O 1 0.9999998807907104
and O 0 0.015867818146944046
GS O 1 1.0
values O 0 0.012069165706634521
within O 0 0.005381159484386444
the O 0 0.0064180511981248856
range O 0 0.012234732508659363
of O 0 0.01907266303896904
MLD B-Disease 1 1.0
patients O 1 0.9999979734420776
. O 0 0.0319521389901638

Mutation O 0 0.05411646142601967
screening O 0 0.03140248730778694
and O 0 0.008833174593746662
sequence O 0 0.007902662269771099
analysis O 0 0.006433193571865559
disclosed O 0 0.012465203180909157
the O 0 0.0057067591696977615
involvement O 0 0.008603936992585659
of O 0 0.0046669719740748405
three O 0 0.004331024829298258
different O 0 0.005033314228057861
ARSA O 1 1.0
mutations O 0 0.010939261876046658
being O 0 0.005645172670483589
the O 0 0.005856597796082497
molecular O 0 0.010377411730587482
basis O 0 0.005496857222169638
of O 0 0.010841169394552708
intrafamilial O 1 0.9965698719024658
phenotypic O 0 0.0728815346956253
heterogeneity O 0 0.2499578893184662
. O 0 0.03457784280180931

The O 0 0.027069710195064545
late O 0 0.03475554659962654
infantile O 1 1.0
patient O 1 0.9999998807907104
inherited O 1 1.0
from O 0 0.007425480056554079
his O 0 0.12378507107496262
mother O 0 0.027175497263669968
the O 0 0.0059482320211827755
frequent O 0 0.009674782864749432
0 O 0 0.016903625801205635
- O 1 0.9994937181472778
type O 0 0.017367083579301834
mutation O 0 0.01979312300682068
459 O 1 0.9951944947242737
+ O 1 0.9826634526252747
1G O 1 0.999998927116394
> O 1 0.9884858131408691
A O 0 0.015608178451657295
, O 0 0.006339546758681536
and O 0 0.004266712814569473
from O 0 0.004077133256942034
his O 0 0.007871454581618309
father O 0 0.08558078855276108
a O 0 0.006649198476225138
novel O 0 0.010695246048271656
, O 0 0.005665203090757132
single O 0 0.009815654717385769
basepair O 1 0.9713670015335083
microdeletion O 1 0.9369251728057861
of O 0 0.01034072507172823
guanine O 0 0.03424263745546341
at O 0 0.012621809728443623
nucleotide O 0 0.013621949590742588
7 O 0 0.011975849978625774
in O 0 0.008390940725803375
exon O 0 0.04800773039460182
1 O 0 0.021255522966384888
( O 0 0.0183908361941576
7delG O 1 0.9996925592422485
) O 0 0.019751673564314842
. O 0 0.023861613124608994

The O 0 0.01917455904185772
two O 0 0.011705810204148293
clinically O 1 0.999460756778717
unaffected O 1 0.577922523021698
siblings O 0 0.024650737643241882
carried O 0 0.010177579708397388
the O 0 0.009064912796020508
maternal O 1 0.702412486076355
mutation O 0 0.02155308611690998
459 O 1 0.9999973773956299
+ O 1 0.9999794960021973
1G O 1 1.0
> O 1 0.9995132684707642
A O 0 0.017616597935557365
and O 0 0.007006717845797539
, O 0 0.004792148247361183
on O 0 0.00445812102407217
their O 0 0.005790259689092636
paternal O 0 0.058834221214056015
allele O 0 0.020105965435504913
, O 0 0.008741015568375587
a O 0 0.011877503246068954
novel O 0 0.020844880491495132
cytosine O 0 0.040365494787693024
to O 0 0.012861639261245728
thymidine O 0 0.05402223765850067
transition O 0 0.025733180344104767
at O 0 0.021710200235247612
nucleotide O 0 0.03638562187552452
2435 O 1 0.9337850213050842
in O 0 0.016711879521608353
exon O 0 0.06256100535392761
8 O 0 0.01988885924220085
, O 0 0.009166429750621319
resulting O 0 0.009407908655703068
in O 0 0.007275358308106661
substitution O 0 0.015857748687267303
of O 0 0.01246162410825491
alanine O 0 0.056352391839027405
464 O 1 0.9910932183265686
by O 0 0.014551680535078049
valine O 1 0.9997721314430237
( O 0 0.023660775274038315
A464V O 1 0.9998897314071655
) O 0 0.026142043992877007
. O 0 0.030754689127206802

The O 0 0.03387907147407532
fathers O 0 0.04541894793510437
genotype O 0 0.05231146514415741
thus O 0 0.01636664569377899
was O 0 0.03378407657146454
7delG O 1 0.999998927116394
/ O 1 0.9999921321868896
A464V O 1 0.9992115497589111
. O 0 0.036851149052381516

Mutation O 0 0.10343937575817108
A464V O 1 0.9979400038719177
was O 0 0.013350429944694042
not O 0 0.003974702209234238
found O 0 0.0037640349473804235
in O 0 0.004979261662811041
18 O 0 0.01270321011543274
unrelated O 0 0.4289703369140625
MLD B-Disease 1 1.0
patients O 1 0.9999971389770508
and O 0 0.013701844960451126
50 O 0 0.023772336542606354
controls O 0 0.03652321919798851
. O 0 0.02642960660159588

A464V O 1 0.9963310360908508
, O 0 0.013825693167746067
although O 0 0.006772223394364119
clearly O 0 0.01207795925438404
modifying O 0 0.025265390053391457
ARSA O 1 1.0
and O 0 0.09565649181604385
GS O 1 1.0
levels O 0 0.1347561478614807
, O 0 0.006994019262492657
apparently O 0 0.008703580126166344
bears O 0 0.010283761657774448
little O 0 0.008027037605643272
significance O 0 0.009737539105117321
for O 0 0.0064039574936032295
clinical O 1 0.998432457447052
manifestation O 1 0.9999854564666748
of O 1 0.9945037364959717
MLD B-Disease 1 1.0
, O 0 0.01989009603857994
mimicking O 0 0.1937723308801651
the O 0 0.017033562064170837
frequent O 0 0.03988469019532204
ARSA O 1 1.0
pseudodeficiency O 1 0.9999868869781494
allele O 0 0.09099610149860382
. O 0 0.036347050219774246

Our O 0 0.026370739564299583
results O 0 0.015060599893331528
demonstrate O 0 0.0108890226110816
that O 0 0.003791223280131817
in O 0 0.004429145250469446
certain O 0 0.005159740336239338
genetic O 0 0.01032607164233923
conditions O 0 0.14800776541233063
MLD B-Disease 1 1.0
- O 1 1.0
like O 0 0.029565077275037766
ARSA O 1 1.0
and O 0 0.01953125
GS O 1 1.0
values O 0 0.012044004164636135
need O 0 0.005712652578949928
not O 0 0.002284832764416933
be O 0 0.0026788394898176193
paralleled O 0 0.011067395098507404
by O 0 0.005353179760277271
clinical O 1 1.0
disease O 1 1.0
, O 0 0.006995744537562132
a O 0 0.006393183954060078
finding O 0 0.00637658778578043
with O 0 0.005447164177894592
serious O 1 0.9990606904029846
diagnostic O 1 0.9999998807907104
and O 1 0.5591051578521729
prognostic O 1 1.0
implications O 1 0.99908447265625
. O 0 0.02806267701089382

Moreover O 0 0.045953620225191116
, O 0 0.01885814219713211
further O 0 0.01864107884466648
ARSA O 1 0.999991774559021
alleles O 0 0.03349466994404793
functionally O 0 0.02990138530731201
similar O 0 0.007895112968981266
to O 0 0.008448826149106026
A464V O 1 0.993346095085144
might O 0 0.00693693570792675
exist O 0 0.003586663631722331
which O 0 0.0025108426343649626
, O 0 0.002823946997523308
together O 0 0.0025703348219394684
with O 0 0.0027968280483037233
0 O 0 0.011568940244615078
- O 1 0.9999992847442627
type O 1 0.535639226436615
mutations O 0 0.008422410115599632
, O 0 0.005454655271023512
may O 0 0.0061187115497887135
cause O 0 0.1619102507829666
pathological O 1 0.9999971389770508
ARSA O 1 1.0
and O 1 0.9998406171798706
GS O 1 1.0
levels O 0 0.0715026929974556
, O 0 0.005092519335448742
but O 0 0.002778350142762065
not O 0 0.0025553058367222548
clinical O 1 0.8263514041900635
outbreak O 1 0.9998834133148193
of O 0 0.14171350002288818
the O 1 0.999936580657959
disease O 1 1.0
. O 0 0.015664560720324516
. O 0 0.020986488088965416

Human O 0 0.44256046414375305
MLH1 O 1 1.0
deficiency O 1 1.0
predisposes O 1 1.0
to O 0 0.2536098062992096
hematological B-Disease 1 1.0
malignancy I-Disease 1 1.0
and O 1 0.9999716281890869
neurofibromatosis B-Disease 1 1.0
type I-Disease 1 0.9999970197677612
1 I-Disease 1 0.5531947612762451
. O 0 0.03142918646335602

Heterozygous O 0 0.09219548851251602
germ O 1 0.9999994039535522
- O 1 0.9999983310699463
line O 0 0.02247411198914051
mutations O 0 0.009183256886899471
in O 0 0.005401609931141138
the O 0 0.007523284759372473
DNA O 0 0.014220514334738255
mismatch O 1 0.9999853372573853
repair O 1 0.9998204112052917
genes O 0 0.007448796182870865
lead O 0 0.007996697910130024
to O 0 0.008842715062201023
hereditary B-Disease 1 1.0
nonpolyposis I-Disease 1 1.0
colorectal I-Disease 1 1.0
cancer I-Disease 1 1.0
. O 1 0.9995287656784058

The O 0 0.28942131996154785
disease O 1 1.0
susceptibility O 1 0.999976634979248
of O 0 0.012217204086482525
individuals O 0 0.005364758428186178
who O 0 0.013694860972464085
constitutionally O 0 0.12780499458312988
lack O 0 0.0078332694247365
both O 0 0.006085691042244434
wild O 0 0.01470960397273302
- O 1 0.9999998807907104
type O 1 0.506686806678772
alleles O 0 0.02182849496603012
is O 0 0.010966112837195396
unknown O 0 0.019281873479485512
. O 0 0.02036779187619686

We O 0 0.013298165053129196
have O 0 0.0049110278487205505
identified O 0 0.006768055725842714
three O 0 0.0036742123775184155
offspring O 0 0.006866159848868847
in O 0 0.003102982882410288
a O 0 0.007600533310323954
hereditary B-Disease 1 1.0
nonpolyposis I-Disease 1 1.0
colorectal I-Disease 1 1.0
cancer I-Disease 1 1.0
family O 1 0.9999986886978149
who O 1 0.9733520746231079
developed O 1 0.9997745156288147
hematological B-Disease 1 1.0
malignancy I-Disease 1 1.0
at O 0 0.47701090574264526
a O 0 0.006469056010246277
very O 0 0.004119102843105793
early O 0 0.005628493148833513
age O 0 0.005816029384732246
, O 0 0.0037351413629949093
and O 0 0.0032647063490003347
at O 0 0.004399555269628763
least O 0 0.00254980125464499
two O 0 0.0020590757485479116
of O 0 0.0027541364543139935
them O 0 0.002523792441934347
displayed O 0 0.007590253837406635
signs O 0 0.008839171379804611
of O 0 0.010900677181780338
neurofibromatosis B-Disease 1 1.0
type I-Disease 1 0.9999938011169434
1 I-Disease 1 0.9448943734169006
( O 0 0.024171028286218643
NF1 B-Disease 1 0.9999991655349731
) O 0 0.02595370076596737
. O 0 0.024790741503238678

DNA O 0 0.028388474136590958
sequence O 0 0.009453590959310532
analysis O 0 0.007157781161367893
and O 0 0.007206822745501995
allele O 0 0.02323630079627037
- O 1 0.9940809607505798
specific O 0 0.007912076078355312
amplification O 0 0.016450220718979836
in O 0 0.005422350950539112
two O 0 0.005000597331672907
siblings O 0 0.016191525384783745
revealed O 0 0.009799188934266567
a O 0 0.010694550350308418
homozygous O 0 0.03346250206232071
MLH1 O 1 0.9999997615814209
mutation O 0 0.023392433300614357
( O 0 0.012433050200343132
C676T O 1 0.9999291896820068
- O 1 1.0
- O 1 1.0
> O 1 0.9999959468841553
Arg226Stop O 1 0.999984622001648
) O 0 0.022125324234366417
. O 0 0.024389050900936127

Thus O 0 0.022800074890255928
, O 0 0.010570409707725048
a O 0 0.013049044646322727
homozygous O 0 0.035094790160655975
germ O 1 0.9999997615814209
- O 1 0.9999998807907104
line O 0 0.3566409647464752
MLH1 O 1 0.9999996423721313
mutation O 0 0.0213389303535223
and O 0 0.01152005698531866
consequent O 1 0.9999996423721313
mismatch O 1 1.0
repair O 1 1.0
deficiency O 1 1.0
results O 0 0.02568516507744789
in O 0 0.008260554634034634
a O 0 0.015044664964079857
mutator O 1 0.9999990463256836
phenotype O 1 0.6820175647735596
characterized O 0 0.01733328215777874
by O 0 0.008138393051922321
leukemia B-Disease 1 1.0
and O 1 0.9805960655212402
/ O 1 1.0
or O 1 0.9989916682243347
lymphoma B-Disease 1 1.0
associated O 1 0.9630925059318542
with O 1 0.8891586661338806
neurofibromatosis B-Disease 1 1.0
type I-Disease 1 0.9999997615814209
1 I-Disease 1 0.9543716311454773
. O 0 0.012052574194967747
. O 0 0.020939791575074196

Missense O 0 0.09771712869405746
mutations O 0 0.019547345116734505
in O 0 0.007815444841980934
the O 0 0.006341886706650257
most O 0 0.006002895999699831
ancient O 0 0.01051272451877594
residues O 0 0.009954645298421383
of O 0 0.007428424898535013
the O 0 0.011928737163543701
PAX6 O 1 0.9999998807907104
paired O 0 0.04278087243437767
domain O 0 0.017475023865699768
underlie O 0 0.020228609442710876
a O 0 0.007431942503899336
spectrum O 0 0.01730484701693058
of O 0 0.01405843161046505
human O 1 0.999993085861206
congenital B-Disease 1 1.0
eye I-Disease 1 1.0
malformations I-Disease 1 1.0
. O 1 0.9997346997261047

Mutations O 0 0.029591063037514687
of O 0 0.010609443299472332
the O 0 0.010328952223062515
human O 0 0.012485806830227375
PAX6 O 1 0.9999998807907104
gene O 0 0.07435224205255508
underlie O 1 0.9999960660934448
aniridia B-Disease 1 1.0
( O 1 0.9998169541358948
congenital B-Disease 1 1.0
absence I-Disease 1 0.9991663694381714
of I-Disease 1 0.889758288860321
the I-Disease 1 0.9671443700790405
iris I-Disease 1 0.9999998807907104
) O 0 0.006442032288759947
, O 0 0.004310901742428541
a O 0 0.005348874721676111
rare O 0 0.009783340618014336
dominant O 1 0.9887930750846863
malformation B-Disease 1 1.0
of I-Disease 1 0.7303304076194763
the I-Disease 1 0.9966272115707397
eye I-Disease 1 1.0
. O 0 0.02926904708147049

The O 0 0.022554464638233185
spectrum O 0 0.0309944786131382
of O 0 0.01989658921957016
PAX6 O 1 0.9999996423721313
mutations O 0 0.02227616310119629
in O 0 0.013294413685798645
aniridia B-Disease 1 1.0
patients O 1 0.999997615814209
is O 0 0.0075888605788350105
highly O 0 0.010423604398965836
biased O 0 0.010183009319007397
, O 0 0.004279579967260361
with O 0 0.0040603457018733025
92 O 0 0.017775453627109528
% O 0 0.004992392845451832
of O 0 0.004310862626880407
all O 0 0.0035678716376423836
reported O 0 0.007620117161422968
mutations O 0 0.006680011749267578
leading O 0 0.008359999395906925
to O 0 0.0064204842783510685
premature O 1 0.7027801871299744
truncation O 0 0.0997089073061943
of O 0 0.008738924749195576
the O 0 0.010030047968029976
protein O 0 0.011781138367950916
( O 0 0.007633022498339415
nonsense O 0 0.020694095641374588
, O 0 0.009067296050488949
splicing O 0 0.018448850139975548
, O 0 0.009676256217062473
insertions O 0 0.02846013568341732
and O 0 0.007935192435979843
deletions O 0 0.021369321271777153
) O 0 0.006211989093571901
and O 0 0.004909159615635872
just O 0 0.006860517431050539
2 O 0 0.010374254547059536
% O 0 0.00664948858320713
leading O 0 0.008825712837278843
to O 0 0.005726773291826248
substitution O 0 0.012655085884034634
of O 0 0.0061313556507229805
one O 0 0.007107618264853954
amino O 0 0.010680761188268661
acid O 0 0.01126687042415142
by O 0 0.004937074147164822
another O 0 0.010329136624932289
( O 0 0.012839036993682384
missense O 0 0.03782898187637329
) O 0 0.015447894111275673
. O 0 0.019508404657244682

The O 0 0.02347789704799652
extraordinary O 0 0.023152634501457214
conservation O 0 0.01434366311877966
of O 0 0.00878003891557455
the O 0 0.012972144410014153
PAX6 O 1 0.9999998807907104
protein O 0 0.012698431499302387
at O 0 0.009327027015388012
the O 0 0.008773001842200756
amino O 0 0.01440818514674902
acid O 0 0.019102875143289566
level O 0 0.011566875502467155
amongst O 0 0.017501428723335266
vertebrates O 0 0.02377159520983696
predicts O 0 0.027263294905424118
that O 0 0.007122661918401718
pathological O 1 0.6468330025672913
missense O 0 0.3025447726249695
mutations O 0 0.00986598338931799
should O 0 0.0040185716934502125
in O 0 0.003757704747840762
fact O 0 0.004142593126744032
be O 0 0.002691325033083558
common O 0 0.0036503789015114307
even O 0 0.0032518096268177032
though O 0 0.0026370109990239143
they O 0 0.0016056126914918423
are O 0 0.001450766809284687
hardly O 0 0.006261318922042847
ever O 0 0.005094672087579966
seen O 0 0.006358010228723288
in O 0 0.008882380090653896
aniridia B-Disease 1 1.0
patients O 1 0.9999866485595703
. O 0 0.025094207376241684

This O 0 0.014628537930548191
indicates O 0 0.014216088689863682
that O 0 0.0041385842487216
there O 0 0.0035279898438602686
is O 0 0.0041372161358594894
a O 0 0.007534429896622896
heavy O 1 0.5931966304779053
ascertainment O 1 0.9999985694885254
bias O 0 0.014681275002658367
in O 0 0.005666040815412998
the O 0 0.005275615490972996
selection O 0 0.008924820460379124
of O 0 0.007415485102683306
patients O 1 0.6104037761688232
for O 0 0.010182890109717846
PAX6 O 1 1.0
mutation O 0 0.016659336164593697
analysis O 0 0.006818024441599846
and O 0 0.004547803662717342
that O 0 0.003395581152290106
the O 0 0.007892074063420296
missing O 0 0.020751867443323135
PAX6 O 1 0.9999996423721313
missense O 0 0.3096062242984772
mutations O 0 0.01917622797191143
frequently O 0 0.01215347833931446
may O 0 0.01134556531906128
underlie O 1 0.8146565556526184
phenotypes O 0 0.10914907604455948
distinct O 0 0.014198505319654942
from O 0 0.01754329353570938
textbook O 1 0.9999971389770508
aniridia B-Disease 1 0.9999998807907104
. O 0 0.03653678670525551

Here O 0 0.02257942408323288
we O 0 0.008438321761786938
present O 0 0.008530485443770885
four O 0 0.009475365281105042
novel O 0 0.027114996686577797
PAX6 O 1 0.9999988079071045
missense O 0 0.308779239654541
mutations O 0 0.012438477016985416
, O 0 0.004861257504671812
two O 0 0.0032588152680546045
in O 0 0.004496919922530651
association O 0 0.008541753515601158
with O 0 0.005997503641992807
atypical O 1 0.9999982118606567
phenotypes O 1 0.9999946355819702
ectopia B-Disease 1 1.0
pupillae I-Disease 1 0.9999992847442627
( O 0 0.012664621695876122
displaced B-Disease 0 0.02086932212114334
pupils I-Disease 0 0.05553822964429855
) O 0 0.009521420113742352
and O 0 0.28078246116638184
congenital B-Disease 1 1.0
nystagmus I-Disease 1 1.0
( O 1 0.8094332218170166
searching B-Disease 0 0.2104264348745346
gaze I-Disease 1 0.9997995495796204
) O 0 0.007133063394576311
, O 0 0.004513185005635023
and O 0 0.003153772559016943
two O 0 0.0026991423219442368
in O 0 0.003961901646107435
association O 0 0.007424966897815466
with O 0 0.00578326964750886
more O 0 0.00958883948624134
recognizable O 1 0.9998482465744019
aniridia B-Disease 1 1.0
phenotypes O 1 0.9919752478599548
. O 0 0.03254566714167595

Strikingly O 0 0.061482977122068405
, O 0 0.012287053279578686
all O 0 0.006472995039075613
four O 0 0.008662544190883636
mutations O 0 0.007437790744006634
are O 0 0.002285265363752842
located O 0 0.0070022763684391975
within O 0 0.0038552023470401764
the O 0 0.0075331139378249645
PAX6 O 1 1.0
paired O 0 0.12916749715805054
domain O 0 0.01358484011143446
and O 0 0.007261715829372406
affect O 0 0.01091864425688982
amino O 0 0.012735969386994839
acids O 0 0.007616900838911533
which O 0 0.003579819342121482
are O 0 0.002517606131732464
highly O 0 0.0088034737855196
conserved O 0 0.00954347476363182
in O 0 0.004562367685139179
all O 0 0.0057247173972427845
known O 0 0.012455135583877563
paired O 0 0.03427514433860779
domain O 0 0.033046331256628036
proteins O 0 0.02420099265873432
. O 0 0.024383293464779854

Our O 0 0.019904524087905884
results O 0 0.010226409882307053
support O 0 0.008947327733039856
the O 0 0.00657848734408617
hypothesis O 0 0.008122610859572887
that O 0 0.0024001351557672024
the O 0 0.00442957878112793
under O 0 0.007180450018495321
- O 1 0.9400602579116821
representation O 0 0.007507667411118746
of O 0 0.007283617276698351
missense O 0 0.029399283230304718
mutations O 0 0.011100861243903637
is O 0 0.0062903729267418385
caused O 0 0.010507329367101192
by O 0 0.0074455393478274345
ascertainment O 1 1.0
bias O 0 0.15650705993175507
and O 0 0.006475127302110195
suggest O 0 0.005579657852649689
that O 0 0.002470034873113036
a O 0 0.00423104502260685
substantial O 0 0.006784249097108841
burden O 0 0.0617278590798378
of O 0 0.011021051555871964
PAX6 B-Disease 1 1.0
- I-Disease 1 1.0
related I-Disease 1 0.9999861717224121
disease I-Disease 1 1.0
remains O 0 0.4292002022266388
to O 0 0.00522345956414938
be O 0 0.005111735314130783
uncovered O 0 0.01759619452059269
. O 0 0.009138796478509903
. O 0 0.015629775822162628

The O 0 0.024920258671045303
chromosomal O 0 0.025413578376173973
order O 0 0.008166469633579254
of O 0 0.007365560624748468
genes O 0 0.007487399037927389
controlling O 0 0.0136895552277565
the O 0 0.006664292886853218
major O 1 0.9884507656097412
histocompatibility O 1 1.0
complex O 0 0.02456614375114441
, O 0 0.009582443162798882
properdin O 1 0.9997935891151428
factor O 0 0.2806641459465027
B O 1 0.9999504089355469
, O 0 0.006875462830066681
and O 0 0.00781554076820612
deficiency B-Disease 1 1.0
of I-Disease 0 0.012739201076328754
the I-Disease 0 0.011164967902004719
second I-Disease 0 0.04762975499033928
component I-Disease 0 0.17877952754497528
of I-Disease 0 0.013226008042693138
complement I-Disease 0 0.041351351886987686
. O 0 0.02683040127158165

The O 0 0.01671619713306427
relationship O 0 0.008759967051446438
of O 0 0.006485970690846443
the O 0 0.006600449793040752
genes O 0 0.008358536288142204
coding O 0 0.016636323183774948
for O 0 0.007727749180048704
HLA O 1 1.0
to O 0 0.006245936267077923
those O 0 0.004205839242786169
coding O 0 0.013034309260547161
for O 0 0.006132552865892649
properdin O 1 0.9958100318908691
Factor O 0 0.37590932846069336
B O 1 0.9999884366989136
allotypes O 1 0.9960131645202637
and O 0 0.0056326547637581825
for O 0 0.0071944245137274265
deficiency B-Disease 1 1.0
of I-Disease 0 0.006852887570858002
the I-Disease 0 0.005980505608022213
second I-Disease 0 0.009906760416924953
component I-Disease 0 0.014125887304544449
of I-Disease 0 0.00751775037497282
complement I-Disease 0 0.08770377933979034
( O 0 0.018004655838012695
C2 O 1 1.0
) O 0 0.007447519805282354
was O 0 0.007615041919052601
studied O 0 0.006489948369562626
in O 0 0.0030422687996178865
families O 0 0.0033225303050130606
of O 0 0.004924332723021507
patients O 1 0.9999681711196899
with O 1 0.9978033900260925
connective O 1 1.0
tissue O 1 1.0
disorders O 1 1.0
. O 1 0.9999586343765259

Patients O 1 0.9718296527862549
were O 0 0.008465816266834736
selected O 0 0.011795192956924438
because O 0 0.004957684315741062
they O 0 0.002728653373196721
were O 0 0.003311369800940156
heterozygous O 0 0.010821806266903877
or O 0 0.00596649618819356
homozygous O 0 0.02183353528380394
for O 0 0.3832876682281494
C2 B-Disease 1 1.0
deficiency I-Disease 1 1.0
. O 1 0.9746074080467224

12 O 0 0.027746472507715225
families O 0 0.010680216364562511
with O 0 0.007654848042875528
15 O 0 0.014965892769396305
matings O 0 0.037176549434661865
informative O 0 0.03096032701432705
for O 0 0.0328134149312973
C2 B-Disease 1 1.0
deficiency I-Disease 1 1.0
were O 0 0.01721889153122902
found O 0 0.015372478403151035
. O 0 0.021247560158371925

Of O 0 0.03292038291692734
57 O 0 0.05072852969169617
informative O 0 0.04593125730752945
meioses O 1 0.947746992111206
, O 0 0.008234967477619648
two O 0 0.005201429128646851
crossovers O 0 0.013523456640541553
were O 0 0.0034262759145349264
noted O 0 0.004795207642018795
between O 0 0.005113551858812571
the O 0 0.017606096342206
C2 B-Disease 1 1.0
deficiency I-Disease 1 1.0
gene O 0 0.014832582324743271
and O 0 0.005805592052638531
the O 0 0.012233678251504898
HLA O 1 1.0
- O 1 1.0
B O 1 1.0
gene O 0 0.009221334010362625
, O 0 0.004558389075100422
with O 0 0.0038415163289755583
a O 0 0.007986997254192829
recombinant O 0 0.024868110194802284
fraction O 0 0.021387070417404175
of O 0 0.015953341498970985
0 O 0 0.031586505472660065
. O 0 0.021278321743011475

035 O 1 0.9960875511169434
. O 0 0.07794296741485596

A O 0 0.04554055258631706
lod O 1 0.8729115128517151
score O 0 0.015410973690450191
of O 0 0.009223339147865772
13 O 0 0.011842307634651661
was O 0 0.008097348734736443
calculated O 0 0.007059706375002861
for O 0 0.00515445601195097
linkage O 0 0.0191938579082489
between O 0 0.01548660360276699
C2 B-Disease 1 1.0
deficiency I-Disease 1 1.0
and O 1 0.9999985694885254
HLA O 1 1.0
- O 1 1.0
B O 1 0.9999996423721313
at O 0 0.00962402019649744
a O 0 0.005676035303622484
maximum O 0 0.007323413621634245
likelihood O 0 0.008971058763563633
value O 0 0.004949415568262339
of O 0 0.004615871235728264
the O 0 0.006758541334420443
recombinant O 0 0.026589639484882355
fraction O 0 0.02074499800801277
of O 0 0.014368870295584202
0 O 0 0.03247961029410362
. O 0 0.027746649459004402

04 O 1 0.9991098046302795
. O 0 0.05930182337760925

18 O 0 0.02936839684844017
families O 0 0.013932593166828156
with O 0 0.008783673867583275
21 O 0 0.019869375973939896
informative O 0 0.02623608149588108
matings O 0 0.028671134263277054
for O 0 0.0068337987177073956
both O 0 0.00680168904364109
properdin O 1 0.98949134349823
Factor O 0 0.07384193688631058
B O 1 0.9995552897453308
allotype O 1 0.9970302581787109
and O 0 0.018543798476457596
HLA O 1 1.0
- O 1 1.0
B O 1 0.9999945163726807
were O 0 0.0119332792237401
found O 0 0.013627935200929642
. O 0 0.023261429741978645

Of O 0 0.03636324033141136
72 O 0 0.05756706744432449
informative O 0 0.05253589525818825
meioses O 1 0.7756632566452026
, O 0 0.010902362875640392
three O 0 0.008688388392329216
recombinants O 1 0.5513466596603394
were O 0 0.0052861860021948814
found O 0 0.005266149528324604
, O 0 0.005003937054425478
giving O 0 0.006886414717882872
a O 0 0.008208481594920158
recombinant O 0 0.028586730360984802
fraction O 0 0.01805596798658371
of O 0 0.013311637565493584
0 O 0 0.031778790056705475
. O 0 0.024556223303079605

042 O 1 0.9673112034797668
. O 0 0.07133470475673676

A O 0 0.04487783834338188
lod O 1 0.550119936466217
score O 0 0.01006222888827324
of O 0 0.005903065670281649
16 O 0 0.00904480367898941
between O 0 0.009915237314999104
HLA O 1 1.0
- O 1 1.0
B O 1 0.9999644756317139
and O 0 0.012268519029021263
Factor O 0 0.2991954982280731
B O 1 0.9999589920043945
allotypes O 1 0.960543155670166
was O 0 0.011257471516728401
calculated O 0 0.010161145590245724
at O 0 0.007090040948241949
a O 0 0.0059777116402983665
maximum O 0 0.008306385017931461
likelihood O 0 0.010485834442079067
value O 0 0.00565449520945549
of O 0 0.004738509654998779
the O 0 0.00696502486243844
recombinant O 0 0.025244256481528282
fraction O 0 0.019679760560393333
of O 0 0.013259991072118282
0 O 0 0.03135645017027855
. O 0 0.024049360305070877

04 O 1 0.9993858337402344
. O 0 0.0684293881058693

A O 0 0.03209025040268898
crossover O 0 0.03558361530303955
was O 0 0.012100819498300552
shown O 0 0.005521540995687246
to O 0 0.004122206009924412
have O 0 0.002825757721439004
occurred O 0 0.004378892946988344
between O 0 0.003041063202545047
genes O 0 0.003857039613649249
for O 0 0.004189494531601667
Factor O 0 0.021306805312633514
B O 1 0.9998949766159058
and O 0 0.010892875492572784
HLA O 1 1.0
- O 1 1.0
D O 1 0.9999983310699463
, O 0 0.006685867439955473
in O 0 0.005833491683006287
which O 0 0.00880313292145729
HLA O 1 1.0
- O 1 0.9999997615814209
D O 1 0.9999943971633911
segregared O 1 0.9798397421836853
with O 0 0.014869634062051773
HLA O 1 1.0
- O 1 1.0
A O 1 0.6625924706459045
and O 0 0.0178054329007864
B O 1 0.9997796416282654
. O 0 0.028043199330568314

These O 0 0.011945081874728203
studies O 0 0.009927865117788315
suggest O 0 0.007073754910379648
that O 0 0.002826469950377941
the O 0 0.0041792066767811775
genes O 0 0.004033527337014675
for O 0 0.004212843254208565
Factor O 0 0.19034358859062195
B O 1 0.9999998807907104
and O 1 0.9966723918914795
C2 B-Disease 1 1.0
deficiency I-Disease 1 1.0
are O 0 0.005196371115744114
located O 0 0.008425039239227772
outside O 0 0.005970235913991928
those O 0 0.003550683381035924
for O 0 0.006015373393893242
HLA O 1 1.0
, O 0 0.005216066259890795
that O 0 0.0023270449601113796
the O 0 0.003501965431496501
order O 0 0.003865224542096257
of O 0 0.005291682202368975
genese O 1 0.9996590614318848
is O 0 0.00980424229055643
HLA O 1 1.0
- O 1 0.999997615814209
A O 0 0.011735350824892521
, O 0 0.007031497545540333
- O 1 0.9999829530715942
B O 1 0.999432384967804
, O 0 0.008660022169351578
- O 1 0.9999959468841553
D O 1 0.9999728202819824
, O 0 0.009946846403181553
Factor O 0 0.02191024459898472
B O 1 0.9998307228088379
allotype O 1 0.99997878074646
, O 1 0.9828604459762573
C2 B-Disease 1 1.0
deficiency I-Disease 1 1.0
, O 0 0.009150783531367779
that O 0 0.004072411451488733
the O 0 0.005599814932793379
genes O 0 0.007137923967093229
coding O 0 0.015758130699396133
for O 0 0.014672807417809963
C2 B-Disease 1 1.0
deficiency I-Disease 1 1.0
and O 1 0.9791774153709412
Factor O 1 0.9999039173126221
B O 1 0.9999938011169434
allotypes O 0 0.04867454990744591
are O 0 0.002861669985577464
approximately O 0 0.004857408348470926
3 O 0 0.009760661981999874
- O 1 0.9999080896377563
- O 1 0.9956051707267761
5 O 0 0.012737595476210117
centimorgans O 0 0.02569572441279888
from O 0 0.006087894085794687
the O 0 0.009860613383352757
HLA O 1 1.0
- O 1 0.9999772310256958
A O 0 0.012316560372710228
and O 0 0.008794217370450497
HLA O 1 1.0
- O 1 1.0
B O 1 0.9999998807907104
loci O 0 0.01821288652718067
, O 0 0.005218073260039091
and O 0 0.0029146133456379175
that O 0 0.002118903212249279
the O 0 0.0037732901982963085
apparent O 0 0.007888959720730782
lack O 0 0.0061643426306545734
of O 0 0.0066419620998203754
recombinants O 1 0.9998503923416138
between O 0 0.005311237648129463
the O 0 0.007749052252620459
Factor O 0 0.022193776443600655
B O 1 0.9992200136184692
gene O 0 0.012788942083716393
and O 0 0.038428641855716705
C2 B-Disease 1 1.0
deficiency I-Disease 1 1.0
gene O 1 0.5740648508071899
suggests O 0 0.00825697835534811
that O 0 0.0024379093665629625
these O 0 0.0021292020101100206
two O 0 0.0028309691697359085
genes O 0 0.005386427044868469
lie O 0 0.00848610233515501
in O 0 0.004814804065972567
close O 0 0.008652382530272007
proximity O 0 0.010798168368637562
to O 0 0.006074417848140001
one O 0 0.008329356089234352
another O 0 0.01596096344292164
. O 0 0.02110239677131176

Distribution O 0 0.020029261708259583
of O 0 0.015496642328798771
emerin O 1 0.9964702129364014
and O 0 0.01028776727616787
lamins O 1 0.9997300505638123
in O 0 0.007477331440895796
the O 0 0.009734954684972763
heart O 1 0.999945878982544
and O 0 0.006053823046386242
implications O 0 0.012499542906880379
for O 0 0.009203924797475338
Emery B-Disease 1 1.0
- I-Disease 1 1.0
Dreifuss I-Disease 1 1.0
muscular I-Disease 1 1.0
dystrophy I-Disease 1 1.0
. O 1 0.9715234041213989

Emerin O 1 0.9365416169166565
is O 0 0.01324511505663395
a O 0 0.011643958278000355
nuclear O 0 0.019915200769901276
membrane O 0 0.02717413380742073
protein O 0 0.009950107894837856
which O 0 0.004345912951976061
is O 0 0.004873061086982489
missing O 0 0.008930557407438755
or O 0 0.0055806394666433334
defective O 1 0.7950617074966431
in O 0 0.010233952663838863
Emery B-Disease 1 0.999997615814209
- I-Disease 1 1.0
Dreifuss I-Disease 1 1.0
muscular I-Disease 1 1.0
dystrophy I-Disease 1 1.0
( O 1 0.9999990463256836
EDMD B-Disease 1 1.0
) O 0 0.03298803046345711
. O 0 0.03593352064490318

It O 0 0.012631703168153763
is O 0 0.006228083278983831
one O 0 0.004475784953683615
member O 0 0.005267896689474583
of O 0 0.0038395989686250687
a O 0 0.005588043946772814
family O 0 0.008136475458741188
of O 0 0.010567217133939266
lamina O 1 1.0
- O 1 1.0
associated O 0 0.012133193202316761
proteins O 0 0.00924406386911869
which O 0 0.004990474320948124
includes O 0 0.01199587807059288
LAP1 O 1 0.9998965263366699
, O 0 0.011835099197924137
LAP2 O 1 0.9999338388442993
and O 0 0.013956371694803238
lamin O 1 0.9999995231628418
B O 1 1.0
receptor O 1 0.9526711702346802
( O 0 0.027356967329978943
LBR O 1 0.9999997615814209
) O 0 0.026872912421822548
. O 0 0.030296670272946358

A O 0 0.02528046816587448
panel O 0 0.02384943701326847
of O 0 0.011618195101618767
16 O 0 0.01980801299214363
monoclonal O 1 0.9967383742332458
antibodies O 1 0.9919697642326355
( O 0 0.017229022458195686
mAbs O 1 0.9999853372573853
) O 0 0.008668163791298866
has O 0 0.006570726167410612
been O 0 0.004830161575227976
mapped O 0 0.012585315853357315
to O 0 0.004450470674782991
six O 0 0.004614293575286865
specific O 0 0.003715451341122389
sites O 0 0.005084960721433163
throughout O 0 0.004166631959378719
the O 0 0.00737497303634882
emerin O 1 0.65932697057724
molecule O 0 0.01843884587287903
using O 0 0.010150504298508167
phage O 1 0.9912452101707458
- O 1 0.999536395072937
displayed O 0 0.02583591639995575
peptide O 0 0.028439516201615334
libraries O 0 0.011736047454178333
and O 0 0.005378886591643095
has O 0 0.004876373335719109
been O 0 0.0034608012065291405
used O 0 0.0039027242455631495
to O 0 0.005627683829516172
localize O 1 0.5362571477890015
emerin O 1 0.9800476431846619
in O 0 0.007703333627432585
human O 0 0.008152777329087257
and O 0 0.016939233988523483
rabbit O 1 0.9999998807907104
heart O 1 1.0
. O 0 0.03398564085364342

Several O 0 0.024753520265221596
mAbs O 0 0.09530097991228104
against O 0 0.016062378883361816
different O 0 0.009401516057550907
emerin O 1 0.9992573857307434
epitopes O 1 0.678546667098999
did O 0 0.010342520661652088
not O 0 0.005408174358308315
recognize O 0 0.013760841451585293
intercalated O 1 0.9982916712760925
discs O 0 0.025945443660020828
in O 0 0.00812640693038702
the O 0 0.01301490142941475
heart O 1 0.9999996423721313
, O 0 0.006691310089081526
though O 0 0.004620103631168604
they O 0 0.0032541335094720125
recognized O 0 0.01096367184072733
cardiomyocyte O 1 0.9996620416641235
nuclei O 0 0.015386651270091534
strongly O 0 0.007976535707712173
, O 0 0.004856901243329048
both O 0 0.0035155084915459156
at O 0 0.006563117261976004
the O 0 0.007755981292575598
rim O 1 0.8876206278800964
and O 0 0.006585671100765467
in O 0 0.0089015057310462
intranuclear O 1 0.9999610185623169
spots O 0 0.029888654127717018
or O 0 0.012406819500029087
channels O 0 0.019600283354520798
. O 0 0.021154170855879784

A O 0 0.06372252851724625
polyclonal O 1 0.9889519810676575
rabbit O 1 0.8264395594596863
antiserum O 1 0.9964739680290222
against O 0 0.021760951727628708
emerin O 1 0.9989092350006104
did O 0 0.008685571141541004
recognize O 0 0.008991408161818981
both O 0 0.005815177224576473
nuclear O 0 0.017430629581212997
membrane O 0 0.028901176527142525
and O 0 0.012102163396775723
intercalated O 1 0.9999884366989136
discs O 0 0.0873916819691658
but O 0 0.006457346957176924
, O 0 0.006132610607892275
after O 0 0.007675188593566418
affinity O 0 0.01594448834657669
purification O 0 0.024605371057987213
against O 0 0.009102481417357922
a O 0 0.00968899391591549
pure O 0 0.07429870218038559
- O 1 0.9999995231628418
emerin O 1 0.9891698956489563
band O 0 0.0126584991812706
on O 0 0.005403867457062006
a O 0 0.007094883359968662
western O 0 0.010895753279328346
blot O 1 0.9977655410766602
, O 0 0.00704598193988204
it O 0 0.005753911100327969
stained O 1 0.9999712705612183
only O 0 0.0067367046140134335
the O 0 0.01095646433532238
nuclear O 0 0.03173208236694336
membrane O 0 0.05092431977391243
. O 0 0.0323469303548336

These O 0 0.009304556995630264
results O 0 0.0077190520241856575
would O 0 0.004260953050106764
not O 0 0.0025704463478177786
be O 0 0.002618161728605628
expected O 0 0.005874815862625837
if O 0 0.004742719233036041
immunostaining O 1 0.7772651314735413
at O 0 0.015102174133062363
intercalated O 1 0.9999686479568481
discs O 0 0.022952714934945107
were O 0 0.005372896790504456
due O 0 0.0051352339796721935
to O 0 0.0032420391216874123
a O 0 0.005038171075284481
product O 0 0.005951416213065386
of O 0 0.004383638966828585
the O 0 0.006644711829721928
emerin O 1 0.9999474287033081
gene O 0 0.00862598791718483
and O 0 0.004789825063198805
, O 0 0.005484556779265404
therefore O 0 0.00456273602321744
, O 0 0.0042090280912816525
cast O 0 0.004629938397556543
some O 0 0.00243587139993906
doubt O 0 0.005873601883649826
upon O 0 0.0037988561671227217
the O 0 0.005231647286564112
hypothesis O 0 0.010013259015977383
that O 0 0.005999919958412647
cardiac B-Disease 1 1.0
defects I-Disease 1 1.0
in O 1 0.9987126588821411
EDMD B-Disease 1 1.0
are O 0 0.005801151506602764
caused O 0 0.009698886424303055
by O 0 0.0049729361198842525
absence O 0 0.012779228389263153
of O 0 0.012808342464268208
emerin O 1 0.9999791383743286
from O 0 0.018344711512327194
intercalated O 1 0.9999932050704956
discs O 1 0.624620258808136
. O 0 0.038802389055490494

Although O 0 0.03247028961777687
emerin O 1 0.791222870349884
was O 0 0.016662554815411568
abundant O 0 0.012845425866544247
in O 0 0.005310462322086096
the O 0 0.007343226112425327
membranes O 0 0.01909157633781433
of O 0 0.011725527234375477
cardiomyocyte O 1 1.0
nuclei O 0 0.027006778866052628
, O 0 0.005610722582787275
it O 0 0.003589844796806574
was O 0 0.006793084088712931
absent O 0 0.008120621554553509
from O 0 0.003360587637871504
many O 0 0.0033763491082936525
non O 0 0.01785099320113659
- O 1 1.0
myocyte O 1 1.0
cells O 0 0.013271089643239975
in O 0 0.00891893357038498
the O 0 0.014919300563633442
heart O 1 0.9999949932098389
. O 0 0.027647584676742554

This O 0 0.010139384306967258
distribution O 0 0.010632573626935482
of O 0 0.009812355041503906
emerin O 1 0.9996435642242432
was O 0 0.009380188770592213
similar O 0 0.004675636067986488
to O 0 0.0038921888917684555
that O 0 0.002962389262393117
of O 0 0.007552324328571558
lamin O 1 0.9999768733978271
A O 0 0.014401105232536793
, O 0 0.005682839546352625
a O 0 0.006167369429022074
candidate O 0 0.009347112849354744
gene O 0 0.005803623702377081
for O 0 0.0035953375045210123
an O 0 0.006211900617927313
autosomal O 1 0.865474283695221
form O 0 0.010269924998283386
of O 0 0.3312387764453888
EDMD B-Disease 1 1.0
. O 0 0.03695648908615112

In O 0 0.020852888002991676
contrast O 0 0.022508792579174042
, O 0 0.017477471381425858
lamin O 1 0.9999996423721313
B1 O 1 1.0
was O 0 0.2621835768222809
absent O 0 0.024861672893166542
from O 0 0.01050970982760191
cardiomyocyte O 1 0.9993177652359009
nuclei O 0 0.023669254034757614
, O 0 0.009217044338583946
showing O 0 0.011475518345832825
that O 0 0.009104331955313683
lamin O 1 0.9999998807907104
B1 O 1 1.0
is O 0 0.007757694460451603
not O 0 0.004278446547687054
essential O 0 0.007616988383233547
for O 0 0.005953664891421795
localization O 0 0.022362608462572098
of O 0 0.010347138158977032
emerin O 1 0.9894621968269348
to O 0 0.01011327002197504
the O 0 0.014189484529197216
nuclear O 0 0.04059215262532234
lamina O 1 0.999993085861206
. O 0 0.03635404631495476

Lamin O 1 0.9999997615814209
B1 O 1 1.0
is O 0 0.013512379489839077
also O 0 0.0077733551152050495
almost O 0 0.007638066075742245
completely O 0 0.012178703211247921
absent O 0 0.024043064564466476
from O 0 0.017968321219086647
skeletal O 1 1.0
muscle O 1 1.0
nuclei O 1 0.8860920071601868
. O 0 0.037436407059431076

In O 0 0.029994787648320198
EDMD B-Disease 1 0.9999997615814209
, O 0 0.010520856827497482
the O 0 0.0069849928840994835
additional O 0 0.007724546827375889
absence O 0 0.011286381632089615
of O 0 0.01079301442950964
lamin O 1 1.0
B1 O 1 1.0
from O 0 0.021196866407990456
heart O 1 1.0
and O 1 0.9894576668739319
skeletal O 1 1.0
muscle O 1 1.0
nuclei O 1 0.7557002902030945
which O 0 0.00607994245365262
already O 0 0.009611113928258419
lack O 0 0.012144721113145351
emerin O 1 0.9999457597732544
may O 0 0.006358971819281578
offer O 0 0.00699874572455883
an O 0 0.004619353450834751
alternative O 0 0.006684113293886185
explanation O 0 0.007061471231281757
of O 0 0.006140806712210178
why O 0 0.007073223125189543
these O 0 0.0041773319244384766
tissues O 0 0.03030894324183464
are O 0 0.0038316550198942423
particularly O 0 0.00920508150011301
affected O 0 0.01416527945548296
. O 0 0.010760690085589886
. O 0 0.018328573554754257

Genetic O 0 0.03812488913536072
mapping O 0 0.025970743969082832
of O 0 0.012698066420853138
the O 0 0.016637243330478668
copper B-Disease 1 0.9999897480010986
toxicosis I-Disease 1 1.0
locus O 1 0.9988032579421997
in O 0 0.015820365399122238
Bedlington O 1 0.9999552965164185
terriers O 0 0.050487689673900604
to O 0 0.010204915888607502
dog O 0 0.024471594020724297
chromosome O 0 0.015414373017847538
10 O 0 0.00733390636742115
, O 0 0.004495258908718824
in O 0 0.004445057362318039
a O 0 0.007280174642801285
region O 0 0.01086258515715599
syntenic O 1 0.5608842372894287
to O 0 0.006870831362903118
human O 0 0.00873193982988596
chromosome O 0 0.023006370291113853
region O 0 0.02421266958117485
2p13 O 1 0.9999997615814209
- O 1 0.9999998807907104
p16 O 1 0.9991818070411682
. O 0 0.0361379012465477

Abnormal O 1 0.9999959468841553
hepatic B-Disease 1 1.0
copper I-Disease 1 1.0
accumulation I-Disease 1 0.9979977011680603
is O 0 0.0064313472248613834
recognized O 0 0.006563845090568066
as O 0 0.004007488489151001
an O 0 0.008418962359428406
inherited B-Disease 1 1.0
disorder I-Disease 1 1.0
in O 1 0.9981332421302795
man O 1 0.9999431371688843
, O 0 0.10755319148302078
mouse O 1 0.9992750287055969
, O 0 0.013615326955914497
rat O 1 0.9999446868896484
and O 0 0.01621226780116558
dog O 0 0.06362135708332062
. O 0 0.027493229135870934

The O 0 0.017355086281895638
major O 0 0.016581928357481956
cause O 0 0.14027264714241028
of O 1 0.9249849319458008
hepatic B-Disease 1 1.0
copper I-Disease 1 1.0
accumulation I-Disease 1 0.9999991655349731
in O 0 0.010018374770879745
man O 0 0.01249206904321909
is O 0 0.005648958962410688
a O 0 0.008607055991888046
dysfunctional O 1 0.9487283825874329
ATP7B O 1 0.9999998807907104
gene O 0 0.012550290673971176
, O 0 0.008376823738217354
causing O 1 0.9723653197288513
Wilson B-Disease 1 1.0
disease I-Disease 1 1.0
( O 1 0.9999567270278931
WD B-Disease 1 1.0
) O 0 0.0291149839758873
. O 0 0.0271039716899395

Mutations O 0 0.02663210965692997
in O 0 0.008238439448177814
the O 0 0.01118537038564682
ATP7B O 1 0.9999996423721313
genes O 0 0.008434545248746872
have O 0 0.003016381524503231
also O 0 0.003569133346900344
been O 0 0.003466762835159898
demonstrated O 0 0.008464368060231209
in O 0 0.007421168033033609
mouse O 0 0.49806278944015503
and O 0 0.015389484353363514
rat O 1 0.9993473887443542
. O 0 0.028803175315260887

The O 0 0.037151310592889786
ATP7B O 1 0.999998927116394
gene O 0 0.014173937030136585
has O 0 0.007091578561812639
been O 0 0.004522545728832483
excluded O 0 0.006861519068479538
in O 0 0.0030741768423467875
the O 0 0.003708602162078023
much O 0 0.005580333061516285
rarer O 1 0.7092450857162476
human O 0 0.009119680151343346
copper B-Disease 1 1.0
overload I-Disease 1 1.0
disease O 1 1.0
non B-Disease 1 0.9999829530715942
- I-Disease 1 1.0
Indian I-Disease 1 0.9573444128036499
childhood I-Disease 1 1.0
cirrhosis I-Disease 1 1.0
, O 0 0.020469089969992638
indicating O 0 0.027185039594769478
genetic O 0 0.028752917423844337
heterogeneity O 1 0.7240649461746216
. O 0 0.03451719880104065

By O 0 0.011577541939914227
investigating O 0 0.014938164502382278
the O 0 0.008914164267480373
common O 0 0.011690882965922356
autosomal O 1 0.9999980926513672
recessive O 1 1.0
copper B-Disease 1 1.0
toxicosis I-Disease 1 1.0
( O 1 0.9996845722198486
CT B-Disease 1 1.0
) O 0 0.011800035834312439
in O 0 0.013106194324791431
Bedlington O 1 0.9999909400939941
terriers O 1 0.9902800917625427
, O 0 0.007009963039308786
we O 0 0.003709641518071294
have O 0 0.0024732486344873905
identified O 0 0.003682023147121072
a O 0 0.0037578835617750883
new O 0 0.006540435831993818
locus O 0 0.10122736543416977
involved O 0 0.006227814592421055
in O 0 0.030943943187594414
progressive O 1 1.0
liver B-Disease 1 1.0
disease I-Disease 1 1.0
. O 1 0.9996521472930908

We O 0 0.013781578280031681
examined O 0 0.019107576459646225
whether O 0 0.007380761671811342
the O 0 0.012242255732417107
WD B-Disease 1 1.0
gene O 0 0.032896462827920914
ATP7B O 1 0.9999996423721313
was O 0 0.018705012276768684
also O 0 0.009658628143370152
causative O 0 0.028897186741232872
for O 0 0.009313240647315979
CT B-Disease 1 0.9999345541000366
by O 0 0.0047410763800144196
investigating O 0 0.007490943651646376
the O 0 0.00796093326061964
chromosomal O 1 0.9218286275863647
co O 1 0.9999871253967285
- O 1 0.9999998807907104
localization O 0 0.16405914723873138
of O 0 0.014659976586699486
ATP7B O 1 0.9999996423721313
and O 0 0.013130882754921913
C04107 O 1 0.9136680364608765
, O 0 0.007827729918062687
using O 0 0.005815270822495222
fluorescence O 0 0.017559180036187172
in O 0 0.010697683319449425
situ O 0 0.4819069504737854
hybridization O 0 0.029043707996606827
( O 0 0.01605858840048313
FISH O 0 0.028497716411948204
) O 0 0.019187135621905327
. O 0 0.024638228118419647

C04107 O 1 0.8981324434280396
is O 0 0.01192359160631895
an O 0 0.010403718799352646
anonymous O 0 0.023592252284288406
microsatellite O 1 0.9817270040512085
marker O 0 0.043068982660770416
closely O 0 0.01514170877635479
linked O 0 0.024223897606134415
to O 0 0.02018333226442337
CT B-Disease 1 0.9999995231628418
. O 0 0.040098223835229874

However O 0 0.023652750998735428
, O 0 0.02482566609978676
BAC O 1 0.9999822378158569
clones O 0 0.20782756805419922
containing O 0 0.02671894058585167
ATP7B O 1 0.9999721050262451
and O 0 0.013119634240865707
C04107 O 0 0.18648763000965118
mapped O 0 0.0207839235663414
to O 0 0.007199733052402735
the O 0 0.009683157317340374
canine O 1 0.9998414516448975
chromosome O 0 0.01860513724386692
regions O 0 0.010612742975354195
CFA22q11 O 1 0.9999908208847046
and O 0 0.010152287781238556
CFA10q26 O 1 0.9999988079071045
, O 0 0.007078530266880989
respectively O 0 0.007848912850022316
, O 0 0.006034137215465307
demonstrating O 0 0.01113647036254406
that O 0 0.007034297566860914
WD B-Disease 1 1.0
cannot O 0 0.009025335311889648
be O 0 0.006959796883165836
homologous O 0 0.020935608074069023
to O 0 0.01653352566063404
CT B-Disease 1 0.9999967813491821
. O 0 0.03545843064785004

The O 0 0.030253689736127853
copper O 1 0.6284456253051758
transport O 0 0.03035680390894413
genes O 0 0.019646625965833664
CTR1 O 1 0.9999978542327881
and O 0 0.013945136219263077
CTR2 O 1 0.9999964237213135
were O 0 0.00709224957972765
also O 0 0.00632488913834095
excluded O 0 0.009675917215645313
as O 0 0.0047215986996889114
candidate O 0 0.009905708022415638
genes O 0 0.007527187000960112
for O 0 0.007087533362209797
CT B-Disease 1 1.0
since O 0 0.007796211633831263
they O 0 0.003473480697721243
both O 0 0.004503939766436815
mapped O 0 0.016673699021339417
to O 0 0.010734731331467628
canine O 1 0.9998856782913208
chromosome O 0 0.0599132664501667
region O 0 0.03765101358294487
CFA11q22 O 1 0.9999642372131348
. O 0 0.036363232880830765

2 O 0 0.06645654141902924
- O 1 0.9994352459907532
22 O 0 0.0488201305270195
. O 0 0.03331562876701355

5 O 0 0.08018422871828079
. O 0 0.04809284955263138

A O 0 0.03487847000360489
transcribed O 0 0.028335753828287125
sequence O 0 0.009523767046630383
identified O 0 0.007656902074813843
from O 0 0.004696069285273552
the O 0 0.007841845974326134
C04107 O 1 0.9924272894859314
- O 1 0.9999867677688599
containing O 0 0.028263425454497337
BAC O 1 0.9999998807907104
was O 0 0.01026628166437149
found O 0 0.003811914473772049
to O 0 0.0031712595373392105
be O 0 0.0028445797506719828
homologous O 0 0.007830793969333172
to O 0 0.003789458889514208
a O 0 0.006349797826260328
gene O 0 0.006248979829251766
expressed O 0 0.00457020103931427
from O 0 0.0038912021555006504
human O 0 0.0063391802832484245
chromosome O 0 0.022040991112589836
2p13 O 1 0.9999997615814209
- O 1 1.0
p16 O 1 0.9995119571685791
, O 0 0.009204463101923466
a O 0 0.009385949932038784
region O 0 0.011533399112522602
devoid O 0 0.019264087080955505
of O 0 0.006887856870889664
any O 0 0.0072634341195225716
positional O 0 0.09664048254489899
candidate O 0 0.028756033629179
genes O 0 0.02089221403002739
. O 0 0.020962273702025414

Molecular O 0 0.03311924636363983
analysis O 0 0.010338987223803997
of O 0 0.00870455987751484
the O 0 0.013266032561659813
APC B-Disease 1 0.9999979734420776
gene O 0 0.012574002146720886
in O 0 0.006814566440880299
205 O 0 0.02753659524023533
families O 0 0.00716337189078331
: O 0 0.008858735673129559
extended O 0 0.016054287552833557
genotype O 1 0.6305899620056152
- O 1 0.9999827146530151
phenotype O 0 0.18992555141448975
correlations O 0 0.02806660160422325
in O 0 0.014142989180982113
FAP B-Disease 1 1.0
and O 0 0.008779258467257023
evidence O 0 0.005639274138957262
for O 0 0.004240058828145266
the O 0 0.005811724346131086
role O 0 0.00858116801828146
of O 0 0.00956149771809578
APC B-Disease 1 0.9999996423721313
amino O 0 0.016064872965216637
acid O 0 0.015715816989541054
changes O 0 0.009472426027059555
in O 0 0.4277957081794739
colorectal B-Disease 1 1.0
cancer I-Disease 1 1.0
predisposition O 1 1.0
. O 1 0.5693838596343994

BACKGROUND O 0 0.05687771365046501
/ O 1 0.6187239289283752
AIMS O 0 0.02952181175351143
The O 0 0.009176136925816536
development O 0 0.010328990407288074
of O 1 0.9980512857437134
colorectal B-Disease 1 1.0
cancer I-Disease 1 1.0
and O 1 0.8352741599082947
a O 0 0.008608992211520672
variable O 0 0.010039995424449444
range O 0 0.008416351862251759
of O 0 0.008017584681510925
extracolonic O 1 0.9801150560379028
manifestations O 0 0.35291215777397156
in O 0 0.01579280011355877
familial B-Disease 1 1.0
adenomatous I-Disease 1 1.0
polyposis I-Disease 1 1.0
( O 1 0.9999998807907104
FAP B-Disease 1 1.0
) O 0 0.012304413132369518
is O 0 0.005755987484008074
the O 0 0.004989735782146454
result O 0 0.0033446261659264565
of O 0 0.003707305761054158
the O 0 0.00599453691393137
dominant O 0 0.01609218679368496
inheritance O 0 0.028402196243405342
of O 1 0.7465735673904419
adenomatous B-Disease 1 1.0
polyposis I-Disease 1 1.0
coli I-Disease 1 1.0
( O 1 0.9999725818634033
APC B-Disease 1 1.0
) O 0 0.024272257462143898
gene O 0 0.02907111868262291
mutations O 0 0.028252819553017616
. O 0 0.024623943492770195

In O 0 0.013641633093357086
this O 0 0.005555219482630491
study O 0 0.006518147420138121
, O 0 0.004629972856491804
direct O 0 0.0053230454213917255
mutation O 0 0.006287604570388794
analysis O 0 0.003740916261449456
of O 0 0.004241049289703369
the O 0 0.008416551165282726
APC B-Disease 1 1.0
gene O 0 0.010054009966552258
was O 0 0.00849815085530281
performed O 0 0.006705355830490589
to O 0 0.005212032236158848
determine O 0 0.009260769002139568
genotype O 0 0.22517874836921692
- O 1 0.9999793767929077
phenotype O 0 0.030924810096621513
correlations O 0 0.01303638145327568
for O 0 0.006077585741877556
nine O 0 0.01217625942081213
extracolonic O 1 0.9999388456344604
manifestations O 1 0.880211353302002
and O 0 0.006307621486485004
to O 0 0.005239495076239109
investigate O 0 0.009798536077141762
the O 0 0.006870005279779434
incidence O 1 0.9630969166755676
of O 0 0.011210089549422264
APC B-Disease 1 1.0
mutations O 0 0.011459475383162498
in O 0 0.007038000039756298
non O 1 0.9991700649261475
- O 1 1.0
FAP O 1 1.0
colorectal B-Disease 1 1.0
cancer I-Disease 1 1.0
. O 1 0.8699894547462463

METHODS O 0 0.037234675139188766
The O 0 0.025716381147503853
APC B-Disease 1 0.9999885559082031
gene O 0 0.019441945478320122
was O 0 0.016142388805747032
analysed O 0 0.022596655413508415
in O 0 0.010038522072136402
190 O 0 0.031133102253079414
unrelated O 0 0.024425601586699486
FAP B-Disease 1 0.9999997615814209
and O 0 0.008423230610787868
15 O 0 0.013617227785289288
non O 1 0.5492668747901917
- O 1 1.0
FAP O 1 1.0
colorectal B-Disease 1 1.0
cancer I-Disease 1 1.0
patients O 1 1.0
using O 0 0.017979521304368973
denaturing O 1 0.9999969005584717
gradient O 1 0.9924980998039246
gel O 1 0.9999874830245972
electrophoresis O 0 0.12178576737642288
, O 0 0.009060707874596119
the O 0 0.008850625716149807
protein O 0 0.015608354471623898
truncation O 0 0.05434798076748848
test O 0 0.017688006162643433
, O 0 0.009664062410593033
and O 0 0.008930835872888565
direct O 0 0.01389318984001875
sequencing O 0 0.030131449922919273
. O 0 0.023137183859944344

RESULTS O 0 0.05100635439157486
Chain O 0 0.10940591990947723
terminating O 0 0.0297363493591547
signals O 0 0.010681313462555408
were O 0 0.003412568010389805
only O 0 0.002797031542286277
identified O 0 0.0045424532145261765
in O 0 0.004630988463759422
patients O 0 0.019196022301912308
belonging O 0 0.006700275931507349
to O 0 0.0044626351445913315
the O 0 0.008742867037653923
FAP B-Disease 1 1.0
group O 0 0.04779718443751335
( O 0 0.011714672669768333
105 O 1 0.946325421333313
patients O 1 0.9999786615371704
) O 0 0.01589212566614151
. O 0 0.019964076578617096

Amino O 0 0.05123315006494522
acid O 0 0.02537849172949791
changes O 0 0.005894929636269808
were O 0 0.003370017511770129
identified O 0 0.004518537782132626
in O 0 0.0038053435273468494
four O 0 0.006004363764077425
patients O 1 0.8193818926811218
, O 0 0.00386869627982378
three O 0 0.0032386681996285915
of O 0 0.004318451043218374
whom O 0 0.00680356053635478
belonged O 0 0.009166811592876911
to O 0 0.0031690713949501514
the O 0 0.005401138681918383
non O 0 0.01991632580757141
- O 1 0.9999997615814209
FAP O 1 1.0
group O 0 0.024744568392634392
of O 1 0.9998379945755005
colorectal B-Disease 1 1.0
cancer I-Disease 1 1.0
patients O 1 1.0
. O 1 0.9047653675079346

Genotype O 1 0.9997672438621521
- O 1 0.9999984502792358
phenotype O 1 0.6295700073242188
correlations O 0 0.02544623799622059
identified O 0 0.008681590668857098
significant O 0 0.0060399859212338924
differences O 0 0.004943261854350567
in O 0 0.0036937547847628593
the O 0 0.004509313497692347
nature O 0 0.004519290290772915
of O 0 0.004970393609255552
certain O 0 0.006250410340726376
extracolonic O 1 0.9999897480010986
manifestations O 1 0.9998096823692322
in O 0 0.4522332549095154
FAP B-Disease 1 1.0
patients O 1 0.9999806880950928
belonging O 0 0.01816922426223755
to O 0 0.010558675043284893
three O 0 0.013072126545011997
mutation O 0 0.026514818891882896
subgroups O 0 0.04189591854810715
. O 0 0.026452159509062767

CONCLUSIONS O 0 0.034962691366672516
Extended O 0 0.03351534903049469
genotype O 1 0.7982124090194702
- O 1 0.9999959468841553
phenotype O 1 0.7383961081504822
correlations O 0 0.01609834097325802
made O 0 0.006406664848327637
in O 0 0.004098375793546438
this O 0 0.0032843390945345163
study O 0 0.004624741617590189
may O 0 0.0032345715444535017
have O 0 0.0020394311286509037
the O 0 0.003562350058928132
potential O 0 0.004916670266538858
to O 0 0.003687659977003932
determine O 0 0.004141123965382576
the O 0 0.003206060966476798
most O 0 0.0029918814543634653
appropriate O 0 0.004748619627207518
surveillance O 0 0.01118977926671505
and O 0 0.008204367011785507
prophylactic O 1 0.9999997615814209
treatment O 1 0.9999996423721313
regimens O 1 0.9999996423721313
for O 0 0.0060772825963795185
those O 0 0.0045637935400009155
patients O 1 0.9749097228050232
with O 0 0.005792032927274704
mutations O 0 0.008175620809197426
associated O 0 0.0055633229203522205
with O 0 0.005843950901180506
life O 0 0.20489256083965302
threatening O 1 0.9997604489326477
conditions O 0 0.2579888701438904
. O 0 0.0240160059183836

This O 0 0.010422664694488049
study O 0 0.010099568404257298
also O 0 0.0055770366452634335
provided O 0 0.005092690698802471
evidence O 0 0.0034835943952202797
for O 0 0.003078827867284417
the O 0 0.005269915796816349
pathological O 1 0.5095058679580688
nature O 0 0.0071720280684530735
of O 0 0.008180966600775719
amino O 0 0.011964975856244564
acid O 0 0.012889610603451729
changes O 0 0.005783568602055311
in O 0 0.007931261323392391
APC O 1 0.9999887943267822
associated O 0 0.007515480276197195
with O 0 0.004186676815152168
both O 0 0.0051801009103655815
FAP B-Disease 1 1.0
and O 0 0.007876438088715076
non O 1 0.9997105002403259
- O 1 1.0
FAP O 1 1.0
colorectal B-Disease 1 1.0
cancer I-Disease 1 1.0
patients O 1 1.0
. O 0 0.2283923178911209
. O 0 0.02619883231818676

Inherited B-Disease 1 1.0
colorectal I-Disease 1 1.0
polyposis I-Disease 1 1.0
and O 1 0.9999994039535522
cancer B-Disease 1 1.0
risk O 1 0.999995231628418
of O 1 0.6833226084709167
the O 1 0.9587687253952026
APC O 1 1.0
I1307K O 1 0.9999971389770508
polymorphism O 0 0.0771937370300293
. O 0 0.037564776837825775

Germ O 1 0.9999998807907104
- O 1 0.9999961853027344
line O 0 0.028194833546876907
and O 0 0.011424272321164608
somatic O 0 0.0377570278942585
truncating O 0 0.12576402723789215
mutations O 0 0.012089547701179981
of O 0 0.007890610024333
the O 0 0.01139295008033514
APC B-Disease 1 0.9999998807907104
gene O 0 0.009292805567383766
are O 0 0.0021925880573689938
thought O 0 0.005020702723413706
to O 0 0.005594602320343256
initiate O 1 0.809726893901825
colorectal B-Disease 1 1.0
tumor I-Disease 1 1.0
formation O 0 0.37578049302101135
in O 0 0.0451236218214035
familial B-Disease 1 1.0
adenomatous I-Disease 1 1.0
polyposis I-Disease 1 1.0
syndrome I-Disease 1 1.0
and O 1 1.0
sporadic O 1 1.0
colorectal O 1 1.0
carcinogenesis O 1 1.0
, O 1 0.9989940524101257
respectively O 0 0.03556232899427414
. O 0 0.029255524277687073

Recently O 0 0.03249724954366684
, O 0 0.011530246585607529
an O 0 0.011693119071424007
isoleucine O 1 0.9999963045120239
- O 1 1.0
- O 1 0.9999998807907104
> O 1 0.9979002475738525
lysine O 0 0.04648224636912346
polymorphism O 0 0.029410917311906815
at O 0 0.018849419429898262
codon O 0 0.03607425093650818
1307 O 1 0.9996401071548462
( O 0 0.014533858746290207
I1307K O 0 0.312391072511673
) O 0 0.0065155657939612865
of O 0 0.0075474949553608894
the O 0 0.011434653773903847
APC B-Disease 1 0.9999997615814209
gene O 0 0.009799715131521225
has O 0 0.005098698660731316
been O 0 0.003371833823621273
identified O 0 0.004356084857136011
in O 0 0.003813012270256877
6 O 0 0.00948772020637989
% O 0 0.006789973471313715
- O 1 0.9815911054611206
7 O 0 0.01135820709168911
% O 0 0.005528561770915985
of O 0 0.005850088316947222
the O 0 0.00864765141159296
Ashkenazi O 0 0.1908533275127411
Jewish O 0 0.02394905686378479
population O 0 0.015989629551768303
. O 0 0.026284722611308098

To O 0 0.014270558953285217
assess O 0 0.01814616098999977
the O 0 0.00853464100509882
risk O 0 0.008486149832606316
of O 0 0.004417772404849529
this O 0 0.004171240609139204
common O 0 0.008765434846282005
APC B-Disease 1 0.9999995231628418
allelic O 1 0.9997280240058899
variant O 1 0.9824153780937195
in O 1 0.8677743673324585
colorectal O 1 1.0
carcinogenesis O 1 1.0
, O 0 0.016512401401996613
we O 0 0.005314468406140804
have O 0 0.0034024331253021955
analyzed O 0 0.009051063098013401
a O 0 0.006266768556088209
large O 0 0.008681343868374825
cohort O 0 0.03311069309711456
of O 0 0.011548560112714767
unselected O 1 0.9891924262046814
Ashkenazi O 0 0.30881983041763306
Jewish O 0 0.014827551320195198
subjects O 0 0.015406835824251175
with O 0 0.011201402172446251
adenomatous B-Disease 1 1.0
polyps I-Disease 1 1.0
and O 0 0.00904278177767992
. O 0 0.007947875186800957
or O 1 0.9997599720954895
colorectal B-Disease 1 1.0
cancer I-Disease 1 1.0
, I-Disease 0 0.41502243280410767
for O 0 0.00892733410000801
the O 0 0.021352864801883698
APC O 1 0.9999998807907104
I1307K O 1 0.9999152421951294
polymorphism O 0 0.07982243597507477
. O 0 0.0354994535446167

The O 0 0.04913893714547157
APC O 1 0.9999834299087524
I1307K O 1 0.9991316199302673
allele O 0 0.038973674178123474
was O 0 0.013152612373232841
identified O 0 0.007540747057646513
in O 0 0.005019611679017544
48 O 0 0.010415693745017052
( O 0 0.004849044140428305
10 O 0 0.0057803974486887455
. O 0 0.004371847026050091
1 O 0 0.00975317507982254
% O 0 0.007220420055091381
) O 0 0.007073544431477785
of O 0 0.012089809402823448
476 O 1 0.9999597072601318
patients O 1 0.9997432827949524
. O 0 0.028148319572210312

Compared O 0 0.017339877784252167
with O 0 0.0063296775333583355
the O 0 0.007442030124366283
frequency O 0 0.0062889778055250645
in O 0 0.0035239055287092924
two O 0 0.002473481697961688
separate O 0 0.0032197192776948214
population O 0 0.002874396974220872
control O 0 0.006248005665838718
groups O 0 0.0029288686346262693
, O 0 0.004551146645098925
the O 0 0.009106784127652645
APC O 1 1.0
I1307K O 1 0.9999997615814209
allele O 0 0.03281299024820328
is O 0 0.00587740633636713
associated O 0 0.004551388788968325
with O 0 0.0026730697136372328
an O 0 0.003732319688424468
estimated O 0 0.006133181042969227
relative O 0 0.00846118200570345
risk O 0 0.01137066725641489
of O 0 0.008658286184072495
1 O 0 0.02504558488726616
. O 0 0.025559820234775543

5 O 0 0.05670024827122688
- O 1 0.9994763731956482
1 O 0 0.05057401955127716
. O 0 0.03447311371564865

7 O 0 0.030657056719064713
for O 0 0.021947111934423447
colorectal B-Disease 1 1.0
neoplasia I-Disease 1 1.0
( O 0 0.012382914312183857
both O 0 0.010009809397161007
P O 1 0.9999922513961792
= O 0 0.26853904128074646
. O 0 0.014825469814240932
01 O 1 0.9999995231628418
) O 0 0.01958686113357544
. O 0 0.021456334739923477

Furthermore O 0 0.03209225833415985
, O 0 0.011362539604306221
compared O 0 0.010344669222831726
with O 0 0.008671517483890057
noncarriers O 1 0.9995428323745728
, O 0 0.014893590472638607
APC O 1 0.9999997615814209
I1307K O 1 0.9999960660934448
carriers O 0 0.0829317569732666
had O 0 0.006210929248481989
increased O 0 0.005304576363414526
numbers O 0 0.003991730511188507
of O 0 0.006929532624781132
adenomas B-Disease 1 0.9999997615814209
and O 1 0.9812743067741394
colorectal B-Disease 1 1.0
cancers I-Disease 1 1.0
per O 0 0.01535672228783369
patient O 1 0.9999754428863525
( O 0 0.01221728976815939
P O 1 0.9999809265136719
= O 0 0.03301548212766647
. O 0 0.00890071876347065
03 O 1 0.9999914169311523
) O 0 0.007040865253657103
, O 0 0.004744006786495447
as O 0 0.00348827731795609
well O 0 0.0032787262462079525
as O 0 0.003530345857143402
a O 0 0.006481584627181292
younger O 0 0.014124850742518902
age O 0 0.013186759315431118
at O 0 0.1430203765630722
diagnosis O 1 0.9999991655349731
. O 0 0.02473357506096363

We O 0 0.01649346575140953
conclude O 0 0.019550176337361336
that O 0 0.005988533142954111
the O 0 0.01142846792936325
APC O 1 0.9999786615371704
I1307K O 1 0.9993425011634827
variant O 0 0.0288517065346241
leads O 0 0.012498589232563972
to O 0 0.008484167978167534
increased O 0 0.02066284790635109
adenoma B-Disease 1 1.0
formation O 1 0.6263186931610107
and O 0 0.006280699744820595
directly O 0 0.007374071516096592
contributes O 0 0.009514986537396908
to O 0 0.00505248736590147
3 O 0 0.008978926576673985
% O 0 0.007949658669531345
- O 0 0.47998061776161194
4 O 0 0.00939903873950243
% O 0 0.004320956766605377
of O 0 0.004064657725393772
all O 0 0.006145487539470196
Ashkenazi O 1 0.9994739890098572
Jewish O 1 0.999775230884552
colorectal B-Disease 1 1.0
cancer I-Disease 1 1.0
. O 1 0.9194932579994202

The O 0 0.0197468064725399
estimated O 0 0.014887413941323757
relative O 0 0.012995836324989796
risk O 0 0.012101228348910809
for O 0 0.005692202597856522
carriers O 0 0.061501167714595795
may O 0 0.006344817113131285
justify O 0 0.01087209302932024
specific O 0 0.006105890031903982
clinical O 1 0.9437395930290222
screening O 0 0.011155042797327042
for O 0 0.004679564852267504
the O 0 0.006920960266143084
360 O 0 0.02164911851286888
, O 0 0.006275350693613291
000 O 0 0.014464565552771091
Americans O 0 0.00732179032638669
expected O 0 0.005612595472484827
to O 0 0.005952592473477125
harbor O 0 0.01577860675752163
this O 0 0.0048738704062998295
allele O 0 0.0135063286870718
, O 0 0.004977615550160408
and O 0 0.004461254458874464
genetic O 0 0.006908904295414686
testing O 0 0.0063269068486988544
in O 0 0.003344928380101919
the O 0 0.0038231578655540943
setting O 0 0.005073851440101862
of O 0 0.004270897712558508
long O 0 0.007678780239075422
- O 1 0.9999721050262451
term O 0 0.013505503535270691
- O 1 0.9996949434280396
outcome O 0 0.008024631068110466
studies O 0 0.00478831771761179
may O 0 0.0036025193985551596
impact O 0 0.005579977761954069
significantly O 0 0.007725398987531662
on O 0 0.016188982874155045
colorectal B-Disease 1 1.0
cancer I-Disease 1 1.0
prevention O 1 1.0
in O 0 0.0854114517569542
this O 0 0.007656825706362724
population O 0 0.009744814597070217
. O 0 0.01790503039956093

Localization O 0 0.05539979040622711
of O 0 0.014871911145746708
human O 0 0.012656407430768013
BRCA1 O 1 0.9999122619628906
and O 0 0.005247289780527353
its O 0 0.005868965294212103
loss O 0 0.02107032760977745
in O 0 0.005246100015938282
high O 0 0.36527204513549805
- O 1 0.9999996423721313
grade O 0 0.40527933835983276
, O 0 0.00744264991953969
non B-Disease 0 0.09803837537765503
- I-Disease 1 1.0
inherited I-Disease 1 1.0
breast I-Disease 1 1.0
carcinomas I-Disease 1 1.0
. O 0 0.2416149079799652

Although O 0 0.012714396230876446
the O 0 0.007803400978446007
link O 0 0.009676575660705566
between O 0 0.005403175950050354
the O 0 0.009696989320218563
BRCA1 O 1 1.0
tumour B-Disease 1 1.0
- O 1 1.0
suppressor O 1 0.9999967813491821
gene O 0 0.008394592441618443
and O 0 0.00604469096288085
hereditary B-Disease 1 1.0
breast I-Disease 1 1.0
and I-Disease 1 1.0
ovarian I-Disease 1 1.0
cancer I-Disease 1 1.0
is O 1 0.9969298243522644
established O 0 0.014279933646321297
, O 0 0.004145137500017881
the O 0 0.004425549414008856
role O 0 0.0065028369426727295
, O 0 0.0036175530403852463
if O 0 0.0026147919707000256
any O 0 0.0023709211964160204
, O 0 0.003353029489517212
of O 0 0.005075209774076939
BRCA1 O 1 0.9984033703804016
in O 0 0.006185686681419611
non B-Disease 1 0.9960590600967407
- I-Disease 1 1.0
familial I-Disease 1 1.0
cancers I-Disease 1 1.0
is O 0 0.017562050372362137
unclear O 0 0.02259380742907524
. O 0 0.0251464881002903

BRCA1 O 1 0.9999964237213135
mutations O 0 0.019359832629561424
are O 0 0.0035201802384108305
rare O 0 0.007417004089802504
in O 0 0.0066507551819086075
sporadic B-Disease 1 0.9485428929328918
cancers I-Disease 1 1.0
, O 0 0.0048822262324392796
but O 0 0.003672701073810458
loss O 0 0.18508948385715485
of O 0 0.012846634723246098
BRCA1 O 1 0.9999996423721313
resulting O 0 0.009049199521541595
from O 0 0.006547568831592798
reduced O 0 0.010647752322256565
expression O 0 0.008467393927276134
or O 0 0.0067363763228058815
incorrect O 0 0.016004353761672974
subcellular O 0 0.03839883953332901
localization O 0 0.026648040860891342
is O 0 0.007355005480349064
postulated O 0 0.015100558288395405
to O 0 0.0049474951811134815
be O 0 0.0027292114682495594
important O 0 0.003222490195184946
in O 0 0.004297606181353331
non B-Disease 0 0.016286905854940414
- I-Disease 1 1.0
familial I-Disease 1 1.0
breast I-Disease 1 1.0
and I-Disease 1 1.0
ovarian I-Disease 1 1.0
cancers I-Disease 1 1.0
. O 1 0.9714435935020447

Epigenetic O 1 0.8183643817901611
loss O 1 0.8949662446975708
, O 0 0.009357769042253494
however O 0 0.005360557232052088
, O 0 0.004081177990883589
has O 0 0.003700824687257409
not O 0 0.0024060590658336878
received O 0 0.005554982926696539
general O 0 0.008631283417344093
acceptance O 0 0.015216090716421604
due O 0 0.00596300745382905
to O 0 0.005412136670202017
controversy O 0 0.011602654121816158
regarding O 0 0.007870784029364586
the O 0 0.009050305932760239
subcellular O 0 0.034407131373882294
localization O 0 0.025641441345214844
of O 0 0.0126060014590621
BRCA1 O 1 0.9999610185623169
proteins O 0 0.009268276393413544
, O 0 0.00433293217793107
reports O 0 0.0038691593799740076
of O 0 0.0032344809733331203
which O 0 0.0026162697467952967
have O 0 0.0022708531469106674
ranged O 0 0.007559333462268114
from O 0 0.0035614222288131714
exclusively O 0 0.00713367061689496
nuclear O 0 0.009278842248022556
, O 0 0.004833054728806019
to O 0 0.004920070059597492
conditionally O 0 0.02295772358775139
nuclear O 0 0.010833390057086945
, O 0 0.005173858720809221
to O 0 0.005239415448158979
the O 0 0.01037635002285242
ER O 1 1.0
/ O 1 0.9999997615814209
golgi O 1 0.9999163150787354
, O 0 0.011815938167273998
to O 0 0.012659935280680656
cytoplasmic O 0 0.04146682098507881
invaginations O 1 0.7591728568077087
into O 0 0.017851922661066055
the O 0 0.02127593755722046
nucleus O 0 0.05312054231762886
. O 0 0.027686472982168198

In O 0 0.011834921315312386
an O 0 0.005876826588064432
attempt O 0 0.01009292621165514
to O 0 0.0052677639760077
resolve O 0 0.01018178928643465
this O 0 0.0034659095108509064
issue O 0 0.007271412294358015
, O 0 0.00461993645876646
we O 0 0.0031090276315808296
have O 0 0.003049589926376939
comprehensively O 0 0.03170047700405121
characterized O 0 0.01270933449268341
19 O 0 0.021124931052327156
anti O 1 0.9999921321868896
- O 1 1.0
BRCA1 O 1 1.0
antibodies O 1 0.9778695702552795
. O 0 0.03118131123483181

These O 0 0.018184524029493332
reagents O 0 0.05959063023328781
detect O 0 0.026621539145708084
a O 0 0.014592858962714672
220 O 0 0.04797542095184326
- O 1 0.9999988079071045
kD O 1 0.9999959468841553
protein O 0 0.025079771876335144
localized O 0 0.024207046255469322
in O 0 0.0100250830873847
discrete O 0 0.020127704367041588
nuclear O 0 0.020280126482248306
foci O 0 0.03919657692313194
in O 0 0.007901753298938274
all O 0 0.009182415902614594
epithelial O 1 0.9999957084655762
cell O 1 0.8490152955055237
lines O 0 0.010384618304669857
, O 0 0.00532094482332468
including O 0 0.004522775299847126
those O 0 0.0042595467530190945
derived O 0 0.007994062267243862
from O 0 0.014079476706683636
breast B-Disease 1 1.0
malignancies I-Disease 1 1.0
. O 0 0.046881843358278275

Immunohistochemical O 1 0.9997636675834656
staining O 0 0.216164693236351
of O 0 0.016259359195828438
human O 0 0.02001485414803028
breast O 1 1.0
specimens O 0 0.029636003077030182
also O 0 0.010127121582627296
revealed O 0 0.02024723030626774
BRCA1 O 1 0.9999517202377319
nuclear O 0 0.01855633221566677
foci O 1 0.9884125590324402
in O 0 0.010980301536619663
benign O 1 1.0
breast O 1 1.0
, O 1 0.9530684351921082
invasive B-Disease 1 1.0
lobular I-Disease 1 1.0
cancers I-Disease 1 1.0
and O 1 0.9507514238357544
low B-Disease 1 0.9999874830245972
- I-Disease 1 1.0
grade I-Disease 1 0.9999998807907104
ductal I-Disease 1 1.0
carcinomas I-Disease 1 1.0
. O 0 0.05374445766210556

Conversely O 0 0.05036638677120209
, O 0 0.017315855249762535
BRCA1 O 1 0.999956488609314
expression O 0 0.009196365252137184
was O 0 0.013955578207969666
reduced O 0 0.013526438735425472
or O 0 0.007143760100007057
undetectable O 1 0.9561908841133118
in O 0 0.004189385566860437
the O 0 0.0041516064666211605
majority O 0 0.004306072369217873
of O 0 0.005270598456263542
high O 0 0.055221326649188995
- O 1 1.0
grade O 1 0.9998137354850769
, O 0 0.01859637163579464
ductal B-Disease 1 1.0
carcinomas I-Disease 1 1.0
, O 0 0.010879017412662506
suggesting O 0 0.007731539197266102
that O 0 0.0029849607963114977
absence O 0 0.007577212061733007
of O 0 0.010101556777954102
BRCA1 O 1 1.0
may O 0 0.005441396031528711
contribute O 0 0.006591413170099258
to O 0 0.004599287174642086
the O 0 0.0071086883544921875
pathogenesis O 1 0.9999985694885254
of O 0 0.005671744700521231
a O 0 0.005305950064212084
significant O 0 0.00479293055832386
percentage O 0 0.007385172415524721
of O 0 0.008493478409945965
sporadic B-Disease 1 0.999496340751648
breast I-Disease 1 1.0
cancers I-Disease 1 1.0
. O 0 0.020407289266586304
. O 0 0.02675308659672737

